0001214659-13-006269.txt : 20131108 0001214659-13-006269.hdr.sgml : 20131108 20131108160218 ACCESSION NUMBER: 0001214659-13-006269 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20130930 FILED AS OF DATE: 20131108 DATE AS OF CHANGE: 20131108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VIRTUAL PIGGY, INC. CENTRAL INDEX KEY: 0001437283 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 352327649 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53944 FILM NUMBER: 131204663 BUSINESS ADDRESS: STREET 1: 1221 HERMOSA AVENUE, SUITE 210 CITY: HERMOSA BEACH STATE: CA ZIP: 90254 BUSINESS PHONE: 310-853-1950 MAIL ADDRESS: STREET 1: 1221 HERMOSA AVENUE, SUITE 210 CITY: HERMOSA BEACH STATE: CA ZIP: 90254 FORMER COMPANY: FORMER CONFORMED NAME: Moggle, Inc. DATE OF NAME CHANGE: 20080610 10-Q 1 a211213010q.htm FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2013 a211213010q.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 10-Q

x  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2013

o  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the transition period from         ______________    to   ______________                
 
Commission file number:          
0-53944
 
 
 VIRTUAL PIGGY, INC.
 
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware
 
35-2327649
(State or Other Jurisdiction of
 
        (IRS Employer
Incorporation or Organization)
 
       Identification No.)
 
1221 Hermosa Avenue, Suite 210
Hermosa Beach, CA  90254
 (Address of principal executive offices) (Zip Code)

(310) 853-1949
(Registrant’s telephone number, including area code)

 
(Former name, former address and former fiscal year, if changed since last report)
 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   YES ý NO ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     YES ý NO ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer
¨
Accelerated filer                     
ý
Non-accelerated filer
¨
Smaller reporting company    
o
(Do not check if a smaller reporting company)
     

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
YES ¨  NO ý

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:  111,396,768 shares of common stock outstanding at November 8, 2013.



 
 

 

 
 
 
 
 
 
 
PART I - FINANCIAL INFORMATION

FINANCIAL STATEMENTS.
 
Virtual Piggy, Inc.
 (A Development Stage Enterprise)

CONTENTS
 
 
 
 
Virtual Piggy, Inc.
(A Development Stage Enterprise)

   
September 30, 2013
   
December 31, 2012
 
   
(Unaudited)
   
(Audited)
 
ASSETS
           
             
CURRENT ASSETS
           
Cash and cash equivalents
  $ 4,583,551     $ 7,371,036  
Accounts Receivable
    955       53  
Insurance receivable
    -       75,000  
Prepaid expenses
    200,771       20,500  
                 
TOTAL CURRENT ASSETS
    4,785,277       7,466,589  
                 
PROPERTY AND EQUIPMENT
               
Computer equipment
    99,156       70,149  
Furniture and fixtures
    53,714       46,130  
      152,870       116,279  
Less:  accumulated depreciation
    (40,054 )     (19,580 )
      112,816       96,699  
                 
OTHER ASSETS
               
Deposit
    63,510       65,000  
Patents and trademarks, net of accumulated amoritization of
               
  $33,295 and $13,678
    604,572       362,496  
      668,082       427,496  
                 
TOTAL ASSETS
  $ 5,566,175     $ 7,990,784  
                 
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
               
                 
CURRENT LIABILITIES
               
Accounts payable and accrued expenses
  $ 1,393,206     $ 704,602  
Litigation settlement
    -       450,000  
                 
TOTAL CURRENT LIABILITIES
    1,393,206       1,154,602  
                 
CONTINGENCIES
               
                 
STOCKHOLDERS' EQUITY
               
                 
Preferred stock, $.0001 par value; 2,000,000 shares authorized;
               
  none issued and outstanding at September 30, 2013 and
               
  December 31, 2012
    -       -  
                 
Common stock, $ .0001 par value; 150,000,000 shares authorized;
               
  111,386,768 and 101,417,508 shares issued and outstanding at
               
   September 30, 2013 and December 31, 2012
    11,140       10,142  
 
               
Common stock subscribed
    -       50,000  
                 
Common stock subscription receivable
    -       (50,000 )
                 
Additional paid in capital
    35,002,330       26,300,114  
                 
Deficit accumulated during the development stage
    (30,840,501 )     (19,474,074 )
                 
STOCKHOLDERS' EQUITY
    4,172,969       6,836,182  
                 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
  $ 5,566,175     $ 7,990,784  
 
See accompanying notes to these financial statements.
 
 
Virtual Piggy, Inc.
 (A Development Stage Enterprise)
For the Three and Nine Months Ended September 30, 2013 and 2012 and
For the period February 11, 2008 (Date of Inception) to September 30, 2013
(Unaudited)
 
   
Three Months
   
Three Months
   
Nine Months
   
Nine Months
       
   
Ended
   
Ended
   
Ended
   
Ended
   
Cumulative
 
   
September 30,
   
September 30,
   
September 30,
   
September 30,
   
Since
 
   
2013
   
2012
   
2013
   
2012
   
Inception
 
                               
SALES
  $ 1,382     $ 8       1,528     $ 1,195     $ 6,667  
                                         
OPERATING EXPENSES
                                       
      Payroll
    1,515,701       886,215       3,912,056       1,740,952       7,072,125  
      Consulting
    1,034,270       242,116       1,931,801       4,422,241       10,235,480  
      Marketing
    1,462,861       143,484       2,037,589       463,109       2,903,912  
      Research and development
    179,476       188,717       612,958       356,096       2,024,710  
      Travel
    274,088       121,344       717,931       365,481       2,158,412  
      Professional fees
    256,296       118,724       652,303       361,036       2,255,260  
      General and administrative
    587,343       320,052       1,512,798       871,823       3,683,571  
    Total operating expenses
    5,310,035       2,020,652       11,377,436       8,580,738       30,333,470  
                                         
OTHER INCOME (EXPENSE)
                                       
     Interest income
    3,167       1,910       9,481       3,448       18,136  
     Interest expense
    -       -       -       (90,560 )     (531,834 )
      3,167       1,910       9,481       (87,112 )     (513,698 )
                                         
NET LOSS
  $ (5,305,486 )   $ (2,018,734 )   $ (11,366,427 )   $ (8,666,655 )   $ (30,840,501 )
                                         
BASIC AND DILUTED NET LOSS PER
                                       
    COMMON SHARE
  $ (0.05 )   $ (0.02 )   $ (0.11 )   $ (0.11 )        
                                         
BASIC AND DILUTED WEIGHTED AVERAGE
                                       
    COMMON SHARES OUTSTANDING
    111,372,435       91,599,649       106,477,739       82,087,967          
 
See accompanying notes to these financial statements.

 
Virtual Piggy, Inc.
(A Development Stage Enterprise)
For the Period February 11, 2008 (Date of Inception) to September 30, 2013
 
                                 
Deficit
       
   
Common
                     
Accumulated
       
   
Stock
         
Common Stock
   
Additional
   
During the
       
   
Number of
         
Common Stock
   
Subscription
   
Paid-In
   
Development
       
   
Shares
   
Amount
   
Subscribed
   
Receivable
   
Capital
   
Stage
   
Total
 
                                           
Issuance of initial 19,000,000 shares of common stock on February 11, 2008 at $.001 per share
    19,000,000     $ 1,900     $ -     $ -     $ 17,100     $ -     $ 19,000  
Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit
    7,142,858       714       -       -       249,286       -       250,000  
Employee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share
    -       -       -       -       8,825       -       8,825  
Nonemployee options issued for services on March 3,2008, vested immediately and valued at $.02 per share
    -       -       -       -       107,859       -       107,859  
Exercise of options on May 8, 2008 at $.04 per share
    500,000       50       -       -       19,950       -       20,000  
Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit
    6,642,858       665       -       -       231,835       -       232,500  
Options issued for services in June 2008, vested immediately and valued at $.07 per share
    -       -       -       -       395,467       -       395,467  
Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share
    -       -       -       -       918       -       918  
Issuance of shares of common stock to investors in August 2008 at $1.00 per share
    2,560       -       -       -       2,560       -       2,560  
Exercise of options in September 2008 at $.04 per share
    1,750,000       175       -       -       69,825       -       70,000  
Exercise of warrants in September 2008 at $.04 per share
    250,000       25       -       -       9,975       -       10,000  
Net loss
    -       -       -       -       -       (983,886 )     (983,886 )
                                                         
Balance, December 31, 2008
    35,288,276       3,529       -       -       1,113,600       (983,886 )     133,243  
                                                         
Exercise of options on January 26, 2009 at $.04 per share
    1,000,000       100       -       -       39,900       -       40,000  
Issuance of shares of common stock on April 7, 2009 at $1.00 per share
    400,000       40       -       -       399,960       -       400,000  
Issuance of shares of common stock on June 29, 2009 at $2.00 per share
    100,000       10       -       -       199,990       -       200,000  
Exercise of options on July 30, 2009 at $.04 per share
    1,000,000       100       -       -       39,900       -       40,000  
Nonemployee options issued for services on August 18, 2009, vested immediately and valued at $.31 per share
    -       -       -       -       10,462       -       10,462  
Exercise of warrants on August 21, 2009 at $.04 per share
    1,000,000       100       -       -       39,900       -       40,000  
Exercise of options on September 2, 2009 at $.04 per share
    500,000       50       -       -       19,950       -       20,000  
Issuance of shares of common stock on September 17, 2009 at $1.00 per share
    100,000       10       -       -       99,990       -       100,000  
Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share
    1,080,427       108       -       -       1,080,319       -       1,080,427  
Issuance of shares of common stock on October 16, 2009 at $1.00 per share
    100,000       10       -       -       99,990       -       100,000  
Exercise of warrants on October 22, 2009 at $.04 per share
    1,000,000       100       -       -       39,900       -       40,000  
Exercise of warrants on December 2, 2009 at $.04 per share
    1,000,000       100       -       -       39,900       -       40,000  
Exercise of options on December 10, 2009 at $.04 per share
    250,000       25       -       -       9,975       -       10,000  
Exercise of warrants on December 31, 2009 at $.04 per share
    1,000,000       100       -       -       39,900       -       40,000  
Stock issuance costs
    -       -       -       -       (65,000 )     -       (65,000 )
Nonemployee options issued for services on March 3,2008, vested immediately and valued at $.02 per share
    -       -       -       -       37,506       -       37,506  
Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share
    -       -       -       -       636       -       636  
Net loss
    -       -       -       -       -       (2,236,476 )     (2,236,476 )
                                                         
Balance, December 31, 2009
    43,818,703       4,382       -       -       3,246,778       (3,220,362 )     30,798  
   
See accompanying notes to these financial statements.
 
 
Virtual Piggy, Inc.
(A Development Stage Enterprise)
For the Period February 11, 2008 (Date of Inception) to September 30, 2013
   
                                 
Deficit
       
   
Common
                     
Accumulated
       
   
Stock
         
Common Stock
   
Additional
   
During the
       
   
Number of
         
Common Stock
   
Subscription
   
Paid-In
   
Development
       
   
Shares
   
Amount
   
Subscribed
   
Receivable
   
Capital
   
Stage
   
Total
 
                                           
Exercise of options on January 5, 2010 at $.04 per share
    1,000,000       100       -       -       39,900       -       40,000  
Exercise of warrant on February 22, 2010 at $.04 per share
    892,858       89       -       -       35,624       -       35,713  
Exercise of warrants in March 2010 at $.04 per share
    1,000,000       100       -       -       39,900       -       40,000  
Exercise of warrants in April 2010 at $.04 per share
    2,500,000       250       -       -       99,750       -       100,000  
Issuance of shares of common stock in conjunction with notes payable in May through August 2010
    483,750       48       -       -       400,694       -       400,742  
Issuance of shares of common stock for retirement of 400,000 options at $.25 per share
    65,000       6       -       -       (6 )     -       -  
Issuance of shares of common stock from August through December 2010 through private placement at $.20 per share
    9,625,000       963       -       -       1,924,037       -       1,925,000  
Issuance of shares of common stock on November 1, 2010 for the conversion of notes payable at $.20 per share
    375,000       38       -       -       74,962       -       75,000  
Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share
    111,111       11       -       -       99,989       -       100,000  
Exercise of options on December 2, 2010 at $.04 per share
    3,000,000       300       -       -       119,700       -       120,000  
Exercise of warrants in December 2010 at $.04 per share
    2,500,000       250       -       -       99,750       -       100,000  
Nonemployee options issued for services from August through November 2010, vested immediately and valued at $.01 per share
    -       -       -       -       13,816       -       13,816  
Nonemployee options issued for services on August 18, 2009, vested immediately and valued at $.31 per share
    -       -       -       -       27,899       -       27,899  
Net loss
    -       -       -       -       -       (1,489,190 )     (1,489,190 )
                                                         
Balance, December 31, 2010
    65,371,422       6,537       -       -       6,222,793       (4,709,552 )     1,519,778  
                                                         
Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share
    100,000       10       -       -       48,990       -       49,000  
Issuance of shares of common stock in conjunction with notes payable from September through December 2011
    150,000       15       -       -       82,650       -       82,665  
Issuance of shares of common stock and 625,000 warrants on December 20, 2011 through private placement at $.80 per unit
    1,250,000       125       -       -       499,875       -       500,000  
Issuance of warrants in conjunction with notes payable from September through December 2011
    -       -       -       -       20,930       -       20,930  
Fair value of revalued warrants at $.09 to $.76 per share
    -       -       -       -       88,601       -       88,601  
Nonemployee options issued for services from August through November 2010, vested immediately and valued at $.01 per share
    -       -       -       -       3,146       -       3,146  
Nonemployee options issued for services on January 24, 2011, and valued at $.20 per share
    -       -       -       -       46,019       -       46,019  
Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share
    -       -       -       -       52,243       -       52,243  
Net loss
    -       -       -       -       -       (2,724,796 )     (2,724,796 )
                                                         
Balance December 31, 2011
    66,871,422       6,687       -       -       7,065,247       (7,434,348 )     (362,414 )
  
See accompanying notes to these financial statements.
 
 
Virtual Piggy, Inc.
(A Development Stage Enterprise)
Statement of Changes in Stockholders’ Equity (Deficit) (Continued)
For the Period February 11, 2008 (Date of Inception) to September 30, 2013
  
                                 
Deficit
       
   
Common
                     
Accumulated
       
   
Stock
         
Common Stock
   
Additional
   
During the
       
   
Number of
         
Common Stock
   
Subscription
   
Paid-In
   
Development
       
   
Shares
   
Amount
   
Subscribed
   
Receivable
   
Capital
   
Stage
   
Total
 
                                           
Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit
    20,426,948       2,044       -       -       7,084,888       -       7,086,932  
Issuance of shares of common stock and 1,500,000 warrants through December 31, 2012 through private placement at $.80 per unit
    2,625,000       262       -       -       1,049,738       -       1,050,000  
Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share
    1,363,185       136       -       -       3,312,401       -       3,312,537  
Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit
    571,428       57       -       -       199,943       -       200,000  
Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share
    350,000       35       -       -       297,465       -       297,500  
Issuance of shares of common stock through December 31, 2012 through private placement at $.70 per share
    7,942,858       794                       5,559,206       -       5,560,000  
Issuance of shares of common stock through December 31, 2012 through private placement at $.75 per share
    666,667       67                       499,933       -       500,000  
Exercise of options on April 10, 2012 at $.04 per share
    250,000       25       -       -       9,975       -       10,000  
Exercise of options on May 25, 2012 at $.04 per share
    350,000       35       -       -       13,965       -       14,000  
Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share
    -       -       -       -       2,219       -       2,219  
Nonemployee options issued for services from January through December 2012, vested immediately and valued from $.11 to $.95 per share
    -       -       -       -       759,292       -       759,292  
Nonemployee options issued for services on January 2012 through December 2012, vesting over three years and valued at $.17 to $.40 per share
    -       -       -       -       39,751       -       39,751  
Employee options issued for services on January 2012 through December 2012, vesting over three years and valued at $.11 to $.53 per share
    -       -       -       -       283,460       -       283,460  
Employee options issued for services from January 2012 through December 2012, vesting immediately and valued at $.14 to $.42 per share
    -       -       -       -       150,631       -       150,631  
Stock issuance costs
    -       -       -       -       (28,000 )     -       (28,000 )
Common stock subscription for 62,500 units through private placement at $.80 per unit
    -       -       50,000       (50,000 )     -       -       -  
Net loss
    -       -       -       -       -       (12,039,726 )     (12,039,726 )
                                                         
Balance December 31, 2012
    101,417,508       10,142       50,000       (50,000 )     26,300,114       (19,474,074 )     6,836,182  
                                                         
Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit
    125,000       13       -       -       49,987       -       50,000  
Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share
    1,133,334       113       -       -       849,887       -       850,000  
Issuance of shares on April 15, 2013 common stock for services
    26,521       3       -       -       49,068       -       49,071  
Issuance of shares of common stock  and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share
    2,872,553       287       -       -       5,170,308       -       5,170,595  
Fair value of revalued options $1.07 per share
    -       -       -       -       780       -       780  
Exercise of options at $0.04 per share in May 2013
    750,000       75       -       -       29,925       -       30,000  
Exercise of options at $0.35 per share on May 14, 2013
    300,000       30       -       -       104,970       -       105,000  
Exercise of options at $0.75 per share in May 2013
    66,667       7                       49,993               50,000  
Exercise of warrants at $0.04 per share on May 26, 2013
    2,000,000       200       -       -       79,800       -       80,000  
Exercise of warrants at $0.50 per share in May through August 2013
    2,695,185       270       -       -       1,347,323       -       1,347,593  
Nonemployee options issued for services from January 2012 through December 2012, vested immediately and valued from $0.11 to $0.95 per share
    -       -       -       -       34,372       -       34,372  
Nonemployee options/warrants issued for services from January 2013 through September 2013, vested immediately to 3 years and valued from $0.09 to $1.66 per share
    -       -       -       -       784,247       -       784,247  
Employee options issued for services on January 2012 through December 2012, vesting over three years and valued at $0.11 to $0.53 per share
    -       -       -       -       340,173       -       340,173  
Employee options issued for services on January 2013 through September 30, 2013, vesting over three years and valued at $0.22 to $0.68 per share
    -       -       -       -       206,604       -       206,604  
Common stock subscription for 62,500 units through private placement at $.80 per unit
    -       -       (50,000 )     50,000       -       -       -  
Stock issuance costs
    -       -       -       -       (395,221 )     -       (395,221 )
Net loss
    -       -       -       -       -       (11,366,427 )     (11,366,427 )
                                                         
Balance September 30, 2013 (Unaudited)
    111,386,768     $ 11,140     $ -     $ -     $ 35,002,330     $ (30,840,501 )   $ 4,172,969  
 
See accompanying notes to these financial statements.


Virtual Piggy, Inc.
 (A Development Stage Enterprise)
For the Nine Months Ended September 30, 2013 and 2012 and
For the period February 11, 2008 (Date of Inception) to September 30, 2013
(Unaudited)
 
   
Nine Months
   
Nine Months
       
   
Ended
   
Ended
   
Cumulative
 
   
September 30,
   
September 30,
   
Since
 
   
2013
   
2012
   
Inception
 
CASH FLOWS FROM OPERATING ACTIVITIES
                 
Net loss
  $ (11,366,427 )   $ (8,666,655 )   $ (30,840,501 )
Adjustments to reconcile net loss to net cash
                       
used in operating activities
                       
  Fair value of warrants issued in exchange for services
    549,915       -       638,516  
  Fair value of options issued in exchange for services
    816,261       478,350       2,756,411  
  Fair value of stock issued in exchange for services
    49,071       3,312,537       4,791,035  
  Amortization of deferred costs
    -       -       78,243  
  Accretion of discount on notes payable
    -       65,560       426,095  
  Depreciation and amortization
    40,091       15,818       73,349  
  Provision for bad debt
    -       -       42,768  
  Loss on disposal of fixed assets
    -       -       2,726  
(Increase) decrease in assets
                       
   Accounts receivable
    (902 )     1,125       (955 )
   Insurance receivable
    75,000       -       -  
   Other receivable
    -       -       (42,768 )
   Prepaid expenses
    (180,271 )     (23,735 )     (200,771 )
Deposits
    1,490       (62,233 )     (63,510 )
Increase (decrease) in liabilities
                       
Accounts payable and accrued expenses
    238,602       346,561       1,715,704  
                         
Net cash used in operating activities
    (9,777,170 )     (4,532,672 )     (20,623,658 )
                         
CASH FLOWS FROM INVESTING ACTIVITIES
                       
     Purchase of equipment
    (36,591 )     (93,975 )     (155,595 )
     Patent and trademark costs
    (261,693 )     (198,388 )     (637,868 )
                         
Net cash used  in investing activities
    (298,284 )     (292,363 )     (793,463 )
                         
CASH FLOWS FROM FINANCING ACTIVITIES
                       
     Proceeds from note payable - stockholders
    -       -       747,500  
     Repayment of note payable - stockholders
    -       (175,000 )     (572,500 )
     Proceeds from notes payable
    -       -       75,000  
     Proceeds from issuance of common stock
    6,070,595       7,936,932       23,796,584  
     Proceeds from exercise of options
    185,000       24,000       569,000  
     Proceeds from exercise of warrants
    1,427,595       -       1,873,309  
     Stock issuance costs
    (395,221 )     (28,000 )     (488,221 )
                         
Net cash provided by financing activities
    7,287,969       7,757,932       26,000,672  
                         
NET INCREASE (DECREASE) IN CASH AND
                       
CASH EQUIVALENTS
    (2,787,485 )     2,932,897       4,583,551  
                         
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD
    7,371,036       186,159       -  
                         
CASH AND CASH EQUIVALENTS - END OF PERIOD
  $ 4,583,551     $ 3,119,056     $ 4,583,551  
                         
                         
SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES:
                       
                         
     Income taxes paid
  $ -     $ -     $ -  
                         
     Interest paid
  $ -     $ -     $ 2,498  
                         
     Fair value of common stock issued as discount for notes payable
  $ -     $ -     $ 483,409  
                         
     Conversion of notes payable and accrued interest into common stock
  $ -     $ 200,000     $ 75,000  
                         
     Fair value of warrants issued as discount for notes payable
  $ -     $ -     $ 20,930  
                         
     Issuance of common stock for settlement of payable
  $ -     $ -     $ 297,500  
 
See accompanying notes to these financial statements.
 
 
NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of the Business
Virtual Piggy, Inc. (“the Company” or “Virtual Piggy”) is a development stage enterprise incorporated in the state of Delaware on February 11, 2008.   Virtual Piggy is a technology company that delivers an online e-commerce solution for the family. Its system allows parents and their children to manage and allocate funds and track the child’s expenditures, savings and charitable giving online. Its system is designed to allow the child to transact online without a credit card by gaining the parent’s permission ahead of time and allowing the parent to set up the rules of use and authorized spending limits.

The Virtual Piggy product enables online businesses to interact and transact with the “Under 18” market in a manner consistent with the Children’s Online Privacy Protection Act (“COPPA”) and other similar international children’s privacy laws.  Virtual Piggy was launched in the US in 2012 and was launched in the European market in 2013.

The Company has secured 143 agreements with merchants, retail and gaming e-commerce platforms and payment processors.  Over 20 of the merchants are using Virtual Piggy live with their e-commerce systems and the Company is in the process of integrating the other signed merchants. The Company is continuing to add merchants. In addition, Virtual Piggy has the capability to offer and deliver digital gift cards.

Basis of Presentation
The financial statements are presented in accordance with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 915 for development stage entities.  
 
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from these estimates.

Comprehensive Income
The Company follows FASB ASC 220 in reporting comprehensive income.  Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.  Since the Company has no items of other comprehensive income (loss), comprehensive income (loss) is equal to net income (loss).

Fair Value of Financial Instruments
The Company’s financial instruments consist of cash, accounts receivable and accounts payable and accrued expenses.  The carrying value of cash, accounts receivable and accounts payable and accrued expenses approximate fair value, because of their short maturity.

Concentration of Credit Risk Involving Cash
The Company may have deposits with a financial institution which at times exceed Federal Depository Insurance coverage of $250,000.  

Cash and Cash Equivalents
For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents.
 

Property and Equipment
Property and equipment are stated at cost less accumulated depreciation and any impairment losses.  Expenditures for new equipment and major expenditures for existing equipment are capitalized and depreciated using the straight line method at rates sufficient to depreciate such costs over the estimated productive lives.  All other ordinary repair and maintenance costs are expensed as incurred.

The Company’s depreciation and amortization policies on property and equipment are as follows:


 
Useful life
 
(in years)
   
Computer equipment
 3 - 5
Furniture and fixtures
 7

Recoverability of Long-Lived Assets
In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 360-10-35 “Impairment or Disposal of Long-lived Assets”, long-lived assets to be held and used are analyzed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable or that the useful lives of those assets are no longer appropriate. The Company evaluates at each balance sheet date whether events and circumstances have occurred that indicate possible impairment.

The Company determines the existence of such impairment by measuring the expected future cash flows (undiscounted and without interest charges) and comparing such amount to the carrying amount of the assets. An impairment loss, if one exists, is then measured as the amount by which the carrying amount of the asset exceeds the discounted estimated future cash flows. Assets to be disposed of are reported at the lower of the carrying amount or fair value of such assets less costs to sell. Asset impairment charges are recorded to reduce the carrying amount of the long-lived asset that will be sold or disposed of to their estimated fair values. Charges for the asset impairment reduce the carrying amount of the long-lived assets to their estimated salvage value in connection with the decision to dispose of such assets.

For the nine month period ended September 30, 2013 and 2012, the Company determined that no impairment was required after going through the impairment testing related to the operating long-lived assets (property and equipment and patents and trademarks).

Revenue Recognition
In accordance with Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin (“SAB”) No. 104, Revenue Recognition (Codified in FASB ASC 605), the Company will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, the Company will generally recognize revenue at the time of the sale utilizing Virtual Piggy payment method at checkout.
 
Income Taxes
The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes.  Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.  Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.  Tax years from 2008 through 2012 remain subject to examination by major tax jurisdictions.
 

Loss Per Share
The Company follows FASB ASC 260 when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.  Because the Company reported a net loss for the three and nine months ended September 30, 2013 and 2012, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and diluted loss per share were the same.

Start-up Costs
In accordance with FASB ASC 720, start-up costs are expensed as incurred.

Research and  Development Costs
In accordance with FASB ASC 730, research and development costs are expensed when incurred.  

Recently Adopted Accounting Pronouncements
As of September 30, 2013 and for the period then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company’s financial statements.

Recently Issued Accounting Pronouncements Not Yet Adopted
As of September 30, 2013, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company’s financial statements.

Reclassifications
Certain amounts in the 2012 financial statements have been reclassified in order for them to be in conformity with the 2013 presentation.

NOTE 2 – GOING CONCERN

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.  The Company has incurred significant losses and experienced negative cash flow from operations during the development stage.  These conditions raise substantial doubt about the Company’s ability to continue as a going concern.  The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Since inception, the Company has focused on developing and implementing its business plan.  The Company is paying salaries to management and has utilized offshore programmers on a work for hire basis to assist in developing the demonstration model. The Company believes that its existing cash resources will not be sufficient to sustain operations during the next twelve months.  The Company currently needs to generate revenue in order to sustain its operations.  In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will need to reduce expenses or obtain financing through the sale of debt and/or equity securities.  The issuance of additional equity would result in dilution to existing shareholders.  If the Company is unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to the Company, the Company would be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations.

The Company’s current monetization model is to derive a percentage of all revenues generated by online merchants using the Virtual Piggy service. Merchants are billed at the end of each month for all transactions that have been processed by the Company on their behalf in the prior month.  As the merchant base and consumer base grows, and as the trend to higher online spending levels continues, the Company expects to generate additional revenue to support operations.

If sufficient revenues are not generated to sustain operations or additional funding cannot be obtained in the short term, the Company will need to reduce monthly expenditures to a level that will enable the Company to continue until such funds can be obtained.  The Company raised $6,070,595, net of stock issuance costs of $395,221 through a private placements of its equity securities from January 1, 2013 through September 30, 2013.
 

The Company also raised $185,000 from the exercise of options and $1,427,595 from the exercise of warrants during the nine months ended September 30, 2013.  

The Company is in the development stage at September 30, 2013.  Successful completion of the Company’s development program, and the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities and achieving a level of sales adequate to support the Company’s cost structure.  However, there can be no assurances that the Company will be able to secure additional equity investment or achieve an adequate sales level.  The Company’s current cash is expected to sustain the Company through December 2013.
 
NOTE 3 – PATENTS

The Company continues to apply for patents.  Accordingly, costs associated with the registration of these patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents (20 years).  At September 30, 2013 and 2012, unamortized capitalized patent costs were $604,572 and $268,856.  Amortization expense for patents was $7,718 and $19,617 for the three and nine months ended September 30, 2013 and $3,374 and $7,546 for the three and nine months ended September 30, 2012.

NOTE 4 – NOTES PAYABLE

In September 2011, the Company commenced a private placement of up to 10 units at a price of $50,000 per unit to accredited investors.  One unit consisted of a demand note payable in the amount of $50,000 due November 12, 2012, warrants to purchase 15,000 shares of common stock at an exercise price of $.50 per share with a term expiring November 12, 2012, and 15,000 shares of common stock.  In December 2011, the Company completed the private placement and raised $500,000.  The warrants were valued at $20,930, fair value, using the Black-Scholes option pricing model to calculate the grant-date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 39.8% to 62.8%, risk free interest rate of .1% and expected option life of 1.2 years.  The shares of common stock were valued at $82,655 or $.45 to $.70 per share, fair value.  Both the warrant value and the shares of common stock were treated as a discount to the value of the note payable in accordance with FASB ASC 835-30-25, Recognition and were being accreted over the term of the note payable for financial statement purposes.  During the years ended December 31, 2012 and 2011, $65,560 and $38,035 of interest was accreted on the notes payable.  As of December 31, 2011, $150,000 of the $500,000 was repaid.

On February 8, 2012, February 27, 2012, and April 10, 2012, $100,000, $50,000, and $25,000 respectively, of the notes payable were repaid.   On April 26, 2012, the remaining balance of the notes payable and accrued interest of $25,000 was converted into 571,428 shares of the Company’s common stock and warrants to purchase 285,714 shares of the Company’s common stock.

NOTE 5 - INCOME TAXES

Income tax expense was $0 for the three and nine months ended September 30, 2013 and 2012.

As of January 1, 2013, the Company had no unrecognized tax benefits, and accordingly, the Company did not recognize interest or penalties during 2013 related to unrecognized tax benefits.  There has been no change in unrecognized tax benefits during the nine months ended September 30, 2013, and there was no accrual for uncertain tax positions as of September 30, 2013.  Tax years from 2008 through 2012 remain subject to examination by major tax jurisdictions.

There is no income tax benefit for the losses for the three and nine months ended September 30, 2013 and 2012, since management has determined that the realization of the net tax deferred asset is not assured and has created a valuation allowance for the entire amount of such benefits.
 

NOTE 6 – LITIGATION SETTLEMENT

In December 2012, the Company entered into a settlement agreement with an investor, whereby the Company would pay the investor $450,000 in return for the investor returning warrants issued to the investor.  The Company received $75,000 from its insurance carrier with respect to this litigation and the $450,000 settlement was paid in January 2013.

NOTE 7 – STOCKHOLDERS’ EQUITY

In December 2011, the Company commenced a private placement of up to $5,000,000 consisting of up to 12,500,000 shares of the Company’s common stock and warrants to purchase up to 6,250,000 shares of the Company’s common stock.  The shares and warrants were sold in units with each unit comprised of two shares and one warrant at a purchase price of $.80 per unit. The warrants were for a term of two years at an exercise price of $0.50 per share. During December 2011, the Company sold 625,000 units and raised $500,000.  On January 11, 2012, the Company amended the Securities Purchase Agreement dated December 1, 2011, by reducing the price of one unit from $.80 to $.70.  This increased the number of units to be sold from 6,250,000 units to 7,142,858 units.  It also required the Company to issue to one investor an additional 89,286 units, consisting of 178,572 shares common stock and warrants to purchase an additional 89,286 shares of common stock.  During the three months ended March 31, 2012, the Company issued an additional 3,922,356 units and raised $2,717,650, net of stock issuance costs of $28,000.

On April 5, 2012, the Company commenced a private placement of up to $3,500,000 consisting of up to 10,000,000 shares of the Company’s common stock and warrants to purchase up to 5,000,000 shares of the Company’s common stock at an exercise price of $.50 per share.  The shares and warrants were sold in units with each unit comprised of two shares and one warrant at a purchase price of $.70 per unit. The warrants were for a term of two years.  In accordance with the terms of the offering documents, the offering amount was increased to $4 million.  From April 5, 2012 to June 30, 2012, the Company sold 6,201,831 units and raised $4,341,282.

On April 2, 2012, the Company entered into a settlement agreement with a former consultant of the Company. In connection with the settlement, the Company made a settlement payment to the consultant of $30,000 and issued the consultant 350,000 shares of the Company’s common stock, which were valued at $297,500, fair value, or $.85 per share.  
 
On April 10, 2012, a company owned by the Secretary of the Company and his wife exercised options to purchase 250,000 shares of common stock which raised proceeds of $10,000.

On May 2, 2012, the Company entered into a securities purchase agreement with a non-U.S. person, pursuant to which the Company issued and sold 187,500 units at a purchase price of $0.80 per unit, in consideration of gross proceeds of $150,000.  Each unit consisted of: (i) two shares of the Company’s common stock, (ii) a warrant to purchase one share of the Company’s common stock at an exercise price of $0.50 per share for a term of two years, and (iii) a warrant to purchase one half share of the Company’s common stock at an exercise price of $1.00 per share for a term of three years.  Pursuant to the securities purchase agreement, the purchaser also agreed to purchase an additional $850,000 of units by November 1, 2012.  The Company has received $1,000,000 as of March 31, 2013 under this agreement.
 
On May 21, 2012, the Company issued five consultants an aggregate of 1,363,185 shares of the Company’s common stock for services, which were valued in the aggregate at $3,312,537, fair value or $2.43 per share, which was the stock price on the day of issuance.

On May 25, 2012, an investor exercised options to purchase 350,000 shares of common stock which raised proceeds of $14,000.

On July 5, 2012, the Company commenced a private placement of up to $100,000 consisting of up to 125,000 units of the Company’s common stock and warrants to purchase up to 125,000 shares of the Company’s common stock at an exercise price of $.50 per share with a term of two years (“Series A Warrants”) and warrants to purchase up to 62,500 at an exercise price of $1.00 per share with a term of three years (“Series B Warrants”).  The shares and warrants were sold in units with each unit comprised of two shares and one Series A warrant and one Series B warrant at a purchase price of $.80 per unit.  As of August 8, 2012, the Company has received gross proceeds of $100,000 under this private placement.
 

During November and December 2012, the Company entered into a private placement for shares of the Company’s common stock.  The shares were sold at a purchase price of $.70 per share.  Through December 31, 2012, 7,942,858 shares were sold raising $5,560,000.

In December 2012, the Company entered into a private placement for shares of the Company’s common stock. The shares were sold at a purchase price of $.75 per share.  Through December 31, 2012, 666,667 shares were sold raising $500,000.

During the first quarter of 2013, the Company entered into a private placement for shares of the Company’s common stock. The shares were sold at a purchase price of $.75 per share.  Through March 31, 2013, 1,133,334 shares were sold raising $850,000.  Issuance costs related to this private placement were $60,783.

On April 15, 2013, the Company issued 26,521 restricted shares of the Company’s common stock to five members of the Board of Directors that were valued at $49,071.  In conjunction with this the five members of the Board also received in aggregate options to purchase 1,050,000 shares of the Company’s common stock. These options were valued at $519,080, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.0%, risk free interest rate of .69% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted will be expensed over the three year vesting term.
  
On May 28, 2013, we entered into a Securities Purchase Agreement with accredited investors, pursuant to which we issued and sold an aggregate of 2,572,553 units at a purchase price of $1.80 per unit (the “Offering”), with each unit being comprised of one (1) share of the Company’s common stock and a warrant to purchase one-half (0.5) of a share of common stock at an exercise price of $3.00 per share for a period of three years. On May 29, 2013, we issued and sold an additional    300,000 units pursuant to the Offering. The Company retained a placement agent in connection with the Offering. The Company paid the placement agent aggregate placement agent fees in the amount of $151,408 plus $155,118 as an expense allowance. In addition, the placement agent received three year warrants to purchase an aggregate of 287,255 shares of the Company’s common stock at an exercise price of $1.80 per share (See Note 8-Stock Options and Warrants). Net proceeds of the Offering to the Company, after the expense allowance and other expenses, were approximately $4,836,157.
    
During May 2013, options to purchase 750,000 shares of common stock were exercised at $0.04 per share, options to purchase 300,000 shares of common stock were exercised at $0.35 per share, and options to purchase 66,667 shares of common stock were exercised at $0.75, resulting in proceeds of $185,000.

During May and June 2013, warrants to purchase 2,000,000 shares of common stock were exercised at $.04 per share and warrants to purchase 2,660,685 shares of common stock were exercised at $0.50 per share, resulting in proceeds of $1,330,342.

During July and August 2013, warrants to purchase 34,500 shares of common stock were exercised at $.50 per share, resulting in proceeds of $17,250.

NOTE 8 – STOCK OPTIONS AND WARRANTS

During 2008, the Board of Directors (“Board”) of the Company adopted the 2008 Equity Incentive Plan (“2008 Plan”) that was approved by the shareholders.  Under the 2008 Plan, the Company is authorized to grant options to purchase up to 25,000,000 shares of common stock to any officer, other employee or director of, or any consultant or other independent contractor who provides services to the Company.  The 2008 Plan is intended to permit stock options granted to employees under the 2008 Plan to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended (“Incentive Stock Options”).  All options granted under the 2008 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options (“Non-Statutory Stock Options”).  As of September 30, 2013, options to purchase 14,053,000 shares of common stock have been issued and are unexercised, and 61,667 shares of common stock are available to be issued under the 2008 Plan.  
 

During 2013, Board adopted the 2013 Equity Incentive Plan (“2013 Plan”).  Under the 2013 Plan, the Company is authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based awards of up to an aggregate of 5,000,000 shares of common stock to any officer, employee, director or consultant.  The 2013 Plan is intended to permit, upon stockholder approval, stock options granted to employees under the 2013 Plan to qualify as Incentive Stock Options.  All options granted under the 2013 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be Non-Statutory Stock Options.  As of September 30, 2013, under the 2013 Plan options to purchase 3,702,500 shares of common stock have been issued and are unexercised, and 1,297,500 shares of common stock remain available for grants under the 2013 Plan.

The plans are administered by the Board, or a designated committee thereof, which determines the persons to whom awards will be granted, the number of awards to be granted, and the specific terms of each grant, including the vesting thereof, subject to the terms of the plans.

In connection with Incentive Stock Options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company).

Volatility in all instances presented is the Company’s estimate of volatility that is based on the volatility of other public companies that are in closely related industries to the Company.

Employee and Non-Employee Director Grants

On January 27, 2012, the Company issued an employee an option to purchase 30,000 shares of the Company’s common stock at $.52 per share.  These options have been valued at $3,718, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.4%, risk free interest rate of 0.8% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

On February 28, 2012, the Company issued an employee an option to purchase 25,000 shares of the Company’s common stock at $.58 per share.  These options have been valued at $3,120, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.0%, risk free interest rate of .8% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

On March 2, 2012, the Company issued a Board member an option to purchase 250,000 shares of the Company’s common stock at $.58 per share.  These options have been valued at $33,975, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.9%, risk free interest rate of .9% and expected option life of five years.  The options expire five years from the date of issuance.  This option was expensed immediately.

On March 5, 2012, the Company issued an employee an option to purchase 25,000 shares of the Company’s common stock at $.58 per share.  These options have been valued at $2,680, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.0%, risk free interest rate of .9% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.
 

On March 31, 2012, the Company issued five employees, options to purchase 4,010,000 shares in the aggregate of the Company’s common stock at $.65 per share.  These options have been valued at $759,810, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of 1.04% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.
 
In April 2012, the Company issued six employees options to purchase an aggregate of 80,000 shares of the Company’s common stock at exercise prices ranging from $.65 to $.97 per share.  These options were valued at $17,310 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 30.2% to 33.4%, risk free interest rate of .82% to 1.04% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In June 2012, the Company issued three employees and one Board member options to purchase an aggregate of 470,000 shares of the Company’s common stock at exercise prices ranging from $1.53 to $1.82 per share.  These options were valued at $217,293, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 30.3% to 35.5%, risk free interest rate of .68% to .72% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term or immediately if there is no vesting term.

In July 2012, the Company issued one employee options to purchase an aggregate of 15,000 shares of the Company’s common stock at an exercise price of $1.23 per share.  These options were valued at $5,493 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 32.9%, risk free interest rate of .61% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In August 2012, the Company issued seven employees options to purchase an aggregate of 380,000 shares of the Company’s common stock at exercise prices ranging from $1.26 to $1.43 per share.  These options were valued at $123,381, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5% to 29.1%, risk free interest rate of .63% to .69% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In September 2012, the Company issued one employee options to purchase 75,000 shares of the Company’s common stock at an exercise price of $1.54 per share.  These options were valued at $26,303, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.5%, risk free interest rate of .62% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In October 2012, the Company issued one employee options to purchase 75,000 shares of the Company’s common stock at an exercise price of $1.35 per share.  These options were valued at $23,263 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.5%, risk free interest rate of .70% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In November 2012, the Company issued fourteen employees options to purchase an aggregate of 1,295,000 shares of the Company’s common stock at exercise prices between $1.01 and $1.35 per share.  These options were valued at $371,313, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 26.1% and 29.3%, risk free interest rate between .76% and .83% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.
 

In March 2008, the Company issued options to purchase 4,500,000 shares of common stock to three directors.  On January 24, 2013, the expiration date for unexpired and unexercised options of 4,250,000 was extended from March 3, 2013 to March 3, 2015.  The incremental increase in value was $1,253, which was expensed immediately.

In January 2013, the Company issued eighteen employees options to purchase an aggregate of 260,000 shares of the Company’s common stock at exercise prices between $0.99 and $1.05 per share.  These options were valued at $62,662 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 23.3% and 26.1%, risk free interest rate between .78% and .89% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In February 2013, the Company issued four employees options to purchase an aggregate of 760,000 shares of the Company’s common stock at exercise prices between $1.07 and $1.21 per share.  These options were valued at $199,843 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 22.5% and 25.1%, risk free interest rate between .78% and .88% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In March 2013, the Company issued an employee options to purchase 2,500 shares of the Company’s common stock at an exercise price of $1.36 per share.  These options were valued at $728 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.5%, risk free interest rate of .76% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In April 2013, the Company issued an employee options to purchase 200,000 shares of the Company’s common stock at an exercise price of $1.56 per share.  These options were valued at $74,159, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.3%, risk free interest rate of .76% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In May 2013, the Company issued two employees options to purchase an aggregate of 55,000 shares of the Company’s common stock at an exercise price of $2.16 and $2.29 per share.  These options were valued at $26,954, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5% to 25.3%, risk free interest rate of .84% to .85% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In June 2013, the Company issued two employees options to purchase an aggregate of 250,000 shares of the Company’s common stock at exercise prices of $2.40 and $2.92 per share.  The vesting of 50,000 of these options is predicated on meeting certain milestones, therefore   such options have not been valued.  The remaining options were valued at $129,343, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.6% to 26.3%, risk free interest rate of 1.03% to 1.48% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.
 

In August 2013, the Company issued three employees options to purchase an aggregate of 210,000 shares of the Company’s common stock at exercise prices of $2.00 and $2.35 per share.  These options were valued at $124,392, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.2% to 30.3%, risk free interest rate of 1.38% to 1.61% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In September 2013, the Company issued two employees options to purchase an aggregate of 10,000 shares of the Company’s common stock at an exercise price of $1.97 per share.  These options were valued at $4,500, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 21.8%, risk free interest rate of 1.71% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

Cumulatively and for the three and nine months ended September 30, 2013, the Company expensed $1,446,783, $210,380 and $546,776 and for the three and nine months ended September 30, 2012, the Company expensed $81,588 and $274,757 relative to employee options/warrants granted.  As of September 30, 2013, there was $1,746,505 of unrecognized compensation expense related to employee non-vested market-based share awards.

A summary of stock option/warrant transactions for employees and independent board members from December 31, 2011 to September 30, 2013 is as follows:


               
Weighted Average
 
   
Option/Warrants
   
Exercise
   
Exercise
 
   
Shares
   
Price
   
Price
 
Outstanding, December 31, 2011
    9,467,858       $.04 to $.90     $ 0.19  
                         
Granted
    6,730,000    
0.50 to 1.82
      0.34  
Issued under Private Placements
    500,786       0.50       0.01  
Reclassified from non-employee
    810,000    
0.50 to 0.75
      -  
Exercised
    (250,000 )     0.04       -  
Expired
    -       -       -  
                         
Outstanding, December 31, 2012
    17,258,644    
.04 to 1.82
      0.48  
                         
Granted
    2,802,500    
0.99 to 2.92
      0.26  
Reclassified to non-employee, net
    (235,000 )  
0.50 to 2.30
      0.02  
Exercised
    (2,816,667 )  
0.04 to 0.75
      0.01  
Expired/terminated
    (245,000 )  
0.50 to 2.92
      -  
                         
Outstanding, September 30, 2013
    16,764,477       $.04 to $2.40     $ 0.7  
                         
Exercisable, September 30, 2013
    9,315,310       $.04 to $2.30     $ 0.4  
                         
Weighted Average Remaining Life,
                       
  Exercisable, September 30, 2013 (years)
    1.8                  
 

Non-Employee Grants

On January 2, 2012, the Company issued a consultant an option to purchase 250,000 shares of the Company’s common stock at $.50 per share.  These options have been valued at $51,692 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.2%, risk free interest rate of 0.9% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed when the service is provided.
 
On January 17, 2012, the Company issued a consultant an option to purchase 200,000 shares of the Company’s common stock at $.50 per share.  These options have been valued at $31,437, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 28.0%, risk free interest rate of 0.8% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted were expensed immediately.

On March 31, 2012, the Company issued two consultants options to purchase 100,000 shares in the aggregate of the Company’s common stock at $.65 per share.  These options have been valued at $18,947, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of 1.04% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted were expensed immediately.

On April 1, 2012, the Company issued a company owned by the former manager of corporate development an option to purchase 250,000 shares of the Company’s common stock at $.70 per share pursuant to an agreement that also required a cash payment of $150,000.  These options have been valued at $43,028, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of 1.04% and expected option life of five years.  The options expire five years from the date of issuance. Options granted were expensed through May 31, 2013, the term of the agreement.

In May 2012, the Company issued a consultant options to purchase an aggregate of 100,000 shares of the Company’s common stock at an exercise price of $2.17 per share.  These options were valued at $79,978 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of .75% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted were expensed immediately.

In July 2012, the Company issued a consultant options to purchase an aggregate of 100,000 shares of the Company’s common stock at an exercise price of $1.55 per share.  These options were valued at $40,373 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.3%, risk free interest rate of .64% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed when the services are provided.

In August 2012, the Company issued two consultants options to purchase an aggregate of 400,000 shares of the Company’s common stock at exercise prices ranging from $.35 to $1.11 per share.  These options were valued at $321,221, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 27.1% to 30.5%, risk free interest rate of .27% to .67% and expected option lives of from two to five years.  The options expire between two and five years from the date of issuance.  Options granted are expensed when the services are provided.

In September 2012, the Company issued a consultant options to purchase 100,000 shares of the Company’s common stock at an exercise price of $.75 per share.  These options were valued at $81,697, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.6%, risk free interest rate of .27% and expected option life of two years.  The options expire two years from the date of issuance.  Options granted are expensed when the service is provided.
 

In October 2012, the Company issued a consultant options to purchase 50,000 shares of the Company’s common stock at an exercise price of $.75 per share.  These options were valued at $5,381, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5%, risk free interest rate of .19% and expected option life of one year.  The options expire one year from the date of issuance.  The options granted are expensed when the service was provided.

In November 2012, the Company issued four consultants options to purchase an aggregate of 765,000 shares of the Company’s common stock at an exercise price of $1.01 per share.  These options were valued at $188,830, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 26.1%, risk free interest rate of .76% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted were expensed immediately.
  
In December 2012, the Company issued a merchant warrants to purchase 500,000 shares of the Company’s common stock at an exercise price of $1.15 per share.  The vesting of these warrants was predicated on meeting certain milestones. As of December 31, first milestone was met resulting in the vesting of 150,000 warrants. The fair value of the vested warrants was $58,595, which was expensed immediately. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.7%, risk free interest rate of .76% and expected option life of one year. As of September 30, 2013, the remaining milestones were met which provided vesting of the remaining 350,000 warrants.  The fair value of these warrants was $549,915, which was expensed immediately.  The warrants expire five years from the date of issuance.

In January 2013, the Company issued a consultant options to purchase 5,000 shares of the Company’s common stock at an exercise price of $1.00 per share.  These options were valued at $1,106 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.3%, risk free interest rate of .78% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the term of the agreement.

In March 2013, the Company issued two consultants options to purchase 1,130,000 shares of the Company’s common stock at exercise prices of $0.75 and $1.48 per share.  130,000 of these options vested immediately and were valued at $54,228, fair value.  The vesting of the remaining 1 million options is predicated on meeting certain milestones, which were not met as of September 30, 2013. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.6% and 25.5%, risk free interest rate of .25% and .80% and expected option life of two to five years.  The options expire two to five years from the date of issuance.  The vested options granted, were expensed immediately.  The remaining unvested options will be expensed when it is probable that the milestones will be achieved.

In April 2013, the Company issued a consultant options to purchase 100,000 shares of the Company’s common stock at an exercise price of $2.04 per share.  These options were valued at $44,603, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 26.5%, risk free interest rate of .68% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted were expensed immediately.

In May 2013, the Company issued two consultants options to purchase 125,000 shares in the aggregate of the Company’s common stock at exercise prices ranging from $3.05 to $3.28 per share.  These options were valued at $51,869, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.1% to 23.2%, risk free interest rate of .29% to .31% and expected option life of two years.  The options expire two years from the date of issuance.  Options granted are expensed over the term of the agreement.
 

In May 2013, the Company, as part of the cost of the Company’s Offering described in Note 7, issued the placement agent warrants to purchase 287,255 shares of the Company’s common stock at an exercise price of $1.80 per share.  These warrants were valued at $409,749, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 23.4% to 23.7%, risk free interest rate of .49% and expected option life of three years.  The warrants expire three years from the date of issuance.  The warrants granted were recorded as stock issuance costs and reduced additional paid in capital.

In July 2013, the Company issued two consultants options to purchase 100,000 shares in the aggregate of the Company’s common stock at exercise prices ranging from $.75 to $2.61 per share.  These options were valued at $124,338, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.8% to 26.6%, risk free interest rate of 1.35% to 1.66% and expected option life of five years.  The options expire five years from the date of issuance.  $124,338 was expensed immediately.

In September 2013, the Company issued a consultant options to purchase 100,000 shares of the Company’s common stock at an exercise price of $1.17 per share.  These options were valued at $26,208, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.1%, risk free interest rate of 1.39% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted will be over the term of the agreement, which is three years.

Cumulatively and for the three and nine months ended September 30, 2013 and 2012, the Company expensed $1,803,849, $687,229 and $818,619 and for the three and nine months ended September 30, 2012 the Company expensed $142,086 and $203,593 relative to non-employee options/warrants granted.  As of September 30, 2013, there was $90,984 of unrecognized compensation expense related to non-vested market-based share awards to non-employees.

The following table summarizes non-employee (excluding independent board members) stock options/warrants of the Company from December 31, 2011 to September 30, 2013 as follows:
 

               
Weighted Average
 
   
Option/Warrant
   
Exercise
   
Exercise
 
   
Shares
   
Price
   
Price
 
Outstanding, December 31, 2011
    3,184,286       $0.04 to $2.30     $ 0.76  
                         
Granted
    2,915,000    
0.35 to 2.17
      0.12  
Issued under Private Placement
    11,967,152    
0.50 to 1.00
      0.38  
Reclassified to employee
    (810,000 )  
0.50 to 0.75
      -  
Exercised
    (350,000 )     0.04       -  
Expired
    (375,000 )  
0.91 to 1.00
      -  
                         
Outstanding, December 31, 2012
    16,531,438    
0.35 to 2.30
      0.63  
                         
Granted
    1,753,750    
0.50 to 3.28
      0.17  
Issued under Private Placement
    1,723,533    
1.80 to 3.00
      0.30  
Reclassified from employee, net
    235,000    
0.50 to 2.30
     
.02
 
Exercised
    (2,995,185 )  
.35 to .50
      -  
Expired/Cancelled
    (1,405,000 )  
0.50 to 1.00
      -  
                         
Outstanding, September 30, 2013
    15,843,536       $0.35 to $3.28     $ 0.99  
                         
Exercisable, September 30, 2013
    14,388,536       $0.50 to $3.28     $ 0.93  
                         
Weighted Average Remaining Life,
                       
  Exercisable, September 30, 2013 (years)
    1.4                  
 
NOTE 9 - OPERATING LEASES
 
For the three and nine months ended September 30, 2013, total rent expense under leases amounted to $117,447 and $244,318 and for the three and nine months ended September 30, 2012, total rent expense under leases amounted to $54,640 and $113,389.  At September 30, 2013, the Company was obligated under various non-cancelable operating lease arrangements for property as follows:


2013
    116,622  
2014
    142,570  
2015
    39,688  
         
    $ 298,880  


NOTE 10 – RELATED PARTY TRANSACTIONS
 
From inception through December 1, 2010, the Company utilized offices leased by affiliates of certain of the Company’s board members without charge.
 
During the three and nine months ended September 30, 2013 and 2012, a consultant and beneficial owner of the Company, owning more than five percent of the outstanding common shares of the Company, was paid for consulting and travel expenses to provide strategic advice to the Company.   On January 1, 2013, the Company entered into an agreement with this consultant, whereby the Company would pay the consultant $12,500 per month beginning January 1, 2013 for a term of one year.  In June 2013, this contract was terminated. Consulting fees paid during the three and nine months ended September 30, 2013 were $0 and $130,000 and $0 and $172,500 was paid for the three and nine months ended September 30, 2012.  Reimbursable business expenses of $6,506 and $30,072 were paid during the three and nine months ended September 30, 2013, and $20,001 and $32,224 were paid during the three and nine months ended September 30, 2012.  
 
During the three and nine months ended September 30, 2013 and 2012, a marketing company owned by the Company’s Secretary and his spouse was paid $0 and $14,560 respectively.
 
 
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
 
CONDITION AND RESULTS OF OPERATIONS.

Cautionary Statements Regarding Forward-Looking Statements

This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act").  All statements other than statements of historical facts included or incorporated by reference in this quarterly report on Form 10-Q, including without limitation, statements regarding our future financial position, business strategy, budgets, projected revenues, projected costs and plans and objectives of management for future operations, are forward-looking statements.  In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "will," "expects," "intends," "plans," "projects," "estimates," "anticipates," or "believes" or the negative thereof or any variation thereon or similar terminology or expressions.

We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Important factors that could cause actual results to differ materially from our expectations include, but are not limited to:  our ability to raise additional capital, the absence of any operating history or revenue, our ability to attract and retain qualified personnel, our dependence on third party developers who we cannot control, our ability to develop and introduce a new service to the market in a timely manner, market acceptance of our services, our limited experience in a relatively new industry, the ability to successfully develop licensing programs and generate business, rapid technological change in relevant markets, unexpected network interruptions or security breaches, changes in demand for current and future intellectual property rights, legislative, regulatory and competitive developments, intense competition with larger companies, general economic conditions, as well as other factors set forth under the caption "Risk Factors" in this and prior quarterly reports on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2012 filed with the Securities and Exchange Commission.

All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing.  Except as required by law, we assume no duty to update or revise our forward-looking statements.

Overview

Virtual Piggy, Inc. (the “Company” or “Virtual Piggy”) is a development stage enterprise incorporated in the state of Delaware on February 11, 2008.   Virtual Piggy is a technology company that delivers an online ecommerce solution for the family. Its system allows parents and their children to manage and allocate funds and track the child’s expenditures, savings and charitable giving online. Its system is designed to allow the child to transact online without a credit card by gaining the parent’s permission ahead of time and allowing the parent to set up the rules of use. In addition to its main focus, the Company is also working on technology that will make the overall online experience safer for the “Under 18” market (“U18s”).
 
 The Virtual Piggy product enables online businesses to interact and transact with the U18s market in a manner consistent with the Children’s Online Privacy Protection Act (“COPPA”) and other similar international children’s privacy laws.  The Virtual Piggy product offering was launched in the United States in 2012 and was launched in European markets in 2013.
 
 
The Company has secured 143 agreements with merchants, game publishers, e-commerce platforms, gaming platforms and payment processors. Over 20 of the merchants and game publishers are using Virtual Piggy live with their e-commerce systems and the Company is in the process of integrating the other signed merchants and gaming publishers. The Company is continuing to add merchants and gaming publishers. In addition, Virtual Piggy has the capability to offer and deliver digital gift cards.
         
Strategic Outlook

We believe that the e-commerce market will continue to grow over the long-term.  Within the market, we intend to provide services to the online industry to allow them to transact with children in compliance with COPPA and similar international privacy laws.  We believe that this particular opportunity is relatively untapped and expect to be a leading provider of online transactions for children.

Our primary strategic objective over the next 12-24 months is to continue our merchant acquisition program and rapidly expand our consumer acquisition program which will generate revenue that we believe will ultimately cover our operating expenses and allow us to become profitable.   We began our user acquisition efforts in March 2013 and currently have over 500,000 system users, which we define as a registered account that has accessed the Virtual Piggy product within the past 12 months.  Our goal for 2013 is to acquire one million system users by year end. We plan to achieve this objective by advertising our product and services to consumers through public relations programs, merchant promotions and affiliate marketing programs.  As our service grows, we intend to hire additional information staff to maintain our product offerings and develop new products to increase our market share.

We believe that our near-term success will depend particularly on our ability to develop customer awareness and confidence in our service, and consumer spending through our system.  Since we have limited capital resources, we will need to closely manage our expenses and conserve our cash by continually monitoring any increase in expenses and reducing or eliminating unnecessary expenditures. Our prospects must be considered in light of the risks, expenses and difficulties encountered by companies at an early stage of development, particularly given that we operate in new and rapidly evolving markets, that we have limited financial resources, and face an uncertain economic environment. We may not be successful in addressing such risks and difficulties.

 
Results of Operations

Comparison of the Three Months Ended September 30, 2013 and 2012

The following discussion analyzes our results of operations for the three months ended September 30, 2013 and 2012. The following information should be considered together with our financial statements for such period and the accompanying notes thereto.

Revenue/Net Loss

We are a development stage company and have not generated significant revenue since our inception.  For the three months ended September 30, 2013 and 2012, we generated revenues of $1,382 and $8, respectively.  For the three months ended September 30, 2013, we processed $50,292 of merchant transactions and $13,764 of gift card sales compared to essentially none in the third quarter of last year.  We commenced our user acquisition campaign in March 2013 and currently have over 500,000 system users.  During this initial startup phase, the majority of our system users have not processed a transaction through our system to purchase an item from a merchant.  However, we expect these transactions to occur and are continuing to market to these system users, and expect that many of them will become active system users over time, particularly as we continue to add merchants to our network and continually market to our user base.  We earn revenue by charging a percentage to the merchant for each transaction processed through such merchants through the Virtual Piggy network.  In the second and third quarter of the current year, we have added online gaming sites which have generated repeat transactions from gaming users.

Our net loss increased $3,286,752 to $5,305,486 for the three months ended September 30, 2013 compared to $2,018,734 for the three months ended September 30, 2012, which was the result of increased expenses as we have expanded our business as further described below.
    
Payroll Expenses

Payroll expenses were $1,515,701 for the three months ended September 30, 2013 and $886,215 for the three months ended September 30, 2012, an increase of $629,486.  Payroll expenses for the three months ended September 30, 2013 included $289,714 for our marketing staff.  We have increased our staff level by 14 since the third quarter of last year and have commenced operations in Europe.
 
Consulting Expenses
  
Consulting expenses for the three months ended September 30, 2013 were $1,034,270 as compared to $242,116 for the three months ended September 30, 2012, an increase of $792,154.  The increase was the result of fees for investor relations activities, merchants meeting option milestones and increased use consultants in our London office for certain software and product development efforts.
  
Marketing Expenses

For the three months ended September 30, 2013, marketing expenses were $1,462,861, an increase of $1,319,377 from $143,484 for the three months ended September 30, 2012. During the last 12 months Virtual Piggy has developed a strong international marketing department headquartered out of Hermosa Beach office. With the introduction of class A merchants such as Claires Inc. and Habbo Hotel in the third quarter, Virtual Piggy has run and continues to run co-marketing campaigns alongside these and newly acquired merchants to promote both the Virtual Piggy service and the availability of the particular merchant on the Virtual Piggy network. These marketing efforts have directly led to the acquisition of new users and of new merchants. The campaigns have also led to greater awareness of the Virtual Piggy brand. Virtual Piggy has signed a contract with the American Media firm Universal McCann to help deliver marketing outreach campaigns. We expect to continue this spending in future quarters.
 
Research and Development

Research and development expenses decreased $9,241 to $179,476 for the three months ended September 30, 2013 from $188,717 for the three months ended September 30, 2012.  These costs resulted from the Company’s continued efforts to develop its platform, including mobile applications, and the integration of merchants into the platform.


Travel Expenses

For the three months ended September 30, 2013, travel expenses were $274,088 an increase of $152,744 from $121,344 for the three months ended September 30, 2012.  The expenses incurred were primarily associated with increased sales and marketing activities in the United States and Europe, capital raising and investor relations activities.
 
Professional Fees

Professional fees increased $137,572 to $256,296 for the three months ended September 30, 2013 from $118,724 for the three months ended September 30, 2012.  The increase related primarily to increased public company costs, including SOX compliance, fees related to our certification compliance with privacy and COPPA regulations and legal and professional fees related to our expansion into Europe.

General and Administrative Expenses

General and administrative expenses were $587,342 for the three months ended September 30, 2013 compared to $320,052 for the three months ended September 30, 2012, an increase of $267,290.   The increase is primarily related to the expansion of our offices, the addition of our London office, an increase in staff to support our operations and the general expansion of our business.

Comparison of the Nine Months Ended September 30, 2013 and 2012

The following discussion analyzes our results of operations for the nine months ended September 30, 2013 and 2012. The following information should be considered together with our financial statements for such periods and the accompanying notes thereto.

Revenue/Net Loss

We are a development stage company and have not generated significant revenue since our inception.  For the nine months ended September 30, 2013 and 2012, we generated revenues of $1,528 and $1,195, respectively.  We commenced our user acquisition campaign in March 2013 and currently have over 500,000 system users.  During this initial startup phase, the majority of our system users have not processed a transaction through our system to purchase an item from a merchant.  However, we expect these transactions to occur and are continuing to market to these system users, and expect that many of them will become active system users over time, particularly as we continue to add merchants to our network and continually market to our user base.  We earn revenue by charging a percentage to the merchant for each transaction processed through such merchants through the Virtual Piggy network.

Our net loss increased $2,699,772 to $11,366,427 for the nine months ended September 30, 2013 compared to $8,666,655 for the nine months ended September 30, 2012, as a result of increased expenses as further described below.
     
Payroll Expenses

Payroll expenses were $3,912,056 for the nine months ended September 30, 2013 and $1,740,952 for the nine months ended September 30, 2012, an increase of $2,171,104.  Payroll expenses for the nine months ended September 30, 2013 included $663,884 for our marketing staff. We have increased our staff level by 14 since the third quarter of last year and have commenced operations in Europe.
 

Consulting Expenses

Consulting expenses for the nine months ended September 30, 2013 were $1,931,801 as compared to $4,422,241 for the nine months ended September 30, 2012, a decrease of $2,490,440.  The decrease resulted primarily from the settlement of a dispute related to a marketing agreement in 2012 and stock based compensation related to consulting agreements entered into  in 2012 (representing an aggregate of $3,845,386), as well as the Company hiring employees rather than using consultants to perform key functions.
   
Marketing Expenses

For the nine months ended September 30, 2013, marketing expenses were $2,037,589, an increase of $1,574,480 from $463,109 for the nine months ended September 30, 2012. During the last 12 months Virtual Piggy has developed a strong international marketing department headquartered out of Hermosa Beach office. With the introduction of class A merchants such as Claires Inc. and Habbo Hotel in the third quarter, Virtual Piggy has run and continues to run co-marketing campaigns alongside these and newly acquired merchants to promote both the Virtual Piggy service and the availability of the particular merchant on the Virtual Piggy network. These marketing efforts have directly led to the acquisition of new users and of new merchants. The campaigns have also led to greater awareness of the Virtual Piggy brand. Virtual Piggy has signed a contract with the American Media firm Universal McCann to help deliver marketing outreach campaigns. We expect to continue this spending in future quarters.
 
Research and Development

Research and development expenses increased $256,862 to $612,958 for the nine months ended September 30, 2013 from $356,096 for the nine months ended September 30, 2012.  The increased costs resulted from the Company’s continued efforts to develop its platform, including mobile applications, and the integration of merchants into the platform.

Travel Expenses

For the nine months ended September 30, 2013, travel expenses were $717,931 an increase of $352,450 from $365,481 for the nine months ended September 30, 2012.  The expenses incurred were primarily associated with increased sales and marketing activities in the United States and Europe, capital raising and investor relations activities.
 
Professional Fees

Professional fees increased $291,267 to $652,303 for the nine months ended September 30, 2013 from $361,036 for the nine months ended September 30, 2012.  The increase related primarily to increased public company costs, including SOX compliance, fees related to our certification compliance with privacy and COPPA regulations and legal and professional fees related to our expansion into Europe. 
        
General and Administrative Expenses

General and administrative expenses were $1,512,797 for the nine months ended September 30, 2013 compared to $871,823 for the nine months ended September 30, 2012, an increase of $640,974.   The increase is primarily the result of the expansion of our offices, the addition of our London office, an increase in staff related to support our operations and the general expansion of our business.

Interest Expense

During the nine months ended September 30, 2013, we incurred no interest expense as compared to $90,560 for the nine months ended September 30, 2012.  Interest expense in 2012 related to interim debt financing prior to the completion of several private placements of securities, the proceeds of which were used to pay off debt.


Liquidity and Capital Resources

As of the filing date of this report, we had cash on hand of approximately $2.7 million.

Net cash used in operating activities for the nine months ended September 30, 2013 was $9,777,170, as compared to $4,532,672 for the nine months ended September 30, 2012, an increased use of $5,244,498. The increase resulted primarily from expanded operations including marketing the Virtual Piggy product, hiring additional staff, commencing our user acquisition campaign and opening an office in London.
 
Net cash used in investing activities for the nine months ended September 30, 2013 was $298,284, as compared to $292,363 for the nine months ended September 30, 2012, an increase of $5,921.  These investments are principally for the purchase of equipment and costs of patents and trademarks.

Net cash provided by financing activities was $7,287,969 for the nine months ended September 30, 2013, a decrease of $469,963 from $7,757,932 for the nine months ended September 30, 2012.  During the nine months ended September 30, 2013 and 2012, the Company completed a number of private placements of its securities aimed at the continued financing of the business.  The Company also received $1,612,595 through option and warrant exercises in 2013.
 
As we have not generated any meaningful revenues since our inception, we have financed our operations through private placement offerings of equity and debt securities.  We do not currently maintain a line of credit or term loan with any commercial bank or other financial institution.  

We believe that our existing cash resources will not be sufficient to sustain our operations during the next twelve months.  Our current cash on hand should sustain our operations through December 2013.  We have recently commenced our revenue generating activities and we need to generate sufficient revenues to support our cost structure to enable us to pay ongoing costs and expenses as they are incurred, finance the continued development of our platform, and execute our business plan.  If we cannot generate sufficient revenue to fund our business plan, we intend to raise such financing through the sale of debt and/or equity securities.  The sale of equity securities is dependent upon shareholders’ approval of an increase in the number of the Company’s authorized shares of common stock (see Part II, Item 1A, Risk Factors).  The issuance of additional equity would result in dilution to existing shareholders.  If we are unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to us, we would be unable to execute our business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations of the Company.
 
 
Off-Balance Sheet Arrangements

As of September 30, 2013, we did not have any relationships with unconsolidated entities or financial partners, such as entities often referred to as structured finance or special purpose entities, established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.  As such, we are not materially exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.

Critical Accounting Policies

Our financial statements are impacted by the accounting policies used and the estimates and assumptions made by management during their preparation. A summary of these policies is included in Note 1 of the notes to our financial statements. We have identified below the accounting policies that are of particular importance in the presentation of our financial position, results of operations and cash flows and which require the application of significant judgment by management.
 
 
 
 
 
 

Stock-based Compensation

We have adopted the fair value recognition provisions Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 718. In addition, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 107 “Share-Based Payment” (“SAB 107”) in March, 2005, which provides supplemental FASB ASC 718 application guidance based on the views of the SEC. Under FASB ASC 718, compensation cost recognized includes compensation cost for all share-based payments granted beginning January 1, 2006, based on the grant date fair value estimated in accordance with the provisions of FASB ASC 718.

We have used the Black-Scholes option-pricing model to estimate the option fair values. The option-pricing model requires a number of assumptions, of which the most significant are, expected stock price volatility, the expected pre-vesting forfeiture rate and the expected option term (the amount of time from the grant date until the options are exercised or expire).

Compensation expense for unvested options granted to non-employees in previous periods is being amortized over the term of the consulting agreement.

Revenue Recognition

In accordance with Securities and Exchange Commission Staff Accounting Bulletin No. 104, Revenue Recognition (Codified in FASB ASC 605), we will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, we will generally recognize revenue from Virtual Piggy at the time of the sale of the associated product.
 
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

There have been no material changes in market risk from the information provided in “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” of the Company’s 2012 Annual Report on Form 10-K.

CONTROLS AND PROCEDURES.

As of September 30, 2013, we carried out the evaluation of the effectiveness of our disclosure controls and procedures required by Rule 13a-15(e) under the Exchange Act under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer.  Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2013, our disclosure controls and procedures were effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is: (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

There has been no change in our internal control over financial reporting identified in connection with this evaluation that occurred during our fiscal quarter ended September 30, 2013 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 
 
PART II – OTHER INFORMATION

LEGAL PROCEEDINGS.

We are not a party to any legal proceedings.

RISK FACTORS.
 
Investing in our common stock involves a high degree of risk. Before you invest you should carefully consider the risks and uncertainties described below and in our 2012 Form 10-K, under the caption “Risk Factors”, our Management’s Discussion and Analysis of Financial Condition and Results of Operations set forth in Item 2 of Part I of this Quarterly Report on Form 10-Q, our financial statements and related notes included in Item 1 of Part I of this Quarterly Report on Form 10-Q and our consolidated financial statements and related notes, as well as our Management’s Discussion and Analysis of Financial Condition and Results of Operations and the other information in our 2012 Form 10-K. Readers should carefully review those risks, as well as additional risks described in other documents we file from time to time with the Securities and Exchange Commission.


Management’s judgment could impact the amount of non-cash compensation expense
 
To estimate the fair value of our stock option awards we currently use the Black-Scholes-Merton options pricing model. The determination of the fair value of equity-based awards on the date of grant using an options pricing model is affected by our then current stock price as well as assumptions regarding a number of complex and subjective variables. Management is required to make certain judgments for these variables which include the expected stock price volatility over the term of the awards, the expected term of options based on employee exercise behaviors, and the risk-free interest rate. One of the factors used in determining such value is stock volatility.  Because of the limited trading activity of our common stock, we use the stock volatility of four peer companies.  To the extent that we used different peer companies to measure volatility, a different stock volatility factor may result which would cause a different stock valuation and a related increase or decrease in non-cash compensation expense. If actual results are not consistent with our assumptions and judgments used in estimating key assumptions, in future periods, the stock option expense that we record for future grants may differ significantly from what we have recorded in the current period.
 
We require shareholders to authorize additional shares for us to properly finance our business

Upon the Company’s formation, our shareholders authorized the issuance of up to 150,000,000 shares of common stock.  Currently, only 4.6 million of such shares remain available for issuance after accounting for reserved shares. The Company also has 2 million preferred shares which are currently authorized but unused.  In September, 2013, our board of directors approved an amendment to our certificate of incorporation to increase the number of authorized shares of common stock by 30,000,000 to 180,000,000. On October 8, 2013, the Company mailed a proxy to all shareholders to vote on this increase at the Company’s annual shareholders meeting to be held on November 18, 2013. However, such shares cannot be used until the increase is approved by shareholders representing over 50% of the Company’s outstanding shares of common stock.   To finance and continue to grow our business, we will require additional capital and have historically relied upon the issuance of common stock for such financing.  Should our shareholders be unwilling to approve a sufficient increase in the number of our authorized shares of common stock, we would be required to finance our business with debt or other instruments, which may be difficult or impossible to secure on terms acceptable to us.  If that were to occur, we may not be able to (a) pay our costs and expenses as they are incurred, (b) execute our business plan, (c) take advantage of future opportunities, or (d) respond to competitive pressures or unanticipated requirements or in the extreme case, liquidate the Company.

We may not be able to qualify to have our common stock listed on a national stock exchange
 
The Company’s common stock currently trades on the Over the Counter Market (“OTC QB”) in the United States.  To facilitate liquidity and trading in the Company’s shares, the Company has stated that it is the Company’s goal to be listed on a national stock exchange.  Listing requirements include financial and trading requirements that, as of September 30, 2013 the Company does not meet.  The listing process can be lengthy and is discretionary.  There can be no assurance that the Company’s application will be approved or that the Company will ever be listed on a national stock exchange.  Currently, the Company does not qualify for listing based on its stock price, among other things. If the Company’s listing is not approved or if the Company withdraws from the application process, the Company’s shares would continue to trade on the OTC QB.  In that event, certain institutional investors may not be able to purchase the Company’s common stock as a result of their own ownership guidelines and liquidity in the Company’s common stock would remain more limited that it would have been if such listing application had been approved.  Further, the Company’s ability to raise money through subsequent offerings of its common stock will be more limited if the Company is not able to up-list to a national exchange.
 
The Company may be subject to credit card transaction fraud

The Company’s business model depends upon the processing of credit cards and includes the sale of gift cards.  In cases where the Company is the merchant of record on a gift card sale, the Company could be held financially responsible for the value of gift cards which are purchased using a fraudulent or stolen credit card. While the Company uses software and safeguards to ensure that credit cards it accepts are valid, there can be no assurance that credit card fraud will not occur.  In addition, in the case of transactions where the Company’s merchant is in the United States and is the merchant of record, the Company is not generally responsible for credit card fraud.  However, given that the Company’s business is dependent on the successful processing of credit cards and payment solutions, fraudulent processing could have an adverse effect on our merchant relationships and could result in liability.  Additionally, other countries have varying rules on who the responsible party would be in certain variations of credit card or other payment fraud these cases.  While the Company is researching such international policies and rules and is implementing safeguards to minimize risk, there can be no assurance that the Company will not incur liability relating to credit card or other payment fraud.
 
 
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
   
None.

DEFAULTS UPON SENIOR SECURITIES.

None.

MINE SAFETY DISCLOSURES.

Not Applicable.

OTHER INFORMATION.

None.
 

 
 
 
 
 
EXHIBITS
   
31.1
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
31.2
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
32.1
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
32.2
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
101.INS
XBRL Instance Document
   
101.SCH
XBRL Taxonomy Extension Schema Document
   
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document
   
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document
   
101.LAB
XBRL Taxonomy Extension Label Linkbase Document
   
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

   
VIRTUAL PIGGY, INC.
       
       
       
Date:
November 8, 2013
By:
/s/ Joseph Dwyer
     
Joseph Dwyer
     
Chief Financial Officer
(Duly authorized officer and principal accounting officer)
 
 
 
 
 
 34

EX-31.1 2 ex31_1.htm EXHIBIT 31.1 ex31_1.htm
Exhibit 31.1

CERTIFICATION

I, Jo Webber, certify that:
 
 
1. 
I have reviewed this quarterly report on Form 10-Q of Virtual Piggy, Inc.;
 
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
 
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Date:  November 8, 2013
By:
/s/ Jo Webber
   
Jo Webber
   
Chief Executive Officer
 
 
 
 

EX-31.2 3 ex31_2.htm EXHIBIT 31.2 ex31_2.htm
Exhibit 31.2

CERTIFICATION

I, Joseph Dwyer, certify that:
 
 
1.
I have reviewed this quarterly report on Form 10-Q of Virtual Piggy, Inc.

 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
 
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
  
 
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:  November 8, 2013
By:
/s/ Joseph Dwyer
   
Joseph Dwyer
   
Chief Financial Officer
 
 

EX-32.1 4 ex32_1.htm EXHIBIT 32.1 ex32_1.htm
Exhibit 32.1
 
CERTIFICATION OF
CHIEF EXECUTIVE OFFICER
OF VIRTUAL PIGGY, INC.
PURSUANT TO 18 U.S.C. SECTION 1350


In connection with the Quarterly Report on Form 10-Q of Virtual Piggy, Inc. (the "Company") for the period ended September 30, 2013, as filed with the Securities and Exchange Commission (the "Report"), I, Jo Webber, Chief Executive Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, that:

 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date:  November 8, 2013
/s/ Jo Webber
 
Jo Webber
 
Chief Executive Officer
 
 
 
 

EX-32.2 5 ex32_2.htm EXHIBIT 32.2 ex32_2.htm
Exhibit 32.2

CERTIFICATION OF
CHIEF FINANCIAL OFFICER
OF VIRTUAL PIGGY, INC.
PURSUANT TO 18 U.S.C. SECTION 1350


In connection with the Quarterly Report on Form 10-Q of Virtual Piggy, Inc. (the "Company") for the period ended September 30, 2013, as filed with the Securities and Exchange Commission (the "Report"), I, Joseph Dwyer, Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, that:

 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 

Date:  November 8, 2013
/s/ Joseph Dwyer
 
Joseph Dwyer
 
Chief Financial Officer
 
 
 
 
 
 

EX-101.INS 6 vpig-20130930.xml EXHIBIT 101.INS false --12-31 Q3 2013 2013-09-30 10-Q 0001437283 111396768 Accelerated Filer VIRTUAL PIGGY, INC. 704602 1393206 53 955 38035 65560 19580 40054 26300114 35002330 638516 549915 88601 88601 65000 28000 395221 65000 28000 395221 124338 426095 65560 78243 7546 3374 19617 7718 7990784 5566175 7466589 4785277 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Basis of Presentation</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The financial statements are presented in accordance with Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") 915 for development stage entities.</div> <!--EndFragment--></div> </div> 186159 3119056 7371036 4583551 4583551 2932897 -2787485 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Cash and Cash Equivalents</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents.</div> <!--EndFragment--></div> </div> 250000 0.50 0.50 3.00 1.80 0.04 0.50 0.50 0.50 1.00 0.50 0.50 1.00 0.5 287255 6250000 5000000 0.5 1 125000 62500 15000 0.0001 0.0001 150000000 150000000 101417508 111386768 15000 101417508 111386768 35288276 43818703 65371422 66871422 101417508 111386768 50000 50000 10142 11140 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Comprehensive Income</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows FASB ASC 220 in reporting comprehensive income.&nbsp;&nbsp;Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.&nbsp;&nbsp;Since the Company has no items of other comprehensive income (loss), comprehensive income (loss) is equal to net income (loss).</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Concentration of Credit Risk Involving Cash</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company may have deposits with a financial institution which at times exceed Federal Depository Insurance coverage of $250,000.&nbsp;&nbsp;</div> <!--EndFragment--></div> </div> 30333470 8580738 2020652 11377436 5310035 20930 571428 285714 75000 200000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> NOTE 4 - NOTES PAYABLE</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In September 2011, the Company commenced a private placement of up to 10 units at a price of $50,000 per unit to accredited investors.&nbsp;&nbsp;One unit consisted of a demand note payable in the amount of $50,000 due November 12, 2012, warrants to purchase 15,000 shares of common stock at an exercise price of $.50 per share with a term expiring November 12, 2012, and 15,000 shares of common stock.&nbsp;&nbsp;In December 2011, the Company completed the private placement and raised $500,000.&nbsp;&nbsp;The warrants were valued at $20,930, fair value, using the Black-Scholes option pricing model to calculate the grant-date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 39.8% to 62.8%, risk free interest rate of .1% and expected option life of 1.2 years.&nbsp;&nbsp;The shares of common stock were valued at $82,655 or $.45 to $.70 per share, fair value.&nbsp;&nbsp;Both the warrant value and the shares of common stock were treated as a discount to the value of the note payable in accordance with FASB ASC 835-30-25, <font style="FONT-STYLE: italic; DISPLAY: inline">Recognition</font> and were being accreted over the term of the note payable for financial statement purposes.&nbsp;&nbsp;During the years ended December 31, 2012 and 2011, $65,560 and $38,035 of interest was accreted on the notes payable.&nbsp;&nbsp;As of December 31, 2011, $150,000 of the $500,000 was repaid.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On February 8, 2012, February 27, 2012, and April 10, 2012, $100,000, $50,000, and $25,000 respectively, of the notes payable were repaid.&nbsp;&nbsp;&nbsp;On April 26, 2012, the remaining balance of the notes payable and accrued interest of $25,000 was converted into 571,428 shares of the Company&#39;s common stock and warrants to purchase 285,714 shares of the Company&#39;s common stock.</div> <!--EndFragment--></div> </div> 0.20 50000 2012-11-12 483409 1.97 1.17 1.80 0.52 0.58 0.58 0.58 0.65 1.23 1.54 1.35 1.36 0.50 0.50 0.65 0.70 2.17 1.55 0.75 0.75 1.01 1.15 1.00 2.04 1.56 65000 63510 73349 15818 40091 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> NOTE 8 - STOCK OPTIONS AND WARRANTS</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During 2008, the Board of Directors ("Board") of the Company adopted the 2008 Equity Incentive Plan ("2008 Plan") that was approved by the shareholders.&nbsp;&nbsp;Under the 2008 Plan, the Company is authorized to grant options to purchase up to 25,000,000 shares of common stock to any officer, other employee or director of, or any consultant or other independent contractor who provides services to the Company.&nbsp;&nbsp;The 2008 Plan is intended to permit stock options granted to employees under the 2008 Plan to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended ("Incentive Stock Options").&nbsp;&nbsp;All options granted under the 2008 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options ("Non-Statutory Stock Options").&nbsp;&nbsp;As of September 30, 2013, options to purchase 14,053,000 shares of common stock have been issued and are unexercised, and&nbsp;61,667 shares of common stock are available to be issued under the 2008 Plan.&nbsp;&nbsp;</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During 2013, Board adopted the 2013 Equity Incentive Plan ("2013 Plan").&nbsp;&nbsp;Under the 2013 Plan, the Company is authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based awards of up to an aggregate of 5,000,000 shares of common stock to any officer, employee, director or consultant.&nbsp;&nbsp;The 2013 Plan is intended to permit, upon stockholder approval, stock options granted to employees under the 2013 Plan to qualify as Incentive Stock Options.&nbsp;&nbsp;All options granted under the 2013 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be Non-Statutory Stock Options.&nbsp;&nbsp;As of September 30, 2013, under the 2013 Plan options to purchase 3,702,500 shares of common stock have been issued and are unexercised, and 1,297,500 shares of common stock remain available for grants under the 2013 Plan.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The plans are administered by the Board, or a designated committee thereof, which determines the persons to whom awards will be granted, the number of awards to be granted, and the specific terms of each grant, including the vesting thereof, subject to the terms of the plans.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In connection with Incentive Stock Options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company).</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Volatility in all instances presented is the Company&#39;s estimate of volatility that is based on the volatility of other public companies that are in closely related industries to the Company.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Employee and Non-Employee Director Grants</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On January 27, 2012, the Company issued an employee an option to purchase 30,000 shares of the Company&#39;s common stock at $.52 per share.&nbsp;&nbsp;These options have been valued at $3,718, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.4%, risk free interest rate of 0.8% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On February 28, 2012, the Company issued an employee an option to purchase 25,000 shares of the Company&#39;s common stock at $.58 per share.&nbsp;&nbsp;These options have been valued at $3,120, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.0%, risk free interest rate of .8% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On March 2, 2012, the Company issued a Board member an option to purchase 250,000 shares of the Company&#39;s common stock at $.58 per share.&nbsp;&nbsp;These options have been valued at $33,975, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.9%, risk free interest rate of .9% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;This option was expensed immediately.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On March 5, 2012, the Company issued an employee an option to purchase 25,000 shares of the Company&#39;s common stock at $.58 per share.&nbsp;&nbsp;These options have been valued at $2,680, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.0%, risk free interest rate of .9% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On March 31, 2012, the Company issued five employees, options to purchase 4,010,000 shares in the aggregate of the Company&#39;s common stock at $.65 per share.&nbsp;&nbsp;These options have been valued at $759,810, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of 1.04% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In April 2012, the Company issued six employees options to purchase an aggregate of 80,000 shares of the Company&#39;s common stock at exercise prices ranging from $.65 to $.97 per share.&nbsp;&nbsp;These options were valued at $17,310 fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 30.2% to 33.4%, risk free interest rate of .82% to 1.04% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In June 2012, the Company issued three employees and one Board member options to purchase an aggregate of 470,000 shares of the Company&#39;s common stock at exercise prices ranging from $1.53 to $1.82 per share.&nbsp;&nbsp;These options were valued at $217,293, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 30.3% to 35.5%, risk free interest rate of .68% to .72% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term or immediately if there is no vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In July 2012, the Company issued one employee options to purchase an aggregate of 15,000 shares of the Company&#39;s common stock at an exercise price of $1.23 per share.&nbsp;&nbsp;These options were valued at $5,493 fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 32.9%, risk free interest rate of .61% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In August 2012, the Company issued seven employees options to purchase an aggregate of 380,000 shares of the Company&#39;s common stock at exercise prices ranging from $1.26 to $1.43 per share.&nbsp;&nbsp;These options were valued at $123,381, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5% to 29.1%, risk free interest rate of .63% to .69% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In September 2012, the Company issued one employee options to purchase 75,000 shares of the Company&#39;s common stock at an exercise price of $1.54 per share.&nbsp;&nbsp;These options were valued at $26,303, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.5%, risk free interest rate of .62% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In October 2012, the Company issued one employee options to purchase 75,000 shares of the Company&#39;s common stock at an exercise price of $1.35 per share.&nbsp;&nbsp;These options were valued at $23,263 fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.5%, risk free interest rate of .70% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In November 2012, the Company issued fourteen employees options to purchase an aggregate of 1,295,000 shares of the Company&#39;s common stock at exercise prices between $1.01 and $1.35 per share.&nbsp;&nbsp;These options were valued at $371,313, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 26.1% and 29.3%, risk free interest rate between .76% and .83% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In March 2008, the Company issued options to purchase 4,500,000 shares of common stock to three directors.&nbsp;&nbsp;On January 24, 2013, the expiration date for unexpired and unexercised options of 4,250,000 was extended from March 3, 2013 to March 3, 2015.&nbsp; The incremental increase in value was $1,253, which was expensed immediately.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In January 2013, the Company issued eighteen employees options to purchase an aggregate of 260,000 shares of the Company&#39;s common stock at exercise prices between $0.99 and $1.05 per share.&nbsp;&nbsp;These options were valued at $62,662 fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 23.3% and 26.1%, risk free interest rate between .78% and .89% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In February 2013, the Company issued four employees options to purchase an aggregate of 760,000 shares of the Company&#39;s common stock at exercise prices between $1.07 and $1.21 per share.&nbsp;&nbsp;These options were valued at $199,843 fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 22.5% and 25.1%, risk free interest rate between .78% and .88% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In March 2013, the Company issued an employee options to purchase 2,500 shares of the Company&#39;s common stock at an exercise price of $1.36 per share.&nbsp;&nbsp;These options were valued at $728 fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.5%, risk free interest rate of .76% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In April 2013, the Company issued an employee options to purchase 200,000 shares of the Company&#39;s common stock at an exercise price of $1.56 per share.&nbsp;&nbsp;These options were valued at $74,159, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.3%, risk free interest rate of .76% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In May 2013, the Company issued two employees options to purchase an aggregate of 55,000 shares of the Company&#39;s common stock at an exercise price of $2.16 and $2.29 per share.&nbsp;&nbsp;These options were valued at $26,954, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5% to 25.3%, risk free interest rate of .84% to .85% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In June 2013, the Company issued two employees options to purchase an aggregate of 250,000 shares of the Company&#39;s common stock at exercise prices of $2.40 and $2.92 per share.&nbsp;&nbsp;The vesting of 50,000 of these options is predicated on meeting certain milestones, therefore&nbsp;&nbsp;&nbsp;such options have not been valued.&nbsp;&nbsp;The remaining options were valued at $129,343, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.6% to 26.3%, risk free interest rate of 1.03% to 1.48% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In August 2013, the Company issued three employees options to purchase an aggregate of 210,000 shares of the Company&#39;s common stock at exercise prices of $2.00 and $2.35 per share.&nbsp;&nbsp;These options were valued at $124,392, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.2% to 30.3%, risk free interest rate of 1.38% to 1.61% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In September 2013, the Company issued two employees options to purchase an aggregate of 10,000 shares of the Company&#39;s common stock at an exercise price of $1.97 per share.&nbsp;&nbsp;These options were valued at $4,500, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 21.8%, risk free interest rate of 1.71% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the three year vesting term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Cumulatively and for the three and nine months ended September 30, 2013, the Company expensed $1,446,783, $210,380 and $546,776 and for the three and nine months ended September 30, 2012, the Company expensed $81,588 and $274,757 relative to employee options/warrants granted.&nbsp;&nbsp;As of September 30, 2013, there was $1,746,505 of unrecognized compensation expense related to employee non-vested market-based share awards.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> A summary of stock option/warrant transactions for employees and independent board members from December 31, 2011 to September 30, 2013 is as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Option/Warrants</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2011</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">9,467,858</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">$.04 to $.90</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.19</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">6,730,000</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 1.82</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.34</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Issued under Private Placements</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">500,786</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.50</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.01</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified from non-employee</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">810,000</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 0.75</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">-</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(250,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.04</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2012</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">17,258,644</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> .04 to 1.82</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.48</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">2,802,500</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.99 to 2.92</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.26</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified&nbsp;to non-employee, net</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">(235,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">)</td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 2.30</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.02</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">(2,816,667</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">)</td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.04 to 0.75</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.01</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired/terminated</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">(245,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 2.92</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%">&nbsp;</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, September 30, 2013</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">16,764,477</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">$.04 to $2.40</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.7</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercisable, September 30, 2013</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">9,315,310</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">$.04 to $2.30</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.4</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Weighted Average Remaining Life,</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Exercisable, September 30, 2013 (years)</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.8</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Non-Employee Grants</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> On January 2, 2012, the Company issued a consultant an option to purchase 250,000 shares of the Company&#39;s common stock at $.50 per share.&nbsp;&nbsp;These options have been valued at $51,692 fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.2%, risk free interest rate of 0.9% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed when the service is provided.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On January 17, 2012, the Company issued a consultant an option to purchase 200,000 shares of the Company&#39;s common stock at $.50 per share.&nbsp;&nbsp;These options have been valued at $31,437, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 28.0%, risk free interest rate of 0.8% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted were expensed immediately.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On March 31, 2012, the Company issued two consultants options to purchase 100,000 shares in the aggregate of the Company&#39;s common stock at $.65 per share.&nbsp;&nbsp;These options have been valued at $18,947, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of 1.04% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted were expensed immediately.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 1, 2012, the Company issued a company owned by the former manager of corporate development an option to purchase 250,000 shares of the Company&#39;s common stock at $.70 per share pursuant to an agreement that also required a cash payment of $150,000.&nbsp;&nbsp;These options have been valued at $43,028, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of 1.04% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance. Options granted were expensed through May 31, 2013, the term of the agreement.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In May 2012, the Company issued a consultant options to purchase an aggregate of 100,000 shares of the Company&#39;s common stock at an exercise price of $2.17 per share.&nbsp;&nbsp;These options were valued at $79,978 fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of .75% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted were expensed immediately.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In July 2012, the Company issued a consultant options to purchase an aggregate of 100,000 shares of the Company&#39;s common stock at an exercise price of $1.55 per share.&nbsp;&nbsp;These options were valued at $40,373 fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.3%, risk free interest rate of .64% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed when the services are provided.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In August 2012, the Company issued two consultants options to purchase an aggregate of 400,000 shares of the Company&#39;s common stock at exercise prices ranging from $.35 to $1.11 per share.&nbsp;&nbsp;These options were valued at $321,221, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 27.1% to 30.5%, risk free interest rate of .27% to .67% and expected option lives of from two to five years.&nbsp;&nbsp;The options expire between two and five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed when the services are provided.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In September 2012, the Company issued a consultant options to purchase 100,000 shares of the Company&#39;s common stock at an exercise price of $.75 per share.&nbsp;&nbsp;These options were valued at $81,697, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.6%, risk free interest rate of .27% and expected option life of two years.&nbsp;&nbsp;The options expire two years from the date of issuance.&nbsp;&nbsp;Options granted are expensed when the service is provided.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In October 2012, the Company issued a consultant options to purchase 50,000 shares of the Company&#39;s common stock at an exercise price of $.75 per share.&nbsp;&nbsp;These options were valued at $5,381, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5%, risk free interest rate of .19% and expected option life of one year.&nbsp;&nbsp;The options expire one year from the date of issuance.&nbsp;&nbsp;The options granted are expensed when the service was provided.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In November 2012, the Company issued four consultants options to purchase an aggregate of 765,000 shares of the Company&#39;s common stock at an exercise price of $1.01 per share.&nbsp;&nbsp;These options were valued at $188,830, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 26.1%, risk free interest rate of .76% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted were expensed immediately.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 10.1pt; text-align: justify; TEXT-INDENT: 0pt"> In December 2012, the Company issued a merchant warrants to purchase 500,000 shares of the Company&#39;s common stock at an exercise price of $1.15 per share.&nbsp;&nbsp;The vesting of these warrants was predicated on meeting certain milestones. As of December 31, first milestone was met resulting in the vesting of 150,000 warrants. The fair value of the vested warrants was $58,595, which was expensed immediately. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.7%, risk free interest rate of .76% and expected option life of one year. As of September 30, 2013, the remaining milestones were met which provided vesting of the remaining 350,000 warrants.&nbsp;&nbsp;The fair value of these warrants was $549,915, which was expensed immediately.&nbsp;&nbsp;The warrants expire five years from the date of issuance.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In January 2013, the Company issued a consultant options to purchase 5,000 shares of the Company&#39;s common stock at an exercise price of $1.00 per share.&nbsp;&nbsp;These options were valued at $1,106 fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.3%, risk free interest rate of .78% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the term of the agreement.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In March 2013, the Company issued two consultants options to purchase 1,130,000 shares of the Company&#39;s common stock at exercise prices of $0.75 and $1.48 per share.&nbsp;&nbsp;130,000 of these options vested immediately and were valued at $54,228, fair value.&nbsp;&nbsp;The vesting of the remaining 1 million options is predicated on meeting certain milestones, which were not met as of September 30, 2013. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.6% and 25.5%, risk free interest rate of .25% and .80% and expected option life of two to five years.&nbsp;&nbsp;The options expire two to five years from the date of issuance.&nbsp;&nbsp;The vested options granted, were expensed immediately.&nbsp;&nbsp;The remaining unvested options will be expensed when it is probable that the milestones will be achieved.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In April 2013, the Company issued a consultant options to purchase 100,000 shares of the Company&#39;s common stock at an exercise price of $2.04 per share.&nbsp;&nbsp;These options were valued at $44,603, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 26.5%, risk free interest rate of .68% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted were expensed immediately.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In May 2013, the Company issued two consultants options to purchase 125,000 shares in the aggregate of the Company&#39;s common stock at exercise prices ranging from $3.05 to $3.28 per share.&nbsp;&nbsp;These options were valued at $51,869, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.1% to 23.2%, risk free interest rate of .29% to .31% and expected option life of two years.&nbsp;&nbsp;The options expire two years from the date of issuance.&nbsp;&nbsp;Options granted are expensed over the term of the agreement.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In May 2013, the Company, as part of the cost of the Company&#39;s Offering described in Note 7, issued the placement agent warrants to purchase 287,255 shares of the Company&#39;s common stock at an exercise price of $1.80 per share.&nbsp;&nbsp;These warrants were valued at $409,749, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 23.4% to 23.7%, risk free interest rate of .49% and expected option life of three years.&nbsp;&nbsp;The warrants expire three years from the date of issuance.&nbsp;&nbsp;The warrants granted were recorded as stock issuance costs and reduced additional paid in capital.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In July 2013, the Company issued two consultants options to purchase 100,000 shares in the aggregate of the Company&#39;s common stock at exercise prices ranging from $.75 to $2.61 per share.&nbsp;&nbsp;These options were valued at $124,338, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.8% to 26.6%, risk free interest rate of 1.35% to 1.66% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;$124,338 was expensed immediately.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In September 2013, the Company issued a consultant options to purchase 100,000 shares of the Company&#39;s common stock at an exercise price of $1.17 per share.&nbsp;&nbsp;These options were valued at $26,208, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.1%, risk free interest rate of 1.39% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted will be <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> over the term of the agreement, which is three years</font>.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Cumulatively and for the three and nine months ended September 30, 2013 and 2012, the Company expensed $1,803,849, $687,229 and&nbsp;$818,619 and for the three and nine months ended September 30, 2012 the Company expensed $142,086 and $203,593 relative to non-employee options/warrants granted.&nbsp;&nbsp;As of September 30, 2013, there was $90,984 of unrecognized compensation expense related to non-vested market-based share awards to non-employees.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The following table summarizes non-employee (excluding independent board members) stock options/warrants of the Company from December 31, 2011 to September 30, 2013 as follows:</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Option/Warrant</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2011</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,184,286</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">$0.04 to $2.30</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.76</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">2,915,000</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.35 to 2.17</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.12</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Issued under Private Placement</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">11,967,152</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 1.00</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.38</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified to employee</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">(810,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">)</td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 0.75</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">-</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(350,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.04</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">(375,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.91 to 1.00</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2012</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">16,531,438</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"> 0.35 to 2.30</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.63</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">1,753,750</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 3.28</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.17</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Issued under Private Placement</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">1,723,533</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1.80 to 3.00</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.30</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified from employee, net</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">235,000</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 2.30</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> .02</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">(2,995,185</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">)</td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> .35 to .50</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">-</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired/Cancelled</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">(1,405,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 1.00</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, September 30, 2013</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">15,843,536</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">$0.35 to $3.28</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.99</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercisable, September 30, 2013</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">14,388,536</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">$0.50 to $3.28</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.93</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Weighted Average Remaining Life,</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Exercisable, September 30, 2013 (years)</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.4</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> A summary of stock option/warrant transactions for employees and independent board members from December 31, 2011 to September 30, 2013 is as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: arial" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Option/Warrants</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2011</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">9,467,858</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">$.04 to $.90</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.19</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">6,730,000</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 1.82</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.34</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Issued under Private Placements</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">500,786</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.50</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.01</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified from non-employee</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">810,000</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 0.75</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">-</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(250,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.04</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2012</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">17,258,644</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> .04 to 1.82</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.48</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">2,802,500</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.99 to 2.92</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.26</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified&nbsp;to non-employee, net</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">(235,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">)</td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 2.30</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.02</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">(2,816,667</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">)</td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.04 to 0.75</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.01</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired/terminated</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">(245,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 2.92</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%">&nbsp;</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&nbsp;</td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, September 30, 2013</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">16,764,477</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">$.04 to $2.40</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.7</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercisable, September 30, 2013</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">9,315,310</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">$.04 to $2.30</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.4</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Weighted Average Remaining Life,</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Exercisable, September 30, 2013 (years)</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.8</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> <!--EndFragment--></div> </div> -0.11 -0.02 -0.11 -0.05 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Loss Per Share</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows FASB ASC 260 when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.&nbsp;&nbsp;Because the Company reported a net loss for the three and nine months ended September 30, 2013 and 2012, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and diluted loss per share were the same.</div> <!--EndFragment--></div> </div> 82655 20930 3718 3120 33975 2680 759810 17310 217293 5493 123381 26303 23263 371313 62662 199843 728 51692 31437 18947 43028 79978 40373 321221 81697 5381 188830 1106 54228 1446783 274757 81588 546776 210380 1803849 203593 142086 818619 687229 519080 74159 26954 129343 44603 51869 409749 124392 4500 124338 26208 1746505 90984 0.80 0.70 0.70 0.85 0.80 2.43 0.80 0.70 0.75 0.75 0.001 1.00 2.00 1.00 1.00 0.02 0.02 0.01 0.31 0.01 0.20 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.035 0.75 0.80 0.70 0.80 0.80 1.80 0.07 1.00 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.50 1.00 0.90 0.49 2.43 0.04 0.25 0.20 0.70 0.75 0.09 0.76 0.10 0.11 0.19 0.95 0.70 0.85 0.75 0.17 0.40 0.11 0.22 0.53 0.68 0.14 0.42 0.80 0.80 1.07 0.35 0.75 0.09 1.66 1.80 0.04 0.35 0.75 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fair Value of Financial Instruments</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s financial instruments consist of cash, accounts receivable and accounts payable and accrued expenses.&nbsp;&nbsp;The carrying value of cash, accounts receivable and accounts payable and accrued expenses approximate fair value, because of their short maturity.</div> <!--EndFragment--></div> </div> 13678 33295 362496 604572 P20Y 268856 604572 46130 53714 -2726 3683571 871823 320052 1512798 587343 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> NOTE 5 - INCOME TAXES</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Income tax expense was $0 for the three and nine months ended September 30, 2013 and 2012.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> As of January 1, 2013, the Company had no unrecognized tax benefits, and accordingly, the Company did not recognize interest or penalties during 2013 related to unrecognized tax benefits.&nbsp;&nbsp;There has been no change in unrecognized tax benefits during the nine months ended September 30, 2013, and there was no accrual for uncertain tax positions as of September 30, 2013.&nbsp;&nbsp;Tax years from 2008 through 2012 remain subject to examination by major tax jurisdictions.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> There is no income tax benefit for the losses for the three and nine months ended September 30, 2013 and 2012, since management has determined that the realization of the net tax deferred asset is not assured and has created a valuation allowance for the entire amount of such benefits.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Income Taxes</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes.&nbsp;&nbsp;Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.&nbsp;&nbsp;Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.&nbsp;&nbsp;Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.&nbsp;&nbsp;Tax years from 2008 through 2012 remain subject to examination by major tax jurisdictions.</div> <!--EndFragment--></div> </div> 1715704 346561 238602 955 -1125 902 63510 62233 -1490 -75000 42768 200771 23735 180271 75000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> NOTE 3 - PATENTS</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company continues to apply for patents.&nbsp;&nbsp;Accordingly, costs associated with the registration of these patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents (20 years).&nbsp;&nbsp;At September 30, 2013 and 2012, unamortized capitalized patent costs were $604,572 and $268,856.&nbsp;&nbsp;Amortization expense for patents was $7,718 and $19,617 for the three and nine months ended September 30, 2013 and $3,374 and $7,546 for the three and nine months ended September 30, 2012.</div> <!--EndFragment--></div> </div> 531834 90560 2498 25000 18136 3448 1910 9481 3167 4791035 3312537 49071 7072125 1740952 886215 3912056 1515701 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> NOTE 9 - OPERATING LEASES</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> For the three and nine months ended September 30, 2013, total rent expense under leases amounted to $117,447 and $244,318 and for the three and nine months ended September 30, 2012, total rent expense under leases amounted to $54,640 and $113,389.&nbsp;&nbsp;At September 30, 2013, the Company was obligated under various non-cancelable operating lease arrangements for property as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="TEXT-ALIGN: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: arial; TEXT-ALIGN: center" cellspacing="0" cellpadding="0" width="40%"> <tr style="TEXT-ALIGN: center" bgcolor="#cceeff"> <td valign="bottom" width="28%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2013</div> </td> <td valign="bottom" width="22%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="3%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="43%">116,622</td> <td style="TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="28%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2014</div> </td> <td valign="bottom" width="22%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="3%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="43%">142,570</td> <td style="TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2015</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="22%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="3%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="43%">39,688</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="22%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="3%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="43%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="22%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="3%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="43%">298,880</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> NOTE 6 - LITIGATION SETTLEMENT</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In December 2012, the Company entered into a settlement agreement with an investor, whereby the Company would pay the investor $450,000 in return for the investor returning warrants issued to the investor.&nbsp;&nbsp;The Company received $75,000 from its insurance carrier with respect to this litigation and the $450,000 settlement was paid in January 2013.</div> <!--EndFragment--></div> </div> 7990784 5566175 1154602 1393206 450000 70149 99156 26000672 7757932 7287969 -793463 -292363 -298284 -20623658 -4532672 -9777170 -983886 -2236476 -1489190 -2724796 -12039726 -11366427 -983886 -30840501 -2236476 -1489190 -2724796 -8666655 -12039726 -2018734 -11366427 -5305486 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recently Adopted Accounting Pronouncements</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of September 30, 2013 and for the period then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company&#39;s financial statements.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recently Issued Accounting Pronouncements Not Yet Adopted</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of September 30, 2013, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company&#39;s financial statements.</div> <!--EndFragment--></div> </div> -513698 -87112 1910 9481 3167 150000 298880 39688 142570 116622 113389 54640 244318 117447 427496 668082 30000 450000 488221 28000 395221 28000 60783 637868 198388 261693 155595 93975 36591 0.0001 0.0001 2000000 2000000 0 0 0 0 20500 200771 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Reclassifications</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Certain amounts in the 2012 financial statements have been reclassified in order for them to be in conformity with the 2013 presentation.</div> <!--EndFragment--></div> </div> 75000 23796584 7936932 6070595 6070595 500000 500000 4341282 297500 10000 850000 14000 100000 4836157 75000 747500 569000 24000 185000 185000 1873309 1427595 1330342 17250 10235480 4422241 242116 1931801 1034270 2255260 361036 118724 652303 256296 116279 152870 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recoverability of Long-Lived Assets</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 360-10-35 <font style="FONT-STYLE: italic; DISPLAY: inline">"Impairment or Disposal of Long-lived Assets"</font>, long-lived assets to be held and used are analyzed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable or that the useful lives of those assets are no longer appropriate. The Company evaluates at each balance sheet date whether events and circumstances have occurred that indicate possible impairment.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company determines the existence of such impairment by measuring the expected future cash flows (undiscounted and without interest charges) and comparing such amount to the carrying amount of the assets. An impairment loss, if one exists, is then measured as the amount by which the carrying amount of the asset exceeds the discounted estimated future cash flows. Assets to be disposed of are reported at the lower of the carrying amount or fair value of such assets less costs to sell. Asset impairment charges are recorded to reduce the carrying amount of the long-lived asset that will be sold or disposed of to their estimated fair values. Charges for the asset impairment reduce the carrying amount of the long-lived assets to their estimated salvage value in connection with the decision to dispose of such assets.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> For the nine month period ended September 30, 2013 and 2012, the Company determined that no impairment was required after going through the impairment testing related to the operating long-lived assets (property and equipment and patents and trademarks).</div> <!--EndFragment--></div> </div> 96699 112816 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Property and Equipment</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Property and equipment are stated at cost less accumulated depreciation and any impairment losses.&nbsp;&nbsp;Expenditures for new equipment and major expenditures for existing equipment are capitalized and depreciated using the straight line method at rates sufficient to depreciate such costs over the estimated productive lives.&nbsp;&nbsp;All other ordinary repair and maintenance costs are expensed as incurred.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s depreciation and amortization policies on property and equipment are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 36pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: arial" cellspacing="0" cellpadding="0" width="60%"> <tr> <td valign="top" width="90%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="top" width="10%" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> Useful life</div> </td> </tr> <tr> <td valign="top" width="90%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="top" width="10%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> (in years)</div> </td> </tr> <tr> <td valign="top" width="90%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="10%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="90%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Computer equipment</div> </td> <td style="TEXT-ALIGN: center" valign="top" width="10%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> &nbsp;3 - 5</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="90%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Furniture and fixtures</div> </td> <td style="TEXT-ALIGN: center" valign="top" width="10%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> &nbsp;7</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s depreciation and amortization policies on property and equipment are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 36pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: arial" cellspacing="0" cellpadding="0" width="60%"> <tr> <td valign="top" width="90%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="top" width="10%" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> Useful life</div> </td> </tr> <tr> <td valign="top" width="90%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="top" width="10%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> (in years)</div> </td> </tr> <tr> <td valign="top" width="90%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="10%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="90%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Computer equipment</div> </td> <td style="TEXT-ALIGN: center" valign="top" width="10%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> &nbsp;3 - 5</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="90%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Furniture and fixtures</div> </td> <td style="TEXT-ALIGN: center" valign="top" width="10%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> &nbsp;7</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> P7Y P3Y P5Y 42768 172500 130000 14560 14560 32224 20001 30072 6506 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> NOTE 10 - RELATED PARTY TRANSACTIONS</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> From inception through December 1, 2010, the Company utilized offices leased by affiliates of certain of the Company&#39;s board members without charge.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: justify">During the three and nine months ended September 30, 2013 and 2012, a consultant and beneficial owner of the Company, owning more than five percent of the outstanding common shares of the Company, was paid for consulting and travel expenses to provide strategic advice to the Company.&nbsp;&nbsp; On January 1, 2013, the Company entered into an agreement with this consultant, whereby the Company would pay the consultant $12,500 per month beginning January 1, 2013 for a term of one year.&nbsp;&nbsp;In June 2013, this contract was terminated. Consulting fees paid during the three and nine months ended September 30, 2013 were $0 and $130,000 and $0 and $172,500 was paid for the three and nine months ended September 30, 2012.&nbsp;&nbsp;Reimbursable business expenses of $6,506 and $30,072 were paid during the three and nine months ended September 30, 2013, and $20,001 and $32,224 were paid during the three and nine months ended September 30, 2012.&nbsp;&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> During the three and nine months ended September 30, 2013 and 2012, a marketing company owned by the Company&#39;s Secretary and his spouse was paid $0 and $14,560 respectively.</div> <!--EndFragment--></div> </div> 150000 100000 50000 25000 572500 175000 2024710 356096 188717 612958 179476 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Research and&nbsp;&nbsp;Development Costs</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In accordance with FASB ASC 730, research and development costs are expensed when incurred.&nbsp;</div> <!--EndFragment--></div> </div> -19474074 -30840501 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Revenue Recognition</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In accordance with Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No. 104, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue Recognition</font> (Codified in FASB ASC 605), the Company will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, the Company will generally recognize revenue at the time of the sale utilizing Virtual Piggy payment method at checkout.</div> <!--EndFragment--></div> </div> 6667 1195 8 1528 1382 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> At September 30, 2013, the Company was obligated under various non-cancelable operating lease arrangements for property as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="TEXT-ALIGN: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: arial; TEXT-ALIGN: center" cellspacing="0" cellpadding="0" width="40%"> <tr style="TEXT-ALIGN: center" bgcolor="#cceeff"> <td valign="bottom" width="28%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2013</div> </td> <td valign="bottom" width="22%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="3%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="43%">116,622</td> <td style="TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="28%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2014</div> </td> <td valign="bottom" width="22%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="3%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="43%">142,570</td> <td style="TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2015</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="22%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="3%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="43%">39,688</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="22%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="3%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="43%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="22%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="3%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="43%">298,880</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The following table summarizes non-employee (excluding independent board members) stock options/warrants of the Company from December 31, 2011 to September 30, 2013 as follows:</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Option/Warrant</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2011</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,184,286</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">$0.04 to $2.30</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.76</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">2,915,000</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.35 to 2.17</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.12</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Issued under Private Placement</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">11,967,152</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 1.00</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.38</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified to employee</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">(810,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">)</td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 0.75</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">-</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(350,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.04</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">(375,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.91 to 1.00</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, December 31, 2012</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">16,531,438</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"> 0.35 to 2.30</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.63</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">1,753,750</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 3.28</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.17</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Issued under Private Placement</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">1,723,533</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1.80 to 3.00</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">0.30</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Reclassified from employee, net</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">235,000</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 2.30</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> .02</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercised</div> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">(2,995,185</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">)</td> <td valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> .35 to .50</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">-</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expired/Cancelled</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">(1,405,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.50 to 1.00</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding, September 30, 2013</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">15,843,536</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">$0.35 to $3.28</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.99</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Exercisable, September 30, 2013</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">14,388,536</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%">&nbsp;</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">$0.50 to $3.28</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.93</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Weighted Average Remaining Life,</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Exercisable, September 30, 2013 (years)</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.4</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> <!--EndFragment--></div> </div> 2903912 463109 143484 2037589 1462861 2756411 478350 816261 P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y P3Y 1 150000 350000 58595 549915 2012-11-12 P5Y P5Y P5Y P5Y P2Y P2Y P5Y P5Y P5Y P5Y P2Y P3Y P1Y2M12D P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P2Y P1Y P5Y P1Y P5Y P5Y P2Y P5Y P2Y P5Y P2Y P3Y P2Y P3Y 0.218 0.221 0.29 0.253 0.265 0.254 0.25 0.259 0.25 0.312 0.329 0.245 0.245 0.225 0.292 0.28 0.312 0.312 0.312 0.293 0.256 0.235 0.261 0.247 0.233 0.303 0.266 0.253 0.263 0.232 0.237 0.628 0.334 0.355 0.291 0.293 0.261 0.251 0.305 0.255 0.398 0.302 0.303 0.235 0.261 0.233 0.225 0.271 0.226 0.235 0.236 0.231 0.234 0.242 0.238 Black-Scholes option pricing mode Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model 0.0171 0.0139 0.0069 0.0076 0.0068 0.0049 0.001 0.008 0.008 0.009 0.009 0.0104 0.0061 0.0062 0.007 0.0076 0.009 0.008 0.0104 0.0104 0.0075 0.0064 0.0027 0.0019 0.0076 0.0076 0.0078 0.0161 0.0166 0.0085 0.0148 0.0031 0.0104 0.0072 0.0069 0.0083 0.0089 0.0088 0.0067 0.008 0.0138 0.0135 0.0029 0.0082 0.0068 0.0063 0.0076 0.0078 0.0078 0.0027 0.0025 0.0084 0.0103 25000000 5000000 61667 1297500 14388536 9315310 0.93 0.4 P1Y4M24D P1Y9M18D 375000 1405000 245000 400000 30000 25000 250000 25000 4010000 80000 470000 15000 380000 75000 75000 1295000 4500000 260000 760000 2500 250000 200000 100000 250000 100000 100000 400000 100000 50000 765000 500000 5000 130000 100000 1050000 200000 55000 125000 287255 210000 10000 100000 100000 2915000 1753750 6730000 2802500 -810000 235000 810000 -235000 3184286 16531438 15843536 9467858 17258644 16764477 14053000 3702500 4250000 0.76 0.63 0.99 0.19 0.48 0.70 89286 0.01 0.12 0.17 0.34 0.26 0.02 0.02 2.00 0.75 3.05 0.65 1.53 1.26 1.01 0.99 1.07 0.35 0.75 2.16 2.40 2.35 2.61 3.28 0.97 1.82 1.43 1.35 1.05 1.21 1.11 1.48 2.29 2.92 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Nature of the Business</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> Virtual Piggy, Inc. ("the Company" or</font> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> "Virtual Piggy") is a development stage enterprise incorporated in the state of Delaware on February 11, 2008.&nbsp;&nbsp;&nbsp;Virtual Piggy is a technology company that delivers an online e-commerce solution for the family. Its system allows parents and their children to manage and allocate funds and track the child&#39;s expenditures, savings and charitable giving online. Its system is designed to allow the child to transact online without a credit card by gaining the parent&#39;s permission ahead of time and allowing the parent to set up the rules of use and authorized spending limits.</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Virtual Piggy product enables online businesses to interact and transact with the "Under 18" market in a manner consistent with the Children&#39;s Online Privacy Protection Act ("COPPA") and other similar international children&#39;s privacy laws.&nbsp;&nbsp;Virtual Piggy was launched in the US in 2012 and was launched in the European market in 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has secured <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> 143 agreements with merchants, retail and gaming e-commerce platforms and payment processors.</font>&nbsp;&nbsp;Over 20 of the merchants are using Virtual Piggy live with their e-commerce systems and the Company is in the process of integrating the other signed merchants. The Company is continuing to add merchants. In addition, Virtual Piggy has the capability to offer and deliver digital gift cards.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Basis of Presentation</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The financial statements are presented in accordance with Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") 915 for development stage entities.&nbsp;&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Use of Estimates</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&nbsp;&nbsp;Actual results could differ from these estimates.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Comprehensive Income</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows FASB ASC 220 in reporting comprehensive income.&nbsp;&nbsp;Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.&nbsp;&nbsp;Since the Company has no items of other comprehensive income (loss), comprehensive income (loss) is equal to net income (loss).</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fair Value of Financial Instruments</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s financial instruments consist of cash, accounts receivable and accounts payable and accrued expenses.&nbsp;&nbsp;The carrying value of cash, accounts receivable and accounts payable and accrued expenses approximate fair value, because of their short maturity.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Concentration of Credit Risk Involving Cash</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company may have deposits with a financial institution which at times exceed Federal Depository Insurance coverage of $250,000.&nbsp;&nbsp;</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Cash and Cash Equivalents</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Property and Equipment</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Property and equipment are stated at cost less accumulated depreciation and any impairment losses.&nbsp;&nbsp;Expenditures for new equipment and major expenditures for existing equipment are capitalized and depreciated using the straight line method at rates sufficient to depreciate such costs over the estimated productive lives.&nbsp;&nbsp;All other ordinary repair and maintenance costs are expensed as incurred.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s depreciation and amortization policies on property and equipment are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 36pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" cellspacing="0" cellpadding="0" width="60%"> <tr> <td valign="top" width="90%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="top" width="10%" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> Useful life</div> </td> </tr> <tr> <td valign="top" width="90%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="top" width="10%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> (in years)</div> </td> </tr> <tr> <td valign="top" width="90%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="10%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="90%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Computer equipment</div> </td> <td style="TEXT-ALIGN: center" valign="top" width="10%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> &nbsp;3 - 5</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="90%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Furniture and fixtures</div> </td> <td style="TEXT-ALIGN: center" valign="top" width="10%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> &nbsp;7</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recoverability of Long-Lived Assets</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 360-10-35 <font style="FONT-STYLE: italic; DISPLAY: inline">"Impairment or Disposal of Long-lived Assets"</font>, long-lived assets to be held and used are analyzed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable or that the useful lives of those assets are no longer appropriate. The Company evaluates at each balance sheet date whether events and circumstances have occurred that indicate possible impairment.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company determines the existence of such impairment by measuring the expected future cash flows (undiscounted and without interest charges) and comparing such amount to the carrying amount of the assets. An impairment loss, if one exists, is then measured as the amount by which the carrying amount of the asset exceeds the discounted estimated future cash flows. Assets to be disposed of are reported at the lower of the carrying amount or fair value of such assets less costs to sell. Asset impairment charges are recorded to reduce the carrying amount of the long-lived asset that will be sold or disposed of to their estimated fair values. Charges for the asset impairment reduce the carrying amount of the long-lived assets to their estimated salvage value in connection with the decision to dispose of such assets.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> For the nine month period ended September 30, 2013 and 2012, the Company determined that no impairment was required after going through the impairment testing related to the operating long-lived assets (property and equipment and patents and trademarks).</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Revenue Recognition</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In accordance with Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No. 104, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue Recognition</font> (Codified in FASB ASC 605), the Company will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, the Company will generally recognize revenue at the time of the sale utilizing Virtual Piggy payment method at checkout.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Income Taxes</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes.&nbsp;&nbsp;Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.&nbsp;&nbsp;Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.&nbsp;&nbsp;Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.&nbsp;&nbsp;Tax years from 2008 through 2012 remain subject to examination by major tax jurisdictions.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Loss Per Share</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows FASB ASC 260 when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.&nbsp;&nbsp;Because the Company reported a net loss for the three and nine months ended September 30, 2013 and 2012, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and diluted loss per share were the same.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Start-up Costs</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In accordance with FASB ASC 720<font style="FONT-STYLE: italic; DISPLAY: inline">,</font> start-up costs are expensed as incurred.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Research and&nbsp;&nbsp;Development Costs</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In accordance with FASB ASC 730, research and development costs are expensed when incurred.&nbsp;&nbsp;</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recently Adopted Accounting Pronouncements</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of September 30, 2013 and for the period then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company&#39;s financial statements.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recently Issued Accounting Pronouncements Not Yet Adopted</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of September 30, 2013, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company&#39;s financial statements.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Reclassifications</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Certain amounts in the 2012 financial statements have been reclassified in order for them to be in conformity with the 2013 presentation.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Start-up Costs</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In accordance with FASB ASC 720<font style="FONT-STYLE: italic; DISPLAY: inline">,</font> start-up costs are expensed as incurred.</div> <!--EndFragment--></div> </div> 3529 4382 6537 6687 10142 11140 50000 -50000 1113600 3246778 6222793 7065247 26300114 35002330 -983886 -3220362 -4709552 -7434348 -19474074 -30840501 133243 30798 1519778 -362414 6836182 4172969 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> NOTE 7 - STOCKHOLDERS&#39; EQUITY</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In December 2011, the Company commenced a private placement of up to $5,000,000 consisting of up to 12,500,000 shares of the Company&#39;s common stock and warrants to purchase up to 6,250,000 shares of the Company&#39;s common stock.&nbsp;&nbsp;The shares and warrants were sold in units with each unit comprised of two shares and one warrant at a purchase price of $.80 per unit.&nbsp;The warrants were for a term of two years at an exercise price of $0.50 per share.&nbsp;During December 2011, the Company sold 625,000 units and raised $500,000.&nbsp;&nbsp;On January 11, 2012, the Company amended the Securities Purchase Agreement dated December 1, 2011, by reducing the price of one unit from $.80 to $.70.&nbsp;&nbsp;This increased the number of units to be sold from 6,250,000 units to 7,142,858 units.&nbsp;&nbsp;It also required the Company to issue to one investor an additional 89,286 units, consisting of 178,572 shares common stock and warrants to purchase an additional 89,286 shares of common stock.&nbsp;&nbsp;During the three months ended March 31, 2012, the Company issued an additional 3,922,356 units and raised $2,717,650, net of stock issuance costs of $28,000.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 5, 2012, the Company commenced a private placement of up to $3,500,000 consisting of up to 10,000,000 shares of the Company&#39;s common stock and warrants to purchase up to 5,000,000 shares of the Company&#39;s common stock at an exercise price of $.50 per share.&nbsp;&nbsp;The shares and warrants were sold in units with each unit comprised of two shares and one warrant at a purchase price of $.70 per unit.&nbsp;The warrants were for a term of two years.&nbsp;&nbsp;In accordance with the terms of the offering documents, the offering amount was increased to $4 million.&nbsp; From April 5, 2012 to June 30, 2012, the Company sold 6,201,831 units and raised $4,341,282.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 2, 2012, the Company entered into a settlement agreement with a former consultant of the Company. In connection with the settlement, the Company made a settlement payment to the consultant of $30,000 and issued the consultant 350,000 shares of the Company&#39;s common stock, which were valued at $297,500, fair value, or $.85 per share.&nbsp;&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 10, 2012, a company owned by the Secretary of the Company and his wife exercised options to purchase 250,000 shares of common stock which raised proceeds of $10,000.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On May 2, 2012, the Company entered into a securities purchase agreement with a non-U.S. person, pursuant to which the Company issued and sold 187,500 units at a purchase price of $0.80 per unit, in consideration of gross proceeds of $150,000.&nbsp;&nbsp;Each unit consisted of: (i) two shares of the Company&#39;s common stock, (ii) a warrant to purchase one share of the Company&#39;s common stock at an exercise price of $0.50 per share for a term of two years, and (iii) a warrant to purchase one half share of the Company&#39;s common stock at an exercise price of $1.00 per share for a term of three years.&nbsp;&nbsp;Pursuant to the securities purchase agreement, the purchaser also agreed to purchase an additional $850,000 of units by November 1, 2012.&nbsp;&nbsp;The Company has received $1,000,000 as of March 31, 2013 under this agreement.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On May 21, 2012, the Company issued five consultants an aggregate of 1,363,185 shares of the Company&#39;s common stock for services, which were valued in the aggregate at $3,312,537, fair value or $2.43 per share, which was the stock price on the day of issuance.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On May 25, 2012, an investor exercised options to purchase 350,000 shares of common stock which raised proceeds of $14,000.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 5, 2012, the Company commenced a private placement of up to $100,000 consisting of up to 125,000 units of the Company&#39;s common stock and warrants to purchase up to 125,000 shares of the Company&#39;s common stock at an exercise price of $.50 per share with a term of two years ("Series A Warrants") and warrants to purchase up to 62,500 at an exercise price of $1.00 per share with a term of three years ("Series B Warrants").&nbsp;&nbsp;The shares and warrants were sold in units with each unit comprised of two shares and one Series A warrant and one Series B warrant at a purchase price of $.80 per unit.&nbsp;&nbsp;As of August 8, 2012, the Company has received gross proceeds of $100,000 under this private placement.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During November and December 2012, the Company entered into a private placement for shares of the Company&#39;s common stock.&nbsp;&nbsp;The shares were sold at a purchase price of $.70 per share.&nbsp;&nbsp;Through December 31, 2012, 7,942,858 shares were sold raising $5,560,000.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In December 2012, the Company entered into a private placement for shares of the Company&#39;s common stock. The shares were sold at a purchase price of $.75 per share.&nbsp;&nbsp;Through December 31, 2012, 666,667 shares were sold raising $500,000.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During the first quarter of 2013, the Company entered into a private placement for shares of the Company&#39;s common stock. The shares were sold at a purchase price of $.75 per share.&nbsp;&nbsp;Through March 31, 2013, 1,133,334 shares were sold raising $850,000.&nbsp;&nbsp;Issuance costs related to this private placement were $60,783.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 15, 2013, the Company issued 26,521 restricted shares of the Company&#39;s common stock to five members of the Board of Directors that were valued at $49,071.&nbsp;&nbsp;In conjunction with this the five members of the Board also received in aggregate options to purchase 1,050,000 shares of the Company&#39;s common stock. These options were valued at $519,080, fair value.&nbsp;&nbsp;The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.0%, risk free interest rate of .69% and expected option life of five years.&nbsp;&nbsp;The options expire five years from the date of issuance.&nbsp;&nbsp;Options granted will be expensed over the three year vesting term.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 14.85pt; text-align: justify; TEXT-INDENT: 0pt"> On May 28, 2013, we entered into a Securities Purchase Agreement with accredited investors, pursuant to which we issued and sold an aggregate of 2,572,553 units at a purchase price of $1.80 per unit (the "Offering"), with each unit being comprised of one (1) share of the Company&#39;s common stock and a warrant to purchase one-half (0.5) of a share of common stock at an exercise price of $3.00 per share for a period of three years. On May 29, 2013, we issued and sold an additional&nbsp;&nbsp;&nbsp;&nbsp;300,000 units pursuant to the Offering. The Company retained a placement agent in connection with the Offering. The Company paid the placement agent aggregate placement agent fees in the amount of $151,408 plus $155,118 as an expense allowance. In addition, the placement agent received three year warrants to purchase an aggregate of 287,255 shares of the Company&#39;s common stock at an exercise price of $1.80 per share (See Note 8-Stock Options and Warrants). Net proceeds of the Offering to the Company, after the expense allowance and other expenses, were approximately $4,836,157.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During May 2013, options to purchase 750,000 shares of common stock were exercised at $0.04 per share, options to purchase 300,000 shares of common stock were exercised at $0.35 per share, and options to purchase 66,667 shares of common stock were exercised at $0.75, resulting in proceeds of $185,000.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During May and June 2013, warrants to purchase 2,000,000 shares of common stock were exercised at $.04 per share and warrants to purchase 2,660,685 shares of common stock were exercised at $0.50 per share, resulting in proceeds of $1,330,342.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During July and August 2013, warrants to purchase 34,500 shares of common stock were exercised at $.50 per share, resulting in proceeds of $17,250.</div> <!--EndFragment--></div> </div> 297500 6201831 300000 625000 3922356 350000 250000 187500 350000 125000 7942858 666667 1133334 14285716 614286 625000 10213474 1500000 93750 1436277 285714 2572553 750000 300000 66667 178572 1363185 26521 350000 2995185 250000 2816667 2717650 150000 100000 5560000 500000 850000 3312537 49071 2158412 365481 121344 717931 274088 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Use of Estimates</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&nbsp;&nbsp;Actual results could differ from these estimates.</div> <!--EndFragment--></div> </div> 82087967 91599649 106477739 111372435 50000 -50000 -50000 50000 150631 150631 283460 340173 283460 340173 206604 206604 8825 8825 1253 P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P5Y P2Y P1Y P5Y P5Y P5Y P2Y P5Y P2Y P5Y P5Y P5Y P5Y P5Y P5Y P2Y P3Y P5Y P5Y P5Y P5Y 10000000 12500000 3500000 4000000 5000000 2 2 2 2 10 6250000 7142858 6250000 1 1 1 1 50000 75 29925 30000 750000 30 104970 105000 300000 7 49993 50000 66667 1750000 175 69825 70000 250000 25 9975 10000 250000 25 9975 10000 3000000 300 119700 120000 1000000 100 39900 40000 1000000 100 39900 40000 1000000 100 39900 40000 350000 35 13965 14000 500000 50 19950 20000 500000 50 19950 20000 892858 89 35624 35713 200 79800 80000 2000000 270 1347323 1347593 2695185 2500000 250 99750 100000 2500000 250 99750 100000 1000000 100 39900 40000 250000 25 9975 10000 1000000 100 39900 40000 1000000 100 39900 40000 1000000 100 39900 40000 1000000 100 39900 40000 155118 780 780 0.70 0.45 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> NOTE 2 - GOING CONCERN</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.&nbsp;&nbsp;The Company has incurred significant losses and experienced negative cash flow from operations during the development stage.&nbsp;&nbsp;These conditions raise substantial doubt about the Company&#39;s ability to continue as a going concern.&nbsp;&nbsp;The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Since inception, the Company has focused on developing and implementing&nbsp;its business plan.&nbsp;&nbsp;The Company is paying salaries to management and has utilized&nbsp;offshore&nbsp;programmers on a work for hire basis&nbsp;to assist in developing the demonstration model. The Company believes that its existing cash resources will not be sufficient to sustain operations during the next twelve months. <font style="FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font> The Company currently needs to generate revenue in order to sustain its operations.&nbsp;&nbsp;In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will need to reduce expenses or obtain financing through the sale of debt and/or equity securities.&nbsp;&nbsp;The issuance of additional equity would result in dilution to existing shareholders.&nbsp;&nbsp;If the Company is unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to the Company, the Company would be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s current monetization model is to derive a percentage of all revenues generated by online merchants using the Virtual Piggy service. Merchants are billed at the end of each month for all transactions that have been processed by the Company on their behalf in the prior month.&nbsp;&nbsp;As the merchant base and consumer base grows, and as the trend to higher online spending levels continues, the Company expects to generate additional revenue to support operations.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> If sufficient revenues are not generated to sustain operations or additional funding cannot be obtained in the short term, the Company will need to reduce monthly expenditures to a level that will enable the Company to continue until such funds can be obtained.&nbsp;&nbsp;The Company raised $6,070,595, net of stock issuance costs of $395,221 through a private placements of its equity securities from January 1, 2013 through September 30, 2013.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company also raised $185,000 from the exercise of options and $1,427,595 from the exercise of warrants during the nine months ended September 30, 2013.&nbsp;&nbsp;</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company is in the development stage at September 30, 2013.&nbsp;&nbsp;Successful completion of the Company&#39;s development program, and the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities and achieving a level of sales adequate to support the Company&#39;s cost structure.&nbsp;&nbsp;However, there can be no assurances that the Company will be able to secure additional equity investment or achieve an adequate sales level.&nbsp; <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> The Company&#39;s current cash is expected to sustain the Company through December 2013.</font></div> <!--EndFragment--></div> </div> 19000000 1900 17100 19000 9625000 963 1924037 1925000 125 499875 500000 1250000 20426948 2044 7084888 7086932 7142858 714 249286 250000 287 5170308 5170595 2872553 571428 57 199943 200000 2625000 262 1049738 1050000 6642858 665 231835 232500 125000 13 49987 50000 100000 10 48990 49000 1363185 136 3312401 3312537 1080427 108 1080319 1080427 65000 6 -6 483750 48 400694 400742 150000 15 82650 82665 400000 40 399960 400000 100000 10 199990 200000 375000 38 74962 75000 111111 11 99989 100000 100000 10 99990 100000 100000 10 99990 100000 7942858 794 5559206 5560000 666667 67 499933 500000 1133334 113 849887 850000 2560 2560 2560 350000 35 297465 297500 3 49068 49071 26521 20930 20930 12500 784247 784247 13816 3146 13816 3146 759292 34372 759292 34372 2219 2219 52243 52243 918 636 918 636 10462 27899 10462 27899 46019 46019 39751 39751 107859 37506 107859 37506 143 20 11967152 1723533 500786 0.50 1.80 1.00 3.00 0.50 0.38 0.30 0.01 395467 395467 151408 0.1 1.1 250000 1130000 0.04 2.30 0.50 3.28 0.04 0.04 0.04 0.75 0.35 0.50 0.91 0.50 1.00 1.00 0.50 2.92 50000 1000000 0.35 0.50 2.17 3.28 0.50 0.99 1.82 2.92 0.50 0.50 0.75 2.30 0.50 0.50 0.75 2.30 0.04 0.35 0.35 2.30 2.30 3.28 0.04 0.04 0.04 0.90 1.82 2.40 2000000 2660685 34500 62500 62500 1000000 xbrli:shares iso4217:USD iso4217:USD vpig:warrants iso4217:USD xbrli:shares xbrli:pure 0001437283 vpig:NonStatutoryStockOptionsMember vpig:SeptemberTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-09-01 2013-09-30 0001437283 vpig:NonStatutoryStockOptionsMember vpig:DecemberTwoThousandTwelveOptionsIssuedToConsultantsMember 2013-09-01 2013-09-30 0001437283 vpig:IncentiveStockOptionsMember vpig:SeptemberTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-09-01 2013-09-30 0001437283 vpig:IncentiveStockOptionsMember vpig:AugustTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-08-01 2013-08-31 0001437283 us-gaap:PatentsMember 2013-07-01 2013-09-30 0001437283 us-gaap:LimitedLiabilityCompanyMember 2013-07-01 2013-09-30 0001437283 vpig:NonStatutoryStockOptionsMember vpig:OptionsIssuedToNonEmployeesMember 2013-07-01 2013-09-30 0001437283 vpig:IncentiveStockOptionsMember vpig:OptionsIssuedToEmployeesMember 2013-07-01 2013-09-30 0001437283 vpig:ConsultantAndBeneficialOwnerMember 2013-07-01 2013-09-30 0001437283 2013-07-01 2013-09-30 0001437283 vpig:JulyAndAugustTwoThousandThirteenWarrantsExercisedMember 2013-07-01 2013-08-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:JulyTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-07-01 2013-07-31 0001437283 vpig:IncentiveStockOptionsMember vpig:JuneTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-06-01 2013-06-30 0001437283 vpig:ExerciseOfWarrantsTransactionOneMember 2013-05-01 2013-08-31 0001437283 vpig:MayAndJuneTwoThousandThirteenWarrantsExercisedTransactionTwoMember 2013-05-01 2013-06-30 0001437283 vpig:MayAndJuneTwoThousandThirteenWarrantsExercisedTransactionOneMember 2013-05-01 2013-06-30 0001437283 vpig:MayAndJuneTwoThousandThirteenWarrantsExercisedMember 2013-05-01 2013-06-30 0001437283 us-gaap:WarrantMember 2013-05-01 2013-05-31 0001437283 vpig:MayTwoThousandThirteenOptionsExercisedTransactionThreeMember 2013-05-01 2013-05-31 0001437283 vpig:MayTwoThousandThirteenOptionsExercisedTransactionTwoMember 2013-05-01 2013-05-31 0001437283 vpig:MayTwoThousandThirteenOptionsExercisedTransactionOneMember 2013-05-01 2013-05-31 0001437283 vpig:MayTwoThousandThirteenOptionsExercisedMember 2013-05-01 2013-05-31 0001437283 vpig:MayTwoThousandThirteenSecuritiesPurchaseAgreementMember 2013-05-01 2013-05-31 0001437283 vpig:ExerciseOfWarrantsTransactionOneMember 2013-05-01 2013-05-31 0001437283 vpig:ExerciseOfOptionsTransactionThreeMember 2013-05-01 2013-05-31 0001437283 vpig:ExerciseOfOptionsTransactionTwoMember 2013-05-01 2013-05-31 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2013-05-01 2013-05-31 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsThroughPrivatePlacementMember 2013-05-01 2013-05-31 0001437283 vpig:WarrantTypeOneMember vpig:MayTwoThousandThirteenSecuritiesPurchaseAgreementMember 2013-05-01 2013-05-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:MayTwoThousandThirteenOptionsIssuedForPrivatePlacementMember 2013-05-01 2013-05-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:MayTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-05-01 2013-05-31 0001437283 vpig:IncentiveStockOptionsMember vpig:MayTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-05-01 2013-05-31 0001437283 us-gaap:RestrictedStockMember vpig:AprilTwoThousandThirteenIssuanceMember 2013-04-01 2013-04-30 0001437283 vpig:AprilTwoThousandThirteenIssuanceMember 2013-04-01 2013-04-30 0001437283 vpig:NonStatutoryStockOptionsMember vpig:AprilTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-04-01 2013-04-30 0001437283 vpig:IncentiveStockOptionsMember vpig:AprilTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-04-01 2013-04-30 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MinimumMember vpig:MarchTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-03-01 2013-03-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MaximumMember vpig:MarchTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-03-01 2013-03-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:MarchTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-03-01 2013-03-31 0001437283 vpig:IncentiveStockOptionsMember vpig:MarchTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-03-01 2013-03-31 0001437283 vpig:IncentiveStockOptionsMember vpig:FebruaryTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-02-01 2013-02-28 0001437283 us-gaap:AdditionalPaidInCapitalMember 2013-01-01 2013-09-30 0001437283 us-gaap:RetainedEarningsMember 2013-01-01 2013-09-30 0001437283 us-gaap:PatentsMember 2013-01-01 2013-09-30 0001437283 us-gaap:MinimumMember vpig:NonemployeeOptionsAndWarrantsIssuedForServicesMember 2013-01-01 2013-09-30 0001437283 us-gaap:MinimumMember vpig:EmployeeOptionsIssuedForServicesTransactionOneMember 2013-01-01 2013-09-30 0001437283 us-gaap:MaximumMember vpig:NonemployeeOptionsAndWarrantsIssuedForServicesMember 2013-01-01 2013-09-30 0001437283 us-gaap:MaximumMember vpig:EmployeeOptionsIssuedForServicesTransactionOneMember 2013-01-01 2013-09-30 0001437283 us-gaap:LimitedLiabilityCompanyMember 2013-01-01 2013-09-30 0001437283 vpig:FairValueOfRevaluedOptionsMember 2013-01-01 2013-09-30 0001437283 vpig:CommonStockSubscriptionForUnitsThroughPrivatePlacementMember 2013-01-01 2013-09-30 0001437283 us-gaap:FurnitureAndFixturesMember 2013-01-01 2013-09-30 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MinimumMember 2013-01-01 2013-09-30 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MaximumMember 2013-01-01 2013-09-30 0001437283 vpig:NonStatutoryStockOptionsMember vpig:OptionsIssuedToNonEmployeesMember 2013-01-01 2013-09-30 0001437283 vpig:NonStatutoryStockOptionsMember 2013-01-01 2013-09-30 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MinimumMember 2013-01-01 2013-09-30 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MaximumMember 2013-01-01 2013-09-30 0001437283 vpig:IncentiveStockOptionsMember vpig:OptionsIssuedToEmployeesMember 2013-01-01 2013-09-30 0001437283 vpig:IncentiveStockOptionsMember 2013-01-01 2013-09-30 0001437283 vpig:ConsultantAndBeneficialOwnerMember 2013-01-01 2013-09-30 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2013-01-01 2013-09-30 0001437283 vpig:CommonStockSubscriptionsMember 2013-01-01 2013-09-30 0001437283 us-gaap:ComputerEquipmentMember us-gaap:MinimumMember 2013-01-01 2013-09-30 0001437283 us-gaap:ComputerEquipmentMember us-gaap:MaximumMember 2013-01-01 2013-09-30 0001437283 us-gaap:CommonStockMember 2013-01-01 2013-09-30 0001437283 2013-01-01 2013-09-30 0001437283 us-gaap:WarrantMember 2013-01-01 2013-03-31 0001437283 vpig:IssuanceOfSharesOfCommonStockThroughPrivatePlacementTransactionOneMember 2013-01-01 2013-03-31 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsThroughPrivatePlacementMember 2013-01-01 2013-03-31 0001437283 vpig:QuarterOneTwoThousandThirteenIssuanceMember 2013-01-01 2013-03-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:JanuaryTwoThousandThirteenOptionsIssuedToConsultantsMember 2013-01-01 2013-01-31 0001437283 vpig:IncentiveStockOptionsMember vpig:MarchTwoThousandEightOptionsIssuedToDirectorsMember 2013-01-01 2013-01-31 0001437283 vpig:IncentiveStockOptionsMember vpig:JanuaryTwoThousandThirteenOptionsIssuedToEmployeesMember 2013-01-01 2013-01-31 0001437283 vpig:NovemberAndDecemberTwoThousandTwelveIssuanceMember 2012-12-01 2012-12-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:DecemberTwoThousandTwelveOptionsIssuedToConsultantsMember 2012-12-01 2012-12-31 0001437283 vpig:DecemberTwoThousandTwelveIssuanceMember 2012-12-01 2012-12-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:NovemberTwoThousandTwelveOptionsIssuedToConsultantsMember 2012-11-01 2012-11-30 0001437283 vpig:IncentiveStockOptionsMember vpig:NovemberTwoThousandTwelveOptionsIssuedToEmployeesMember 2012-11-01 2012-11-30 0001437283 vpig:NonStatutoryStockOptionsMember vpig:OctoberTwoThousandTwelveOptionsIssuedToConsultantsMember 2012-10-01 2012-10-31 0001437283 vpig:IncentiveStockOptionsMember vpig:OctoberTwoThousandTwelveOptionsIssuedToEmployeesMember 2012-10-01 2012-10-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:SeptemberTwoThousandTwelveOptionsIssuedToConsultantsMember 2012-09-01 2012-09-30 0001437283 vpig:IncentiveStockOptionsMember vpig:SeptemberTwoThousandTwelveOptionsIssuedToEmployeesMember 2012-09-01 2012-09-30 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MinimumMember vpig:AugustTwoThousandTwelveOptionsIssuedToConsultantsMember 2012-08-01 2012-08-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MaximumMember vpig:AugustTwoThousandTwelveOptionsIssuedToConsultantsMember 2012-08-01 2012-08-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:AugustTwoThousandTwelveOptionsIssuedToConsultantsMember 2012-08-01 2012-08-31 0001437283 vpig:JulyFifthTwoThousandTwelveIssuanceMember 2012-08-01 2012-08-31 0001437283 vpig:IncentiveStockOptionsMember vpig:AugustTwoThousandTwelveOptionsIssuedToEmployeesMember 2012-08-01 2012-08-31 0001437283 us-gaap:PatentsMember 2012-07-01 2012-09-30 0001437283 us-gaap:LimitedLiabilityCompanyMember 2012-07-01 2012-09-30 0001437283 vpig:NonStatutoryStockOptionsMember vpig:OptionsIssuedToNonEmployeesMember 2012-07-01 2012-09-30 0001437283 vpig:IncentiveStockOptionsMember vpig:OptionsIssuedToEmployeesMember 2012-07-01 2012-09-30 0001437283 vpig:ConsultantAndBeneficialOwnerMember 2012-07-01 2012-09-30 0001437283 vpig:AprilFifthTwoThousandTwelvePrivatePlacementMember 2012-07-01 2012-09-30 0001437283 2012-07-01 2012-09-30 0001437283 vpig:WarrantTypeTwoMember vpig:JulyFifthTwoThousandTwelveIssuanceMember 2012-07-01 2012-07-31 0001437283 vpig:WarrantTypeOneMember vpig:JulyFifthTwoThousandTwelveIssuanceMember 2012-07-01 2012-07-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:JulyTwoThousandTwelveOptionsIssuedToConsultantsMember 2012-07-01 2012-07-31 0001437283 vpig:JulyFifthTwoThousandTwelveIssuanceMember 2012-07-01 2012-07-31 0001437283 vpig:IncentiveStockOptionsMember vpig:JulyTwoThousandTwelveOptionsIssuedToEmployeesMember 2012-07-01 2012-07-31 0001437283 vpig:IncentiveStockOptionsMember vpig:JuneTwoThousandTwelveOptionsIssuedToEmployeesMember 2012-06-01 2012-06-30 0001437283 vpig:MaySecondTwoThousandTwelveIssuanceMember 2012-05-01 2013-03-31 0001437283 vpig:IssuanceOfSharesOfCommonStockForFutureServicesMember 2012-05-01 2012-05-31 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2012-05-01 2012-05-31 0001437283 vpig:WarrantTypeTwoMember vpig:MaySecondTwoThousandTwelveIssuanceMember 2012-05-01 2012-05-31 0001437283 vpig:WarrantTypeOneMember vpig:MaySecondTwoThousandTwelveIssuanceMember 2012-05-01 2012-05-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:MayTwoThousandTwelveOptionsIssuedToConsultantsMember 2012-05-01 2012-05-31 0001437283 vpig:MayTwentyFirstTwoThousandTwelveIssuanceMember 2012-05-01 2012-05-31 0001437283 vpig:MayTwentyFifthTwoThousandTwelveIssuanceMember 2012-05-01 2012-05-31 0001437283 vpig:MaySecondTwoThousandTwelveIssuanceMember 2012-05-01 2012-05-31 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2012-04-01 2012-04-30 0001437283 vpig:PrivatePlacementSeptemberTwoThousandElevenToDecemberTwoThousandElevenMember 2012-04-01 2012-04-30 0001437283 vpig:NonStatutoryStockOptionsMember vpig:AprilFirstTwoThousandTwelveOptionsIssuedToConsultantsMember 2012-04-01 2012-04-30 0001437283 vpig:IncentiveStockOptionsMember vpig:AprilTwoThousandTwelveOptionsIssuedToEmployeesMember 2012-04-01 2012-04-30 0001437283 vpig:AprilTwoThousandTwelveIssuanceOfEquityMember 2012-04-01 2012-04-30 0001437283 vpig:AprilTenthTwoThousandTwelveIssuanceMember 2012-04-01 2012-04-30 0001437283 vpig:AprilFifthTwoThousandTwelvePrivatePlacementMember 2012-04-01 2012-04-30 0001437283 vpig:NonStatutoryStockOptionsMember vpig:MarchThirtyFirstTwoThousandTwelveOptionsIssuedToConsultantsMember 2012-03-01 2012-03-31 0001437283 vpig:IncentiveStockOptionsMember vpig:MarchThirtyFirstTwoThousandTwelveOptionsIssuedToEmployeesMember 2012-03-01 2012-03-31 0001437283 vpig:IncentiveStockOptionsMember vpig:MarchSecondTwoThousandTwelveOptionsIssuedToEmployeesMember 2012-03-01 2012-03-31 0001437283 vpig:IncentiveStockOptionsMember vpig:MarchFifthTwoThousandTwelveOptionsIssuedToEmployeesMember 2012-03-01 2012-03-31 0001437283 vpig:PrivatePlacementSeptemberTwoThousandElevenToDecemberTwoThousandElevenMember 2012-02-01 2012-02-29 0001437283 vpig:IncentiveStockOptionsMember vpig:FebruaryTwentyEighthTwoThousandTwelveOptionsIssuedToEmployeesMember 2012-02-01 2012-02-29 0001437283 us-gaap:WarrantMember 2012-01-01 2012-12-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-12-31 0001437283 us-gaap:RetainedEarningsMember 2012-01-01 2012-12-31 0001437283 us-gaap:MinimumMember vpig:NonemployeeOptionsIssuedForServicesTransactionTwoMember 2012-01-01 2012-12-31 0001437283 us-gaap:MinimumMember vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2012-01-01 2012-12-31 0001437283 us-gaap:MinimumMember vpig:EmployeeOptionsIssuedForServicesTransactionTwoMember 2012-01-01 2012-12-31 0001437283 us-gaap:MinimumMember vpig:EmployeeOptionsIssuedForServicesTransactionOneMember 2012-01-01 2012-12-31 0001437283 us-gaap:MaximumMember vpig:NonemployeeOptionsIssuedForServicesTransactionTwoMember 2012-01-01 2012-12-31 0001437283 us-gaap:MaximumMember vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2012-01-01 2012-12-31 0001437283 us-gaap:MaximumMember vpig:EmployeeOptionsIssuedForServicesTransactionTwoMember 2012-01-01 2012-12-31 0001437283 us-gaap:MaximumMember vpig:EmployeeOptionsIssuedForServicesTransactionOneMember 2012-01-01 2012-12-31 0001437283 vpig:CommonStockSubscriptionForUnitsThroughPrivatePlacementMember 2012-01-01 2012-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockWithRespectToSettlementAgreementMember 2012-01-01 2012-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsToDischargeNotesPayableAndAccruedInterestMember 2012-01-01 2012-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockThroughPrivatePlacementTransactionTwoMember 2012-01-01 2012-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockThroughPrivatePlacementTransactionOneMember 2012-01-01 2012-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsThroughPrivatePlacementMember 2012-01-01 2012-12-31 0001437283 vpig:PrivatePlacementSeptemberTwoThousandElevenToDecemberTwoThousandElevenMember 2012-01-01 2012-12-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MinimumMember 2012-01-01 2012-12-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MaximumMember 2012-01-01 2012-12-31 0001437283 vpig:NonStatutoryStockOptionsMember 2012-01-01 2012-12-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MinimumMember 2012-01-01 2012-12-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MaximumMember 2012-01-01 2012-12-31 0001437283 vpig:IncentiveStockOptionsMember 2012-01-01 2012-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2012-01-01 2012-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2012-01-01 2012-12-31 0001437283 us-gaap:CommonStockMember 2012-01-01 2012-12-31 0001437283 2012-01-01 2012-12-31 0001437283 us-gaap:WarrantMember 2012-01-01 2012-09-30 0001437283 us-gaap:PatentsMember 2012-01-01 2012-09-30 0001437283 us-gaap:LimitedLiabilityCompanyMember 2012-01-01 2012-09-30 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsThroughPrivatePlacementMember 2012-01-01 2012-09-30 0001437283 vpig:NonStatutoryStockOptionsMember vpig:OptionsIssuedToNonEmployeesMember 2012-01-01 2012-09-30 0001437283 vpig:IncentiveStockOptionsMember vpig:OptionsIssuedToEmployeesMember 2012-01-01 2012-09-30 0001437283 vpig:ConsultantAndBeneficialOwnerMember 2012-01-01 2012-09-30 0001437283 2012-01-01 2012-09-30 0001437283 vpig:DecemberTwoZeroOneOnePrivatePlacementMember 2012-01-01 2012-03-31 0001437283 vpig:PrivatePlacementSeptemberTwoThousandElevenToDecemberTwoThousandElevenMember 2012-01-01 2012-02-08 0001437283 vpig:NonStatutoryStockOptionsMember vpig:JanuarySeventeenthTwoThousandTwelveOptionsIssuedToConsultantsMember 2012-01-01 2012-01-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:JanuarySecondTwoThousandTwelveOptionsIssuedToConsultantsMember 2012-01-01 2012-01-31 0001437283 vpig:IncentiveStockOptionsMember vpig:JanuaryTwentySeventhTwoThousandTwelveOptionsIssuedToEmployeesMember 2012-01-01 2012-01-31 0001437283 vpig:DecemberTwoZeroOneOnePrivatePlacementMember 2012-01-01 2012-01-31 0001437283 us-gaap:WarrantMember vpig:PrivatePlacementSeptemberTwoThousandElevenToDecemberTwoThousandElevenMember 2011-12-01 2011-12-31 0001437283 us-gaap:WarrantMember 2011-12-01 2011-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsThroughPrivatePlacementMember 2011-12-01 2011-12-31 0001437283 vpig:PrivatePlacementSeptemberTwoThousandElevenToDecemberTwoThousandElevenMember 2011-12-01 2011-12-31 0001437283 vpig:DecemberTwoZeroOneOnePrivatePlacementMember 2011-12-01 2011-12-31 0001437283 us-gaap:CommonStockMember vpig:PrivatePlacementSeptemberTwoThousandElevenToDecemberTwoThousandElevenMember 2011-12-01 2011-12-31 0001437283 vpig:PrivatePlacementSeptemberTwoThousandElevenToDecemberTwoThousandElevenMember 2011-09-01 2011-09-30 0001437283 us-gaap:MinimumMember vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2011-07-01 2011-08-31 0001437283 us-gaap:MaximumMember vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2011-07-01 2011-08-31 0001437283 vpig:IssuanceOfSharesOfCommonStockForFutureServicesMember 2011-06-01 2011-06-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-12-31 0001437283 us-gaap:RetainedEarningsMember 2011-01-01 2011-12-31 0001437283 us-gaap:MinimumMember vpig:FairValueOfRevaluedWarrantsMember 2011-01-01 2011-12-31 0001437283 us-gaap:MaximumMember vpig:FairValueOfRevaluedWarrantsMember 2011-01-01 2011-12-31 0001437283 vpig:PrivatePlacementSeptemberTwoThousandElevenToDecemberTwoThousandElevenMember 2011-01-01 2011-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2011-01-01 2011-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2011-01-01 2011-12-31 0001437283 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0001437283 2011-01-01 2011-12-31 0001437283 vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2011-01-01 2011-01-31 0001437283 vpig:ExerciseOfWarrantsTransactionOneMember 2010-12-01 2010-12-31 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2010-12-01 2010-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockForFutureServicesMember 2010-11-01 2010-11-30 0001437283 vpig:IssuanceOfSharesOfCommonStockThroughPrivatePlacementTransactionOneMember 2010-08-01 2010-12-31 0001437283 vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2010-08-01 2010-11-30 0001437283 vpig:ExerciseOfWarrantsTransactionOneMember 2010-04-01 2010-04-30 0001437283 vpig:ExerciseOfWarrantsTransactionOneMember 2010-03-01 2010-03-31 0001437283 vpig:ExerciseOfWarrantsTransactionOneMember 2010-02-01 2010-02-28 0001437283 us-gaap:AdditionalPaidInCapitalMember 2010-01-01 2010-12-31 0001437283 us-gaap:RetainedEarningsMember 2010-01-01 2010-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockForRetirementOfOptionsMember 2010-01-01 2010-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2010-01-01 2010-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2010-01-01 2010-12-31 0001437283 us-gaap:CommonStockMember 2010-01-01 2010-12-31 0001437283 2010-01-01 2010-12-31 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2010-01-01 2010-01-31 0001437283 vpig:ExerciseOfWarrantsTransactionTwoMember 2009-12-01 2009-12-31 0001437283 vpig:ExerciseOfWarrantsTransactionOneMember 2009-12-01 2009-12-31 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2009-12-01 2009-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockForFutureServicesMember 2009-10-01 2009-10-31 0001437283 vpig:ExerciseOfWarrantsTransactionOneMember 2009-10-01 2009-10-31 0001437283 vpig:IssuanceOfSharesOfCommonStockMember 2009-10-01 2009-10-31 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2009-09-01 2009-09-30 0001437283 vpig:IssuanceOfSharesOfCommonStockMember 2009-09-01 2009-09-30 0001437283 vpig:ExerciseOfWarrantsTransactionOneMember 2009-08-01 2009-08-31 0001437283 vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2009-08-01 2009-08-31 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2009-07-01 2009-07-31 0001437283 vpig:IssuanceOfSharesOfCommonStockMember 2009-06-01 2009-06-30 0001437283 vpig:IssuanceOfSharesOfCommonStockMember 2009-04-01 2009-04-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2009-01-01 2009-12-31 0001437283 us-gaap:RetainedEarningsMember 2009-01-01 2009-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2009-01-01 2009-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2009-01-01 2009-12-31 0001437283 us-gaap:CommonStockMember 2009-01-01 2009-12-31 0001437283 2009-01-01 2009-12-31 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2009-01-01 2009-01-31 0001437283 vpig:ExerciseOfWarrantsTransactionOneMember 2008-09-01 2008-09-30 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2008-09-01 2008-09-30 0001437283 vpig:IssuanceOfSharesOfCommonStockToInvestorsMember 2008-08-01 2008-08-31 0001437283 vpig:OptionsIssuedForServicesMember 2008-06-01 2008-06-30 0001437283 vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2008-06-01 2008-06-30 0001437283 us-gaap:WarrantMember 2008-05-01 2008-09-30 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsThroughPrivatePlacementMember 2008-05-01 2008-09-30 0001437283 vpig:ExerciseOfOptionsTransactionOneMember 2008-05-01 2008-05-31 0001437283 vpig:NonemployeeOptionsIssuedForServicesTransactionOneMember 2008-03-01 2008-03-31 0001437283 vpig:EmployeeOptionsIssuedForServicesTransactionOneMember 2008-03-01 2008-03-31 0001437283 vpig:IncentiveStockOptionsMember vpig:MarchTwoThousandEightOptionsIssuedToDirectorsMember 2008-03-01 2008-03-31 0001437283 vpig:NonStatutoryStockOptionsMember vpig:OptionsIssuedToNonEmployeesMember 2008-02-11 2013-09-30 0001437283 vpig:IncentiveStockOptionsMember vpig:OptionsIssuedToEmployeesMember 2008-02-11 2013-09-30 0001437283 2008-02-11 2013-09-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2008-02-11 2008-12-31 0001437283 us-gaap:RetainedEarningsMember 2008-02-11 2008-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2008-02-11 2008-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2008-02-11 2008-12-31 0001437283 us-gaap:CommonStockMember 2008-02-11 2008-12-31 0001437283 2008-02-11 2008-12-31 0001437283 us-gaap:WarrantMember 2008-02-01 2008-02-29 0001437283 vpig:IssuanceOfSharesOfCommonStockAndWarrantsThroughPrivatePlacementMember 2008-02-01 2008-02-29 0001437283 vpig:IssuanceOfSharesOfCommonStockMember 2008-02-01 2008-02-29 0001437283 2013-11-08 0001437283 us-gaap:AdditionalPaidInCapitalMember 2013-09-30 0001437283 us-gaap:RetainedEarningsMember 2013-09-30 0001437283 us-gaap:PatentsMember 2013-09-30 0001437283 vpig:TwoZeroZeroEightEquityIncentivePlanMember 2013-09-30 0001437283 vpig:TwoZeroOneThreeEquityIncentivePlanMember 2013-09-30 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MinimumMember 2013-09-30 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MaximumMember 2013-09-30 0001437283 vpig:NonStatutoryStockOptionsMember vpig:OptionsIssuedToNonEmployeesMember 2013-09-30 0001437283 vpig:NonStatutoryStockOptionsMember 2013-09-30 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MinimumMember 2013-09-30 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MaximumMember 2013-09-30 0001437283 vpig:IncentiveStockOptionsMember vpig:OptionsIssuedToEmployeesMember 2013-09-30 0001437283 vpig:IncentiveStockOptionsMember 2013-09-30 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2013-09-30 0001437283 vpig:CommonStockSubscriptionsMember 2013-09-30 0001437283 us-gaap:CommonStockMember 2013-09-30 0001437283 2013-09-30 0001437283 vpig:JulyAndAugustTwoThousandThirteenWarrantsExercisedMember 2013-08-31 0001437283 vpig:MayAndJuneTwoThousandThirteenWarrantsExercisedTransactionTwoMember 2013-06-30 0001437283 vpig:MayAndJuneTwoThousandThirteenWarrantsExercisedTransactionOneMember 2013-06-30 0001437283 vpig:WarrantTypeTwoMember vpig:MayTwoThousandThirteenSecuritiesPurchaseAgreementMember 2013-05-31 0001437283 vpig:WarrantTypeOneMember vpig:MayTwoThousandThirteenSecuritiesPurchaseAgreementMember 2013-05-31 0001437283 vpig:IncentiveStockOptionsMember vpig:MarchTwoThousandEightOptionsIssuedToDirectorsMember 2013-01-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0001437283 us-gaap:RetainedEarningsMember 2012-12-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MinimumMember 2012-12-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MaximumMember 2012-12-31 0001437283 vpig:NonStatutoryStockOptionsMember 2012-12-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MinimumMember 2012-12-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MaximumMember 2012-12-31 0001437283 vpig:IncentiveStockOptionsMember 2012-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2012-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2012-12-31 0001437283 us-gaap:CommonStockMember 2012-12-31 0001437283 2012-12-31 0001437283 us-gaap:PatentsMember 2012-09-30 0001437283 2012-09-30 0001437283 vpig:WarrantTypeTwoMember vpig:JulyFifthTwoThousandTwelveIssuanceMember 2012-07-31 0001437283 vpig:WarrantTypeOneMember vpig:JulyFifthTwoThousandTwelveIssuanceMember 2012-07-31 0001437283 vpig:WarrantTypeTwoMember vpig:MaySecondTwoThousandTwelveIssuanceMember 2012-05-31 0001437283 vpig:WarrantTypeOneMember vpig:MaySecondTwoThousandTwelveIssuanceMember 2012-05-31 0001437283 vpig:PrivatePlacementSeptemberTwoThousandElevenToDecemberTwoThousandElevenMember 2012-04-30 0001437283 vpig:AprilFifthTwoThousandTwelvePrivatePlacementMember 2012-04-30 0001437283 vpig:DecemberTwoZeroOneOnePrivatePlacementMember 2012-01-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0001437283 us-gaap:RetainedEarningsMember 2011-12-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MinimumMember 2011-12-31 0001437283 vpig:NonStatutoryStockOptionsMember us-gaap:MaximumMember 2011-12-31 0001437283 vpig:NonStatutoryStockOptionsMember 2011-12-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MinimumMember 2011-12-31 0001437283 vpig:IncentiveStockOptionsMember us-gaap:MaximumMember 2011-12-31 0001437283 vpig:IncentiveStockOptionsMember 2011-12-31 0001437283 vpig:DecemberTwoZeroOneOnePrivatePlacementMember 2011-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2011-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2011-12-31 0001437283 us-gaap:CommonStockMember vpig:PrivatePlacementSeptemberTwoThousandElevenToDecemberTwoThousandElevenMember 2011-12-31 0001437283 us-gaap:CommonStockMember 2011-12-31 0001437283 2011-12-31 0001437283 us-gaap:WarrantMember vpig:PrivatePlacementSeptemberTwoThousandElevenToDecemberTwoThousandElevenMember 2011-09-30 0001437283 vpig:PrivatePlacementSeptemberTwoThousandElevenToDecemberTwoThousandElevenMember 2011-09-30 0001437283 us-gaap:CommonStockMember vpig:PrivatePlacementSeptemberTwoThousandElevenToDecemberTwoThousandElevenMember 2011-09-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0001437283 us-gaap:RetainedEarningsMember 2010-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2010-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2010-12-31 0001437283 us-gaap:CommonStockMember 2010-12-31 0001437283 2010-12-31 0001437283 vpig:IssuanceOfSharesOfCommonStockForConversionOfNotesPayableMember 2010-11-30 0001437283 us-gaap:AdditionalPaidInCapitalMember 2009-12-31 0001437283 us-gaap:RetainedEarningsMember 2009-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2009-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2009-12-31 0001437283 us-gaap:CommonStockMember 2009-12-31 0001437283 2009-12-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2008-12-31 0001437283 us-gaap:RetainedEarningsMember 2008-12-31 0001437283 vpig:TwoZeroZeroEightEquityIncentivePlanMember 2008-12-31 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2008-12-31 0001437283 vpig:CommonStockSubscriptionsMember 2008-12-31 0001437283 us-gaap:CommonStockMember 2008-12-31 0001437283 2008-12-31 0001437283 us-gaap:AdditionalPaidInCapitalMember 2008-02-10 0001437283 us-gaap:RetainedEarningsMember 2008-02-10 0001437283 vpig:CommonStockSubscriptionsReceivableMember 2008-02-10 0001437283 vpig:CommonStockSubscriptionsMember 2008-02-10 0001437283 us-gaap:CommonStockMember 2008-02-10 0001437283 2008-02-10 EX-101.SCH 7 vpig-20130930.xsd EXHIBIT 101.SCH 002 - Statement - Balance Sheets link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 003 - Statement - Balance Sheets (Parenthetical) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 001 - Document - Document and Entity Information link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 102 - Disclosure - GOING CONCERN link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40201 - Disclosure - GOING CONCERN (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 105 - Disclosure - INCOME TAXES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40501 - Disclosure - INCOME TAXES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40504 - Disclosure - INCOME TAXES (Schedule of Deferred Tax Assets) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40503 - Disclosure - INCOME TAXES (Schedule of Effective Tax Rate Reconciliation) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40502 - Disclosure - INCOME TAXES (Schedule of Income Tax Benefit (Provision)) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 305 - Disclosure - INCOME TAXES (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 106 - Disclosure - LITIGATION SETTLEMENT link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40601 - Disclosure - LITIGATION SETTLEMENT (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 104 - Disclosure - NOTES PAYABLE link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40401 - Disclosure - NOTES PAYABLE (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 109 - Disclosure - OPERATING LEASES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40901 - Disclosure - OPERATING LEASES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40902 - Disclosure - OPERATING LEASES (Schedule of Non Cancelable Operating Lease Arrangements) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 309 - Disclosure - OPERATING LEASES (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 103 - Disclosure - PATENTS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40301 - Disclosure - PATENTS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 110 - Disclosure - RELATED PARTY TRANSACTIONS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41001 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 111 - Disclosure - SUBSEQUENT EVENTS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 107 - Disclosure - STOCKHOLDERS' EQUITY link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41101 - Disclosure - SUBSEQUENT EVENTS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40701 - Disclosure - STOCKHOLDERS' EQUITY (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 108 - Disclosure - STOCK OPTIONS AND WARRANTS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40801 - Disclosure - STOCK OPTIONS AND WARRANTS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40802 - Disclosure - STOCK OPTIONS AND WARRANTS (Incentive Stock Option and Warrant Transactions for Employees) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40803 - Disclosure - STOCK OPTIONS AND WARRANTS (Non Employee Stock Options and Warrants) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 308 - Disclosure - STOCK OPTIONS AND WARRANTS (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 007 - Statement - Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 005 - Statement - Statement of Changes in Stockholders' Equity (Deficit) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 006 - Statement - Statement of Changes in Stockholders' Equity (Deficit) (Parenthetical) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 004 - Statement - Statements of Operations link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink EX-101.CAL 8 vpig-20130930_cal.xml EXHIBIT 101.CAL EX-101.DEF 9 vpig-20130930_def.xml EXHIBIT 101.DEF EX-101.LAB 10 vpig-20130930_lab.xml EXHIBIT 101.LAB Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued expenses Accounts Receivable, Net, Current Accounts Receivable Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Additional Paid in Capital Additional paid in capital TOTAL ASSETS Assets ASSETS Assets [Abstract] TOTAL CURRENT ASSETS Assets, Current CURRENT ASSETS Assets, Current [Abstract] Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Commitments and Contingencies CONTINGENCIES Common stock subscribed Common Stock, Value, Subscriptions Common Stock, Share Subscribed but Unissued, Subscriptions Receivable Common stock subscription receivable Common Stock, Value, Issued Common stock, $ .0001 par value; 150,000,000 shares authorized; 111,386,768 and 101,417,508 shares issued and outstanding at September 30, 2013 and December 31, 2012 Deposit Deposit Assets Patents and trademarks, net of accumulated amoritization of $33,295 and $13,678 Finite-Lived Intangible Assets, Net Furniture and fixtures Furniture and Fixtures, Gross Insurance Settlements Receivable, Current Insurance receivable TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Liabilities and Equity [Abstract] Liabilities, Current TOTAL CURRENT LIABILITIES Liabilities, Current [Abstract] CURRENT LIABILITIES Litigation settlement Loss Contingency Accrual, at Carrying Value Computer equipment Machinery and Equipment, Gross Total other assets Other Assets Other Assets [Abstract] OTHER ASSETS Preferred Stock, Value, Issued Preferred stock, $.0001 par value; 2,000,000 shares authorized; none issued and outstanding at September 30, 2013 and December 31, 2012 Prepaid expenses Prepaid Expense, Current PROPERTY AND EQUIPMENT Property, Plant and Equipment [Abstract] Gross property and equipment Property, Plant and Equipment, Gross Total property and equipment Property, Plant and Equipment, Net Retained Earnings (Accumulated Deficit) Deficit accumulated during the development stage Balance Sheets [Abstract] Stockholders' Equity Attributable to Parent STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY Stockholders' Equity Attributable to Parent [Abstract] Common Stock, Par or Stated Value Per Share Common stock, par value per share Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Patents and trademarks, accumulated amoritization Finite-Lived Intangible Assets, Accumulated Amortization Preferred Stock, Par or Stated Value Per Share Preferred stock, par value per share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Document and Entity Information [Abstract] Document and Entity Information [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Period End Date Document Period End Date Document Type Document Type Entity Central Index Key Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Filer Category Entity Filer Category Entity Registrant Name Entity Registrant Name GOING CONCERN [Abstract] Going Concern [Abstract]. Going Concern [Text Block] Going Concern [Text Block] GOING CONCERN Stock issuance costs Payments of Stock Issuance Costs Amount raised from private placement Proceeds from Issuance of Private Placement Proceeds from exercise of options Proceeds from Stock Options Exercised Proceeds from Warrant Exercises Proceeds from exercise of warrants INCOME TAXES [Abstract] INCOME TAXES Income Tax Disclosure [Text Block] Income Tax Expense (Benefit) Income tax expense Net operating loss carryforwards Operating Loss Carryforwards Operating Loss Carryforwards, Expiration Date Net operating loss carryforward expiration date Total deferred tax assets, net of valuation allowance Deferred Tax Assets, Net Deferred Tax Assets, Operating Loss Carryforwards Deferred tax asset for NOL carryforwards Deferred tax asset for stock based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Deferred Tax Assets, Valuation Allowance Valuation allowance Income tax benefit (provision), percent Effective Income Tax Rate, Continuing Operations Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate U.S. federal income tax benefit at Federal statutory rate, percent Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance Change in valuation allowance, percent Non-deductible other expenses, percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other Non-deductible share-based compensation, percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost Effective Income Tax Rate Reconciliation, State and Local Income Taxes State tax, net of federal tax effect, percent Income Tax Reconciliation, Change in Deferred Tax Assets Valuation Allowance Change in valuation allowance Income Tax Reconciliation, Income Tax Expense (Benefit), at Federal Statutory Income Tax Rate U.S. federal income tax benefit at Federal statutory rate Non-deductible other expenses Income Tax Reconciliation, Nondeductible Expense, Other Non-deductible share-based compensation Income Tax Reconciliation, Nondeductible Expense, Share-based Compensation Cost State tax, net of federal tax effect Income Tax Reconciliation, State and Local Income Taxes Current Income Tax Expense (Benefit) Current Deferred Deferred Income Tax Expense (Benefit) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of Components of Income Tax Benefit (Provision) Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Deferred Tax Assets, Liabilities and Related Valuation Allowances Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Reconciliation of the Statutory Tax Rate to the Company's Effective Income Tax Rate Legal Matters and Contingencies [Text Block] LITIGATION SETTLEMENT LITIGATION SETTLEMENT [Abstract] Cash payment for settlement Payments for Legal Settlements Proceeds from Insurance Settlement, Operating Activities Proceeds from insurance carrier NOTES PAYABLE [Abstract] NOTES PAYABLE Debt Disclosure [Text Block] Accreted interest on notes payable Accretion Expense Exercise price of warrants Class of Warrant or Right, Exercise Price of Warrants or Rights Number of shares entitled by warrants Class of Warrant or Right, Number of Securities Called by Warrants or Rights Common Stock [Member] Common shares issued per unit Debt Conversion, Converted Instrument, Shares Issued Common shares issued for notes payable conversion Debt Conversion, Converted Instrument, Warrants or Options Issued Fair value of warrants issued as discount for notes payable Debt Instrument, Face Amount Note payable included per unit Note payable maturity date Debt Instrument, Maturity Date Fair value of issued equity Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Capitalized Amount Equity Component [Domain] Equity Issuance Number Of Units Authorized Equity Issuance Number Of Units Authorized Units authorized Equity Issuance Price Per Unit Equity Issuance Price Per Unit Price per unit Fair value per share, common stock, minimum Fair Value Per Share Common Stock Maximum Fair Value Per Share Common Stock Maximum Fair value per share, common stock, maximum Fair Value Per Share Common Stock Minimum Fair value per share, common stock Accrued interest payable Interest Payable Notes Payable Equity Issuance [Axis] Notes Payable Equity Issuance [Axis] Notes Payable Equity Issuance [Domain] Notes Payable Equity Issuance [Domain] Notes Payable Equity Issuance [Line Items] Notes Payable Equity Issuance [Line Items] Notes Payable Equity Issuance [Table] Notes Payable Equity Issuance [Table] Private Placement September Two Thousand Eleven To December Two Thousand Eleven [Member] Private Placement September Two Thousand Eleven To December Two Thousand Eleven [Member] Private Placement, September 2011 to December 2011 [Member] Repayments of notes payable Repayments of Notes Payable Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date Warrants/Options expiration date Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected life Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected volatility, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected volatility, minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Method Used Pricing model used in calculation of grant-date fair value Risk free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Statement, Equity Components [Axis] Warrant [Member] OPERATING LEASES [Abstract] Leases of Lessee Disclosure [Text Block] OPERATING LEASES Operating Leases, Rent Expense, Net Total rent expense under leases Total Operating Leases, Future Minimum Payments Due 2015 Operating Leases, Future Minimum Payments, Due in Three Years 2014 Operating Leases, Future Minimum Payments, Due in Two Years Operating Leases, Future Minimum Payments, Remainder of Fiscal Year 2013 Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule of Future Minimum Rental Commitments Under Non-Cancelable Operating Lease Arrangements PATENTS [Abstract] PATENTS Intangible Assets Disclosure [Text Block] Amortization of Intangible Assets Amortization expense for patents Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Asset, Useful Life Amortization period Unamortized capitalized patent costs Finite-Lived Patents, Gross Patents [Member] Schedule of Finite-Lived Intangible Assets [Table] RELATED PARTY TRANSACTIONS [Abstract] RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] Consultant And Beneficial Owner [Member] Consultant And Beneficial Owner [Member] Consultant and Beneficial Owner [Member] Limited Liability Company [Member] Marketing Company Owned by Secretary [Member] Monthly Payment For Consulting Services Per Agreement The monthly payment for consulting services per agreement for a term of one year. Monthly payment for consulting services per agreement Related Party [Domain] Related Party Transaction, Expenses from Transactions with Related Party Related party expenses Related Party Transaction [Line Items] Related Party Transactions, by Related Party [Axis] Schedule of Related Party Transactions, by Related Party [Table] SUBSEQUENT EVENTS [Abstract] Subsequent Events [Text Block] SUBSEQUENT EVENTS STOCKHOLDERS' EQUITY [Abstract] STOCKHOLDERS' EQUITY Stockholders' Equity Note Disclosure [Text Block] Equity Issuance, Per Share Amount Equity issuance, price or exercise price per security issued Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Options issued Stock Issued During Period, Shares, Restricted Stock Award, Gross Restricted shares issued Subsequent Event [Line Items] Subsequent Event [Member] Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Common stock authorized in private placement, value Equity Issuance Common Shares Authorized During Period, Value. April 5, 2012 Private Placement [Member] April Fifth Two Thousand Twelve Private Placement [Member] April 5, 2012 Issuance [Member] April Tenth Two Thousand Twelve Issuance [Member] April 10, 2012 Issuance [Member] April 10, 2012 Issuance [Member] April Two Thousand Thirteen Issuance [Member] April 15, 2013 Issuance [Member] April Two Thousand Thirteen Issuance [Member] April Two Thousand Twelve Issuance Of Equity [Member] April 2, 2012 Issuance [Member] April 2, 2012 Issuance [Member] August Seventeenth Two Thousand Ten Issuance [Member] August Seventeenth Two Thousand Ten Issuance [Member] August 17, 2010 Issuance [Member] August Two Thousand Ten Issuance In Exchange For Option Retirements [Member] August Two Thousand Ten Issuance In Exchange For Option Retirements [Member] August 2010 Issuance in Exchange for Option Retirements [Member] Award Type [Axis] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Class Of Warrant Or Right Number Of Warrants Required To Call Single Security Unit Class Of Warrant Or Right Number Of Warrants Required To Call Single Security Unit Number of warrants required to purchase one additional share common stock Common stock subscription Common Stock, Value, Outstanding Fair value common stock December Two Thousand Twelve Issuance [Member] December 2012 Issuance [Member] December 2012 Issuance [Member] December Two Zero One One Private Placement [Member] December Two Zero One One Private Placement [Member] December 2011 Private Placement [Member] EquityInstrumentPeriodFromIssuanceToExpiration Equity Instrument Period From Issuance To Expiration Expiration period after issuance Equity Issuance Amount Of Capital Expected To Be Raised Equity Issuance Amount Of Capital Expected To Be Raised Estimate of capital to be raised in private placement Equity Issuance Common Shares Authorized During Period Shares Common stock authorized in private placement, shares Equity Issuance, Common Shares Authorized During Period, Shares. Equity Issuance Common Shares Authorized During Period Value Shares per unit Equity Issuance Number Of Shares Per Unit Equity Issuance Number Of Shares Per Unit Equity Issuance Number Of Warrants Authorized Equity Issuance Number Of Warrants Authorized Warrants authorized in private placement Equity Issuance Number Of Warrants Per Unit Equity Issuance Number Of Warrants Per Unit Warrants per unit Equity Issuance Shares Registered Equity Issuance Shares Registered Shares registered Equity Issuance Since Inception [Axis] Equity Issuance Since Inception [Axis] Equity Issuance Since Inception [Domain] Equity Issuance Since Inception [Domain] Equity Issuance Units Agreed To Be Sold Periodic Installment Amount Value Equity Issuance Units Agreed To Be Sold Periodic Installment Amount Value Installment amount Equity Issuance Units Agreed To Be Sold Remaining Amount To Be Funded Value Equity Issuance Units Agreed To Be Sold Remaining Amount To Be Funded Value Final payment to be received Equity Issued [Line Items] Equity Issued [Line Items] Expense Allowance For Placement Agent Fees Expense allowance Expense allowance for placement agent fees. February Two Thousand Eight Private Placement [Member] February Two Thousand Eight Private Placement [Member] February 2008 Private Placement [Member] July And August Two Thousand Thirteen Warrants Exercised [Member] July and August 2013 Warrants Exercised [Member] July And August Two Thousand Thirteen Warrants Exercised [Member] July Fifth Two Thousand Twelve Issuance [Member] July 5th, 2012 Issuance [Member] July 5th, 2012 Issuance [Member] Q2 2011 Issuance [Member] May And June Two Thousand Thirteen Warrants Exercised [Member] May and June 2013 Warrants Exercised [Member] May And June Two Thousand Thirteen Warrants Exercised [Member] May And June Two Thousand Thirteen Warrants Exercised Transaction One [Member] May and June 2013 Warrants Exercised Transaction One [Member] May And June Two Thousand Thirteen Warrants Exercised Transaction One [Member] May And June Two Thousand Thirteen Warrants Exercised Transaction Two [Member] May and June 2013 Warrants Exercised Transaction Two [Member] May And June Two Thousand Thirteen Warrants Exercised Transaction Two [Member] May Second Two Thousand Twelve Issuance [Member] May 2, 2012 Issuance [Member] May 2, 2012 Issuance [Member] May Twenty Fifth Two Thousand Twelve Issuance [Member] May 25, 2012 Issuance [Member] May 25, 2012 Issuance [Member] May Twenty First Two Thousand Twelve Issuance [Member] May 21, 2012 Issuance [Member]. May 21, 2012 Issuance [Member] May Twenty Seventh Two Thousand Eight Private Placement [Member] May Twenty Seventh Two Thousand Eight Private Placement [Member] May 27, 2008 Private Placement [Member] May Two Thousand Thirteen Options Exercised [Member] May 2013 Options Exercised [Member] May Two Thousand Thirteen Options Exercised [Member] May Two Thousand Thirteen Options Exercised Transaction One [Member] May 2013 Options Exercised Transaction One [Member] May Two Thousand Thirteen Options Exercised Transaction One [Member] May Two Thousand Thirteen Options Exercised Transaction Three [Member] May 2013 Options Exercised Transaction Three [Member] May Two Thousand Thirteen Options Exercised Transaction Three [Member] May Two Thousand Thirteen Options Exercised Transaction Two [Member] May 2013 Options Exercised Transaction Two [Member] May Two Thousand Thirteen Options Exercised Transaction Two [Member] May Two Thousand Thirteen Securities Purchase Agreement [Member] May 2013 Securities Purchase Agreement [Member] May Two Thousand Thirteen Securities Purchase Agreement [Member] November And December Two Thousand Ten Issuance [Member] November And December Two Thousand Ten Issuance [Member] November and December 2010 Issuance [Member] November And December Two Thousand Twelve Issuance [Member] November and December 2012 Issuance [Member] November and December 2012 Issuance [Member] November Nineteenth Two Thousand Ten Issuance [Member] November Nineteenth Two Thousand Ten Issuance [Member] November 19, 2010 Issuance [Member] October Ninth Two Thousand Nine Issuance [Member] October Ninth Two Thousand Nine Issuance [Member] October 9, 2009 Issuance [Member] October Twenty First Two Thousand Nine Issuance [Member] October Twenty First Two Thousand Nine Issuance [Member] October 21, 2009 Issuance [Member] Payment Of Placement Agent Fees Placement agent fees The cash outflow for fees to the placement agent. Stock issuance costs including commisions Proceeds issuance/sale of stock Proceeds from Issuance or Sale of Equity Proceeds From Stock Option And Warrant Exercises Proceeds From Stock Option And Warrant Exercises Proceeds from stock option and warrant exercises Quarter One Two Thousand Eight Issuance [Member] Quarter One Two Thousand Eight Issuance [Member] Q1 2008 Issuance [Member] Quarter One Two Thousand Nine Issuance [Member] Quarter One Two Thousand Nine Issuance [Member] Q1 2009 Issuance [Member] Quarter One Two Thousand Thirteen Issuance [Member] Quarter One Two Thousand Thirteen Issuance [Member] Q1 2013 Issuance [Member] Quarter One Two Thousand Twelve Issuance [Member] Quarter One Two Thousand Twelve Issuance [Member] Q1 2012 Issuance [Member] Quarter Three Two Thousand Eight Issuance [Member] Quarter Three Two Thousand Eight Issuance [Member] Q3 2008 Issuance [Member] Quarter Three Two Thousand Nine Issuance [Member] Quarter Three Two Thousand Nine Issuance [Member] Q3 2009 Issuance [Member] Quarter Two Two Thousand Eleven Issuance [Member] Quarter Two Two Thousand Eleven Issuance [Member] Quarter Two Two Thousand Nine Issuance [Member] Quarter Two Two Thousand Nine Issuance [Member] Q2 2009 Issuance [Member] Restricted Stock [Member] Schedule Of Equity Issued [Table] Schedule Of Equity Issued [Table] Securities Purchase Agreement [Member] Securities Purchase Agreement [Member] Securities Purchase Agreement [Member] Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Vesting period Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Options authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Warrants exercised Expired/terminated, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Options exercise prices Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Warrants issued Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercises In Period Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercises In Period Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain] Stock Issued During Period, Shares, Issued for Cash Equity issuance, number securities issued for cash Stock Issued During Period, Shares, Issued for Noncash Consideration Number of shares issued for services Stock Issued During Period, Shares, New Issues Issuance of shares of common stock, shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercised, shares Stock Issued During Period, Value, Issued for Cash Proceeds from equity issuance Stock Issued During Period, Value, New Issues Issuance of shares of common stock, value Value Of Shares Committed In Agreement Value Of Shares Committed In Agreement. Value of shares covered in agreement Warrant Investor One [Member] Warrant Investor One [Member] Warrant Investor 1 [Member] Warrant Investor Two [Member] Warrant Investor Two [Member] Warrant Investor 2 [Member] Warrant Type One [Member] Warrant Type One [Member] Warrant Type Two [Member] Warrant Type Two [Member]. STOCK OPTIONS AND WARRANTS [Abstract] STOCK OPTIONS AND WARRANTS Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Share-based compensation Allocated Share-based Compensation Expense April First Two Thousand Twelve Options Issued To Consultants [Member] April First Two Thousand Twelve Options Issued To Consultants [Member] April 1, 2012 Options Issued to Consultants [Member] April Two Thousand Thirteen Options Issued To Consultants [Member] April 2013 Options Issued To Consultants [Member] April Two Thousand Thirteen Options Issued To Consultants [Member] April Two Thousand Thirteen Options Issued To Employees [Member] April 2013 Options Issued To Employees [Member] April Two Thousand Thirteen Options Issued To Employees [Member] April Two Thousand Twelve Options Issued To Employees [Member] April Two Thousand Twelve Options Issued To Employees [Member] April 2012 Options Issued to Employees [Member] August Two Thousand Thirteen Options Issued To Employees [Member] August 2013 Options Issued To Employees [Member] August Two Thousand Thirteen Options Issued To Employees [Member] August Two Thousand Twelve Options Issued To Consultants [Member] AugustTwoThousandTwelveOptionsIssuedToConsultantsMember August 2012 Options Issued to Consultants [Member] August Two Thousand Twelve Options Issued To Employees [Member] AugustTwoThousandTwelveOptionsIssuedToEmployeesMember August 2012 Options Issued to Employees [Member] Award Type [Axis] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Warrants outstanding Class of Warrant or Right, Outstanding December Two Thousand Twelve Options Issued To Consultants [Member] December 2012 Options Issued To Consultants [Member] December Two Thousand Twelve Options Issued To Consultants [Member] Deferred Compensation Arrangement with Individual, Exercise Price Option exercise price Incentive Stock Options [Member] Employee Service Share Based Compensation Incremental Increase Value Represents the incremental increase in value of equity-based compensation arrangements (for example, shares of stock, units, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Incremental increase in value Unrecognized compensation expense Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized February Twenty Eighth Two Thousand Twelve Options Issued To Employees [Member] FebruaryTwentyEighthTwoThousandTwelveOptionsIssuedToEmployeesMember February 28, 2012 Options Issued to Employees [Member] February Two Thousand Thirteen Options Issued To Employees [Member] February Two Thousand Thirteen Options Issued To Employees [Member] February 2013 Options Issued to Employees [Member] Incentive Stock Options [Member] IncentiveStockOptionsMember January Second Two Thousand Twelve Options Issued To Consultants [Member] JanuarySecondTwoThousandTwelveOptionsIssuedToConsultantsMember January 2, 2012 Options Issued to Consultants [Member] January Seventeenth Two Thousand Twelve Options Issued To Consultants [Member] JanuarySeventeenthTwoThousandTwelveOptionsIssuedToConsultantsMember January 17, 2012 Options Issued to Consultants [Member] January Twenty Seventh Two Thousand Twelve Options Issued To Employees [Member] JanuaryTwentySeventhTwoThousandTwelveOptionsIssuedToEmployeesMember January 27, 2012 Options Issued to Employees [Member] January Two Thousand Thirteen Options Issued To Consultants [Member] January Two Thousand Thirteen Options Issued To Consultants [Member] January 2013 Options Issued to Consultants [Member] January Two Thousand Thirteen Options Issued To Employees [Member] January Two Thousand Thirteen Options Issued To Employees [Member] January 2013 Options Issued to Employees [Member] July Two Thousand Thirteen Options Issued To Consultants [Member] July 2013 Options Issued To Consultants [Member] July Two Thousand Thirteen Options Issued To Consultants [Member] July Two Thousand Twelve Options Issued To Consultants [Member] July Two Thousand Twelve Options Issued To Consultants [Member] July 2012 Options Issued to Consultants [Member] July Two Thousand Twelve Options Issued To Employees [Member] JulyTwoThousandTwelveOptionsIssuedToEmployeesMember July 2012 Options Issued to Employees [Member] June Two Thousand Thirteen Options Issued To Employees [Member] June 2013 Options Issued To Employees [Member] June Two Thousand Thirteen Options Issued To Employees [Member] June Two Thousand Twelve Options Issued To Employees [Member] June Two Thousand Twelve Options Issued To Employees [Member]. June 2012 Options Issued to Employees [Member] March Fifth Two Thousand Twelve Options Issued To Employees [Member] MarchFifthTwoThousandTwelveOptionsIssuedToEmployeesMember March 5, 2012 Options Issued to Employees [Member] March Second Two Thousand Twelve Options Issued To Employees [Member] MarchSecondTwoThousandTwelveOptionsIssuedToEmployeesMember March 2, 2012 Options Issued to Employees [Member] March Thirty First Two Thousand Twelve Options Issued To Consultants [Member] MarchThirtyFirstTwoThousandTwelveOptionsIssuedToConsultantsMember March 31, 2012 Options Issued to Consultants [Member] March Thirty First Two Thousand Twelve Options Issued To Employees [Member] MarchThirtyFirstTwoThousandTwelveOptionsIssuedToEmployeesMember March 31, 2012 Options Issued to Employees [Member] March Two Thousand Eight Options Issued To Directors [Member] March Two Thousand Eight Options Issued To Directors [Member] March 2008 Options Issued to Directors [Member] March Two Thousand Thirteen Options Issued To Consultants [Member] March 2013 Options Issued To Consultants [Member] March Two Thousand Thirteen Options Issued To Consultants [Member] March Two Thousand Thirteen Options Issued To Employees [Member] March Two Thousand Thirteen Options Issued To Employees [Member] March 2013 Options Issued to Employees [Member] Maximum [Member] Maximum [Member] May Two Thousand Thirteen Options Issued For Private Placement [Member] May 2013 Options Issued for Private Placement [Member] May Two Thousand Thirteen Options Issued For Private Placement [Member] May Two Thousand Thirteen Options Issued To Consultants [Member] May 2013 Options Issued To Consultants [Member] May Two Thousand Thirteen Options Issued To Consultants [Member] May Two Thousand Thirteen Options Issued To Employees [Member] May 2013 Options Issued To Employees [Member] May Two Thousand Thirteen Options Issued To Employees [Member] May Two Thousand Twelve Options Issued To Consultants [Member] May Two Thousand Twelve Options Issued To Consultants [Member] May 2012 Options Issued to Consultants [Member] Minimum [Member] Minimum [Member] Non-Statutory Stock Options [Member] Non Statutory Stock Options [Member] NonStatutoryStockOptionsMember November Two Thousand Twelve Options Issued To Consultants [Member] November Two Thousand Twelve Options Issued To Consultants [Member] November 2012 Options Issued to Consultants [Member] November Two Thousand Twelve Options Issued To Employees [Member] November Two Thousand Twelve Options Issued To Employees [Member] November 2012 Options Issued to Employees [Member] October Two Thousand Twelve Options Issued To Consultants [Member] October Two Thousand Twelve Options Issued To Consultants [Member] October 2012 Options Issued to Consultants [Member] October Two Thousand Twelve Options Issued To Employees [Member] October Two Thousand Twelve Options Issued To Employees [Member] October 2012 Options Issued to Employees [Member] Senior Vice President of Marketing and Licensing annual compensation Officers' Compensation Options issued to employees [Member] Options issued to employees [Member] Options issued to non employees [Member] Options issued to non-employees [Member] Options issued to non-employees [Member] Point Zero Four Per Share Exercise Price Class [Member] PointZeroFourPerShareExercisePriceClassMember $.04 per Share Exercise Price Class [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Reclassification from Non-Statutory to Incentive Stock Options [Member] Reclassification From Non Statutory To Incentive Stock Options [Member] ReclassificationFromNonStatutoryToIncentiveStockOptionsMember Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] September Two Thousand Thirteen Options Issued To Consultants [Member] September 2013 Options Issued To Consultants [Member] September Two Thousand Thirteen Options Issued To Consultants [Member] September Two Thousand Thirteen Options Issued To Employees [Member] September 2013 Options Issued To Employees [Member] September Two Thousand Thirteen Options Issued To Employees [Member] September Two Thousand Twelve Options Issued To Consultants [Member] SeptemberTwoThousandTwelveOptionsIssuedToConsultantsMember September 2012 Options Issued to Consultants [Member] September Two Thousand Twelve Options Issued To Employees [Member] SeptemberTwoThousandTwelveOptionsIssuedToEmployeesMember September 2012 Options Issued to Employees [Member] Share Based Compensation Arrangement By Share Based Grantee Ownership Percentage Of Shares Outstanding Considered In Determination Of Discount From Market Price Offering Date ShareBasedCompensationArrangementByShareBasedGranteeOwnershipPercentageOfSharesOutstandingConsideredInDeterminationOfDiscountFromMarketPriceOfferingDate Grantee ownership percentage considered in determination of options exercise price Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date Percent of fair market value of common stock the exercise price of options may not exceed Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date When Grantee Ownership Percentage Exceeds Ten Percent ShareBasedCompensationArrangementByShareBasedPercentOfStockMarketPriceExercisePriceMayNotExceedWhenGranteeHoldsGreaterThanTenPercentSharesOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Warrants vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value Value of vested warrants Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk free rate, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk free rate, minimum Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Options available to be issued Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Grants In Period Aggregate options issued The aggregate net number of share options (or share units) granted during the period which includes options excluded from valuation due to their vesting being predicated upon certain conditions per the agreement. Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Excluded In Valuation Options issued, excluded from valuation Net number of share options (or share units) granted during the period which are excluded from valuation due to their vesting being contingent upon certain conditions per agreement. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding options Incremental cost charged to expense Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost Percent of fair market value of common stock the exercise price may not exceed, when grantee holds greater than 10% shares outstanding Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit Minimum option exercise price Maximum option exercise price Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit Fair value of equity issued in exchange for products/services Share-based Goods and Nonemployee Services Transaction, Stockholders' Equity Two Thousand Eight Warrants Issued In Private Placement [Member] TwoThousandEightWarrantsIssuedInPrivatePlacementMember 2008 Warrants Issued in Private Placement [Member] Two Zero One Three Equity Incentive Plan [Member] Two Zero One Three Equity Incentive Plan [Member] 2013 Equity Incentive Plan [Member] Two Zero Zero Eight Equity Incentive Plan [Member] TwoZeroZeroEightEquityIncentivePlanMember 2008 Equity Incentive Plan [Member] Zero Point Seven Five Per Share Exercise Price Class [Member] ZeroPointSevenFivePerShareExercisePriceClassMember $.75 per Share Exercise Price Class [Member] Exercisable, exercise price, September 30, 2013 Exercisable, shares, September 30, 2013 Exercisable, weighted average exercise price, September 30, 2013 Options Issuances In Period Private Placement Issued under Private Placements, shares Options Issuances In Period Private Placement Exercise Price Options, Issuances In Private Placement, Exercise Price. Issued under Private Placements, exercise price Options Issuances In Private Placement Weighted Average Exercise Price Options, Issuances In Private Placement, Weighted Average Exercise Price. Issued under Private Placements, weighted average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted Average Remaining Life, Exercisable, September 30, 2013 (years) Share Based Compensation Arrangement By Share Based Payment Award Options Exercise Price Abstract ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePriceAbstract Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodExercisePrice Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Exercise Price Exercised, exercise price Expired/terminated, shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price Extended Expired/terminated, exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Retirement of options, shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Terminated, exercise price Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price Extended ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Exercise Price Granted, exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Granted, shares Options, Issuances In Period Private Placement. Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period Reclassified from (to) non-employee, shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodExercisePrice Share Based Compensation Arrangement By Share Based Payment Award Options Other Share Increase Decrease In Period Exercise Price Reclassified from/to non-employee, exercise price Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePrice Outstanding, exercise price, end of period Outstanding, exercise price, beginning of period Outstanding, shares, beginning of period Outstanding, shares, end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Option/Warrants Shares Outstanding, weighted average exercise price, beginning of period Outstanding, weighted average exercise price, end of period Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised, weighted average exercise price Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Expired/terminated, weighted average exercise price Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Terminated, weighted average exercise price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted, weighted average exercise price Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price Reclassified from/to non-employee, weighted average exercise price Exercised, shares Issued under Private Placement, shares Issued under Private Placement, exercise price Issued under Private Placement, weighted average exercise price Expired, shares Expired, exercise price Retired, shares Retired, exercise price Reclassified from (to) employee, shares Reclassified from/to employee, exercise price Option/Warrant Shares Expired, weighted average exercise price Retired, weighted average exercise price Reclassified from/to employee, weighted average exercise price Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Summary of Stock Options and Warrant Transactions for Employees Schedule of Share-based Compensation, Nonemployee Director Stock Award Plan, Activity [Table Text Block] Summary of Non-Employee Stock Options and Warrants Fair value of warrants issued in exchange for services Adjustment of Warrants Granted for Services Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities Amortization of Debt Discount (Premium) Accretion of discount on notes payable Amortization of deferred costs Amortization of Financing Costs CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS - END OF PERIOD NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS Cash and Cash Equivalents, Period Increase (Decrease) Debt Conversion, Converted Instrument, Amount Fair value of warrants issued as discount for notes payable Debt Conversion, Original Debt, Amount Conversion of notes payable and accrued interest into common stock Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction Fair value of common stock issued as discount for notes payable Depreciation, Depletion and Amortization Depreciation and amortization Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Loss on disposal of fixed assets Income taxes paid Income Taxes Paid Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Deposit Assets Increase (Decrease) in Insurance Settlements Receivable Insurance receivable Increase (Decrease) in Operating Assets [Abstract] (Increase) decrease in assets Increase (Decrease) in Operating Liabilities [Abstract] Increase (decrease) in liabilities Increase (Decrease) in Other Receivables Other receivable Increase (Decrease) in Prepaid Expense Prepaid expenses Deposits Interest Paid Interest paid Issuance of Stock and Warrants for Services or Claims Fair value of stock issued in exchange for services Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net Income (Loss) Attributable to Parent Net loss Noncash Investing and Financing Items [Abstract] SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES: Stock issuance costs Patent and trademark costs Payments to Acquire Intangible Assets Purchase of equipment Payments to Acquire Machinery and Equipment Proceeds from Issuance of Common Stock Proceeds from issuance of common stock Proceeds from notes payable Proceeds from Notes Payable Proceeds from note payable - stockholders Proceeds from Related Party Debt Provision for bad debt Provision for Doubtful Accounts Repayment of note payable - stockholders Repayments of Related Party Debt Share-based Compensation Fair value of options issued in exchange for services Statement of Cash Flows [Abstract] Stock Issued Issuance of common stock for settlement of payable Exercise of options on May 8, 2008, at $.04 per share, values Fair value of revalued options $1.07 per share. Fair value of revalued options $1.07 per share Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, shares. Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, shares Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, value. Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, values Issuance of shares of common stock in conjunction with notes payable from September through December 2011, shares Issuance of shares of common stock in conjunction with notes payable in September 2011, shares Issuance of shares of common stock in conjunction with notes payable from September through December 2011, value Issuance of shares of common stock in conjunction with notes payable in September 2011, value Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, shares. Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, shares Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, value. Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, values Issuance of warrants in conjunction with notes payable from September through December 2011 Issuance of warrants in conjunction with notes payable in September 2011 Additional Paid-In Capital [Member] Adjustments to Additional Paid in Capital, Other Fair value of revalued warrants at $.09 to $.76 per share Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Stock issuance costs Balance, shares Balance, shares Common Stock Subscriptions For 687500Units Through Private Placement At 80Per Unit Common stock subscription for 62,500 units through private placement at $.80 per unit Value of common stock subscriptions for 687,500 units through private placement at $.80 per unit. Common Stock Subscriptions [Member] Common Stock Subscriptions [Member]. Common Stock Subscribed [Member] Common Stock Subscriptions Receivable [Member] Common Stock Subscriptions Receivable [Member] Common Stock Subscription Receivable [Member] Employee Options Issued For Services From January 2012 Through December 2012 Vesting Immediately And Valued At 14 To 42 Per Share Employee Options Issued For Services From January 2012 Through December 2012 Vesting Immediately And Valued At 14 To 42 Per Share Employee options issued for services from January 2012 through December 2012, vesting immediately and valued at $.14 to $.42 per share, values Employee Options Issued For Services On January Through December 2012 Vesting Over Three Years And Valued At 11 To 53 Per Share Employee Options Issued For Services On January Through December 2012 Vesting Over Three Years And Valued At 11 To 53 Per Share Employee options issued for services on January 2012 through December 2012, vesting over three years and valued at $.11 To $.53 per share, values Employee Options Issued For Services On January Through September 2013Vesting Over Three Years And Valued At 22To 68Per Share Employee options issued for services on January 2013 through September 30, 2013, vesting over three years and valued at $0.22 to $0.68 per share Employee options issued for services on January 2013 through September 30, 2013, vesting over three years and valued at $0.22 to $0.68 per share. Employee Options Issued For Services On March 32008Vested Immediately And Valued At 02Per Share Employee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share. Employee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values Exercise Of Options At 04Per Share In May Two Thousand Thirteen Exercise of options at $0.04 per share in May 2013, value Exercise of options at $0.04 per share in May 2013, value. Exercise Of Options At 04Per Share In May Two Thousand Thirteen Shares Exercies of options at $0.04 per share in May 2013, shares Exercies of options at $0.04 per share in May 2013, shares. Exercise Of Options At 35Per Share On May 14Two Thousand Thirteen Exercise of options at $0.35 per share on May 14, 2013, value Exercise of options at $0.35 per share on May 14, 2013, value. Exercise Of Options At 35Per Share On May 14Two Thousand Thirteen Shares Exercise of options at $0.35 per share on May 14, 2013, shares Exercise of options at $0.35 per share on May 14, 2013, shares. Exercise Of Options At 75Per Share In May Two Thousand Thirteen Exercise of options at $0.75 per share in May 2013, value Exercise of options at $0.75 per share in May 2013, value Exercise Of Options At 75Per Share In May Two Thousand Thirteen Shares Exercise of options at $0.75 per share in May 2013, shares Exercise of options at $0.75 per share in May 2013, shares. Exercise Of Options In September 2008At 04Per Share Shares Shares issued for Exercise of options in September 2008 at $.04 per share. Exercise of options in September 2008 at $.04 per share, shares Exercise Of Options In September 2008At 04Per Share Values Value of Exercise of options in September 2008 at $.04 per share. Exercise of options in September 2008 at $.04 per share, values Exercise Of Options On April 102012At 04Per Share Shares Exercise of options on April 10, 2012 at $.04 per share, shares Stock issued for Exercise of options on April 10, 2012 at $.04 per share. Exercise Of Options On April 102012At 04Per Share Values Exercise of options on April 10, 2012 at $.04 per share, values Value of Exercise of options on April 10, 2012 at $.04 per share. Exercise Of Options On December 102009At 04Per Share Shares Stock issued for Exercise of options on December 10, 2009 at $.04 per share. Exercise of options on December 10, 2009 at $.04 per share, shares Exercise Of Options On December 102009At 04Per Share Values Value of Exercise of options on December 10, 2009 at $.04 per share. Exercise of options on December 10, 2009 at $.04 per share, values Exercise Of Options On December 22010At 04Per Share Shares Stock issued for Exercise of options on December 2, 2010 at $.04 per share. Exercise of options on December 2, 2010 at $.04 per share, shares Exercise Of Options On December 22010At 04Per Share Values Value of Exercise of options on December 2, 2010 at $.04 per share. Exercise of options on December 2, 2010 at $.04 per share, values Exercise Of Options On January 262009At 04Per Share Shares Shares issued for Exercise of options on January 26, 2009 at $.04 per share. Exercise of options on January 26, 2009 at $.04 per share, shares Exercise Of Options On January 262009At 04Per Share Values Value of Exercise of options on January 26, 2009 at $.04 per share. Exercise of options on January 26, 2009 at $.04 per share, values Exercise Of Options On January 52010At 04Per Share Shares Stock issued for Exercise of options on January 5, 2010 at $.04 per share. Exercise of options on January 5, 2010 at $.04 per share, shares Exercise Of Options On January 52010At 04Per Share Values Value of Exercise of options on January 5, 2010 at $.04 per share. Exercise of options on January 5, 2010 at $.04 per share, values Exercise Of Options On July 302009At 04Per Share Shares Stock issued for Exercise of options on July 30, 2009 at $.04 per share. Exercise of options on July 30, 2009 at $.04 per share, shares Exercise Of Options On July 302009At 04Per Share Values Value of Exercise of options on July 30, 2009 at $.04 per share. Exercise of options on July 30, 2009 at $.04 per share, values Exercise Of Options On May 252012At 04Per Share Shares Exercise of options on May 25, 2012 at $.04 per share, shares Exercise of options on May 25, 2012 at $.04 per share, shares Exercise Of Options On May 252012At 04Per Share Values Exercise of options on May 25, 2012 at $.04 per share, values Value of Exercise of options on May 25, 2012 at $.04 per share. Exercise Of Options On May 82008At 04Per Share Shares Stock issued for Exercise of options on May 8, 2008 at $.04 per share. Exercise of options on May 8, 2008, at $.04 per share, shares Exercise Of Options On May 82008At 04Per Share Values Value of Exercise of options on May 8, 2008 at $.04 per share. Exercise Of Options On September 22009At 04Per Share Shares Stock issued for Exercise of options on September 2, 2009 at $.04 per share. Exercise of options on September 2, 2009 at $.04 per share, shares Exercise Of Options On September 22009At 04Per Share Values Value of Exercise of options on September 2, 2009 at $.04 per share. Exercise of options on September 2, 2009 at $.04 per share, values Exercise Of Warrant On February 222010At 04Per Share Shares Stock issued for Exercise of warrant on February 22, 2010 at $.04 per share. Exercise of warrant on February 22, 2010 at $.04 per share, shares Exercise Of Warrant On February 222010At 04Per Share Values Value of Exercise of warrant on February 22, 2010 at $.04 per share. Exercise of warrant on February 22, 2010 at $.04 per share, values Exercise Of Warrants At 04Per Share On May 26Two Thousand Thirteen Exercise of warrants at $0.04 per share on May 26, 2013, value Exercise of warrants at $0.04 per share on May 26, 2013, value. Exercise Of Warrants At 04Per Share On May 26Two Thousand Thirteen Shares Exercise of warrants at $0.04 per share on May 26, 2013, shares Exercise of warrants at $0.04 per share on May 26, 2013, shares. Exercise Of Warrants At 50Per Share In May Through August Two Thousand Thirteen Exercise of warrants at $0.50 per share in May through August 2013, value Exercise of warrants at $0.50 per share in May through August 2013, value. Exercise Of Warrants At 50Per Share In May Through August Two Thousand Thirteen Shares Exercise of warrants at $0.50 per share in May through August 2013, shares Exercise of warrants at $0.50 per share in May through August 2013, shares. Exercise Of Warrants In April 2010At 04Per Share Shares Stock issued for Exercise of warrants in April 2010 at $.04 per share. Exercise of warrants in April 2010 at $.04 per share, shares Exercise Of Warrants In April 2010At 04Per Share Values Value of Exercise of warrants in April 2010 at $.04 per share. Exercise of warrants in April 2010 at $.04 per share, values Exercise Of Warrants In December 2010At 04Per Share Shares Stock issued for Exercise of warrants in December 2010 at $.04 per share. Exercise of warrants in December 2010 at $.04 per share, shares Exercise Of Warrants In December 2010At 04Per Share Values Value of Exercise of warrants in December 2010 at $.04 per share. Exercise of warrants in December 2010 at $.04 per share, values Exercise Of Warrants In March 2010At 04Per Share Shares Stock issued for Exercise of warrants in March 2010 at $.04 per share. Exercise of warrants in March 2010 at $.04 per share, shares Exercise Of Warrants In March 2010At 04Per Share Values Value of Exercise of warrants in March 2010 at $.04 per share. Exercise of warrants in March 2010 at $.04 per share, values Exercise Of Warrants In September 2008At 04Per Share Shares Shares issued for Exercise of warrants in September 2008 at $.04 per share. Exercise of warrants in September 2008 at $.04 per share, shares Exercise Of Warrants In September 2008At 04Per Share Values Value of Exercise of warrants in September 2008 at $.04 per share. Exercise of warrants in September 2008 at $.04 per share, values Exercise Of Warrants On August 212009At 04Per Share Shares Stock issued for Exercise of warrants on August 21, 2009 at $.04 per share. Exercise of warrants on August 21, 2009 at $.04 per share, shares Exercise Of Warrants On August 212009At 04Per Share Values Value of Exercise of warrants on August 21, 2009 at $.04 per share. Exercise of warrants on August 21, 2009 at $.04 per share, values Exercise Of Warrants On December 22009At 04Per Share Shares Stock issued for Exercise of warrants on December 2, 2009 at $.04 per share. Exercise of warrants on December 2, 2009 at $.04 per share, shares Exercise Of Warrants On December 22009At 04Per Share Values Value of Exercise of warrants on December 2, 2009 at $.04 per share. Exercise of warrants on December 2, 2009 at $.04 per share, values Exercise Of Warrants On December 312009At 04Per Share Shares Stock issued for Exercise of warrants on December 31, 2009 at $.04 per share. Exercise of warrants on December 31, 2009 at $.04 per share, shares Exercise Of Warrants On December 312009At 04Per Share Values Value of Exercise of warrants on December 31, 2009 at $.04 per share. Exercise of warrants on December 31, 2009 at $.04 per share, values Exercise Of Warrants On October 222009At 04Per Share Shares Stock issued for Exercise of warrants on October 22, 2009 at $.04 per share. Exercise of warrants on October 22, 2009 at $.04 per share, shares Exercise Of Warrants On October 222009At 04Per Share Values Value of Exercise of warrants on October 22, 2009 at $.04 per share. Exercise of warrants on October 22, 2009 at $.04 per share, values Fair Value Of Revalued Options 107Per Share Issuance Of Initial 19000000Shares On February 112008At 001Per Share Shares Shares issued for Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share. Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share, shares Value of Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share. Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share, values Issuance Of Initial 19000000Shares On February 112008At 001Per Share Values Issuance Of Share Of Common Stock From August Through December 2010Through Private Placement At 20Per Share Shares Stock issued for Issuance of share of common stock from August through December 2010 through private placement at $.20 per share. Issuance of share of common stock from August through December 2010 through private placement at $.20 per share, shares Issuance Of Share Of Common Stock From August Through December 2010Through Private Placement At 20Per Share Values Value of Issuance of share of common stock from August through December 2010 through private placement at $.20 per share. Issuance of share of common stock from August through December 2010 through private placement at $.20 per share, values Issuance Of Shares And Warrants December 2011 Private Placement Issuance Of Shares And Warrants, December 2011, Private Placement. Issuance of shares of common stock and 625,000 warrants on December 20, 2011 through private placement at $.80 per unit, values Issuance Of Shares And Warrants December 2011 Private Placement Shares Issuance Of Shares And Warrants, December 2011, Private Placement, Shares. Issuance of shares of common stock and 625,000 warrants on December 20, 2011 through private placement at $.80 per unit, shares Issuance Of Shares Of Common Stock And 10213474Warrants Through June 302012Through Private Placement At 70Per Unit Shares Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, shares Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, shares Issuance Of Shares Of Common Stock And 10213474Warrants Through June 302012Through Private Placement At 70Per Unit Values Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, values Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, values Issuance Of Shares Of Common Stock And 14285716Warrants In February 2008Through Private Placement At 035Per Unit Shares Shares issued in Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit. Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit, shares Issuance Of Shares Of Common Stock And 14285716Warrants In February 2008Through Private Placement At 035Per Unit Values Value of Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit. Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit, values Issuance Of Shares Of Common Stock And 1436277Warrants In May Two Thousand Thirteen Through Private Placement At 180Per Share Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, value Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, value. Issuance Of Shares Of Common Stock And 1436277Warrants In May Two Thousand Thirteen Through Private Placement At 180Per Share Shares Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, shares Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, shares Issuance Of Shares Of Common Stock And 285714Warrants To Discharge Notes Payable And Accrued Interest Valued At 70Per Unit Shares Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, shares Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, shares Issuance Of Shares Of Common Stock And 285714Warrants To Discharge Notes Payable And Accrued Interest Valued At 70Per Unit Values Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, values Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, values Issuance Of Shares Of Common Stock And 562500Warrants Through June 302012Through Private Placement At 80Per Unit Shares Issuance of shares of common stock and 1,500,000 warrants through December 31, 2012 through private placement at $.80 per unit, shares Issuance of shares of common stock and 562,500 warrants through June 30, 2012 through private placement at $.80 per unit, shares Issuance of shares of common stock and 1,500,000 warrants through December 31, 2012 through private placement at $.80 per unit, values Issuance of shares of common stock and 562,500 warrants through June 30, 2012 through private placement at $.80 per unit, values Issuance Of Shares Of Common Stock And562500 Warrants Through June302012 Through Private Placement At80 Per Unit Values Issuance Of Shares Of Common Stock And 614286Warrants In May And September 2008Through Private Placement At 75Per Unit Shares Issuance of shares for Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit. Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit, shares Issuance Of Shares Of Common Stock And 614286Warrants In May And September 2008Through Private Placement At 75Per Unit Values Value of Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit. Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit, values Issuance Of Shares Of Common Stock And 93750Warrants Through March 312013Through Private Placement At 80Per Unit Shares Issuance Of Shares Of Common Stock And 93750Warrants Through March 312013Through Private Placement At 80Per Unit Values Issuance Of Shares Of Common Stock And WarrantsThrough Private Placement, Shares, One. Issuance of shares of common stock and warrants through private placement, shares Issuance Of Shares Of Common Stock And Warrants Through Private Placement Shares One Issuance Of Shares Of Common Stock And Warrants Through Private Placement Value One Issuance Of Shares Of Common Stock And Warrants Through Private Placement, Value, One. Issuance of shares of common stock and warrants through private placement Issuance Of Shares Of Common Stock For Future Services On June 12011Valued At 49Per Share Shares Stock issued for Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share. Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share, shares Issuance Of Shares Of Common Stock For Future Services On June 12011Valued At 49Per Share Values Value of Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share. Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share, values Issuance Of Shares Of Common Stock For Future Services On May 212012Valued At 243Per Share Shares Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, shares Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, shares Issuance Of Shares Of Common Stock For Future Services On May 212012Valued At 243Per Share Values Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, values Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, values Issuance Of Shares Of Common Stock For Future Services On October 92009Valued At 100Per Share Shares Stock issued for Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share. Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share, shares Issuance Of Shares Of Common Stock For Future Services On October 92009Valued At 100Per Share Values Value of Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share. Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share, values Issuance Of Shares Of Common Stock For Retirement Of 400000Options At 25Per Share Shares Stock issued for Issuance of shares of common stock for retirement of 400,000 options at $.25 per share. Issuance of shares of common stock for retirement of 400,000 options at $.25 per share, shares Issuance Of Shares Of Common Stock For Retirement Of 400000Options At 25Per Share Values Value of Issuance of shares of common stock for retirement of 400,000 options at $.25 per share. Issuance of shares of common stock for retirement of 400,000 options at $.25 per share, values Issuance of shares of common stock in conjunction with notes payable in May through August 2010, shares Issuance Of Shares Of Common Stock In Conjunction With Notes Payable In May Through August 2010Shares Issuance Of Shares Of Common Stock In Conjunction With Notes Payable In May Through August 2010Values Issuance of shares of common stock in conjunction with notes payable in May through August 2010, values Stock issued for Issuance of shares of common stock in conjunction with notes payable in May through August. Value of Issuance of shares of common stock in conjunction with notes payable in May through August. Issuance Of Shares Of Common Stock In Conjunction With Notes Payable In September 2011Shares Issuance Of Shares Of Common Stock In Conjunction With Notes Payable In September 2011Value Issuance Of Shares Of Common Stock On April 72009At 100Per Share Shares Stock issued for Issuance of shares of common stock on April 7, 2009 at $1.00 per share. Issuance of shares of common stock on April 7, 2009 at $1.00 per share, shares Issuance Of Shares Of Common Stock On April 72009At 100Per Share Values Value of Issuance of shares of common stock on April 7, 2009 at $1.00 per share. Issuance of shares of common stock on April 7, 2009 at $1.00 per share, values Issuance Of Shares Of Common Stock On June 292009Valued At 200Per Share Shares Stock issued for Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share. Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share, shares Issuance Of Shares Of Common Stock On June 292009Valued At 200Per Share Values Value of Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share. Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share, values Issuance Of Shares Of Common Stock On November 12010For Conversion Of Notes Payable At 20Per Share Shares Stock issued for Issuance of shares of common stock on November 1, 2010 for the conversion of notes payable at $.20 per share. Issuance of shares of common stock on November 1, 2010 for conversion of notes payable at $.20 per share, shares Issuance Of Shares Of Common Stock On November 12010For Conversion Of Notes Payable At 20Per Share Values Value of Issuance of shares of common stock on November 1, 2010 for the conversion of notes payable at $.20 per share. Issuance of shares of common stock on November 1, 2010 for conversion of notes payable at $.20 per share, values Stock issued for Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share. Value of Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share. Issuance Of Shares Of Common Stock On November 192010For Future Services Valued At 90Per Share Shares Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share, shares Issuance Of Shares Of Common Stock On November 192010For Future Services Valued At 90Per Share Values Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share, values Issuance Of Shares Of Common Stock On October 162009At 100Per Share Shares Stock issued for Issuance of shares of common stock on October 16, 2009 at $1.00 per share. Issuance of shares of common stock on October 16, 2009 at $1.00 per share, shares Issuance Of Shares Of Common Stock On October 162009At 100Per Share Values Value of Issuance of shares of common stock on October 16, 2009 at $1.00 per share. Issuance of shares of common stock on October 16, 2009 at $1.00 per share, values Issuance Of Shares Of Common Stock On September 172009At 100Per Share Shares Stock issued for Issuance of shares of common stock on September 17, 2009 at $1.00 per share. Issuance of shares of common stock on September 17, 2009 at $1.00 per share, shares Issuance Of Shares Of Common Stock On September 172009At 100Per Share Values Value of Issuance of shares of common stock on September 17, 2009 at $1.00 per share. Issuance of shares of common stock on September 17, 2009 at $1.00 per share, values Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 70Per Share Shares Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 70 Per Share Shares Issuance of shares of common stock through December 31, 2012 through private placement at $.70 per share, shares Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 70Per Share Values Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 70 Per Share Values Issuance of shares of common stock through December 31, 2012 through private placement at $.70 per share, values Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 75Per Share Shares Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 75 Per Share Shares Issuance of shares of common stock through December 31, 2012 through private placement at $.75 per share, shares Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 75Per Share Values Issuance Of Shares Of Common Stock Through December Thirtyfirst Two Thousand Twelve Through Private Placement At 75 Per Share Values Issuance of shares of common stock through December 31, 2012 through private placement at $.75 per share, values Issuance Of Shares Of Common Stock Through March Thirty First Two Thousand Thirteen Through Private Placement At 75Per Share Shares Issuance Of Shares Of Common Stock Through March Thirty First Two Thousand Thirteen Through Private Placement At 75Per Share Values Issuance Of Shares Of Common Stock To Investors In August 2008At 100Per Share Shares Shares issued for Issuance of shares of common stock to investors in August 2008 at $1.00 per share. Issuance of shares of common stock to investors in August 2008 at $1.00 per share, shares Issuance Of Shares Of Common Stock To Investors In August 2008At 100Per Share Values Value of Issuance of shares of common stock to investors in August 2008 at $1.00 per share. Issuance of shares of common stock to investors in August 2008 at $1.00 per share, values Issuance Of Shares Of Common Stock With Respect To Settlement Agreement Valued At 85Per Share Shares Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, shares Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, values Issuance Of Shares Of Common Stock With Respect To Settlement Agreement Valued At 85Per Share Values Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, values Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, values Issuance Of Shares On April 15Two Thousand Thirteen Common Stock For Services Issuance of shares on April 15, 2013 common stock for services, values Issuance of shares on April 15, 2013 common stock for services, value. Issuance Of Shares On April 15Two Thousand Thirteen Common Stock For Services Shares Issuance of shares on April 15, 2013 common stock for services, shares Issuance of shares on April 15, 2013 common stock for services, shares. Issuance Of Warrants In Conjunction With Notes Payable In September 2011 Nonemployee Options And Warrants Issued For Services From January 2013Through September 2013Vested Immediately To Three Years And Valued From 009To 166Per Share Nonemployee options/warrants issued for services from January 2013 through September 2013, vested immediately to 3 years and valued from $0.09 to $1.66 per share Nonemployee options/warrants issued for services from January 2013 through September 2013, vested immediately to 3 years and valued from $0.09 to $1.66 per share. Nonemployee Options Issued For Services From August Through November 2010Vested Immediately And Valued At 01Per Share Value of Nonemployee options issued for services from August through November 2010, vested immediately and valued at $.01 per share. Nonemployee options issued for services from August through November 2010 vested immediately and valued at $.01 per share, values Nonemployee options issued for services from January through December 2012, vested immediately and valued from $.11 to $.95 per share, values Value of nonemployee options issued for services from January through June 2012 vested immediately and valued from $.11 to $.95 per share. Nonemployee Options Issued For Services From January Through June 2012Vested Immediately And Valued From 11To 95Per Share Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share, values Value of nonemployee options issued for services from July through August 2011 vested immediately and valued from $.10 to $.19 per share. Nonemployee Options Issued For Services From July Through August 2011Vested Immediately And Valued From 10To 19Per Share Nonemployee Options Issued For Services From July Through August 2011Vested Immediately And Valued From Ten To Nineteen Per Share Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share Nonemployee Options Issued For Services In June 192008Vested Immediately And Valued At 01Per Share Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share. Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share, values Nonemployee Options Issued For Services On August 182009Vested Immediately And Valued At 31Per Share Value of Nonemployee options issued for services on August 18, 2009, vested immediately and valued at $.31 per share. Nonemployee options issued for services on August 18, 2009 vested immediately and valued at $.31 per share, values Nonemployee Options Issued For Services On January 242011Vested Immediately And Valued At 20Per Share Nonemployee Options Issued For Services On January Through December 2012 Vesting Over Three Years And Valued At 17 To 40 Per Share Nonemployee Options Issued For Services On January Through December 2012 Vesting Over Three Years And Valued At 17 To 40 Per Share Nonemployee options issued for services on January 2012 through December 2012, vesting over three years and valued at$. 17 to $.40 per share, values Nonemployee Options Issued For Services On March 32008Vested Immediately And Valued At 02Per Share Nonemployee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share. Nonemployee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values Options Issued For Services In June 2008Vested Immediately And Valued At 07Per Share Options issued for services in June 2008, vested immediately and valued at $.07 per share. Options issued for services in June 2008, vested immediately and valued at $.07 per share, values Deficit Accumulated During the Development Stage [Member] Statement [Line Items] Statement of Changes in Stockholders' Equity (Deficit) [Abstract] Statement [Table] Balance, values Balance, values Nonemployee options issued for services on January 24, 2011, vested immediately and valued at $.20 per share Nonemployee options issued for services on January 24, 2011, vested immediately and valued at $.20 per share Costs and Expenses Total operating expenses Costs and Expenses [Abstract] OPERATING EXPENSES Earnings Per Share, Basic and Diluted BASIC AND DILUTED NET LOSS PER COMMON SHARE General and Administrative Expense General and administrative Statements of Operations [Abstract] Interest Expense Interest expense Interest income Investment Income, Interest Payroll Labor and Related Expense NET LOSS Total other income (expense) Nonoperating Income (Expense) Nonoperating Income (Expense) [Abstract] OTHER INCOME (EXPENSE) Consulting Professional and Contract Services Expense Professional fees Professional Fees Research and Development Expense Research and development SALES Revenues Selling and Marketing Expense Marketing Travel Travel and Entertainment Expense Weighted Average Number of Shares Outstanding, Basic and Diluted BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Cash, FDIC Insured Amount FDIC insured limit Computer Equipment [Member] Computer equipment [Member] Furniture and fixtures [Member] Furniture and Fixtures [Member] Number Of Merchant Agreements With Gift Card Providers To Deploy Technology On Their Websites Number of merchant agreements with gift card providers to deploy technology on their websites Number of merchant agreements with gift card providers agreeing to deploy technology on their websites. Number Of Merchant Agreements With Merchants To Deploy Technology On Their Websites Number of merchant agreements with merchants to deploy technology on their websites Number of merchant agreements with merchants agreeing to deploy technology on their websites. Number Of Merchant Agreements With Partners To Deploy Technology On Their Websites Number of merchant agreements with partners to deploy technology on their websites Number of merchant agreements with partners agreeing to deploy technology on their websites. Number Of Merchants Using Technology In Live Use Number Of Merchants Using Technology In Live Use Number of merchants using technology in live use Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment [Line Items] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Useful Life Useful life Schedule of Property, Plant and Equipment [Table] Schedule of Property, Plant and Equipment [Table] Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Comprehensive Income, Policy [Policy Text Block] Comprehensive Income Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Involving Cash Earnings Per Share, Policy [Policy Text Block] Loss Per Share Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Income Taxes Income Tax, Policy [Policy Text Block] Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Prior Period Reclassification Adjustment, Description Reclassifications Property, Plant and Equipment, Impairment [Policy Text Block] Recoverability of Long-Lived Assets Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Research and Development Expense, Policy [Policy Text Block] Research and Development Costs Revenue Recognition Revenue Recognition, Policy [Policy Text Block] Start-up Activities, Cost Policy [Policy Text Block] Start-up Costs Use of Estimates Use of Estimates, Policy [Policy Text Block] Property, Plant and Equipment [Table Text Block] Schedule of Property and Equipment, Useful Life Common Stock Subscription for Units Through Private Placement [Member] Common Stock Subscription for Units Through Private Placement [Member] Debt Instrument, Convertible, Conversion Price Employee Options Issued For Services Transaction One [Member] Employee Options Issued for Services Transaction One [Member] Employee Options Issued For Services Transaction One [Member] Employee Options Issued for Services Transaction Two [Member] Employee Options Issued for Services Transaction Two [Member] Exercise of Options Transaction One [Member] Exercise of Options Transaction One [Member] Exercise of Options Transaction Three [Member] Exercise of Options Transaction Three [Member] Exercise of Options Transaction Two [Member] Exercise of Options Transaction Two [Member] Exercise of Warrants Transaction One [Member] Exercise of Warrants Transaction One [Member] Exercise of Warrants Transaction Two [Member] Exercise of Warrants Transaction Two [Member] Fair Value of Revalued Options [Member] Fair Value of Revalued Options [Member] Fair Value of Revalued Warrants [Member] Fair Value of Revalued Warrants [Member] Issuance Of Shares Of Common Stock And Warrants Through Private Placement [Member] Issuance of Shares of Common Stock and Warrants Through Private Placement [Member] Issuance Of Shares Of Common Stock And Warrants Through Private Placement [Member] Issuance of Shares of Common Stock and Warrants to Discharge Notes Payable and Accrued Interest [Member] Issuance of Shares of Common Stock and Warrants to Discharge Notes Payable and Accrued Interest [Member] Issuance of Shares of Common Stock for Conversion of Notes Payable [Member] Issuance of Shares of Common Stock for Conversion of Notes Payable [Member] Issuance of Shares of Common Stock for Future Services [Member] Issuance of Shares of Common Stock for Future Services [Member] Issuance of Shares of Common Stock for Retirement of Options [Member] Issuance of Shares of Common Stock for Retirement of Options [Member] Issuance of Shares of Common Stock for Services [Member] Issuance of Shares of Common Stock for Services [Member] Issuance Of Shares Of Common Stock [Member] Issuance of Shares of Common Stock [Member] Issuance Of Shares Of Common Stock [Member] Issuance of Shares of Common Stock Through Private Placement Transaction One [Member] Issuance of Shares of Common Stock Through Private Placement Transaction One [Member] Issuance of Shares of Common Stock Through Private Placement Transaction Two [Member] Issuance of Shares of Common Stock Through Private Placement Transaction Two [Member] Issuance of Shares of Common Stock to Investors [Member] Issuance of Shares of Common Stock to Investors [Member] Issuance of Shares of Common Stock with Respect to Settlement Agreement [Member] Issuance of Shares of Common Stock with Respect to Settlement Agreement [Member] Nonemployee Options And Warrants Issued For Services [Member] Nonemployee Options/Warrants Issued for Services [Member] Nonemployee Options and Warrants Issued for Services [Member] Nonemployee Options Issued for Services Transaction One [Member] Nonemployee Options Issued for Services Transaction One [Member] Nonemployee Options Issued for Services Transaction Two [Member] Nonemployee Options Issued for Services Transaction Two [Member] Options Issued for Services [Member] Options Issued For Services [Member] Units Subscribed Units subscribed Units Subscribed. Conversion of notes payable, price per share EX-101.PRE 11 vpig-20130930_pre.xml EXHIBIT 101.PRE XML 12 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY TRANSACTIONS
9 Months Ended
Sep. 30, 2013
RELATED PARTY TRANSACTIONS [Abstract]  
RELATED PARTY TRANSACTIONS
NOTE 10 - RELATED PARTY TRANSACTIONS
 
From inception through December 1, 2010, the Company utilized offices leased by affiliates of certain of the Company's board members without charge.
 
During the three and nine months ended September 30, 2013 and 2012, a consultant and beneficial owner of the Company, owning more than five percent of the outstanding common shares of the Company, was paid for consulting and travel expenses to provide strategic advice to the Company.   On January 1, 2013, the Company entered into an agreement with this consultant, whereby the Company would pay the consultant $12,500 per month beginning January 1, 2013 for a term of one year.  In June 2013, this contract was terminated. Consulting fees paid during the three and nine months ended September 30, 2013 were $0 and $130,000 and $0 and $172,500 was paid for the three and nine months ended September 30, 2012.  Reimbursable business expenses of $6,506 and $30,072 were paid during the three and nine months ended September 30, 2013, and $20,001 and $32,224 were paid during the three and nine months ended September 30, 2012.  
 
During the three and nine months ended September 30, 2013 and 2012, a marketing company owned by the Company's Secretary and his spouse was paid $0 and $14,560 respectively.
EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`:,QE5V@$``#$6```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F%UKPC`4AN\'^P\EM\/& MI)MSP^K%/BXW8>X'9,W1%MLD)-'IOU]:/QC2.63"SHU%FYSW,90'^@Y&JZJ, MEF!=H55*6-PE$:A,RT+-4O(^>>[T2>2\4%*46D%*UN#(:'AY,9BL#;@H[%8N M);GWYIY2E^50"1=K`RK[?9HII4'Y3N^GD&&@T>8 MBD7IHZ=5^'E#8J%T)'K8+*RS4B*,*8M,^$!*ETH>I'2V"7'8V:QQ>6'<5<`@ MM#6AOO-SP';?:S@:6TB(QL+Z%U$%#+HJZ:>V\P^MY_'Q(2V4>CHM,I`Z6U3A M!&)G+`CI<@!?E7%SC2M1J!WWD?QFL:/-A9T9I/Y_S>`3.3@2C@0)QS42CALD M'#TD'+=(./I(..Z0<+`N%A`L1F58E,JP.)5AD2K#8E6&1:L,BU<9%K$R+&;E M6,S*L9B58S$KQV)6CL6L'(M9.1:S*TG?'A$%@?0'[%K.M#=PGAGKT],"#.A+J`E:";,FF3>$[ M_`(``/__`P!02P,$%``&``@````A`+55,"/U````3`(```L`"`)?]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\ M(V(T'4\4"_'L)MI< M3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?```` M__\#`%!+`P04``8`"````"$`_GO?E-(!```<%0``&@`(`7AL+U]R96QS+W=O M_%[)K?BL"EJL2UI0]@)88@((EL]X>W MKX40%*F=7J*]1+*C.*/)>KYX9XNOPS[[<#YLFSI7U.NKS-5%4V[K3:[>5L\/ M$Y6%:.O2[IO:Y>KH@EK,[^]F+VYO8WHH5-LV9&F5.N2JBK%]U#H4E3O8T&M: M5Z<[Z\8?;$Q#O]&M+79VXS3W^R/M?ZZAYC=K9LLR5WY9DE'9ZMBF5_^_>+-> M;POWU!3O!U?'7]ZA/QN_"Y5S,2UJ_<;%7%VF@C[=(=-+FI7^0T[R0U;.!,GA MD;`<'D$Y)"V'D!PS$)9C!DC.6%C-&(DA%E9##.5(FT/0'1X*N\-#Y(Z1#D$# M0U"Z='#E2$<@X0A,!!4%!/=1Y?!46LX4R9'F`\2#=.'`NB%Q:Z`W+(U.AN@T MTI%C8.:83FD5*NM=^1I]^ND.:;N>?TQOIM&FDF851!5)JR$HAZ7)R9B"'XJD MK2'H#4O#DB$LN5-87MHUUYRY3)T[.`R/=D8ZA/EWA MUI:F$H92TB_9\+L`6]_T-.??````__\#`%!+`P04``8`"````"$`\):9AG@# M``"9"@``#P```'AL+W=OH8 M'21HF49(PZKU:F>%C>Q(E@QL&OWW/9"*)VRT]2I9X'WW?#P']N3L:5D8OWE5 MBU*.3?OKP#2X3,M,R(>Q>4TNOAR:1JV8S%A12CXVGWEMGIU^_G2R*:O'^[)\ M-,!`UF,S5VIU;%EUFO,EJ[^6*R[ASJ*LEDS!LGJPZE7%65;GG*ME83F#P8&U M9$*:6X?CZG\\RL5"I'Q2INLEEVIK4O&"*0B_SL6J-D]/%J+@-]N,#+9:16P) M<3\5IE&P6@694#P;FR-8EAN^ MBSO4RQDZSD'S9%.*&\$W]:NH61I/MT)FY:9Y%$K[W*U<"WKH5FB\5H=`I&D@EU#,-Y;;ZHH06-E4/(3/; M-*IC`7^J,+.;P+'+.2N83#E-FJ=KI'*0RGE?16>L@M;D7(F40=&[G5WDT187 M[YPHIJ"P4M6T7-!XQ:MM2Y%^B/3#?@R=OI'[.9,/O*9"TD25Z6..7*#$7?ZC MC[E`Z5Z3P3XM`&]GX[,ZIQ=`&Z[H-Q3'-RV.ZZLK;WY'XPN:A)=1>!'Z7D2H MY_OQ=41P&`?(YK!O`=T1;,'?4$4 MDR"A,^_..Y\&6':$91IL8>3'5P$EWJ\`;S:$,7G=3(-M&I+PTB-A'-$D(&0: M7$&P:-/A#N`Z9R3V?WR/IY-@GM#@YW5([K`83*$S$RCTG-Q1`OLFGM^&@C/` M7-H?!`L#/L1DV1I:R;N$0AF[21EBV&R-MN3-FE+"[K$/AA#>I;U75[^NC;J` M;Q4*!./H:#B^GQ$TM?//S&VSN6^VPP#8[.ISZ>>TQ&>,8=GC(:ZSY>*,8/$O MAR3->;8N>//5W/E"8$9=C=&W7T5-MW!&&%FW1=9JTX7C"YP.4CA7-3_-P:0M MF_5RJCS]`P``__\#`%!+`P04``8`"````"$`NDUA2EH&``",&```&````'AL M+W=O7QM6F_ M=8>R["VP<.HV]J'OSVO'Z8I#6>?=JCF7)QC9-6V=]_"UW3O=N2WS[?!2?708 M(;Y3Y]7)5A;6[1(;S6Y7%672%"]U>>J5D;8\YCVLOSM4Y^YBK2Z6F*OS]MO+ M^:%HZC.8>*Z.5?]S,&I;=;'^LC\U;?Y\!+]_4#2-FMMMQM[,]TG3%B.T^/@T#_5N5KI_W;Z@[-ZV]M MM?U:G4I0&^(D(_#<--\D^F4K'\'+SNSM;(C`GZVU+7?YR['_JWG]O:SVAQ[" M[8%'TK'U]F=2=@4H"F96S).6BN8("X"_5EW)U`!%\A_#YVNU[0\;F_LK+R"< M`FX]EUV?5=*D;14O7=_4_RF(CJ:4$38:X;#Z<9RMF/"HYW_`BCM:@<^KE8\N M!18]^`.?5R,?7HH_6H'/BQ5_Y3(O$`MD<93$0\22O,^?'MOFU8)M`")VYUQN M*KH&RY=0*6&GX+T7.PB:-/)96MG8@6U!6#I(N.]/OGATOD..%",2O8&$)A)? M$)D1TFQR>7`U2\U7T@MQ>253#^#OM)*`3.\XX/3D.22([OG;R7EQ4,+2P)]"Z1W2(,`:">+1=`PBC>R+U((;Z*-QPD`4$;.M8)(7Q&D8E$!WA(&?%\ M4^54)VC@DM!#>97I1$`"!N5_LF'X#_5XN?\21OZCI44*&?TGW&5::54U3R>8 MRRA%)A(=H"&G`DN8ZH3K,L9<)'*F$Y0P[KGBG1(O&TKM<+M=XB6,!+AN++4# M%#(*X/I,^&AML4EP5Z!-E.@`(SSP!#H%4YUP?4X)`C(=8"&1:?1V_,./N"]A MY#ZJ2I%"1O>#T`U0=&,#$"*@2,!$!WS*0@]-D>H`]WP2HBDR'6"$N0%])_84 MVM;EP1]HY#[2/1H9Y3^#K2G0ZF.#H(QR%X??($`?V`)3[(8<2PV"^Y#XP0= MK*EA@_N4<)P&!L&8YS'_O3R0_=%R#50WI1_[6/^(*D:MWQ,!=]'Z8X/@\.L3 MU_#$(*A'61"B9$H-!/:28&B:S""X+[BG-8?&24!EC[1)AT8X^Y0AB!6)O)GA@(I3P(7!SJU&"$)TC`D529@4`Z<>YJ M1Y.IA.R=EBNA.BWP=>IY!(I"1!5SJR^ZCR3WD?0^DMU$3!UD%[5G^?21;824=&J?P00O^(9LI,PH,>BU]#92HA M.ZGE2JB^RU`"E>6(ZKW96SF@C[^5`_KX6SF@CS]`4=1.OD'GS%C!@P=9H!56 MTWO91RWW7G5=AO>HNXFH8M0/P@>/$SB\D4*QR3`"!Z06GG$G&':@+/H^]-IF MZ4Q-0P)^!OH>2LS,9#@1+O&TAMN40W96FASR)HA##W6[:::J'S-D01LS&IEP M^-WT0%8$+3.>`;-C0LTR6:"H)4JQ!0QD(Z!OT>LJ#!W@8G2F@PNEY;8.PUNH M=\+]X\BHK4OE:`LN2 M?4L5=.],+ MX-:_A*M#L@)XUS3]Y8N<8/I_A*?_`0``__\#`%!+`P04``8`"````"$`[*9X MJ94&```5(```&0```'AL+W=O.3[GJ`'[^^+TZ6=^*IBWK\]9F*]>VBG->[\KS86O_\_>7#VO;:KOLO,M. M];G8VC^*UO[X\O-/S^]U\[4]%D5G081SN[6/77=Y;8QPE-C$J/>[\N\^%SG;U5Q[C!(4YRR M#OBWQ_+2#M&JW"1$<)#I?\\;9.!#IY7E7P@JX[%93[+?V)_:4!J'M MO#SW`OU;%N^M]-YJC_7[+TVY^[T\%Z`VY(EGX+6NOW+H;SO^%4QV9K._]!GX ML[%VQ3Y[.W5_U>^_%N7AV$&Z0U@17]C3[L?GHLU!40BS\GH:>7T"`O#?JDJ^ M-4"1['O_^E[NNN/6]J-5&+L^`[CU6K3=EY*'M*W\K>WJZC\$,4YJ#.*)(/`J M@GC>W4%\$01>11`6K0(OC-<&5!Q<5J_2YZS+7IZ;^MV"K0?$VTO&-S)[@LA< MG@A$QL6,@EW3"];(@WSB4;9V;%LPO84D?WN)@^C9^0:)R04F00S\'S%,1:1S MA.=O1HP#C$?:H*1,6Y_-@1T'#QS((E(9L6;75>1>*O68Y0QS,*5&JC-!S$!MS:(H(E64 MJA!.?F*OZ+>YAQP'4W+^N'4PM8@9R`4:W1`A)]^_0HY!M9I+UZ,I/5*7B0`A M/Q;%4+DQ%4_%T/I6Y&.\:1LGMT>3!AB2G9\(D*P/@:2+$)4?[^02/[/Z8-C_ ME2883@6(B1:@19X89],W2GFL/>I(>GY)AJ?I5@L1=#`EJ7(9> M9"4>@O!:8N.ST&>D1:4"(JL])43E"9@'A.2SZ,:DAN,A:!"2[-M4#)MP)%[# MM82G%S?NJ/B3@AG'J1>+;3DWE#B>J3D'75.3N,[R-84W=QMO=ETF0'J91-U@ M'#U$S3;QG!O\T&M4UYY6+A1$D/['!;\EB,KO(L>V6 M("H_WK_OOECP-?X1DS0F`J112)`TM@[_+NOHT6K=>K-;90%:%-'8.OR[K*-' MTR3/Q%OR!:'?$D1-\D/6X9M8AP!ADMEJ31IXJHR[JZE_JP3O<@[?Q#D$"(EY MJ\V,F.PL"G&%6?"0=?2SU"T8SZQ#@`:&WD;Y(U>,J8)V5U*UJ7SOLI+`Q$H$ M:*ACZ9=Q'XIQ?2FIY.ZRDL#$2@1H$'&69C%N0NXA+PE,O$2`!I+$:E)E>&$K M\J8NM>IE*PDXFG:9J?SZU"4"I%='9!?CZ"%J=A^R$GZS0F]%Z!9+!&@0\%:I MW#86/)W%<\>J:`Y%6IQ.K977;_SDE<'3T?';\53XD]>?ZXX#<"A[R0[%'UES M*,^M=2KV,)57IFTU>*R+'[KZTI]JOM8=',?V;X]P_%[`N1\\@+6M?5UWPP=^ M<#P>Z+_\#P``__\#`%!+`P04``8`"````"$`E?^YS7(H``#_40$`&0```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`Q?+ECG[N7N\\>GQ[_?00.+]T[7#13M7,>0 ML=OP^AK1]HDCW$NFZ0;\Y_5PFV5_-S/WFE>D4FWZS-PQKNY";EC*#2NY82TW M;.2&K=RPDQOVYP5R[B3L8DW6*UPMJLDZ0VY+U@MR6H!N8H!^8 MK"/D7I7UA-R6:U>XMB>[\NE([.N^KI?V M]?*+3F6"BVVRJXU3^X_=REP[P"L3]"L3=`H3]`H3=`L3]`L3=`P3]`P3=`T3 M]`T;]`T;]`T;]`T;]`T;]`T;]`T;]`T;]`T;]`T;C`KV.BRX:VJ#8^\:5 MR?>$]QB&KV,QWJF\L3C^=NF&W#-]'G*O==V&W%7WQY)V2N3[3L4G.B'1:%9] MIALRHDJ/$OT(4?=W,X@@-2'5,,+X548A(=^7QB$BCF<2$K+(-$1$D5E(-"KB M#6$>,O56PS^B1<@T*F)?2P6S4C#KD*DT1'LV(=-HB2ZSC3!5P>QBC!@/]R$C M+\0A1!JMEG\*CQ'F5ER*4XP1I]F8$*K4Q7$9&T*-6UDIHF;C5AAA(G96ZJ+= M)J)G0X8*XPPM7Z):+4$L]D^1B1C:J$DHYFA+7#/#)3412^4)BEDJFQ/QM"*' M#,---1%593>-D=?VG MW)`-BJC:D,J;F*Q5V7]BM@903%<)V8BN\H+8F*UR_+!16\49L#%;?57HP1`V!? MP0P4S%#!C!3,6,%,%,Q4P$(O*&4,3>$(KH&T(1?T,H M(G`(10P.(!LQ.(0B!H=0Q.`0BA@<0A�RAB<`A%#`ZAB,$A%#$XA#0&6XW! M5F.PU1B,^TB7E)3/0/F&>_&K)N+7^5Y#%3>7BN>YSJ_R8IC8,AQH@)DT6,$7-Q MRPC3$I^)5C%&Q/EUC!&A>A-C1&#>QACQ/KV+,>*:[F.,.(>'&"/.SS'"W(IC M/\48^19M-)"-0>(,F:LXN2Y]*P[?7&7*0^+XS56P/"0ZD;E*EX?$63)7$5^A M9EET(W.5,P^)W;UV7K;!\R%OF%HZTUZFD1O:Z89$H-YSD!F."+3;8 M$EP\TPF8X/*9X/J9X`*:X`J:X!*:X!J:X"*:X"J:X#*:X#J:X$*:X$J:X%*: MX%J:X&*:X&J:X'*:X'J:X(*:X(J:ZR5]'0TJ=3%JFNMESD-R0`RNO`VNO`VN MO`VNO`VNO`VNO`VNO+U>^7P3Q7'8:V?(0_(X@OYA@_YA@_YA@_YA\_W#&PKQ M%)DW%)X_YM4@0/''O/.K\'$P=YNC69%O@2F#R'1]]D6<@38E.I3H4J)'B3XE M!I084F)$B3$E)I284F)&B3DE%I184F)%B34E-I384F)'B3TE#I0X4N)$"6,X M8CG"M3/<.\/%,]P\P]4SW#W#Y3/U&I."*=Z4\W>)SL&G^:P>,B*5,4D2C128G&Y=DP/$9R M^>??)^SFD2C1H[OI4V)`B2$E1I084V)"B2DE9I284V)!B24E5I184V)#B2TE M=I384^)`B2,E3I0PAB.6(VV.9.(5R&LR\8H0;I[AZAGNGN'R&6Z?X?H9[I_A M`AINH.$*&NZ@X1(:;J'A&AKNH>$B&FZBX2H:[J+A,AINH^4V6FZCY39:;J/E M-EINH^4V6FZCY39:;J/E-EINH^4VVD(;O8QT_E9P_AN*Q1GI3,N,)&?`4J9@ M#&VG1)J`\#7->A49R$]`'5JDFR]2Q:U'Y"2_1B]/)'B:H%9KBCLL?0]!W&L! M\JL,\LAMK=%LU<5]DV%*%!SPB!)C2DPH,:7$C!)S2BPHL:3$BA)K2FPHL:7$ MCA)[2APH<:3$*252(?`@]_DC@=\+C:%%C.5(9EY!5S7JM6K5?%F&4R_S*F4:\FM:K0W&0&IDPU:=4J\LMCABMH MN(.&2VBXA89K:+B'AHMHN(F&JVBXBX;+:+B-ANMH,A\+^IWE/EKNH^4^6NZC MY3Y:[J/E/EKNH^4^6OYN:/G;H>7OAY;;:`MM]'(2UH=X0TXZTS(GB>QA4Z:@ MD[53(AUP&DFC(2IT:(5NOD)2N6V&(8G6Z%-B0(DA)4:4&%-B0HDI)6:4F%-B M08DE)5:46%-B0XDM)7:4V%/B0(DC)4Z4,(8CW#F325>@I>'>F4R\HBH]WERN MGN'N&2Z?X?89KI_A_ADNH.$&&JZ@X0X:+J'A%AJNH>$>&BZBX28:KJ+A+AHN MH^$V6FZCY39:;J/E-EINH^4V6FZCY39:;J/E-EINH^4V6FZC+;31"T@)OFKB M)23=@TF7E\FH)#YZV0QJW%YNFHEGCMO97PL&VPY'NASI<:3/D0%'AAP9<63, MD0E'IAR9<63.D05'EAQ9<63-D0U'MAS9<63/D0-'CAPY<03KAYT5QM.$N5O@ MX@E`K"C&&8601F&D42B)EQ12&H651J&E47AI%&(:A9E&H2;61>/G1R$G MEDKC=11Z8O$T7D-U%)IBY39:!VNY<4;A*=9[ MXW44GF)-.%Y'X2G6C>-U%)YB;3E>1^$IUI_C=12>8HTZ7J?84S]HX=O`0=!J M8!?%M^Z2\\MDT)+?[LD@%[1*R>7II.M_!,DKK5GPAM')*A8@78[T.-+GR(`C M0XZ,.#+FR(0C4X[,.#+GR((C2XZL.++FR(8C6X[L.++GR($C1XZ<.(+D145" M\N),6\$HC$3RXOM2.(E58GD=A95(7KR.PDLD+UY'82:2%Z^C<-,HY$3RXOM2 MZ(GDQ>LH!$7RXG44BB)Y\3H*29&\>!V%IDA>M`Z2%V<4GB)Y\3H*3Y&\>!V% MITA>O(["4R0O7D?A*9(7KZ/P%,F+URGVU$]>Y[5&\P]+*:>XTB5*O2?+J^(! M#YND4):\RJ4@:J5_+\A1G:Q$`=+E2(\C?8X,.#+DR(@C8XY,.#+ER(PCXX<.'+DR(DCB%I4)$0MSK05C,)(1"V^+X63B%J\ MCL)*1"U>1^$EHA:OHS`348O74;B)J,7K*.PT"CT1M?B^%((B:O$Z"D41M7@= MA:2(6KR.0E-$+5H'48LS"D\1M7@=A:>(6KR.PE-$+5Y'X2FB%J^C\!11B]=1 M>(JHQ>L4>^I'K?/"=_FH12:WTG7RT(3KE_<:#7'OPB8I5)"/VASI<*3+D1Y' M^AP9<&3(D1%'QAR9<&3*D5F&9`_9A@]"SSW@\JBT_Z3T(@1$U%Z&A%]BY0&U M\F42U$?6'M(*V[GQ@!H669./=&\](CD_].WO8^$(PK''*D`)M$*I2M=++5CL7D4U!J,HSE48$X8>CN*=!)DJ3P2(Q3N(4GQQBCL0Y+B=9Q_11?;*5C$ M.`N+&.=A$>.K&/UFA*\B?HL0_WR1D*."ZR`1W\;HCGP?TSLC8D>^D%'$5[(6 M:ZZ3LNC$**Q$A&*'C1^!RB,7;_U#0G[*$\U&:`M^)2I%"MJ+^)0O$QL@\$-2 M$A%-<5:FWB;G;XV)RX@?FN)-<586-==YF>TJAJUQ5F:#50M? M,).9Q$E9L"/G9!3Q0Q,.Z2VAZ8R+.X+!KWHD*51PLMH1_H<&7!D MR)$11\8_RH8Q[`3_^*+XK@:2N^ M%X6`>-HJOR/\QJHXKPA./B"^3(O0E/Z]E:Y^X@_PR$N\F0KQD)AX'85Z2$R\ MCD(^S#WQ.@K],/?$ZR@$Q(]3\CK.0I#7C]3BS0L_8,GK.!6+ZBATQ-Q3NB\G M054VQME8M".%D4A-]*`0FSCCI"QH#Y(3KZ/P$M&)U_'5+)>:X@0B._$B"D/Q M0YZ\CC,TO9K5DEPE&[_TR8LX/5V7"(ZHV$T_.IV7D'W#?%.ZXFQ^OJE9E8M3 M)RF$`_DG@]H1_H<&7!DR)$11\8U&B+F+`0?Q= MCN5'OHL31Y"MJ(#(5IQ16(J$E=9).U)2"E88<)(ZH"ZZ#K(5;XG"440L7L=9 MZAIS*P.CPE&D++XCA:5(6;R.\[2@:R-E\3I.T*(ZSLHB1JHHWDN1L-*V7,<5 MD72=A^[O4F5$*[^`O$#.PK0`DK@$`@=E$YV$18>I$!$W\^AI1Z821R,:@T!% M`.>@Z['RLQ:B%&^&=#"I>8.Y^%B%5)663#^LB`]WN)''=ZAP$3?R>!VGH[O: M\M=0,!G%BS@7W2F47[)3>&B=AZY&KMOY<>J\JO$;XE2Z"+(?IUY_"N+ROF,3 MNE)RFR,=CG0YTN-(GR,#C@PY,N+(F",3CDPY,N/(G",+CBPYLN+(.D/2WEPN MR;?!C??WI-02Z7#+=[$3)6JB5^]YB0-'CF(O,E"=>`FD)>H7TE+*./WEQS;, M1/F`_#5AY"2^%X6`2$OY'55*%3%X8R;*!X+?A'?VI<=2*96!16%#;B22B^+X62F(U*ZS@1 MDO1>W^4^$?Y#9`7C_"QJOL)1Y"C:?$0ISCA-"]J#0,7K*$Q%BN)U?%F34DUF M$R=K48,5OF)NBC?&^9I>VVJI(ANCD!6/0Z4[0V1SH.9&O]SV<@C6DF] M)<[;V`/J6`Y4_DCIQ",JS5JS+CZ:33TBJ9W7%!6I8.8AU:;\J;:Y__=$_@#; MPO][%0M_^0>Z](!*0YZ(E??W)OJ/_#G`M4J$[)0R M:>]K5!H-D281GO)$":L&C3#R99],J[4JD&\\F4[/Q(F#L6Y5G1>G6Y%C!.NB/&5:^!!C"`O M^LHEM4HY6-W3MZZ5M!J)/+N^>)5RM2X[-6*3=WI;&(5JLHRO7SUI!*?7UZ^* MY4K%*(.'GOS]W-8DX?M7JY:#[N0;B+GOIA@/C6]@K5QMRB[K*UBM))7@0X&3 ML.@2*C1$/,H?<@NG31PRPE&>J`<#"AYWR@-)J]4*OJGE'"QH+1YW2LL4,;Z) M2)!B1A@S3/FVU&L5>7UPRX[OQHE8U!3G8NHSWI'D.(H))J\MZ/NBS^*.79ZH ME6^;LELC%.61!,.&7&07L2B/5!K0\#IN^*'HO-IQ/A3I?NX\21=)]L.1/)0, M*CAC;8YT.-+E2(\C?8X,.#+DR(@C8XY,.#+ER"R"X'GA:U^Y3!G.-=!"`RTU MT$H#K3701@-M-=!.`^TUT$$#'370*0*)?(I$Q5II7(824Q32V4QYJO"6O)L*2Q&(`OK!.<* MH4Q#J3S&K%582[0GD/-TFZ3G(^ ML37D!*O-H,+$1M=;[O`J78[T.-+GR(`C0XZ,.#+FR(0C4X[,(HC\;#57,`L% MLU0P*P6S5C`;!;-5,#L%LU$-`44\S.H M%#,T@&*.!E#,T@"*>1I`,5,#2.$JTEEXFN0U4=B*=,;KQ'R5^XKY*IF8KY*) M^2H9C:\(9^&!!6=:8RRBF:*2QED$,T4EC;6(96$E>9H4VB*6A77D64(J4T`: M;Y')PDJBV5FL!9J'A#^WM@B!6_?XP^6_Q:VZ9-D_:U.?(^NU%(:Q36&H6V1N&M<>(6*&"( M<<86,8&TE5O[U[DWZ:=PZ_GO/+NB;7+B-O/!EG]/4%P;!@0J/ER&&< MQ`550HEO*[D#P=UX?[PRSNFB\Z.PVBBTMD[K:_LK=*' MW9WPKR]H%#[39IW]!8=O0^'E36CKA'_=;_6RL,/UV.21*>RW"ONML[^H_4[_ MU\9=UK^XMBV8AU*,!58Q%EC%6&#=6/#:N-R-=3_EG5=!?4/*2Q=-]6?+[H.B_CEJ!44/_BN:\L(EP2N.O!DGCB`]TK-H%.8;A?K&N9_USF:I M$1P5`F/:GB)&83\2(S\NA?](C%Y[DE)3O$<&_1()DN]:,2(@0?(ZBC$!"9+7 M<<-`@2G&B5_$.-6+&"%WJ^3+$1E`S-J_"HIQ#2E27+C($((B MH6B>8DA`D/2.NE9J^>Z$;RS(E?R(W`B1M1;?91=U\X.9$]BO,0D[@1K!T3M5B>!P2]<']!+62[ MD&K*+T!97%"'9AV\.S$/,X MW&/4Y*9XHAT!3K/'J,VYJ^.GMO,ZMF^8'4R7O44SKJN:-1IB;MQ6Z#*\;8YT M.-+E2(\C?8X,.#+DR(@C8XY,.#+ER"R&Y/I(^@T*#;300$L-M-)`:PVTT4!; M#;330'L-=-!`1PUTBD'^.(>Y/.H@YO(BC.P#2&T:*FIK4"LJ;$!%G0VHJ+8! M%34WH*+R!I3"7Z2VR-D2UT9A,%(;KQ-U6.QKKJ@3-5C4B0HL&)6_2&V1(PO. MMT3@'2X56Z'.EQI,^1`4>& M'!EQ9,R1"4>F')EQ9,Z1!4>6'%EQ9,V1#4>V'-EQ9,^1`T>.'#EQ!"F-BH24 MQIFV@E$8B3NN?%\*)W''E==16(D[KKR.PDND,EY'8292&:^C!:/[TKA**;/>!V%I8AAM`Y"&&<4 MFF+:C-=1:(KXQ>LH-,6$&:^CT!0/T_$Z"DVM0E/<]N3[4FB*Y^>*ZOAAZ[RZ M[ANFR-+%>/TI,KD4#;[B>DYB:,-U'DV$[#9'.ASI#6E%=`RIJ;$!%I0VHJ+M$/ASI>#(,=AK\3?)3KPDLAKU$UDM9:XG'`L&OS[% MC/\EODF&V"9?0+Z_JO`;$VB\I<[P7$O%4^3^<(W9--E2+"SK_1,O39>Q^E?5$>A/";:TGV]=B;QM1?Q9FK<"%"T8X7U2'KT()'T..-$+V@/DAZO MHW`;MSQYG5#G2O&W>9W.10>@,!AW/GGCG,&O5QM+N^?_B6$4\W%IT=P+_"^X MR!>#(,=RK'W+%@9QX261#ZB>R8KQ8W-^[NN+# M!/(?/QB%\,A_O(Y">>0_7DOUK50K^<%%?G!&XDN+YE[0*!I=,`4H7]`H#KS% M:ON)[[P`\QL27[I>5OI]A*N*BSN$!MCG0XTN5(CR-]C@PX,N3(B"-C MCDPX,N7(C"-SCBPXLN3(BB/K#,F4:95\P\KAL@$;_Q6*+XUO>3-VLFBX]L"> M5SEPY.CO*+:ZQXE70;:C)B+;I4QV:A5?_D>Z>_-+%#9C[H^WUOE\[0A5?^2L M!TL5(/UYK<7Z-[AJXA,"%KP34!5?_Y>0PG$L6,(/0F$Y%BSA=12>8\$27D=A M.A8LX744KN-I.E['V5X0.+`D":^C,!J/T_$Z"J>1\M(Z6<=4+`.">3Z^:X7E MR'FT#G(>9YS6!:<=.8_747B,G,?K"'$KI8Y MBZ]77*SS$5D_1"$UPEZZZZPLU@_!F"9&(DSI%;7/#WCG]9S?$/#2Y9_]@">F M%6PE7",Z"'@4Z?`J78[T.-+GR(`C0XZ,.#+FR(0C4X[,.#+GR((C2XZL.++. MD&NOCZPPM?&99DG!TW%A2\B2/^\3H*^Q'_>!V%\(A_:9VLF^+CIM?ERN%BH8A_?-<*YQ'_:!W$ M/\XXR0M..^(?KZ.P&O&/UQ$:*]8IQ+0?+ZNP&/&/UW$69U>\6O+O_]R&;QR8 M^.-EG=19V:34P`@GABO$OZ)"7ORKONTG*BZX_(*KF*"V&5304=H M1_H<&7!DR)$11\8-0DJCL-(HM#0*+XU"3*,PTRC4-`HWC4).H[#3 M*/0T"C^-0E"C,-0H%#4*1XU"4J.PU"@T-0I/K<)3J_#4*CRU"D^MPE.K\-0J M/+4*3ZW"4ZOPU"H\M0I/K?,T^Z)UI5:MRDFN8DW]D'5>%E@_QU9-5Q'VYMAJ M9\BHS M7F7.D05'EAQ9<63-D0U'MAS9<63/D0-'CAPY<00ABXIDK()I*QB%D0A9O#T* M)Q&R>!V%E0A9O(["2X0L7D=A)D)66B<=)O#@94O\O`XB%M^34_.?JRC,1,!B M;5&8B7C%VZMP$_&*UU'8B7C%ZRC\1+SB=12&(E[1.HA7G%$8BGC%ZR@,1;SB M=12&(E[Q.@I#$:]X'86AB%>\CC.T(+W88D?]?(6H])9\=<;%)%9-/.-KJRE4 MT,(V1SHLH!$7$XG44BB)B M\3I.TH(W.T0L6@<1BS,*3Q&Q>!V%IXA8O(["4T0L7D?A*2(6KZ/P%!&+UU%X MBHA55,>/6.N$_(ZR@$Q7U"7D>A*.X3\CH*27&?D-=1:(K[A+0.4A9G%)[B/B&O MXSQ-/YI5(XL)XS9A6B;[]!9#%);B+B%OC<)2W"7D=126XBXAKZ.P%'<)>9UB M2_V,A?S]EHQUQN4TEOANNZVF4$&R;W.DPY$N1WH1R$H,A:O MHU`4&8O744B*C,7K*#1%QJ)UD+$XH_`4&8O7<9ZV;CY__.OS>5FA1#RP@HR5 MELF05OU6$@I)$;%X8Q22(F+Q.@I)$;%X'86DB%B\3K&D?L0Z+Y;[AFFL=&U= M?QI+/$Q@JW0!WC9'.ASI!TG9?HY.UTG MUY\)1\+B9116(F'Q.@HOD;!X'8692%B\CL)-)"Q>1V$G$A:OH_`3"8O741B* MA,7K*!Q%PN)U%)8B8=$Z2%B<46B*A,7K*#1%Q.)U%)HB9*5ULNFPY/*=;-]3 MW"OD^U)XBGN%O(["4]PKY'44GN)>85$=/V2=UY/-ARS=CV=6TV5H_;`ELW`& M(11>;RP*I,V1#D>Z'.EQI,^1`4>&'!EQ9,R1"4>F')EQ9,Z1!4>6'%EQ9,V1 M#4>V'-EQ9,^1`T>.'#EQ!&&K:%WHRZ]V(&QQ1B$DPA:OHU`288O7<5*FHWCD MG@:R%J^BD!)9B]=1:(FLQ>LHQ$36XG44:B)K\3H*.9&U>!V%GLA:O(Y"4&0M M7D>A*+(6KZ.0%%F+UD'6XHS"4F0M7D=A*;(6KZ.P%%DKK9-EK72YC"!K\7TI M/$76XG44GB)K\3H*3Y&UBNJD6>O]\_?[^Y?.W7E\>?E__Y_?[NZ_W3&0#\ M[?'QQ?T?G*7W?S\^_?MREC__OP````#__P,`4$L#!!0`!@`(````(0`2.IY5 MGQ@``-O2```9````>&PO=V]R:W-H965T?QY]O?^^>7A\/3YO'!Q=7ZV?[H_?'UX^O[Y?+EH_:MZ M?O;R>O?T]>[GX6G_^?R_^Y?S?W_YW__Y]/OP_.?+C_W^]4P4GEX^G_]X??UU M>WGY]W=?CR<]_KR,KJXJEX]W M#T_G6N'V.43C\.W;P_V^<;C_ZW'_]*I%GO<_[U[E^E]^//QZ2=4>[T/D'N^> M__SKU[_N#X^_1.*/AY\/K_\]BIZ?/=[?=K\_'9[O_O@I]_V?0NGN/M4^_B,G M__AP_WQX.7Q[O1"Y2WVA^7N^N;RY%*4OG[X^R!W$S7[VO/_V^5P5;M6@6#V_ M_/+IV$*KA_WOEY/?SUY^''ZWGQ^^#AZ>]M+<\J#B1_#'X?!GC':_QD5R\F7N M[-;Q$4R>S[[NO]W]]?-U=OC=V3]\__$JS[LLMQ3?V>W7_S;V+_?2I")S$95C MI?O#3[D`^>_9XT/<-Z1)[OYS_/_OAZ^O/SZ?%RL7Y>NK8D'PLS_V+Z^MAUCR M_.S^KY?7P^-:0X5$2HM$B4A1KCXY'EU$U7*A7/F`2BE1D7I3EGKZ2"+Y)3T]O&=$\B"/%U_\?W7O M8MJ]XU_2JPAO@V+:O279WDX/[5>7.H*.B=:X>[W[\NGY\/M,7B?D6EY^W<6O M.H7;6#G-,IT\6;J]%VZ2:K&*BF4^GTOS2FZ]2"3__:52J'ZZ_%M2]#YA:GFF M8!+UE(@C,Y9MZ`+Y;R8;%6_,DYIYYOK*1%JI[JG,MWG&ENFG57LN;Y`RZ>4-[8*1HZ*"=<'C]"1/39.426N:V@4SNV!N%RSL M@J5=L+(+UG;!QB[8Z@+Y;]89[);>\(;D'HK*^FMZ@RGIF5I+KB2KKBAF3 M=+S3/I^O+.MZV6FYCJ:2GG9]?'D_NBGI6(9TR3*+2GK6R6E91\HJ.^TVE^+X MS/82)H;MW4.7U-TQ';L[U:VE!2?M;-JIGB>NK1MHY)&H;*HT'8A)M#1A=(K( MLG\[ST0ERQF=/%.)(K.N;IZ)*A63Z>49^[[[>20G,PA@A@ES=8S;4N&J8MWW MR"%2MI@QB4P(F!(P(V">`*?&+EJ=9>%BBF;;+P.850"SSC-VQ]PPLG4A5NOO M\DS%?@%1*@1*'%E(.X,,X6Q=C/:^=B['> M8R@5`M4<4,EJ:94XSK!/#DIK+*9=>293/E\FO)>B;* M9=B2U>#*Y=B2]?Y&N2Q;LA^+R[,G0S`C066FP4A0?W+&M)&<=D'=+FC8!4V[ MH*4+]'Q;/"!OVP4=NZ!K%_3L@KY=,+`+AG;!R"X8IP5OX^Y*9#V0B8NQGLBT;NV!K%^SL`J72DI.+L2<*5"V% MTII4TC<,9]KMJ9+^8D+63:BD#[UU&97K1"K7BU2N&ZE1:"#11**%1!N)#A)=)'I(])$8 M(#%$8H3$&(D)$E,D9DC,D5@@L41BA<0:B0T26R1V2"C%"+M.L>T4^TZQ\10[ M3['U%'M/L?D4NT^Q_937?T:*C:?8>8JMI]A[ MBLVGO.XS0E46;P_G!B@PM`3,3T!&>/X8B0D2T]-KB"Y*Q:O3'^O% M=H9R75A/;8GGKY!8FS58SW5C';4&X5O_X1W6KA0CB;]TOR[8;:#J MK,#N4FPO9?GKRO[\P')8T6HKE7@L\Z=]/'&8)T<4VTPE/O.I>+UF9*8LN#0R MT_^Y0TR;65DI6Y_$U#3CN;HZ$@TDFDBTD&@CT=%$\G;JNG!=L6>&NZC10Z*/ MQ`")H2:2=]/E.+.L]$2),1(3)*9(S)"8:R*YE6/ZFK>R0(DE$BLDUJ>742Y7 M\DVZ,0C'A6Y/@:KCH>SP*I1BA!VGV'**/:?8=(I=I]AV*O&=)T,4&T^Q\Q1; M3WF]9T2I+!#Z2)8><3-,RS>6:VL)Y&F).B,-1IJ,M!)$&_.Z4))M%]9HI6T@ MLB,C;YH.5]1EI,=(GY$!(T-&1HR,&9DP,F5DQLBL$6%*EGO1==O#=\_N,#!@99HCC*D;9P7>O8LS(A)$I(S-&YHPL,L1QN\OL MX+NWNV)DS_= M1I9T99TW$[ZO$^!%25>NR^]&,UWC)?D?2%>]@E\N(5M35;[)C5TUY.D)]0(B M#4::C+08:2>(GE1X9\8`+[=KJ!QG'>SYSQY?2Y^1`2-#1D:,C#/$D4L3XZ!\ MRX(Y/SK-#I_T$Q.9,3)G9,'(,D&2V=SCC)!Y*2N#./8`$UAS+1M&MHSL&)&@ MQA)#,E8UDE-Z-,) M<*%D+-?E]Z&9L7(]'\G8&+=G9:VFKQ4TY+G3.B,-1IJ,M!AI9XBSKW6RP^_& M13=#G`J][/"["GU&!HP,&1DQ,LX0Y]U,C,/6@'^:'7SW5F>,S!E9,++,$.=] MK(S#UGVLLX/OWL>&D2TC.T8D5-%/$JK,O)DN;A#K2T^DY($NG MS\B`D2$C(T;&#B1W3Q,')-_^9H[UIB[(1&:,S!E9,+)T(+F[6CF@W%VM79!Y M5QM&MHSL7(B]F47B%FTE<%Y/F-&)HQ,&9DEB&Y\UQW/661AB,@V!5DH8C[!)8NL&%D;]5S? M.-:L;`RD$O]8*V2W!E$H%.7'FG7;\:5([/+&JM2(R=M^V8A8MM=7JM2)R0-P MK#N3U.6J`JPHJ:MU=%5QO[0?DXQV3Q&]6MI\DI*YIXBC@66HR]>;FM'C`4E< MUDG]Z-8Q$S?>^'&:N/#AE]XG*^ MP.0;(K6*!VFR2HN1MG&YQ^=O^;3#(EU&>D8]I6*I$%6MA0Q]`XEN\BDY,(A" MOK,.#<"U('.4$)Z&'3,R863*R"Q!=%F[/&PM2(F\1Z?DL663&R9F3# MR):1'2,2M.@.&=^>^K!4+58*92OV)6A9IQ'`!%A1DI;K2LWHZ9R2M:P3X$=9 MR,4ZJ2-]UY-ZTLV8:1OO\OA`VNI-(:=I6[$?8:V`.T?JC#08:3+22A!MY^I- M5+5>&MJLT6&DRTB/D3XC`T:&C(P8&3,R863*R(R1.2,+1I:,K!A9,[)A9,O( MCA')7'2:9"XS`7:4T2WK!!A2,I=U`DPIF'?) M!S)7;T8YS=QB9,58+?X._VR$*U_JD1MRU`TBR@]L&@G@?M$XCH";AD:Y* M]T>$!^X1-UHST&1DP,F1DQ,B8D0DC4T9FC,P963"R9&3%R)J1#2-; M1G:,2.CZMBL=WPZJU)"G;K.<)*'+.@&.E-!EG0!/2NBR3H`K)72U3A)&$A#% MW'?H!_A2!1A30M>H2SZ??"]T)3^-T`U;K1#%I]D#7BOO:@F4!/]-.;*_YK)N M$%$U]P+32`!/=VD:&J5J-5=+BT7:C'2,>AS7VF6-'B-]1@:,#!D9,3)F9,+( ME)$9(W-&%HPL&5DQLF9DP\@V0;0]Y"/FJK42=L<:DKG:B!Z#2.8RDSK1IQ-@ M1LEQ]8=C/7JVT@0W2L=*TF:#@V[GI:#L>II,])AI,M( MCY$^(P-&AHR,&!DS,F%DRLB,D3DC"T:6C*P863.R863+R(X12=V\UZS^+:G+ M3(`?56I(7\JY/&E?3X`G)77YF@-<*2-=U@GPI8QT6DP4B3D18C[00Y2?F369GCZTF'5;J&BEYB:KTJ M]0PD_@@Q-\;O97$ZY@U,7[TYPQS[6FM.:Q'NX*@STF"DR4B+D7:"Z/35J^KS\8NWU#5E M=+;F\A=E^GS!`T:&C(P8&3,R863*R(R1.2,+1I:,K!A9,[)A9,O(CA')7^Q3 MDK_,!%A2\I=U`DPI^@$&%/RUW=?9O[&>R[^0?[J MK1IF_EHS5;4(]W/4&6DPTF2DQ4@[09*9-]=>KPZK=!GI,=)G9,#(D)$1(V-& M)HQ,&9DQ,F=DPD_1E)L"0DKZL$V!)25_624WI M2\T`5\K<`]<5X$N9>V`=OS/-](WW:9RFKW^/6J2W=1BI6[!7\":0I\7JC#02 M1(=AO#K#'HHV6:3%2)N1#B-=1GJ,]!-$W_-Q,Z0YF3Y@C2$C(T;&C$P8F3(R M8V3.R(*1)2,K1M:,;!C9,K)C1"*7-UG5`I@`-TKD0),!KT_'C-QX>\4'(E?OQC`BMV+M'Z]%OBT;QWG3.B,-1IJ, MM!AI,])AI,M(CY$^(P-&AHR,$B297='3(F:\CUEEPLB4D1DC@R$V!(25W6";"DI"[K!)A24I=U`FPIJZTGJHI$D=9FI!S`! MCI0%95Q7@"=E:0/K!+A2IA=8)\"7,KW`.GYG&JE;_-A^M2-N+FDHWUA_)*R6 M0)[1>)V1!B--1EJ,M!GI,-)EI,=(GY$!(T-&1HR,&9DP,F5DQLB^]$`GG#5^MXD`:K-!EI M,=)FI,-(EY$>(WU&!HP,&1DQ,F9DPLB4D1DC)22QJQWI,9O$+C,!CI1A+^L$ M>%*&O:P3X$H9]K).@"]EV,LZ`%/&Z;`78E?OX1#Y;%6S?+>P M^0I<*^)&CSHC#4::C+08:3/28:3+2(^1/B,#1H:,C!@9,S)A9,K(C)$Y(PM& MEHRL&%DSLF%DR\@N02HWY_KOQ$35&^/'FN.3"$;C200S$^!.B6#6"?"G1##K M!#A4(IAU`CPJ$`8MT>^]M*&HH8\+\9U1AJ,-!EI M,=)FI,-(EY$>(WU&!HP,&1DQ,F9DPLB4D1DC.O%!\;!>J>&.0ZVOZ^LZ-O.H5J,-!AI,M)BI,U(AY$N(SU&^HP,&!DR,F)DS,B$D2DC,T;FC"P863*R M8F3-R(:1+2,[%Y+_PY8NRIP0E-Q%1\IR!V8"/"FYRSH!KI3<99T`7TKNLDZ` M,R5W6DQ MTF=DP,B0D1$C8T8FC$P9F3$R9V3!R)*1%2-K1C:,;!G9,2*C772)I*YFDA7" M9?EK=M9(24*790(,*:'+.@&6E-!EG0!32NBR3H`M)719QV],,W3CC1_GR8[]_;=R]WGWY]+A__KZO[W_^?#F[ M/_SU)(L7"I$\H:SX['G_[?.Y:A9NY0\=G5_FCW3ER,!UI!;=UDJ.,^K1;=U5 MWHAN&Z[R9G3;=)4KJ=A57BOSG[NOTE#7EU,&T_L?KX9Z@Q3>E-HH[7)J* MV+N%V_HE11&6UVZ!.E8 M,/HV\QV[8\BTF!<2$_BR$P-E3A^RV7),V6+>U^>7A(,]NR>VUH?/1A9?90M8 M;#PF?P`;K;<>^ECX1[B9O=F][@_@FR$%E'S7N._Z\`5D53L\[3$&\KEFQ?,* MK,""(DTRZ&T(W:`!O!(E?6=@0?BQ_S_(PM4Y'4Z2\30=9@@G&[!N+3TE)6)G MG5:_`RCSIB+)X(4$_U](LDDR&HRGMU>PL."H#[CBCB_F1A\(-@UJVH[[%LQF MR'Q*%GS$K.]%17N>Y,&SY'1*"::P>#S[Q20;S]D>:RI>,,N`P6O$#(9W$IO:_QH`G9%FB"XU-J=%G[>XV=X\0<``/__ M`P!02P,$%``&``@````A`(IA'@&?`@``]@8``!D```!X;"]W;W)K&ULE%7;;MLP#'T?L'\0]%[?F-)=U@D,OP(C55&:\+A+\ M\\?]U0U&VI`Z(Y6L68)?F,:WJX\?E@>I'G7)F$'`4.L$E\8TL>]K6C)!M"<; M5L.;7"I!#!Q5X>M&,9*U3J+RHR"8^X+P&CN&6+V'0^8YIRR5="]8;1R)8A4Q MD+\N>:,[-D'?0R>(>MPW5U2*!BAVO.+FI27%2-#XH:BE(KL*=#^'4T([[O8P MHA><*JEE;CR@\UVB8\T+?^$#TVJ9<5!@RXX4RQ-\%\;;*?97R[8^OS@[Z)-G MI$MY^*1X]H77#(H-;;(-V$GY:*$/F36!LS_ROF\;\$VAC.5D7YGO\O"9\:(T MT.T9"+*ZXNPE99I"08'&BV:6B M6RJ,Z%X;*7Z[E^&1PCE'1V>(=W0.(R^ZF86S.02[P.*[3%IA*3%DM53R@."R M0$S=$'OUPAA8.D4NCU[C6Q)!FR6YLRP)OL8(5&AHR]-J'DZ6_A/4DAXQZU

V==A##,RMJ>P]EJ[WSO`VFE(P;X2 M5?!:HXKE$"KPKF'&E5M<[F!DTRZ!G32P>-K'$KXO#*8O\`"<2VFZ@YVQ_HNU M^@,``/__`P!02P,$%``&``@````A`#G%IO35"```=#X``!D```!X;"]W;W)K M&ULE-M;;^*\%@;@^RWM_X!R/Y`$$@XJ_320\TE; M6_MP32%MT0!!A$YG_OUG8X?!*]1OF(M.ZSY92>P5)UG43W_]VN]Z/\M3O:T. M<\/JFT:O/*RKS?;P-C?^^Y_@V\3HU>?58;/:58=R;OPN:^.OYW_^X^FS.OVH MW\ORW&,1#O7<>#^?C[/!H%Z_E_M5W:^.Y8']YK4Z[5=G]N/I;5`?3^5J<]EH MOQO8IND.]JOMP1`19JS8>?^R1JMU$_OR0RO\ M?KL^577U>NZS<`-QH.USG@ZF`Q;I^6FS96?`N[UW*E_GQG=K5M@38_#\=.F@ M_VW+S_KF^U[]7GV&I^TFVQY*UMMLG/@(O%35#T[C#6]B&P]:6P>7$?C7J;K!F%HO<=+/HE&O'?]7OK,-YE.\\S-P8&SW6I35+EI_/ MSF3T-/C)!G@MS4(8]O5J+%4L&\%'DX?UVF'MX5C=R&],LU%`&T+:$-&&N&GX M$HQ)/$.6D75X:,;-@V]HB,2M0V MSF2B'D_<-C8YK>0.H;M*.YBL;5J'D[=-Z[2*MKF-HV0%FU64K.!7\)!-M_KL MX%LIV4$;EK3!$PVW0^],2#_Z'4S0P80=3-3!Q!U,TL&D'4S6P>0=3*$WRMBS M"5L9>_V8BT`DE-5R2&OKKD.NYP:;X/\,]-=6T7`BC2PDH M/"A\*`(H0BBB1O#'0HN<:-S\\J8SU*Y(H$BAR*#(H2AT0LD&]ABL3!3Z;.": M9@-Y,%X(H\L&*#PH?"@"*$(H(B$FXB7!9/_4X8YAA`2*%(H,BAR*0B>4A.`U MB=N7+'U"<$T3@MRU%L+H$@(*#PH?B@"*$(I(B*\3`D9(H$BAR*#(H2AT0DF( MZ4,)P35-B*%ZU2R$T24$%!X4/A0!%"$4D1#.9888639]68MAA`2*%(H,BAR* M0B>4A+#8"]L#4\2%TY1HU5MXS+FARPD91T,\3'Q,`DQ"3"),8DP23%),,DG< M2Y9:3NL^EN,8A9:H^<%K0MUO(98H(:F/F.2=8B&19O"7F'B8^)@$F(281)C$ MF"28I)AD5\*?>LT^Z?S\^NLOGWL++5&S@Y>+'L@.45U2LX,4Z!:60-KL@,3# M47Q,`DQ"3"))OKZOX!@))BDF&28Y)H66J/G!2TH/Y(>H0*GY08JS"TL@.?]9 MUG#BCEU2HUFJR+1&UM@Q"?(DTF2:CTF`28A)A$F,28))BDF&28Y)()CXF`28A)*(P^5W=/IN M&N$@,28))BDF&28Y)H66J`G"JV$/3"*B>*9.(N327_`/=/6CO\3$P\3'),`D MQ"3"),8DP2251"2K;4Z'I(Z2X1BY$F-BNPZY.@MM##4[>'7L-CNZ5<^0 M]F0".R:_$X9D4:$E:HKP4MH#*2(J;VJ*T)JII2O/7<9_B8F'B8])@$F(281) MC$F"22J).[U4.\S^<#JY/!XU7TA79SADCDFA)6JZ\$+;`^DBZG)JNM"*JJ4K MWLET@<3#47Q,`DQ"3"),8DP23%))KNGBVN3!+\-!JZ_: M[?JJ:Y*[W4(B;7Z(.!KBX2@^)@$F(281)C$F"2;I'>*:I+J0W4%D"'),"BU1 MC?@6W.Z21"ZR02:;-#Q-$0#T?Q,0DP"3&),(DE MD35FQW%)'2Q1P'!B#LFEG>*=9)CDF!1:HF;'8[56OHJ$9@?]0[N%1)JA7V+B M22++CNV/O7T%7(KH:JDN4(!U>8-41:B*.S$B*33G$F.28))BDF&28U)HB9H; MM-(*9HYVA=6U:/7,%DC3GTM,/$G$7W+9]W(#[B;`NPDQB3"),4DP23'),,DQ M*;1$S0]>JKNMA71\_A`5/J4F8I&ZSL*&9<`E)IXD\G.VL36BY0$?!PDP"3&) M,(DQ23!),B#/4P\2>3-9N*P5%%O M%3X.$F`28A)A$F.28))BDF&28\(7[WX]1")1Q.)RF6YV]6]=?7! M%][R/Z2YMEX7!7\?\16'I-VS9FS19;L]MF9L766[?6'/%O?B+.T96Z/$_."Z M`[;F][AZ*_/5Z6U[J'N[\I4=FMD?LT>BDU@U+'XX5\?+:M>7ZLQ6^UZ^?6>K MNTNVJ(G]=9;1>ZVJ<_,#W\%UO?CSWP```/__`P!02P,$%``&``@````A`&*Y M$]DA`P``E0D``!D```!X;"]W;W)K&ULE)9;;YLP M%,??)^T[(-[+-5P2A50EI%NE39JF79X=,,$J8&0[3?OM=XP#Y=(E[4L"YN<_ MYW^.[HSE!):QSI+YCK MMYO/G]8GRAYY@;'00*'FD5X(T:Q,DZ<%KA`W:(-K>))35B$!M^Q@\H9AE+63 MJM)T+,LW*T1J72FLV'LT:)Z3%"C< M\])EKE;TDF*>0 M4)`Q'$\JI;2$`.!7JXA<&9`0]-S^GT@FBDAW?<,++-<&7-MC+NZ)E-2U],@% MK?XJR#Y+*1'G+`(SSB*V8SBA9WO^=1531=0:3)!`FS6C)PT6#;R3-T@N07L% MRITS%4?O]7]6P:,4N9,JD1[H&KC@4)ZGC1<$:_,)F7C.^,LQLNT0F4&I MFW0#K[KV>,JN(V3YP%+O"[(U]/5VI;KP)2S#[]X;JP'0[OTXX_=NYT0P"2V9 M(Q.1W9P8B(SLN!^Q(^%(!_$^>B\(Q_''BED,F3&QO4HD5XG=)6+D#P(9EDLN M0Q>VZ>6RR4G`#3T$DR45*^:2SZM$]B?A21U#:URE6#&7 M_%TEDC>(<+*8=V\P?20CA_Y''$IXZG"R26+%A.VIXEL++Y@`VR'@^&'H^7UD MZA09`F\I[(;`1&'D#0ZX]U=/PE-O[CBR6#'*6Q#8DTVZ'3YVW6`QGIT,']M+ MWYZ`)=N1TW^PG0%1MTP-\1.Y"::R7.X566$<#R8JJOJAM!F[8W[:F` M?MA>%O#Y@Z$I6`;`.:6BNY%'?_]!M?D'``#__P,`4$L#!!0`!@`(````(0!5 M2DDFL`8``!D@```9````>&PO=V]R:W-H965TD'6FUVL,UP=A&,<8",IEY^ZVF&N@JVIAD M+I)Q^J?\4=55/W8_?/I1G*SO657GY7EKB\7*MK)S6N[R\V%K__/WE[O0MNHF M.>^24WG.MO;/K+8_/?[ZR\-;6;W4QRQK+(APKK?VL6DN]\MEG1ZS(JD7Y24[ MP\J^K(JD@9?585E?JBS9M1<5IZ6S6JV719*?;8QP7\V)4>[W>9I]+M/7(CLW M&*3*3DD#_/4QO]1=M"*=$ZY(JI?7RUU:%A<(\9R?\N9G&]2VBO3^Z^%<5LGS M">[[A_"2M(O=OAB%+_*T*NMRWRP@W!)!Q_>\66Z6$.GQ89?#'ZNU_UOUL7S[K"[+%RG]NI-_@HN7 MHZN_M!7XL[)VV3YY/35_E6^_9_GAV$"Y?;@C>6/WNY^?LSJ%C$*8A=-BI.4) M`."G5>1R:T!&DA_M[[=\UQRWMKM>^,'*%2"WGK.Z^9++D+:5OM9-6?R'(B&A M^B"."@*_51#'>7<05P6!WRJ(6"\\QP_"&2A+O*TV2Y^3)GE\J,HW"[8>@->7 M1&YD<0^197J@'.IF^H1=RQ?(Z@B'BL<=]-KED#<8T,F=6QS-3LZ*99TLB02-\(_Z"A._S:M(C8H_%Y" M2"!I\TFD&':0EH,@"/JX"(<:3],,[XQP4PK"!D%T-EE<%SIH.EORHJT-">CK M%'@A8T3-NJVT6/NN\%PFB76)*T+/"8<-02!AM^F0TW!2S.&&+8()1(V""WPW M\%<4/]85SD;XJ]6@(&SK][!),6,+6%8BU'1LCNN[+F,C"K%9!\(?-B>!@W;3 M$S>ONO(B#LD3B!J$!$0].[@!=<%=*$!P)7_21;7I,EU;*69HVJUC;5&#:'?. M9N.+D'<'D;3T5^`V[X&38@87#G$1#C4*3G@K0^:(1.[,:YD3T*?S4]>J&9[O MT9T5*9':?'[HP>X;>A(K2S6\L\GV$W)EBY0(1D<_>Y@DGI10 M/CG#Y_/AQ"=CS^>C6:!HD@\EFW8TKA:KH0@43L[P^7`X\>%GGY?`YUTKIFQ! M57=*0OGD^-;XY@T7@4.?)''-NT2)N@RM^0!DZ]IS!"5DOC&3T&`@:_8<$LGG M0VCVCE"P;1#S]2OS63#WF$EHL)%P1(BBCG"40K8\N!!-X8<<1!@L)!Q2@*-0 MB3K`%5N/U;K>2>ZP42@E,Y&9:32XR7IH1D6)HBL4JF7,.Q#RJ-GN_!B2BH'/COGI0.V@0%'=H4MZ<2]:EDFR)6ZW,@Y>!G MD/)CWO0#F8-V02%9/2,ETB&"D#5:;!!=2R<$TDEO$$HUW9'.Z*G"09%..+PY M-OFDA):;V_1QF.OU9<(GOUJ8W[JMFK9N,'K@5J*.:[3E MU+JY=2@<\Y/I7><:?"3D/J)$'1Q/&EO>#.U$P3[D'Z[!/P(V=2,EZ@#'V<,@ MAG5*R,SC1NK0-.C(XZ;AHLA<-]QSDQ+*!V'T?3?O4<&55[']%[`:1DK498@M MQVK9?!N4\5VVX>*XUXW7\7G/*I'YS54.9]N&RVSC1HW1+FB-67*B-N2TK4U* M:/Z8:BR+[" M&7'JZ\Y"^PQ+R3[D*:[)4T;U1U'8?A/"'UU5!%P<*D+8/.8G\VK>7L7Z6OOJ M&6NN1)B]FS4GZM5"FQ*4]UT6XQDL9N1_2G1M_JAE\PB@;,QEIG>@9W"7D?TI M$2\A3IXKBY1)F@#[4"(-_08;6H<^&X.1\WDHNMH=9'VB_I17.H;&>X-3JOD7 MGMP'/129"Z@R.26A?,QC9O;+V&L";8>K?D'1]7S>-AH\H<6SQR*K#EF9SV<"1;/O?(QS!9W#V!T_7MK4ORZ9[(0^/^T/]Q_\!``#__P,`4$L# M!!0`!@`(````(0`1:,;_N`(``/8&```9````>&PO=V]R:W-H965TJ$2W6S?O]N;^HJ1UOM5H[#68M,H1$O(7!BX(1FG%R;&BK#$30&BN(7U:L MDP.M(6_!-5@\'KLKPIL.$`=6,_720Y'5D.2A;+G`AQI\/[L!)@.['RSP#2." M2UXH&W"."73I^=JY=H"TW>0,'.BT6X(6*;IUDWV`G.VFS\\/1D]R\FS)BI\^ M")9_8BV%9$.9=`$.G#]JZ4.NIV"QLUA]WQ?@B[!R6N!CK;[RTT?*RDI!M4,P MI'TE^4M&)8&$`L;V0DTBO(8`X-=JF#X9D!#\W/^?6*ZJ%/F^'8=AL(XCP!RH M5/=,,Y%%CE+QYJ=1N6>6H7AG"JPX4US/]N+0#=>PZRL4QX34.\RPPMN-X"<+ M3@WL*3NLSZ";`&6P9N(8S?[-*YC4D%M-25&$+'`AH3Y/VRB.-\X3))6<-;NE M9GU]*;D;)#J%FIL-$[^Y[N62_:#0]0-+HR_(UM37GTLUA*_%.OQAWYV9`/;H MQ[O<]VZIB&:A94O)#+)?*B:0"SO^_]C18CACD^C#8+;USFB"J6;F\%5%]JIB M_R_%A3\(Y.WETN(40?+&ZD3Q["CMC";NSZ+K1D$0S>Q-!7`3@]7E^VSZW@L" MWYV=9V@X.HIA!]^?A&"LF7YB;EM#14GO:%U+B_"C[A4^A#;.CFWLUM.'<#:_ M/^^,"Z#M=+BDG[$H62NMFA:PU,X M)Y**#@?"5-_"4'4M&%\JMI.\LP&B>4LMQ&\:T9LC3;);<)+J[:Z_8TKV@%B+ M5MA7#\5(LNG3IE.:KEO(^R494W9D^\457@JFE5&UC0!'0J#7.4_(A`!I/JL$ M9.#*CC2O2_R83!N MCVX1-.-SS?O.@+G=V8E+G/ILTS@9#9Z>HKK(%L*ZW=.)SSS' M;SS#=AX\QRD,U""X\(1^WN[IQ&>>V8`,>8;MX#F:Y$4Q[%]8YO]CZ<3.\M34 M23)@@VV0A/*FDZ(HWJ8:[FX8[9YN^%>J-Z(SJ.4UC$HC^=U?/OMO3PXKWG=%-5QX](5<9W\F%7;XOBTUY3;;/R[195:?\"$]V M55VF+7RLG[SF5.?IMGNI/'B,$.F5:7%T,<*ZGA.CVNV*++^OLI1[FZW!]D9O/W0K M\&?M;/-=^G)H_ZK>?L^+IWT+RRU@1FIBZ^W'?=YDD%$(LV)"1^W8MON-ZXO5R(@/@7<>VG:JOP/(:I#81"F@_B@ M7C]G*Q8**N3743Q4U$WP/FW3N]NZ>G.@:F#,YI2J&J1KB'QY1C`5Q7Y7KTW!D%?7Z;7)<]A.?HP( M'R#]P!V13!&&-!AGOC0%;UR(W4L++&F(A%U.N0A](:A))$,B\`-*_'YZAC28 MWWQI"K:DA>;`,2*\DQ8).V/#I\(_OVHH@AJ?KTC!EJ+H'!;7$1$8^9Q/GYA( M@HCL1`>"D/ZYH4PN4:9@4YEO+5*,"`X+/3H(+"`Q`1!VUFWH"I;H4K"EBYW# M8L8005T\"`4+K`),AD3`I11AGW5#FO*TV0U#P>:F]/L:06F(#!?3+K$IPI`6 M+9&F8"MK=B]#!+,61=!GS:PFP^:P9%'?#"1&CQ&$43=!(A+U\,W.+'(".+<"W^ZQF=.8H"ZE=;P81 M21E=2YQJRO,3ART<%/;MM`^L5Q69J5U*IQ`S=8O\0)VSK(W*^S71\H;M7OJ" M6D"B@V!NY74_H)8AJ(,>A^!?'(O&SL"MQA]WD3_WA21K/A_]-UU_WEFD9 MW$I1K!G=7?S(9Z0O+VS,!A(0+DE?!:;*1:[!QJ[!K:%CS0R3.+`L+0_CX`RX MVL/]+C?EJ1X^N_TQ[/A&"=J^H9G)Y&$8C5`QD;U%SL'&SL%MY]#,=/8PSA7& MS!]`"_*G:/.,-S@(X1YAR`P'M^HSF41,>99]J#TBO]XC8QL1??UHF<@,98ZK M<)(QA5XPDP!>_V(SC\W$_BX8,V0^BXW:AIB8`!Q-K^WD15;"QE8B^L`ZA\A, MYQ`9E#^UD1=Y"1M[R>`+J5:'S+0Z9%#=S92\15["T`2&?<8^?<::P:%]&)KY MXP+$.,@PZ1-"!\=_HP"5/DVIBRS%OV`I]I%5,RB1TX!%TD(2`Y&A+^G@W&/*4]U]8"DS,XF>8"RY M[7QP;:G:)][\7#[=&,CETPW>7.+%WBE]RG^F]5-Q;)Q#OH/N2%:J[=1X;XD? MVNK47>0]5BW<-W9_[N%^.8=;/K(">%=5[><'=3-ZOK&^^Q\``/__`P!02P,$ M%``&``@````A`##!VLP#`P``QPD``!@```!X;"]W;W)KJ43WL\^?)FLN7F1)J?(@0B.GJ%2J'0>!S$I:$^GSEC8P4G!1 M$P678AG(5E"2FTEU%?3",`EJPAID(XS%-3%X4;",/O)L5=-&V2""5D2!ORQ9 M*[?1ZNR:<#41+ZOV+N-U"R$6K&+JW01%7IV-GY<-%V110=YON$^R;6QS<12^ M9IG@DA?*AW"!%3W.>12,`H@TF^0,,M!E]P0MIN@!C^<8HV`V,07ZR^A:'GSW M9,G77P7+O[.&0K5AG?0*+#A_T>ASKG^"R<'1[">S`C^%E]."K"KUBZ^_4;8L M%2QW#!GIQ,;Y^R.5&504POB]6$?*>`4"\.[53+<&5(2\F<\URU4Y15'BQX,P MPH!["RK5$],AD9>MI.+U/PN9C'9!>IL@$=AOQGM^;QCC./DX2F"-3(*/1)'9 M1/"U!UT#]Y0MT3V(QQ#Y=$:0BF8?-&RF@*R$97B=Q8-)\`J5RS9(>HST7&)^ M@HAW2`!:.S?(^'HW#4-=D;=W&^["&OW4(OU#Q"7FEPA'#>YSJ*8;(H*VNEP^ M/6F*X!Y[Q9$KD%ID:&H;1;W1OC(FA?GA.(Z2P3Y%1P]R/-2[K*5A5RL).UH6 M&1DM_.6N[P[/SPX[4M#JUTMIN".%W;NF%DF,%&R(^N42\TN$HY;Q3;DZHE2_J# MB"5KI%?1`C;/T!_`HRWL06PO%&_-R;3@"@Y0\[6$/TP4CJW0![C@7&TO]%&_ M^PLV^P\``/__`P!02P,$%``&``@````A`,6GYMF\4P``>G@!`!0```!X;"]S M:&%R9613=')I;F=S+GAM;-Q]Z6X;2;+N_PO<=R@(&E@&*)J+1$H]W3Z@)=K- M&5O2B'3/:1S<'Q19DJJ;BPX7VYJG\;/XR>[W161F96UD29:[T0;.XA:K,B,C M8_DB,C+JQ__Z-)T$'\+%,IK/?MJI5VL[03@;S#U_M'.\%R-9R- MAY/Y+/QIYSY<[OS7R__[?WY<+EK`'0$W=DJ6MT'O9E.`+I_?+%Z M^>,+/JJ/'P?OYK/5[1*/CL-Q^M=^>%<-FK5*T*C5F^D?S^8?JD'M*/_'+60$ M_].Y6JX6P]'J_Z6'?9;^@QMJ<'\7IG]\5J_M_RO]QPX8,!8FO)X,;]*_/KL> M3I:9@=PL%^$BFI-UX^!TN,H\9UAZ&=Y$7``8?3:<9IYZ]DOO# MU]%RA"%^#8>+0L*?[>_7&_O->GIXMW`SB%G_:\C1,OWLLW]E2$B_+C3DOYPG M1(8)KZ-)N`A.P.^;^2++@B59"3=.OO1I.AK-1B">A;_!IVSTZ#[K_>]BW=8=7JFD_GT;KW"3G*E=]3`]!.OUXM9M%HO0N'*=?2) M_\Y0]&8Q7RZ#NP7,XP+VBZ:L<,2WX7+Y0S`

RM)R(AXQ`F=!0-5SGV;C!? M05'*C7P^^+E[6;"QI^'=?!EEEG4+VLD`8C:B^ M[75>]=[V!KUN/_VZ$\.[X3UE4(@!;Q=K:%Z1_+S%,FYT&2!I-0GS-CXI9!M( M.#D_&_3.WG3/3G+HZP_.3_[Y\_G;T^YE_YG(X>#7]!H@[M-"O["_PV6:B.&Z]4MMN,_X?COP0S..XB62RZ9^SB/[4

(V/!&89KGWP2)CVO5_:89("9]XB108!,-VC!T!9@ M:R!]6EL/FB`-_3!=VH*==%]<'XG&R?S'Y>(]4A8\EO*1Q!V_87=`DPT=V!,W MNWZK/^VB,;V/S.#$#\JZN+Q?=EI//@H6/);RD7,GD/60ULV.!!KW]:-F5XWY M?>3$RO*RE0@,#T5?UW+HL=@Q=.X&QNR(V=D)X\#.L3=4[,H3%1\Z\;0Z\>3' MLI]:#5R&E>7D!9=+_XC?_```` M__\#`%!+`P04``8`"````"$`H>G`M6-BI(S?*X@?F+4U:):[0B&1.NB.OG<_4IX44%(9ZR/&O>9%#? M*Y+-CV/)Z_@I!]ZO)(J3:VSY,`A?9$G-!3\T,P@7J(D..:^#=0"1]MLT`P:8 M=J]FAYU_1S;WX2LVAX\9_R(6TD M%8.V,>#[&F,Y6ZSF(;D=)%#SD?0>XB;>;VM^\:!F`%)4,58@V4!@.Q\@@KYW MZ+SS5[X'MRKUS@LW,AG4<`F!TP@(T'1F<$QL3B3.Z5 MH0]#[3#A%!ATAI7I33XB81=7(2N?J.>SZ#PT@N`RGB`Z[WP*M+J\#5*K?$8@ M0TF-1T9GB=SE5EF(-A<2V4DNIT"ALPZE+)%LO7YQ0(GU&6"WA1',Z^/RQ%%Z M?&4A^HHZU@NE>G0GH+,.I2Q#*FL]K!2.->3V8RHX2H^O+`:5I7U5".C;>"[2 M6P=K34,V!/N[ER5)ARQF-]=&#C1`6JW05V?EH(0=WP/^.'U8O$;^6A,D$'6^ M7VR8TWYHY+2,1E!24@!-V[6.#`52JE/Z[*`T22%()Q'O:%=%&##"%NXE"QG1 M""9U(VNJ\S5"RF00>A=]/9&3U(`,Y:`U`=J`D4415BO<:V]Q&HH"L:D"G3L6 M:9(LD*$NM"9+*UF484%FJ]N4AN)`;.I`73OO)'6@Z*TW;FL:4J(6=:"A/!+= M6"8YTD"QR0-U;/.X<_8K_N-"E]X&FE(,D"FS]*A%'D:5GAQHH"C)T-N)OA\Q MM':BD_1!>AMH+GW`MNEG"_5A'"4E!WV%D+%,R:..XP*=I!#2VZ#D.C%0BT"0 M.1W13G*D@6)5",>Y@4Y2".EMH+F.#M2B$"/;:2@1,MA@G1P'B'"21$AOG5-K MPET?:JM]5Z".O3VTR$8([T>WU5V.-)"MLN'8@L-)LB&]#;1.-OH\'?MC:%&2 M<34J1QK(-BD)';M8.$E*I+>!YI*2\/]*B1QH@"AUT=4Q=.QBX20ID=X&FDM* MX!YAH(ZC-F8YT`"Q*4EH;F+JVD&]EQ>L/K*O+,^%E_`S7BE0>-/NK-UUQYT\ M=IKV:'.GKD&"[A^XAJCB(_L9U\>L%%[.#A!S+H6Q5A<9ZJ'A%<@#W$;P!FX@ MY,\37#@Q>-V>XV'XP'ES?<`]LKO"VO\"``#__P,`4$L#!!0`!@`(````(0`X M1H+)EQ0``#YC```9````>&PO=V]R:W-H965T[W73N.DAAC6X&E3&;^_5:S^V5U5W%E M.=BY&"7%X7CW_/GNW_YY^YP^? M7WX['K]OKZ\/]]]V3W>'J_WWW3,=^;)_>;H[TE]?OEX?OK_L[CX/3D^/U_.; MF^7UT]W#\Z55V+Z[E]]^?/_;_?[I.TE\>GA\./XYB%Y>/-UOJZ_/^Y>[3X]TW7_,HKM[:`]_ M4?)/#_Q^'KP_7QR^[7\6+P^?VX?G'46;YLG,P*?]_C=C6GTVB)ROE7<^ MS,`_7BX^[[[<_7@\_G/_L]P]?/UVI.F.Z8K,A6T__YGN#O<449*YFL=&Z7[_ M2`.@_U\\/9C4H(C<_3'\_/GP^?CM_>5B>16O;A8S,K_XM#L<\P7EQ_^-P MW#_]OS4:KF@4F3L1^CDAF8D:39P=\[BQ>VQP<4CJ].]Y]>/>R M_WE!ZP1=\>'[G5EU9ELCBV2V(Q_3^[]E-Z6U4?EH9-Y?TI11XAZH)'__$,?K M=]>_4QG=.YM;;3,++1)8F)HQLJD$F02Y!(4$I025!+4$C02M!)T$O0>N*;1C M?"DM_A?Q-3(FOHC,+0`'?"Z""0NXI!)D$N02%!*4$E02U!(T$K02=!+T'@B" M296B@KF@XIU>>9&;QHO66"\WHT44!NO6VLQI%CF!0Y-D-!D#JDBF2*Y(H4BI M2*5(K4BC2*M(ITCODR"V5/LJMN:N]L:%P,B\OYS3#'(@XTT8REMG="K:H\D8 M;44R17)%"D5*12I%:D4:15I%.D5ZGP31IL`&T3Z=P<9Z""J"<6L)[7(XS-%2 M)'4R&L$M5213)%>D4*14I%*D5J11I%6D4Z3W21!#VE"\(8;&.HRA)56*U$JG43JM\_(7\&@9APMX-QIA9>E]Z2"&M`M_0PR-=1A# M2_P8*I):$H=C7H9CSD8CC#EW0EY8E70Y>OD+[2J4KD8C2-=*NE'2[>AU0KH; MC2#=^])!I$T;$X3:[N6O3#-Q_/9P_]OMWK:5$VF\H#V[V\D;E7`*!F':07EY MK%'J4$P[C/'63ZU,&*J,K7!!.;2\>0#B,Y;LZ,N+G47%5I"OH<7R#1#+M^QX M0KYC*\CWT!KDP_DP/8&_?,CY^-?^^]"`3W82A M3F:C%0:;:I0!F1/^_F$3+5=KV;GEL%GR`@3$+4GIT#(:K2JV\@B'S>K3BO%8H@Y;-Z^5J<4/_A4HY;#CQ M"B`_KZUX'(Y*;+8KYTA6&%4-+99O@-BJU:@#0A++=K6'P402FY;C#9-@S$42 M6[2@^XRWN(@=0&*>%9FIXF1)-"8:I0!V1)8SZ8JP)V.4[2`EU\!UDI4@-P%.<>@`I1\`WF_`L9KQM5T ML**MN9>$8C/1PVJB#$P3](:)L#U3,!$6B3(0=Y-D-EIAZ*E&F4.TO'M7LU:K MD=6*Z+;-U[P6R5=H^5*CBL]HB^-&+%T\R=FJ(S-ZZV)PSFR+6)O.M( M9@JE0'QOR1P*-DC6D5+(-:JM%8-Q%H-'%FK!6*M#HY\J^J!)NX. MIG7SX_K*!M-V>D'\7/,7),Y:;9!&*T0FG2F4`=F[PVPUC]?+2"P3.8S\%'=2 M_OW!HO#^L!9:E=,*[@].B^4;G-%/<37X#E;8(45J`?*5@P5H+MODT[,PF(<[ M)(>\/7VB40K$V9(YY&`4?.O!*(M2HXBVU>#X-!.4SBM_6JM(;(;;Y#X?Y& M[LX3ML+EIAIE#HG]C=@?YK`ZO;^!%>=BZ5!,VT2^&Z]%Q5=LA:'6T/(+PO7C MG/VML_):F0Z.8PL@MA$]#";*PW2+YR_R<]MM0N)%9R9TG6\$QU2@# MHDV"%SJAE<.*-FV>E=QYPLJOF:G6>"/JKW*._L(/+;]FK)97[RVLN(PZ(-2, M:LY@,%$SIF7U9^:7=IYSHR+6,XO"4MJ(\"7.T4NSU*'(OB4T//P'"J9B(](O MA]4KI63'Y=UN2N<8A_)BZ:W8"KE5\QF!&H>\"VIAQ1?4`05GE%OI'E83]62: MPU.S=MYFU+RD)*?-HHCS.7%67@ZF#GE/-3.-QM[$;<\6MH^3>1\1)1#"VL MJ"GA)70EZK;C,]JV7%Q*#Y6),C!MWO^@#&RW&-QN7`/)69/,%4H=\E(W`V+' M'(A3M]!:):PX=2L@UJJ!6*O16BVL6*L#8JT>:*(,3!=Y*J[GE8'M18.P6B3* M0.SPDOEHA4Q*'0K*P%I%M@PVBUF\F(F;;`XW3M,"R*\"JQ14@46B"D1FUM!B M^0:(Y5L@DCQ5!>,9;16(M:&'RD05F*[NU&R=>3.PS6$P719YJW4R5RAU**@" M:^4MNCFL.',+K57"BC.W`N+,K8%8J]%:+:Q8JP-BK1Y(5X%YB2Z(Z^F>>#`/ M5WV'1+J+/7H"*UZ$4R#>D&<.>?N6'(C3KX`C:Y5`K%7!D9.T!F*M!HZLU0*Q M5@='UNJ!=*HN9)O\2[O-045$VG7/E'=<8QNQI4^7W-V)?EK#->.O4*-,HUZC0J-2HTJC6J-&HU:C3J`]0&'S9 MN;ZR/.L6E>Y8)I^#%T;CN0A[PE8(G7\E"H=0A__U(C7(X\F=L!1#+E]JQTJB&(VLU M0*S5PI'N$WP75N])LA6JIX?6(!^&5+9XKZ2D;N5H$VJJG%9QG"[1*'4H>%TR MGHO'51E;02N'%D>F`.(SENSH1T;T$Q5;0;Z&%LLW0"S?LN,)^8ZM(-]#:R+P MIA_QQ;SQL];XF<; M0#^O!X577YQD*P0KU2@#"3U3CN?RP@:TP MJAI:+-\`L7P+Q)74`2&)9R++>QA,)+%L'%])8MT@TEN.P[)!JX=7L^+A5L)6 MN-Q4H\PA^C$TYK/-\DE7J,, M*%R%Q58FAQ5M7L=YC]1[>[#B!"X="NI#?;Q1L14"7$/+KP]U02VL_/IP5OX% M1>K#.#A.%(GI!OT[\RO38YO'8'HL,C<3#I;Z<-N\>&?NP)Q4J4:90V9A';7B MN4BV'%;^LX2)Z5%G+/49*VB-[P6(ZJYAX->,4FZU<@='_UHF9L9JT2I&N1`T M#_093C>R?7-09Q8%.RJ%4N?HU5GF$!458I$#<5(7<.1=4`G$-5O!D;5J M(-9JX,A:+1!K=7!DK1YHHAI,(^S']95URIB+M+=(I+W8NR3T<9&ZC2B4P4_,8<1K>N$0_"5F,*'/E546 M*Y3!RF7Q*J8O#!)K:PX;SK("B+.L=$@DL=C=5FR%C*VAQ?(-$,NW0'X2N\M! M$L_$'JZ'CTYB\[GX&R9A,`^7$H>"+4\\%SN'A*UPN:E&F4.T@1[Z@M5\$2_$ M=.:PX>0L@#CM2H?"MD!J56R%4=708OD&B.5;A[P[2\=6KBT(5ZT>Q_5R3D]_ MWS0'ND$>%$2#',M?JTO8"E>;:I0!N09Y,=$?PX03M0#B1"T="NH@4N^ULA4& M54.+Y1L@EF^!O#H`0AWD=Y*! M?'"O,$^/@V5*[B3/>H8]J(C5:VPL>?]/2W]8NXES]/?_#GG;Y0S(WR[':B<$ M+=JN>AV'V.,4L.*$+QVBG3T[ZB<=;(7YJ*'EU]-XV;!JG95W01V0?T$3L^:T M)HJ*'$_.VGG[?[."R&*SR-__.RL/I4"\V\D<\G=.0)S4!1R]G1,0:U5PY,JJ M@5BK@2-KM4"LU<&1M7J@B1N&Z;C\G=.O58/MV_P-E5D1S(.)8,(WZEX^6B%Y M4N<8<[IF0&M[+X_7$=W,Q1J3XX2KD55O8MQ9LK^4Y2#^6).C"MZ:GY.K,.;(<;3)AJ>A/S\KN9 M0\ZW%(CS+7,HJ`/KZ'<0<&2M$HBU*JU5`_EUH,;5:JT.CGX=^.,*[PJF&3T5 MU_/N"K:E#<(Z=KE>1FQ$\B:4[:Y:N`XL"NK`(5<'U!JO)^K`27&B%E#G1"T= M\M0KH*`.(M&XU-!B^0:(Y5MHT5A.U8&[GK$.Q`:]A_)$'9A>\-1\G5D'MJ4, M)DRUITFL4`K$N9LY%-2!=0SJ0&F56JO26C607P=*J]5:'1S].O#'%=:!Z?_\ MN)Y^$A';=C&(GT5BX1?/FA/G2(]$..%'1Z#,6=$+"4`Y$.=?H;5*6/'*7P&Q M5@W$6HW6:F'%6AT0:_5`.E7-+BL(Z2_=8@>5<,/ID(BTN'$EL.*QI@Y1=2&L M&9#[_9$K<:/.H<*A*ASRIK"$%8>J`N)SU4"LU6BM%E:LU0&Q5@\T$7;9"LNP MG[="F!?:)1JE&F4:U1H5&I4:51KU&C4:M1I9+X6?+AL+Z[V:[[M M=R(_[5Z^[I+=X^/AXG[_PWR%-SV3^/!NQ/;[Q6_C+7TI)>68Y$OZWO$IOMK2 M5PQ.V"_F6_/&K3[R<;'8?J2QZB/T9BSY#!^IR+,O(CHRI)4Z0@.F-_DFU);C M5Z4+'WH\M#4/?[0//;6@(U-CHZZ9CDQ=#W5F=&1JU/1=[1^G/&YI8%/GN*60 M3=J;L$R,]F.T_3@9XEN*UE2PZ*6%;67O;#(D$5T>/7B;"$E$EV?;0N43TY&I MT-.3?#HRE1;T>)2.#'=@H48O'6X[^P1?'*%W^K;FC;V)L=$1\[*=/D)OTI': MU!%Z(XW4ABVM.`^]3$9J4T?H/3!2FSI2SBFB])OL>@3TB]UT9#*B.F*^35`?H:\*W)HO`M1' MRAF-FKZ::^H(Y0%]6]'4$9IM^C8+?22E29B,)TW!%&]I`J9XNMEF4_HEG7B* MMYLM?>LDC>=ZG'SZUPN^WWW==7#Q>/NR^T--(7Y%.;^V+__0/[EZ/[ M0L-/^R/]NP7#=QM^HW^G8D??:DK?SW5Y\66_/^(OY@3COWSQX3\"````__\# M`%!+`P04``8`"````"$`,739@YT#``#M"@``&0```'AL+W=O$,W[BN5[J?M7Q_6%RZ>9$FI=U"Q0'5C'UJDE=I\Z3SZ>&B^Q0 M0=PO9)GE/;=>7-'7+!=<\J/R@,XW0J]COO?O?6#:K@L&$6#:'4&/&W='DI0$ MKK]=ZP3]Q^A%3OYW9,DO?PM6?&$-A6Q#G;`"!\Z?$/JY0!-L]J]V/^H*?!-. M08_9N5+?^>4?RDZE@G)'$!$&EA2O#U3FD%&@\8((F7)>@0#XZ]0,6P,RDKWH M[X45JMRX8>Q%JT5(`.XN?!D0Z*D,2="3P[4F(%]Q%)(J1 MY<;.L-L)WVXGB;QE$*WNM/_KG;[1K]/QD*ELNQ;\XD"/@4+99MBQ)`&V/@^& M8\-H^A@)JA'S`5!HN:"0FC!MYNGSQ%N@C:9Y"A<+FR'>X,) M(!%C(FU(.D#FHI;7HK"C?[.2R+)Q`XA\5!"M;`W[#G1+Y@"9RP1)\]P%D??[ M0I%'"QWJV5G@,T@/XUF&TP$TUQ7;NF[7$L&V\\YR-[17.K58[0S'9)J!VYX0 M;'OJ+!-/4XOE"6^KR>&^[0G!MB=C(]NYF2S>"O>6+'_: MMR5BFFCH+I'M2]O$D6YH(G-)I1N:B?O#V5Z)@(O>J M-(LMJS--=5DF6P4.NG?7A2!ZYLV8"!1^C'EI']*TVT>@9B,H#@>4+0E'W?LE MF<$(4V(X?'!9HTH"U1B]18,S74Z\T74H4(41%(_"C21S:9M;JJ;B1%-:5=+) M^1DOY'LHPV`='@L[+65FW^,C`B7.[4&2OHD/$QBOU_C=,MF9Q\B<:)FD^G3, M[5$"@^:::!\G,!;>L*^25%],_D`$CXTV.]&OF3BQ1CH5/4+L"WU\A'FNF(7J M.O;`%3PS=/.6\*RD<,$M<*H>.5?]`AS[PT-U^S\```#__P,`4$L#!!0`!@`( M````(0#*3MG0A@(``(@&```9````>&PO=V]R:W-H965T,=4*;JZP+]^WE]]PLA8VI6T M51TO\`LW^&;]\:T])MD2](XOB:2B@X'AEQ/X5!5)1B_4VPO>6<#B>8MM9"_:41O3FR23:&3 M5._V_153L@>*K6B%??&D&$F6/]2=TG3;@N_G)*/LQ.T7%_12,*V,JFP$="0D M>NEY298$F-:K4H`#5W:D>57@39+?+C!9KWQ]?@M^,*/?R#3J\$6+\IOH.!0; MVN0:L%5JYZ`/I0O!9G*Q^]XWX+M&):_HOK4_U.$K%W5CH=MS,.1\Y>7+'3<, M"@HT43IW3$RUD``\D11N,J`@]-F_#Z*T38%G:31?Q+,$X&C+C;T7CA(CMC=6 MR3\!E!RI`DEZ)('WB>1Z*@D)"7E_=]32]4JK`X*9`4G34S>!20[$;QL")PZ[ M<>`"+S""7`TTX6F=Q8+*L2/F-F#@.6"2`4%`=%`&M>G*#NR476E=*K0V?]' MU.T[5PB1Y+RIKXUOR1ZEIT!K6\`LHX6H`7':Z2L+"J]^=QJRQ<`?YG`S<^AW&/G?%* M*7M:@#`9_D/6?P$``/__`P!02P,$%``&``@````A`$)09X+2"0``TB\``!D` M``!X;"]W;W)K&ULK%K;CMO($7T/D'\0]+XC\:H+ M9F9!T7"R0`($P6;W62-Q1H(E41`Y'OOO<[K9U^HR91+[8GFJJZL/ZU0?%LE^ M_/7;^33Y6MV:8WUYFD8/\^FDNNSJ_?'R]C3]W^^??UE.)TV[O>RWI_I2/4V_ M5\WTU^>__^WQH[Y]:0Y5U4X0X=(\30]M>UW/9LWN4)VWS4-]K2X8>:UOYVV+ M/V]OL^9ZJ[9[.>E\FL7S>3X[;X^7:1=A??N9&/7KZW%7?:IW[^?JTG9!;M5I MVP)_&QWMO/N9<.?M[YT;/E'$/Y\W-WJIGYM'Q!NU@$-KWDU6\T0Z?EQ?\05B+1/;M7KT[2( MUF6>3F?/CS)!?QRKC\;Y_Z0YU!__N!WW_SI>*F0;/`D&7NKZBW#];2],F#P+ M9G^6#/SG-ME7K]OW4_O?^N.?U?'MT(+N#%C*`UD9/M-_GX<]^WA:9KD#]EBGD1PG[Q43?OY*$).)[OWIJW/?W9. MD0K5!8E5$/SJ(-%#O,RB+!=1>F8F:B9^UTCC;+&4ZXN@@F,S]*##(B@A0BRM-T,9W@FANP^?4YRZ+' MV5)3:0Q`'>`8C\O,78!11!$9!I@"]T08+.O8AE]J#`D*B**`$ M)<@7C\Z1F(0R<7*4I'-_P4WG$R,1-I&^2VE<**@T!"4J>B"3(LK3-,:5&P1) MFOL8-LJI#Z9QH3`!R*"OO&37.9JC2@=2)\+XL)3%I2Y)5W[:2N-$8478]FY21G(GPU#R M,JH.VJN//>L30,4T%VH_?Y'P]C.E31Z#%&1IO0(`0DZ=`AK+8=3),C0**W12 MKDT>B_0.5%JO`)I050H-P0965Z3$V5-/J@,;[=5+XP]E/A+*ZD"]0Z/P)C0J MDT\C%2NY#";*'LR[&XN;B@M`T)@G#XL1Z1*1"#AEPH]1TB1+R':4$#!1=F8^ M.$;A1]P%(R/Q+HS4A['17KU$JDBR\_.A$MF_0Z21=UOTRN0324"6D?$*BIX( MNB`R68I^=W#=AVH?*9-/9.9GL+1>`3A.\$<@,X+O$DG[F4AY]1)I?"C4F-P# M^HF4WG[1:Y-/)`%96J\`@-!J1Q+&[TC1>9(=J4T^D0M"I/4*P'&J/YQ(T9%V MR%PB2?NPT5Y]1%J?`"JY"]PATH@]XJ@G"F7RB20@R]AX!0`PD1*Y7(W9D=#M M@$AE\HFDG8Z>&$JKT`47W)WL"&]2YLK4/02+1[!2QH17J(XQ(^1Q]H`0`^_) M,A`!HC09P>Q-)B?=5JDG,ID8I-QQJ-S:M#0=3.F9O/M$3&3Z3MY#*98!D`%W M->4E3?YJ1'?OK&;DU>Z!SH3^09O*6)G\?-NG?P^`>)!VRTQVB9EL+]K#;I#.)KL!>,^T9M!.JQ#KEM@OS(0U2 MS2143642-V&[&NT4]#Q4AW7*+7`?$J.C([K`Q(BHNR9!MM%>X,P@(SZE]:&2 MGZ!^W'*_0ZCP)G6M3,!JED_R`(#Q"@`P0AO%BQ%*FRA9=9[+M`FK.^!H9V.] M`G"#E#8)E5:;G'N.9_++ABBME)X57LD"_L"[3A+*L#;YN:"-E/4*3*27[/:Y*>"]DG6BZ8B%?KHI**[1PPF M28:1R-SJ)!W11GOU[6_K$T`=)-AI*-C:Y.]O`K*T7@$`(L\R5ZG\K#&TJ--0 MN[7)8W)!6RGK%:#[:Y0ZY91Z83N,KCW77KU,JDAA1YKB&MVBZ]]_TIM4O0@` MD\&+EY11ZGB.:`.U2<8AT)1T^S3:3DCFK]03PXXX)3H]=D,:`7;G=Z/T]DM>FWP:"@4`B+`+&D<]H&:AYFN3SR-MFZQ7@(W3?`0;*!29T7N['3/Z,G:CO7IY5)%" M5$Y8QBC]F/YK&W(5!2GTC%P.,7AY5)(9'<@?HE]7,"#TNN5-U;?)YI'V. M]0IR171=\"AV[]":#P4_4R:7Q61)>QSK%2`C@G\G-:&L9\KD-.Z>R:N9G-%P M\7)I8!YD&+^:M1K?%D23L8/3'< M:CDCYR.VF@PCD;DP2'.PT5Y]6\WZ!'DDZMY?3[D1<<3IMIHVH:R,+"5+`K*T M7@$`(;GD\6LDD2(2(5*9_-U&-1-GPQ3=!EQWUJL[W'2N;F]569U.S617OXMS M7'A/]_QHS-TALTTN3IG)745&BCQ>%]WY,S("[C!'ON((1A*,)$+$@Y%4GV8C M(T66K`OH/S,'(R5NK=P(HN%^QHUD&.&B%5F.Z^&N%+*/.3D;;8$1>5Z*H-YD M2XS(=\?!R`HC*RY:/D<.Y*$\,J=(%^L"G2MS/1@I\6C!C0`!6FQN!`C8:$4V M1ZY9YC!2HM5DHF6H$-Q%N!'4`1NM2"-<#\L<1DJ\*F"BI8B&9WAN!'7`1BO2 M%.NPS&&DQ,,N%PT5@B=,;@1UP$>+P0+N(,R<&"QTGQ4HIXG`QF84(^)U*!,M M`3:\#N5&@`TO";D18,,+/6X$V/`RC1M!A>!=&#.2H@Y8U$6T6A?=5RIRI1N, ME'AUS42+$0T?;;D1U`$;K8BA.WC5SWHZ79G*J7G&GGLMO:K?N3';W1ZN^K;W4+2X^ M5+S6=:O_0.IFYC3^\_\!``#__P,`4$L#!!0`!@`(````(0!H'#XXE00``-&PO=V]R:W-H965TWIK9>44%^UQY7]\T?^.;(M0HMV7]2X12O['1'[R_JO M3\LK[E[("2%J`4-+5O:)TG/L.*0\H:8@$WQ&+?S/`7=-0>%G=W3(N4/%GB]J M:L>;3D.G*:K6%@QQ]PP'/ARJ$J6XO#2HI8*D0W5!P7]RJLY$L37E,W1-T;U< MSI]+W)R!8E?5%7WGI+;5E/'78XN[8E>#[C^/&N1O8SGK)`_2K0E>B_=LB)WS]NZOV_U8M M@FA#GE@&=AB_,-.O>P;!8L=8G?,,?.NL/3H4EYI^Q]=_4'4\44CW#!0Q8?'^ M/46DA(@"S<2;,:82U^``_+6:BI4&1*1XX]]KM:>GE>W-)W-WNO#GP+)#A.85 MH[2M\D(H;OX71JZD$B2>)(&O(G$GL_G4=V'/1PM]N1"^>.2*N/$UI08OULL-7"VH?(D?.!3M);@QD M*C]BZSYC?TH89(J1;!C+RI[;%N2"0)6]KF>!NW1>H3)*:9.8-B.+K;)@9.#C/F&M3>B40@=IHJ?Y2/WD@M2PTD M,Y!<1P8NP]%_WF5F/'19(J*#LZ.[-9#40#(#R75DX!^T%MT_UJ;\B(T,V22? M[E2,:.B[1(!*"W2LB?\V'E M3=WQ^5(&_&XDIQ';%.KN!F7*:L9I7#<,O5%OS95)R.])^HQRV?!ZN@JX]4B$ MF'[!5(D85ZU#GG1+W83]Y?1`C$!JY.EZ)*Z!;@F9#E[;*X):-5$*!W]-D$@I# MKLU?A%$TY,D5SYW\L.GU0-H/?/Z3-&A,O38Y`W5M`O*CWL^M:T"I@F[)RR0$ M"5=QRA5T)S-L/CUP_[G,R"&G>R^@0.L^\((8G8Q40C-H@7U;#>:CPY$IJXBG MQUM$4624GN36\B->&^(:VZ#NB+:HKHE5X@M[24"MKI<]+)XYR2*&9@)!&^'P M_-EP:2,\8<^B._:)%\-US>1)_!CN.B:^">*->%Z--PABN#^8"Y)9#$/Z#A[& M,!SOX/,8ILP=/(JANP/N]!O#L^I<'-%_17>L6F+5Z`#!FO*3VHF'F?A!95GO M,(4'%:_P$SR@$4SUZ02.]0%CJGZP#?HG^?HW````__\#`%!+`P04``8`"``` M`"$`D+NM4+0H```X\@``&0```'AL+W=O2IN_7;-^!QOLA46>`)FE,K#R?;&UM=N8:(B&1UB1!(Z!6]]OO'Y41 M&8O7]^]^W#S^?KNU>W7FR]J^?WVV^?K>_WG MMS]>WWW]=G/]_M3I\Z?7ZXN+_>O/UQ^_O)P]O/GV%!^WO__^\=U-N>\?7[W%'>?K[_]X\^O__'N]O-7N?CMXZ>/]_\^ M.7WYXO.[-^T?7VZ_7?_V2=?]K]7V^IWS??H/N/_\\=VWV[O;W^]?R=WK^41Y MS5>OKU[+TR\_O?^H*S"RO_AV\_O/+W]=O9E6N\N7KW_YZ:30?W^\^>LN^/>+ MNP^W?]7?/KX?/GZYD=P*E`G!;[>W_S"F[7N#U/DU>E>G$/R?;R_>W_Q^_>>G M^_][^U=S\_&/#_>*]TZ79*[LS?M_%S=W[R2IW+Q:[XRG=[>?=`+Z_Q>?/YK< MD"37_SK]_>OC^_L//[_<[%_M#A>;E?_F8U6 MUM7L9&V=Z&_&R0,=-[;C=NFXWKVZW.VV^\N##O]`3[6>SEM_[2'7VU>'U<75 MYI&.>]M1?VW'[:OM>G>X/%WP`T<\V(X:.NZ(3SS7*]M3?YT\*Z_Q`X=<*1WF MZ$C_,P^ZQ#!W5!6>D?MN-J_;3S51SG\WUR0%_/^7A* M[^+Z_OJ7G[[=_O5"DX:N^.[KM9F"5F]6S[S)=6_E^E*<>/E5^/FYY>* MG9+X3N/SG[]L-YN?7O]30^J=M7E+FU5L<7069OP8MT4*RA14*:A3T*2@34&7 M@CX%0PK&%$P!>"UI%WV5%<^AKW%C]'7*O'7`"[Y.Q'06KDN1@C(%50KJ%#0I M:%/0I:!/P9"",053`"(Q-5(@YD:#-S\+N]PTO33?1KFYC<5Z.]NL%<4E@7>Q MR7$Q600%*4$JD!JD`6E!.I`>9``90::01-IJ[$-;L\*=.1$8-S^_7"N"BY"< M":S10VHO)HO:("5(!5*#-"`M2`?2@PP@(\@4DDAM"1NI_7`&&^N3J$Z,MY8H MFH',:<8N1JY;`5*"5"`U2`/2@G0@/<@`,H),(8DTU-;B#`V-=:RA)?,>RRPW M1Y`"I`2I0&J0!J0%Z4!ZD`%D!)E"$@FFY3D2S*SUFTNS83UWE!M/L9B6R%60 MD/MD"EV,EH0$*4$JD!JD`6E!.I`>9``90::01/J::B_<2ST\J(UUK*$E?I4_ M@A0@)4@%4H,T("U(!]*##"`CR!222##MU"/!?CPAC:=83$OBA#PD";D8+0D) M4H)4(#5(`]*"="`]R``R@DPAB?0UA4TD\,,9>3*/570HF"2)"J*2J"*JB1JB MEJ@CZHD&HI%HBE"LG]G5/WU$K^8B0)L?ETYO'8K3\#))0V_E.A9$)5%%5!,U M1"U11]03#40CT12A6%*SMS]#TKD4B"2U*$Q)H,*4XV9&\%8E4454$S5$+5%' MU!,-1"/1%*%8/[.!/T,_N]\/4]*B."6OTI1;[E9?90%5%- MU!"U1!U13S00C413A&))S2[]#$GMICZ4--SGG^Y<',V]E#C_"J*2J"*JB1JB MEJ@CZHD&HI%HBE"LGS+I'/V,>;+*6!2EY/8B3G&DMJ]O!GI*3=\H\(NXY^M2Z(2J**J"9JB%JBCJ@G M&HA&HBE"D=KK\RJ?DWF\)CD49"M10502540U44/4$G5$/=%`-!)-$8KU2RN? M'\Y6X=4NH'J(>J*!:"2:(A2K;8J5 M<&YXN$XW=]=325'N')V53^""J"2JB&JBAJ@EZHAZHH%H))HB%.MGRI!0OQ_/ M5EO0!'/K>JEQPFQ-'B`=O97/UJ6C0R6M*J*:J"%JB3JBGF@@&HFF",5JGU13\TA4$)5$%5%-U!"U1!U13S00C413A&+]S+;_>;+5%A!AMEH4SZWI MDR%SRS\ND@JBDJ@BJHD:HI:H(^J)!J*1:(I0K+8I<4*U'YE;;4442FI1<%]^ M#500E40544W4$+5$'5%/-!"-1%.$8OU,\1+J]^-SJRV#0FDMBK,U?6RT7JS< M1%H0E40544W4$+5$'5%/-!"-1%.$8K7/J[+6K+(<\IO\(U%!5!)51#510]02 M=40]T4`T$DT1BO5[MBIKS2K+H3A;TV=*WLIGZU*>.532JB*JB1JBEJ@CZHD& MHI%HBE"DMOGL330W/#RWGLSC*LNA8"=`5!"51!513=00M40=44\T$(U$4X1B M_9ZMRMJPRG(HSM;TT9.W576AE660V&V6BN/"EJ51!513=00M40= M44\T$(U$4X1B_91)T=KTP_O6C?&4+%L61=FZ2Q]8N8Y^*U80E40544W4$+5$ M'5%/-!"-1%.$8K7/J[(VK+(<\JEY)"J(2J**J"9JB%JBCJ@G&HA&HBE"L7[/ M5F5M6&4Y%&=K^BS+6_FY%8572:N*J"9JB%JBCJ@G&HA&HBE"L=KG55D;5ED. MA=EJK3PJ:%42540U44/4$G5$/=%`-!)-$8KU>[8J:\,JRZ$X6]-G6=[*9RNK M+%I51#510]02=40]T4`T$DT1BM3>GE=EGOJ>R92GE M4)R2Z0,K;^53DJ44K2JBFJ@A:HDZHIYH(!J)I@C%DIY72FU92CD43J`LI6A5 M$E5$-5%#U!)U1#W10#0231&*]5,F/4\IM36>DK7)HCA;TP=6KF-02A&51!51 M3=00M40=44\T$(U$4X1BM<\KI;8LI1P*L]5:>530JB2JB&JBAJ@EZHAZHH%H M))HB%.OW;*74EJ640W&VI@^LO)6?6UE*T:HBJHD:HI:H(^J)!J*1:(I0K/9Y MI=26I91#/C6/1`512501U40-44O4$?5$`]%(-$4HUN_92JDM2RF'XFQ-'UAY M*Y^M+*5H51'51`U12]01]40#T4@T12A2>W=>*74RCYB@J@DJHAJHH:H)>J(>J*!:"2:(A3KITQZGBIK9SPERY9%4;;NTP=6KF-0 M91&51!513=00M40=44\T$(U$4X1BM<^KLG:LLAP*;E,1%40E4454$S5$+5%' MU!,-1"/1%*%8OV>KLG:LLAR*LS5]8.6M_-S**HM6%5%-U!"U1!U13S00C413 MA&*USZNR]"8\3``6A7,K4.$Z>JN2J"*JB1JBEJ@CZHD&HI%HBE"LW[-563M6 M60[%V9H^L/)6/EM99=&J(JJ)&J*6J"/JB0:BD6B*4*3V_KPJZV0>+U<.^3P\ M$A5$)5%%5!,U1"U11]03#40CT12A6+]GJ[+VK+(Y92%ID0^>\#[M,'5M[*I^3L2QT=*FE5$=5$#5%+U!'U1`/1 M2#1%*);TO%)JSU+*(D7-*7,D*HA*HHJH)FJ(6J*.J"<:B$:B*4*Q?IKE^]0][7X#IJ$@\FI.29Y.BM MW-E/SM?)?2QI6B\]DI(LBO8S"O0[$A46F9MBP:DG#ZA*;^5.O7*^O#*U0UZ9 MQG<,W2=/%%IOY=QWSI=WWSODW0^^XP/N1V_EW$_.5T;XM'0R-P%7NU?F_=7W M'SZ^^\?;6P.R+Y'=Z$W&\_N-]ZRH+(KB,5L%J+!6YK99$(_DIG;IK=P55X>\^\%W?,#]Z*V<^\GYRL0C5XJ%\?BO MVZ_?BX>^Y;D$A'78?D;F(^%>ZD-ZC\M;N9,MB$J'S`'_^T*-L]HN5JU#&M#!B2:W-SIGY=WW#GE?@T>AKZ3X')W5X70Y%Z]6 M289,SN!TL&CB.IQ7S)W,X[74(GVOH?0T.>5^CZ^A]30Z=?,7ZI<7IQ6; MMW)B%42E0W->[P^;"_TO?L]6Y6Q\XM4.!7EMD;F?'21QLFEOO94[J\[Y\NY[ MAX*\)AH=Y M!5%ID3X#:":7W<7%X3)9H"MGXG.S=LAG74/?K;)6?8N7;ON*>7@6AT M'2_L%'*1S%>3,\@,@?,JQ`,K1(N2(9"(=O167OW9ESHZ5#JK>0A!59)\-=TW1*T_XCPX+I(9 MI',&X>B8CZ\K=M.1< M)ON#H[=R%UE8I$_5.E0ZI*OPH4@OLG*^?';7#OGL;IPO[[YUZ$'WG?/EW?<. M>?>#\^7=CPX]Z'YROC*#)RV*TQ`];>-Z8+%L4;1!LL6RWX@4SLHG8FE1M$&: M.VJXN+#5KJ/WU3CD?;7TU3GD??6NH_ MRV"]#,I=X-O#C)(758'=:[R_TVF28J9^1SL'8H7!_F M`\;KPV7BJ[4=H_7!GJEWWSOW88KC>D9GY79(6TQ`H>=X`DK+Y$>BP'KX8(M? MGQI'HL(AGRVE15$6S[ZB+(;[AKY:^NH<"K,8O@;Z&EW',(O#\XKU,Y7?&5D\ M%XI1%MO:,9Z?D,6+E4O9X@!4.C1G\?KR8JU=9KK-M]U\EM6N6YC$LU62Q,FN MLK4=HR2&^]ZY#Y,8YSXZ*Y?$ZV2;-SD#3M&7Y]6J)_.X5K4HWM^DN_.CMUJ" M0%1:E.QODOUAY:P>WM\X*Y^+C47F(RY^-;Y,1GSKK=RI=LY7,"`L"CHMBH:2/:*_H-%UC(Z8;J4G9Y493Z;V#)>;-&I/ MVXQ>SB5LN`Q9I&]\N$LZ6A0-*ELA^[0L:54YY/.YIOO&67E?K4/^)#J'O*^> MO@9GY7V-#GE?DT.9T:#5]T%=GS8:C)=D^II1,AJ2S>#QF^<58^=5N'O*_.(>^KIZ_!67E?HT/>U^109AAH7GJ&86"\),-@1LDP2'9X MQ\O%RN5\85$T#&8K?=O'I,W59K7;K))%MG+=?)K6#H6CP'H*1\&,DE&09&;G M?'GWO4/>_>#0(Z-@.>(\"I*Y87)>,J/`5'7/L!C,Q6&T&,PH&@5`Q>6,HE%@ MD<^VREGYS*TM"MPWSLIG;NN0]]4YY'WU]#4X*^]K=,C[FAS*C`)3[86Z/EP3 M7\[%8:3?C))T3_;H1]LQN/]3.!24R18%^Y;*(9]^M>OH4[EQR/MJ74>?I)U# MWE?O.GI?@T/>U^@Z>E^30YE4-?5>*&FZ;WG:^CI7C9'2MI#4'[_27"5;^N/E M;!5H6#CD+[*T2&/?C,35JR1>E>OBI:HM"D+8..2E:EU'+U7GD/?5NX[^C`:' MO*_1=?2^)HR/VV=/+F))W2'_$@\$A5$)5%%5!,U1"U11]03#40C MT12AZ*[/U7EE[\Q;V:H^THJV5!)"J)*J*:J"%JB3JBGF@@ M&HFF",62IO7HPY/N%0M/A_R0.A(51"511503-40M44?4$PU$(]$4H5B_7&7X M0[\S<\7BT*+HD[J[]&;#T5OY;)U]A9_4I55%5!,U1"U11]03#40CT12A6&U3 M\X3KV2/9.I=(X<)U99&_.7`D*HA*HHJH)FJ(6J*.J"<:B$:B*4*Q?KD"[L>R ME37.#I6TJHAJHH:H)>J(>J*!:"2:(A2K;4J,,[)U MKDBB;+4HG%N!BBN@DJ@BJHD:HI:H(^J)!J*1:(I0K)^I:D+]S#;JQ[)UKH\B M:2V*LS6Y"7F\6JQ<:A9$)5%%5!,U1"U11]03#40CT12A6.WSRJ\KEE\.A=EJ MK3PJ:%42540U44/4$G5$/=%`-!)-$8KU,\7.\V3K7#9%V6I1G*W)/8OCU6+E MLQ6HI%5%5!,U1"U11]03#40CT12A2&U]CBR1^^&MP&P?%P,+\]EYS##]WK8Y MEOIZ._W@-IA^<1M,/[D-IM_2$TQR@DE.,,D))CG!)">8Y`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`>3^F!2'TSJ M@TE],*D/)O7!I#Z8U`>3^F!2/V2)^J;H"=5_++]MD10I'!9.ISE#\PB8YA$P MR0DF.<$D)YCD!).<8)(33'*"24XPR0DF.4.6R*FDC>3\&Y.X<94NEY;IC]]< MK]*'>RLS<9FN_F:&Q`>3^&`2'TSB@TE\,(D/)O'!)#Z8Q`>3^&`2/V2)^*;H M.2>7;9$4Y7)8.+E7-;#5&PR'--"&VPR\)30F_E<)I/X M8=5U6E$E/IC$!Y/X8!(?3.*#27PPB0\F\<$D?L@2\4TE$XK_R+RL![!4V#)_ MM^ZX*9=A)SG!)">8Y`23G&"2$TQR@DE.,,D))CG!)&?($CE-:1+*^>/S M\MI6.>&\[%B2GPPB0\F\<$D/IC$!Y/X8!(?3.*#27PP MB1^R1'Q3R(3B/Y;+MO")%`Z+(;MA7H,IE\$D)YCD!).<8)(33'*"24XPR0DF M.<$D)YCD#%DBIRE-0CG_1B[;*B=2VK(XEW$;R=PW28L_,HD/.XD/)O'!)#Z8 MQ`>3^&`2'TSB@TE\,(D?LD1\4\B$XC^6R[;PB10.BR&7RV#*93#)"28YP20G MF.0$DYQ@DA-,8Y`23G"%+Y#2522CGW\AE6^1$ M2B^%3YC+>$JX7LR"7`:3^&`2'TSB@TE\,(D/)O'!)#Z8Q`>3^&`2/V2Q^)LS M:[^3?5+[.1;6?F3%BJS,L"K#Z@QK,JS-L"[#^@P;,FS,L"EFB9RF,@ES^9&I M86,KF3!A+8N_T+1.OD5^7'DSG[!D4G@^1/`U)RD,)H7!I#"8%`:3PF!2&$P* M@TEA,"D(E'85"3G*&PK&*_F MVY5>8V"*AEAA,"D\L^A-^[MU\C!5.;R8N2N0Z-9=)#H.(=&7OJ%(29FC."QF M[A"*`PZA..`0BL/2]X%#*`Z+F3N$XA`>(HF#*4[".)AM1OB2]R=]S7^UL35. M%)Z9Q>$!4WAF]LB+]P,S=V$*CW47A0>'4'BRATAV.PK/8N8.H?#@$`H/#J'P M+'W#\"2'4'@6,W<(A2<\1!(>4^P\%)ZGO0Y@M;%%4Q2?F9GD\`,;;^%W767F MSE@A6[HZIN%CV?PFP\WJG@%DC_Q("36)PIH"!*3J6J019SG>W3IXC M*V`XA`*V='7GJX`MA_#NMGCCT6+F7MAV2.[#*7SA`9/PF7(I#-]C&Q];7D5A MFEGPP@JM(V"*B67^S1.*R%/>L.?](8_ MC0;XDYRAOT1.4RZ=(Z@]B8FIHLZ)B:VZHIC,+'KYSFZ-!Y&FW:SW/L.5]6"*R4)!L5;1.+#,OZI%09E9]/;.W3K9_R@HBUD0%!Q"0<$A%)29Z8_KJZ`L M=G-0-LE])@4E]!X'10/^K*"<[)/ZU;)HH.S25[P>5][,G7N18>7"-+J#V3O9 M(56+F>;4Q6Q[F>S5ZL4L'#WV3*+1@[?MM:YK^`9D02;1,77?&$#)OV#<%`:3PI;97PS8ZRV4VW19E>;6RJ\%TGQFX>L/'8N6&WF, MW]VN,,Q=X^4&AU`8+/-C3&&PS`\*A6&QF^?(?2*'@A)Z3R8P4VF>$Y2Y,HU7 M&ENM1CD.I@A8%N7XS.(5WCIQSI1C+.;,XQP])4)7CBUF0XV#*<27:)B$GI/8F+*QW-B,I>; M<4QF%FVF,O6(I@,S905;&&4]F&(R,RU=YGKT2R6;W28)L&)BC:)A8)E?$A23 MF<7E2.I.,5G,@IC@$(H)#J&8S"RX+HV,Q6Z.27+^"DGH/`F)J1[/"X0_B1-3B[X,+&A847E@FB[.KWT5UB!OYBY6PL_N M=CZ3-58LNYRW!;O+K?8%R6Q4.:L@:>N%^:15*'`$A<(RS2S+,-MMDKL`BLYL M%AQ"T;',G["BLQS"N\L\,7%F\]O^+UZE[_96^,(#)N$S5>9#X7OJ*)FKU6C! M,D\8S7XM&B5@"I9E/@L5K)D%6:W06.:S6J&!/X4&_A0:^%,EK,@E$RLWB46&9'B0KVR]PH ML=[\1DJAL,RGL$*!(R@4ED6C9)L438H.#J'HX!"*SG*(AT?)%/ M"L.?%(8_*0Q_4AC^I##\2>'07Z*PJ1I#A=--T1/GH;GXC/-X9LD\E"Q^$MZ: M>4&5VC.+YR'+[$\YO4J6?47!.HJB,+,@JHJ"M?.+MZ)@F3\)10'^%`7X4Q3@ M3U&`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`/G<<::UM:Z;%+,3Y=7BM/OE5V"S"^35X M+:WS*_!:6N?7W[6T_L[JJS[?67O5YSLKK[3.K[MFVRNN MCI,=/Z?E-CL65M+Z.VNMM/[.2BNMO[/.2NO\*JLNV9&@#MFQ(YFSHT`B9^<; M29S-YM."FIMMS#/&-ZEFP[W[YZ>OU'S?C];<_/GZY>_'I MYO?3';F#;NA]FU]]>O'*_,?][=?36U!_N[W7:U%/__QP<_W^YINY?Z?VWV]O M[]U_*#"O_[K]]H]3R?[+_Q<```#__P,`4$L#!!0`!@`(````(0!SWP[8T0(` M`/@'```9````>&PO=V]R:W-H965T7;`@%6,D>TT[=_O#&Y92**&%P3#\3ES9H9A M??,B:_+,M1&J26GH!93P)E.Y:,J4_OYU?W5-B;&LR5FM&I[25V[HS>;SI_5! MZ2=3<6X),#0FI96U[8L[P[)VH^"8.Y+ M)AKJ&%9Z"H>EO_2!:;/. M!3C`LA/-BY1NP]5M&%)_L^X*]$?P@QG<$U.IPU%&"3)FJ M(0&X$BEP-*`B["6E$0B+W%8IG6"7_.E#GR'=< M76IWS++-6JL#@7X#VK0,IR=<`?'Y7"`)Q&X1G-(%)2!CH(#/FR1.UOXSF,[> M,+<.`]<>$_8('T1[95";KHQ@5,:J8"JW+C"4B<[+S,8R6/09M.YCHW@(<`,3 M23SO^5T&#A,/,3UB9!0@TXTB&%H,]OKZG=;8@29(PUP,I=%\-,?INN`?SW59 M]/5VD=FPX$F\.&]X/E;]N-0('DNY"#0)/Z;AQ,#@';M)0F]QT0V>&TNX2#AN M\/5Y-[A^)W\A"!Y+N<@9-\LQ+_8F#BYZP5-C`1>!Q36>Q=--2=.Q)!*O>9_O\(DN#(DMNS;IE)KDO^A=>U(9G: MXPZ-8#WUT7Z_;R/,^S@>K[:0!1KJW\#>;5G)'YDN16-(S0O@#+I9TVYSNP>K MVFZ'[I2%C=O=5O"'Y;"B`O1>*&7?'U"@_V=O_@$``/__`P!02P,$%``&``@` M```A`)X'"RTQ`0``0`(``!$`"`%D;V-0GCTK0,?-80L MD6Q@TE5H%Z-C&`>Y`R-"D1HVA=O6&Q'3T=?8"?DN:L`30F;80!1*1(&/P-R- M1#0@E1R1[L,W/4!)#`T8L#%@6E#\W8W@3?CS0I]<-(V.!Y=F&G0OV4J>PK&] M#WHL=EU7=-->(_E3_+IZ>.I'S;4][DH"XL?]-"+$55KE5H.Z/?#]FV^R$'8E M_IV52O9V3'H0$526WF,GNW/R,KV[7R\1GQ`ZS2G-R7P]H8S,&+G9E/C<&N[S M$6@&@7\3SP#>>__\<_X%``#__P,`4$L#!!0`!@`(````(0#']F&K[P(``.`( M```0``@!9&]C4')O<',O87!P+GAM;""B!`$HH``!```````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````)Q676^;,!1]G[3_$/'>DC;1-%6$BA*2HB608:== MGBP7G&*5V!%VLW:_?A=86M(X3-N;[7ON\;D?^.)G'VU>DI3D=%""C:R7IFRKMW/GYQ%*;>LU)RI'E`(-;)RK;=7 MMJW2G&VH.@>S`,M:EANJ85L^VG*]YBD;R_1YPX2V+_O]+S9[T4QD+#O;OA%: M#>/53O\O:2;32I^ZPZ];$.PZWG9;\)1JB-*=\[242JYU+WA)6>'8;:,#ZA!+ MGTNN7]V^8[>W#DIIP7P@=M>T4,RQWP^<6T:KI"TH+Y7K[/35CJ5:ECW%?T': M+JW>`U6LDC.R=K3D5&B05<&:3;TNMDJ7[KTLGU3.F%:.#8#FL%ZVL>TU'[J# M88V`U2&R8FB4@.%0(^:Z8"I>+VBI#9('P[;F6D6CN!&TKR*!WB"!T)`O$HJF MVERVE;_%<$,+*E)&T%%P)R`$I$&CY$Q#[:!0;[`J<8T,I*EF53"OO9A88 M$6'DQ_.`8.]'8*:8A3B<>CB,(X("C&?!'&XS4B$<^]]NX]DX2!`)OB]#O#J- M(_&BXD3$B\;DWDL22(190+P($K@?LC`+/'1"91+,(`UC"#7!*X*!#7E^?8%9 M0F6%F_]-8 MG9B#!NM$MANM$VALN$X/0^/]'6^N"N3#F+7Z"K-+*-)_=8FD,+HRY8]7J9GXK37TF5K[:D@U'R87C,N'A2RRV68WB.]]/Q\-!!.;SF&S$\[P_Z,*9;9X[]_FOB_@8``/__ M`P!02P$"+0`4``8`"````"$`&C,95=H!```Q%@``$P`````````````````` M````6T-O;G1E;G1?5'EP97-=+GAM;%!+`0(M`!0`!@`(````(0"U53`C]0`` M`$P"```+`````````````````!,$``!?]^4T@$``!P5```:`````````````````#D'``!X;"]?`,``)D*```/ M`````````````````$L*``!X;"]W;W)K8F]O:RYX;6Q02P$"+0`4``8`"``` M`"$`NDUA2EH&``",&```&`````````````````#P#0``>&PO=V]R:W-H965T M&UL4$L!`BT`%``&``@````A`.RF>*F5!@``%2```!D````` M````````````@!0``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`&:4,U9S`@``RP4``!D`````````````````RUP` M`'AL+W=O M`9\"``#V!@``&0````````````````!U7P``>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`&*Y$]DA`P``E0D``!D`````````````````5VL``'AL+W=OP``>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`##! MVLP#`P``QPD``!@`````````````````U8```'AL+W=O&UL4$L! M`BT`%``&``@````A`/MBI6V4!@``IQL``!,`````````````````\.,``'AL M+W1H96UE+W1H96UE,2YX;6Q02P$"+0`4``8`"````"$`)$,^29@#```R#0`` M&0````````````````"UZ@``>&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`!A%3BBR`@``4P<``!D`````````````````^?D``'AL+W=O&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L! M`BT`%``&``@````A`'5"$*1="```H28``!@`````````````````)0T!`'AL M+W=OK0@X` M`'YE```8`````````````````+@5`0!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#A&@LF7%```/F,``!D` M````````````````A4P!`'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$)09X+2"0``TB\``!D````````````````` MY&&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`'/?#MC1`@``^`<``!D`````````````````I)\!`'AL+W=O XML 14 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Operations (USD $)
3 Months Ended 9 Months Ended 68 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Statements of Operations [Abstract]          
SALES $ 1,382 $ 8 $ 1,528 $ 1,195 $ 6,667
OPERATING EXPENSES          
Payroll 1,515,701 886,215 3,912,056 1,740,952 7,072,125
Consulting 1,034,270 242,116 1,931,801 4,422,241 10,235,480
Marketing 1,462,861 143,484 2,037,589 463,109 2,903,912
Research and development 179,476 188,717 612,958 356,096 2,024,710
Travel 274,088 121,344 717,931 365,481 2,158,412
Professional fees 256,296 118,724 652,303 361,036 2,255,260
General and administrative 587,343 320,052 1,512,798 871,823 3,683,571
Total operating expenses 5,310,035 2,020,652 11,377,436 8,580,738 30,333,470
OTHER INCOME (EXPENSE)          
Interest income 3,167 1,910 9,481 3,448 18,136
Interest expense          (90,560) (531,834)
Total other income (expense) 3,167 1,910 9,481 (87,112) (513,698)
NET LOSS $ (5,305,486) $ (2,018,734) $ (11,366,427) $ (8,666,655) $ (30,840,501)
BASIC AND DILUTED NET LOSS PER COMMON SHARE $ (0.05) $ (0.02) $ (0.11) $ (0.11)  
BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 111,372,435 91,599,649 106,477,739 82,087,967  
ZIP 15 0001214659-13-006269-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001214659-13-006269-xbrl.zip M4$L#!!0````(`%&`:$,Q_\EHO/```$FB$0`1`!P`=G!I9RTR,#$S,#DS,"YX M;6Q55`D``VI1?5)J47U2=7@+``$$)0X```0Y`0``[%UM<]LXDOY^5?-!H-$-W\^6]?1SYYI%'LA<&'AMR6&H0&@]#U@OL/C4_]5J?? M[?4:)$ZI&U$FH2^ZFI'_6_71S]CLY]WRH M&Y.+BR[YL=$_[S9^:K72XN,H="<#*!\&1)%DM27++ M13X!N8+X&-KZ\J'QD"3CXZ.CIZ>G-MYKA]']D2))ZA'>OG-BVDB+/XZ]^USQ M1R]*)HX/E^^G[4$X.L+'2K8JS6I@>U[-$[P`H0_F3_CZD(S\7/DGE966;=L^ M8G?G19>$SQ7%N[.B+EW(P)X?TT'[/GP\@AM,Y)8DMU1Y5GP2M^X=9SRO,G3B M.]9R>J.DBA>'FB*;=4AYB;2"""705X3\C#B.X\$#'3DW=$@8KN-D.@9-B;W1 MV$?JV+6'B`X_-+"+6K->:'^-W08YX@T!UN/.B`8N_#\Y]YU[XKD?&KDK;5F7 MU+:T^%^##,(@H5^3&VQ[&(6CU@P[_)>$Z5]V"YY5K`NU?QDZ?DQ_/EIZ]$*B M[B2*\*(7#QS_,W6BL\`]!:5GPE7=W+JNA#Z-!Q,1O,BUS3R M0O<V+B[>+A-X_L1E<3F6K$Z4WMF) MJ/QV7N#<4Y?%O85QF9,2+VQ=.%EJ_3,O%CYF(B\=4D8=,B3'=9V6N* MM55%UZN!.'$K'+86$^-2<:PP"3Q>.F:M-XA+!]X(S-B'!C(ORZIMF(:5`U8C M4A$E3-\TZH+NW(=1MDMRU[?>(9W!@$+[S)=@3\J*GWMT4=X;>N_%T&U![]^NOG)NE==MM9F?-/YT*GD_,Q@`TG01)?.U/G MSJ>=P(4KT82Z%YYS!]Y3XM$X-?%\!A0OWP:U-@043.'3R5+QG()]ZI\6M,N4 M-$-2?C[:`,D^*=!DH3&6=FZA^`H*8'BIBF1LD8,;.J#>(]:]I$D9Z+(".^YH M75T&6";&=A'MLM]L7=\04D036!N=?1W3(*8S&+F+((NIMQ79D/"G;BGU1D;. M&1EYWD,FVOK25FIPJ9:DYI'E1-L,C66*HU%R:!;Z!FVLC\;0=4-:`\UD-/%Q MTCBEXPC:<;`L_.ZS2C@41V&4>'^RZ]=1.*91,KWVP2K#O;,_)MYXE%'-K32V MXX$IV[J5)V@K4K\.8G=I'S1)TK6=$^NZ'A:')9#CN;V@ZXR]Q/$Y3^7W=JQ/ MBJ&"+RQGD9?+L0T@N^P_59+;L&+<7"4/-"IPL*(T]VED"5P!T%-[+86H=9)*FMRI6NR` M%4769'W+M)2U^1IY,7;`2['-U\:+9A5[=FT:EINH,2N694ARF559(>T^*3%T M9$)=_(F$=L,X*4['ZS<`D'5SL]D) M)NH,A_#7C$/=?%&STRZYLS;DKG[#X$UPAP[>9MS5>HQO@CL<8IOY3O6#]@7Y M3CL>M1MZGBOV^=X">SC,-F2O=N"^#?9F(W=][W[UR'TAWOT>1NX&:Z.5(_?P MV9N-W`W86SER#Y\]'&="Z\_Z@;K6^M/0)4E:;X%1!>!E<6D)_WU0]/T?V^0YZ.5^Z8U@Y2408/>1)>R>!6WG3N<.KU M_7"`9SW8\=@3)Z9N-QSAD2-GZ;244-&VJF@*._N(SKR)J,T3&-% MJ7T>C-`40[*S[\17";-84V"?*FU:,)2K.C@OUG81OKK#/-^&]Y5K<"^`4O<>'D2/8UJ*N%B$ M=PQ,KFI;466Y5I?KN[:DC3J-UC6C2J&+,FX?LBVO`=DL@VS+:T-655-[-LBH MCH*0:Q5Z/?K\\(1MN3 MZT\G%[TN:;2.CGY3NT='I[>GY/>_WWZ\(,`3N8V<($Y7AD='9Y<-4C+7WM[P MR'T9*Z>_MI),S;:;N`W2:OUPG[Q'&5SO$7\EZ>\D3J8^_=`X[?6O+SJ?C\D= MHG]/;L]^OVWU+D_/+F^/B31.&K/Z@*&?.%%R'CGWN(#E+:]J[OSJ\K9UWOG8 MNX!KM]Z(QN22/I&;<.0$Z=U^[__.CHD,SYI=N/U\`5=P+>P-TFN_G?5^_3M( M=!?Z[GORL7/S:^^R=7%VSH6<7[GAI=@E[+,6-'$?'!-<=7O#:0KO]*Q[==.Y M[5U='H,>NC3RO8!60"=,;4@X)+!BB`$W,XJ(^DB0T34I^$9L2_+?/E`RY!ZC MXV-2C(2R_0<"JVDRYIBH2[R`.#`R(A<]-O+D)0_D?%YK,69(GV75B-R8G(3P M3_FM;NAZ0V_`J"(_-LX[_1/2Z7<;/Q%;ULDPC&#`/U(_Y"$W(-,])12#4#T: MMY>X!'1^IZB1=)XJFT,2_ M''^2IE$0*0F63]&$??.9W4Q77])2[1VYX]L'K4K5%G0^.RR.<>:+K_+.+$/6 M,].8D$P[!ZP)`%[XX>J*;LU[X+)L2[KQTA#OTE5135E27QKBG;H\NJ7JNKP# MQ#RY1B\81-2)Z2GE_]8`+Z^PUZU0,3+*!=TO)WO;+%5L5;%L\Q5PLK^7*RW% MM$S-TG=(2LDR0JCD]U7$]U5$S@M'=2'@'O-?,HKSBE82Y^"WCR?1.(PI6Q!% M=(S;1.#Y#Q#4T`^?XB9)8+V!+^B<8(HZ'WO`#"PV?)^7+#C9PG6'C`\B2)O`'J(CP2'D]!)W&5T&1D#B@\GRTT MN$0N2`2:R^^%HQ&-V/)E[(QIQ-3=P[+&)R,GF41LP8$5;8FXSI0]PJ=Q MC%+<42XP7&+_TD6?;6V)(F1+E@W5^6FOVPOB240QHG^2;M&4WMFQWZ+@&0LI M#VA)A@(`WXGC>9SO573CW3\D9U^QJV)Z#9U-%T'`Z5V^D;=)Q;:JJ!:^?K;L MQ>OG>AHL_@8;JDGE%;-T_!L4Z]]/Z4.SW"B-7Z2VGF5F`^F?DSBV*@/DBB1$ M7&$Q5UKQK1"GL20R&@:;R:`]NJ7I5>L4TPJK!1.RZ+&K_#)P&6#6IO*+X,):T`R!.V92XI8IOQ?XI=AN/ M]O"CK(5T6I73Q\S]4'"GH*;Z6R%19>HC:4+:I[0D+=U9Y`?O2BJ^&>+4G-F7 M=6/UM*',IPU5+4P;Q?KBT\;KGGU3&LUOI+&J_IO11KU`@ZZ*T&BF-.I+-.;K MOS$:K6^DL:K^BQK4EY/1'8VNAGTZ2'!M[7*\L9W^6F6:N M8%0KF-+4VN",*OIA\[N[78I21HVE':\#I'1GKF<-C4[LE]+:=6T0_>+NS)KZV>RPZ:WOWL1)4K[RYU-QR-/!Y% MBF\/0W:ZD08#+\WX6W._Y.26P(G$-0YR;>=$XCZHMRVS^*Q]2]3Z:Q&:VP_7\HFT!20;9>@M_I: M>R^@^8>,.I/D(8R\/_',=1YL\?Y6>[;:2!6<[VIYM@EL>[VW>V`\%K\<%+^W MAYZ29$TV=.+*L6_^+7'L#`/+Y(,[J1$U!3?3TG8".0Q6^V MU7ZM[44HXM*WVK:%[07HYF'%BH@SO15 M6?4QA=*>577%LA33>):.-81A+C(=*<8F,#75DBU34I\%IB4*4Y86,*U-8!JZ M:D)=Y3E@JJ7RBNPVKP_3L)X/IK#2%N>2M6$^]XPBBK,PKZR/!Y>W\=25\6::]+KS(QC86+.^Y_-.'ETU19G**@P#O])*XL:^4*6R[P.*(/ M-(B]1]H+!N&(5F>9$"W\/4+L>X18/D(LJSB$:\XK"@Z[S81]#4,?8\'(+.\# M410)$TQD`L9R8#T&MOV#,QJ_#^[B\?O%;]V2@L2+B4-&8<0N^!-V:Y'B8O&4 M$4T>0C?TP_LI21Z;![VD(Q:<%K+O:I511GX$$/%/S;J;R!;]8P*@DC`C2WIW>Z%L@G:O:%H! M?`#F!,FZ\>(OW8BZ8+7AM]2:5M[_;D"_&]""``S]1S0* M&*+X2NWJR$'C``,\C7.->4RKDS-\(MG9C[6+BK@?%EY;SN,=\?#JTE16GN_$5AK7&J,D)OR97BV-S5WPS;RW:JFH_ M,X.*A1RNP6`5CCHRK]*\*'BU>N25E-JG`3;SQRE6RK8KP/O+^E4XP_1Y\[IQ`=\Z()AW"^]C46;([H>0R?.3P9*6)$.'G M++`7!1I/HL$#)CF4=5:%S[YL0YB]#X*.0YN!R`)"T[C>#,:VS@&R>K.MF(1& M(R@\]B+<;"J1`"'4/K"4$^BM4SJHZ:RQ3Y$HO+K<7?C,R`'I7>2G>E<'-YOF M##U10/6(K\-+^/4FF<2($A]Z`@_[T@*['/H(B3D>C"NV M$1^ZE.T_S[;&^8;W/3ZHY>*?BT:1CB0C1Y,SBY?X>P5LT`&/9L2=FV/<*X=A MYKD44$X]ZKM-[``Z0#X>0]R(][UDBNVJ=MOZ*\IA*/!+DT2X-3B,*.H1=!SH M)-"4,!':\E\9;?.64DB^-V3WY;9"IM2I4&$DLD*=BK1:2M/0=4PS]ZZMZ2C< MN[:94:PLX:7/.@E3>E+&4AI1^&2%&$E$\?@ZT(G#*_TR$HJ`%7.]41QT2[G" M9Z]Z+%6'";&EZ$UF_X8A2_#-# GO'<*'H![NTRTW3#WZC,\ZQC&\QD(20F M]QUE2H`&A74-^"Y,2C;XRB3&E.,E2=#GZ0Q+B3V=1#/M9CU-0,'@:?-QJ,I\ M3#.Y^*!\9^A-W9#8E7>JU914'>69:]<3,CT7.Y@+&L\D+16DP[JO^%Q\G)Q: MNQ3S;'"SYT1T['CN\@N>MS+!707DG-Y%$R>:$FMF?>=7%#-KD#M@J7R08W;M MGC\U% M,-MY`2K@G>.S@5;Z'!0+-8J=@Y^I&=^]GVO"8+9&Q!(A@>5D$];D&M8 M+(>$2N/Q598B3,W$7"XO'+*G7N4TJ"!-$;9<<75,$DOFHA36A$+RUI%R#IY" M)I5HU4T>$+%R)Z0JCJ)^\V/EL;(JJ>J`?>1I7J>G.*TO0\O>!BE-2WR;AV&; M+P072$VK`NDO_'P5G@JNPI05IP15]FN@O6"`W\-Q^21U&0:8I/8JNH:%&DQQ MZ=]L0>FP]+D+\-_2RE[3P%NJ)MD%JKY%^)?*Z&OMS#_(*U=E&LA092]3Q5J2 MZMH2FL3D=O9K!ILC>V$$9[]X7)G*09#@RK8$"98/BF`8HF:6%-VV)`&"]1S! M/.<+MB35M25(L"4=%,&:E1O6LJZO)'AI'I+3S\Q+[=JV!/U<73DP@JT<*1JF M&%Y)L)(C6&EA/#.V)-6U)4JP=6`$VP6MLP0(5G,$JZD&VTL:;'TG>)E@$0T6 M)?B[!B\3;(C88$&"C4ULL*$?%L&V5M"ZRF1QE:<5T_1;MK:DP?4YCLN]"$4] M,(*-'"F&H@D0;)<>!S4*!!?:$B18UPZ,8#.O=9SP>H)E*4LP_,4UV"QJ<+XM M08+5PS(1NE0P$8:RBF`U9X/5F0W&EHHV6-F$8..@".8+C?GJ2]8U$3>M;J%1 MV9:H%W&(*[DL*?86";:_$\S=M`PIN@C!=6Y:95MOU4W+DZ))(FY:W;G;RK8$ M"38/3(-M):]UAH@&ZSF"TPS*ME+48&-]#58.;;N2+S2RPUK$#ZY;:%2V)>H' M'YJ),'*D&,K*#?<5"XW*MD1-Q*$1;.:USA:PP;4+CQ`$Y]TT318A.+?A/LN'8Q?=M$);HN_D#DN#=:DX M,8F\5O M*^$/+])9K0),F6OPGY_(3UU3!KB6XHAO*X[/0>"]L^<6+J7CM3 M]F6.0M3EM[7Q/3KS+41G6J1%^K=7W7^0JVO,^M0GG=M_LY$L M:2`2S@$\-N0D="(6%'GJP5#&0$KR8X-=;/Q4B,`@CAN.9Y&!V`(Y^V."X7`] MEG@)T\5=^TX`]=E-_!W:8#GO6+#2>!R%CU#];KJ()GL`#:`5D6^?,$W7XF'8 M7CY6$9/W+;X4DH0\"C`-K\N'EO`04Q[(4A>AB<&E`0;X#<'QB9IIPCPZ&OOA ME%(,K7-3GJ!,$__F09-!//$3]O`HK>.!]&,,\PI8]"D,7%;KZ0&D`AX\S!T8 MT^@1GA//XN128)5Q@',>$#J&Z+`H,L1)HY&7I!AF^!D;_/X,0,QSG^5)Q0*8 MU0_4!L/WO'EOYIOC-?N4G[O6%&6F'CV,%0)[1&[H(PTF",/E@8VV93191."( M2_IC8Z$J+$4J2=-*-'XJCU;S_24T)0":L_QD$0MIRC&3`5;Q;%;-I>`%LPIW M_\_>MS:WC6-I?]^J_0\8CWLJ7451O%_2DZYR8G>/I])QRO%LNM\O6[0$2>R1 M2`U)Q?'^^A<74B)U(4%*-D$*M=LUED*!Y^`\S\'!`7"`VP@&]'?^^K0FIL4G M]#V^I6=%2ITQ*4`0MCDXEG1/U+/6NDSTR>9?*;WA,0@\"B07L+G$Q,T"<3"D7_9_28[ MM8^02#T?^7;PB(.O7+O4`R,EO.DT@M/T;'1MAYQY,BGGB*.<`R[QG6E_[/>= M$A(P>RD=E-(!RYM+=?UJ]B(F]]/(\:U->UK'5^+@:KJW?=VQS^7IDJUHDGD" MCP=427/MLJ;H,=B><_WN#.FRQ+U`$6(-U[X`:Z=$6UB-^*U M:/B#$!2C1LGA_Q&Y3#&!I"9#!'&$1`$ZAO@\O1_@4`,*R,V6I&P'?8I"=?W,NCC!$LU$D9,@)_>)\:&'WDR>D])RS=D9 M?%PR)/V;2AFO'O]$SB2+P]9-)%E/G"\8;@/L78,T[",5&@[X$VJOW>HFQ`YI MS0M<=Y;6NP9S&&,T(,>@*LH/66^3"A4++_HW3(IE(PI43NL=C--19%T!!+Q! MD%35LN;6E;5C2&O!4"1!@+T^K3""RUE0N=;MA+F[8%(1"G.C/=6OSP4@_[.I MBX*]ZYQ6#L:'%F.$`1A#,GKY\8'#_)B*B]2.N1(KM,AZ#&@8D=J[6(*%1AO+ MU>,L%6]8]BF)T&*YO,TC:%?0X%O=C%I4'7)H[*%0Q"T9?J5%8%RM<-7\7I$'[R(DWK&DA]?ZVRK7@?NS!( MRQ_GZQ+-L"*X_4T4@Z*5[OBOEZS-HSE'<5';KJ7&S$7G%%Q4-:777%0JRJ0) M*G:?BK]YB$M`*Z-AFO):T)3!(28V'A9/045=\ MC+3FH;]8P+&/FIAW*'I_,\UI79:V0PM*N7J5FU)5Y7^.@<%.0DUT3 M`2S.B5G(;=@OP6Y5-G5";Q6A\BA^:XC@FJOW>/A79)TRW)3-"H9;]*H`V=;Z M07"\\)^;?@-_0I?2\8(=ZD'A"]:^`'7.05^`>;_96^HM$WHBP5CHV M&\C).2*EWJ]'/<.+W5)L_H;_C+0TE8$+3M/ MR_6MDH<7G\)5E,#:,3`^C=&,L-M1\"-,GO#[+W%-(7IWVM'LU6U5TM6^#JM9 MCVE6=O4DBH/U$CIG/Y!MBSXO._H9DENL1%&GD&[B6I\1WQZI]RX_FY7G^*B) MLF-[AR[LW6RL-K+#9%@&@B):&(.R*(S($3",+7HH+'<@;"TB3I1+V68RNGLH M/2%',)BNO=/W8!'S7Y@Y`G?V/%_731F[1^B;R>J6>'GL1N MI7TIT;W9@W^(V#B0K$EJ^]2D1E2V,U)KZG%)5->5'*.G,\`U MJS6<2"6L-NNR6FSG[SZKLTCP`*7S&XOW\7G[9/^1&1OK*,+:FM-/LN+H1ZM. MUUB"CYWGXWJ/8$,^[LS1CES;.)*1AJ2:;D^3,'3G?UG61;"R)ZS\S2L)>Y.G ML&;4:YYRH4.358M&O)JLN<BN`<<4_.T\?[,MNZ]AZ+>AZKRO.HLJ*GQP6,1BK:H9DNYJ/::_D1T64JKIKSLI_<7VXQZ$'H4-BZ>*/QK2^-`L_\B3?G1I MN+_D566GBK.VH&K'J?IAM<`00[T^?R:FQ/L/-CV%OT$A+$2@#)(9LA+98["O M,&Z>X.M^OU0EP[`DVT$/7.)16'?2P=/$7]M6\U=JAU[IJ)+I..D0;1N2;=JT M3")&5JZT<8:\X9,7T5JY*71J5@0F\XALEX2-U#(5$S^["B(X"J<^=24U=S#4>I;6G-"A4;9M?BI-)XG/K7^&U[ MMCBNM>U>OU@_E)`:TNEC^\MT9@A("`("A(`((^`"3;3G\WCIX7$,WZM#/B^] M\3C[_.2/D]F["UP8-_?"://G&(]K2*AW%X]ADH2+M5(3Y`T:"?436'><'\R1 M8]D[/\+-;_HL&7=*(N1><*\'^'8TY$&>(F_Y[H+^+P_2IF\E>+WZ>/OKIQ1Q M.VKP)[HPO3!]5TU?:RS?$?;XL1S74H?1H='\*]T/.097*#;WIG!GK.H)DH;Y MT4T,=.<,>3I%'7Y-YQM]1;P`TDL#*;O%5B!(($@@J-ZHFPKS^>KZ^O;3KX/W M=P\/=[^]!=KR^XY2;2O156G?W]U?W]ROA7W$R6XL,HC#N3_>Q4ZGF40NY&4= MR_?8,6VW2^02N.P`+LD-]P*6`I8"ECR%(N!QBNP71N\N_CH:03B97.05WU8E M39=;Q@\7(/VG8JZ^13N7+=7<;6Z5DW;75:K,?Z`7U#V=P`>#JS&Y48$?J;>: MJ8V8O-813N8=5-NE:KN28=F28SJGZ4G>B,Z$7-I1'(C:%+K%-_`!K$M9,=+B MW9GT#68*9M)4KIQ(%PG8XK:I.% M/[&[1DJ!9X%G@6>NNYA/J06>N<\!=2GO\RO=05TWP['D)0S9AY&(S>9FAKY_UW9V_861))#[D*1386>^7.T*I_1/X`)=\>W MNU-DW>@1$$^2N.E4-')+SYFN@C&,\,+C-WR.\//<&Y%BMY5[-CJ7<.WF=.35 M<[/XU*[M6/V<:9S'(A074K>PJ&"*Y:WV)16@K0=:1>TG:,\EJ7,/1W,OCOV) MGUTO@`^I9T>K1:ZG=PS&+W54D>EI7;[^97H4V39%ID`MK>@/2H" MXA>Q=5(T-"9*[$%GEOO8CZE%GCF+J/7Y4U7I164 M*@_+B'T(G4O(XY>JMJ29CF09?3IW(O9=M;CO*BV,)`[8<>!#A+O;.6!G'%4* MCC,@BGP.1USB7FHQ7Q!X%GAN76R!Y]:[F$^I!9Y%/D=41A(S&::9C"8YBH:O M`^_1=$;D;5K,VRBRZ^+$C2:[(G'3M@\1[FXG<:,=53Z%,R`V3]QT*0+)'^/? M]`SR,?G3_!*2)Q%!2B]9^T;3S;:/R34\&R<"C]<^J*_)NB("#^'"^')ABJQH M/0+BN20_&I_0%[3L!"W?:)*C6I)EV2*V$+%%26Q!=Z.((D`<>`;AQ'9CBZ,* M%7(&1/:D1IUS>MV*.LAA]V$"HX4?>`RK+\?T!!]4.?J88G=4>:W0QGCAI,GI M;CG>%^TT@#0WD1`3$&K=C]VY@"E+QC"O`O7CSFSABX4OWNV+TQ\.YPSV)[HJ MOFTUSJ).&,,]V,QMNB_0YJ&]7F7OZ-H>/;&SD*/.YLV9"CP+//<)STD!:(0>D]8:SI;(NXC=VV1N=(U7`.%P]SF&OBE/EU7KUZE2J M)=F6(1EVR3K7'DAUNTS5T6SI1#[I*+HPQ.W\@?DR78V[U&2C)+TI\-QU[_^: MQ>\)L#B1E;%:^SGY\G-(,'$@G)C:\=W9O-%2X%G@6>"9ZR[F4VJ!9Y%Z:VLW MMX<"=I%Z$ZFWUYFGN9*NFN@_D:D0F;<>9=YT@><^XUFDWDI3;R5E;GL'?I%Z MXW6VP:?48FHG\"SPW+K8`L^M=S&?4@L\Y=@;\X0?P;L)_$HD=6@X M%JS@#U^"%=SKTC56Y"/788+#L\W'?!S&&FH^$.D^(>GN3Q5JCF"0P(@AV'PY MFQO%OWF,P)`[>Y:>9P[`/[U@ MY47/0*-W/$L@F4'P(5PLO>`9^'&\@F/@@5$8Q*MY@GH*>`$(EXD?!G@ST7(5 MC69>#(%F*KA@&8AG7H0T""?Y=@AH_JJ[/\6HH<4"_31.D.[`2\`E+C:U1%,3 M\D-YWUSF80;1"^@[8S#SOD'P"&&`64^$0XV8JF2Y&IAX?D2_/M306K-5C*3$ M(K['X?+@RV@6SK'<5+-EY(]PZGL1CN$<;-:JZL_2`AQQW_&TPBA%D?4Q3&"8BP#.@)179_0)89;UI(-9G[ M$_+`Q$?=1B9]![LFZV%(*ACF?H'>&2Z()N/T=1@77C#:W\UW:3M3>OD40'8E M8@4Q^O`T0Y;#3<4P^N:/D"HQZNT0=\-8YHDV?Z[BQ)\\M^H'3RUTCNZJ?23? ME3;YKJN2H2,->DMX1U:J".]P2_@GF&>\OUC`L8_:F3_7(GBW1MEJYOWF(>H` MA-S#O$N>PASSXK6!\L13B\3SJ3?UIM,(3E-CL3+1,H]GHNI(KM%C)NIJU="K MRHHAJ-@I*EXAD,U!&1/Q"$B_")\"]/GQ.853M$",08)Z4_2_R!JC,%J&!`IC M^`W.P^4"OD",;.?&3-P>1D""VT8O\A#S(7EK,D,/>_,X!!'\SPI7H<9Z>/$, M++UG\@1ZY:5*I6A*>$.7%,T1A&^!\*"DE-80&I+%+35;M6@,S@4&.HK8K MN;9SQ@R5;5.,R)WBXS]72?&R6H^D;1J]44/7/$!O1T?5X_PN0)3SEP M`_@U@N>OS//-;K'FX_%IQU\4SAU%8P>O#O4X1Z69LL5`WK+Q%[.M%DW7/^!R M<4BL]E`NWXV2\#@F-TQ9O0R134EW^CP:ZY6#L%JQS!L&=+!DI7'V?$T6YUMB M8_*3UY#*?1M>/X7?*D;72;B*:D?2MF6>=,:K'!6^Y:J'(N2() M97$[YWW))-2>U[?(4%61U?HDO8:CRA!X`3$5T;#YY$5D"]G6N'G:#)3*,'(" M-`%+,*;IVV*X$8VZ7V3ED4>0&"#Q(7EV!*/$\]%G'Y$M0>-!+(,K(O"Z$_!B MPL2/$+;7#Y$&%Q"A'6(WA1M*5Z)S,J0K36LI9("%W*4G_@D&95[82].13-=$ ME)WYHQGY:B]>07<]B"';1WJ0]6B?6FSWH`_%;K0^R[VQ,O4!V(2TA[/!>0M$ MN=_JV^8\!,.=[MM&XJ5IN)*K5EOWT!O6K=5RC&<<=:QW>:XQ47LB<-KPHMXF ML)WP0E(5J[^QA5Z93[?YW?U5F`>@8#<22]`'EJ#Q?K"#A&3:"R:I^FD2Z)B5 M"IZ>8U`A?AI.!3^S%Z\=?"9?.ICGO#AIS.89]]G*? M/7':4Z7]@HO;_SPP:9AQ1B M6PD(J6Q6$G:4[R$9_=H3NNL.SYN"K]H3>:^?#; MF6<[Z$Z[YE''J7?6*,9Q"_F&9"EZK[,:52["XC?R$%MK2K:Z'1%E:.9I=IR7 MK]KKLD*7[759JXH^*I8)5,FQW!ZS5$]7[=$?53OA-)>NVNMJ%Q8`3SA=$$N` M)?27<*2[]*(DZ^-1&">'B7PWF<`(`W8,XU'D/V+OBEU*T$^7B#UT M+[HWA8=2HYIC2YIIGBR7X+#E$C89J)W=>:YD&[SXBTS,$SL,(W,853E'HV*% M,9GAWY6[BNWT7.XW#<+]=6N%<3Z"HS#"^4J$9`J1K"$"YI@H@>:"JQ%^9CSV ML1;>'*'>)^@=>4L_\>9G'1IDNVZ/B`U.=1JM8D>?;:975UA'KDMJAJ3K/3Z^ M@ACN4*I;59N"5%DWR:.J;/&S5)F9J&11X(P96]BJCGEX7Z6H?7C?`!1J*]SOK[@PVJ!(8VLG";8 M)V':E:2K\#XEFDHKNN3@\/C2PH&[ MYN+?Y/RUHSJ2I;K-A=`.O=K0),6QZ)*$AJ0P71U%=%1KS.L@#`8P*^.3XG^X M'2WN!7GI.MZ6/>PSDLOI##P4'2^IA`>1D4;^AKHZ+!GX# MOX_FJS'=:C*&2XPFY(X>0]2A8$'L&/^8CE8[8"@.8DG8.GGK#B;HOR0 M>V&NH.].L>JVB[9U02+DEG"OHR\T[HK>U:FHR)_HPO3"]%TU?=MER\MK26[? M.;,S5O4$2<5R]9T"&'\2=1OR='8]_$KCTKX"7N#HI7&4WN_06YLO1M*]%5:?=>28)$!G$X]\>[V.DTD[Z0=11&'NVQ(TM%>\[()7#9 M`5Q^QFMT`I8"E@*6/(4BF^OJ_CH:03B97.05[\NE='>K)$Z\`&?]I=V5EBKS M5]\MM^X$/AC#HZ.^9'U)>?W^"7:J1NFZ(<-AI+U*41DTDNFJJKD6K:DFGWB:P=&CCZ')J9"ZR.D MX:X(383#X\?AH"_D<:N`3W^44:PH7Q[<(&/4+A2;:N="K>R`YZU5Z1Z=_612ZD M?O5]:&_2BWO:C$#*EV59@A&!QGZ@$>_4/4TG\C:T"-#V%K1'14#\(K9.RJ7& MP;J.A4>X7F9E<'2,^GR0IOR0(<,@WAU57BFSH]L5.V&.E>-TQQ_W15@-(,U- M*NCT!V<[ES%RU9IK4_TX3"M\L?#%M5)4_8"].'(E)D7L4HLM_0+/`L^MBRWP MW'H7\RFUP#-W^:TNY[!*B^UH5=/#;DR9.C0E>J7]SI9D(A,;O=H$R&7=5W8' MSF%AMAVIJP]BZ6*W,U=@$^YNBM>-+;U'2!3Y'(ZXQ+W48KX@\"SPW+K8`L^M M=S&?4@L\BWR.**$C9C)LB1O)-G7TGRBATZI\?=H+1$^/Z;+FB,Q-VTY$^+O= M$CIVCY`H2NB($CH]92J*3#1=,O4^)5H[,'#T-S)192>-3$0%G?:=B/!WNQ5T M^C0).Y?T2*&"S@2](9"OXO@ MU+Z@H1_50(0W%MZX5H36#]B+0U,X3-)J.0JIEJ,WG$>6=1&_Y=_WSEN0*F`A?S*;7` MLTB^M;?/W4,1NTB^B>3;*R7?#$EW')%\ZWFRXFRR;W33F\B^]1W0(OM6GGTK M*5/3._2+[!N?$PX^I1:S.X%G@>?6Q19X;KV+^91:X)F[[%M?,FQ?(<86'(.K M;S#RIA#LNYE-J@6?N M`K1S6![-]=OZKXHE4_#F&7I1_&-57'=FN?-NNB#^TNRJ;)Q1EKTQ3_@1O)O` MKT12AP9DP0K^\"58P;TN76-%/G8=)C@\VWS,QV&LH>8#D>X3DN[^5*'F"`8) MC!B"S6V9_S(8W`3C7R)OBF_[&0RROBX&F.F'OP]7\6#J>,"47$L7OGW<:OGKRHO&Z<>"/D0%.VZ:LFHHN*YO_P\6U M`FR!>SAY=X&O)AC@&'V@J/C_DS#]Y`YT9>>WZ-<_IWU_???AX8_/-V"6+.;@ M\[_>?[S]`"X&P^%7_<-P>/UP#7[_Q\-O'W'9*_"`Q(U]++DW'PYO/EV`BUF2 M+-\.AT]/3_*3+H?1=/AP/_R.VU+QC],_!TGNE_(X&5^`C9T9\;L75ZD.7Q(O M2HH(:IL.93.O*Q"O%@LO>@;A!,F'`1,N<><,D<7Q=9R`])(S`L+9K.JZU[5[/3>2QHV1SUU[D>W/$*#C']>I&?C!]=Z'0 MSTMO/,X^9R.$HOR0>TV4'X+XJQO&O41E50(YD)8YK.-/=&%Z8?JNFK[MW&EY M0+N]],V8$NT7K7&%LKT[JRE5YN]<<9!N;EAX]>UIKF18MN28)840NKS'@`FYO.W- M?(DZ'*]?9D-6#%)E0W:/NG*^X]CBS"MR5!&CA8(7:DFYV2XC4=2VX-@Y:9Q'HM07$C=PJ*"*9:WVI=4@+8>:!6UGZ`]EZ3./1S-O3CV)SX*ILCY MZ"`,!MF!:I'KZ1V#\4L=561Z6I>O?YD>1;9-D>D1SHXO9S?H$0K/+\V3G66K MO>PDIA@=Y>S6%..-9E8$*Z^Y%7&?0_A1H/%LT(@FO$E'U8%2@Z[@UP.4'Z_L5?'QG%8\>9"&YSCY=2N"(H(B M@B*"(H(B@B+B)%T7@-Y->HJ3&@+/`L]5A&[$/H7$(>OU2U)^JQ7U7:6$D<<".`Q\BW-W.`3OCJ%)P MG`%1Y',XXA+W4HOY@L"SP'/K8@L\M][%?$HM\"SR.:(RDIC),,UD-,E1-,D4 MY^5$WN94Y^5<%R=N--D5B9NV?8AP=SN)&^VH\BF<`;%YXJ9+$4C^&/^F9Y"/ MR9_FEY`\B0A2>LG:-YINMGU,KN'9.!%XO/9!?4W6%1%X"!?&EPM39$7K$1#/ M)?G1^(2^H&4G:/E&DQS5DBS+%K&%B"U*8@NZ&T44`>+`,P@GMAM;'%6HD#,@ MLBIQ#GM5G"JOUJM7IU(MR;8, MR;!+UKGV0*K;9:J.9DLG\DE'T84A;N&Z]B_F46N"9L]1;7])K7R%&%AR#JV\P\J80W,.%YP=^ M,`4?_0F4JO)K72.2H#]'G!9X%GKGN8CZE%GCF+#P[AY717*^M_ZI8 M+05OGJ$7Q3]6175GECCOI@/B+\>NRB4W+/4NQ]Z8)_P(WDW@5R*I0\.Q8`5_ M^!*LX%Z7KK$B'[D.$QR>;3[FXS#64/.!2/<)27=_JE!S!(,$1@S!YK;,?QD, M;H+Q+Y$W7:`F!H.LKXL!9OKA[\-5/)AZWO+MM1^/YF&\BN#=Y,O,B^![+X;C M#^%B"8/82_PPN(HB+YA"W&K\_GGSS&?O&7]W]>1%XP>DP7O<03__]W\!\/>L M\1LOPCG,^#.,LM_YHZM@?.W/5SC;Z8_?750\(ZN&H\O*YO]PK:<`]]@]G+R[ MF"!8#/#MR`-%Q?^?A.DG=Z`K.[_%OUX%/OWIO[Y<_^\21O\;X[=>@#$<^0MO M'N,24C\/T&_532=5R/@22KLJD]+V/J6+OZVCM**UJ;2I,%A:+UA:SY3>^FUW M+&TJ)I/2]EZES<:6-D^D].=P[H^>UPY@K]);SYS:TC^G_N_Z[L/#'Y]OP"Q9 MS,'G?[W_>/L!7`R&PZ_ZA^'P^N$:_/Z/A]\^`L0.\(!\6NQC]^;-A\.;3Q?@ M8I8DR[?#X=/3D_RDRV$T'3[<#[_CME3\X_3/09+[I3Q.QA=@XVL9QY"]OCW5 MX4OB14G1BY]X2*)?//SQ$7WC)VC8&:7??;VA8])C.!\W&+G^7,6)/WE.U;N^ M^7!W?_5P>X?"A%4PAA&=^^X?UCZ&<0P06`!!"T_#<5&I'<$?9A#@L=(+GL$D MG,_#IQC\9C``$5R&48(7\V!*#("8"0@ST3_&JSGY1S\` M"6IOB;Y!MB=C+P@GX!&S$7C!&(Q3O[+;BKPO"_4>CKQ5#$FCF9!4%-2&AR]] M`7/<\9,P(L\DLPA"\B+4.@0+1,E9#"`RWGA?$@L_B(<="9%W@1Y&)L+\A_]9 M^2@BQ-&"A%0:S5>X7D?ZC^$2:Q63WZ*X`=^/%X,G&.'7)OZ`*.A_0SA!\D00 M"08E(IJW"%?XT;7X6.;=CB'J;+J6-(Q_'GL+U$4GBI@JG-N6MTSOV/D"HV_^ M"!Z(L!!P1N2ON\D]'(73P/\_%%_!R`_1K`QJ"45]-/NDJ;4DI:RL_7.4'*>34'#?U/25HFY=%MUA+58K.44>MA`KJS:6EK!6MI`%&87&&1L%>1II1W`XTMMHJL9=JZ\)<;.;2MQR8Q6`N MJV`N*S67ON,,+59GJ-J:JPM[L=C+V.ICD\%>Q82]3=TA:FG;7B:CO4Q#6(O- M6F;1@:D:@[6<@K6 M6VV5AH:Z(NC%9"Z[Z,!QM9^@R#UXZ,I@P%XNYG*TN9@CE MU4(."GVB[-K.:FRU59Z#TE5A+P9[FNVLGM*<(6ZIM*T2>UF:96G" M7"SF4K<2?2Z#N;2"N;2!YM"6MI.&+FNPX;J.(>C%9*^M4-YBH9=>L)>>TFLG ME+=8Z65K(B//O'YB.FK6P09+6J-L_>1@6V7S+M5RA2]L9*Y*7UC#7*R^4%<- MW1;F8DWRYKK89#%769+W8%ME0Y?C&L)31<;"DL2JBS'>["M$G,9NB+& M+C9S:45&6"SL,@OF,M-ILK;-+HN57;;KVL)O`-C24*5I7@/ME7&+D6W M11C/G./-.3!5/3+'>["MLE!#4S5-Y'B9<[R;/K8T_<@<[\&VRO89HDA>Q!K, M.=Z;*O,7JIB"6NQ9@SSP7=E9%B1,3S85NGBOR;F74S.T"AN7;.4*G+A ML)!XP*W39[@EI:RM,G(9AF4[(I1G2D/I-0U6?@2XF<$TV[!-$1LR11MJ`WL= M/KW".7C5"J%I2KXHV#;95.OI"]#%<8C#7>J&.PJGBCB<$T!?U"Q(?,\49=>Y7% M&XT(9FB*(P8PYH"CEKTJ`HXF]G)4QU*%/V0...K:JRS@:&(OR[$U3=B+R5Z6 MK)F.D.#ZI9\+"MLKTUAB4.>+%[PW47FZ[- M;*LTV'`L,7@U,9=3><"+W5S%MDIWKKFVR#\QV$O7C,*(XQK5!_+TPM8U/=VZ M1EHJ;:MT]#)T<:J!S5[J5A^S).3=W?DQ:6G;7JP)><-4Q,R+R5J%;=PZV%;IU$M3N#37IS#X!N,$M8!K MK\A).M1:[F:_ZJ;5BF4K?< M6A,E>V4IIM3N84LUR>:ZBNO4366KT$ZGC M;9"$Z+Y6JE77L>J*HK:A.ZY?S:J[FQ_8Z2BN#FZ6RJ^[F5\[H)\IU]4C5]594M]D!CWU<;M%061_QMH\&?#NJ&^RJ MJX5(5EUGJ&SC2-6U=CP\!;S&R'6SP/5TPFYF@-]IA=7J1BNJF[54=PNJIR&- M:793=8M==3/J)6MWJI.K6`:$/J&X75$_3-);23=6U6JJ7Q?"=4]VHHWHN M34,_4:L;W52=WCLJI>?,C_&ZNVHSD[V'=4SJSM'D+T]JY-5 M-U;5RU?=NJ=Z#:M7C6X-55=;XGJ:DF794E*=DFVZI42Q6U&=3MTL1M6=@NII M2M;,IFX[K?"]_$*G;BS[*JHS5$WW5;0T:U795:],Q'=,=;V.ZJ7KC9U3W:BE M>GF:IF.JV\RJ8Y,7C15U8Y4W6QO'Y&CN2<9UW=: MX3J0M35FU>EN@GU["[2C5%=DMQW5+7;5U4(E$74]<[.M(U4OG)Y_[40\D^J5 MB?AFJK=U&"`-9%GW#)8'LHTWSK43TA#`ZZS[B-1]X[J5`GZW%=;--.TDH\FD M55<957?VAC3II'6W%:[W$=&,+)OJ51G9QJJWDHQ.,[)LJE=E9)NKW@[@35G7 M'>QDZ2X#O;*:S_;VN37L<9JJI"U6E]?*0$>Z`[`:[$/"DF3O;WD9#L2W&;E#;7S0K9/PJ>JLQ\'+56]\'+Q-J[-NQ2I7 MO>E^I'9"HYU1H/;-0R6CP,&J-F7NKY75VQWW=VPW'&R+-17"14R0/PQW+!J* M;?$<$^"B^S6[H;1\__'=H+5RP&Z;%$>CX6!;K`GQ-I)D%`VUNJ$"#<=V@^5P MX1M8+G-G]0U-9H]J*WG#'5(6ZKNML*X-MA$A9HOA3'63*A?#F]9-:F7??J8Z:P6==)&\3<]O,&V-J%2]Z:Z09I[_%\^/_L>;K^#= MY!<_0$_[WOPVB)-HM8!!$G\.Y_[HF?0!TY.9ZSHFZ,G_^N>_S9.?_C(87-]] M>/CC\PV8)8LY^/RO]Q]O/X"+P7#X5?\P'%X_7(/?__'PVT>`HA[P$'E![.,Z MP-Y\.+SY=`$N9DFR?#LPW<7U[=?/G^\^N,M>)R'HW__!!YN?G\8W'ZZ MOOGT\!8HR^0B^SW2X4OB1_`7,`:? MX!.X#Q=>D/[KE]O_=_,6J.A=V1? MWB)LCF$T]P-X0'6`40,(;$`X`6O@@!QRF.-@\S"'"E:2]X M_INW6/[T5]W]*0:3M5;^1BN,^]B/$ZSVR(MG$O!&(\R_&$1P!/UOWN,<`B\8 M;[Y?>L_Y+Z,5'`/X'9>UAK%,WA<\QLN?-G]A<49>%#W[P11\RSKY!&\#WG(9 MA=^1>TD@F&`3DM8E\`A'WBHFKTEF$'T?S\(H`>BY580\CKQC2X3[FV!<1/W. M0]F'C0-C,'41]I=Q3%,XJO1:+58S;V$U->/$O__ M2)UPZM9J_PQ-R77KL(];UT??S."+CV_[].W:];IEYS)7]>5KKUM('?BJ;MDJ M&\_:+;JNY=%NY_+]AD!E5^N20F5E/-_:J4'X/BN.8^_&9E^@4*B%LL:JT!6J'@&HUR_G?\5UZI0__ZPM[#L%0]-_\]*,:I='E);V'J=GX)@U&7 M7ST_^(B^O0NN_7@9TK#^;D*]"M&G]`DLI%LYCZ'%1M0=G[#UVPH%!YJMY9A4 M*M>IE72V)FO?8_]MX,_?7:!("S8H/E&B\_?%/(C?HA>\VS,?0WVI#G__[>.7 MT0PNO`&.H_',]0(,3ZSQSO2406/FV>J+:`P#&'ESA/:K\0)Y)!0#HW#F&[RA MH3K5N?R9UP2S;CFZ:>>V(U3(]A+*;H/ZE"@N*.O8JJ/IK>KJEGC>@_=3I+JZ MM>)OA!!3:U/7TV:62J=@IJK9KM.NLB:3LO9>9\W7^JD^P[VT&,$ACOIH[:3AW,X20YU!>4!2+SO69(-/'DQN%3`)(QP M+@W]%T&:C0O\`((%8L(L!C`8PS'X`I<)7#S"".B*!#`+R(/8F^^FW,ZB/Z]B MG(/\IQ>LO.@9J+13)-*1:8(6S#S4E2%R?='F&D7<_X_(P4W\));6^=!H[`?3 M^7/QYV,?_SP!ZU\#'_DF--M(`+(8,J$W3WRD\G@5X?0K,4H$2=H))"6O/93) MC2"2.$:/P0"+/9IYP12_\W!+V:NQU"R8H0HGY%48?.@M)/'KS0D(5RC\C!(4 M/I.79*%S##S2U;O-[5<$_?09>E$,L/L&.*S$R`Y7TQF!*^JB!7Y%O'K\$XX2 MW%/PNX?&&9IZ?'P&"^]/S`C4SI](O7CLCX@89XIS"@R?&,O?^)`4`FOG@496 MG+8_TI=(($;O0,][@3>%>.0AD!Q#A'MD(@R_F9>0-T00WU=+C487`T``$R+; M&$Y@%*&'/3SGHK(G^,.*?(G>A1L=H18P53RRM$`;\N;S\`G/@M:*(!%\I+]' MEV+1B^+5:):CTHF6&\JBE`,!#XP_>_ZX&./0[_9,MZHGF8UG7R>99+)IU;5D M`9-6G4L(K#5(`_+WJ2LH:%?\MR[;KI:6V[-A-BT;38[;T_(\$+LS`6;3LM%\ M^+1:TL7I`]/@K7\44^#6I\!\[9=)YXED@.(I1F7?&(-B-QS&Q>"7JR_OP=67 M#\`V%/`T0].:=.\)GK/@`&\3ST(T&7N:^2BTB^!__C][5]O;N*VL_XJ0TP(M MD&SU_M*#+>!-=HM<9#=!DG.+?CI09#K6/;+D(\E)TU]_9TC)IFQ9;Y%H.9M^ MZ,8V1A?M=S!P][R8&M[/?A``N&05 MI!)STV@$#[P=#/L5^$DTGF?!XGO\[*TK/"*C_4\EL+'!;_72S)$,W&?VIACH MH4$_,`5HE\!=?'A)8C^:TK[8\."7/#[D!^YG>)G7Z\)/7KJFC#&TE.G_NVOU M9]T!=QX"/YE#CU1J0@(_)$&,0,G&Q^#&*J,Y\Q5XJAYR?X5,2VDIV9SQ M$^9(H2>"F.1M`Q6";8`-VG%'LT<>,Y'SYH",\O(WQKQ M0WO7K_6DMA:ZG;42!B0A%X3]>QE.LK"T&\9LW'UF,6E7W"3(5M(.CXH\`E,L MQ;#X&.QN)!^>8\+.T33=-$SEZ!DF[H!*U6R3OTUT6(;=;B)(J]FS:2AROCF& MT803&^*&Q2ULU@#CU#$A%R?^3C/9;X[[@M#M[FO<&^=B29HT%"GIIF;P1;": MD#09E MUK9[/YD[^,F<@.!433J3;B;W\,L;CDMM<7:'(NZ'*T)/4_`\B!UN+5G^6^F9 MQ(0/H/2B!(\RDB3R?!K>]>RG\RQ@[#$+)5]'C,$:DW4LS=TGPD(?/7=)CV+_ MSF+%7!;^A6F\[`#+E;`;_W&>GN%!*IYL^8D4/9$L8@RP+NBK`_^)':G1LY?L M13^I,CM!^;D<3%H='[<*-[3PE++N,_C/&++W@RGKIX:ETH=_4$W[U#;,\G?R MN=?Y^1/'=18H;)U:BLTZ4YQ34[%>$^SW@W:J63K[TSHU=+-;9R7!QYV/C6H5 M\HZFI[&X16.E\)U(P]/0%%LK'/D42.E"NS`KTI$-4^Z5].,+PVJ`Z@B]MT:H MCB[,BB'@(CHW7PCU-77'WITU2$4[@H]O0Z02S]%.D^RD-/-W)N'T6Q1Z!3>I MMAUZ>5C7WI2Q:IUAJ[7.87[KIT9O#"I[L$H"MYW$6@*WD8.!E.(ZS:(V\@XR MN.4_"HVDL!7-Y`&6D]0/*H'1#KHM"I2P]&#%*9Y,#@A*X#FS;BO"0(G*]]44 MTVH-*JLD>#V[2\$4!YWRAQO'+C@G7Z+XCL1/OD>2Z_@\Y@FA1R$6 M2&IAU[0-I:+9(DXI:8IJ:-9QL$6D3!Y5BQ==OAZ%4,A$K;"VK8)IN'@@,3-+7277LRN2)(3L.[&H;?5^7O$]G%"C!F[[^WB(_M)IG_U42J/4Q72=+!D%U11-_Y(".I>S1!66H?*# MHEBGNFYEIP6Z?JIEN_W=-N9;OMW03TU=SDX7@';-=IH?CQ3+9N!A1?0`C*5G M,.R53V[L1RNL`Q">>6@_!2RA9DGP/"A\9#1)U)1ZS!*CZ`%(C$TPZRO)L\I^ M/=PQW>MZHT]/KBY___:KY!'TLD[6S5+*CJQAN6[)Q1\XZ089+<7>X-\@2):N M!PS%U8A^7KK3:?[YV9^F\X\GNOPC]^:X@C[IX=&+@BC^>/(/SR-D-N.>FV+9 M!I@]'T\>HC2-%NON5?O'$RG[*<93NI/64SRE4SR$*1[W-<4I)?LF.`KQ[AE5 M.FV"5MV@Q3(>:YF8P?QL-J([:->\\4,\X"S5G-C]/E)+!I22M@^#]N.(J-[J MIK5D\*B9^.V#K6>X%<4\-56U'T:"BGN.W>7'$_;OP1G[2QKS M[G36WZ?S.*@^P'36U5-PPKZOZ5RV/F?DW4PN+L!7./MT?7]__?5725W^M1?Q M<4YVHVZR=^'$>!7!I^O;B\^W:Q0/@>O]![%(213XT^*4.1Y%48=*O"+1G%/3 MMEN)4SOF'XMR:64K'!I$]=H^`NJ.>CEO/XO&1_=;F98MUGR]9LT_-,2.E!_9 M&@U8I&FT>@A(O\M9$_7QPTAH;:8T5,<^M>T*&[Y$3-[.VOL+W0X4L3W9,5B[ M]BQJ^X#KT0V^NFE*XF023L]IBL$C"3V?)-N'7`U:OA]T'?M!5U6]8WK*94IG MTM7E_>7OM&J>=/?Y_O[J\U=H>+C-_P.?05V&T@7QV+E+=K[#G;G0[7I:OPZS M=J1DG<1*L`LUG8MWE;Z0?=D$]E M6<;:93%)5W&X/I=:MV'?XVG.Z#$K+L*G_M"FSV+RYT+0N$V:FR=\#VIQ.<>P0%D=K688% MJGC4W!`7LFJIMN68SF#<8-D8C;E1TESHQ:4@&;JIU7*CA$QQW!!7CE-U5&WD MW!!8=$UU;)7W$7KFQG4>.]B,&R7-Q5[Q*YL@'(9=RX\20L7Q0]Q+8UF68LF]L(/E\5WE1F3A&Y1;^X,BV]8'0S&=#7%MBW7"I]Q0A@[E MLBX',/_KT1E61W0./X[P*4<''8X'G6EV0Z?(!2F5U^A,IS+/AR_6D.H#^W M^SRD_NR`KU9_C@)?IC_;XZO7GZ/`E^G/#OAJ]>?XX!7ZX_.^"K MU9]CP(?:3K?[MCYW>SR4[NR$K5)SC@0;:+DNV*JUYDBP@8;KA*U28XX$F]U- M)JNUY3BPH6;KA*U24XX#&]63IJ%ND=)>,^[V4;EY:VNV;1;V;C=4=5&'S2!4 M*\!V$%15,W6K+PRH]AIAJ%%T[3#`-',41^X)`ZJW9ABJ%5K+<;!4W7+Z&@>[ MJ2S5**Z6XZ#*FF.I/8&@^JH9B&H-U1*$HIFFKEH]C015*W(E^=4JJ?"T,&4D M[GQ4DVU=-OC26:_5HK6$5^K/QH3WKCGKZ*[6F8WI[EU;UM)=J2>;\[M?#2GL MP-LVX3_^HMK7:O;6=!=T>G,YZ56;BZN6B(_:EJ;WMPK5TMW3=9^]KCSB:A^> M&9ILZ(V7GN?LDEX_?+R)HQ#^]%CA+W9O_-;M\1FT=@^])XH=/%'L[O[/*_B& M7I/C#5$E\>+S^?4MS1+[E=6:8QFJY4E4>*E9F`8OTF0:+;$ZW4:<;3GGI\\26M)8C^BB5`A*QE(\\=BPJXJ"B.:L6198`P^Z MJ31WH8F$]RQA/3J)S&:8?Q6%?#(93>[ZA^;\,Y%F+!X66H)OG[*.=K.LQIK, M-V91OF0I=GLE6?H6I=*?),UE_@U(=BZ[[I;H9MF&G.3B1M+4C:=8>3*57H`+ MN7@_SWUOGF4[TKO'>A?FCBF#;1>YK745VN(^%IO_$ M*S+;L(!_;F!V:(YIVZVYP1/8E3//41>^9$\-G3&MJX;57D@V]+5GRBU9N#Y: MJM>S+W[BN0'VTY@YI4\/S23%-%6U'9-*Z:QDUBT\EFG8;R0M8TBQA=![411- MLYV]'"@2UC=*8?:*H9OZ_KDP*$AQQHNJZYJR7Q$.C%+8G2J*I>M6-Y3H)[+[ MA!FFS>>AZSNHELX?4G!O;D/BD*K0-&W95AN0F.O!+U%,Z]G7\P#+&HC< M*-!M6U65781E=/4+4=ABK-JE8S@X0I%W?!F'&D2\B%=7Y8:*ISB86C8CV:V\ M);V,!;N7N*$0B_,8:$C1X1$+-*Q-Q71*!+HKXM+Z2>6P2YN* ME&_%,`S'J,!>2N'P#!`F[H[F6./#+W#%-@VG9,%NA3\F,Q+'A)5)O''CZ_@. M3\JFM-+<#8GOYGAV1_$W:MJWM_9O\"'_G6#//'C]Y#=H*?-!B,W(&QY]KXZ@ M0/2T03)9I?,H]O_&"K4[J+>;]#K6%&6RK=YE>1"6T?>@\) M?HLAP=Q]$FV#*`LBAP@N\1.$!+VO`F0%?+K`B/[UE(>M?DY:PU$&?+`ZHK\#'ME-Y M6WM$'B'3Y`O,X,O\DHC-&)1MRE[/SJ/%(@KI MC5,UR3(,O(UM+WE"8Q57<=C2S4''[4)#%[3F9LB47=QW[@`P: MY0G4WTW@L@#J"MS;34<(?IO$P3F@6QB):=)(3(.>A%5P@J9SEB5WXFPO[:4J M>F=G_V)$#&EXI%C#D'9'BF-EB*/0L(Q&)XZ5<5VEO53%!FBZHMJU.O(`'#E4 MN(OJ6,8H181!,7MAR$XO50=9(YTR>$AOF$9#?A@%?AA,ASCLD+ZDEPI^V-L! M0^-B2%,!J69(*P'1Q\D/U(.&H772J5;&#YWQ8[>7N@DS/H88J`;!!6@T8[2" M@&BY@&`?\#^*=+$JG$R>I'Y0;3M1 M'6JJ-?6I>MH5[H1SQWEX;7TUD3AO28!GO#=NG+Y]1BS#=(KBFVX3)Y[]([/G)^L2WII5(839,9Z_N+25N*,3B`I[W MVUPB`8O;W%'L_[5SION;N%O]U`:."D;6F: M[)0#W2:L7XS'O#1UP"MP]NJJM7=K=M`Q-60;9YK1:*]Q9[Z:&5:;S=?=7BIO M7M9D3=^SM38D9DW5G`^JH]M.0\S%W$(;=13M0R[OI0JSI1I[5%0MXAE)$GHD MGUWP'KM>>D?B)]\C"5\7HEE3H1I+5C5#MXO`&]`X/`N$V2.ZKJJJKHR/`\(R MI55=511S=`P0J.,=3;'E\8F`P`QKU/=6CVK@"]GH^\*70D,'5,-0S3VHD)AN M]`M339H)X[)G8G8G7US%*+"'5;UG\@4>RALJF$&]DR]J2JN&J3IMA&=)XO3E M)@!+AT_K^3W.R\I6-QDX&A86*-4J>E85Q/2/;="*-(9J;^G>UV.[7"Q=/^:/ M6NK:O0?&OL7`V-<5&(V>2.P^^`$&@$8SZ2H*'\^N_">L-DJS7H\H6O8RI&5! MXRGN1[!HUB_K(%FN=NK=NF#HIPC^D7XZ^3*Y^W3RDY#`R$OP M/XP;AE^]N1L^$AIC[/FQMUJP?1W\8HKP":L)C/'!'KC++\@E%I>,-+LA(T5: MN"^T#BN0,UL%P0L&(C,9"XA$HX^S3H!&:"`A#%H"-IU'8#QG>+*JKP@4B'27 M2U!NL0]$?)#N-^5:@7HW6,&W\$`J$=>;2P]N0$<_F1,@9HID`U:L>I-#1?X4 M`=*@Z?;.'5)B:08XI2>:PY4/43;9`C`: M@8\)>U5"@B![-<^=C.G9JU'+XES!PLS3E4>J\&]K*S;#GOT@0%@)+'I('@^/ MC1Z0RW%G33WPY3RC)2]\[FX3VYZHI.REH(^?W$>2<8TE2X0@N+@2K),ET-!# MFQL[R$!L,?C[51A?L@$*04]("UB_YGF1>EJ??E]!>W0B3OFZW!MMD^EG6!OX MU0PF94QHX0(8SADTE1XCIFOB:/7(QHEKG^(0P\\Q.Q#/M<6Z?&Z)=/RTS,QK M2B!9EW?`3TOH)%]9P$J=DH4;_R?YN<>DF5K+OJ'+D-?]JVHPL)OGF*;3Q,O; MJ?/W6E##5AQ5[:W]U=>B*KL;I6GC=S_OW<\KZ.$;7GFMI>:(%I*;/=H7C!&: M_4BM(#1AF#$#;N!JL6+*?4J68*_XS'_#QW$]V3+[P*B@5S^$#\GRGYN_Z![X MU$>[C!D;(4`NZOZ%^W_P/=EN2,U'7$F*M'KNDDK$WYEINZ:-H,^66\<)3`'_ M<0ZDT643O)>(XHNIIY.LL/BY3YB5N^F!61S,C$.'BQG::UL&UB^PB5)8TYC+ M50IX`C991)TEL._`=8[1?4-.95C1!`^I?\7>@Y@(.RB@EK$?,B?J^[5X[DLO M$]F5P078[O[?[(LE:F],5L6_]PNZBZ(5H&?PZ^'8^[K>"MS6S+(4[Y/UO!1,)EF7Y>NM-I_OG9GZ;SCR>F_"/WEGCS MYQ0M?:#DXTD:+=?-G:QY^4[//I)2*GJH,&(F>F6;0!(W"?DM'L;$=,J3EKV5 M#L#DZO)WT/MX)0Z)3TJI5H!J,).?8W?Y\83]>])Z_NR`Z#9_=FG>-WW^E6\* MSZ">:T-:-6H')*T(C.EATRD*7L/(5EMJF/` M.KM"9Y_LM6A?KT/'/\,V4J%)9Y+18IIM).-Y[J?DKRSONRNCV%UY=]C>';;CL`[?';9C MM^_?';8W-J#O#MN[PW;X&?;NL+T[;.\.6\&G:NBJ,6OC"HR-:E]MTXXY7*KF MZ!]TU:JI;U?ILNWV\=N-]6<#D!MB!D:I*)K)*-0T6_V@:Z;1$>N^GGZ[T4:+ MV-+Z0LSW]-N-\4K$3S0Z[$L47T2KAQ1:95'&Z[2$O0V$WL.G6H4+KRK(ZA?A M$::UOP;OT55-=!JTHG`GZ:S,L/R>I!,5GZ:HKU:=)7U4%E4QS#)5T)MU^OIK3;W>3)NP_7H55@2NZ1VISO,>L;[-FG"648+371G:
A]#]NN,*$,":=6E$ZZ9DF MO6@0>L-:((_`59:;S?+D_81CURG6Y(@)B"[?QW/T_^V];7/CMI(V_/VI>OX# MUYO=2JIL#]]%)IM4>6;LK'//C'V/G9.3_7**EF"9)S*I)2E[?'[]#8"D1%)\ M`2D2!"@DY\6611#HJ[O1W6AT;U;H,G7\:8:XWT%R&[*,*)5<(G^`\_(JX"!ZF;7SC'.V9YW".6_(^HM)? MF.Z+SEST"E(U_23^;Q4O.8=SZ16KINK\"]_EA$X0X6^\! M73M$5R:WK`+)]IT)7V[&,T&3FZGQC`];]6D\H(I6JR2#JZ?0`>IA\/*5LJ3, M&O8$-B==IX'[T:&H5`*($F6'U0#2G7A;*]^][L`\`!$2>30,$MIP[6]"L!.5 MK0SIIX8I2U!UHF(S4-6NWGHKR=#"F"Y:[5#!X5ZM-X][O4:J_CAFFS[%*!XR ME,^QGV5:"ODR]R(P\#]6/$:'92Q=W'Z09JHXD='9V&X6WJ!50 M!!HL+IT`!>G"BUTYKH\X1)J:8DU?&[@6X9D"%9\NSW)'\$US&FZI0U8HA(]8 MNFSDC\C;+O4%>!N`:H8O/:SKRFH4-GY+Z'FAYPMZ'G.,E&$9OC7Y'8"J&*X# MQ"5A+[_%I=51,//9Q?TYI.]/[BY1'7D(^.-CMN[\^\UJA>*AZ!L7J";]%_\< MSEP_EK/;A4S9^"%_QH,K-@?Q*/]"1:#C"3=.B,ZT`#II2HJ!.](<4M!_QD4%487D*'`?-A$ZIT%-UY;Q,5%< M;QM]`U(3K+&S&]=D#T_AZ'!X1T)Q7W<%@M/<*/`_KT_^"H0._!.:'\`5Y=', ME[Z_B!^'SZ,/U@$Z\')#=,<0Q&6GD\+"*!X4'U!\[[[\`#42A&$>91HCX,*, M\!5ANO`0C1,`)_31PV^H4#`J$'XNW6T>_@F?3<[5H+$_A\P``M<2>"!P MTC+Y><(F=;W1%<3L!)*38,0L?W.#:.-`;>JO)-,W9WNQ#LDG2"W8IV>:3[29)S=^W.LZ08HLW0^T^ M26JNMF:I39-$(;_%9@5N'J]P2X#/KN<^;YZ_0D%U5K=)\/+*#V[2(]46-X6ZV4D8:]-J=S1151Z,I_;F!RX#S_`T>*RQ,A\DUZ

3YWMD< M[?`C:)]MAU>M_SB1DC\%J`XU$R4D\$RJN!HQ<5.YB*K5JKO5;LM9L5%W*`LH MGEK5&K3Q*]CL9ET8IC5G9%<=LU_5LO5DW8IBGIJJV@\ARTIPL5@:J+H`S"3$ M61?BS,:L1Q!G73TU9O)QB7/9_IQ,[_;BX\?K+[]NZ\^IZV^5*^93V.M+8'6D M!+N*H$T]07X41=.JZ"L2S3XU+:L5.[4C/B_*I96M,/8BZO=V!F;']7;>7HK8 MF_=4Q++%GJ\W[/EC+['CS#G;H^%:I(6_>5B!?KYDOR-G+P4#5J<4=NJ[X'EU.11%EX(6X:/X7WP//ZY7_!L!'-P#S MR`_N(CC*Q:L3+%`]Q0MT1\>-WFK/,7H=6YQL<'6R47<9#75QB,\7\)VT.!J_ M>7YV`O=?(#ZV2#E$^AY\FZ\V^(*MZRT`ZMR(CLUSUZ)_@(M$W.?C*]KANU=\ MLA$5+^%*B$=V%[>U^!:J@H[^R^Z]=3L#X>N:=>>6$`5U3'P:HLC-W2&2[6/L M/8*'&:'4%TAU^('*W![;QAU@;^H">@$]K]"/'4&N+YK_!T!."5A(%R_07EW6 M=Z+AF).:>ZXPRV#LS8AOEK_!ANF[/V*[=*H,+_AH:#ZZ_`:"N1M.5F4*#A(< M--2FV^)4>NQ%\#K;^D/E?=[A6I)P<).T[57'PVO&A$OP)0=\>8MN30FV%&PI MV)(E4Z13ZNG^24L3_!544)C-.R`^`E=82OJ@EV!@ M)ZE]IXJEGZJ6V0\E61/TH^#<_!O8X*OOY'-91\>WWZGG6A\IZ+PRURYYG`WN MHI9NI32F6U%G2OE\-E$]=W#",C)GQEY$K3PQ,#FN+8O6PL+>M'D32L'/@I\% M/S--8C9G+?B9^2@03Y&?7U%F`UBT#?%PZAVS,]7A_1OT4O745@S4]^80(65, M,JNYD1EWNL4)`&?WR.5SS4"1&_5.=@YIFR:&#(R M393SQ-P5IHE0>.PH/&@YUU3)X8X3CR4^\A7,5TX8QJ7;H79)+S@+LV224OJ] MI"Z5L:\OF,M*@>=_I=J#!>5=C9A+BPE]05KNR-]*)7 MZQ.9Z:4N,C%KZGEHWVO&Z!9(_;$LB3$BN'$:W(@R=?LA(FM;BV#:R3+M0180 MNQP[5%5SOLRCM1LT&T>'+)\-H3FX?#D_2Z$4V=%F#9DPA\ZCO^N/9196!Y9F M)A34_\59[B)&MM+R;&H:EVF%+A:ZN%6(:AIL+ZY<":>(?-8BI5_PL^#GT:(YAU1;;49O<0SY<)HY<(DKYSN:I`2'6)Y4$R&3=5W(% MSF!AMKU9-U_$TD2V,U/,)M3=$IT;F]J$.%'$9G+?P%P<^"GT>?MN#G MT4G,YJP%/XMXCBBA(SP9LL#-ZE7*#X]IAVKEHB/3Y3<O/+P<81;.A?I$<8+%\;+]^JI;1NGBF70F8FH`\BE M49*DX)X;1VB2"!7&M@H[ABJ`1UCXYMT'QYN#U4J4P!%E%]J;-1XZ%XBT0@OF-DKH2=;&S[B+A?!-_8]#?8G+5P[@0_"WX>?=J"GT)!RN.)OH6)[V)Z-O4&5I$ MW^JC;S5E:B;'_2+ZQJ;#P>:LA7/=T].`-X[(5A\\)_7P`N=R/6]+[Z75NK_Z`9@'OG!700I-=S"/WQ8W>[A$Y[^%*WB-"_?+__W^2]%_;EX`5!&MYX2T^.\%?(((_ M7WY#KP"2N_CYI/K/YXJNV^?R[E]4"LM#]/H*'G\^08T$SE19MLYD]4Q1SB+_ M#-G79[)]ILE[SZ*G-YX;/_K[W<<3:0'F[K.S"G\^D4]^46U9LQ4U0YK*:?6W M.DMK7)VBGLD*^D^\.G6[NORS#:O334V1;;J+LQ6BQRJ2J=T^(KHZ8^9I1GRX`NB)U:68JIF+PA=!('C+7&3O?=ONZ_< M.F_H([Q1XO_Y&P@1-]^"P/472@T9N@UXKJFZ?*Y"U:F>:X9]KMJZC7_7ZTEI MY4AIG6G)2'5C_7*K_=E$NFZKX(S@2H%("@'![7W>Q2,5":X(@I<3W+"4+9&T M`PE>-98@."(XW"1R7*D81J-*V=MN%*12\$AU8PF")P2WAPN"-Q/<)%$IA`0WA4K9)[A=4`.R M14!P/4=P/?'*BSH\/Y8@>$)PK:`&3`*"FSF"FPG!M3V58@J"[Q-<+Q#)("!X M/NXTBU4*'*E(<$,0?)_@1EX-*"H!P:T3&$@1/"&[FB&2J.@'! M[=+(JED@>'XL0?"$X+.\&K`)=+@B9PD.?].2D>2:L03!$X);!2(1F(5*SM.$ MO\4<7G1\#!&\VB>X(1N MO16/5'3M;4'P?8(7S$*3A,.U',&UA,/WS$)3<'@)P>'&9EAZQIZH);6>([6> MG.)@^Z1D%$'D'9%WG&A8!DD,O(;4E6,)@B<$GQ6(U&A[0Q(;.8(;B1J9[1%< MV-XE!+<+1&ITY[5<_$1+XR=HI"+!N7+G/[KAW-]XT15<9YP/<1NX!*"8#](#'`1KZ@F>R__=N-';M1=&P09]&-Y$3R"X M?W*\FS4:(D1,`1;77LP5AT'5\F7($;*S)YR*KC0:G-")RITEP?_$/JR=/RTM MCK6%-$13#XN@0@]!;DP>Z9\$QX!R\4R/8Z<[R=4P:W5-NBCGR?&L?/"*-J@A!<@(RF380;4=1U_^7!S*S\6 M%+@9BGJ:LH$)K=9;6$H.*&4;T9_%\<[]47Y)PZ*YM/9^YMX3<;=@783AYCG& M%.7[SB&J']T7=P&\Q=>#R4[Z%D1,^]Q`:02&8MI%HIY(WT+W1\]=_7P"^1%4 MH915K>>&/\'T_GSQ%T?K'=^]>7U_/7[5S/UB^4V59 M>??WSY_0[8UGY\SU4'NT.7SJW51AJ<]#(X"E8UJ:@*4>EMIL-3)8NB2O"5CJ M82GFM%GM82%-<;,$+)UAZ2`M73(/!2RM8#$[["U=\A,%++6PU*9+!TB7K4\!2#TMM,B@9+%UR0P4LS8']W1FCH7?P\NL"^Y5#"UA:P=)6 MB;6`12BQ=J'*#.V,#K#4A2HKAQ:P-(8J,XD2IU,56L/2UVHLG)H`4MCJ#*C:>SV6WYMJ+)R:`%+8Z@R0[O6P9>&4&7E MT`*66EAJ,]3)8#DL85W`4A5!SII+;;?\A@ARY=`"EL909=:Y:&L@-X0J*X<6 ML-3"4G&[G0R0=I?=!12-4%3?@3\8D.JA!2RUL-3>E">#I0%+/2RU]^G) M8.ERO5[`TJS$LGMQSTJL9:+:P4TWN_=&$7"TA&/H4LY"6;6'@U+19P%-2VCHE8<6T+2$ MIO;@J]="T@*:#E)3>132X[&*V/H/A<8B"<)T.5HI*;\NH&GR66I*2/98CO*7 M6^5/];.B?A3XM,&'8KMDL>&TA(9>8V4!34MH:LM5]EB?4D!S,#3#=<<6T!P& MS8!]M`4T76*95#IN"VA:0D.O-[>`IB4T]+IX"VA:0D.OW[>`IB4T]#J#"VA: M0D.OA[B`IB4T]+J-"VA:AI_I]247T+2$AEX']ECC M4D#3*;Q969NRQSJ7`II.,;3*0H@]%E44R6B=8FB5Q1![+*R(,IX$-*UC:)4% M$7LLKB@46FMH:NLM]EA@44A-I_!F96'$'HLL"JGI=,FFLFI2CQ68!#2=PILI M.37-4L]US<0)RVD%RX,J89:/**RU`V&::7W#5#:BD*9.Z1QEO+^MS']0A?_R M$84T'0C3CO?[@JEL1"%-G6)NICX[5V0EWNM)XJ%U0;?*P80,=03'ZA.)`X[IG$Z:V ML)$&PW2H>Z)-KHPX6^O5E:%QOU2X,O1,)%H74P6F]#"E=:-58$HWY$#C*FRC MB20.3WL-.="X0]L8P3<%IGV&'&AL.4UG7? MQM#@3&#:5VB0UCWA1MT[<1OIL_/-?=X\TX(V>1W-9M=-GHU,%^&$`D<$-*W^ MS(U;+EW3^,B`IM@*DK&DX.,#VBZ`,U1CR4:)%D`/+]$TVE0V6F%THX]'#_1@ M32\;@:;K0AT;T/1::#8`;5(^RSTZH*DUX6IRKS2Z-S^.#VA:+;V:@#;H1JF/ M#VA:7:@:CPWIAJZ/#VA:W7D8.Q\^-J#I]?IA[##J^("FU3FH,3(F@!Y^C\X> M'S8>6Q%6J]L;J^E00QACPTIT(8?+)(EUDQ3YW!NK2:*/!&C7HPIT_#J&`B:: M33E@$E/@>(!F)F`B4XYU'QW0K`1,:"<>'!W0K`1,*.=O'A_0K`1,:/O11P8T M.P$3REF!QPGB)9B(+5.S15($>+PN4Q[F&!9N7NE3:UTZO/ M('KR%[_#;_:/ZFYLFK+ZR_N5,__K[&[^Y*]`*/EX+M(Z<.>NMY2>_048",+= M!%ZU.1,UXK01@)(#1TI$"L!XEC$9?*`%8'X`-W/1)@-0?2%1:.@G`>@*, M5J!5`-838+0"I@*P'E4BC8YH`K`>52*-2+4`;!C`!HLX"\!Z`8Q>.KP`K!_` MJ'6`%(#U!!BM]HX"L)X`LPM2,53S1@'80(`-U9E1`#8,8(/U712`]0,8M;MT M`K">`*-U)TX`UA-@M-J6"L!Z`HS6940!6$^`T6HB*P#K"3!:'6(%8#T!1NO: MK@"LIV@]K>NW`K">`*-UC58`UA-@M#IB"\!Z/%ZAT>Y:`#808(TJL6,O:P%8 MC\%?&IVJ!6`]!G]IM*$6@/4$&*T>TP*P'H._-!I("\!Z#/[2J'(C`.LQ^$NC MG;<`K,?@+XU>W0*P'H._-!IQ"\!Z`LPN[#LD@'7ILBT`ZS%:3Z.%M@"LQ^`O MC1)Y$P?LJQO^=14`<`T)%H`P&J9U?=E;:)9_J*ZXHJ.**[(R6$7+LI5/&DX: MM08:X=1L`>>!<`YS"L6<2.: M8M\<`,VAKA@+-$=`<[#[QXU!('FHPNC'!">UNY/-+J>P:GN`D]9%O68XAZIF M?U1PTKK&U[AUS@2:A\>#:%UH$=%::A$$&M==A%T[!II#W841$01:7@J-BS+" M2Z%B!]&Z1B/@I`(GK4LVS8;04'TQCPI.6E=PFIU.(9T]Q1!HW/=HA%,57F=/ M,00:MT$:X52$G](#G+3NBH@@`A4X:=TD$7!2"?'1NF?2#.>$PPB?G6_#M)"M M>1D;G8(3+Y3J65E"@"/!>/PFP2G&-/7Q$6%,L5ER.:B5?:\&6,AQT-A3*M2>C/&PG<:3^F M>'T!P\XC_&EYLHB<_V8,(2H#(7,3[U*7WT`P=T/T@OB]AT%2-6J*16INM\1B[[$& M+'3-L@RMCXA9U8*X1B$UEEJBL/=8/0JVIAB:TH=$4`?A#^`NGR*PN'@!@;,$ MR5_`;>#.#[Q#W.Y=@XG-[WC10]BY[E5`J M",H^/-B#D7QH?NE#ZY=^!<\.=*>\Y0=(P,"91QMG=0^"9V6'*MWW(F=4:Q+6 MRB,$.W%GM5+)_>56^5/_K.H?"W#27>'10ULKO(30%L=`T-J?%8LY:`]2%6LW MP,^$U]XM"%S_0'>X>MSSI#$'D=052W6F,0IKUK!?EAHX&C+X>[5O]E;',2S# M*<-&ZU\6N#2)RYXF^Q:Z/WKNZN>3*-B`3M+3[!Y\>UYYX8_P33^?/$71^L=W M[UY?7\]?M7,_6+Y395EY]_?/G^[F3U!)G;E>&#G>'$[E'$O&2!&>$J3"DPEH`E!PO]VROE\C(3N.1PH=^DKSS" M(K:7'"ST+P*5^RY"C>5QH=\$L127GL/$W,-"OYFA@(4`%OI7W1].]%K2W[+R7^#:,PLO]=2;HT9/0-"O^]M971,H)([>:';OE;$DKO@0M(<\;!&M.6XB%U_/YA,MZ5L MN9TL<-F/)=/M#2OT&`DN])N\"GDA#2;3[=8J<"&-)M,M8U%Q6"EPV8LFTVV' M*^2%-)Q,MZ]M*2YBV]\/)]/M3UL1A!'1Y!PN=F%+(,'EL$:SU>(B<,D'D^EV MC*W$1:"2"UG2K3=5ONF+O.0\+F:!EHW&F)9S]K74V4[\6 M%XNDMPTA+E:+Q"35FJE&'U4_)X'+*#V'RG$1ERKRN"@%6I)XDG8.%QRHQ",5 M<6GA20I8\K#0;]\D7!92<^XC%<+QI*'3'D=`)>; MZ`D$U]X\`/`+X4>0_-"K(=#PCA'WG3.K9].Y8:D3Q&ZTO4G5^C49C@^ZT;8O M(77]2-T(.]P9WV*WB5"MNX7K+7NL_KTW*A0,K52CE58@5K;2I,E=%*&F6+IJ M]5B"?6\]W()@$H.P4VF:V04$Q30T5`Q?H+"'`LUV!(:E:[VV(Y@,"EJILB=3 M2&W;$>CFS#*$*%0H)#(0]A122Q"4F6I8IMYC5?K)H$"Q,X=BSB`&LS[:"$T2 M!3J=G-"U,JU?JW5:*%#IVZ3->@Z.308$K5@UL?(<.0M&;MU;<.ZJ5-?;N5'@64@_B,]5":/7:!$E".V]#+%E`.I6![ M]U[KH50$E(,IV-Y]X'HH]6&"$<<.)>4V>['9,XRM2@%*_&EX'88;L.CGM*AL MQ&V'#Y6HY4I3;X_]41J.]NQ^CB+*EM82A[`!_13C[5G3X9+5ZRLK\R(.;R!% M;-W0Z2/%/U(561`$2'5.BA!('2!35)NR":0.D*EA MZRE'`^Y6+Q7;'5]HB2V/)[3$ML<36A5;W^&RQ1E:^?3WX8$B?Q^=I/6&`*7: MHWE"OO0CPIA&5XV"SX>HRU-DE:`N/.K@?-@?A94X)R_'W9[E/&^PP<@C^$%[OA+$/4 MMZI#6CUO3HCM9^T3@Y%^W:6&7)'&&G("QB*,HU1GK(,1ZFP!8WL8$\6WZZOK86P.2`D82V"DW[J['L;F%!4!8XF)0[^?]*'71@2,)3#2;S_=((V- MIW4"QHJ]D6X?OH8#.6&I=I%&^AU\A/L_D/M/MV=&?3!.$99J%QCM`ND;FS5J M.;]12_U&-%(1QO)FC?4PZOS'5']?KX>%L?`"%D/C@^V-A;5/#$:V0N/JN3F4 MWSAA&!D,C:N-%YL%C'LPLA<:MX?R&Z<-(VNA<:LQ04#`6`(C:Z%Q?:@3CFG# MR%IH7%BJG4P27=_O[^ MT_4'Z>3LW;L_M`_OWGV\_RC]_;_O/W^2H)TBW0>0#BZBB+-Z]^[RRXE4>/T@-:_4_2_>7?[\^NOWR\_'+_HR2OHY/T>;B&N\@)HJO`6:)[`/'( M3<-=W7RY/[NZ^'S]"7YV[SZ#4/H"7J6O_K/C)7^]N_Z?RQ\E!;XK^>"/R^M? M_QN^_<%?+7Z2/E]\_?7ZR]FGRZMX0MM/OL;?PA\A?,Z<%43X1^F?FS!R']\J MEB)]N;F_E!3I3+K[_3,++_?2Q8P-1NKZ\0VM\=RC]'@+IW78`TM&ZD._N_L]/\!,W@O28#T'2CYW%_? M?/D1*@@/1^$\+OAF$;&O3-`.AUCU"DT_>54[&2 MZ-OIN1Y:=SSFW]P@VCA0L-WE\NU4NO;FY]+W)VC%2`$ZWMN)Y`=XT>C-@TWC M)#>/DQ\D-Y0A$:9X&^Z0;2_,E=+>"'4N1+D&YH M\>B/Z/MSM,A'R,#)]P,';A1H?/P,7LB_:_9/H02^P2ULX2(^#D^ET'F!^T;\ MS!SN:%#.'E9`6KKHXV3ZN;G!I2]`"#D3$AC.`D]U]Q[T$5;;SCQ*%__JPBUR M$T&*S0,`7RS-G6`A/;Q)2\?UT%O0T_%:,].$N^2S&X:(4LX3#XG6@Y]`FKM(^!#:"=?%T"/,,0XGV"R2%.L$,FSP M%P0(2J6#F->#'T-;)'0A6WF9)SXD/)[AA9OXQ="(>G'F;_#_?2A[6(@NX+N^ M/_EP/9Y`V5%4"D#DN"L,W1*J8J@6,MIZO7(BJ*B?8P6Y MCN^,(L&80P'P@Z+N*.&?&[@50+!3DV'[8@EM1$B2E@6I0YO'5AJ@SL_N'5@% M;S>$+06A3DX8+9D9>AMB_24J<96HR50PL.;>3N,\!P4<"+D'KK?!3T'UOLA] M]]I#GV"3_+0P;80BW@:'0]QYN[D"FPJ1:+*1*/=;RF6(\ZT,L- M%N@R?BP=5]NG=OZO=(=JAR.FDM[[R,HH_=,'?X$]9[R#?']R=7'W7KJX^P`W M$%LQL%U6:F-"M@?E>P1+])YC:[C26Z`Q9P;%Y/<0>P"7<(!GR&*M/#8&)`0* M`K1R8X:%RR@5&"@B4'>CS0KI7BPBSH[[H9T#GU@C,VX)H.D%+>@W]'>PSGA* MOWLN^NT.#1K"C?%_-RZ4P,33>$Z,[&?G+R@.*2%CVSH,-\]Q#878!7*@VH>6 M&3;$`73'T*C.,YH+UE7P^R#Q:U9NO%NXR5`+-YRO_#!QLN/-:(G>7/5,_)9% MXN)%E>HDV3++IA-`:?X1LV\4F2+?.^"%,QKB@?YD2@*8HV@TAP3:K M".VCFQ5:#MX`49P-C11F*">VO0/D&1DL`7B"2"%KZ1IZ_<^`,YE.;:Y'/_;V MTVU(4J&U"`5RQW3SW&)=O-A2%OQ0\L4X5O'L!_B#U0;_:29@P7:YU8.^$GGZ!/!WWM.58RR##T_$AZ```M:NXO M/>R%)SH'?FF^66U5FX>]H\H5WKEH_X\*WH,'W5!L&,,!8C.WC&32]W`1X0^G M=7]$U()J#RX*:KK=7)*_"I$]0&2O'.C,_,U9;3`7[:RW:R^,@@W6TGQ*<":: MD)6)[:K2*`<6'B=\.DWW9;3%SH'[@B-N>!]-/X>.9O;#8`-V&U.I7-QC20J" M-R3)+RF1>WB;Y*RA3_D-;UG2(X(0CWX*Q7GN;,)TTX6?AT]0D4#K((+[9O0F M1.6@W_!6.SGZ`\/(I,I!-D.:&VG1.,6F!4R(%8;>`?+J&_`+4#9YK\"OK[ZTT`60@DWL#6[D*+ M>D3&V6G.Y,#Z?(%/>%:K^%NI+CU-617:2LCH"3D(\9?!$XK[&/$$'S M*':8T.N!YZR0.W,:G\-`"RL.4,0S2F0D_EL<"T0"LG:@-Q++#32VEBZ*<"?J MUXT?M&7H&+WA5ZQ05!#.X@'$$X8?X?\'.\Q:J>S>CS&/-#!QBPX&`NBP(W"1 M`.&@$T?BDUL`2!>`!0"[WPNDMN<^-'\P"T)!V3PC>Q^@D#`TPR$K8Q6/C0\4 M@H8RY@9X#&1S5]@[EYE#3!RQ\^"2,V^'@ST[_X2?@^(7P3=HBN$H?VZN- M.0)Y)G&X.ID;_#V.TL='R8&#*D!*^#PJ]IC0^@(LJN'F\1&EW\1QDMT(\`]0 M)2`:0%%$,7`T5!H'6*3';,@702'R\@5?0$T3NS9^L("B#O0'[,)H!7!CUU&QV+?Y\%GI/W_%7^P3O*I4,;`NIK1G3#U MXG\]`:<(/QA>H#6H3+FU/+$E!Z6D MY!V#LUKLNFC'W4#6V^V8M2S638>R+V$[KM"D,\EH(68[SH">902FPA=7F\## M5CDVIQ[=;]A"/W+>F!'SQ3ML@E&V$:?G?7\%<9@P25CR'Z5/OK<\^P3=L(5T M@4^<.?)PKCLFR<0I,"<_$&7+Q(DRFBF?*?*99E1D[.51+MLH3ZYWCCYTRS^Z MX=H/X3Q3#%89#$YR6^FIM-I](4D+B"-;3V`5>^\;[/5BY>*LWI!/CUS_3&CA M]0EX`+GBZ.@_PA$RE..V!'$>A1O,-\]QYP_TP0+'XN*SS2A[TA(G$>"4!B^> M"HYLQ\>=$K225V_XR!/S&'29<,IW,L@F-:-?XF!=].2C5.4DS0''#_%"4?X< M.H-9!RB6D,_7`^@P)D[#B"3@S)^D!V>%T0^?`)P,3HN`:\6!@V2I.(J86R`. MQ/OS.$"0GOTF:X:@A"Z:^HYX(H2`2+\`$;/XUQF$$8X3Q]RZ@]I M0'CMX('Q6Q..1&GXY8R*/HZ9[%RZ\(KAME/)?91\+UD/^A4OSTOF'\>2\!#Q M@'!E<<"[Z6W)F4W\<&:!NS#8'BG.$^E/A'N!-03`%P&0>.PR>6)Y6J&:<^D[ M]Z829`XOMQ`EPH8#DW'8#%\B6*V25V>IDQ`]>372LO$%"$B339*24+'^HK:* M)>S57:W0LJ!#N4#3RRXO1@_E_NZHLYT]I,N'9"[I%1*G.-GVDPK+7@KU\0LZ M0HNI%B>8>4GF_39?'UVK,*X2@#P<+H;[UU.2028!#_'/ M'4J_>WZ`?*O)I_A*`)9I=)<@?^2TU3:)?D89+YG=S-EFZT$X'Y&[M?1C71/X MFV6,4^;[$8A#X`&(`_&)MD#QS3A??)\[OJ\*?^*T^&B78Q=REM5=8HG>H1L>NSS/RV^QO84X/+WG]?W)W24R+J'M^?B8-4;? M0T,*P)_0-RZ0H?K%/XIA>!(Q5):^OX@? MA\_'=T9P0SF4O?0-Q'M1HFV0S1H?27_OOOP`M3^$81YEO"5\)N:L<+)PDD/K MHI^=T$`38 M/=M]LS(E'EG1<=@5.1#>!HL2MA7!,[H;';PE>>D`NW\/('I%N;GUN?/P?0]. MDB)3\>*=71LGP>,47^=;ZODN`#[FQIF&2?)]D@.@[TC]%)T M,3,F6.SGKM=0!/"0B=42&U1XK)TKDEU?>A0^3TR=]')",K.:;.._8>\:GPPC M=G%VPX4H_N:&Z(HGYAIH%4,G`E%VYQ(L4L@R6"5S3FSQ[*P>D(Z+$Q!*YW*] MPSTYUT]\,_Q1FL+I(V6/;H'CWU+_(+$YUZL-WDR@9M\DE_7B/3ASU2'Y*B1F MV?0+B)>GHL*OX\.D^-8#NEN_M4/Q)=D`H'2%;&H4^(8N7L:41KXRSMQ`K_TG MG%BX2#*E1'[2"+K^DP]]XUMH0^!R-U/1]JJ9:/N=%H8WS!OL<'-=@H.(UWZ7B;]7P<`,*D<1+2Y&Z&9TF37.!T%KA(#X[0K"00>TR^ MES582J^][;Q&H5'[8.7K,-S4<;+TQ8^D/Z&YF/#\!#@[Y5VGP+IN3(H,YX;; M'`5TX/Z&XC`)>\>!@%=\!1^?;@MF/I"940)X1TY>.6&XS2#A2?=^2&ZZ%Z)5 M.(A1&BC#K);>N?CZ)@@W(JP$G//,?SU"8&/6W4.1X#+ELE&SM;CCF\\H+?X0C_UPBTW`\ MY=W?/W^ZFT-]ZYRAR^0(NQ/IW0%+,\HF5;$618V;/*@&R5IVU<>AFM.,7!'Y MO:D`7V;@5FZQ7H6J[O5I\KL$A7H,B[%5BM5V`:VFR8%6BE4RE=@;)= M@2:W7X%I#;4"8BY"':32%;3G(D6&T`VS!%TA7L+6($$/M5Z"HN2:[/8I";@[ MA6(B\EE;G-5U<64JG['%:>6SZJCR65M<.5N2JOSZU>14_MGP.K\+1"4ZGS&( MH+K6K1Z,_/U!QEZ843(G$O7>M)*B`Z:90S$>5,B$2R@H\59+T%3=G,VLP>(I M9$LHJNI62S!559W9VF`!%<(E%!1RJR7,9--0]>$B*H1+*&CA5DM030W*L:(/ MIH4)UU!0NNV$`>XCJJ8-%U/1(.V6X2FJK)F#A?#)ES%GM)MMPI])MN&,=`JM-+I$.G==JN8Z1K\=Z#] M3R/FJ#W5VVX5BJW/='DVH/(E7$91^[84#-G294-6!M._\N[?3IHW]_SX.C1<4+.F\-7EF#V?+-DZ[J%&)R6TH]F!&N"83 M3+R@1$DG?@:W,7THFT\C8)2BWB2=N&EIIC+4,3)6?4T3+VA*THGKRDRUS8-. M\+_X$?BX[;I2:/Q-^FV1?C5Z^A6%WM\SU/O[_N;#__GOFT\?+[_>;3-9I.>\!&N-EGG%:-^P:O49;F M=P;J&X'^FW9QP6V1TS\KZJF1_!G?:PO3F@3[:<6YFWBY2W9PG/4&M=@,03*L M>9HTK&@U:F5CF&20_9M]N/:0ZV%EEG3@P$7$T.]QER0WK4CTZF>'016BDJ%0 M205GMX"XF`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`P&A0!1\S!Y:2W'*ULE8(3 MUV2%3.6_HH*-#V^I28AJM05O!5[`/(0,ME?W$6RU_6);D".[G>R[!;D-(RE/ M%>N;=>#'%5<1NRKRT1L/GYTW0K6S-=UW%F51_WB^=_;[^=TYKN_G>Z?HJ\AB MBSN];QMX;\N:GR>[ZQ$46S]/:B$ MOO@O67]3K304_.%G4;CJ=?"M](W:?[FJM MSAE]1+5'=X9)7+5P"2%:(A\)^=BGFJF=*M"4:.6=(*:''/D"92(L,UR2V]*[ M5R%+1CO54,Q,FYWFZG%#4T8]U[6=2&T'3,J-QZ],!#`>>.'@G33UE,7>MO6+ M'6\7:JFW)_:-5%)[0C]Z>^*WS>KML%B$4AM9SL8H>XE"I$,.$(-(S:+](.[W M)W?0^X:ONY#^2*9V\D-C_!N'U8FWW^++=_OO[O7O,Z^G'#'9$F`;.LG_X7W7 M4'JF.RB&\V*SA%PK664\F=O+RZQ&.8W^;K?Q/=:=?@'.OB>=1)*WEA="/GLZ M4>^)[.L.O.?V>"2T8^ZF<%Y=J#&N[;I=URXT/CNUDQ.$O?>A3061YCOCU#"/ MW#DMG%0.SA122PYHBC'5<(!IFJ>F.:O#7SYR]#.G38]N`/7W_VZ<((K/ZK;U ML#CDAKQ_>`K=#$6#YK^FUS"#51.[N,X?B>5ZEY3M5O'XWT'E,K.TXV6O78#2 M."WAI\1)5,U30U50,(+\6W=/I5G2M7)#S2/_[GQV;XRY;,*D3<=[U'+X[&Z.NW@DK\!RB`3EV5^`%5K!W%G- M-ZNX.1V`=AVT(L]PT[=\MZNXNP^>Y>GN+"0NBXV/QB`7/,=__Q$5W8/LC'J5 M+*0W%ZP6I[M"]2\^?-FV_8=JG\O_<2I!X_H?TDK1*0LX%*_8O"Y:PHI];1L=`A94JHE=0W,_J\V9B1V\^ MAP^X$7XHCG*$9?'W5[`7=B]&OE246W)J&%I#(%[).F#2]XA%3FZ28^63'TZ+ M#N$#0!R3]\D.[Z+.WJ`YFG^%@]O?RN?%#W$]H.S*9^ZZ51;"3.K*% M&/86-SN#6QEIM_'G4EXM^4F3LRE'ZT)`OQFGBF*A(#FF?-RJ M8]L_!!],IY0Z+9W`=MO*J*'*/*<<.UNS4]5H&<:M";)860[Y_@[.!64:2]89 M3D&6;C(=`]+@R@_G4*M$N=!"%H(4VF1.ITFS.O31'J7B,$F$.Y?&?T-[%ZX, MB_KK?,,]"E=O**_"TLQ3Q9BQIY_9TMD=/1,L^UCNRTRG64,(&0390VUD%LGG MLIZ-])<&IO?RI9I'U8SLJ)A[2D;..Z1$`\^,TWPOD'SDS#*$`YNP"2(Z3I%* M]HDRK:66),,U89#CF.KHL0JAE4_-W$E6,[S90'8MT-!YE4\U_8CSMQ*H\=$' M0B&).->@K>DXE-\":F(XT&97(G:=BZ$27JLIN;L35VE7=M=SD@_0S2&[\09. M(5)S=XC4[0JLXAVBP6YD M5J]G[Q(4P7J([T0-O)Y8WFZQ68X;<(7QYU=^\`'UR2ZLMN'K$!`;E\J1<1TQ MO>%B&(1Q5@:JG53*V1]E2XQ8W/>*@,B*I15O#A/-G!J!#'D&%V7JLW-%5NQS MU;!T8[?*2F8Q#M5B^L`Q.M%'LU55,XJ%.!@CD!UKDADA@?0< M@?1$'\GG%:,T$*BL)!F;]#%[H<_>*/7T47F@#Q(PPS0(Z6/DZ!/K:32&7#Y* M/7T4J]+B8HT^I/Q33Y^6_,.%?"$;QC"T3O;0+*%/7%"U9)0&_N%@`[/1!F]8 MA/HYN\'OJC[8\09?,DH]?6:VKEI&L>0&BP32%:L'`I6,TF`!H7^*%>G8HH\A M(P5D*D0.QY[7I26&=*R`2D9I$#!%@_\42Y^P12`=>@>&89)8B'&<(*5/_)MJ MQT/(I8,TD`>)UTQAW$)$U:G(Z6/DZ),XK(;:B3XF(A#CU('.$R%UZOVO#M3A M8/>R-&+JU$:P.LB6K"J:OE?MC37Z$.N>/?JDW&-UU#T&^]$-M.^0DJ=VZVI/ M'EN#K@7CQ"'GG=H`69=]2S/5&=MV#Y(+U;`TTD!KM6R5CM+@N*-MG6W5@^.L M^7AH1_XI':4IL#%3H;?&!8&(/*]&`K7UO-CWW%/Z$#E>C?1IZ7AQ$)I/Z6/W M0I^]49H=TZ'U\Q?PBO\4-I-F^U6D4RMBZ40VH9+H9?F\4T1>F4'%7"QHV3CI MX6F2!`E)@_#U0<*6JD;13$VQ#.:(8LBH,#04`,V(3^XR>W"E$.DY(=*3,^.X M6'354`U;E6FHI">F78B#_Y@D\EUN\S`:"57Z6&+U*(:EX*4>8//LC]%CJ+ET M\J/1#.44$-*L-BNA-7Y*]-5-F)H'+OS]K6J2A=-):5GF=2.1& MI(S1Z@S1RE'&2B@3]RVL.T,LZX_,.F7HG!Z6-!@U3!Y(,_RY847O588I0^O$ M<)\RUO"*AL@7R7^3GG]6TJM#4U1#:]ZY\S,>F!ST/;.2%@^V/&MVR^K(@$#EJOT$ULQPJ7UW)Q"UJ9];W,HO9Z'VFG^>9 MW31T2QEIE79-/Q*B?&S252KH7%(?9Y7]MB.I;=:HS&QM)"P-N:;K4V:5L])5 MMFD!I MW'56<,IP-;A[:I>_>[@PP5V$Q2KIBA%*<)W.$J3EQ)^=OX`$ML*'[_F'VP(<<8D4Y_$1 MS",\)IRY'Z!1XSOG^/8;_#Y(RLNO7.1PDZ$6VRMK\74[/'M\N[SBF2A7 M0B.NJU)"'?181!ZMN-A&Z MP[6`ZWKOA.XUN[RQP_X&C9V M7.\V#^$\<./=Y\H/3'RO!>UD85++[3:NK7:;%BJYB"P9NKCH*YB*?0T6'\LH M,LI+).W`373.4S)DCQ=W628HDM%N!*T5^N,E:'+TJ-1UNB<]>]P;I"EN^U_O M>B4-^]1.#BV)J-UT:MF&VF?'2>Z4N3D+N1NUN0^SBIC3A3 MMXI*X%#38G_$(]D($>=U(FK#GGF"P1N:E&A8EX^;Q>^6\`)/EXVZR'NZ3O$VJ2FC3%1O`F!$C[ M`*"/_A;73[Y^?@8+%Q?LO/#B@_'%1:3H][ZN0MK@N`6F--4W\AQO.`IHRKRV M0[%I]@0%.,3@%)V./L"I=V0$.$3@[-O1O7LVQ2Q=$V5-V6;D&-0^#W' MFC`H4S;1.8:EZM#L4&$1L/0B+5/TF3B&I>H0K@]I$;`<)"VTG5C5TG13)K2L M^UOL<0!:?E[8^P%A_DZ/+BLS30`ZG(1.,AC!,2C\GGI.&!1ZL2&Q@PTL6XTP M]G)_D;]]ZPY=@TK>JC6]557O?=,Z",<#WG=,P23N8#F6N`67P!R#B\P=,+1] M*E4V35GON#<=L-JCPO0H+'CN8*%C_'$A8)^=8/ZDH1(SZ"5@47Y\++<[DF\_ M+*IE8W6SY?+%<>!OJ<,%!V3$EF.*R-TLLWHJLV&9,4?F]G96,YG'M[.8(C.1 MU51/U596DV6I!K%*;[LDCF'H8N@TP,*"H<,4D9O,EGIZDIHMM#D\&0S_^;T3 M@L4'_QD5GL$U?JZ]>8`O7S@K_"/\.QXT1^=.(R!K+EL$&=545`@J$.;M0B6I M4RF?UXY56\C-*`8(.ZTG2UG<]OX:LGRP0=^,JQBB#$*$(!*#>__RV]I-RBAA M4K9Z9-M_8;=>0VZB75,7AHJQ?KDU_DSITVJ2M`EBY1:A9^O<5A(D5PXV;0-H M606"Y,?BAB!V`56+@"!::25N>X]#K"D0A(1#2`DR!0XQ270((4%,'G6(79![ MF41D:GN%5XS%#4&T`IN;!`0QR)C\D@0O;`(@X`@==VNJ\;BAB!& MGLT5E8`@=:7[J\;BAB!F;A&FVEA6&U?/*ZNE9Q8(DA^+&X+,\FQN$^@011^H,&A#C%D MI>!_V`0$47,$@;Z,%8]4]&5L'@E2V'9-$@[1<@1).UKL;;LFAQP2N_]IHS+X MDTYBJ=:Y_U5C<4N01I%I01`.12:6\\PB#!*"U#EW56/Q0A`[OPA=)C'=ZYR[ MJK&X(8B:1]4DX9#:IC@58W%#$+W`YB2F>YUS5S46-P0Q-.+3WN1",5"<)AB"`6F:Q;?ZC(5(W%#4%R#J!AST@B\W4B4S46 M)]ON'D&LQL,LDWM;;S[=TW(6B)98('BDNK'X$!FX#*6P M"!('T,X1!`>1\$A%@O#G`,)EY.*N=AR';2)(O@':+.&00MRU,!8W!%$*BR#9 M9>HXI&JL'@F2?"DI:(^[S5ULHB<__RU+F):/;O/29"+SO2DC;7^4 MIEZ#\3]YNK5CV1VF@GVJ,2K],NGZ7)^EQ M7TGUCH,H5Y&53Y-P2BO"53=4;4LX_2"1'9]PE.2UHJ'70(3+]18-;S-=40B^ M-[(24TLI4CK3P=8_YB;(Q/JQV6@:A.NO/:C?'X6#]>.C@6R@K?NY_/XH]-:/ M6QSM%$@-!0K?A/-7\=&Y'(>ZU7(:..&9_QB+?;J)J+'8ESS89/O5KKLPOT%7 MKE7HK8J5IPI/D[LI/%,U*C>"49:OM%C^+I=-4[HM?P8?L0RKU^7_X02!XQ%2 M8/_+;/+`_CR)Z="L`0O?'-N1(2($J18\A`JCNL/L4`'-W-11CPW%+FYJG;;% MZL$XHXG5)TVJ!J-!D]O`A?]328CLGP>U#J"G](\U"/Z!EUK3!+EZ>MDE?@/! MW`W!S6-2U^`BDO7;I$#!M??9>;M_]>^?_$WH>(O[)S>(`$@BBUV>K"Q3V7]= MROP>NJWBT&768]-+Y;5^Y%C$XK*FXQC$HEYGT;95KD61TR*&8Y!*WOT[9%7I M[(XW!D=EST2Z/T]G8RSW+XU#2;A_+K(_BF:DHZ!"26^*WH+C2)X=R[+0:BA' M,F\6J#8A^X(>P29B8]`A&&T[0Y%U>S8!R9R,N4&'7'1,#D4V:C=,.LQ5;W>0 MCS"BY:')]98'^2+JR3DSNMJZS4^.%M&H)EOSI,IB>%;&6# M)'7D:WRLLO5#K[T>R@_)ZN-`C5/O2"Z>7/%C=,A5X@%4GRG>A4QT,-#]&A4\E9=J4V M:ICP.`3J&'.I)=@HN_^P).H0:6DD$?6=?S@2D<57:BG2:M>W[6I3FTDQZQ9/ MJ2?8"-O]<`1JC*+TTC->Z;2!D3!.VHDIYJ>DY.@1KM^\WS7E,2G5T_VLI-Y(!,#RA.@0`&@DU@ADP M+*'(0@"U=.G1&&!9]KH%`>HI-XI5,"R9&L,`M13IR3;HAX]4:%O([:V#BL?@ M$DV3U,>5H=R47&3A6/T2%7:3)R!SH=Q%8]T*EC M9*"6;B,;!D.1J4-TH)%,(YH%0Y")+$)02Y5VJ9Z*/>-2[+I%"NH)-ZI-,`21 M&J,%M?0@M@C4CEL<"0_]YG@;)WA3S7;Q@H;'1@P7*$T60]> M+N`WI-EUY93=Q?UVBYJ>FZL,'N=^FF:\YB4FE#$ M?7A"323R/BRA:$?@&_9^EH5O,M'X8Y%D?QR8'97#VZW<-C M=0E02XRJ=C-G@W+\-PP8A61\MPV@3C+:S0-FMC41^>2]BP!U@C7NFKWT$K!* MO6KJ#%;G9;<:8L2F`FI%LGN79320U)#3@>(&!4^!OUD^76R6FS!JPXTMQQG- M1BEIU-9Y$2R3=DI&S.B$G(II,RHAJ;=EU/29IE;Z<=,2]^G81*.2D8ZEA#C3 M*.GDQ0AG-EA0G48;TY@R;4.Q]K-]#UQ1+8;!^HI$\^Y"I08. MJGF&I@SQ3VO@'(]!4MOQ!",1&+45F!6PZ>_P@Y*&SNY=76>J#9RJ[ M-#?L[@W/C5BKH:+](O'4NQ*L@9.(&G?3K]Y0TGZ1>,YC4HK_>@X4"<5W;0=* MA*)=YZ&T_2(7LL=[X0=*9&HR#?HI`E'>?K$?/KKQXA0!52&J!$'Z&(-%EDFG MWI%S4]!A+U99)YSP>G?@O`D&-3'R7@*!")C9*,+,O=;Q7?Z!"I$:#8,"* MS#VQ4*9U8RN#H.$YIBV"AKEWI5@#0S4\QZ91T##I,4DU);M@<$)-Q3(8E%"L MV08,"]]TS(-!R<2&@=`/'VEM8P9-#W)A(U1-OC/1"-FJZD&VS82J68]+K2E: M"@.2:FJVPD"D8M5:8%,&IVU>* M-3!5PW-LF@L-DQZ35%.R%08GU%0LA4$)Q9J=P+#P3<=(&)1,;)@(;?AH#;P0 M7*Q6_BLBWY4?W*X<:&``+[I8PO^Y`EN2$'P3E56`^L>P=`-I#+V>&*@8@Y$K MS6!@8J`QY/)1ZO8UPU"475UI@MEFZ'#EN`$FSLWC5_""?E@D%;P5>992#].! MZ)N5!2H.+:/2N-4?+C.#D(+7`E*#$8/'(E"#$(-ZY4HKU9Q$DQQ\^5R66AJ$ M%$U[9S_EDGK`/_W;!__YV??N(G_^UV?GF_N\>XOWPG/_$>T8F5K+6CR>>WCV?7_8PV"?V#'.4L)]>07^7RV1XKJ*9,2PO7( M"!%_CQ%"Z`8)(>(I9PCQJ^]ZRP\^%(_`NX>S?+^"7\-++_U+WVS^RW^NHI_^ M[>SLX\V'^S]O+Z6GZ'DEW?[^_M/U!^GD[-V[/[0/[]Y]O/\H_?V_[S]_DI1S M6;J'%F+H(B9W5N_>77XYD4I4P/W7=]_06`IZ./GQ+,H\>;Z(%B?2V=E_+J.? MT!P6[@OZ44I^EL+H;05^/OEX?7?[Z>+/'Z4'M/J?I/O+O]^?77_Y>/GE_D=) M7D1$T17@;-$%EH\$+;3[[& MW\(?(7S.G)6[]'Z4_KD)(_?QK6(ITI>;^TM)ET MC'>'DN@AD-YM!R`=K26%^B;'_1.0G/G!>XCHK.&$GPL9X M*#TY+T!Z0,7WU@%80Y%;2$X8;I[1`]&3$\'_`=*'>!#IU5VML-"XW@8.'DJ. MM$2BACY#LG;^G\[S^B?O(5S_M/OI/C/`$WS&]>:;`+TGA*MP']TY])JDE1^& MD#Z.MY``=!X"%\`!%Y('ED[DPAG.G?!)>H3NA(3D5/+A5QR\64B+31#/%4"U M\@)6_AHM#"UQ":KF$P(TXX4;CQ`XT(&3PLT#VFLC1)^%OWF().?!W^36C\?X M=\W^"4[TP5VYT9L4^9WH40K%PI<\/T+T66T6<#A(+V>!0([_C-%X=I=/D12` M<+.*8E*@^<%Y0ISA_S_"7]T0ZEWX]LAQO>CM_&CY_PX2$B!J`FQ6G.8X&3'B MHS_?A)#)?"_E'`0=8D'W>;W"H,`/=L"Y$(2'3>AZ(`RE]M"[X]A.A` M#JP050_B*$6O8`5E&TXF>@K/,3L]^EAV,3^5;!E;%G.]%<0AYL\="(@YT0A; M_9#!49A"3PT,0`7\P*0^**Y!@L09">/EKY;0"G>UQY>$!HD MVM>84+DAZFQ?EJ%1^M[*UYWNZUXT>_0`5)\;R-P@CK/`AP+)?\!#))H%DQF7 MOL2#0/;#VF$!'C#3O8,/@/_=(`T6`D@O"4[4$W`.<(MXA0N_`62#<+]^`CFD51XX6EF-]GN:OB=,28A@BW+Q,>Z M(=R7[N2):D!:"$3NOS(Z$3$A1!JRK(L!@22ZU:L>;+&G`_5M8F"1JMH$L4WD MQ(P0LS%^$"2J-C-@UMC>P/]?%=1\=G*-MAFV^A?2=^:I/)-/#=LXA7.-D*B% M$8XCI)M>K,/AY]]I\$NJJFQW5@>)S0OBR75ZNH&_B`VFXNX:6^N_.1YJ-R8I MIQ**+FR'VMY=E30Y_E,K]NV;@PHV%1]LGT77687^%F+%,DYE6=[Y2R`YM8MW MQICKD<[Z3CG5U1EBAO+OOB9G?#E+%NMZ;,(B70W?5X9E"3,>K7HJ>$B)%MES MWM$&2$C*N\T<[7:/&V0!(=\-;^)^SJ3,;/G95R5>5;QGH:\[$5(@^&]P`/CG M1S;_W9V=NDM\O'6O2^EOR2Q\=*8=B8:?IWL5S>/UYZ+HEB*'6?FQ5EV MNU:7"LI<1/419*4D^?#P848LB)3.-2'9X6OIB;Z9W);#AQFK?I)B]T+8O208 MQ@C+:[DE!LG(8S$FQLA(NU23,E..0LKY+.S$&!$;TRW[*?MD][.CU[`D_OO- M8R;;X`JN(&D:%=MWV:+2R4>WL?._RVR,5+G6HAKJ-2,6F;9-7(1R#YZAEDH) MOE)A&>HU8U6_MDV-`FY4Q6X$W'@MRSU!&'@L_CTQ&&B7&%=L59>UF=!CAR/' M9?7SB8'0F)W:3P<5FY;1UB0TX86W2"].9896BF.6@4#Z+*3.S"`UKY09 MSG"$UO&R;<'QCA-G@6P=K9M:,HY@W=`E6`<[I)%@E.T0>@0CLQAJZ=/*8M!M MVYI-0#*[[=?U=*2^7],C5^/.6DL9TITUUWUS-.:J#CZU&X'.SEE^DI?K;7+0 M*FKHF;-UX*"*K"J:/M/3P1,+Y[>-!S09OD&M-'EFR.3Y'2ZIAO:#O0U2V2*M M90)AR>*D;G&R.E5_465=-6W=J@!JL"73!;7:$QCN;71`+6F3(^LZ/30;'81) MH=G1FJY%=PQK>G*@=+#8&T&A;;%/"A0RKZ`6@W9U"61+MRR*V]AQ*;YNSDH] MO/2=E4E!TN@0U5*?U"&"$4-*"D;Y0C@4C_]FC$P2$[SS4B0%" M.Z-5U6W5,H6FZQU'SC-H)P9'DSG?3RYN;52>!6'23'4VV[WPL_-V_^K?/_F; MT/$6]T]N$`'@5;Y:L;:9"X0(]O:^RIJE_1.+,\%L6:J853<*1I^Y2VPQG[)[I3!_^B&<_C%)?CB1R"\==Y0(0OX MO8OY'*JFQ36D'!PE]D<6W9)]^GWEB!D_!CX"(`2YWU6/@'`+=[[?5XZ5_F.0 MNH/]+O?XH)UJ+M"$X)EB5M!$X*&='Z38MJV3FC9"-1X([B2SA28"3J/'V$O> MD%IWD8(9>3-P]8OVV4I6!P>BIW>->5>@KE;(4.NEB68+R>SI7:-=$C!)4_IZ M6N@QP#A5CX!K0*;H`W`+"'6K7];MF48:[!*JCAS(25KXW,)!QZ97Y#;90_2E MR42![4RVTF?G#7ZZ+4%>F[0TZW`;H,?WC7@CP#3;W`CH<ES;XV*/"=*IWA28!#!3O#'`/3#4;PYHBJ4)+3@LII.\1<`]+$T.04^W M"31DXC,M8+8V,XI.R&AZAW&2=SVXA:,QNM_/ M'8\6L7W*LG3E!U>X/>==W'`[O/'000)ZEY(F`>EVV]L;748=LZ(J<495EX4- M`P6IQ'09=;2R\`-@,*0X#(_!5&K,,T_D*=2E9YK(U&O96[8MU$D1A$D4QF>: MQ(T692_%]/72QH_C<_=GYTU%8ZOIV*JN]6`\-@\[8NZVHIF:8A$=AG5:VD!P M'"`*S<..E7P-L1@`AT'%@@(.D\R>9I/,D\N)9H_,M#.=-4U1=5D1>F4?B>FE M*K-'Y$:#LI<$9,3D1E6ST'&9_&8>^0\@L"&X=CJ^(K>N*--U9$A)@]24D>TL M%O"W%`NCFV4I6[*N=@6%:'7#X7*`:!"-3`>7LB`E44)WUV7Q#DC'W-U:@%BT M-9DA=H=\W$9BLV9Q,D%LLAS;6MJVO&%GR9IB"V53`TFG%-EZB-@S0)D@=9,9 M6D]54C-T4(NG-<]_!9$;X//UFT<=GQ'?K"/7]T)HX!H=[,\6X\5]RPD#:+6= MS]O?6B--5&VWHK[IWH+M6XQ'A^XE=\KZ)/@PC#XDP3M&*&L!8,%J9(*P'6*2 MC80=VT(;.X?G*<.'FQ66[""$V=U&[K//2()IQNH2Q2$H71>74# M(D/*[YV''LO((^L%WWE9_$,R23.0;7)/SCADE]RT349H`)@V42/3(U8Y$[0K MV25V4Q"QLWE9Y/N93E2$#-*2,<>\6D-\]ZG]LH8``#G^DG^1-&K;(.[D[-.R0E_;M&4LU>XD?3$%S3/#2##O$;;0( M>[DN`]F9K&;C8.Q\XUVL`W29TB#C);$!ZI)M<;A\=TM'.U--LVS:G)[P3S*ZC0[@FHZ:?7+D> M]MVV7(>N#JNY]#JUBR5#,,RHMR[(Z4JPDIZH2\Z@!,.,=W>B![+VRK0#D'6B M-L\89)R@_4.;C-1O+4!;B*SP"N=B/DGKB#81Z5A*:E\[>EN>_.*_X'`1NALK M7_G!!]][`4'H^M[-8ZX!)WQ)>S.J^^@CIJ:AQ#12++HO<%B(R`6A^^ACY:B1 MM70[9&53P6:2R6H\$'UR*6NL$YUVXMI,M\F:Z`HU-,D$-M9)WF2U]I/&-K"A MU%D*[.0E^=NWJ;5L'V+(MAMZ1"M6P?^T!*?=Z@9$IH.DM!MZ+.-U,$@&%Q9* MD$S=9F60W%.V5ADC-VT[U;9MBZ@^RQ%KG&F;IXP1FXYAVN:`='"^3VJ^*.8! MF75-8W!R&-VTC#Z(2L[(36.P?@;=-'\6J3G1HV>Z!)S@H3,]`M(^;FYQVLRC M0$_RD)D>^9KLH;Z*UO6Q1[=EPNU=!.602P7-HW!B_#0OI!_2DK-H\RBLFT#- M*V"5IA,UA.@3<8+&$%TB,FP0\2O>DS2+Z)*0/=.H/W9,BG9\!',\WOV3&T1O MCVX01O>O_OV3OPD=;W'_"E8OH+*?[JRU,37$6\_':VLVLW75,HBRP898^3A8 MD\K9$&^E@W5)G@%9C:@AEGRL($^R(=L409I<.[>I@42[&9QA&+8J$]5B%@JS M1YBGUVEN:A`U.13]]*DS#)/4H^!>_EJW&!GBK2-Z(";ZAZ@7S!`+'P=JJG*\ M7Q%^%`=D#(S'%.?Q,1;^!R<@"?^#<9!H^Q^Z;=N:)O0E992%^\$Z1)3<#^+S M#`;$[[,3S)_B%U\57XP^!<#KW_GH\Z7GBB%KI`:IEL,7_F:?:7(\0J<+7AK\ MITU@O,^%CP)T2QGN\Z5T@"Z[+]9F*^USQ<>)<$>_HQ9Q5OR."4'4P>MHA(@% MKV,B$)'Y'+6(M"L&K]N6U29&(Q3EP1!W>VFC)-GJE)!./A;TW'2+-'?:.I.APY?FLEE;WP^.T,$W M4`VR8L_DB^F3U,2B03Q6):D)NI/K:E-R(YF^RR>LJ1VF7CL2KJ M2?05A&LPC^[].Q!%J]AZ6P8`_Y`65+!:QV^[CCQB@HA&;!YW7=QPL)`*0->1 MQTKFT(CZ;'5=%>]X3#+Q@F5B3RZ!@E5BTTZ$4.V93M;3[UAUS023%E@E=6,T ML)?D`\CRQE#F3C/+QSVD%*,DI)AY\Y4?I+6]RHG>>IBQSH8K3X9;KX!=JD[F M/'9\,D[BS'1<,M(^U]1MV:R\WSPA*9_(8>*X1&S0EIT,H'K: MTC2`1B5>H^%32R?BV,80[/<9SO9I]0:_AX(><5^<<+.*7&^9[MRW(-A&13#) M6CY#TSA4U%WXI^4T,T3YXGO@>;WRWP"X62-ZAA?>8DMH2'JPR%@V5W`!OSG> MQ@G>T,23Y+$LP;6_@3`"B^OG9[!PG0BLWNZAU03?^R=P`C1V'&Q"`\FR?>\K MIID&G3#!&9I/I3UZJ+M$P6ABB(QLPLIKK(LA0K(++(_1-X8(R2:PM..!,TM7 M]?2>`T/4$#S3@F>XC'4R1$8V8:5C8'.I`$JG$N<:)K-(>S#!2MXTNV!W^MLI[H8?>#6(G MQ,,?)%-*.Y@()#S?UITL*-/*XY@(*#Q?M9XL*--*C)D(*&/-FL M-JOTA6F)/D5I>*5\[RMV)P0/?=DQQ.\X!&3JH2).(9ER3()#2*@7B5,5N^4& M=.A"CP3(2;M*'`)"QRJ?JCS=`^_>_^)Z`)5XH81BZ3N/(`&??W@FG@,^#8`F MG(;,/T"TDUH-5=6UP3>NT@4?);Q3SK'D'YY&6[&7W#UN9.[:0W%&Q4:=.?K- MMFP_,L^MMO@CM=$QD"K;60&!OZ6D-M@)I#)&:HX[GO%';*-K/+J>L06Q:SB; MQ]9S_!';Z!K6;^9L0>P2SJ;=`]!6+'*3L?VBN(;#(#P_J6?U5G"86HOK-T<& M![>]&_DCM='QP*E!$@2I2[FZ*3S03PM-H>EK^;T1A%K6)@6!*?U^DW1(52RT MH+HW:*UAZ#+VQ`,$#))[RH7@&"3WM,,$#!)\VN7<&"3XM,,%#!)\VB79&"3X M"$$!1=;-%FG]71;&/2PC%%]39Y;=(CGO*&&9!T4]U,P;U?EH(7Z_/W[F(5+D]&AT&GWA6-:L$GW">-,LDGVCF,ZLDIYW+ MK)MRFTLXG58V$62FFH;,*L$;#9Y>$HL9%H`D>?DCF*=U1W'M`M=;WKR`H*3; MST6DS.Y]O3M(![]QXO4$^(=FPI4%I@'.1&L,\`\.[6H#FCTSE`X;T\'+/3I@ MIUI]@']H&DW`7NH0<"-IGYU@_J0U9DRI[6%K._+$;Y8Q1NII)XXQ1>IIWRQC MC-A33QECBMC3OEG&&+&GGBK&%+%'N%FFR#/+:!4V;+LNKA$9(8],FQERB^L' M1P;(E*^7,4;J:6>%,45J:M?+A+IO8OE&''I)%:.JY#`C="(0QY7L:;+B" MZ^M-`(I@E'Z5WZ9*(%6NH$_E]#($ MR#`MTL7A-2HXY?J+V\!]@0QZNW+FF,1X_:1?3L^1#$LYUXQ#SBI*QMB2(D2B M$A:Y1;'-F6*DF9RD,QZ>(G'S*B**-#2K:DN1F:H9FL8<09*C1EL]F$7VQJ@G MB"'#?=0/(/X"Z?H`]Q\0("9PF(B-AB"#JF6STU M-:N:FBV6PA99:=A_#62M85)NR3J^[,O*@&0M*5;3&$:8Y:(M?0W&+[,,$EI'VQJMJ&;LWV]>M!2."$UEP=D#!.4SMG,T!Q[Z[PA"^+F M<6M,7"SA_UR!)+1?\W=D.4(CR;!T?)=2;PY*&SGKT\#D0&/(Y:/4'5D9BBZG MYGS-'#,KQ2M_[X1@\<%_7@,O=!`Q+X+`\9;XH?=ONZ_\"C^-`+AY]4`0/KEK M2+DY_`HTKFX>\;?"FTV$&';A>LL/$!-W`0)(>.\CB$#P['IX\)O'CVXX]S=P M+I`(GYW@+Q!AH^SF\1&Z;][R(\0(DYG5R=$[<%"0S9N:O*R2HRL[)1QZ\>H$ M"X+7_/$$O.I577Z;`[`([W$/CWD:(&=H/E291NG&-,-2H`\^293]Q7(9@"6< M`G[]-O!S&.;U8R,,[(SG"I6SD5'.E6B:.33-!$T[YP7OC55_IJ(:LKP-(`ZT M7/[!TC/1&_B3J1.`I>7`TI*]6,]%@O;&:CHCU;A"*XF3.`^KD@#24(,C`U#) M"$3-<9$3GOF/.=V('I6K'R:-+.D]052UQNEA5'F$0H)1^U,3=1=4%1C58T1P M[%J-44\GU@(C4HPZR-%AIX^JQ1U&N].]P9"J>`4+AW1];TX52YTB;*.>5@G8 MVL,6G]T26(*$)[ALF85'">&AN3:'6(WR^59=3*& M,2,OZKFM3H8;\N?ME]_FJ\T"I4NA/$(\5"^X-[Z%H2R4/I-0&M<]32192%$Y M,U&M$WDB8/8=8ZL9G[582V\QTIHU3P6YB<9%C@`YEF(8ZKDR$\AUE;EQ+^#W ME@)S!,CE8P.'[W.,N)A'@!Q;P8%METF!7&N9.W2?.\215\ZMOASY(T!NHB$8 M.LC=1$_)=]L.6=#@VU"?J,PK46\GZF/YF MCZF,`O56LCZFK]KCM2>!.H&L3\[/%:@3R#HK/K)`?1Q9']._%OOZ6+(^KF\^ MA7U]5T1F`'@K!H=2I]5X4*4W:'>MXC6Y!_>KMVMA56N<`D9F2XQV2A4^RM"! M^(0Q&KM:@,"HM:YKKA90H^O&W:8FC)'9$J,:724@L=!6@\>0RT>I MAT33#3HR\CN<1GBW>0CG@?N0W)$M?)8,W"?7$7(/DL M]_27S3,(G,@/MG]L.S?\Q+NZ$3.O^P@\'[>2J'LAQB]="HP],-=)^HD!WVA#7^8/"SB-;^N5.W>CSP`UCI<6+OQ>"+?8GT\VX=G2<=8_XNWT_FT- M+KZYX;8@"GYZ.SGT:UH1Q7P7__$DEJ$OOG<7.=$&XOIV%_GSOQ*W(G[A?[TK MG4>KB>+77/[O!I(S;;QXY\+_N8;_Q>_J-O$[^#!^U_VK?__D;T+H`]T_N4$$ M@)>L(>[N=.^C3C6;5814!=FR4L3RN*2?YE@C07"],UZRN$9.$.%N-SNVW(Z] M_5OA(>`M1BL]R$$3<"8K47$,2S`PK(K#1B@TX---N`CHBF*-L8!J>"<>5"]PQ\@JR] MN/:@);%T'U;@(@Q!%+Y_^^S\TP\^K)PP;,V`Z?BW$)+1S9,9<]16L(-$6MY#<;_>!XX7.'&N=]V_9OW1FK$_N,V37!7D"(H MFNUX;X+12!DMZRV:LGKT>SRWWF)A-X?K8&1#YTL:MA8OE`;A%?)I\;)IV'(F M!XJP/YKX;!=XN_`6[X$''N%UEP)^!4HR2S)(RH[IW<"A>#6Q<#R0A'A[8=9&0VK(QTJV2W`6/H1$_.\@TKE!N>X9QAO_@U[GC/ZHZKNG>B^"_@_B/1_TW M*O_)@O\.YC_!<74<9R0MK-#%'<,P!<-5'&PG;,4=,QDTS;.(]#AV%4OA-!D5[XCD='852^*]Y3%GQ'SG>" MT]IP6O&6N."T:DZ[`_--X$8N"&\WP?S)"<'V1KQ@NA9,)\X:CN.L850>TP6/ MU?)8LFT*O_00)M,$D[5E,N&"MF,Q<6;:EL7$5MF.Q61Q2E":(Y6,E1;"NGE$ MI;!0LUX3A/4TRV>=Z&;8ER$=SF>=>&,>,L MUBL_$/M)+X(R$Q6ZIBPH#-V'X$M$LO\P"MQY!!980)B7C(MUX*Y*9"-]Q[BRH+>7!7W8 M)-)J62B(`(]B('B,=1[+%$DR3%%[FEN#O4HD6#79^1*2K,DNA(1/DYU00A@Q MVMF3#VV_Y0F4#SVWB>R:+*+M)#%>CE1*AM]*MBX":FW4V<'X['KN\^:9>?G] M[`3S)XYV.*V]!&O#NMUD$IRV#A02S(T$.]^$!`L)SCAR1QTYX]N1$T(RI)#L MBN`:IJC7QJJ6<6XHILWKB4PJ&<@XPLE-,?^A[A*^!W_MW@GE8K%P M$7*OB$#QR7`\L+IW`<[WER/J* M)Z82C9QX:N3$%6?M8OV&I5G\&XO'$4;_`E5Q8O8EUF#F0LTV!?H.!"_N?&S# MD%MQ4(0X<"(.EWE9V!,`EBXW\B4.VW,DL3OPP.`XF# M:`++;Q-8GA@-Y="+&@NEIP2.&_S-66W`S>-7\()^6+0ZX!#PGG@XL'@UOF[YS):N(,KSM-L_5Q79RJO?+<-NP8^)%'T!GD`-QM% MK+A&H[U_.^C:W-4F@(RV"0`<\\K]AGX2BHVXD+X%U\%(!A>?TL"YZ3RJ%`A.RJ;+"BMY M\&1982*/SN/"1.:#QX5]W)7'D7VL'+U]S.>U!S;O-O`I!\=M&1_`_X*-,!LI MXG2_^80LO`P\\PKDXJYM7#P2"U]KPFBDNS1`?P(9?P1RX+\[#2F0K MM6(R<>NO!9,)UB)E+471S/@.T@)LIX8I*MDBO$ MA,]TF&*5W$O4"+L@'A_=`,RA]`OAZ"8M8H!%](_@ M5Q6GE@HWJKBM@9PP[DA2DG$A;?GHI81/%Y)41%CP()D4$#DG(')BJ\R*VXAM M'+V`<+N-W,PCGZ==1&XO)/*PME:=D&1W$?/HA83/78100AC91)B3#]G.RD>2 M%ZE#:2@4/5*UHY1._@P5\X(9LIV8C)H2FN#F&1J'ZBB;S"?VPBQC+"Q MD3`H(59.0JS$T#(J:J&B:&J2&'&D(1/QM=CL%<*=-(C*X/S;NVP:MIS)@2CIS&M)9_YX31;E M0$K]]G7@KLI#60Q5G^&,W;BNG\02YF-..&1;F8";EHE`OBRGY" M+B8B%]F"72(YE=M@%!(*;H[].9,0<>PO]/#@7)8M>B4N9/(9!B51POS&1@<6 M#C,G'&820"AV#S4,<1&35^'(%]EE6#C,]L)A#AOQ,?9K.VOJ+"G.91K"/BFM MS_EV!R`]%XS:)P9;A9WS7(9_B^V3I(B]:@LN:UO$_LH/KC;1)@!W('AQYV/K MM;80+1I6-UHY/;,F4.#:O>-%]RDBD%(UM'+R=\IKU@(>$D[X4S MZ9!%K(FUX301:JKF-#@95L-,O+&9N)7-]:UL]MA-R[&;%DF%Q&WK47+OB<(E57TQK+RT#Y[_624OF"H(I.@KRZ8NU%15& MW#)N!<4000N.!:7B:$_(2+\R,A,RPJ^,E'LE0D3(1$3-B8AZIMI(1"QQ5#GE MHTJU/1LBSAB)#3-',);0U'QJZBOP$&R<($F+NT2Y_[SH;/:$19.G2H5X,Q13Q3AVS M%:J6[WOPU^Z='2X6"Q?QHK.Z==S%M??!6;N1LQ*L1E<"WV6"=2Q/XZFL%^@P"267LX`O/*#M&1#)MN8^"*T MD(BB1$S@R$1(Q+Y$C)Y_SZU$*!,X!"6)$![$)"5"[!%=)4)X$+Q(A/`@:(B#\""F)PYB=V@A#E`(-'%1 MK;QOZ+8D\]WF(9P'+AX,\MSOGAN%]T^!OUD^L769B#?.$R626I<'_\.-GKZ" M<`WFT;U_!Z)HA?GN8AD`P8"M&5!(LE,"N_]CRXD@1,L039I%7[C M8CX/X`9]#2&!SPNF;,64HJ17:Z:LV(V%D]2="Q7!A?USH?!-VG&A++*##]J@ MA9-R(`N*.T53O5/$%QNFA3=V"1`39OU?7.?!724FC..-W`&()T83R4LB M>6EL%LRT:S%EE?^K;LP?J`\D,84ZLW`=C)2:Y4L:=G6937D"M3+8/DFB(PI" M#KK(@2),X.9@;MKQ"EHD[X$''N%#=&OH$ZAH=JW?[F^.A3BMWB/TC`,HZ0[/:CK2#O"@TU7:UO$R@\-'1RPM) MJT4A*IU$)=ML<0)%)(\R5)3(2=S!*]Y=>&GAQ9FP"+_SB/S.(1E-.5,RC165 M;3;7S$XSC'!V8,$#Y8W=ALL2;)5H)!SECG*3<&D;N5&&SD*R(]M9V4D3 M4&:6L!4FS(88]'9L.&AN#AQ^EF-#*U'AHJ_MGKKFI6TA3UVI$OYK*1'6L(JY M3B)$GS8.V_`(B3A0(LR<1)B)J6+&D375%OYDV\@:Y+RK3;0)0,I_XW*#^ M_16\H!^V9V&"]\EY/^,O"=[GQ5\2O-\#[XL@[F2#N'RQH:BNRE]U50Z93'CE M?%17Y8RU1'55QJNK6XBIM1 M#.D]C#E3>J_`A:G>DX7/,!&?H1O3#:SZ]"S3P=\PTYFV\!EX]1DPHNUX#,,^ M((]I.1Y+*EV:EN`Q;GE,:\]C0Q:YE''QP@R/J6W_6M82^3?P'3';B;PK#O.N.&0R88WQD7?%&6N)O"O&\ZXXXR>N\Z[8IW6:=V4:(CVA M9E]@.3VA`XL-F64EV]D,F/BWF,72U#Y+L%C;2./]JS\>CZ6(MN"Q%/;1>$Q$ ML_F*9O/(8V*KY&JK9)/%Y!R+R0F+I/R7%BX^1OX^2+ MQV:V<`!::S7!8#D&RQ3!C7^+<_)489EQ:IFU+7";HCX2BPD=QIL.8Y#!K!R# M)?5B34488KP:8FUSUU/81^,QD=_"^84)-IENEF.Z6<)TLC#.>#7.6E:63E$? MD,7,'(LEE:4-6QAG?!IG+0M)IY@/R&!ZCL&22U^&)1B,3P9K>>,KQ7Q`!E/* MSI:,F;@IP=--B11(ILZ4ZEA+W)1@_Z8$;TPE4M8Y3%GGD>-GWA.6>>`UFG*NI'V$1,!1>X"BNU9;-"4=2MWVFMM3WN-]%:$.(SC M[##.:G_@:PU[X-O(8T*-\:7&F&0Q*\=BR7FOD6:LFX+%6I=I]*^]%Q!&?C"F M1V6U/^:UACWFM7)G<-;N#"Y-)#8$KY7P6E5"P;B\U?;XS1KV^*V1MT3>"N]Y M*TPRG5%JGZ&,3\,P!<]5Q(@2VW]<9C*8L\2JF0EJ,%EP4VM+[,+;=I.LJ)TM M6+".!8W$&5"$O\FKO]F!Q8QA?0`MQV))W6)#%G;:=.RTEH6,4SX8B^D4D9M7 MJM<$QPW#<8INJ^>:@6[J&V:F#PIO?+?-L7MU@L7]V[ICFV;$IG!6+P#;;*W* M?XXH'9^=8/Z4[1;M+I^BG*C<^Q_=`,S'CP.R)QPJZL`1%Q33MIZ.CG/Q%:B/ M$^$P9?7HA>,+`Z/XIQ6L/?TEPTW1)W2;BZ2]*>M5*TQV$M<9>$@[LDG#&5 MN$O"XUT2#IE,;(M\W"7AC+7$71+&[Y)PQD]'YBM1H74VE*^>J3:B]4PD^=0* M+Q-)/FVK-R?XCL),(LEGDDD^?+&@*%3#5Z$:=AC,"<_\QSAV"TT3V3K75'Q1 MB3=[Q/4@$2$\NY5L!T_^TB.EME%N141>68^\YA@C%Y\?G#%$W)3-N.EX+*'9 MAG:N:HK".TMU5Q8*;`_:O_/R#`_\6968E%F.8/0-_`.R*6T&S!$BE+ MW'@`^HD`'#5'I$EVFF:IY[J&>WD>*U\,GV*W-5;@]M9^DNG3G^%.^;QY/D8F MG6F"23EA4N?;<3*I2%<6Z7CMA,/X^$I\$&:="ZLP\%3SH5I>""'"M.0 M#PX]-KM07-RAR*.3OKC#`ASEMH_'#5QG@@U.*5QY65,U?-W(UBU;Y&&6:-3?-JNW"V]QL5ENPBA3?N7^ MR0TB`+PT%3@MRK884[BRU92'8!EI#:K+2=*9!8T]Q4:,I!O\A[MPSN&V M2$MYM@_N2$X&(9@!%NU^29 MW!AX@RTR^4PP>2.3$^L]P>1L,'G2'$TK%AP3M2EY/;=@N#9EGK65(5E;W=Z+ MUTQQNXJCVU5J_D;_X(PA;E65$R=#T12,6\IF\>VG8JD8MXX]-CV4I&.R5XZ)GTF$.F8G*5C MCL`B(M;)0SHF9<80Z9A,IV-2Y@:.TS&'IU2:N*KIHM@6N12-76Q+'3A-M\`7 M7$O0X)2:);K&*&2(*0:2)MX3"XXW0PRE8%^YCU$VP^#^%:Q>0/J6,>5_-O"^ M4.3JF>#J2:2$'3=7)XF.FK:GJTV1Z,BQKO[LO-T!"/J"2:X>-+.QA*MG@JLG MH:N/FZOUQ`-18ZZ6#7S(KO+JFR;'XQ$(;YTW%*;-\TLW#BFV`+F#[(;?G,V* M78$7X-W['\&\_$]C,I$^L'.69R)=UL7EKQ(VNE@'[JK<*ARWR0Q=9DEO""2U M'E31I:B,63)Z)*DS#?_#$IL,FFVO[(++LLBVYRC;7ADXEEYD#)%MSWRV/666 M$-GVV6V$FT3FD=,#1V12D1[(#9..G"$X&I-ROKE.+=N>.A^(;'O>BQ[:4BVYZ];'OZ3""BG1Q&.^FSB;B4P=FEC!%81(3$>;B409DQ=IHE9\D MH5'L%H/JAV&O$!6X7J0Z"B8ZF(F$L2V,[2/A?'EK7JF62,CC*"%/'MB:+#*& M2,AC/B&/,DN(<#9_X>P16$1L*#R$LRDSA@CJ,1W4H\P-'`?U*%!*23S3I`.; MIHE,@[($E&2LF\>[)R<`X'9<>?9C<$B8D/AP+.CS1C"LV/9LZ/-#?QZ M=H-3RMI1RA#V.4?VN469,81]SKQ]3IDE4)4Z65PZ^C&Y58+^BYO7)E&E]"K2 M[">/DL(EXTWEVT$%A$V!@\N&V7&$"X;TRX;96[@V&4;GE*R>J;@PSA= MN&Q[7/J+"(V%#[LQSQNUSJMS`M7U^ M**7B3^`/_P]02P,$%`````@`48!H0W)'=4*P#@``]+@``!4`'`!V<&EG+3(P M,3,P.3,P7V-A;"YX;6Q55`D``VI1?5)J47U2=7@+``$$)0X```0Y`0``U5U; M<^(Z$G[?JOT/7L[+G`>(S9VI,WN6(3!%%9-0(;,[^[0E;)%HC[$XDIV$_?7; M,C:8BXU,D&/-0S(XQOWUUZU62VK)O_W^MG2-%\PXH=Z7BE4S*P;V;.H0[^E+ MY<>LVI\-QN.*P7WD.Y,9D,C$^5V6A0^;5:C6Y?,>H$-MQ//:-N6HVJ957-KO$/PS(_P^_^ M]\V=\(`_/HL?<\2Q`0`]_OEE10#0L^^O/M_&>*3,:2$5H-HP-F0SZN('O##$[Q\/XVRBQ4TW7Y$K M%)P]8^QSD!P^YIGAQ9>*,%4UMH8`]DMX9;Z]S5^OP(TX6:Y<8.CF>CBFB&'/ M?\8^L9$K"6JE`M4MM8,E0.E[SM#SB;\>>PO*EJ']I7`Y"!,5P+Y1:)P#"HPQ M.2!/MFH8M]A'Q)7SH2?;40%G#!%OB1_1&Y:#07S%*/)P0GS5G(B@Y@0NOE_< MX@5F##MPN<\YM+A\0#EU?%0$'\*:,OA%\`F_CSE6K8CVCN2C<=)6UG0GSR%)IUAGW?Q2+X2N%Q ME?1*I^#D,9S+E9CLCOH8.LFU,)<4#D])[YB$D8<53XTCWZ\P`UMY3Q,,:9$< M%.H6@"0/-]0M@IM=?+JCWD`D7JXPXOY=?<:0]Q3Z?$X5.(1GZJKI(0XTR1&R MJ*LD9$VA1_(D_?7C^`['-DB=,I!8BLEUDG# ME(:P9=.\QWBO9Q<-%6R='%Q\RK`8: M]")A)G2_&"#^/'+IJRPD>Z$4$0!Z%GD:>/&I(+4@-I$;0@%2HBQZ[NB+$CC9 MO(!3JJ:+62X16]\O9N3)(T`2>%K?MFG@B=QR2EV@3=KI.%*2V,EAS->``:JB M7$8&:WY>/Y#87'$'H*H-/#+-//^\>=3F)5B&)]J!&S;<"7R.[R>^"U\PS;I1 M-;98X?_1?+ZQO[`@5+IT46(##;_!8,>!*!5"B\&YU([N@G$L=K]4X,)_-C.; MM;;9ZM2L9JV]3TAR.6F!^#Q<6`EX]0FA5;@&=8-=G\=70NJJIA4MT?P278YD M[$-TQ0(193%]$A@'`1.&`ZC=IF*HD2@IQ`F3]UD,?L'H,IM?GY[1C3+PW'"1 M4ORK&*^8/#W[FPL58\4(9>#3X%45(^``CX8IPT":,)+M_I9K::Z-$@*0X$VSL^)7OG1A*`Y<8D/8^"M,G6K MWE9FX&.![QA11:$T6I>&7A.NL``[)[1JM9OJE,H!Y!J^*V6TP_XF)TEZ9143 MROF`AE,ZV+/7H8;(/4R:K'JWKBZ_D,)0N/GS,Z-M``/7/IXN$]0T%!K]C/@K MVUM6Q:WULUU%KT9^2O-.PZPK,V[IS'F&`;V&#`.Z7!(_S*C$>'<;HX"76@C[PG(O+%4*EP$MAL*!P79`LOSI8Y2-"K&:9.\']CD"***7Y3W8)4 MMO#+1X#?D?U,/,S6)Q2J=[OJ9HW3!5_#57/;*O9>23XTBTL!@S89,#%V'9$W M\3\>Z62V+'4K.JER/]3$9JU0_W-34L79*8NV"H9C MEFABJ-GNJBNI.2'Q&HU#:J(@L8J3J;5>-A0C2.HE5.E8#75IW:&TPHV7I:Y> MBV]]QR$;^5-$8.@Q0"OB([?6ZEH*URU."RW!D\$HMDS8EAL:[(9F6/G:^#_ M\`CG`?0PFXN;70^[560(6FUUD]CO0?:1\?Q=-)8W)Y7R'KZGHE!,W9QIMNP/ M]X!T*DJWVO';S2$;$_@L6U??-%MFTZ@:MX3;+N4PK(A\=C_.9P9 MG^*MW`9=&/&Q'L8C>C,V\Y._&I^B#2*_YBS"O^C@D-Q%^DL2&&`-O%'==^BK*%FM=4^&F%0D`)?"1;%;2THB/2Q7?GTN`K]PIQO;I6]E"QJ:0(H`N:+R8Z,\N%^8.AN M)V`B-]'P06N%]3[O0::3:\FPJU?J(J/U'151/X#;YBZ.LKN,-*YGM3XVEN7# MJY/_76Z)TDW2O-LK-T*$-]%H1O+1AAG6.HFGD:%+\EFYI\KT#R%YXQ,O>`/)^.GSH/X[OOAF387]V.(@$FHS=T:+& M=L;/"`_N-)*GBUX^G+SRN::YQY8'\D>!*+W[3CRR#)93M-[($,4CC;;")7M) M%)(@(AFMTO1M`C(5JL;OKN8ESZ.-%Y6DLW M2?6^M,8T.P?GUNU.JA0YC#APQ]@[ZU,R+\D\+S1WEG'Z^)\I!KH=2%29L.@M MWORNM;LJBSMS(+D\W1"'WX"$\%T9P-#7]0\N=EYM7;@O4O1P,R4X9UUAG90\ MD<\O>9.6[H%Y)7NI9]B8>,O1?,CY54>,J'/)#2>\@Y\O3*/U.4'!$/AH5' M2K;4C57D@93>0\Z1IU>B&6<]C[1O`U60#9W:*`FJ->KJ]H_)@;B&9[PK9&XW MQN3G+*UC*6G9[9&&ASN^A7(*RQ//RB^O+V0RI5GU-5!C8^SP$7"6?(?,+9X+ M]^YUU'486:(5&E^N9TQL>)3C1Z^\\@&O(J^^7QRKU>HV5>[.21==&K-+\Z-Q M)I4FMC3VEN)%L[0OH=*8\T"L$MTO$EM,A&X-I8>Z9\LOI?'/ M,Z770GI2M^1[AX9OF(6OQ!"ZM=25WI^57THO.,]4Z=:]I;T@>MU4K);(7KN= M8D+_H>A2VCZ3'[TVYDZW.4SHT'%L$W5JX:!%X9:;+-'E,;LL/Y'9.YID>4#. MIJYG$A[*TJ@KW$*[)TNA9>4611(3>RD,Z#5.ZSO_#;B_>2]6_)[`;^(G=D:4 MS3![(380T>HJG+J3PU`:T^>G3*^^_'3M</B!S,F&MVVBI&[#)("B-)^2E*W*&GA[.$'+#X1F0N-S2 M8.XO`C=^I8DX:U'MXDRJZ-)87YJ?..DW];#[80'#V#M^<5K-LNH-=:=3RD`H MC1_DYBOV!UT6ZX\5##?B[+0#=JQ&1]VBW7D`)7:&3*YB5]!E!>]8O?U7\8%R MS7J1CK`OOL1ND,%3[`0E.@@EIQ-$K^'8>\^#5:\7V4$<0RBQ,YSA*W:(HU4^ M;1Q"YM5W(A":ZDJ\+@-58J?)S6GL1II,+1YKG/T*4!%#K2)#3#:<$GM.#A[3 MZ@M*&GF^(>*)199[[Y;P,*:&DS)Q3#5;'74E)IFR2^,-\@QI5DRVJY4)ET\A M',;K+8F%EGLV#8C-S@^+QF7$7;%!, M.W@NSPY%L<(@M@!L!A&\UFDJK)$_E";EMZ>C-/;$Z6PB8W&6Q"/<%TR\X.U@ MR&SWU*TLG)%^C>9XWC#;<)R#"KV*!2`6+3#G(8(1%H&G9745[N`X$%>L&3.5 MU6L+WR-#+U@XY-#S,1,OBA`!:^N/G79/W7Q.INQB+2I/0^DZOS-[+3B&>\5V MQ5L,&M+5GEZM;E==W4:F[&+-*T^#7A76,^RZ(M_SG.^(_8%%[K=5JMU16%F; M+KA8PTH2H%>55;)[B5Y'S9#MQSGYSFVMKKK:2CD0']?O2A*C5^G5!,TI`\VB M;5];A>IF2UTN=5IHL9:54%RO>JIRET&GY`HOV`M$-MNV%%;GQV*N-!&2R?*N M_S^A6FD'6%=2.JOU:3;;=T<]&D]N;73?1HA&HZ>P9:7)+=)YY937:URR.05! M).$;C<9BV`57:I;5[:E+6]/$7L6<.7QTMU@C04-IXU2*93,' MTC[.CNE*ER_4IDZ71W\0/^:(8[CR?U!+`P04````"`!1@&A#S=)+\@5#``#! MQ`0`%0`<`'9P:6`L` M`00E#@``!#D!``#M?5MSXSBRYOM&['_0UGF8[@>K1-W5,;5G5;[TNJ?*\EBJ M[C/G98.6((O3%.DA*5_FUR]`$A0E@B1``F12UD1,=94L`YE??@`2"2#SK__Y MMC5;+\AQ#=OZ\DEK=SZUD+6T5X;U].73C_G%='YY>_NIY7JZM=)-VT)?/EGV MI__\W__S?_SU?UU<7#I(]]"J]?C>FE]?_GBX_J_6C6'BWW5;W[Y=MG[Z-+^Y M_/3SQ47X]6?'7NV6^/NVU>IVM-Z%IEUTQJW_T](ZO^#_3K\'W\0-_/D+^>-1 M=U$+"VBYO[P\&UB@C><]__+Y\^OK:_O%<+R=;N*/G][;2WO[F338F?2P`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`0;VZP"F_W\=&=;E\3Q,HD1#[\U=1S=>O(Y M+ZB"BZ=GVU2S0AQI(C!EV::2*>L>KT@6I^^L9!B&`HB82,T`?,`LPKM([+U[ M[PO,'5=?DJF33R3G68EUTF0200N+I@2O^>[11?_:8>-=OW!3R$5*1/'LY9\; M//D@Q[W^UP[O=#B%T:H`1L18+E)CJP1`@D*I`8I(-7OV&8WWJ'_H9,KF)9*M MOU8HDQ!<6#1U5DS*AEU@3#.\P8C]?/_C^+1Q8SO76!#['8DMZT0C@_SAK17R M,ZD97MZIO)+L8J&JK2.PQ/L(JQ$-KR*^)S1;7^KNYL:T7WE%6JZ52H0%VA`_ M#;.8-4FMC:7!MX7"DAK*9L\]?*$#Q^L7N+:M9HG9;G7G?;:>&T^6@4'"3)LN ME_;.(K[EO6UBV+A)Y^I*'#L^&<4&,!95D2_#(ZLXKC4"*S3O8%'53CP\PUP\ M;AZ.>0Z4=6=)I0__&E<@.IHP+._SRMA^#K_S63>/!$DYSZ!'.>0L9.#+%_M- MZ5)9MCVL-VTB7&7S0L@ZS5W_`_Z=<-S\3? M[W?Z':UUT;HRW*5INSL'X7_B3[FX8B`K M>O.0M<*NBB\KE=:TE^&W3/T1F5\^X0_^7S`_7MK;9]LBP5O?9&UM/.JU1^TA M$TH?QK7N/OI8[MR+)UU_]H^E/R/3<^DG_FQZT='"4]O_"#]F]W@HOTF.D&V' M@IVI`&YH:P=3_G>?:&VM,QZI$C[1&Y?@>YY,':K"VK&W(B;P['Q];05\^ M==N##O[?I]:S8]@.;OO+)_R/G8L%M/W=PW[Q"P=1P?D@4!I_AF@I\HME*9G:!VMW8%HG_BKIF.FE2&3D^%08J4B1&ADY%F+D^&#Y4LI(EG/'2\FX MYQ5H<^NZ.W(^Z"O>U0;C;G)V8>\M^N-L1[>UZ=)/:LE+9I!J/$ M580@[-U+.ES?#`O=8@""H=YO3TI3/&I1Q33J!]5]40<21%W$;\`I86,&O/DS M:4+98Y(%,;I?2``-K;Y\\IP=VG]H6QYZ\ZZ#6X=?/KGH*;@-*9&9B1B[?#Z6 MGW(E\/&PP;L=&8BS]0],"'>Z\S88SG^C%1:XW^.?3[G:K)2;C,E26'&52WWY M:?!0';P2X#^00]3Q=1@7-%Z\(5@62U,Q-%,/IIFNT*-W:[EX.B,SU@U>J*=; MC0:,,:?"GO%N85DT M!9#0I@.8-KTT==>=K<-0_LQY,)XV'ET>YFA)-#*0>XD=!+3Z^DZO8H5?=-NC M3F^H[`RJG&QULT,>M"&%A@VBT/4; M._82H95[@^&@:L_6QW&^MC;H=!CQ!#FFY9.A;DN+(T4C3AV8IH\>)R#GQ2#I M'YBSF&F&.3=F:_+V^\DB40N\*S9L_#W7P[[4L^'I)ODTW%M-NJS(N*1#9S4R MU\TM]::@7`0:8R^\A-[HAO.[;N[0%*.]#=ZO?$?>QE[]P-_$2^IDH(R,BH2N MFXP5V(*R$6BH4RH"V,E#2P^MKHP78X6LU4/@ZDT&REPEY>*?%$/S[$.Y"C3> MJP2+WVT3-V-B)0D:W[$=M[LMV9],E#F!U>EQDNS-M1BE,=!`=Q6@Z&\1*,I. M0JK3XR/0.&DQ2F.@L7VIH#P8[I\W#D*WEH<10;P`CE;#8.@329*2:I$;A#L5&X12DN@)Q>1+O?(\;6-OTH+ M_9JNUA\SMD\I%TXX6JS;\H)*4Q,"/1_(U"9^.%H$;<*DTM2$0,\% MILNE@TCW9!JQ7-0>X'5-U8Q^W%G=ILQ0GM[1`QK3?T#/P;+@DO2">PC:Y$:W MLC>Q:;W6;4<>-*A!@0;&J6\92GZYXN?,&KG)J&Q)[%3.H\`F0H)BQYY/EI>1^E5J4 M="F@YK]1.E93X3NXW'Q4$C,G)$P&)7."(@/S0J+P?8^(>?_Z^0@,/&G^R9UY MJI?,/'4_75S?+>:%"%3.:>;CT9V&I!B8W8LM#K#)./ M'^40E$>`XK/E/F]\1C\!4_LCU@M/2:.06PP)0[*02:-A602PDWDER@^=(@=1 M[6A(;_V'B]8[\YNQQMO\3E?=,02/!)4.`59,4A`EV"]08]J$2\:OCNVZ6(&> MNOA'2J>`+)N&!>QWJM.M[7C&O\/[K,<`M`>3L;*P1G;7=5N6&QC8+UD_35&5Y%)!#A>N48>KJ%2X\,@L3/=?4^6Y5'H+@,\4) MPZ,HNR3>U$XT?J`I[R@VXR!GUBG25/>IS,LT6-S`' M_S.``Q+G+Q4(UCK)0/##];?IXOJJ=3]]6/RCM7B8WLVGEXO;V5WQV#!G#4'A M8'%*N_OM67_0&ZN*H>9U+B-(G`;#GP3L)FF2E<>+!222,+B%#9P,&Q># M\&0BR'P(*KM2IFJ(I+0<7O7SG_?'C?V'X6WBO]+6!J-1U6KS"E?9N&%>MI.& M*^PP]'<\:#?F>WC__@8O\5@=[&4:UE/X?M^]1\[TR4%!1H@NUHP1RTRYQR#8 M>IT6+P$$[-@TW\3O.W7]0;^C:DO(+X:$&`[-X( M;1FCY^Q0LQ$\B5BMEHS5SG]\G5___MX0:">^#=KK)!F=*GC!'(8XPH=)JK.I#1)&+` M?1P$JSU2%B9/Z50>#_>6JT8%68%\;G.DL?!(\9.)SV<#HRKYBGR>%DW)$[[. M^]5_K'=K!8E02?Z=/KS\2$Q9E0\.F0F0#\CU'(.D/O*_YK,WO!P_ZJH+,A63 MJ98YH#1ZL*^>,]S0,%""$5&7EBRM5VDN7!BRP4HH.W]F]JA@&Y%NDA0O+J$[ M\&A5UDY(T5%%F4U@D7%4G1KR:LMSFB5C0YM``/R5[DRE%9WS5LW%ZM2HAHN, M(VH>!$!,MP0/AQ` M;!_*V;/*^L9EPWMA:V05FUDHNI`U[//?.&,UH8I@*3!3BN5I`SM@%Y-^\6K' MI&>$6O-M$351ORV8VL`^JPNEO[5>D(OA.F03XZ`NVQZ)9NJU2:96L$_=CC0X M9!:C,!R?78",E4RM@)]W*=M%U76-0M66->5B[<&)9VC]_K"C[!(-LT<9(>4J MB+"_39L-&^SU_O`:Q-S`?]SB__L2A6F9^ZR'4BES6EYSQ=F9U3)-JH)%9:2D M*B"JM!V*.+SL^REY^H+?27,"D=B&PN69#%&KYAEC1RRF+_R=,;<^O&Z:)/LQ MA?W[3G<\1'Q@[&XM-O;.U:W5-7'6:']['TQCW-A*$9FW6<7$2X.;4J^(]K!7 MTQOTZ&"EWH_UN7>,%]U#V*-8^O['_M'9F']?+=9XS;8MC@3L/?EW':N$Y7Z? M(W+[8,.MWV#(;^EBG=1L\?+(P-[UA[/5`EN.9[[B+\O)WS",^5H0`=@Q`^8: M=$>N#B<5X@^Y<;8*PYXBNH?&!%KOB1(4:Y.K$./^<\[XS&D5AC%%=`^-";0L M=\ILDZ(2_U$1=[M`#"JD?VA2H"6M9TO/QK^,53AP#Y@J#2;\TRUWNS6;M)#^ MH4F!EK@.50H\OQO#<;U\Q?B/2`1;AV'>(EB$1H9:!'OWM#M09H$LJLNM=?VV MW)#`^HT=%HI\0)[A!''V6'85_M1_9;NKF08RT:+A#J!EM@-5@PT?.MKTQ;3> MZ\6J;9+)`LZV09B\``[4OD#C67?VB__;4VMUA9;^7W,T&[!.2U-+E0JU7K.- M2V!!K0PTID4U(TL4%WT'`E%+L<:!V%@<"6IBX,&K@]WAM4DF+,9F@M^ZW.T" MV4P)Z4]M"C1T%9N%_ALY]LPB]PW3X^NL2Z$I5A5HN6:[%L2`6A9V'.LP,(>W M%>8+:^O/R/(B$I9DM0MCM(KI3VT*-)PUQ>*8-\;Z<$GQ=4KG:X=_JRSBC0-P<(%4*#&!1KQ"M0Z]@W9DU.?558Z MT[(<[8(PJZ#^U*9``US?]?)3,URB($(2(YM24 M0&-*OBN84(=C4XZ' M.)L&:>=\%.BK$:"1*#ZU8F688@DQL)*"H8U"'37"\'D(41I`#FJ)*!G+OX&5 M%'P[5JBCIM&`B1"E`>38EY"2Y/I_3$W^^Y-ENFH<%=@H43(`#91A-:?6ZK<= M>1T`6N;?&*2-S].^F-^UZ%@+P!.7DIB M0ZT/-.*W1X?4'*?EK0@@@V0QR]QT-K$VN"S'OF@152:.-QS4FB17#C1NP3): MDDJL3.BB^Q1\:IU,#,03),-NL>I!RJPLZG4[CB-=4\\"YBJFO#R4C9A"U=W!J&OTK$86?Z88^= M0!\\"9)!Y(\<_HLI'"U"F2)2U82=RH>M#(V:Q-7A/Y3F:A.*W3)4A9V?AUGN M(6)C=%/F4C=-M/KZ3O4,O^BV1YV>LAH')66KGAORP`2>O"=34:K6`\+H.6BU ML(G"<^S#FB@$X9T.$H'$F%+Z!,:)(E`!S_O#U)?&S>\=@SS?91%?V2:OB$!` M:,(/&_`T09E!Q\1V=J2N:@ZW'&!V_#D8`4\T<^_82X16[@U&9?]\_SA+0UL; M=%CY*N08G4^&Z@TNC@WPW#.%-ZUQCM]:`>_)AG7".'>N.43`$K5!X8$\I(%G MPLF<(_T?'M_T(W/E4-G4(BX/L'4E%S/@Z7+B M+X>Y0CIS?7^YHJWU)T/&C36%GL-!_T"\AE1,@"?/.;JSY4])#^C)<#WDA`=ZNK7"SF5[I/65&3.C MWQHB=EP@`$^X$TXT[FP=;1/(8G5INQXA9&^HSG7.Z+F&@\^&X_^.&X_S#.!%U-(%;I"3QHW27CA'HBYTP5KY=Z9XHH^M:G=%L*(!G,SJ,F0079DERGM7"_HKFMKD*)E5C M>6MA,INF3W+_[KOO@_L`\5\I*=E;W2&E4O``3VR4J^D#(GW@R2S0CWQ\L[-6 M:+77M.@-4>'>`!*!'Q[@29#XKD77>+(SL#K^TNB_C&!DOZGR*@E+ M+F!'@-P8`D^3=#@D`MK/UI?ZLX%G0NR8HZ47#(\'W3\&(S5]^',C";9>]XP@ MI#[PQ$8<>5[P$IJ$9A3>%LOHN+X(50X*P)-0!)'2\)D#<5H- MSR,W4:(,C"1$PPH@IPS+W/:J-Y20BL"S1OA*/.;O.1^/]YPWNN'X0$PQ;-LH M.!),0LC9:FU22UYM,$J)W#7M^Y7;`'@1RK+!CU_](]1X3(Z5G0)&!.I0UN8% MFM*QIK,=U.##]MFTWQ&:(^?%"&]L)'$P?1O@O\W6#VAI/UGD>66@JW]<%+I< MY%/Z*K_;448V13+7X+\J!Y^R#VC$H_"P8\WSWY&WL5<_W.#A[P#>7)#%6R%H]Z)Y_LC!0][1'M?@-YV2>12@[@49WE&#Q MNVWB9DRL)$5#W46T"A0X$8:F6X5R%&B@2BH:#X;[YXV#T*U%K@N[7H1%,]9R MEO@-YV>>12@[3VT+[?_Q.U8X.C@@D8,)J_)TS41D2-H@SN7@3.D%].IAB)+E M>LZ.J!1H$'^ELK#WUZ/\XP?A7#"6I5H/'ZD)^S=?0>>?J$_[A! MY#+E8#(6N$&:WE)MAREY:E'C`+TC2APFRT4D*/)*.'9C.RGZ\!^H<+59PP`3 M596:#NC!2G86J:,<@?PUNWB;K?MXFD]AX/46#E4*;^`=I=U+Y.YL=X<=@:+C MA?JHV[H%H-C?+1F<@JF#G_D*%GV_RML)?&,GP=A?.`%I[?P,_@/>AZLE"Q-P MD/&PT,7TS0@LU^&6,:\Y"003`C3E^72FFL?%%"3R:8/5=I:[1W2!/\4^2&)_ MP7U;G97ARU=$ZVB3I+D49C^KTZP\,"BL."#-G/YN?8%_Q9>]-U!FP8..ZK): MBK:1H>3/XR*&^NOG([WQ*O9G\!/&#V@KAD?DZ'?&':UUT;HR7%)[9><@_(_Y M8G;YM];L?G$[NYNWIG=7K3^F#P_3N\6\]=,5\G3#='^FTARH\_KZVGXQ'&^G MFWAN?7IO+^WM9U^?>"Z6_=-$-VSM4#7TYB%R5_M3$1H.H="P6!32S0R/^0)8 M*[SWL^[T+0KK.@TZXZ$JO54(+&$49]J=.Q19#FR%JVXTYB]6#,2*S]'C#SHX M%.G=F,$QKG)PC!7[,+'!@=;ZSO24.*2**%/.(>57)#2(UNEV*E5%&HGYS9/I M6B=PJ&;65DA,10M]'<2L4I6JB,GP0_APJ&;&+.%.Y*I1909S`7.R3_9L#-)_ M(\>^L7<.+2-VD`G`[Y86.M6&'?YWU4)MJV)DBF&B(\"B^JNC6YX]2BW=0DX'+(0&[Z.4#\5']*;??&PY4+2-1+\5G&;^)$%TL MJK)=>JP?"71+AY>2BZT7^`WQD6**_&(5O%$IJBK>,%QTME[P]XH)N16Y.J+V M8`K['9MHN]N&XO9ZZI)-'?0DBT`I,%,*I6D'VR_YKK\=2*VN^N-!3U79)$4[ MV%[$_B2H>"PL.#?JC\<]5>=?TJ24O(\_D:-;V:8O=,Y;[_'AJ9_SJC)Q]J$P MZ,L83;Y#H\J2-*QJV8IN=NFW,PB2RY6@`UI:%']5\B^XS#CJC M;GL"[,52)%Z)0V.YI%&%4*5>7,XPDT^FZ%!9@3&.UU-BB97W"[FMA%9?/GF. M?^,[_-"V//3F70>9P;Y\00SMV:&,05RT[\/"\;%W%.1A MJK(]MG1Q`8UJF4\Z>:P#/$8@+^MX`(9?;5+94:ET<4^4F#S6H:\T3HR81V/R M13=,LN#>V(Z?N(P@P'JT`VOB/);Z1&DJ8"OZX//$V$JNI9,\9N0M^7?=^1-Y M83'X-2(OK*["'!0]>$L]A^0GREI!FX7,!?K*524*?VR0Y0]DA&:O%G+`KFTQ3XPF MX"=)HZ^0AYRM884Y+WEF%H*@HM*J%:IQ0B.F)N.'PP=H`HRR.Y4^,O9U9?[=0VE^>LOJ?,YMP,P-HI M;`K/&8!/F=7K*YIZ\SF%31@`Z M2H)3NVU"TK!\MU<&GI#]7[FUEH[_"[H9;XG4B/(+W,/;W`IH`)N-5=N04AK\ M/95?;7OE3JW5G6VAPV)G[@*#X^I+(J6?)VYCFU@I-[B1W]9&'5:N?-F$+2I? M4^@H`W]*ME,[5>'?C8=/'?$('$^:'%8)]6@*>:NT)R4YT*VI\FUZ^,+:/[Q2 MYG)6I<4'(CBG+2F]/\)))!.2:,1/.O#\8$$M/CJ]D[;^PA"]:L;$) M"[VT!Q--632)3P38S!*&D=(":#"2J_PS]MQ?,/%1D('57=B,K>&=[?T#>?OB MT.U)5U/FIRJ3&C;YJC`6Y2O0;?T56B/'2<7V#\/;W%HKN0&=&5DPQ>$]?=/!W]86(E8,0$2-7,/-/;?^'^S7Y$3_,W8 M&AZ)851=L%..Y+!Y697-*'6!KMY28?CQ_'P,0[??".H>2?Z!J)MA,TI=H$=. MIU6W5J735[;&K08TX'+OV/XKI+@J,V>N[TLDM;7^9*AL$Y'?/VQBB.%'HV\? M]T;J/B0YGE2\KJG0`S8YZ[$G)3GD:ZJ/^:`\BH"R0,Z6%*S7%%\#4R)W`TBL MW%YTF09ZMLT5=`K#H@9Y+[D/*P6N"@DXN9?ZL^'I)OETNB6O*=N3;D?9A6I% M,L-FJWI#4:8"C0T6QM;_XW?D>E'M9,T_V:DX<%-,4MBD5&43NM(#?2IXF-.5 M%D"A`ZK7598V)JMCV$SAA"PT/-`[,EQS<.R"I?]7_'/?6?#W[OQY5DKU!9P+ MLF"DIUFGMNL]#@JY,V^#G,5&M\)\`+_[1X"Q]PCC";S53%`+V)RMPY:4WI#W MNQ5`XI]Q1WLN_QUVX\E^J-.9^MEVI@,!Z!ZZ,$"T=`\=I7GI#L:L M?!&R$[-E2W&BW.2'GI(/Z$E;600.%;]^6YJ[%1F39!"&9TX8"_[#.>7RG#8A MA%:\'6M_@4$YJ(K$SY2)L;RC!<4NRBPKZG:9[T32AF3&2U5 M,9IDF)F.+TY0%-;`DC`P[LB#.-W;8:C?F7H,QHP7,BG&S6ZL:?;EAV9?8`>B MB1_0DKP?CY[=DF/\N&X+.YO)0U;A\Q0&E.JK:021!FR4B!\D?Q:O-BFU3?Y_ M31(/T+U4J)K_JGM?7IN?*]SM-HT7A0"#7=TU5&EFH06V*!2]K/Z:PH><8Y/Y:V/34,N9*=O@%S6Y, M,5ML[)VK6RO??0_3 MKNTS[SG&B^X1+V[I.XXQ5VXLXOD6Z*1F(Y='!G;)N=]T:Z?C??LKEOU]CE[P M?S8QG?'GY@O*G:$&`_X]L(0>:^:$9,Q@5WF[08_.7EM_#!10MC_F/\.2T&/- M!)&,&>QB:M_Q%S=SM+2)8N*#@'_]*-Y1S720@Q#LTF&^CC?&NMA,R#\Y%.X' M`@?*X@.[_)6OXF)C.-[[C>&X7@%%A_QN1,G>(-!!#E:P+VU/L3AF@;6OP[\N M%.FB9O.7105VW;'?=A8J,LOQW[8KT$/=>X9RF`#/E?+;SGPOHAU_3<\"/=1N M\5*8`$_L--T][8HL6WU6XKJTB;U('W7/[&5Q`9Y:9HYA\']=7,4A*^-1VCW6 M@MW4;'T9Z`!_"#Q;>G8A!0<3_O6]6"=UGP>41@9XCV=ZY*1DKVB??T]7KK.Z/3]I2`&O;Q4I2HY`$,\Q M"%M;_MMS$GJ$0@XYF`$O?B4:YV+J.N#G1^G^&A87S,0+>!4I/PA66,L^*\-1 M5H2PD7R0A!'PC"[?]=Q("9/H0Y&)0;R+VN>"[IOCPVT*OY\4;(6$H.6;F]RD80H7%`#D+` MZ]UQQLJ8\]R$W_$KVDTS(HF9Z`"O",<;+V/J..;W^PKWTY!X8B8^P.MC7:%E M81W[K%)J*1PHW$_-')""#_#2>4'`X^B2_9%^5X:#\(SHQ/(P#U_Z/;\WM2DW@70M:1BJS+$?R7!XIV4_?N3P(ZP).>[V_'B^O8%UCZ M"_<#YO5`"7PH!X#Z_\=3'#_)635K.&?^1EB_/#+`2Q-QSW#L(!?_PE^\HZ:L M`9D(`<^"):`#/$$E MIXJ)E6XP'D@W/RP?H#PR>Q\`9`K&HZ--?O5$)O[&.?YE4:$A7Z#AON,G,/SZ MB3P3*=!'W>Y>65SV=F_N8&*',$)[&H#,K'Q\NXU[S9N(I-POV$OMCF!I;*#7ZN&G.%O-DO>_FL$# M62A1,M1W!O37ST=0?IG>+>>NG*-ETRT\]WPJ@:F'P6F'6OM8"_^GJ M2Q_"UMIV6M%$^G/KIRODZ8;I_DRU.0#B]?6U_8)-L---S*ZG]_;2WG[VD8CG MN9]:JRA!H)7,@[__<5P0[-M%8H0R'`**WCQDK=#J$X>/%27N)IEM>X-),N>S MG&(M!QUQC1?VA*`L1;DBO6LK4I,]W63:G;LZ4CFPP2?:3H*42%3]00:'(KT; M,S@8R;X5@PT_._@#4=1'J-\;#E11).JE^+#PFPB]'2RJ,C;'^I%`PG1XH]HZ M3+VJF54E$D?1PJN"."I%544I+%GQ28HPATBG:P"PY\U]\.I!XQH@.2;!+OJ2J;I&@'NY+` M?+E!JYV)9NOB#M5"?S11NS\>]]H#18ZJ+"E++D;[:5V1HF*K9DXY,66F/5C( MCC!12/<-QL)9[A[11;2@R=I8*C*G^,:R;I.F0*-P89%F55EUJB;^00#Q:??GD.3NT_]"V//3F79M^ M%U\^N>B)_$7JH-9-L]Y!K,BQK'40%^T[/.R8[3S7TZV583T]V*9Y8SODAR3F MQ;BO5S->GRF#/QNE M$AE.FW6YL,,NBU96_>EJ9032[X^OW0@&##JCX@V,*3)3\M/F+*_18!=LDS1R MB4-XM_-C3]IPPGIQ!X.O"7%/FZ.9UH%=*$ZBZ@>KB[^J\%<04R7&A^%=*OBP M*]1)1.`/1#*RH-7T!3GZTQ$@>#SVP:[NG$I\&"[S6A)VY3U?V\=\0!Z%`7E` M1#B\=;RT+=\-VNGF`CE;#8/3U=32O%J%&D#Y^BP,N\:@Q`A)WGR@[MB_(B7J MI'FAO;&",!BOD6'??HB]!"!/#-QD+?I,/4FJ4/[GM>4Z:RSIY&$OT-9'R44^[C#A=Y MI(@.$KN#4QP]OX:O23FGE/JN7LA3Y...BF+&CO:IHY,<`==OSX:C!QLQ3E>S MI^PQ2=7:?-RQ4,+LIWT.&HMD[8^`61F2P`4FZS^@%[NZJ"#VF+08["AC6=4/ M5[1?'=MUB?*=^G:\X@)_/,+F6.VT;XSZ6Q.Z*W'IMB1"@P`QJL^_*"?\QZ.R M@#6!7TDE>82"O$]7.P>C%RC@*^_&DQ!1MPCK-NHJO+@G+$\#R5<*\X8'NL7] MC;([58)^>,&X0^!H< MWR/P[PKP7V+F;;9Y;"D"V*E>KLC++`8NQEDRC1L3/E8BS5C!.X&LP!DM53%. M9)B9CA).4$X[MA2;61)O$GK\E6)4B0%@[N5\_*H@SIEJD-.FY&'@+`D"_V2E M4)*/1TQ.LWR`N&;FE8LD,`+YUJN5[N-QN(3Y@`/&GD2K41_.X5AK*VL.Y9Y&%&2;0^'F>#/Q8AB_4@@83J\YV)$ MYV)$YV)$YV)$YV)$YV)$<9NRY&%!NY MYV)$(#EZ+D9T+D94,^_.Q8C.Q8A.A*#I7)8+#VG-5HD+W?,Y5B:#3^ER52.8UGG-5 M(MA\/UIT!J0,D8_-U>MRXW!'2W95A!!:*- M;6)EW;^TKO^UPRJ2TD-K8VEXXJ6'PDYFZ["+6RO>0=!\V/BAX@)UAH)6"(ML M"_<5QBFUL;H4W,P>BT>5]Y=:[W5C=6M=ZL^&IYLT)[>Z%XJ9'4L8XWR6B=+S M\L$`.Q[R0(IF66AUK3LDD0$-?_>'`V4'N^PN*S=?KN:P-_Q8S:T=S$[SW:.[ M=(RC\XN^QAB'*8MJ=F.5FX9?M_W#V";9Z`$M$5[&'TT4TXAQ)"EHK>-FP=@M M2]_(@GA/!]J"H>A:9ZPL=4^BMSHMF-`7^*$3]=V"=-P#O&=25@'CH*OB?E34 MSI&-7#_?/]9`62V$S)YE;):RC;&_(LH'0",J'E!=ONT34FG#OK+\_(GN)/`P M9BW58DNK#9`/>X)MQVJ>3L+^%#"4W6*7Q\'IZI\[U_,O^2SLE)U5[$8YC8M< MVJZ'E1P/E3WA*R.80GXS]Z-2((1]A,2CI'_(BS4:*$L*PRT%/`8<@P/[!.4. M>;?6TMZB;_XSNEYWJ"RX=-!5M79+U9*N3!V@-[23P=&V-NIUU+T)2/17K:&R M]8VL-8%IK?CVW'^%%;MJV!XI=!2R.J[6@)P04$MJ0#>[=.V>K6\)++JI37PY M.Z%2U@UZ=':Z\ZYIW4YG//4Z'>T^O/CTNV[ND$M",!/^Z[WE.ZS6SG(!B@;V MZ;$A^(JO+/\UQ?(=-H<-28`H&X">Z.R5#;5;QR:]J;72^MWQ`$]U?^A.>*&7 M:D]T7VP<>_>T.3YFQI#T!AB2'QB_:'P,6`M]+F642E47KRJ#FI(/Z/9,.2+1 M^XJ4V/ MZ/\[I4+(3)&(2L,:V@T&8[IYVKA=XFEJGD]@Y#/I% MCJU*]0IHG2H&%25'$[UR'HWWJVZ_R"E6J5X;1HXD5)0<0#WEQ%;TUCKPR=CA M!589:=YM>&X'->_%A0"@U@7J?HHHMX\V]/E]!_$.X%HW"0"]K`G4>=PKM]]6 M<7!W)'#D(MY#7?8M!`$U,%"W3DB[/7U'_"Y<@1X`&S@)`34P4->,$0C^3;?\ M4^0A5F["9N^@R`#F[:#V2+@``+#S=8CHMF?NH,C@Y>T`KG&3`,#.GIVY4YA9 M4RRM.0J49.X=N_P^5IFN`&V?!$`)30_4J2ZFY7YG*'#EI4Q733!]$I30]$#O M^.=HZ8>I281Q0J.)72;-)9U;%[(/YDKD@+1$(J(&;X[ZE:Q>[;ETJ!IO7`V`#)R&@!@;JRN7L,"--M:RP8T]: M+#:_/U`;<#%X*!6`.F(E=-W'&GK28K/Y_36&"DEXZ+47H%Y;IJYX:W*S(V4" M]AN4V=*S<6<'H2CF4-`D16Z+R@"(,C)@I#0"ZAY*UG\_C#1)(=^B,C2:1DD8 M*8V`.J$Y,V^HKC;,6H(E7[A[J-[``!-3`0)TU(>UB`>\BA[[UB=Q?X7]<7Z`&P@9,04`,# MO7^;-3_U,HZ/G(0-LK4[*(E3BY7%>^[5/TOSJ4]."WP?GZA9;?DH\.\YK'ZQID^I3TS;E M3>H^OS?9WZ<1=UCBPEM^#S7/RV(04`,W)<21I5WLPDB).V_Y/0`V3[P_`V=[:'W'O]G51*]3.AAIE/:5(QK1-["RNI"DQA M(0!=!I`")&42T,B7;`#VER2ZDDJZ%!:BV4Q*`DG3SP"-K^7=NWM`GN'X8,[6 M?5^#,%HQ];H#QJ-\_M"JQ)X!<:8X9)0H0*-U4K2.7'G.`H$JI56B@&F;`,:B%0) MQGZ#,2G\XD>!0*?#MB3`E&U`HZ(YMY#O[)?@_@31'T_PV'U\08Z+Q9VMX[XC M<\0->I)\IS)R`%H@9<%)*04T)JL`@]@F1)*754:.QE,J"2>E%-"(,"\&DQ"$ MP[=5]#75A#6F),69"@L!DTS%@:1,`AJ&E@W`?BCU),69"@O1;"8E@:1,`AK[ MSKAMFG$;8E"J,&=.![5?]Q$`@%H7:#Q:1+G89:92=3IS.H!KW20`-(LUT!@Q MZT0NOM-+N1-1YB9U7@?U'TGR`T"M"S2P*Z)<[')$F3O4>1W`M6X2`&I=H-%8 MCMR+B2@.]4;\HU'^*GC\X[T:H:IE4?5`4^8U(S*;F]'#K[R(D="HUOT)(RF, MI!P71?H'M&,H"Q^E3A,#&&*ZQX[/)&7&*-)_8ZF3A(]2IXD1BYP+';&242$6 M?M!/TI0CW#D@TI0"CC(&:&1"FN*Q.+&DJ4:\]X9R)@D=)0W0@`=72G-:QZKO M#XL,_VY_UN#[=_P7>56)`-8@<3+)K'LIGTT#I=K='QP1!^\'-LL^KM61='5. MIERP"*8$;KIZ`:5@#('Y[M%=.D:PNN-U?3@>82V(5FE#;NJ-J>+DN$<@\"RK MVVH)I`(L6I6K`S3.S.OX!5O/V)`A`R;;\].TA3T9'+A\_`Y097+!]+.EPAUQ M$*@;I6[SH746MC8YP(1_$JM*+)@,E`EV1$"@H2?&U:7O^GN7)*'JICRW+Y4% M,Z/QVN]L<2H>F11H+(E7LUA:C%*9:S,:AVG2I.*TI#S0\P:&8GY.#*V3SM9^ MJ1K#F>*R@`HJB$#1DHCH)L#R?KO(SA]2=4L MB\K0:!HE8:0T`NKBYP4'N^/!2-N'!NTKPUWB+SZA@R>1UFJZ7#H8BUO+0[B5 M")DH0K@?7QU)-V"D"P>(>$J!IXP$ND.I"IA8S%K2-3[IPITF(Y/`T\,"H#LL MT4NS9%^I^8%)>N^HWV/6B$!FLN> M)("4/4W<+>+)=C#L#CH=\:/;,<,_D#0AR9,*$,_40$W)!_005#DB,5=`TGPF M3ZH3(U\2:DJ^)F8_DG-M91\3GDC*AB13+E@$5`(WI6`3<[H=Y;5;;`S'>U\; MCNLM7NW%QMZYNK5:O"+S!65#<^28]/C/9BJ7#Q`E5<-/HR1`+[!5B,W>;>D5 M>4A2D7PG2\TD_)2:'W;69(7;)5WS52'?J5$S`WY*S2;ZE'*QB0U;2;ZE"OE. MEII)^"DU@>ZU15ZZ)E,J^W=@#>MI]D*0\3'AGB0L0>:,>VU8]?$#WH5WSUS M]E*O-U<`"IK*!>CD4U##6)RS>"Q/J*]&&#X)"S5_0\;Z<4A\TAL-CH]D_,*Q M/7+\W!,YD]'DO5*6)!6@G:$:J*.5IHGW1F1`$CN.EG?Z)4FJ$V-?$FK*/JV) MMS#C$`1QFIOC.`WY%"%++(@H*0^,`O$`\5$Q^!$QF_CN02HVL2O$WNN'N6>N,XEO=,?]U&;!7B(;P,)F!.5(0YW.9&%KP^%!?)@_$@I(\KJ#]B!, M%C$=Z'Y6-,*<@"@KQ-SM+NSA^""DQS_/52@9K#BJ(L@C)@(][$SX$>'K[@'# M63B\[$^!:W<'(X'7[N4[K-G1*@501`>MW3U-.E!W<8`WZA62`H0/+@&L&$'Z MC2#(\>7D?F_8'8WV>:"_Z^\B^PYM'#NCQ[#(RSDJ43)`6SUUD,>8./S@3(P- M4WD)DJ7+=[*L3,(?X^88(C<327/B>7+2H/`5+%%+E:>/BGWNLC#$0J#:R=@Y M1F>!?5GQGAI@\R0D,A"1F>9"[R61]Z;C?$J0R&::QNTBN3[%NZK)Y<3!B!A^=DL'W MU"Z48;M(9\TP?A*8&`6`[]+WF@XZAW-;/,%\"N,+I>4NW&/]9"@!48P1DQ-E M1&P8"+Q?D=5OX]B1A"O.D0%`CD3X7/]KAX6ZM+?/MH6([F^&#]6D/3XV>URL MM>X^^K+MW(LG77_^3.CP&9F>2S_Q"7+1T2YZFD^1\./LGKDLSR;]86M7/D1M M;3SJJ5*$V:-,ZG*9)F)QCOZ4D"H.\`TLK8M_]P(KIN],3QDEAZ="246*U$C) MH1`EAS%**KD8O*W-[.;U;M*:7E[,?=XO;NU];][-OMY>W MU_/63U?(TPW3_9E*=Z#;Z^MK^P4O+SO=Q(OKTWM[:6\_^\K-=]NM[KS/UG/C MR3+6QA*O6=/ETMY9Y'K/O6T:2P.Y8>.'FJ,W#UDKM/J4S]Y[QWY&CO=^;Y+F MK16QYC/AP`*W%-JRWQTR@@5RN,S1?_&A24BY\Y`3-?K=7TO;FM9CQ#CE*)32 MIX3A6<14L6)\.4BH7#DD7)/>.1@8//:PWC?&&_F;&ZK0[4T81U-RC)G>;JEP']9&^?'+14Y"/1.)XT$U3[0BH>E\D802DMOW#1>N=^@`J)SW"O!1&"[6@_Z-93N'KUA@-5'F?42W%>^DV$NQ@LZE"I MJ-*V<>GP4C:Q]0+OTAXIILBW4\$;E:*JX@W#J63K!=]Y3,BM:!D1M0=3V._8 M1-O=-A2WUQLS3D+EB'O0DRP"IQHWW?][4!JUNMV23:)]U2535*T M@^U%B.T%!@W8-I6+XRC24%8<)^>DKZ@QMRXW1&VW95@M__W?QC:Q MRNY?6L%!-CFO71M+P_NY]=.][N!?VB#/6.JF\/DM[72V#KN\M>(=!MV%G1WT M5/@P][S3.^_TSCL]Z+PY[_3..[WS3N^\TP.[TZ..2^`]#K1A3]E^[J"KLG

7*_D4.^^RE.RR^`P% M>"_%-]B_';Z@4'7NG>BNQ$$^PS*JQ99U*,\!>W0(GZ;FR1RU<[SB@[1QR+QMA0%?!2Z$H;^.E[F[:VJ@[4N8@\\NAD+P,#Z@8/K#]H\,UF;X@ MFV[)S?SVI,[XVK-R@E!:$>@J;=]F;_J>+(DM^/Q(JH'R#AD*0]B MV?NOW.OO?JZO5]VAF:LQ<=?(OX3MWEH!K]O:<,)Z2BEID,L7N.+90"WB(=V` M9@R_0H_>K>7B99FH=6E;+\CQ#+RD!W\E+MR]8RR1UAZ-.LKNE7%+42TSBH`3 MFAMHVFQ2P,6=[Q[=I6,\HA7>J`T%"D(<_7:UQL@0/<0<:()HSMURXK!!91A` M6-#PMC@159,BJK0+\N+P\H0QDOJ"/R_A!")Q.`&79S)$K9IGJ<_C>?6%?[[" MK0]W\@XY]F,*FYEEESY.'(Q*5+=DM*B8;FD@95D M%EA95U^2'\XLM-=.$\@.6:"+FDE0%A78@08![1:O=DP[@=20!;IHCLV9J,". M-B1KFW&3NLN_`!3LI6;+2\`&=MA#3,$#=G?YMPX%>VF4\9G8T'KS,(V?R'F< MRN4B*1XSVJQ[/A?5.S0CT+KM6>HPC19=JUQ^]9Z02Y&-JX8 M?[D3L<8A1SHRD:`F!AKZ2F9R3EWZBU0TR6H4S`S+JSDU)=3P5)9"A\M_D7(E M68U"-B530C_?NQ@O\>%[RIFSXYZ.B*2(\_."BA M1\BL$<>,,@1HF#&F6WA1WA<&3['^Y?G MJIO!#*1H"8&&JA,7B.(+809IR8]_K!ED2[`7:X00X4:'6A( M\T8WG-]UR%\BY6*Z\,P3`!4`'`!V<&EG+3(P,3,P.3,P7VQA8BYX;6Q55`D``VI1?5)J47U2=7@+ M``$$)0X```0Y`0``[/W[DQLYDB<._GYF]S_$]$7,[_'ZS].C) MV2JE1LJJWMFRM3.*C%1R.Y/,89!2:?[Z"\`19)",!][AH&IVN[M*8@#N@+OC MXP\X_OO_]?OSD_>EV)3+]>I?_N1?3_[D%:OY>K%;CZ]N;__D ME=O9:C%[6J^*?_G3:OVG_VOZ__Q__/?_UP\_O-H4LVVQ\#Y]\SZ^>?7+AS?_ MTWN[?*J^+;V??GKE_?E/']^^^M-??OB!_?QELU[LYM7OURLOF/CA#[[_PR3S M_F_/G_QS];\W/\,OJP'^\<_DOS[-RL*K"%R5__S[I\W38OLO?WK<;E_^^:]_ M)?]ZO=Y\_FLPF<1_A;_\4_U3\NG^EU^_?KW^&M+?^GF>_Y7^[?ZGY;+MA]6@ M_E__Y\\_?9P_%L^S'Y8KPOZ\J+XJE_]F:-3YO4A7^=<]!YR_( MO_U0_^P'\D<_^,$/H7_]>[FH23QCIGV2/U4+YWFP=)OU4_&A>/#(__[RX7;_ M]<.L_$2_W)4_?)[-7OY*?O#7I]FGXNFOL]^7Y>OB8;9[(NM(AWG<%`_'"WXV M`-G$OQ9/VY+\"1FM_('NZ\1G7/R_6\;=?GNII*A?B M)_+/U=2!5N([QM;+P,-F]OFY6&U?K^<[\K]4K+2RT3N#&6;HFAEAXFADDZ(4 M&A2E4)Z!4Q.0`P>+XF53S(DQ[E[ZHT^?-IO3+XD%RHD%\A-*<\>8!FA^7?V7 M";K/QM5&^ZKX++/8[+-3BMM&TTWJ^V*S7"_>K#33W#ZL&>(_;F>;'M,B3_[Y MP+H9N%]O9T]Z23\?4C?1[PK-JWTZH/95KH"LL"$96.6S(342+;&\VW,Z>=>4 MGG(_5?_$?DE&[(&6<#("6FZ,7/R^+5:+8@&(LY^16?YES]5?_#_NYG/ MU[O5MGP_^S;[]%3M-O8Y'*WFSJ5E^V*R?-7"\75>#S#X)#>('499< MQWX2Q/&UGT63)/Z3M]XLBDWES?W)>ZFLVV:Y_?8O?ZHAOMA>7 MV68^(`?L%W^=KRL?Z&7[P].YM%4_:5VB$Y'0P9N`Z)[3N2G*]6Y#/;GGIXHL MXN06JQ]^^?@G;[G00^"T'L!C(WB5Y^RQ,;S&(%<>&^:___6P2&9T*OWN="I5 MTJDLBH-)!!N;P,8FEZ-5[=SQZ]6VXT34K5RM=![4ZZ6A7C.F7L7O+\6J+$HY ME?I0S(OE%S)HA5,.$I7$QL^EMIGU*`T?3Z=:TOI5D`:P&2EL1NJ$2O"R8NM< MX:3G(.>'#ZZ\ZA/%8Z-7'HR>$R/)>.=)T/95RJP.VXT,=B-S5M`[^;%J[44H M:Y-[84G?/>^>:/B'!H*6--Y9_?-30?Z!'#K/Z\UV^5_TS]]OUB_%9OOM?<7" MMOJ[-_^Y6[X\4PE*TYQ(4&Q*+;20J:Q"IA:KH6]ZIO#S<.)72DT$)IF`P.38 M5=,HZQQ:/!0?$5%FD[Q,?RK*\I\)D*MG\1:-:48V`:;`WR5:@#90J6>&,&+. M=DZE)IU\'\K?PK8%L&J*]FEC;*\Y^)6W'QY")HT)KKQZBNJ?R"17]"?[>03- MPV*Q!-%X/ULN;E>O9B_+[>SI.LY\@R'(]DD5E9>7D[TN=GP0329@D'W8)Q^W M:O%S85Q3N$F9'G[JD=]ZRY7'?JU7?,W`U3'$]QQ+MG]0.Q,,5`2PY(&+,MS) MBAV/38RHIDB_,)&>2XET61;;\CJ9D`"(?YT;D6`ZAZ+`=M"YET_X>[I:/ENM M"%8KQ"V-O80+R%Y'3II']OI(F-[?W=_\Y-U\_/CF_J.2;)DYW/7+UOG1#7^? MI7$&BQ/"XD0N"%8;U<:/YLZII_!7,G)T\ZG<;F;S[7423,P=MD=3Z1"K3K*/ MI6O_,W^2)AGD7A+(O:3(\\H\]-LY0SDHF_?+APYMW]PJX[G1?#9I#@]+880WKGV63D$$8 MR`^GR#.2@\3;L84]%#!3*)M,;PY_.-E,AE_:9M0HB9U,M`KD`=Q0Y89(5PJY MG!1Y2DZ$#XMXD8^BJ3:#>;KAYNVF!:GM-Z/[7U?V@)U'D)7(D">2N)FP:E;[ M*#DUK]*0\]6L?+Q9+??YT][8KKRL$*C0DQ M%PEJ0BW)92WE?)_[/HN#I)"2R'#G>.29,JT%TI1-R2O7W M'AW`I)X8@2CH].0,PW!N'#UY?=@[2'5DN%-)2GQ9P3@J%!ZT9D[^H3A\+Z@B MZ^?GY?:93ER1LEYMJXF+U7Q9E->I'_CF#I#NB175082CO1+T?.3[^22$Y8=8 M>88[:R7,B_&C09"@:>,#.!B:G^B7;S.&?TSY/C?R=S__?'O_<^4D?;QY]_K5 MW;O[VW=_>_/NU>V;C^_6V^(ZN_;S($]CJ$M*(<.8X4ZB2?-DQ[A+4C<]^JFX ML*]7'[?K^3\^/LXJ(C_N/I7SS9+N$Y$.@Q<:^N=6%WD1OII6O?H!^8[=BUH5 MV_4#_8/-OI!^_3"IC$S@5YL0S;8_5P+X&/H5EW[UIZ^K7SU_*C;T#R;5S"_% M?+O\4CQ]8]O';!=D$S+G0.KP1Y_%0LC"BL,0`VLL*V MPK">[_PH9[$_R!EGN-.?$MS8@&)B)-6"3K^Y`B_\RCOZ3$WF/^YUY\?=]I?5 MLBQWQ>)H_,.=)R(Y@36-$*%,K[ZHK4F7-@F-ZD=9#J(`Z:$,=Z)7.Z^V-5&5 MX!,]I6-ZAT&]3[NM5P][HK_2EPJUB&TLW9WN@G7YL"AZE)EB&"@?3:'<(,.= M+3?!+H=*]_0QLZ39K:2WHDWZK;=1UUV(,Z9^:*Y6Y'0V;2K607N+UK!H:I2S M!`1+R^%.S'/1;_&HZB2B'2;>4EG7))BFPQ8F!;,C-''X);M,$L#-_PQJ&W+< M*7AN'BP&`8:I.;*E5]X_>=>3R<3W7F8;[POY[O_K^?'DJOHS\A^OI%Z2-]MM M'ZO%_Z]B4?VU[U^%67*5)AF-3OL3_RKRTZMXDM4_!QM/_W:]V](VT22%.=MZ M'ZM5IY$&+YQUN5R6]?VAX&Y.-_15&K:,D!U MK2K'/X-T&(1C,DB'Y;AS]EST6U$1'DJF[$"#[Y5! M"4...PT^3+QI^#!(02URGLP%I+?+U7);_+3\4BQN5Y6A_;PD+=3H0.\*TDXY[H2V'$-6+*H4:=/WE7-9Y[:WF]FB M>)YM_E%>>:MBZZT?CMJ]S)[)7K"&#^0O_RD,KX(\IM_^DQ]>)6EF1F&,&&\, M"G-FWP<^#-,4O)T,*A1RW&EQ"6Y,GP#B)$WADQ_H-][A(Z\NH:V^$Q3[W:8: M<;?\/HX2N(J20;8PQYW*5>#*M$+(DS;=?^HUOCUJ8RQUZ5)0A(Q`''R: M<@9].+^GAS24VF>0?,MQITF5^+("B50H;"B-;)JST4*_.L1H=N!Q_53M9TFN M7&R_7?N5?QX;Z]@P-+V:5D@P5RO$\*0*)Z)PE3W#G2F59$E`#^?8/DL2Q MCA`_W=[\>/O3[?WMFX_>S;O7WL?[NU?_XU_O?GK]YL/'_^:]^?=?;N__PY1> M&`%76/3B#%(-?AH%$4.^-/?M3W#G:*7X,0VC9(B:-C[:M[G=?M,K]?O;V^$D M,9_/K]^\O7UU M>_\7PYHTRC$RDB8)GRK[$2K#!R`X]V$;<2>7E?@:^Y3I(Z[CM)'NV-'Z3)YO M,-&F^[DY+@9:Q/W0\"R`=H]Y"&N,.^7,R8%%$>XAHRFLDF&DONTU[1@;E\\^ MY_>H(1^K3,DC6%G<>5Y^)FP[N/WDG#0Y;(`459%MGL/FNL!VSZM;@KOYZ1;D M!B8,H.XDCV'E<>=S!3FQ;WC[R&DUP!JQPID@F'9+;0MVG^O9V@/0A_Q*GL`6 MX$[JBC-CV[WD(VNJ;K/797GH6/*-/G,[>SKK>!1D!@O8N6A0E'A)-O?2S_<] M>3+.A\JI/(--PIW95>++CDXH4%B=`MOE9RC4+/?)+J,*8@;@H%.0<]S#]7T4 MI]#-($]ACW#G>Q;Y=:./\_FC\M5L?G6?%B/E8D% M66:NH6/WQ&HJ(<10K0=]']';/=3Y"B<3V!#<^5MQ9JP<"<)DD0N&+[MJ1MJ5 M4>(E1AY1,&+YQY3M,QO?\U$>1,P%@_2@CSL'*\B):6LN1LYT__/CQT6EZCKO MMH_%IKY^&&9A;BR^V)A)37;[2:Z%]>A7U'F*P"I`V,O'G0WEH-Y*#'&8CND] M&=U;DQ]Z,XGK@JW;:<28FI7`,W/9_%4<1BDL'.0(?-Q9Q"'231O$@?FG].^E M+JCIXTX!"G!AQ57BIV=Z=_^O;SY(/=CS MOA+"8K,I%D<-B9+,W#NV+3.JB2H?"[6LMO[:GP3,[X1@BX\[OO?;B'6U*[)GYK7EUW4[)A\6&J+F/N[$G0@;5@RL`$$-`:X[79TU MN@KZVERMUJO">B.KBNB7V7+QYO>78E4>;@=%*7DDTYRNG,^IK"U<;#3TI>WW M-+Q(RWI#'\*+/NX$GQ`?MC2&FZ(I^[%7P*\%G;V!33<%32S+;AL\:?E],DE" ML$@LDH@[]\;/A`6`PD?)7EK93R4K/]]OUB_%9OOM?47-MAD1;I1'&[P+,SB] MJC`+0ZZ%/P8J`/^[#M0L?=XI-FB=+MEJ.NNG[#W?OWWRX_P]ZRX7<:WE/ MWMTQI0>&##D2/6BQ[T.?)F'"M@3N3P2XTW%R#)FW^Q)43>NOKCSZW7&*3CH8 MV$D+R]E6.A@9R]SU3VY(#;H8&U2"NKL3*0B#Q($/R:H`=\I/CB$K64`ITJ;T M+ZMUAF^I(DB67_`*B=USP*+T\Q\!\&%EF`"<^I`S"W"G&R6X&W\:3SRH#!`D2']+.`>Z\J#`OH]GW#H*&K+MP]]L/Q7:V7!6+ M-[/-:KGZ7-X<6DR_+AZ6\V4E&LDD-A>H'"9`3>JE&*QEG^/C=)*R(QA2A`'N M?*LD1Z;U0(ZL:?V95W_G_;GQI<<^%>Q@(B(Q1D*?F%3B+/HY_'&=>&2[!8G' M`'="5X$K*Q%0>?JF[.^/'@]8[#8D6[M]++Q%\:5X6D-8J-S./@M>M_FXK08D M']\]O%VN9JOYWF/D`5^ZDYP,1#@9J^R/%8*PS7UV3O_)R=]I#) M"7!G=%78,GV:*-`V_7'V!,UX'PN5LLFVWH(IZ8UM3@WTMDKD8N`@X^<_GF0A MQ.("R*,'N!.]O"R8EUTN.J;-W_VWN@O5S7:[67[:;4D[7&^[]M[/Q/.^?1MO M),9C4W+/XCF=#5?A@DG`,BJXL[?\3%B)W7"3,U5O5]O3O:VR[N;J*$VU%!3A MIUN&C_/BP036'6+$(>XDK#@S5@"X,%EV9-L2E+`FVQS(8O]-FK&"CP`*/D+< MB55!3NSCC#YR1."&-&9N/-1;C72WH3!^08N9WQ<;^F0Z>3?9G"O)08":!DAQ MV/(R=.?'_B1)`2K&D`$/<:=43[Z52CU)) M/>BTYB;6IPS!'+6IP]I$?Y9`SCR%G'N).UHJR8O%(X*'G MY"2`3[S#-_K%V[35MR_>?5;^?`^HG8'\1PPYPA!W,E:"&]M6G9.N$VM^=FM0 M4=CA;BTY_,T5VG=,JEG(NSCI%'#V@3\)0W#*8DCMA;@3JD)\6+?ZEJ=TV+W4(]-WAZG(*C#9#>^,B#F=HRW M73$?-N-'.T&M30R;`3F]$'>>5(:=<0SZ,&'M5GTM*_-OEZOEMOAI^:58W*ZJ M$3XO/ST5K&/3H7#LYGF]V2[_B[8R)^@I"(RI@CA!:@JB90%JO9$9C&81H?-$ M`E&R"'>F5A^35G1,&[G3]]4/R1OMI/9^NYDMBN?9YA_5@=.LL)P]D\UB`]E3 M12/@RR55/$-J$H.%(50%)I#5B7#GE?4P:!K3::%R"J/\0(?Q#N.P'I=77K/X MOSF62E>V[KQ&E)AMX,-!A)JB23/:WLZM)U$:LH;-"83'(]Q9:16V3"N2`FWG MK0LUIJ=%9`D[5P+%+-]O*)B M`6:-HP,#L.KLPV3">A\DD+6*<&>Y);BQ"Z)X2#K'3HH%'6TDU&F<*,G-Q9B[ M)]8O[9T,]4GZ43(+RNI3"'M&N'/>XLR,9N5[R>JT\#(Y0QZQL&;9;[DN!0_8PC]$%&=HB^=)N<6$FLPQK[\O$-]+9\YOG8K4@#2?>/LV(=`RA][*87W]>?_GKHEB"Q%?_ M<"KHU1\=CZLFTOTDUN)[\JO*<$3LTC:D/V/<*6D>\JT()@=8!RTQB@?WHEX6+/1;Q=EO/9TW\4L\V;U>+U M;%M<^^3ZEA;#UC6%8I$;+^'[^K;.#XC&LD6%^'^,.V4IR(D5(RA&TY3]W(/? M>^0#[PUY.:KZ1*\`:S"4XPCP>1URUP=U/PI(_L:X$X<"7)@VJ_RD:)37U^OY MCK[HL%J\66VKG;E=/:PWS[.C?F6!'P5M>9`O+\O/5$(G>3BA\DG^A&M,-6&5 MI+H67:[/_2R,?1]24`$$XV/FOF*K+$`)(P,:X?D_L0@P.3@AA\AAW6DZ,D1&L[@!)9Z)+O4?]@JO=WMH1 MW`%;VUC<`%+\(>0Y8]RI-`$N[-K9/E*TBRI8Z7UD*QDJ#-[NETMBM__1T%>B-`5(&H=7TW4^$BN9:[CUQ.H0PLAIY+@ M3F-Q\V!:#GD)F;)H//NE1W_J5;_5*)P:#EK;PGEV]';\FH!I*!D.(=N1X$XT MB;!AY3`6($BOJ/:VCLIU'=O#DVD18A%F3B2Z]],).(H1Q(X3W$DE.88L&6(Q MJO:BWM8+6_KF`;^PZ+/8""2_RY;W?DK<`DB<1)#Q2W!GHZ1YLFGEA:DSJ0=O MET_%YM5L6WQ>;\BY'VH5_*/1=4AZ/[G'HGWR6[*RX(E$+.*'.TO%SX1%X>4@ MIY96^E.O_JTVV=0&1^S(9@?@./YM#J5"$8OWXD M-FNU?3=[)BU^="5(VX;7(8P#!!]+X^F/)Q!_CL`_3G%GG'A9L".1@W34,GGX MH4=^J4\HM1W>MH2RX_@^_3%QAJ&;:@3.<(H[Q23`A<4#G(<>+2+ZMW6%2%^1 MA=P<\U*`;5$\+_KO6;@(%@ZJ;E+:&\+W[?_EC]X3_H]@M\]^H&"F6S9>0D[:4-*P;Y5 MLV]$=\J[!QJ&)ZW?9M6DK];EMKSV(_JPE*FF53U3JXFQ(%/[=E6]GQ%`/Z$6 M(<&1)/V],V/=9FDTB M6/X,EA\WJA#FQ33:%25H6G_@K1\@&>K5WWBO).1\LYX7Q:)\6PE)/<[=P_O- M\LML6[Q_FLT+,MFU'T\F)OLJ\Q"A*/NRC![:$_(-0"T2W;5DDL*NX4YIJ3%F MYPQ0(7%Z\[S>K;;>9K8LBX5'1()L`OG4>ZF_-:LUAMK8XM.:EJ:V7`,D`:2* M$G)AO-HVY._W*7!E_#R1)FU:?PHJLC]5JG.&?>Z]5U<7>F3=T>TKW_Q>;.9$ M*8D`Q28;W@[,KT])>-EKTX^.;[,H#@-:LUW!`?*O$?)7D:5YLGZ6B%!WHAX% M^SE1#UAO!>0U(#7&CX]QE:+WT&C_-@FA7C9-<]@?=R`6/T,VCPINJD[4`#P0 M]J&W_U)>%?X^VY"<>ST2\4NSU-P#K7U3ZU,`#J;:9/_\L]"'UZS3C.:)(X=P M$A\S-F6>BZ(3>6??["5=P>AW"X5Q$#2&I/="G_//Z!D#@)Z\$Z7V$$0;F_7;CJ M_X:*4[5*N*;\KB!3/4+>^(QN0@J;P'*2N+U9&7:LV'4)PHZ$W82$V[+A5B6< MQXP?/@L3Z``=3UB5$F[75)B7$4QX+T%3^,"KOO`.GRB4V^P)>//[2[$JBQ^+ M5?&PW!)Y""T`E>-9-<'-C%&KVTU+*[K62W@!^* M2>S=2[&9;9>KSS^MR_)5Y6E^>UAO*H]S06(SQ/2;$MKNB=7D5HBA6G1[/YJD M4.Z40(C*SW!?OA'FQ8HXBU(U?5=LO77]D5=!C-*;-S_3+^9&0,:88GX&-7H^ MBD,_@2V`=B@9[EL]@IR8AAMBY$SW/_?([[U7)N2Z.C:6&UIR#[U5PV0RU,_` MA)0?DV%*Y@>9'=:`TR&"##G>%F5E/!UHI:=7":Z\PS<2?6?%!<4RQ!E7*P3@ MS^D061PB[[4GS,O(\*>=JB'X0\!^K1\+\;[,[$7IRKNX* M3.,MZM?,B2LB[0_>E]G3#F1Z]O2T_DIJ(34*MA'D8UFPSUM&M_TZ MF-#>!M7JLR`7[JPF-P^F(0PO(=/ZAS1F>,.$N/JQHK3VN!%IGIN#[P*$:)9M M$8X[1;YGD&KSL(QX&4'^J!7J_($+_D%2 M=KC[L+/08C_#G6_5P9X5)T$#H0<-V\,KK_K&>W?WDTKX](PRDBQF?\;R$Z_6 MS^1_X6':U8*E*TK:-?;'65DLFC\@UR8K>31X>=T$Q9I5U<@:=NJTCME`Y@*0 M.C:781P;88ZA+EM2T@L(G\A(WKPQ%"*38@Z@N[4UL([D#3'2#OEIY5C]%VRZ*Z\Y'GVSOIZ2-9__`6S.T<_(O(J& MY]6MWP<^%$&^PP]7'/<%1&R+%G7 M03ZZVE5J_ZUWHREVVB,U<7#QBA&?M?GC^)HX8A1+0<0PAI1_CKN60HDO#AW) M04=6Q>?9MEAH@KT"-$Y_54TKO'EX*.;;Y9=B7Y3WH6+EU7I5^>:[RCUG?OIZ M55[G/BG.,Y1%XZ=#34]4^-TW5>C'UH7RG%!@_2!`!^`&FR''<%BBF6QU%C9;J[ M]=L['OO*FVT]-KRW'__TH_&TWT@2YJ*T__S9(/7!61J/-E"LQ`K2>#GN:AV3 M;%M)H1AD8/K+]<=K[X&I^?(,0+DW`AL*!S1"Z6->7CU6JU#]@"?ZD?NA MN5HYS<2:-PU**R=B)D0FJE!F`F+'@NRX2YILL(\!/"CR(``D8*;*NG@M@6#U M.+`IQ1@-83AO4J20A\!$]6D&N;N`%0#@+NJRM01H$(D&9J8'R]%2:6\0@;Q; MKQ;%8E?][--3P=*]=]O'8E.)>#"N^]%)FGE3(+`J(HK?/6P<3(*$IA&K!7-> MN[GY1*/"O!1/JQ_^J^T/UN1.(/8=,$G&7 M7-E;!-2GNS`[IT=_V:A[;-9:6P8!''J`"ADX:$>T88B^^MR4/BY0^80,:^(N M3+.T`EBQAQ@;ZKA$8XTU#\LDLU+K[A1XQ:#Y(@0+Z#@=EEZBH`,W?B_Z@(86N1W-RT"L MRU*>0]>H=@LMO9[_M^.'4A`:D@*.B4DKC_ M0*9T,HKT_;70<'ZDU)V1!3IKC*PP^"1+()T3QB`PN,L$3;%L^L0V1'>SQ;CE M=+Y.R3;;O?P"5+^[)[IR,I=AP01$"G>)H$&NK1SOYNCO3\%KT>R.QO%#9:Z5 M#.?6SW!^Y&P@$86^F!!XZ_.'B4Q M<9G`D%K8A`P79$UX@83EPPSD$7?!GYT%&!->Z&5%_BJ"%KO174Q1 MR7ABX2TD*^5#&I@?4/"!FC$X2GS8WU:!UN=)1LD+I/:/NG-E*ZHLSZ@RMTC46L/=8L1`WRX"\XT M<3CFB2Q(*U<1BB5=LWG$(M,UWF.S> MOH+-5[O-IEAM.\+)U_"0E2'UZI];39M$^:IU9^`[/PN@:Y_/P`GNRBH);DQK MACA)4_9);Y;3B-0;`7`(I/X,G0UM2G7\UP]T!0%>PE15JM`W)= MVCOE(56=%>??00=3][--3<5_\OOVQ^O0?UWX2)N:N92M0IJ8U>I>D5BFE4<.$ M=0'U01@"W*EC[;R:5D;=!$_K`4ELZS`D^;<^U?5^HV-[9'"/COZ_1]!F(ZC. M;6T^@X,*HZ8,JD-4E!4E!+B+JTRP:P5(&B"<3[=_K!\R>;]_R$16E<]N@I!` MX'+V:?FTW"Z+\EQF,QN'LA!5NE18=2G.U5=PQ,K60[S5#T$><->`:.73WB&L M3NR1DK9=>:0Q\,.0&D]>21DU?.JZI*X]IZW0B+4%A]H?/P+AP%W%H9M5RZ>L M%J*'E/?J2'.))G\HGF;;ZCJ*VE8IO'XO&Q>&]?F_7]&^(ZSQ;??MO9;?9UNR+A7L>$5?/OQ<5#15P.-`?3#)S+T^Q$6#FNK*LEGK*.?W M81*29'(2QVR+<5>L*'!E^AR5)VU*/_78MQ3I'GU=G8VRIZ*@%!DY_O`IR]F! MQOD]M8@1[![>1_?W-__].;G-^_N M!15D79:'2;_=?"JWF]E\>QT&B;G*QHY)%76`EY.]T'=\`(L=PF)##X``=XV+ M("?&3P(AV96 MDVPQEFKQ[OTJ#_(H@<(+G^T$[MH6"6ZLV&]QNJ:O9N6C]P+?>0_KC5?NOS$@ MZD8,^+BB?F;)^[Z*$Y_M`)R;(>Z:$E%63-MR07JF]>^I8`.N;WPB*-^;];PH M%N7;2CQN5^5N0P+=A]'N7HK-C!PR-\2KIE'R:S^>&'Q<2YP@16W0L0![)9$8 M+*KO&82X"S>4>3.N1HH$3NL!/"(=WGZ(AG)=>?M1O,,P]C3.#*9R2./.$9CX M8*014@K7&D+<-1?JS-G!9ZIDGFC>[AI%V*&^$YNMXQ#6Q,H#HZ MQ)VF%^3$BJD6H^E8FO6*L`4S;$F$!PQQ,\(\@?#RA)U\N%/2(FS8-<*]M$S) M;[W#CQ4R6S?S^:8@>\"*NRMOW&!;G=/9U*1VF/9:7,]^26)J84A*Z9(D@)*; M$'?*EI<%*S:6DY@I_*Y85'BWFJTHM]YZY:W6VZ(DD4M2**%)6HV86DO2>F9< MSWX99`&L+!1]AKBSI3SDFS:F'#1,][^IKY8)=K=XFI7EWXT$3^O/R+;,:6GK5_:E1>TSTV?)+>T[[\DD-5KFLT,?RK!" MW.E?;3R:/K]T$3JE`Q$U8[^N=L>C/[_R]JKXOE;%>L3]CW0HY;O=\Z=B<_?P ML9CO-C0T^FKV]%0L?OS6)IOFZBH4B3.@JBHKTZNU`@.#F9Z`V$",+\*=VC;$ M\7@GJ3+M4QB!:#!MS%UZQ6J[W%9#>)^^Z3Q?)036WE'KFBKS'<`B`V=^!I(! M14(1[F2["79'.9;5:.X[H0]Z?1C;@\&)9BL?U^OG9](M=3W_Q\\%F8D\E&L0 M()].IZB'P]3O->O\I\201A`2""&N&N%.E'/S8%P'.`F9P@\]^DOO-_BM8'2Z M,1=M-5_>EN6N6%RG/MC0S+"<-B?5)JW]G+3(;/.#C&$`MMJ0QXIP)[M%6>&7 MX"_%YM-:&HR)D57+,X-82_IC[Z6RS[O54KAEZ*?MJ_6J(K^D#S*0?]J2[G;E M=K,C!25-@BK4GY"G6`PF%/EI4<\SJO#=3#\*C.-':02><0B-B2+\:755]FRD M*Q5IA#3F89`K;S^,=QB'O3)2>C"4%44S5GR"7-%:2U5$=IE:SASV&=H+1?@K M`-09M%;8HDQJ^RE&JNR/TK+>?#^19H4[^$1W=.<;,AB:+5Z4(LNP&O*O!K=& M=@Y)3#!XGR$D02/<%0^:.1W]0!0BE_=L;,8`V+!F#LI!21WGS,2JM^(G:;=X MD,+%,`(!@=J:"'<%B'9><9RO@E1/W\Z6&^_+[&EWE.>NS]Q9Z2V6Y7R]8]=Y;WPUUI(;4D^Y]OKV;:X3E/2QL**;#?GU2G=_?RTR_?1 M-[`#X*VRU_EBW'4(XLR,(.,<9!U+^3/[P%L(=Y3CD`@+.,2JA`]@D9/5AZMT M"7M6/<:=GA?DQ"X>&2+G')'47WBOA>7ZS?/+T_I;47PL-E^6\XY'M4D'Y3G] MI[L'TMOQ\VKY7\7B?5%MZX(\AEV^FKTLM[,G\J?LT,F#B3G'V1#1:AIE;25K M=30U(;G;'4&198P[]VII!:P<;79X.7';F;=>_.>NVE984"J&\H::JOU;2Z_7S[/EJJ(W-=>)LW5*197GXV*OL.T_CZ(`JJ4CJ#J( M<1=^"'!A7'FX29G"3P^O>WF_P:\%B_U@&!)3)XUQZJK:7U;+;7FSVSY6.U5I MQ'7@1ZUYXB\OR\]4/"=Y.*'"2?Z$;U`=DBI.]['H#GU/G7=6/1Q!.C_&75JA MQ)<=\98CKA;X^NNZ3OONP:,#>(<1C&J`'SBJ`@?")70@@#NE$:3*8]PU#$I\ M\>O`8CVG<0X*+DSJPAF16'0A=505SD,6/-^GS#*Q6"ZDG&/<10%JC-D),*B0 M.`5YGVF1=WHEMW(+R)A46-K"YUQ"WAQ)IV0/4-@NSD.YEJ,^[YF2QS`A:(("G82W/ET*7ZL MB+(,9IWDRINSRR7DTROO&399HZ3/?M]+C4`,D&-(@Y+>23./I-=? MPR[`E=08RAP2W!DD!:Y,@V9YTD#LZ;<4=-"OO:.+[FP`@T+/B:AQ2?TYQN;? MA1!V`2K6$MSU%@IC0IY>TGALOG:< M?RI`.B"/=:D7A#Q'NP"!KQC2;`GN'*<"5R@@3R^)'%9?3.YO62?\]W#AXM5N MLZG8NEDMWE5[`?]2"0_MDF*H-)R#`C4MD6.Q5A*NKX-)'C-+!:F-!'?R4YXI M*[!(FCS:1'_7?.!!Z@*SD,08J6#$I11G@(GKZS@/H50IAJ1T@CN;*LV3:;`D M2]BT_M![+Z,$Y!Y>R;X\3B_<_+XL*UP1MSXKU8&%^D=3DV5A2FLQ'OB07,1@ M;P4DN'.J8HR8%E@A:NA]S[(64>\TH_H;^42PH>XB:4BRR7<>_="D="N; M[#'$6\1PGRP_N-8I[J2G!#?CF^\NTD:0\WOR1U10,23']QI0`*QMIFQ(L8IP;*PT)@!1W8E*0D_&-Y_[K^OYQO2MGJ\6;I^)+L;I?OR[F[7_% M'O\)_*2U&TV'U&N<6DU#S*Y!K4PZ9X%K!7`!-X9P;HH[ZVF!>]/GCGD6IFP* M;S^'MY_$JX;RZK$\&,R[7WOU3*U_+_?4EA%]X#P*+]LHG!^Q^H6*5>JR`#GN MO*\%[FT=Y>99N63KP%?)?=G&X:S\2>,L]4U$=HN%Y1UP)]9ML&^EI,H"(^>V MX:IA'"I-\KUMPQK0/Y!3_P_%R^P;F:"\>VBZ+]6485DP4FTXEF"?^:>=GR19 M!(Y*`I6C8(^8*'>T-R6/#GVFA\./WPX_>0]SWGR= M;19O?G]9;NB/H9UZDJ6^,[@+&,PP;%I3C5`] M[>H`[#4&]CY].^H4S`;WZ.A7WF%\B0<+M(NW$7!WF9;@##KJFH$VJ8=RA`QW MO8M?^-]6Q9/@LU*+:H(+B_DXBR0/L^%>^Z4A#"I,$*10X:[$&JW:Q_D@-6GX47Y)+(H]\7FN7(-$C_/S=HS(X1K,&2V M%O3(@IF:-*RCT+A+WZRM@14[98$1*Z:)S(O/(IGS\;Y3B]3NU1F9-(5(`T/U MN*L!+:Z"/<_-"C_3O05Y6CY@"!;]NGZJAGFJI(N`K'W3R"3+S75HL<<(0N>- M=\&->G$=1$1Y!I4I*P8FNI.0/U" M3*.=$'L'$5F23-B3:2ES-7"77XZ_..X&W478/""Z+_NO)+L'V^"E;I%9*55; MEP5WK)B.)K"C+KA-*U8349WR3'ZA&7:.N\)U[*6Y!(#7P]](`$^FQ_08FNHL MP'/5-(X"\&HBZ.$.#Z*G4.Z3XRZ4'G]Q+@;@];+9`?!&MV(_%]O']>*7DCSH MG)!^SDZ@N0/5B.Q3[U(:,4:-&=,D89$7:%6?7VAYN,0R.(6_^GDQB;5@9H], MC

X8=0SM@CL^#H,".[HAK"]?44&C'E%UJG+KD4[@&?8:;HH[;+U6?O>;VH MUGA7TJ<@O/GL:;Y[`DNU?O`^D^+W'TBAN_>P?TYE1*/S85G^X^VF*.I^_75) M9.J(^6FC'Y$AXEQ>(R:I?6XJN_!V20I9]?P[JGD761/WC)0`=U/R6^^A^O'A MO9K-N-=O^G4%OV?FM"DRZZVUSEV!?':&0E5T_AT5OW,OB%,>'"]7)GTY:M<( M$=[^"2*)ZO=M]0F9#7I,$A+7J^I?2WB`H](:E*PI?$:"B_"A=_C2 M^XU\Z]&/S2F$D2@A'H4XB])Q?)M%<0@O!,<^/3C#">Y*,6F>K$3)9*D[.Q_$ M=.#NI2"=:5:?8?X/!*+_3IS5XEU1'4EA^T-;>N2_=VXUV1=EJY;[@>^"E';6 M2"=)`.N/N_Q'@AO3!X`X2=/])QY\<^61KSSVV957?6A$YHW8_/%E_LS6#WQ7 MH=(D]V%3F-7!77TBQ8\5&R]#V?1^O9T]>>09>Z"!*HO]V MMZV.&%;;QJ*/Y>M=44E+XM..,;D%)>BB0JLZ"+#:H1C=(]"-8W8KAHW#70RA MR)F`LA#AU:(L@C2"VAA6#ANH"(ER#"&ESA'B((]A;R+8&]RI>!6V+&,G$=I: M0!1\7E^UJ'-/I?=:M%B'DZS;U7VE)L5_%+--2=&(N6:S$A194:>!)1!4K>/1 MJ!4,8=MSV';XT ML"X6D1QK0W3R'W%7Y(PCA:MT0(^.:$H=OZYK24Q\*F6.MJ]K4P?;A^)YMB01R+N'M\MR/GLB\U"HE8VJB*UTF5=( MWN404BFK4YJPD@3=[JN=^N]Z< MD'A/WO5K%'`DT<3@11\=-"I6WQM:IGV9OI[Q4^S05BN?I@]1G<1.Z\'HZ7A\ MAL*`ASS%PWKCG1Z\WF]T6$^Z)%"S!)NY7'QQBGY^25C/^%D:I$E^'01AX..N M63'#L)5CV0CI'(;@U?KY>;D%6_`+1=3OUJL?7LVJW7BB1N#$.#0OW@EZQ7]; MKQ=?ET]/-ZO%;37WZO.R&O^F+(O*=]\7:N[K^(,H-U<=($2*FI(K_@-(]<\,.^'%F[NCDH$!- M9^18K%6%ZVM2!1Z%L#>0_/)QE]0H<&7E`).GK]8(@VI@Y!#!I09G)P;/UUD& M_3ZB/(7=P%WL(LN2Z7-!DJ[IX3L//M1S(^OF>;W9+O^+-DJX>S@E[CK.,W-W MMOOG5M,'4;YJ31CX+H](4*LR3+BOH0AP85K>^4F9-G]*O)`SD3 M"HQI40^/'.IS^+K:/.BZ'##CA]MUEN9I1(7I)6Q(4WXC7WOT.<0X-:!_*C*(2V78$/&XS;"=?"WXB:Q4WD@)9= M'9U&9"SO-QA-F\[]4A8/NZ>?E@_%M3\)\C$T[4""*?7J97)8J1J?IT&4P^;A MOE(BSLQXZM)!4;]N7'GPF?>3\-/+8G)BQ,_'I@QG3C_/Y^"(@=_VZS+LI*(,#3W(&['K-HD?8"5%N$^^H(N M<@:+C+MNFY,#VP+<0\OTE]4,A+8RYO/9RW([>Z+_#($K;[XN%:)7[1MO&L=8 ME.$^M'+T11KD+#*.NW*2BWZ+F*23B&,8PGYVY=$?BLDK^Y:UL0WSV-QUN*.I MU$1S@.I:'H]_%L[R^F'B34OB(`53]@O)1L>-VK]NMY56^EU' MJ<&"!GXZM-6]"O/;4MLZ-`;9JABV"G>&5YHGTPH@2]AQ_>E`S))^+Z@Y'XJG M2O.J\V&S_7:_F:W*V9R^[K"OP8OBR%SGS:'9U;1$G+=:-P:_A!ZH"?1`93=Z M<(=,9%DRK1F2=$T_O/GIYO[-:^_]S8?[__#N/]R\^WCSZO[V[IU\76@7*>WM MH5.#ST8*4&)&1?A8'E*7[N[!*6PGJ^G%'5S1P)T53U6=SAZELJ!)5D\8')K$ M??"TC9*D.7ND`;I-^KA=8E76QCJ(..F;LN\].H#7'$%/3>JK:J3=4P7ZMC>K MQ8_%JGA8SI>SI[NOJV+#'*O`C_RT196^O"P_4P69Y.&$J@?Y$XX1U51"BN): M$S@^]BMN_(`U*6%&#'=@4YXIT](O3=GT\*57?>H=OO7HQY(>O8CL'*X8.B/N M!Y*%Y3V!#8#+'P'NR),\4_SROEC/=^0N)0[*2M^@C1Y39&?Z1/YGY;/RPHX_;2T&'L M*;"^J=740I"K_8-'O9^1?:";PKK(!+AO)(@S8QKF"%,T95]X^T\\]HU1:3?S MSM?8TG[^O%??9RF]_YU.X"62##RM`/<%`SF&K)A]*=*F/\\V_RAH\XI:[(FI M7]`7HXOYIMC.-K*:\/-ZM7U\^L9:<[Q=;]CQ4DWVL=A\6O@IPWR30Q*$M M9UL/N=/[Q\)[9FKUPM2*7!*=']2JK-7JI5*K63T@_=7,JP[19Y)/7Z\*[QOI MRVA)W?C\=3>T[0S*R>UM#GL+CRP&N#/HFCBT`O;TT+H_O(2T3#Y5R*X217%D MKL#U?#Y]>;\N^MNR>_6UJ3">P+L\&834`W>2X7TLV,S6]=!QDI63NU[6D1ED M3V:6;RM9:*;[_K[G>U%Q+>D7JC&2]%99F(!/./[)/7J2@TL`"F$ZF MQ]7X'2EGKD1T=R+]JGYKN?2(!![GV+]68WM'GXZDY#8+PAQ3&N`##$\9@%9HJT[_7]A>H[Z_HC>/FD@[2?]CT@HCBT?@3_I*<=B3AO M`^IU^#))\PEL!SP*&>(N)Y#B9Z0SL)>H[C-.H?-(5P';C]^:?T-[!U4>BKD& MAOQTF*FXY.%WJ-ZR;8PL`=.5PWM8(>XB!$7.1M(:3O)ZBBVO2&KJQ.N3Z'-U MN+##1RF[;)6EYFX]2I&DIF*:5N'\RIG(<)7]A*Q\#EF5$'?1@SXF3>N@-DJ/ M;JF)J:;,G;6/NT]E\9^[8K5]\X5<&MU?%8H#W^#=SHY9%36,FY>]$G5]`7I+@=.:C!XE".;,(G8VH/7&.*.D0MR8ENJ^\F9'G[NP>\5[JQPR(&9IZE& M$^OS)Z2ZOZ%&)8?U9ZXA[ABU,"]6PE*B5)V;;4&AWE9C/ZZ?JFTJW_SGKMJ@ M=^MMT3BX)^9\Z_ZY%:5;D*^]A/=_!T^6@)F90&%AB+N(4XXAXV9OWFP\?_YE52?WO_'_(HI96$UANN:>B;>T>`FPX3"L'';K]R=%_) MGL`&,HR)NY!3F3<[QX,BE:TJ9%QO+)X>&/2&\U!I&R/-?&@.,H&JCQ!WR:8: M8^,<,IS439M?5YI"O_?(`'INP,.`MV6Y(X]KOB\V'Q]GF^+F>;U;;:_S,#`7 M>NV;64U7Q'BJM:/WJSBCQJLR9;@#I?Q,F)9Z;DJF3*;KGU[1LGWZ:P]^;D"B MC4"HD27Z#"?U?942WX.\=D)W`;?O(,2'%?PC0E$MW\N]?%<+/"^J!?>*WXO- M?%D6[$](Q6]9S'>;^N>%8(MF2L6/L[)8D(MEQ:JD5PH:;R/_^.WP$U;'?/-U MMEGKM[3]M#7?I)'!F/_6HE51%>F%VX/P?1.E"81+8/P0WB% M)4;NW)CGWCB8,\["E'[_PR3#AE?>NV-*^E^O-0[$D;Z\+5H694A4S08WOP,:T3@2WF),)7,(,V;&& MW!^TLP)V0BU6>)FR7\O!#N*BWM(/7U?@9?49YJ)DE1^*8>Q//@Y.\TE'@Y0E41S*0;'5+(]^2`^8!Q$,7M4-$9>::&%07MI"%52IPVU M*^F7ART]@\U4I3QDY[;$?R\=%1D'+Y(LS@&K,$6W*EJC'X^ M+!<9]1)S5F*D<.GA9-[ZA9'`-W?;IW5*K4+VVAH$5.YQVF.IX(JZFIOS3V1W3:C5@'MX*%#/N'7E2%(P!!`.B7!?=>, MFP?+DMI)2(NX:BBNOZ_(I+=PXB`P6)C0/JE>F>WDI$MLZP^JQ:87D/P(?*0$ M]\TO$39L"V\/+>?R2WXM=WGK?%;6(Z0R6>;>@.Z<5KL<=W'3(\G[9[K)FT=T MY>'QM01WD8`@)R/(!T$4('[768H7XZ$,&:JF M\-=>20.%L_W?DU1?M>1?9MO">WF:S6F*X,K[0C;8JFYP]L%T3SF.>V**[QW> M6ALI7OBU0[[/I0QAIV5E'E,8^+UW^.`T&@_;+:8K-]4^/KU=/FP?[[^N[Q_7 MNW*V6MQ_+9Z^%.]!&=_7NGAXOF$2\9\APA.HJ8@.?FKZ0E38>;2`\G02?G%5[`*B@2/?5G$-')Y6WMOQ#G_[P#*Q!;R3I M/U(7KC%@1R+8$;CN%^$.ABGS9N7H42"0J0,=H?7(L:\@(B<,2@WI.%%X!B'I M9[I/,>P3-`E!'!70Q)W54T2)5*8P_F2T`T0@)H!2/=IC`#QCU/YG`GL"_44B MW+=:U)FS%P-0(=.(7C1(>5QNMD6Q.A6J.(M$'?[!475HA`3EQ^HP/$`01!,' M''A^3NQ@)5YR:F1TA(G8%[:E6\3DXY+N#F//MPDN^`;(3[LJ@.]JSC&G$:6]7E)`!T]U`W&+*I-K*'!#*] MX3@P!G>-/FI1[1IT`8]P7][4P=YH1XLXK4R!`D/>+Y>,27H)R#1EV&/H&89% M)S*H4,CA74W$)8?:^!O'NY"@5+.B[#[ORNW'@I3Z%J?1JW-L6,E86S%ZEZ:( M#*ZH*HI\['5%:!RR0Y'/=@A>>XYPW\#4PI]Q/*:!R"D,XC5&.4%G&OP8.:'C M163HM:<%DXGO7,"0`!3#1<@+$G7P9PV5:2`6L1IQHC7T6G2.UT3&2=G&^;!Q M4`H7(T]K:&'0#F+306JM1'Y*0=M$C\*T4W*[>O/[_)%TKWJ[WD#;J0_%=KFA MA5WE0?9:>W;WZI#\?#K42BNWQYJF,#3L=P#[#25R,?+@M"&6[6!"[737JME] MIMVNO'ITTM:1-7_T&A.,KL5"@-)]->Z"G'RD/D3=B-\6P1)>NGOM;F8]"\;&CP@U8-)DWL M]@T_R#-LIOIN',VDJ(B]1.]UZNA704P3EW&`7"DZB3:.-KMFGM*_D>_S\NII M5I9W#W^?D0[#V[O-A^7GQRV=Q)\8[//2.:V:[`EP4PMB]R=Y4F?5H286>;=] M,49,"ZP0-5/Z:]*GGOV>O)9!O]`GTW6/F8G!'EP]$QN0ZRZ.>B5[WVHGI$^0 M)^D$2D:0MW@7YF44^>XAJ$_$I7H9M1)0]\I@?UI^*/YS5V&0Q?WZU>SIZ>-R M]?FI^,B>G/EEM=Q2T-OVYE<'Q-E5T_BW:\],HT'\WCU1!Z9:51-YPS.79ZJ MGX?I=(H-,_A0%H.\Y[M1OFT%[$PR<6DZSQ?`NSR5/POE:1F?18]2,O&%]*B3YLPWNVVY7:V6E0Z>PTM M@$V%:;HGUB;TPQRU2/S91_XD#1-8?BC>0=[Q7Y@7XXZA($&U;-,O6'/0*Z_Q ME7X1-VW:[8MXGU$__0BZLD0Q\[JA#@;YZP`R[-@WZ+RD3=_.EAOH&*V`8UX7 M+;$X*FP.U%@GN0@!EWFP%R50)/6B(CLM] MPE+%%[?"J1%GL2?.$5*V%0R:0I(\P5U[H,J:E?B1(I'&5.%_%9OUW:JH_G]W M9^/6HH5A=1@:6IM*2/#0HA:#HU`$.Z%5>:D/N?4$=^&"!NXL8BA)$H]Q%!G$ MJX:@_]'5X%Q*UL01%4*%Z456G!L6PX9!3CO!78B@@;L1T)4DJ5@U1QAX(52< M/@`V-`I+$TT`!/B0&$YP9_5UL&<;B,D2>@3&?&VZPEZ>6I7;#34+\$C4VTH. M:[AWOW[S^\MR0^T%%36)U\\XAU=3&756:K41'(EL6#RA]Z"RA$898^1/9^AA MT-:AHX7:J=@H=K2(S[UQ08G.G!S!@>AFQ;!9N#-^:HR9=FV4J-L_*;C_G#T: MZ)$!#@&`^[5G6U.$7J)%K2EG($ULH)39MP#V+H6]PYU2T<2A%:BFA];IX2?> M"ZC0[*&BRENR052>JKUY7N]6V[N'5[.7Y7;V5$U5S+>D`.S'XL-L69(G0BMA M$\@Y"@ZO16\4>#E1'.Z1:#>_%++!/M3!);AKQ:.G0423S[$%;&(@4'K.A MO'HL<@+]6'@PG"55DGKO&:LN=?H\@GL(^64?*N42W'6)FCBT[/4HDHMD/<8+B\^]U/$Y%85J?P@>GG4'?`I_=QTDDT2@.[#<+#K52X&S=BWC M'S"(`N2=@A4YLXOZ1,D[.YCJ.F3Z*^\PA`=CU)$(^'N[VB1S2KFA30-GEM"F M(F]YJLC9"">4*(W'UU1F!PUJ.X^NX"*794V2"I);!*[>M7%EZQ6L?'(GCH1)9=D#!O: M.Z).%NS10534J+XL#1-5H]:WY4.!1TDYAM2I(KPTMRO$Z_73TVP#SFWU+1WD MS>_;8K4H%B%]GXB^:<."KU#VGCI1K:#(X`@`3I+4*5.+EV+C[80;:0@)D\RI M,;8"#)P([5]#*(<^49,&"BOE\76H:@Q;4A7.<(V(F+N\A9E;5Q#@-N^GI48M]N[#"(:;50.AK&UPO> M0Z)S=^"V1@!7`%.7TB/BK(U[7'#3B4M!5#SF\?5CP'?N'H+=RF#="082'CHUHXG.I:.O'8.:U(ENNOD4X@C=)G"4AW"U+W,I M^R?(U[@0JI\XGN/!A%-Q)DI:H-,8.B`*FH[W@]DCN*>7N11(%>0+!USJ)Q*- M,NB`26/H@B!`8M^S0'8"T#6$BN[,I6R;*&,(H-$`B0=;:4+'2U3?`"I$\>*I(%'&?C:15E M'FH[A/G\TSB8Y!%;5Y=2M<.L6`8:0_2<6V+RA;?_1.HE1G[)D$,:HPGR(-KH M6&[(8V0NY5B'61D)80S195VBV?./1$A\/;99Q]NA4A3S2#7[F"PZO$<<9BZE M2'F8&=-&MU(T+--2CXF*R(@&2VU;K,6L=7/A66+!I=0F#S,8+'8K95;DFP0* MRYO/FP+N-W]^4IQ!;"MW*4^JC6.[QXHNLL]TDP[LP@AOSQVQVYJG>0 M4.D[<\+3&=9&85ZYM7%@9&JATQ@V%^[%Y"XEU;5Q/#HBEB*;^RC=CUZ?G_!W M,(.1PY17I'5A8B?T5P(3<\E%`G(!MWAREXH(M'&,!A-+D7\!BJP)%3NAQ^*H MN'_DE(E%"F(!&:3814 M1\%OY'<>_:%TKJ)UAX4!FRW1ZP-79\O&(+0K=1`]]-L'/MW$Z)/!WU^*55G< M/#VMOQ(+_7:]V3^M=?.Y^J^W!>D,%^=9(&`->095%%%)NO<2R_=]$`8^\I2P M$"/&[:<(-5/V:V__-I-_J%1SXQ*M2<@!J=4)^#8^[5#Y"G9%"N@DN`5)\"\S\H("(4:L80L1JLZEV'NH[/.^LX`WH_;Y MH1#N^?JV^+39S3;?&@^TOUE^?MQV/_2:"3SK)#:ZFL`KA;S_4X'AU(VPNVLI+'>5BXH$3GQX?4]L$=S`A* M;W/<<%\/@[:.&RW4HM8F/M_!!64Z\R;$!F)]B@*X]QG1.M]H@ANC:>+0BO^A MA]:#+E5$9=JTY]]V3]]N5HN;W>==N6U0>/^XW&R+8E7W9'CS>[&9DZ>B:N'+ MHTR@FX+D-&KZI(^W6K&D1XRS28`[D*K*FFEXITC?E'SO50-X,,+QB50/KM\V#XV2?U:/'TIZOJ/O<\1QP*7['C'55J; M*L,UA%_Q%_CP2$04`#C'G9%19Z+*^K,V3Q2E"@%38FWCU<$GP7V-8/?I<&H&*U. M"\\0*=N/$/8C@OW`?85$F3=K;HL*E9HUXM]WLPJ7;0@QC5#?4_&E6)T)5>(+ M!*&Y!U;3"17Z:Z4@_^$>A\4Z?6:I8M@7W'8.Q0(M]&3F4%,935S5VB,W7!!$/FZW78DOTPZ("G'3ZF/JIY// M37OI:L+&=]2XID)G!Y#T;B*O2E/BR\IQHT(AU:-9K4=ZP\=J`L;ISKNF-^=N MOKP9Q)V`4>++EG.O0B3B,^B^^M=R-B=+L;)L9S2M0]. M+"CN$+1&+G&!P3Y2)=6R,:17C8E`34T`1]QJJ@@JNZ4"=]!/(Y<(`6XT@48NT4+>,U(UJ"GY:'PU-0QY$:JI/LA[(A6X6]=HY!(WY#VC5QSR MXE!-TY`7H6YJA+PG8H"[?9I&+M%#WC.2QSY+/Q;5'BXXJJ,2@69KO.,JZYXL M]0T%XQN"MG[.?2B:2*!H`KU6*;%F`8ZJT$?U!@8P40\L+EO\!Q9*U6@]?+C& MH(6H9(M825$*6X0>$"HR9_&H4:.4:DJ@I_117*ZX72R46M'F+G$-P1X+R%DI M:@:;@?MJL#)OMEPC)2HUJT,U]6K+76*>)$(@BG]P9<50XJ.A'0+CT/W)F+G* M87_0US>J\V)HTFZ*NT M='!H$7QI(!>.G'C4,X<;AR%7FC9$QC\.`P59!#L$77=\]!7!&ABTAL=H1NAB4B=.$)#JCZ]"&UXH#T@@(:),5S1]M$7(.G@<`2$ID`NG#E^UYDC MV#Q94MJ$(1I2K>F#:,/CU+``&B/&<(G;1U]1JX%!VQ!-GM0!=9'4EH_DMO(1 M;.QOBQHG`BW'Y6;1I#^JG)TIDMB`=!,CYI7"C6\??5F=1D:MX3D=U#:!'1O/ M9%ME51D5Q7H.J5\/^I/9:.;G0@;;1U\\H)%1ZUA0!]6.Z:$@>'1(#;OAI-"` M#,M$S)&&]+B/ODI!)Z=V`:86F@%IIE=ZNZ%3&L_J]N[H9K?=I8]$T[:<8VM0 M+'DNCM2)>Y@@<*"T1YP?*Q!1D"AV`K55A+(/=5SSEQ`A@;,&L2*TGRM">^1` MM8(H/_;."$'*X"0@]Q?&%7X1AP>Q]'X00;@^.OL`'1X%TPKW<&J8+!3LWEP'"NK4N,,%$_M(=>%>#F^NIF"F,CT30/,/-OF2\A$#?"'%FJV$.O(F==LO1.) MUA!*S61;_WHXE%>^H]8U+E2QJW&'#V2>DBBO;BH=@Y1%T12\Q*-L&J#E\5X[ M4*VKQAU26'E*)S>H'%7!C`%*/!JF`TP>;ZX#-TS4N,,+)$])17.N?2SFNTH, MED7YOF+Z<586-Y\KH-JL4JT$4JPQGLPT)O1-AK=^7>,8D>1:750T?M;&08W< M]/6HUF$,KQ[$VX\REEJI8$7L:L6)$CGWUL6P/S]K(^)#;B(/X!"E*BFA0NRZ MQ(L'.3?317^+G[5QD2`WG9;/JG?K+_2SF]7B=3&G_]BDON5Q[#@3N!X[7`YUH6:5@BG?ZI>6/ M\Y!R0YG.#R6Y363M%Z`[(_(GP#5Q:.N(TD,N=JWB\Z+<4*HSKTEPI)3M84;W M,($FCA3 MDD`C2.0/@NMD$PDB%*&Y^PA3;IJF(HY:T"`J!1/%A!VM[L@>0@.2!#I#(G\K M6".7&)"A`+T6-.O=8&(J`%H_('\75Q*%57*=&ZT&7_/Q*2YSO;KY= M`UE'%!$RSR4M#_E1'/?`:NJB0G^M*?QCT`:,,0O#0@-&Y*^Z*_-F&K&I$CAE M`WATA..#A0PR@H)P0C2\&G(.S$1W*8==@IQZ@+NX09DW6W!,E5"$JL*'O_!J MRAGJXAZ#=?--6`8"\N0![L(%=>:L8"UE,O>*0D'6)->D&.V/BG2(5R0,M7B' MUZ(D"KR[5@D!..1*U07F>$>JX03D$U+(<8>X MRP]TL6@3V*D2N])Y-'=^]GWTC=N+N8?_HQLWGZK_>%D5Y'<1YYO-CN9ZA MU+1"C,9:`WJ_"L(`>7UQI?', M'@\N)6[WF8=\*W:4@Y#I00YG5`X?S,@A)RH?5Q#/T?;@"N(.>?*0;PLG<]`R MO7\LO/FL?/36N^W#T_JK][#>4(GTMFMO6_WER[&T"CY&S$@H[QX^;M?S?]1H MX-6ZW);7?D0"1)449,>2RM:$KL?#K/Q$%V57_O!Y-GOY*Y'@OQ9/V[+^$RK3 M/TS\'T*?2C7[X]ZIM4@V+U,GDMWQ&G^(J@`F_6\*!;EVTIZ:CKN M-A]G3\7=PYO_W%4;6DE,3JIVSY"#)C48)$!1&608W*L$Q\=TNR!=GT+I2XB[ MGD^>*3L019:\:?WE7DO^6E9?>>L'KR3*8TXQDDM7C'/O66( MNSY/DB/C/J0460=5(/M]"')4V.DC4PGX6%XGZ'D$#<=N5HN_SS:;V6I;-QZK M\)N?^"+!#^Z1]0F],`=MPC\P"(2AX$9T"L5<(>[2.G7F;*J$%(4'[2!#>("L M8!!Z^8\-LV^CIP"I>&6,UQE&K"8MKK+H1D'92@H57B'R`*,R<];<;%5*$>H+ M9Q`3L;KT^AK]@]39#2B(3*'**T0>=U+GSKKW(4?G"?:BKH<'JT_OXWUEVE+( M:_6@JS8Q8GL`$90(=P!+D;-1,!0W>=W' M@XY:4&&Q4@%0H^L$)WSJO&3%CFX(DT2XHU6*G(T*GKC)1*8<"LAI=-W@PTV= MA;>L?"&#H$B$.S2ERMIXJ(F?2`::E.N=6\FH&\^W")/`73:!H0TH`S??(A]A'COH*F MP-6HX(F+1*0*H@"@T.@''Y#JVR46^,!]WUF!J_'@$Q=]@)S\T(P&M#=N37R! M5Q.Y!S8A_7ST]\M^>X_N((\F4+B307>&&/=U2F7>QL%/_`3V'!):VJ)+")@2 M@L*@(;SHJ7N7($"80R^&V,'TM@AOXR(I?D(1JHH*EL*@*9PXJJ-+-MDDJ$;( MH;]"[&"R6XBY$5&5`)D,7"FW)6>$W%?"S9,:%GB8D']D+2HAQ\&)3O`,`NDE M>``OA_X(L1/9;07F+"$L>0KWYP8=PESYAY"4B8$LE(K2";/XMPK0<`ZU;+$3 M&7`%YBP#+7E*46J,$-9"J3!=:(MC$):!BMA1SV*,3F3'5;BSB;<4Z)S^>ZBS M>.J4DHZ4LL#;@-P#&U$*+OH'=**S7`'N*^<068R=R(G+\S82UN(FL._@T%@M M(B)@:D`+@89PPZS.76*`&,K=8B=2Y?*\C0RRN`E%J"I*"`N!IO#BJ^X"'P:$ MH<8A=B(YJ,#%^/>V`]"B%#_ZE"#(\! M[^5`+6@.!6^)$[4D\KS9`E>R!!Y.#')6'/GD=)`1%$007.'3D&YPQ;M+4!.: M0T(W<2*;+L^;;7`E2^@HJM(!37+%D\04L!*GO5=%.H$O[<">32"-FSB12Y?E M;)03A)N\;J70Z6]PBY7*V3&Z3G">&YU[$\'>0,HV<2)M+LO9J&<&-YG(E$/, M%<>E&YUN^,`(M0,8PM9`_C9Q(WTNRYI5%UR2R.F_!UH<\`]%N=TLY]MB05L` M,;&I/)NV1(:>;I^M4ZJI`R<7M>RW_]Q/XARW-]U+MVF:G#1^ MG#\6B]VAX2<1[F)Q/_OT5!!3%@BTV>P92DW6Q&BL1:[OJS@(XP3RE@GN<@L! M+DR+(S\IT_JGY.41^+$'O_9^H[\W(:2<0'I<*3T'S(.KRKQYW$4.`ES8`L+\ M)&D7UV*^JW9G693O*QH?9V5Q\WE3T'RR(%?:GA-,QHQ;S'3G$M/\]N) MSZ)-N(L,I'FR9L(E"1Q;WOG"%GC$_2Q4,?AMRE8^AI5G\2/;XL=JI,6K]?-+L2JI!M^0[L*?Z;@_?CO\A#TY=/-UMEG0__JU^W4.DT:1;3B/4'>!<`@U\9QFS'2I_2[ M'SZ1#[WFX%YC=._3-Z_YN_I94#KZ%?R/QV;Q8!H,QL+(BV"7;BS.CW*=T\1! M,(EH)4Z"O*6.2;;MP`%S#$QK77^QJ>MO9\O-K[.G77%3EKMG*AWEF]]?"A+" M_G7]5`WS5`G0A]FV(-*UJYU""9<$XB+_,>:TG0NDIJ M?.GPHP@%'B7!:]!PY>WMVX$,C]!ARV M7M(CF[0N>DB;Q+G4)$$:?;T0NV3Z!K@1D>"W$SA0;C2F^U_ MB<9*X`(^SED)?:"FJ,C-NN>XP,,;HI'LE:""VA M/G/1,AL%K^QB'70H2'%?WK*X"HX8#%Y^IO2GQ8)0^[QDYON;);E\*( MN-MMR^ULM5BN/O^]('T0B\7-EV(S^US4@.O]9CFGF8L,8;Y:C(MQ39/\4NLR M5]P4T&.2W0Z%$OL4^1VR<5?&"4"DQN,^;EM[540(YK81DK`.H41-EVFNM*,K M7@K2!#K!9Q/HH)4BOT@XXK)@1V$*O&E%9@TZKKR:$H^1XM6T>)082Q800MIP M:;/IVN0(O<,V6D>R9IS+IFRS6N<),A:>9!>W4N2W0HTSC];^\'*@P\JPY!2[ M?VW;\>M7"%SNG3-V1)^KUC8/>_XIF8`PPK6X%/G-6RL+@-OQ$F'ED+9:TM_C M25AS-G#XCA+6^E!#]V20W`0OW(<.7>F%WA\07@2T*$*4$T`3WH_]:.)'AB;8 M[X[0A+L2=E[N_.^6MV;U>)]M:+O9L_%Z_7S;+FZCB=9V]NCEKP4"8H-FQ\M M:\AM?F1F\Z,XI#XT#1)G4>)Z%8VV11@=Q.CBA"LD4G)U:""3>J05,YG6(_-Z MO\',HKU=2+]0<+Q>[S;[:^)-A^SM>O-J5CY>^VF0&C0JW(0HF@H5AO<60&20 M/(/0>X:\!%^6)^/Z*4G8%'KALN@A?,I.Z#JT>%7_[<-ZXY$1S"N/F;@A8N4Y MC_CQ#T)Z<[)'W#/D1>C23-F)S,F2-V4]4)>LT?F5MX*[(^6AT=CRH$-S0SKT MKMJC:NA7ZU6YK&2`GII$Q,*V1\ELZE0;839TC'-!Q'2N8]#'R M90GY[<;Y61:;+Q+%@GVTO2N^TK\J*21K>\/!@@;NB3"H;7V,F$9;7@QE6&O&!2$XNC'E;\=&J^_%9G&&4K(!6$U?ZI MATQ;Q4[#CL&(=8Z@D8L/MZDSY$6)VI@<_Y04(7>Z_X'6@Y%V`CR+CX<&WT'@ MI<.(8G&Q.Z!/K6/D]4XA+_"39&FDTVV(KEXWC'YL)H_6)T8VSR4$6L-["K6, M0:)/&=Q.1?[`JC1/8YXQ@]1-WV_6\Z)8E!Z1`*\XSJ?I4Y0C3SYK*T@WKR1F M(Q:#;/(HQU'$*:@=S)`@T>KL8\6/I)XSE;-$?XNL3(^I$RCK8('26G M$2:V?,N(%#@BE_6U6ZTR)/(*?77 MQL2>K_LR'JD_@S6#W[(+QB'$``.X:YCC3O3+,V4%T$B3Q\3]`&7FZR_%!IH^ MS.1,/+NA=;OZ4E1H:'.W*@Y/'4=MKQATB'C7.&J2+4!=+="=GT`H&Z[,!G#) M+<>=>!=EQ30V$:2G;D'@U1]XU1>2CRL/"P(G`!E+3L_AQL!J0J>8`*I\FF..)[CSDJ*LC`0"ANBR*[!2(,":O`Z!@/TG M]1'%XC,9+";N1*$P+V.`@$&JSL4U4!-6TC/A&`^VU5_U"^K1&%J$=(BJ$P$] M_CE=N0ETR`MR6#G<23D1-BP=^#RT[(61-MY0=IXZ-EWLD+]O*T=>4 MLW`"*X<[5R;"AN5#G80*$)O",5>C#NN%. M:HFP8=$^#M%R+(K*N+)CT\7MHQ59[+6/^]_7J;X)1)/#`-8.=[Y)C)$1;.0P M5=VB*9@\?;TLYT_KEUJ)5,>MMC^$)PSC"?,J<&?%S#!L^I0P0O7TX_W=J__A MW;V_O[U[]]&[>??:^_O-AP\W[^X_>K_5WPJ>+=R$-OO\E??%[]L?J\__<9VE M>5MZP[("MQ-G28-Y5T98A3L&!N&@%CWV&>[%G3`TQ+&5"(T9VGM4>1S]'?<` MQJR_\D=PQ\"Y#W7+\81%4G!G3TVPB^;XY:=Y>AB35&0=W5]GPWITW*NV^^NE M]QL9W:/#"Q[1-T]4](M%>T_>-[^3?RRNX]PW]P8/'PUJ"BO+9ZV7G-^3_0S8 M*]YA!-N+.R>LQIB54U*)Q*/&$//&9T;UQ,B)AU!/SLXOSN^#+(*`?TA+_"KP M<@E*TL:5Z=-(GK3I_M.C0^7H\&&?"^I*M7]/;Y>;G1,&BNM1_5@V+HK47UA]W[M-8:6#/IKD5[.W(#; M*GJ>:5`7`995A#(A'W?U@`%N;>4L])/NKJ[RU8:YK:KG/INR`#!G(@$!P%U: M88!;.]Z==KJ9FOI77B7BP:E2;K4I99/>Q^5F6Q0K#FF-$X&K<++S:%!'/=P= MZ:+,D&1/D3<`4.;-"FI5()`IU/&)Q\8P=^8I":#`@>>@>K4?==([C+M`2YDW M>\>8`I5,QXB,(E4I$7_/09WJ\/2DMQ1WF9DR;U:].`5"L9Y=;YY?GM;?BF(O MAW$6ZP>&)[-8T;%AS@05[&S`((@"W'EM1(9#L*[['H)5*K[CL4J%-BT#@+E:6W5N*Z4 MV+CZ)GN0(5*X#Z'C_L&G58^Q_'2%"@^^&QM:69E1=M]WAUGQ3EAFR)KQI&D&GU3^-Z>PZ8J>YQGF)-Z=7Z2J6PN M\N)&1=;LG%=J1-;*92JNJ"IOO/Z8D\K4XI6I[";R0YYD1V&_KH1BR\C+S20R^GXQV"*F1/)8>SK(2R?IL+.LCAMW&-R$)=.30' MCEB(&7EQB&961_+KE(AN^'F&KKQPT=L2(?<%GJZ4FL2&Y@WS):9WK7G5`&XR MQ1!?#EP+2BKPB0-]\A$KACWMN'^=XJD5=V+2.UG,V;['4-`00W?=P+4XBP*? MN/`F']&<:/-D,*MJIQ-I8M(Z2939GDX-H(PAAL;!@6NY`A5&$2%,3I('\*7R M,?=UMEF0?M$WOR_+ZS`VV&VN.9.B,O42O5>1HU_Y<>Q'T/TE0%[+V$>W'0'N MH6!*_Q):C/]&_EY0X%X]SN/1C_1)^.OU\VRYJJ0B M:*MD,"CC,+$!*>_BJ%?.ZX_H/D!55PPM(P/<]782W(PGZ[UT]4D[?*A#WN]V MVW);09_EZO-U.@G;PL`&A;XQNP')[^6M5_R;7\+N0*NK&'KH!+@SG[(LC:<( MP\35;Z94"G'XK2'Y-]*<%HG\GX5CA[_,6`.IF&%+W/E&*7Y,AU=EB.JV_U?> MG:P.O"[FU/N42Z2UM6[N"-U(3Z2F!SKYVS\Y(#TFW4G5"UMC`H%MWBS/FYJUSGN3_% MG<6=\%-GSE:63YG2,_+[>/MQ40_;)<[&9/;WXO M-O-E6;S?+.=%!6H#@^]+2M.EJI[ZUN.@G=)C^GZ40^0H@0(,Y%>*=+-J'GUJ MI7=:CW?\C$AC1.]K-:1W&//*JT?UZ+#6M=?,XY+N:F\+M5]3*^2*NG+?5?JRVRR_%Q^UZ_@]V>!^P7"Y0*=,S ME)K"B-%8JT1=[=`L4PJA3"F!BHD0=VZ?CP$KHLM%RG2_3Q[=J#T4E`-]]9P? MB\V72JS;G\ZJIMQ0[9D]T7^L_O[7V=.N('(1)/RA0J7)U*1;-Y^G\B\W;@7T MPXA9&MQU!5KY-`WE=!([K0?SV&CP1)SWX_D3<8T1O7I(CXXYBDYR!C_<5\KS M((@&`6`&%W?^5RN?MD(C.HF>?BA>JBGIT[_;Q\);-E1P6:O@0?5F!Y!8>G]^6&\JQ#>K2"VNO)*02!-T)3ERK[S=:DE>(*;_YJW9 M`5Q]L:YHV+`YJFG+[8:N4_D7\/6*NC3TRELL-\6\TI72(U&=>;'9SBHRYXT@ MSG]6^'3Y\&VY^NP18K85+UOJ-L[*PT#7HU@6/J3JOF'I1+L*H@M5/R'NVBJM M?%K%SCHHGM[V61$#&O=NO?I2E-MB02MYR_MU-7'S[\F#Y^_6V_\HMA^*^?KS M:OE?Q>(Z#UHO6.B)VA@CVX)>ZUE-(967FA+"#`TOH0=XF2W85`$870Q4U' MF*+E)?LK;S^G!Y->>73:XV`&F;CZY=;[5FR]P]QBINEM\6FSFVV^W7^MP-2W M-Z2D\5'BQF76EESN\#HT3*EF0,SP7-L*':.38XG$\ZD$0=N,"'C.W!X):Z,6@5<\Y0Y67I]GG84I^L`.9,H1HAPIV!,\BUK9"F.1:F M&H8>4;'Y(H67I==G(00-HZ=,/*`X(87L5(0[96B2;2N!`8,,',[N(+LRU4GB M0+]P@]]*E@6N`$E/I$MKU?D[UU71,4D,F=WIC7!'][7Q:`\[JQ':1,IV6E5K M$$UA3.R:[O7A7ZG]ABO$$>Z4O38>[6-;-8*=5$)1_.J:#O9@5<$Q-8@*]#2/ M<.?`<"R09?P[(JL-I-SR;HL&E,Q5]\R'@\>MS3[#LGU?07$Q]-Y(H9PJPIT< MDN#&-#X5)TES]3:77'`"R7&%]QP,#B\N!,13R('%N.^%2W!C"^")DS;M^41, M@/]MMB*V_6-1+?)"YAYT'`F\':XVFYH6:.>TUA/%@6E\*H-795)H21/CO@1N MAF'39X41JJ=L5`^&M7957)<%HF`]V=2\+)CW#?"S3!LZY@T M0OU4;=1QM)8O*'()2GL6'A$:N#T7E,%[-2EXN#'NPALC_%H)7IB@?'_]`9CW8]M'S3JD7!0Z7X1J]X!H95%AH3HHKXQQE]88Y-HZG-;.PE3# MT",JMB"ZO@B][L;9\J.SYWM2"%YF4%$9XZ[,,VGYM$WE/P! M&Q*5H'$\$4;?*E-J467-/)^HLM+HX([E(!%0UA7C+O,QR+4E]&V`]+T*LPLK M;'!+-U:TBKD8_+X0W>Z$W^JRDH.GEK'4!NX:((-<6X;?!EB8:AAZ1,46@M\7 MHM==\%ME]/KF`WAG&29/:ZN#P3%O%!R6UEJPS28*[@$H?D];PLRJE#;C,5S"OT?U5D$]1:.R@ M"O8`8`0MLO@UC4NC9O2N"NB.P\EC1NF#MA?6N[YQ-!9CYQH@I*F44TR+.?3N&S MSIK?URF5NC$G,J53P)NMM^N@#T7B1)&#,HOHL&8_O0YJGV:4B4SYY!%FZT;# M+:K$B>)!919QHPI;*>[9[D7)UEE=DS5J<4-4]E-Y!5LBJQ9<[O4Z!S[M.*NE";M[&0QH(UZ<$U\=6D6[XV`PPU^SG+FKIUOBGQ M.=9AIT*T4PHHYZ/AU[]!_TQDAZ%Y?,X*B-QRUI3X',5S4Z%X[\89NL7$06I; MO#O6"S'U!O*U\"2B9FWU[K$/EUIR5I*`O*!9'Y<8H"4?J2+GFNZ8OI!0:@25 M>#1-#E"V[FP`5TMRZ+^2(J]/UL-;**!C9P$]Z)&]:-L54A42<29&&J4F$15R_3P==`SJ?&"(`J1 MUWPH,68>'RI0-R5?VRNH4I,XWM/*-4UJ.;&DMQ1[3%^%,4NGD@*)H$X=2>B1 MM8?;J7)-?=H<*^D]1%[YJ\28/?=)@3R.11W86O"<=/'7I$G_X"7JR MY]!^+D5^@5,?E[;QGCRI;:IF+AZH()221Q=N31L^MCB&\S.VM[1_>CZ!IG`I M\EMC.OD'R[?)!K-)7R0TGIB=2T32=_M<[)CPDO;T6PP?!^7(K;:]/. MJVF(J9O@*1W0HR-:PIL:9)83=;JKE.<(5'7C8]AX*&5-<<2#H^YJY!DTE1Z3`:$P@#JJ&YV0%>5W6=6&*IE4]SER_J9M0I>=5(^E1_1OF8*X%='%;,=P:H\-IFS MZ#G4U&:XBYT-<&L/PVJEFQV>W0^":CDI:6G`M[?+3;F5NVLF\!BH\H0:M%,S MOT=*JC0V/$W%C#/4Y6:XZZ6-\6P%YQH@G&DLC.S1H:U=@M4HW"+H]R*TN0,+ M:Y`09M.A8"3#7<%CC&>KR-@``U/E@4=390&X?!&:W`Z>5<:NWXR$?+@/%2@9 M[O(@.%3<3J[BCO,JZS:MN?IP)#[4,.2 MX:XM,L0Q-BC-1[8\D+;M$W>*M"$0C5-_U0%TNUPP`PYE,)D#-4KZ.<8*GOG( M%X;.Z@%F'?)L!C;CU%UER-R1D\]!%*!()G.@DLD`RRCA,B?QPV!9SUE[H/;- M\O/C]H38U\M-,:_THBFV`H]Q2DRA0RU5>3I61;'1R,L#(=M%!ZJ5U+BS`V]5 M2*RA;!.]TE%:P.M^I#$42@BPNJ)17AN"QSH*Q!C3N[@%.%5&=42P1. MNJ)9';!18C^A6BQSH)A/C3N+8%"%SKKL8#+)6C"?;CT2>94U$6A3+SN/7HU2 MX*Y+K;B')-N9N^!V*?!F&_Z)$MAV0AE]`D)=`.7.*E?4:_#4$MMAM_PK8=Y& M.;%$J=R?5X;>+5(7.DG/RA6=&O:QQ+;4+2`HS-M8_I4HH5C/KK9`ML`;EG*S M6-&Q8QT0/HH*50KY@Y4@2LSB`0>]E,IJ&>Z@^ZBLJCW,$.E9M('6>L& M0_E@[D+-IRJ#R(ZT?FH=TS>M_A@J=9/UQ=JV-X$:O]R%"Q.J#&+RROI)[7'- MM*2/?U\^[Y[9S&&8ABTHD"T079R'6?F)KM"N_.'S;/;R5T+87XNG;5G_"=6L M'R;^#Z%/=8O]\?%4JEK32_5!%YH_\Z,T)7>K4Q^JTI,)=O@V2+UY;#9$PI3] M1*OXI4Z*7XLI/EZ]/(G@OG"./?_90[;]9?IEMB_=/ MLWE!H%9][%8^O5!=N?Q:VHPSE.AMB`RLQA7/#[.!#2N=4`":K!7Z2AQ MA@!3]I#'KU>:3`7>MN8N^\I,`7'F#706$?K!M7;71".D1Z(PGG M6KR&:`E^HH%P'D6.>0=Q-]!+YJ)V5/H%:N.I0)=X.D>$DB%B;FPA*29Q" M=4IL6@9Y*K2VZ)O)YKLJDBEW>*%7N,'#2V1[67>:!+;7J;-,BKHZK1K.W"G:9: MU^94BEK43_5>.XY^1BJ%$UHI#'V#DPGRMI/#U!M';8,D3-E/M(J?F5)KT^)W M;IQ/5R]/0E@WY`V+^^BV8SY[*%"4N'?KU<<*2>VJ_?[V<;N>_X-9U<-1FPET M=NH?34W*A"FMY:[ZL`XS[$\6T@>2G2PIK"3NTA1N'JS((R\UT^J'/^PWS:.[ MMC^VS'=,#']*E#E@4((.EQIV_EF/(]&$N1161:&\8,GF`0 MZ?.`"-=B,_^:W5O#7=HDQY"M((<4==/^KT2E^@O]2LJ[SP2B\](3J:J"/OX. M2B([)L2G`KJA`7-&<-_BTLZK^>-"+\'3>D!K$40-(LM]!KFJDVTGE]J^A[#O M]*&(!/EE$^V\VCOO]!+NI'+RNNBNZF:+8Z^VZQ'LN@^[CCNYK9U72X$"O50? M]-)8!H"7Y)9N/[E`VP'):>PHX3!OHBIX_HA2M;TA/"L<0"S3QYWKULPI%KC* M1Z[H>:A:UJ4LJ)J!*BXME`>I[;L-CQ(&D&+U<:>^-7.*#:#RD>V<.NJ%IKBT M41J6MN\U1)P#*._S<6=&-7.*"I+RT3P(2%55[VZ^7*&^[#AD.1CX^[\D0WJU80JF:B M]PII+&3*27";!Y5H1ZA:G4-MG`GJ7KOSP;)44+#AXZZ/T/1]HV&;%3(LE&XZVOT,HH,B_)1[9@>:D6AJ-10%H&V;W,, MVPR%5`'N@AJ]C&)"GWPD#V%/99U[>%C.*UY?K9]?BE5)CF MVJ945"\^)O;*T_KS"G\D/OCB(:1M`]P%+2)LV!%\?H*F'XM5M9S>K]4'WOMJ M[.6"M!Y>/W@_SS;_*+;+U6>/G#4_57^_*N'?5KO9DS=OC*U3THU<4+4MZ>?. M4MO/XX!=,PJA6B_`73;"S8-Q%X>3D&G]P__FO9*7UB%DD$P$;FD9Q3:BE.Z% MD^,\9%-0*1;O&,>C,<, M!A2C!+@+%.08LN;MRE!G7K8;MWN;,B/P]/3@@%H%G(O>#A%O^1:6':+H(22; M`^1U`+(\63;>W(2UR/AJO;(IYW)F?$1!'S3FG8L/%]-"R!<%R'/LLCR-9-*Y M"6R7^!\L2CQG^!&-P)_'13B7'M(U(10L!,CSU[(\V8F82%)G2-C?KY>K[?\J M-NNW%>'OB\W'Q]FF>/-[L9DOR^+]IG)J7SW-RJ8@M;VCW"'X0H.K*8$J'[5" MB(U#>P),6`X%-4X'AW(JT?RZ%`>'[\&O/&1P3&B=E M&P;W#B-(X8>X<[MZ&+0"U+20.OVGZTGDO9@X>CY41!:FOA/_R$-`D-:9-05B*-_'F*`-X[Z7X2+9J)%7I M801ZR%8,=\IGD'8K)JR'@%K<7J^?9\N5!H$S9\A,"5R[,3NL69X`9$?^!EH/ MU?8,6NO\:C)6S`F66SXLY]15>UOM9;,UY/WZMEJ\U7;YI6AM`IH$`G?^E293 ME$S-?.Z%N7W<.C9Z2/0V\7:4,&<5"G%"W!E'72S:41,]Q$Y/Q_&(*'G'+:ZW M:V\O-%JZ`VL24KX@M_O*>`YEE,8%28#\103EGR'N#*D1?HU#)@-$GZOK6Z:N MC?[=]TC5E3.H[KZ^G@?==<@")%`BJ`<,<:=XC?!K*RAO@O@SQ14:5$Q=/\X? MB\7NJ;A[H#'-'V=EL6A6/=]L-@1(DP4J?_QV^,W[V3?R9S=?9YO%_>S34W$= M95E;/%^/,Z:-3#6=-[A:M?;KFX+>W)A`G4W$(HBX\]G&>;>"MDUS,:TG(-=M MZ.<_?"+?']U6\)JS>)^^'?V0S>31J;S?Z&2"Q[Q^33`2-;Q8NW$&\_5-D28) M7">(H#@OQ)W#-\NX:>!OE'HY0(V:RER*&JZ7R[U6 M*PT;9Q/LRJN#/^,ZJH'(Z7Z0DV8,;!PCC<'T""5?&-MUU3L'XJJ['N%.16OA MSPZ@UD!I0_^([")6-\[(E^OZ=A[W4M]FW.5R6OBS%=?202SV,^_L9DTEFP*7 M\N5GLJ9_PQQ**-_9H`3AX*Y3T,`=(I#90:*$NJEV'](ABMKA)3IE4X&6K7N- MNS1"`W?88&4'G<.@$H."Z0>4Z#1,"4RV;B[N$D\-W"$$DAVD8CG7>+N.)X%J MQ-)"5W6M'/8J'6_G[B"/9!Z,B3KI)+#3<(8;CA$#J8O5'C%!5`Y MJ1Z&I\H'XE"]:[/<]6_5GVZ+XN[KJEJBQ^7+^V)#+L#,/M>%L^7=;EM66'FQ M7'TFP'E9R5>QN%V]+JI%?5ZNZ.!W#Z^7Y7R]6VW)C1IXJ8+V[KE[>"@VU9>O M9]N"JH'`N]%8^5`T(DBY:MF=O9'"2C)TDTI!PZ"->83[#JUK2VG<^7!K/:;0 MG^S'WEI_[T=6ZL]^Q\CV]G1[!\*].W9_H/0:M'L'XKW;E7=$/OFB9@#N'0,+ MK%=:S81'N+BTVEG!&4A`RL>E'Q7G@1"D)-K$UDC+R(R?IBH`JCZ.!HRM/TH+?GP=4ABO%P&L6X MLA;&D-8P,\V8OG.SI88*A:>EY4/@H"50/A0C+_(:83GP83,]C$T9I"-HZ6&V MW'C/8("^S)YVM*W+?/W\7-FSDK9NW#X6)UBJB;*>9]^\U7I;_6)>%`L\YNKO MC\6J&\F^H=26]\6*_1EUS]H:S>MPGLV2CM>ZJ>^!#6,H2B5U60+(;2=0^Q4C M+\O#OWHNHT0]2R"57SMNI<6;&_,(Q?VY.4:U5Y%=__$%V'832;0_C+OT)N"U M[LSG@QK"&'F9)_[50YD0&V4IQ')@;*R[!]J1N4'8T2MS/\^^O5MO@8(&E?^Z M?EJ4?]L4%>V;^\?9ZD#;6137DFE_\Y^[2G%N5^5V0S>YO*M\"TH;JP3\M2BW M)))C4N".Q*KQMST[S,R166ROM"?X31*]^OM[.GM;+GYE02)KUFZWG%H=LR4 M&P9K<"-LFZ]3@M(P9T&M"ZHJ-;4^EP+I^I@<$>!=>90PCU#F4=+H<4CQ'@U-1XAY\IC!&&W MAK@0WX5;0WVH3I@$4I@70/^V%`KSD@LMP-2T-+B1G!XFI]1Z/1#KM:%&ZQFG MT5JN:CV*VMXV<<5H`1O8C5;G8MLS6C4)U5D./>]2".XD%UKWJ&5AW(=P/=R- M`^&`(.S6T%$(YZ8U'`'"U230(QQ:8Z=0X)5<:*6@IJ6Y$`C7R^0YA+-JM'Y: MKHK;;?%<7L<38JVQ8;,]?2/9F9[U438@A['3)($[5RE4.2476L[6SS%:`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`;L< M^Z'?*>,4M@N]PR6\"*XX:MP<3=_I=-+(3R7\LDH(R+\1>-3GEXWEDS4ZZ$$: MC:1@\PF^,ILN>L>U;SS+I\N@)Z?:<92.AE)[+X%\$)IXN;G6GS$6,& ME"Q9BO<5YS^O%\L'$L.N/KE=S3?T@]E3J'!9@W+@ML,J3,X;7Q2>4[EUIM7,WVN,$_E=16_DR%L M=463TB%`=VEBE%QI.4ET3M&Z9(F,Z/#5"@M>DX'LVA^OV(CL@9S!M/2P!WM@.6"8`!K-I)>4]1M[(1&BQY&7 M1/EUR>,G):^\K^2U,L@P%-XC(;#Z-THA=/_U)_\?R$:4WMK8FS9EEY&A_W5? M[>3-BAZ'[V;/Q>OU\VRYNHXG8[K:$A0;MM-:UI#;WLK,!J$=Z%>804^'U/&> M'AJ7`8>MT\<0%_PL!_`GU&V1:;W*\``<)3-[O\'<6CH`@/&]V6T?*^G[KV+Q MRZH22&K?(4Q)9BV/[/L'0O]/ZZ_%!OYI^;RLW+UT,K']:H,>TDU8)F.+VF^B M=$WK1T%>"73JA]"5*W6QR8C)Q1C':S;(4:>]NMK?]-]/Z^W(O!Z=F&4SJ6TJ MK[QZ7EY=3[0@B-TS.">F(3,[PHAHQ.6?34E%,0!2A MU4[J8B,"L\OAGLGA8VS*>FZ[8W+P>V<.FARSWMGIM.E>#J&Q8.IB=:G!M7#* M-^-@R*AK1N?7X9K];;U>E#>KQ;OUJGA^>5I_*XJ/Q>9+-55YOZD(F,WI*A'" M2)R],O/P0A75(AL.F"R!N@R0Q@4Z-S/R@]-S+8#H)90Y9ZY42NAFVC)*T4S^ ME/:\WV?""GC5$J[ID5\.(Q'VU[T$7 MTH.G2<;D!]KN9:[D[;5R;`\IZ"3["`_0@6EVJ#&T5X_M-0:_\IK#_S?V[*V8 MWM]_7=\_KG=E-=^;Y>?'[=_9.Y"WU,KBTB\),P MXV\?(C>+FL)JXZQ64LD!B6V/V),H&5P`R'"_A*.74=,JJ97::36:5P_GT?&\ M>D`/1J1M-F!,;S^H]QL,*YB_5951SJOO+JK?^25UI8UFV7PH)LUP5VGH991? M_]0NFVNE>BHWFEWMXZNL=5'YSOQ2N0%3MKMP^RV'2R89[LH#S9Q:\4#UTCRM M:,K.3KVEUE/O?Q6;]=VJN*\TIZC?-2=EH,LO!;TE<)#'MG=(NC6-:UQEW9*E MOJ%-?$/$H>\G4"N;X4Y[R[)D`1W*T$5Q(/G0J[[TZ*?,O?+V'T/UGBT5X(=Z M*'6@%&N29!ER19> MDB%N2D3,A.23_U#@UBL\45NOJ'[1'QY8B^Q+T7\B_!QCT!M$.3R"E;.C&G=[ M%&7>+,$C:0(/1P/]+PB8C:PA8D@)H8IT8B7N;8*KTSG4@N>XNWDH\V89/4D3 M.N4>P+B*".$GA!K2A:"&QV#W4'-(P>50:ISCKH]09\XFJI(G$P)/.D\/0LO[ M]7*U_5A\*59O"17%AB9;C^JV7CW-RK(A8P(Q)_$9U)1%"T>UUD@,1G,#>BXIV!GT$Q^,X8^,`70HP\IQ MUP1HY-(*&-1'[_2?KM.8=F[7?G9)]XIB[5X9*>1!XR.N:.,GBT_;=-%AXJ:- MD=6I=;GQ27WQBMZ[>EW,Z?Z&?K5X`91+A\Q]@'+I''=5@1IC5C16B<1IX^NK MDTMS5Q4&?=G2,;QPE2L1+;;>VCG`HU" M"RYUBYI_92/,8(3!LX/=?LBAUC/'G<;6RJ=MDZ!,\;&AJ(?SV'C:CWDFG:3@ M<%;MW?[AJ=/RQ0I`QKG`X[6\XZHII0+UM59Q#Q&3=CQ0L)GC+HF29*$7+A9<*8/98TVS2C&:90AS@6N*$I-8D=EAO@2U9\3D$=V,LY@)VFQ0O6_ M%Z%+7'QB.6AXB!4[?4XBI59UCC.SYY[2G>?WI`;T,]CB9`);',(6XZY#TXRUCT M,HH*37*1/`PM55KUM9!Z0F1OH(S(IT#1F-ILVA50C=,>3109&!R*!'8]AEW' M7?-BAN$1\*@ZU1W`]`R1UD-[;&S=$%5*DN6QJG-*RX5>!4:N45*8@D`D(!"X M2VE,L3PBGM5!/S^P'=!B=:0K)=O2D-8!P0(#U\$\%FU(02!PU],8XG@L M6*R!]F%\/)"_LYOMOUDLEB!!Y-W%IW6Y([UV/Y7;S6R^O8XGJ>V7AS21/FYB M7W!5E9_OY9K6]S-Z%ZZ2U@RD%7?!SPBK81KTVV=)QV.]>T!RF-YKS._]5E-@ MN>R73\M0EBC[X,\X:Y2L;T4MD(FEOF:FIH/FZWA2W=\KZ9&NY_5 M.245OPF('^YZ4%M+@-VCXN0#+(GW8[\;]2-SH]COCMRHVHOR&C-B03"GMXE0 MAGO" M+I.9-%.]%%12#\Z]#]5\/NYRRS&7Q2&3)LJ;.4.G/U#T:7B%/@FOT(?B>;9< M+5>?7ZU7-/*UFSW=%YOGRGU-`M^P-;3+D0;+./H6'%E)Z]2$T/XX]7%7QXZ_ M.%8LYI@<6K2;>XJ\!DD>H'#17=@C%M:!P$DYBY6;@+FA&LCKTT MXJA\GN<4#R;OI^5#<6(@SQLK>'_^5LPVY5]&\:H!6^]3\R3>+7#1U@@1*%S@ MP771[/">S`>/2$-9K\^.;=R5V%;7P1&7EHL9_6F!NIUB/3$JPV*WI,$ARV*L MF*%5"N%*G@\W!GS)6U\&Q,@8NIG35,!Q/ALJL6&W.ZI!5T5YCV3H?J[<+ MX"*##Q<9_,LN#1=;""=J*H58FAZCC7&LP?X>^GG9CLA]4+/DX#`0_$NEVU1T MS`R]`>#ZL0\ENOYW4?`DN""N(1(A[K1!D_99<5HEN\$5EXV2L7!+Q\14..'B MDW_95T/$%L*5@`L7-P8B+LWF;2[@(KONDLL6R)@#U3YQW3()HH0!%`_[W\5- M$]$5<Y)[#;.1@-E;%Y]FV6-R/:3V&V)G2GQ0+8N.>ERM"KUQC M9@.D]E5SOOE]6ZP6Q8(?X7P1Z=TL*DU M;+4GJ!&X&KCSXM5T.68SLS]LIOFU'=UF5EX1ZW\:.%"9/?X*\=O,:M!/:T0> ML`2WK5[RF(&UM^O-0['L@9R2_9;:ZKR$\9!1`%4UP MV=7;(LO@1$I0@*'IAV);X19J4M8/WKHV)V,$^%O(YO85?(L!?DDZT5D6V<4U M:'XXXKD!E>`0VB<&EUT!KFF%7`GPZV%7.<`O2(9C1M).8=;W:2-M(#2.YSX2 MZ&(40A>CX+++3'4MD:O(3H;9Z3W>*)68QME)5WZ?ULQ&B(L[2Q7"VY[!9=_? MT;1"#@;()-C4F*YL1L^PIRO_5OUPVUU4'@867>$>6L8U?H*+I,O"]4U+C^(( M;LZ'D#@*+[M65F(U7'%5Q5E3=DM[ID1H@.P`,[?MCW:`U3.70 M$#6\[()U[C5P"[IT,Z*U"HI!EWT!%/F3:F)$=@=E'91;=LN&#%`_+C007UI=5HIC M9M9G)X)BM/"RZZ:EU@.[VR+#E%87AA+@[2GP_KRGX2]C7>S@5CF4SLUE6#/M M3L_@S/2^`#Q6'S%O_;*KK257Q`EG2(ZWZ8=B_C0KR^7#LK)81.J]/V_7?_%6 MZ]4/Q?/+T_I;48QS5X3R0W]1,U7SU)T&"2T6Q@C2A\`(J2VF5JLD0`KD'^`* M0`258>%EEPAJ6B%7/$0]["H7WPB2X8@QM%.D\WW80C/NI@`E5.)93/.RKWPH MKHP3+J@T>QH+@<`5A=_5I'@U+4CJ@Z3UU4[-T/=A^\PXI_R4U'4H<,\I@J*X M\+*K''4MD3ONJSJSY_[L7[?K$V]VS(JEN]VVW,Y6B^7J\[FF11816P<=(YLG M_M719H>ZIH0:?^9F0$>?Z++K&T67`CW*$N-')ZPZS#PN=!K4)UO!,D?-C8'P M5[]0LO,,NO=$EUT(*;H4S@2TQ/A2CUQUS(?.UOA_V!JNY3%N:^*`S`H">-D7 M5'F7@-^VO(`SLEJ,Y"?Q,31M_.[4XZG^?;4@O>!>QJ@T&-:#R1]F@FMY3)L) M\O@[/;%B>F+%4)D777:-M/ABB)J.C]O99HO+>'0RUV]&/A6?EZL5<7+&-R;O M=L^?B@VIILDG;58$2:72*<%HK$WW^ADP,_5DM%8?'H6/H=8NNO""2MXU<-.H M]/)T;$N@I`BY#?'_L"%ZUL^<#2&PE]7I1I=]6620=Q=]F%9.VBT%#J?EP_KI MZ>UZ0_[R.IYD,=XK'JTTH[$5O>MHP%PTY_/]+(-'`V,HA(TNO.Q98!D<2NH, M\:+WTD8CI?,;F=EC4_]O5*8(Y_T,]TR1_GJ7#KFE5?F0BHQ9].["2_N$%L*- MVA41EMBUUK_^?;:!5A9T:-N7*PX4]_??3_(L<"*>QX28_)=1D]O&60.:YX5\D;\-H3TNRU./!>AALF0"@O4M2VQXUJ+K\W4"9.21A.X;AH[7B)K=F708T,E]O1BP^9[NFBQH;3.X@P1 M?B<&4W^84)04&BR"VH?8\0M)AI?&C5"A&I/3>[2(\/@%G$'U&O&V@CY.1C9K M2DNNS:*)4)%&*0,!CE]S,+8HZ(&?+&=Z,=_YVWNXX)Z,:N)$>A=M#?7C.P$J MZ-&>@'XX?M'"W*JX@>JD^3N\!H@+S0WW0!U2L-S'B_#4N!O9SFG?&FVV3Y6R M-/)9^M#Q@FBK"X4>,>KD5B^*;.TYOW\#[2]XX:4N&X`3_U`M[M>OX/\CAOL7B]VRQ7GX%DRD])__*D5'-1 MG2M!0ML8QH$1*RA,D:+ATK(">V,C/!II8AY$?@*QZ@3YQ0\-['&H=0YJO2H^ MDXB]I&*KD]HL,2[I=Z8?G3\I:'/LS?FSBC#N(:IUGZ0`5A/<9?VR+%FJP)(D M;PJ*XNU6U<*?/\QN5OQ/N^3&>:9?%S1"75U\B6K)6>G;)(5^:PGNE`5[68/Q*N?2;E]G!OTMO23/&XG$\XUU-6UI&6ZVHT`ISYQO%Q7!_^V M/#X+O-17#.00L0$*^XSAF]^W167X%O3EB8F]]U0ER41G."37UJ!MZ:.(O:>9 MI+3O5P"I\L3QVE=+2X0CU&R'V8,)&Q/KM-3SDG,ZH5TF8I0]<%M('M=D<:ZA M+GO4,EV4POG(A,OQXE0=_`MCG?OQ#`H/0],/Q78\P"-8]7]T*/O\88Z1R$1G M/237UJ"!Z:,H8P<<:W0*KP`GCE>$6EHB2\$<).P>C-B8D(=6"M1%`F5=)7!T M=*JVAI MB5PR6NKLMM5]!NKUODRFLE-X/A,D5=%VED!5TP- M%S4+)6.\[G/<_OI/&@R9Z4(NVG0LF&3P'EN(N5QU[:7`DULPR>4BH MX;J++-V]"6=;U>^D=9;^MJH2K9/\'*I94]R5Q6,O#19$9I;-0_0PG,4LUI;@+SJWP MSV]J6GCAL#$VF)@>)B$/6-(AE/JW>+_=SSX]%1Z9UJ/S_F\9"`:+(L4(J[HMS2"EB):]GA9?IQ]_P\VWRC5H;T1:C[/'FSU<*K MX_/WU7^7LSG\Q<-ZX[UA$$8T9C]_+!:[ITZ.WJU7-3AZ73F=\TK-*%&4E??5 M,MU4-'RI)(X:LP9O210:?#W7#-6*7IJUI=Q[7Z9F#-,L`K%D40?DE>0VU\$T MF+')S+2>K`_27'F-*;UZ3F:;`,J0::^\>F)E9&-8S-1D[* M=`+2"[?)4[R%Y997P3CVL6X6_V=7;@D>NWNH1V#M MB]]6E!>;+\MY45['66#.'>*C04WU9?FLT07G]]6VQ4%*3Y:ZP6F*NZ!:C3$K MKH82B=.WL^7&^S)[VM%S_2O[WEM"\XWERBM^GS\21X5Z#B4;S:@6&7$#$&K1 M&4;G_#Y*0KJ+['&Q%'>UKSQ3IM&S-&73PY=$:>IO/?8QU92/BII2WJ\_%&0# MED_%NV)[NYJOGXN?UF7UYZ]FY>/[S?K+?"JWF\KMOXXGYKQK$P3K4D*#2WBNL1HG\^,T!)'SP?O*<-?0VEL$>Q;! M,"<-"U)ZV[6WG\NK)O-@-N_/9+Z_D+\F4WKUG"13\&V*U37BE09!(+KE:&NU+6YC)8AO3&&3JU1)N])5I5 MENBIFHG\*?GG.3%".[`[WGIO=F;[F01MS?-ZLUW^%XT*W#V\+CYM23R;`S@OAS$79V)"R*AV*SJ9#2G'QE M0.(M0"+K$C\`A$Z_2F+8!>COFN$N;1)EQ2[T&:3G3,#W7WBOQ"6<."XWJP7Y MGS?_N5M^F3T1Y^-F^VJVV7RKQOR59".NDRRB'3;\B0E9YZ)!3>AEV:S%G^][ M8I'"((<-2V'#<%?@*/'%KQ@O\&;0=K;9RAT$*G1.7]U\_%?OYMUKC_[#FW__ MY?;7FY_>O+O_Z/W@_?CF;[?OWMV^^YMW]]9[_^;#[=UKHPKD?Q\*Y"LH4#B! M#82V>A%EOD05Z,U*LJ6["I6]ZO.F^F.MB@,W@TYO#%6"%5)XR#QWL"7@GZ^WL2:=6"1$Z???FWKM]]^K# MFYN/;[P_OWX#__27ZL^\3KVSH&=&?!KD>G;F\PB-$I%^X=1R0FE"AKL21)DW MTUZ1*H%3FJW!:\R55\VKY:K[X4F[+:2_BG+4G]E-O- MCEX<>29A-_\Z3=+0W`503BH4[UY)\[J_5,4[@A^E40*&$I+T.>Z:"S7&3"N2 M$G53FE`Y?'[E[0?P#B-<>3"&8>TQ<\$1I_:<7TGDWL8\G/BL3"Z`U'*.NV1` ME34KH6A%(@=J>V?E(4E#*A85LC3'A-YMEI^7U=:2/SW(F$&0-SB]3D7BXJY= M@]H^)1:01H^2$/().>Y51WF_>SS78Y>V+_ MWKC8?IVF86KT@%$B3UWG-*].4R?5AO8GOL]"3%`CE>,N/##$L8T#3C_9<`#6 MXT(RUZM']F!HCXU5;:K'1M__46/\L13>V"%Z$0K?>@@KRA$],B#V%4#U5XZ[ M^L(8S]8.<1/4G[B'SKULGQ9 METNH7[PIRX(4YT[BU#=V?/3.K:86HFS5"M'_73;Q<>>P>,@W?0IPT#`EOZDO MXU8BW/@AP4WO-^0NW/8;;6RUI4G?%TA0O?E]_K0C;^EX=\LG*OE_JP#5_O?D M#^Z7SY^*S?[/C&A#'%RF.ASXXM,'/XO#!'[7&@23"-8PXY@GN&) MTU]6W@[+*>>PCKAS^CSDF\83'#34HDA_Y+V7$<63IPUNYC1$4\U(`S,$F$-^ MYJ?E[-/RB5[.KS8\G"0F)5:"*&7!UK,0#?F7&C"$#O!1Z,,>X\[@:^32@C9I M(G7:4GA)^EC4XWGO&]E--J37&-.NBII".\ZI:!MVDA@08A-DS)@UHR52@=L7 MT,RI+2RFD>;I7CG;2@^*WTE367V:^:&8%\LO9)I*\`*#Q00\))C2NEXFAW6L M^7FU4\S(AK!AN-/^\DR-=\@-4#9XIAV^-ZDD9N)+V+3D/-K$]SV-B;.=BV#G M<"?+5=BR%)E2(/%PIFRT*.CNPK M[9I@35'ZR=&M-,+,=RO0T%!)FC%;E\`&X\YYZV'0OFI)4-FE9_NAO,98&C$; MK_#9PF\X58\'UPV-13(.,=OV%+8==[L#72R.AO>DR)T>-$X?^#MTW*7'Y;[; M;I#&$XOG6@<9NK6*F]MN9>H:HMJJ&JUGL&.XNQDHX2_>@HU! M=$JR3J:+ED9@O2%5D^:P45,@R.?8;QD]I0 MNT53[9[TE4O0T.7!H:,5`6EF\P@[(4"[*@TSV*,_9Q]7QA&RYQ%DSWW7:AOX M6!KA3.*AJ_,<(A\W(GH&U<)6$&\\O>`)U)U_30T8/.$20>+<=ZU.@9>IT8)Q MG`1.01WTA=[>;PI2R/T&"H%(2#>P>40<3Z];$0:9Z]:"TT^3*&='.*3!?=<* M$'@8LG\T<%#5=3"P3SWVK2E%L'4HC*,)/`?"\;=1PD(SS)&$5+CO6MT!+U.C M'0B5J`=_5QS.4@\#F9+X;U0+#3%B6^4&" MIFRWA&4;^JJQ"UMI;+)&YC"5JJCV$GV0R*.?9>S0A#2MCSUQ/D"[>1C23\"T M_H'4Q;*V_3,4QS0K="U!R.;/Z!51YI]`SM/'GFP>)M]2`'&0D(,(2ERS97VN M[AX^DCY4-ZO%WUG7XK?KS<=B\V4Y+\J[S:NGV?*Y,KE$NLP91A%:%(58D>V] ME(N-,PF0OQ@AQ8]Q$RQ!U'3?8G']X-'/Z%VF^D/:7*W^E/19A(^MZ(X9^XY> M=\Y/"*%QHBR?T%+J.$R0!Q15^+)SIBA0>-+$\*A[X7)5>9;SQVK*@BI8R882 M4ZMWQ9:\YO)^L_ZR7!2+'[_]4I(6_/L7,&_FV^67^MXQ>1O6U)-A_(2H*902 MP[4VB0Q"7ZF")T=CR.T'N.N5U)D3T"OYM\*4R9Q6(WBTS^\+&\/[],U[V+_] M.ML/8%ZEC$`\S"IU!NX$!JEL),M10O59@+M<29$STX!/C3RJ1/0]L/<-)?HS M&:,ZH?[2>$KYQK@Z[0L[PBC/$6B5GD(E'?R+*UFC,BT+8=-C*)$)<)[O'[VW'^Y^]M[>OKMY]XH\BG[SZO[VU]O[VS>"C\YVT':[^E*4VS.0 M!<6J-AVU%D*,*!L?PP-:UCH(W4EHAQY#C4.`._:ASMR8CAH_F0=';0?'6O7_ MV;>ZG;1>Z;())U&H$R]^;!ND\A4RV$#/5'`>ZJ+UTLXE&[7CIE]$^WD\8C MBC:=-(RJR.ND]>X_+92"&^TK'40NI,,WT!-3H"[IDZ=N3&=-'XRSYVT]?Z> MLF8GK5>Z;,))%.K$BQ_;!HGR"92MQU!B&>`NF%+D;"2TR$G>$$AL-*FQI5S?_XDIVY!DPJPGIT]#).A!A%O&H72^=,OJGVTGC$46;3AI& M5>1UTGKWGW9/AM+N!`J"0B>+2"28'--)$R?WS$F[>__FPXVJDP9O%)''W2B. M,O?4U=%(MG";]%-!S@CURQ9[-O-EN M-\M/NRU]Q6.[]M[/-L5JJT4J35E[PU+99J0/OV./Z<90S))`VCQ$7\K`P8`M MXSI,"A73I^H'@F)8K55EN`_1M-5B7_YPNRV>F^=Q8C!_PTN&HO3*<[L7;.XA M_"BOCS?(S(7(RPO4.#-NJ)7(F[+/&[D7? MWGAW;[UW=^]^`!C?4@7WSV**]7[VC;9#9[>IZLM5K]8E:5(0A2!>9MIA],VM MID"B7-5:T_\=O?4"5^@3R$6'N,L"9-CAT`T=+3$D2)M^W%_7HW=CY^2WA3CS1(:_W3^%D$`1 M1(@[=2['D&F_0XJJ:?T5"0^Q[[S#AU*OD9T1\O-L_KA<%9MO%71[4_W)"_EK M(C!!;O&$:*5"LU9P<]JI&QTCT$YN4'^>L,P0[I2X&F-CG1HB1$[?5Z,_DBZ3 MZP>OJ']L5E7L'!T(-&7X$&D?(,]R=L1#`5"$.Y6MP)7UXX2;M-8S9?\UA5IO M)-5ELYX7Q:)\6\G5H7W)J_7S\WI%G9IK/YZ$Y@I#!N=75!()]O;Z,?AMXK,. MZBDD,2/X,M#Q35J*TTN2=*,>RH1QS4(Y233G>K;=%61U)\$1E/)D$5G2B M.:T^51A@IDT#CC^A41`H,4LAZ13ASF^+LF)=VCF(.I'Q%?G">X%/=`NV<>!C M4[![8<[1)TG`^FBE4&D0X;%IW'H).!)Y] MXM%O//*1L)Q_69;5CKQ=;UZO=Y^V#[NGF_E\O5N1I%$IOQ,3\0_&RKSHZ/^7C+#+X#%K?W&IR M+LI5+>C]WU%,R;8#4H<1[L2M##N6TK42I$WWWY"`HC;PSB/C;%/\."N+Q:OU,WDM<$:V MY]I/2)L`4Q+>/JF:;',S4DMUQP<5<(0$1@;9O1AW$E6`"].2S$_*E/[TAT_D MMU[SQWIEUXC+.8;LGKF9[1^P"WDI>#X9).!BW$E/04ZL.)=B-)V\E`/K6>I] M*^?CMC+RQ.;?/9#+[6^?UE\/EV(JB*>]Y/=]E:89')<99#-B MW(E/85Z,6W!!@J;[#VBE"[G42+^1OKRXO^%2+"K]2H/87'^$YE2J@MQ+]$%R MFS\CKVW!:D(..<:=S1PFWKQL#E#`+CW!3W2(G1GX8%CLSJ'"T<_R<%(M&JP< MY`-BW(E&'O+M@()A0HX>HVR6-K&3?[M]VAM+J=J0-[\7F_FR+.X>[@!EW*U^ MGGW+*OZRF^TD>E]L*'3YE6"1\CKPZ:WS,T'^\K+\3,5S4G%!A9/\B=C@:J*K MR@>1;;$QZ(NZ&7DL(_79H\XQWHBT%MZ,:X4.*J?U($WH7*E--9"777EDK"MO MMO7^Z7H2>2]%I45DR"N`VX(@FN!T2@P)M-`!%HQP?Y+6U!)I(QI=Z7C`I39< MHZJIBS3A1$_X/HZ#29#!KB1X`WA2O/#KP6(]WQ'[W.+1#ZB"#&$G?N.&?;?7 M@G_RKR?I0>:OC0H[WQ&!3]9325%GX52\B1HI7HR;?!FJ!.5<^FUN\G%Y5)!^ MLUKD81I/ZE>/[Q\WZ]WGQY^K'7@,Z8/5[$_>;Y9?*D?V_=-L3@':S3:;5-S\ MLEIN8=A*X.))+G`J6*)+3==&7#RBKK:F)^+(RD`2O,'0D5;#QNDX#FM'WA@U M+>697T9N*N;A536]]Y7-[VUA.H]2X(4^0:%^N/_C%R##>ZGI`'B:3:@)VU74 M7+'9!$]LZ]K(=^;_8#/VEK@? MU[AHXX/'F"Q7U;_O9_.^5M,==Y>`.YS[2?*]76^)^="=+&RMZ3$CUBX,!06`O*/2B&B*0G-8[.Q)C MT;426DT%3`("%E,!B^&J1H+W=KH=YMT!&GULV,09U$O!839LHPS$=L,0QF@* M70)"!]=B$KRUE7:8=PIA]'%B#&#H-A3-$,_]XW*S_?9VN2FW]U_7]X_K73E; M+>B?%L6J,_23QG4)TP&C1[XN4V*`0(/&QM)R#IHC$W30^C2X-Y+B+78=>UE& M-V'F>>0Q;NV1VZO]G\\Z@K>3ZS1N5JSKKPDRJJ(:?*X_#-[Y:HYG[U@*`V_% M\]C+,JZO9YY!^\8.JZT[9(^C`"6Z,YZ#M[2<=JU=(V'+6HVDCI9[6UB6RT)W MK3S:-'C:*XR,:B@V<.>VO1L)W#5E'L(UJ:-%X1:6Y8+`72N#UFV=-+BK2[)$ M`I14UU(9RR4SFRX[I(G38ZLB-2@-[68L+03=>U(7*A9U,FO1`F@D^TBO]]6$ M>I)UXVBPL+/EK@IW.4(*\L'2,RR"Z<+M"9W,VG5:-%(NJ\9G>3,QG;U9+)8@ M`N]GRT7%Q^QEN9T]_4S'NXXR<]W5>F=6TTXQINHV6/U?D7Y.D]2'78,;*RG> M*EMI?OCUIX6V`;V1)6IZ^,@C7_UPN_+8=]YO\*5@$\&;Q?_9E=OZ:=MVDNZV MCQ5%<1:;>TJ6FPQ5=9#F]J`;O$-4IS3M>E9M(,254[RUI!HX,Z\O*N1-&Y_3 MAYB/%8D<'FR,*X^.8EJ-C#1,1*M&9YT6!78S"V/?AUYH,3SAD>(MM=3"FW'W M2P>57:V*]H@-.M'E1-O^Z3I-9+L6\=#9Z#=9@\=7ZW);5O*7F.O,KT*9>07D M7Q,1G>PS@"%YZ"J3XBUK-,,LA@-0B&*1,['9+_CJ\&8['7P$?3;SFI+C M"GW^&)/*L%%"#?^$M2&-X29>BK&MF M9=GA/^X"R]461L+NG#2UV?C#T-8TPM%9#.V8O"CG8[M M26%[(!V>X2Y>4&5M;/3#22KO>?"PV7Y;SHGQ;B>*_S5:[V>9;I0,! MBVS5-R')'_U:E-OEZO/M\W.Q6,ZVQ=.WF]6"QK$6-UL_NE]'0?/EV2#@1V=6 MB5-3U+'7L=9VNW00>?4SD-<4*FYRW$4?*-;'-&+%P.2T)L)C5+!:89K1K@GQ M""4>(X5[F9>O`8_1X#8*\BB(/2"*Y;S_R[M=>%'@D!?Y1_%;!2`K, M"((K[PLSA\N& M.21O";)+J+00HC*(].YI91(5.W(-+>#=BM'M=0UARJ4$&%'W\!VL&KAI'XXA!>U3:Z#@*8M M)M=))MLS M(N#!,YHXXD8QS)P0K#+)`*M4O^HK(IL$*+&)KH#2Y5@5B?"0I/2Q[`Z]\IU/ M<%^9M+<(2$)!FMBQ9%$DTW&_%YOYLBSN'M@Z5`Q%-4.WU1)\:WDM]SJ(TUBD MLE1F$D7SH(FOO060&R_P,Q]YK:828\:]"!7JIO77WMW#WCD@X#[:@WOOEJC= M-Z\:Q:N'\>IQK&H2YRGLG":=GZ7R6XJ\_$^),3MGG@J)!W5:/^R/,@B_3:+# M.43>^B$JQ4)XY$RRJDB\7K)SFM3BZ\IO)_+\HQ)CUGQ2%2KEM4G4=92A$EZ. MH+(G4D`E/]4(FM7)HY)ZU:.274:>_M+`'DK\=TRC*@J$G]APJTX%TB`D1*-T M>N!A<\>1)W@TL(<7*AX3RC2/!#?XC[AR+&TSB1O1J)LF#-G<9^29$`WLH<:3 MQ[0JJ)PZK`SCFE@2._WF1UWNC$A)A-PTVE5-DK<>+>,;L=K6`'E:0)&U$2"D M"'U=\)&.P>#C'6@3'<=`&%%,]J11HP-ZQ8,6^3<7>;]!1=;&0HDB1/8$0<*X M<5RM:P6[TAI6%!,^>8#H@&9Q`4/^K47>OTZ1M1$!H0B=:MIE!P\V'!2!QQ>4 M)AM%TSKY5%2W!OP/D/=(T\(@4K1X3*4Z9M05=)013:,`$I$*Z@*3S;UWKM9# M@D',P/*85.D#4%,04D8JS:),1.JG#7$V]]RY"A$)!I&CSV-J%550'82F>Y)[ M*RQ2)?`Y/(EVE9/BJT?3>,8C6^IS,B[IQYV!*8[/5C"(")P\'D6L2%_SCW4[G:CX$&!L1 M[O%3B5J;&IY'9ACF&?*O%'A4TJXFEG>NSD.8/93P[YA&51"H*ZXH+I`&$2$: MI=.##AL['CI7^B','EZD>$RHU`FG*8XH+HDF82,:==,$(9O[[%Q)B#![J.'D M,:T**J<:-[Q=-1IB3;)F(69-HQ]%*AGKP1DT*Y@,1YUJ-3P8N0J?3=C+33E< MA7=,N:29M(XC92EM19,5?&RVTB7#'=V5T8(@!:11]BA#K&`-RF>TK\E9QD^Z'@JG?JAX]CZI@0=C_85GG+-0MA7Q^JII)E$ M!QU[R96'CEJ:,-ZM;BI1>/(GY)FV#H=&)94],+YF+1/GIE/'AH8B;^9-`N9] MQ[";CM592;)H'3#*T=D*%^]6'AW+JP?3'W#DED')DPNI1@V?6ES;&#+7.H%M M=*S<2I+%<4XL.6);SZOU0:VNX!E04Z$.;GF4=<20JA>'$\:WGS[L)^L9[5BI ME22+HSE@LDO^&RY";`H1$73)P;<57;0WV"2)A; M31]\R'W'"JPD6<0##GOIE`"'6B*)W#*H&QR.JU$*X/!H&YGS#&4%OF-5'I(L M(@.'O<3*@T.SP8Q3>=0.#L=5+Q5P>+2?4+:30U[3=ZS&0Y)%?."PE][^V+P5 M4/BZF-/()*%\DK=[+?%$"1<.3:%=TR1XZM&UP=%H+#B#D%4.M3N^8Z4=\ER. M@!$E2>V"B?5P7CV>B3`BOTC*'V>(]8SK4./;UQR"6#DD75Q[)DF>RQ&/-DF2 MN4,?#0VDKYCEXQYTTNX:8@7D<=HXMQDB7#F4\KCVN)(\EV.Y;I+T=GEO'+JF M+;K?3?K!Z8E]0]C2D!.50T^/:(TSR7*+"EKVDRF%+35%( M?I$T@2U'US-%;'FTKQ`#RR%!ZMI#3/)&J8 M\FA[66`,ZGU<>XM)GDM\F+*77B5,J2DI4,\55-HSZ?!X`BV0LF,&8PK'SQ&' MOG4-1C8VC^$V1@Y%"JX]Q23-Y(AP4HS2033)AC,9J!R41G4LB4[!A)!D_Y8R M!P&2J:X]Q23-)`(<*4:Q>(@RH*FXB4DT.2BGRF`2G>:)0,G^'6:.`A0'N?96 MDS238P-),7('<62GDFD/39X1WG!R0C,PTK#?QL^1C*XU_(.\4MUJ7RO1@GUU MKL)$DDE,,+*74BD8J3DF.2B-!F#DV`JF!B./MC2$+86LCFLO-4DSB1%&]E+, M'XT<`SZ>RJ=^^#BVQBG!QZ.=C6!GH6C(M7>9I)E$!Q][R56!CYJBD/\V6^UF MFV]!TE-W$2G!QX$9M.N:.$<]NC8T&`TO!Q/85Z@7^+?5A2R&!X]H;3-),C@@?Y2CF;/.X;NJ>N:0V MMZ!*XTBTJL>#(_FVF/GB4"#DVIM-TDR.A2/ER.W"D<-*IBT,V4EXP\.)S>!( M0SZ;.$H#7+M42=I)C'AR%Y*I7"DIC`DMS0:P)%C*Y@:CCS: MT@RVE"5PG*L7D602(X[LI7@P##DJ?#R53_WP<6R-4X*/1SN;P\Y"19!KSSE) M,XD./O:2JP(?]88AXY[R"I7'9H8F,*5I_/P,*UK76#2T/&&>.-0#N?:,DRR/ MXR%',4*'@&-LK@J25Q"582,VS1(!C?V["=ZV#UF;T+GB$#D>QX>,8@1SUS_N M=+3)3Y4.+R' M#'ZPI(M[M1T2'(Z)",7)Y8\@@I893#QS":8\)L2G9%QX<'!+(X8]H&`G=*^Z M0X+#T;"@.*V=2+!?G_1%#%M);K@F:H_&]`UO2:TZ>1%6JZ;G',:PD5"=$[E7 MPR'!(1HG^@:"5R`!<@109Q,Y5XHAP>`(T$^'-8P@#DON1)TG/HWD@5EH:XE=JXF0IR_$=TF,4K[ MO":F05=F(WEG]#8\#;5W3;H'MZ))G7P(:E(CYYYF4',90C%+[%P%A#A_2.!= M+Y&B\$Y?"&]0Z/3"NQ&U1QK>'>T<-.X)(NUCM(,@?,GC72RQ7L,$@K/M8 M;5G]R$/7=89$[:V$H2FTJY8$3SWZ-3@:+0QCC\Z$D(./G:N'D.5RA*-*DM2N M`VL_G!>8NV/(+Y+RAQ=B/>,ZR#CW%>),(2038^?*)&2Y'/%0DR29.W+1T$!S M]>?\PBH=Q4"L@#P1#71OC+O''*8L7.5&;)&J8\FA[H4`T MA!*'?9YO-;+6]6[TM/FWH:Q!GC](V7!ZI5Q6X MI]"EIE0E]0A3LL$(IJR'\^KQ-,8K M)412&%.ZH&=]F%)T7Z'/702)T\25.A!E+NUC2E62^^.57YD&KH\T4'L770EA M%<66+BA@#[84W69HB1="05WB2O6(,I>6L:4JO5-Y75.-5W*0WG!]I-Y?X)[" MHLIU\B2EJ:(+8_V M%;(^$61]$E>*3I2Y1(DM>TENCU?BP92G0FH`4XZN>&J8\FA[H:(\@MJBQ)4: M%&4N\6'*7GJ5,*66>&79I!7NHB;W7]?WC^M=.5LM[A^7FVU1K*Z#.)5KU"LV MCV;ED^>N4P.YAPS\S)E7*R5YLPXG!0EL`Y&E=X(9ZZX>9""O'LFKA[*M7I+' MFB/J-7S`">VP8WZ;*&_C'&:"5+8=824]KB9'Y]6^+0%]U=P/V?EE6[]D'39' M%(S#=1/:7\<<-E'>1G/3!`E55#)5OXR3VCI$'J=R37UE9AM'X3HY5=6Z>F"R M[8XY;7(<8H60QV1J`))Z\MZ2\FD656+21&T(LRD`KEPA4.(0-=H\IE7^.-22 MAY,43DQN:J:J`&9QI.:Z%M"]/WC9KW[_'BS M^[PKMQV^DEPK8NDI]>ND.L]]>BD\.I$%5ZXBJ+,Y!F25I+43M]+Q&&Z]!=5D M8WHPJ&=J/&D<:(N06VWQVJK M-;0J+;@*4-==;>4#O3)BXC:V\F_ M1A5N>$S./#RJBUD'L/(QQ;H1L[:PKZ)@6X//2!7;!)1N2HY[E3YJS+H"JX_) MUG)4ZXHA*TJT/8R-5*6-X.VFO+A77J3&K$/8^YARC6JM#,%O5S>5J#SU7!_, M5(!V[_"Z5524EVX][!^)%D?[<.$N@NY\B6LY5RD.[<-C&3+;,7$%@NE0GJD[ M_KSB)WT08M0EGD.-8P\#Z/\506>4Q+7,J12'XQU?,N1RW>4OR8EUT#+]-ZYX MQ5+6?<2H8ARN(,^&0L.O"#KL):ZE/Z4X',GIDZ&U'1(.:),NWZZ#X,9U/Z6K M5+W#6U*J3EZ$E:IY0ZEM23XA`7]NNE51+[Z;E/?[MZ7EDF M1P./4N1VXL2J4@I*Z8(J\T&H"08RN8&H0\VE*H$X@AYY*Z5[`AQR1&"-E+\7"4 M<3SH>"J=^J'CV/JF!!V;^YI`!4$,93FI>R4=4KOGT#J]?Q\1XZ5.POI$@B,R<`*C/2=TKYY#@<`RL*$YF)U"D0YD,-'*) MGP)$Q*=+?.!P>`^AFW_,,C+NE7%(<#@F+!0GES^L>-`R(\"02RSE42$^%>/" M@\,;"NW[8ZC/R=RK[9#@<#0D*$YK)PSLTR9]X<-6@AN.26@``YKRL\1X$5:J MHT("AN:A/B=SKZQ#@D,T&+"73'$,J"M2R"5^NC'@J+JD@`&/]A!J!A+(JF3N ME7!(<(@.`_:2.QP7'`/[G8JC9NPWJFK)8[^CC80:@02J<3+W2C3">D=@@MT@J8$.\>L:'$?GV%7SG!%(HF7MU&I) MPM_R!`V/5=`(>.2657D`B5?_N(`DWR[#1;\$ZG(R]XHX)+D<#5#*T=L)*H'%WMU/#D MT>9"^4X"Y3N9>Z4?DESBPY.]]"K@23V!RKL5-%\,_&J>O,/7253@Y-`,NM5- M@J-N;1LK?:-1]EP!B*4_-(HC2/Q M*A@/BN3<4KBVE$)V)W>M)$26R?$PI"3%G/6,ZX;JD8?H)KD!+,DOI[)0$J_F M<0!)SAV&6TP)E`#EKI6/R#(Y$HR4)+<=1?(HF:ZP9#?A#1;2GD4E/( MY^2N59/(,HD11O92/!")'!D^GLJG?O@XML8IP<>CG84$:@K50KEK526R3**# MC[WDJL!'75'(_2WO'L]&Z<&6P2GT:YLX3WWJ-C0:W=L,`LPI%`OEKI612',Y M!H:4([431!XZ$Q@,1G*+I`*,Q*MG?$"2;U^9$DG(D\X@AF<`J+*M?)DY3*-?V&#&X#IU`OE+M64B+-)2ILV4NJ'+;4%:'D%DD3 MV')T/5/$ED?["I6P9-PLGDS<*R>1Y!(EMNPE>3A..2ZF/!52`YAR=,53PY1' MVPL%L02JDNUUK\A$DDM\F+*77B5,J3M>&?:48F1*S\L,SV%.Z02XXM&ZSN'H M!N?@-)!QR0:[5V(BR^:8P%*0UF%D&;8EOW6'+8?E4@.VQ*AN8NAR8',A_Y,% ML+GNE9G(LHD!7PK2+!&\#$VFQ/DE5AUJ8M1#(;`YL-=0I9[YL-?NU:+(LCDZ MW!0D>!AO=JN<_B#F.?$'ARA3>HQF>`Z;FM?)E9SF-3V*'#R*+(0==J\H199- M7("SEU9)P*D[ECDLET8`Y_CJI@HXCS87:B"R&#;7W:(4439Q`LY>F@4BFB,! MS5-)-0$TQ]<_1:!YM,=0$9%%L,?NEJJ(LHD0:/82K`8T=44V[^;;-8W)]OA" M2H_7#$ZA7^_$>>I3NZ'1Z.ZFS(U(8'?=*U"1Y'(,C"E':B?$9,-Y05NV7%=( MDULD%0`F7CWC@Y=\^PIWD#.6'W*O+$62RS'!I1S)_,',@P8:A)C^Y-MFN(VJ522Y'`U=RM';"2Z'=4U?$+.3](;[H_0HSN`4%E6N MDRO4$622U38LI=4.6RI*WK)+9(FL.7H>J:(+8_V%>H@ MZ5IDARB1);]I(\'+<<%U.>"JD!3#FZXJEARJ/MA3J('.J/?/=*5"2Y MQ(^E5PI0R\@:FHE2W>M M2'S?Q\&D#F_YN,M)I/@QC?YDB)J2CP"W$:17?^>Q#SWX$N"=F*C?EN5N5BWU MW?CKATQQ[1I731&^;0>F:@K&]L['IRX:?7P7CV^!Q,H M)`%TBC>GWW9)&GWNU6F3$09K(`_KXRY/,<>T+9_/&``<*@U]W-4PYIBV MXFD:(W^J5;'E\ALJS!TB)[G(XY3J4XZGX-TLZ]!P.CH3%BAIS)F/AKOPQAC/ M+ISF?0PFXEK/\*:P0+8MAZ)E'W?%CS&>T9_@?=3K/L!E M@LDZ1=U\A`V;P9',N<'1DD ML"[5/\#L'I0DD_GK;N=LND8WH0,-'B/"VU/A58:+TJ$E,V!>"X4C#7\8KKY( MA6%1IA7TX00*+@+ZJOO$6Q7)@ MQS)[4\NF2S6YHW]Y&I$4@8>US5.$UX)UKI@-"]8(=N1A!"HYPY!*EDJ[1?R3J/5UBCPUF%`N$?TLRB._``D!$K!`U=J>K5P:MG7 M4B3WW($JO6K$0XN$II+ZYSZ29164X!K*RRGPJ M:G:=5Z,2Q`([4'89NE(EJY%?I,"WEVA5^*NCO$Q6BLUB843JJ@T7'XD""V)` M'CQTJ@A5#[_(,7(O\>I(^8I]9@@C84A!&*">.'2J"%,/ MOYCQ="_EXZ%J#35'Y5%`O5H.?Q+X891&];*P,/J_[59%.*DH##KCZBF)J_]2 M$=;0EUP>@1LC3*\-L;E^7?;&'`TT-9+3ZKK0ATKAT*F*2OMK8]MCL,U@&THY M+4\BJ.64CGV=$J'$.R*EO4J)DN,1>K0X)!8450X`_6'HSM9O#$,7DINC(.M0 MB10%=_[DJB+DJJ+D@.^VQP:/`KQ@"."E#@(\R:#-'X;O M?`''LGP^R#U4OX1.%6[:7YNQ@DRV&?W#^+6LV+Y*,9Y,4'FW!LH[K:Z?1=/7 M+/S+(0SK0_%RZ%2QI_VUN0#OMI?!,;Q;#5=P;"@J&N_644,WAG=[).L0N/:A M3#)TJW[5^MIHG]8K=[MLKDN:'G4.'=-MJG-@AI=V>!&(/9 M6MWJJ0O5?9>V30+1:95QN/#G0PE6Y%99NN6508/FC+)Y\BK3>*(#W$57 M%5U7%6$'<+<\,7Q#N*ZB<0_L%"MOC6NNIB#>=VGUQ`-X6F4>+E;Z<,TC&>61VWO5;.`,Y655UZH1:Y6(G;&ULZ:G3MZZH'%:>!:3.36 M30C+*^.\Y]K+GGW/U4@F5K=Z8O%I<-#_;MZ&\#N(TUIIOU4:: M:7MG<@WY;9Y&*H+JWQRO+S&P'./[J=IYXG=.CZ8FOFDUN5?-[M73>_7\7J^C M"D3`7`[8,EVX[7NV91+X3;.@NUXXHG\YD"`U[8QQP[.K:NZK:O(C=$9L&M'N MJSTRFW5@,[_N84+G8.#,`7NF+>SV/1LTF?";7DGW7:\6T;\<>`)MVGD;U:AI MCZQI6YZZLJ%22ZW94LT$.F/@.M=S!"M7TT(4P/4B$5.+3F%J4"_1OCSF\),M',]"'.[_KU\MR7OWP<_%NO2W*][-OLT]/1?6[F_E\ MLRL6MZOJJ"I*R#POVEJLQ>194ETNKE[JS)H\XRO):^XT$T)[E;$NW`'T*HO< M;EAG9X'&=GJM<,GK`!\3X]VOO3TY'J7'8P317S.2O)HF*!1>6.A2;$J)];B^ M?YA#":?7B!Y`[7P`?A:YW??.S@)A\9BM M>Q;NL:5@@B?'VWC5H;QE;1M'/=5^D0;X(W8`+JB16Z7+MM9H$OQHWNY M'-./-G$+UY02X_*C73:'H_G11WH`;^D&T#TM7:1[C)(@G$_$>U%E+ M4"S6YT!K(LNL/32W=KQV4!<%\#X6`P30=3)VN[C:\,J,[22;98_7.SZF0OB- MH,QL;EF[>NIQAK]/TR;L_NJ5<':80^^UV.T":L,K@\+A-FU=10:R>XEM`^*U=(PB5(`)W-N)XYM;.FJUK1FHF\%I""$6RL=M] M^`ROS&6`NUX>1P=W*,-TIRJ+!=PY:>]&`'='(@^/)810`1N[?3G$\,I<#+CK M97-$<.>$M4.2E'#2V-E/2AR).E1NA=!0/';[YH?AE7$^*='+'F=2`HCP6I,2 M0$=OPY?*MADMU$M($^I&!^J?9]^J/_U8B1Y%G+V-J-.6E[M2?>9-(VEF39S9 M->0U]IB2NML5^9L]-<,/!:5F M7[@UHK2:O-COV_*)>[/Z)1]>=0ZA%C5V^YJ&A=7!XM6:9[7-LWU8;WA?$TKH M:QO)64.8V9EM'')Z4V-/"AE1:CWIC._;,`JG-?2K`PMNP[VEV.W[&A96!T5Z MPSR?O.$^(];/3#Y7RZ(U0E<9,K_81NC/[!I:-8+-E[8R5LH`E?B)VQC#0B>*BTFO]A9RS>27WPD^=#K*(3*U<3M*QD65N>B_.)>5H7? MU?UN/.%3-4;D"3MK"L?QA(\4`-H:A7!'*7'[!H>%U;D<3[B7SY$]81/%+WF8 MQJ=)])\KV7L,?6*VA*XBY/J\8$UDF35^YM:.U_#IHB`.)D$*4?#$[=L;AE9D M;"_7#%N\GNW1[/N"%CJ_=T3`*#=OE=?F@#_\"2(39@._F5L[:R:,44`E&TI4 M$[=-6"M;]DV8B;#\9/,J^LGXG2NT5?LZRN/"-78JJPG9.2J M)@L'>\[D)67B`GUE(BCA3MRNW>=G$D7HA9M%5>VGR+\6?XU/ MO7-..ZKN]_"N2?7W,X#XP.V$B#EZ;M=H*W*.7/$'R->H]Y"%'E_M[3C?2/5> MWO6NQ]H[>%!^'\$-I,3M>F-^)K$YWH,4Z]/@*U#A$?SN MJO;OH%8\@EKQU.UB66X>4;G<0]3J\[@UZNO;]>;M;KO;%!^+S9?EG+@-Y,8\ MBGR<\>P+24M6E9UZ:%=@KSC]XJ MB7):&4E'T^E*J&F2!J?BHBR+F*.A((,LV@R7ME*':QAUKL'XCHI&;G@<&14C M8B"A*,9]HY1.U^/`,@2@L26=ZV'`EC3*_O,$;C]%1_QAJ_5*'BS2U+@)*7"+-C@(P M`5O"GGEI`)/@.@IM!UY%%,A0Y,1EFZ(>.^$60`C\QU!^F#I<%:IU$;!&3Z0Y M^@[L2B-3DQZ M/#;R.B)*8]_CP6Y&C'H\1W+'D@!0-9E=5@FL_"(XY_'TLF,!F8P=BSU5H!$\ M'NPVQ:S'TQ1`G^4"H-0INZRJ6/E%<-'CZ>7H0NS*W7R[_E1L\FK]\WH)_,FD M)7*@Z[E(62+L&A?9=9$U+WSSD6QCED`?EAA*M+/+*H]56@=L#I`*,PH^$)O6 M:\Q+W""8V6+B1U"'#,$6]XV+.G@1$<2$"F("M0S9917,*JT#5@BCPI3.VSU[ MLT.0S21O(AO_>C*Q5@(GJ%UF`C#N6QWE,(R(7,(S33$4=F>756.KM`XH@S$J M'"GX3=P&QDZR:&`5&B$(72\*RA*!RLYTKHLA.],HU,P2J(=(H.P[NZS26Z5U M<,QUZF7&L.MD(X,DJ$/CN$X.&!?CKM.1($)51`+55MEE%>(JK8.CKE,O4SIN M##GB,IUJU2@NDP/6QK3+="2/T%`_@3+Q[++*=976P467J9!U^TYS$3^^F@N6BT7F\T22>F#)@?';:,@[LR("Q7SI:%\ M*G>[LE8#]U@<%W56I#,]FX.Y6%-S<57-[JV9P:!7DX/8F*AEP8"#82*7(J4/-AT,M$;!D(-Q)%1P M/R.!>H#<[>)5#=P[Y6#TLB*<#W'`L3A5$(N.!5HC8<:Q:(I6"'K_[%9S,N7?E]O'=^MM4;Z??9M]>BINR9TA M]CC3S>[SKMQ6%F!R<+\#7>]`2U-AT&CH7!DN^W$\H1G:1-B`LP^*&E,HH\X= M+E=U9'G'MX!N+!2/B5VNJG_?T^=]K6;U5F1:[P7F);\@5Q3KM\-@;G);<6(@ MB*/!HFB(YURHK16+\LA/"-((5]A2J,/,'2ZNU;X0H\9^='/#$P:Z77F-23TR MJT>G]=B\Y!?$R-R?&QGM26>)!6@X/;K>!I>F`I>)Z5P94R;F*.@`6R,RY`&K-VYNC,@_JNE-9W^1.'*WJU+H*+=J:7(Z'T.W[[\K&2 MI>+Y4[$A[R`U3NG03C2F9?KQ#`K?6N@P)&TSP0M7+-.0@+@Y7.NK;P4P1USX MV=`6:ME/Z1WF',E>4%-(5437V\O"LR.Q%ETKH=U8P$0@8LS+3D'$'"[\U;8` MSIB*/BX,60HZI49#<;>ZJ:3L*27WG3L:G`6ZGBP2W5'568YF'N6]6WET:(^-;;AC++<(ZX@C.*"I@C$!/CD`N)=- M0`X<+J659!>%GR]'NU3D<+W78=;QPVPO(6[AUI#==$"%Q3*5?&(!M[#2',3" MX5I327;'SSK*$PK4A8^W%=7>K M?]NMBN"H2V?0ZN[I>@V-:T:C"BS',:<:\PQ.A83U*\LB$!*'R^&4F!X9-\M3 MSHF>R01><-)=/S`<9A:2<#U0VBFE%H;5_&+"G"RH-O`=+CY38AH)Q);G0#84 MS=3]O/ET8!!W"\F^%O3ME+:+(G%^J6'N&90D^@[7B"DQC0&5RY//BO5+:X9Q]/O3HYUZ/>1'P<=OS(H"/(=KNM28AHS1.^E7!M$-Q#G M%I)P"Q`=FU+KA>A-,6%MNC+(6_I.%W,I,.T"1._E0#06C@^:G\J\>6B.3UZ\VJ]^E*M M9"5-=P_-JG/"=(M_JNOY)Q5"C%H#K>O#:204YJ3W`"((!N50E^@[78"F?RU& M]@:T,\3I)-3S>O7$WF%F\OOC.Q_4@3`:XM>A6'KZ8E#_6F#PL;1SQ>EZM5H@(>MC)&$BLQR'T$2H MZ\TL%4+0&:'.]3%HA)K]7R*(_^50"^L[7?RH?RT<],IZ&;+AE1G(ZNA0K/&\ M,D1'/0R=-^S. M`R7"*QD5S;S\=6X>\/`J5.,TU];"69H,7+:F>VGTVYJCXP_Z`N50QQDX77:K M;0GD%NJ[I%5)+U!FTLR,=+A&AE9C%E0$8K6`Z?+D#4O M!*I`C1:6A*,T,E#&;+YPT;UZ>.//9/!+M)YTC2/J*YR`X12+`,2"E1LX75DKRS&2](HD^;*9 MVX-B6^H0S"_K6N"^(WHM"N`YI20$*8&:ZL#IJE59CC%`LK4`;`/1.'Z) M-@VP4:FO1H!])!8YB`54OX1.%T_*8/>2+UJNA`A8G\JX86"-2I_U`>NF M=*03D`XHG`V=KD^4Y1@WL.ZE72>P-A"YWK\5[?>]OACJ>]!Y>$*CVBS%+Z<^ M1X98DL3S@FR#X^P^ZV/V1F(8XO(MAZ@[9`R"X-M M7@%)P.+[4"X1.EUT)\\S$L`MS8!L3+NIYI;`MXC4:X'?#FFY*`3GEA>6RX3J MR]#I4C=YGC'`<&GJ.8$XET(;B7'W<=9P-?6]'#T\X6AZW2[@F*&X@XBTBV^:A.#)EU@K%CP0D!0&!K&;H=&F8/,\. M0/%>!D2CW\@@^*FT&X?@R+1;)P0_DA/(=OI03A@Z73\^/[XNYG3V^\?E9OOM8;DIM_=?U_>/ZUTY6RWNOQ9/7PKVT_>;Y9?9 MMGC_-*L^J0SIS39MG+9&2.T^-76^2D$B'THCPP=+GRS MN4:CNAP6&>5Q4=@<7DV/UR#(JRCR:I(\H&G_`:/*VY-%;M:E)I,,9E5:AR?T MAXUL7="1C606@5Y`6CQRN*;0YAJA\.0L,CR&L?2HYM*V-0 M"RCKC1RNW[2Y1N,[QA:YY7&DMZ>&,H0^O<'^;UZ817S96T1Z6SHUF^C2NTR- MZ).N]^A-$.B,4>QMG:\X=F M51J?E^VXC1S5RV[J108WM7VH>8D<+BRVN487Z&7W,CRRE^V8M43G93MN+,?T MLH_4`F[`^U#7'SE$RG),7G;L5NAQ>#WM&<53 M6D`%H&@Z@&L1D<-E[C;7R'TOFX_1$8!CC#T[TZG2:+SL2[&18WC9K7J1,[V` MLK;(X3L#-M?HMANAQ^'U',$H'@6:H/E``#>>(H=OLMA< MHPORLGL9'=?+QIF=Z51I?%ZVXS9R5"_[2"_@)D7`:MZ^]VLUG&MT@5YV+\,C M>]F.64MT7K;CQG),+[NI%CG#$'#K+/[>;]=PKM&E>=F]W%KTLDWELG^N9.P1 MUNCMZ1J1/RV*E5"D+-+U.KH!^LR;1,.K*6(1M9(2!Y,@@RA\[/[5&9-+@\&A M-LB?"#2D9#!/U[>K+T6%5C?E[>IF]WE7;JL-RCI:PD:Z7ESE MG]:DR5+AG<\2\<]`^SM-6"H/[N_'+E\W4>9\7#NB2CZ7F5A[^UFJ?_)@'@\F M,MS;7D;VM:0&7%5\T3"^J`!!J7P`I?*QRYG#)*H2/\[:I!$`Q5BXH3=/()X$)V[/*]`67.$82557G@"A8+ MJ;Z)VBL.+AN>N:['8?FG'=D"=/*NS0(T>KVF.)Y!J#*&@-W:YQ%N9'DRX`-H+0_Z^W#Y^*,J78KZ] M7W\LMMLGR(I\WA3T'RB'BYMMUE:OH.M)6UDB#%H'C>O"92NDYR.U2I,`8E$A MR]P[7.FK>QU&=20T,\/C5I`I/38G\3$.LWK[:<&A6)!48V:RWD)=AS1@C8NT M+6(X1%$,(;05PNV:Q.'*6-WK,#Y&TSP[)$H#(UG>MBR-(TKG9,`A:N@SMPBU!5VM(C/#Y\R76/D@TS M_DDJ"]$=5E(.\"TI#X[Y\/)LIB)0X=I5*E5?\@/B88+VP6$\5D[)(V\+(.!7:`%YNRHQC]R-4>74$ M.Q]3K7PP:RD34I9D:S@:IR*;P-1-.7'LCJ,JK^[@ZV/"-2FS-,S^^VRSF:VV MY6U%[>K_[%9SLBHDP/YNO2W*][-OLT]/Q>WJ8[7CM.MF18Y/LS*I#+B6F4V7 MXFKB]%Q;I08F]UKRC%6)0I^+Q!4TK9-A>Y!:(]5'N+H>E]PT;HP,]2]T;(\- M3GZQ'YXHMB^FM>_6J^+YY6G]K2CNJ"R4-ZO%GBW:&J5A9]Y6.O!OL]5NMOE& M5)*U16NR%_Y:E-MB3W:S]) MZH0:48Q4H($9(M+5[`DB1EKVH#9.F*@D.I/BSIEA7"[3AA$AS],&31XCRJN^ M;)A8Z/]T%)4@(WJ,-J]!W+&I9>1Y#?I(42*ET*,DTIE8/2(=DY+I`9T0^[@` M<\T7/4%$^@6:Z[,8#B8J*UVL1OC#7`LNEY5($D+&CVPVR$7YUZ^UO5Z6^WY] MMM^HN29!:U9O18?\I\GU)"<_^*<* M$"6'VJL+,-JYK%#E6Y[:VGENBVI$0)H-"]AT3QH M*9C@SI.,NS#V8Q`6N6N--G0&&%CWJ#JV4%/A'<@X"BTT8@DW6X_2HB>$8%8Q MI8'F'S:-!QX:E&[H`1!!E\0$=QG'N`LS'N2SR.6A268+RNL&=\S*;=NL7"NJ M:T`Y>NEIXCL#WV0CH7^8.H[XI4%13T'4H1=D@KN3Y[@+,U),TB*+;3ZLG'43 M-6YR]U`X%XOYV&RU_FVW*L@[M]TK1;[Q_?MU'A\I:Z#=S*D39L72&5D_06.G M@09Z73F"Z\H1=))+^TCZ#!>IW:[]`$2KNVVC0`VO5&T.$N=2T[;7EMD#FXQA@]^+@K%7M(***V M4-X4FO%T=:JPUES%=V@"93,6&FB@0@^-RA/='6Q,D>0KMC(FE*&K#=G]J MV/KS$_1;0H:7'UHPFC%HNZ=Z<>I'/WQ_8'DF]VL_/])'@9=R;-%EQYP96#U1 M:Z9,`CW)PPSD'+K]I;A[0(R]-*@\6D-,"CJTNZ<#>MN_ZN/[O+[L!`"_*.K";!A]O%=AA!>1MHR(G5 MI[UZ?=COS?9)>[!ZY#Z"%O(1M)!/<5]U'GMIL/BSAO@3=&N)I;L_MW0\7NV$ M7.#+T7FU]\7J?OUNN2I(EX@C515X]M$R>5CM'>]:FC=[[91`!P%6N``=!-*+ MJ#DVO4+N&D$1-JW9PHHHDE6TZ0CW:0,$@F*HYTHOHFK9 M]`JY[Q:+L#MZ9-`1ZSAV/N22C*/%[$B?*K!`$=Q72B^BSMGT"CF>*Q'A]?(, MX^V*)*PK;B>33.!&@L#+GT:(,&[DM*R+@"F3F(^(:)HG<';#':34^5(5?>N` MP)/5Q@RWOWJ[@@*4YIPC79%5T2!];N>%F18I%U):#"%L$D,)?.;\)0A]ZX#( M'=3&%#>V6>YM#.F3/,D07%%542EM3MR%F1H9ATQ:&%D$`FHP,^>O&NA;!RS. ME3:.[)D98^5E=RMPYORLHBOO6XWP6*\$NK<;(L.XQ=&T-@(V1VI&(IM9!.]? MQW"W)7.MCYO1E4#@/6EDA]M_(N\T0:"F.6N/!Q4:]*#4=$F?#W6!AD;*CU(0 M2+A,'$/M=>9\[;W.E4#D2VED2[P5T+IA>BCBR;D03VC4L5+3,FVNU05:(!GW M2D$^X1IO#-6`F?,U\#I7`HN+I9$G;B?KW.B(VAR#7E;=C#?J3^+=;(/)D7YE MFMTL"3HL&!\]JR-D?62F_/^W=[7-C>):^J_HPU;MW*KNC`%CX`M5F20]-U7= M<2I)W]E;75M;Q)$3=AS(&ISI_O>K%S#8@-$KB+YW/LQD$B2=(SWG13I'1S20 M2I.177K_PI]\'KK2J3!BJZ6.'YZ]UKZL];P_G_(4]I/-#*0OTZ"!IXH933#KF441;R=.![U-8?A&3I3G$_N23 MR?7/CTEZ31>3(LJNS"0_*`D&"G(`IJ?K@2RD`BT/YY//9QHSR75(L,K#J']I M52AX<*56#`*ZWUC0A&%_\AGD^N?'J$,NSRB;+"T[%_:94H=I*F6`CH M.QN;AZ,V,8J8H;'-2-#@MJ8I_+(;9VNE[@$J=QV_E2J17`;*0A#F@.X MH*G&P>3SR-7-@U';0D5,\?@[A8[A2?"T]:8[B(N4PNW<3Z5JQ+9G@F"D%S87 M--LXF'P>N;IY,&>[I8BCX=2,V)[I=")]+_M>39`6,XYMDJIQY72*1NY+-:)L M"'I/H3C%I"G#@=FYX+I9U[WET4Q_R')#EFU?XPGN:]3CGW$K\[.*?W/#HAA$ M]-AN01-X`[,SM'6S/M2V1#,?>SUPZGH9NTO@">\\U(L#VV;C9U4&C2V%8B#1 M=WT7-)TV,#M96C?K@VP<-#.A3Q&([0WN8![%"7RZBK9)G#QG7TA\YPQ1W/9L M5#'K9,;74?9(IGV7?7R.HK=?L=#_"C=Y5OZ&J(&/,^NC8Q%%4/RZ8TPYR6;E MHQ33CN])O6*/WJ!9T#S2P.P483Y&=+O37-2$EW`=K^(X;ODVF)<'HS17,#`[8921`]U(9B,CW'\&ON$/`?E2%)_+]7V> MKOY\23=H=;*K_]NA=3E_S/)MM,KQDK>5.E,,V5,D*$(Q'Y<-8)]L;OGSP%\4 M1I?F/01FYP1*\368$`@05Q.-=`TN7E#_U,6I]_2?@/8%?BELP=_`M[)?42EZ MB!XW^"$]'`?2+2YD+$5RT4%W0P#H=X'MT)"Z1[,=`[,3O1BH'PS,G234M3GY MB!N"QS)R9GG.C+ZA/-,#Q.,19<'(PD$%R>;7ON/.BH)>7A$A,3N#AYT)=H"B M35F%O$>I@);C[.[G8&08:>!NV'H`,S M))23/O_`5+VG,*3',C+4-/PQ`1 MV(%Y,ECG7*19CN_U7'U_@TD&LS-$M[YCO^/1Y!1"/^VE'][XTK)\VR=G'\4J MSI;A*BP;%05O"O1:D;@?^&BN]IZ%%5Y%IT=0*Z.F:'$459&D3E"Q(7_G9^?WT! MSF\NP>7UYZ\/5Y?@YNH!?%[>WP-D%,#%\LN7Y0VX__OYW16?3/P.$^3P;Q`) MYT^O<1)C"Y3'[["P26?6;!'H\]M[1I<3"G[62JGH:^DXY'[1PO%)QH+MFAVG M%&%'MTT0H"DLVA`#<-BJ]/0U85^+03`#^PV+T-.RT%!.0!>'QI-=LR]5B[(T MB$40).Y`&**#EGQ"<)VLTE>XS[?:[T'LQ5R?WN\85`[SS)R44.]J0&=\06?< MIC-N]N5?3DYT*W<^VUPG2"!AEN^UG;5P]=TR.!I- M%L1]I%?H/?S204X^G5D:TG?-3=5@)5\_3GMI",MOQ%R,SN5T[>E"T6W] MX8/UP-;F^G8-*XM79F8JW'8U(;-=*`,:6G#-CCGRLC*(<\M)5(7FF'RN&LR: MS/\X8&YQ"#J:^.@?.M,TVNN:'7ODXD._B\!.3%A]#.C7'T#Y/1^4D;2E6[0E MO(/D+N[>`MLSM^U]+05N.^;Y6(]:7Q MT8"&H!9F1_&$>1KDP$.4NG#Y\/>K.W!]<['\N"[-CBG*,#2(B M4B2&Z/-LM\'BI5NTB MXA"0G[@!>0 MV7'&DW3K-^_=@X?E'SF+/<,-^M4STII?HNV?$!^?[>W:PO/TA0J[!Y;#'A=# M^Q+0W8V\N1_0J:;!*L_LJ"`G)[H1RT=.6'Q.K/&^@9@KRH(#+59Z3&`W+'EW M(X^^1>86QHG&FSRS(WP"W`QB[_GI"O`.T&U^<@'66@UI5T83Y9(&IQO:8HD0UG3;!#_%2Z M6_@49@7Y:I7N$KQ?NDTW\2JN%:B=6_K*Z70/*R=;'.R4TG.B"?:^'5K*:%[< M`/?,CISR,Z/;4G%3%-Y__?+E_.Z?8/D)W%__?G/]Z?KB_.8!G%]<++_>D,K( MM\O/UQ?7"/;"KY?&STF\CE=1DC?I>X#?\]_05W^BW8-ES_6=9S$1(7FV)F9'7.48&^;T2X9$#C'2*SMZ@AP&RDXS^,'6@><5,:>B M1HYO=B!8@BOM01%ATL):4U"U!65C\`TW!Z0][_,24?;RZ1()6I+MML@Q?,5] MGY&K6MI>2FD;4DX8&+G8ORK1^KEM%_E_OMFQ:`;J=4.YGX00?_(!X(]`\16@ MGZG$IYZW3X;&9_/5D];/T2YL[M"@J6]V-)J)_D&<%!9*0@+2N`#I)GZ->3&: MOKZA??(6OW9,TLB^0+RO1DOKZ'RNKW5029RRP/8=>I+GFQU:9J)? MNS9E("(L/P+[K\`W^AWW@U*GUUC3>U(CH+7E-:G6!AY5"(7M,CM4S,K",-J5 MC9@*NU`2NY]VVR3.D9X^3YX^Q=_Q3UDI+.0:G";X=H\KAV`>?DH0GVA#IIWN ML7VSPUCL3`P"9&9RPOV7)-2T+K[5!V&YQ[NJ;G=_`RH)N M/X*1CB,,?Y+#)U?1-NGVVWZ'J,%S![2 M2X@?VWZ`JY].LA3\$3505ZI@S0!.5$'?QFF#BS[W_J@=3KT M*@2SSYRU\7B*L%J MM@OLX^I4!E+`GF&4;L.]U!.=?!-$JG/[IRC.G MD\\+&;.SWY3S:H!3ST\UB^%^W0OU\"Z\"*R5N.[3E6I>5YT7-&:G?ROGU0S7 MG)]P/LD>TQ&_C;9YPKP=]53YXGF$NEA?>[L:X;&JCBX3C['[_!K!LG.L:T8 M'Z/T=G:L5CYYZ.\2P.X^+,2BY9$:KJY'"Q\&T[*@W+P-[?OR$MCB[&:`]%%W M:*\3@+M!?^!]!9 M+WJ#V_S'[09[D$(OGW^/L;&YKK`W+0("<&`EQ6'M4IK>QY?BV M2^OG!V9?D!+@9A`9X:V M1Y;Z5VH>V/124&!VGBP_,[KW'MP4#2\'G^,$7N?P%8-$XT--_>-KDH(3_/4* M0=46+9)5*"NS[V=Q\S*:"'00=%H"P#?<#)!VJB0`R]1E^AK%"8+(0E]Q<08" M-,G`*0Y[A:#6&-OL17$P8G:6I``WXWI&G72Q603:5*-$#&L4QI`(=K-07ZNY MOZ"730.S+Z'S,S.:8>BB:`Q)0/OX]6[S.5[C-_#L65ORO691J"C0)`HG6>R5 MA7KKN>\6CJS9V3O\S(PF"UT4]VW)8HKJJ#)2(8=] M<5[WI519>R`'?&1YG)G9`3I1E@:1!$'BPK(=#C3T;*E)>]ZZW;Q`TE-\V$RA M:=8?9E[$16`7:VAVVH<@1[H=*3&R=`L+?F,B6ZZ/*B'_H/^NJB$O'%M?)6(V M&N0$193/4DP8VUOS4L^9'=`684>W@`C0%)(V6#2J5A]H/>X?X%OQ7^&BW)R8 MT>)[&2@;#;^+K3TR/\Y\/K?HVID=KA/D:!"O2XRV2E)NT1AE'A9_$7!DKO!_ ML-5YCS8X9;']SY!%[%DF_L1VZ1&:GW:5E0I)01'FM5X\G:D'VR^7 MRNSPGQA#VJV*"%7A02M`FRFT);S@T?:&@(&"TOK*`%,/^%G-1;&&9J>.B+(T MC"D1(ZY59GCE`LUMDF_)EN8NSOZ\V,*G.,<_G7GV3%^2R(F!9='/P5$%^.Y& MMK^PZ8R;'?]FYD&__F`3]=UM"/U_9YNWO&-(;PGX`/X5;1-4,OL%F[)2]C' M=B.8:4P"[QE<#NCI%B`K+1@"U`J29 M.DW/"A'G-*O)`^<;3%&\ M_4>TV<'E^E.<1,DJCC;7299OR:7QXD3J+/`T/A?-1((<_@6YW#_2Q-3<<@*; M'G73=PL=PTO&2W"EVS2(DQ;BIH"TQ3[2OC6H-5=G,?API>=M/M.DI_EB'TMS MKU!NM-2*0X\I#'^$18ZQ02R*%(DLLL0G+_24Z2'ZWK!LEA7H>WZU:U@YL>!@ MIA2%[B;.S)X%=/X7=/[-#DQS?/W,"_:OE-VS1!/ZY@S50T*4.BI4UO M\Y(C)P@*F*\$),Z1H3Q_HOA.UZCO^SQ*GJ+M4T8.]KQ"#YD=(^;B8R`=STY1 M>`?QB>GF!R"?PZ=:MBHX7&"23K'__#K+=B>_ODES\$^8E_T.)61:K,I4A*Q9 M0I.[*\OWBXVBV?%F2[A-EJ&Y/5)K=I=18VX"-'3LP4,%_=;N7MRK$7]-R^2(.VS(Y] MJV%0M]`IH3(DO0#:#3CN!U0=?0"UKH:2.TUWQZIB-CPN#'GV4/G)<;KU[+VUN30C.B6C6$=J9%E M@]VE:J;L!3-:),`V._=%D*/1G*N39/5Y6*I.U.Y@!M$4XXN+E_`=;E+2_]7W M-YADL,S)<7U?WR$:`P5RPB+&8BDG3*WG,X' M:)SN(=S[/.*J;)@TKMYAIE8V>\64E@Y^]2BYZV^*4)JK:7'J\;YN=2B#* MTD`2(41<6+0#M8;:9$"30V6*#+0X4[UMYS.7%L=P9W1)S`[K"W*DWY$2(:L- M^^H\I_L\VN9?W\Y7>?R.NH89MB^E:?(L7V/]T.Z1Y62!CZ5]F=!3K>:V3\-+ M+@TOV68'VKEYT8U\7H)"TN#C[@U433X0UV=8X.NI-CTJ\)M%I4^U(LXI?6O4 MI8E%MMF1;@%N!G%\^.FJ9$#`Y?^:P>7Z*LOCUP@_&VYYOL:".8>#R6&XE_`2 MMLUZ.V2%>!NIU>PG])#0PJ#*+M:MF>3UN8XT0I-(=GCK%8/][7/5(25$H MSIEH2*J+E]&"41T$]3W32,KD#R,)`S_6.+PD<+S5>%#_S2]6:Z*)"YW,C)NR MT$56ZR,2RM[ENDA?7]/D/D?CWN\>]WFGG]+MUR3.LX>7;;I[?KG=QN_()"&: MZ0V++Q"_-7]FN[[3=E/U_2U^)@(P"YP9@3_^C=184KD@QCJAY?V40(0S&$<)+^)A7E4@NTN0=F=<8^9CT MQPP',K;Q"B)OR9OIJV#(3(:<+$IP6XH=>Q>.-S<[FLS+BFY+QDE/B+^OE='! M081]D_)_<"-`6G&6,7Q]VZ0_(%R2)NR2@-J#\H. M0*T'@+H0M"QR6/-^2@EJE@857DRSS^&D^!KD'$*&PDXQ6ILF1HR[HZG)47,W M)+Z<9H=NI/@::ON2W98.I44%D&Z]\+!UAXOB-DGU'R,:#OLC'R&!ZG8>JD0#^@$!<1TK;@Q\""*]UJP_CIVEG M`?E!#W@=#/=F.%D94X.WT-,+<=)F*)`KT./CH9Q/ES?6PNR;U+RLF*#/6^@: M#^[U'9_M*-+HBC:N@G0SP?Q@AU3KQIA?HIR)I0?6M*YX2D_?)R,JL4;Y/2C6Y./TH(1%5I\)'AS:O&C M99B*(\[$B1%:O$&63IS7GDF]@^_XAZ?"V:]@,F^[0M`!\+[^Y*`M0&W+6[P= M3=%D>V:??3/SH%M/LQ)R](YN^>U^/ZD;LXQ:V130-C4QVT2;?93-S,-0VI>5 MH,'06^KTVOU!CN3%W@Z5P[>7WA/P/6Z+I]IL'YF=B1'4;CLE74?"+I/N;9MMLQU@=B9&U+[M%&D",%$M.?O%7+*+OPRCS\KI+D2H+3O02G1Q(< M34B"&?W,GT^$F_ZJ0IR8G<*OEM&A_%ZE5$_'$*>7<;9"GSS#FS2'V6WT`Q=# M1%^.XDC_UH3&0-)NO3<<(L^[XBXR)'99^*Z63?&/Q>C MG]O>YRG8#P3(2*`8BGQ7#`;*T4Q5'ZK]@I]*?TCX#B(H-#L\H9MUX_P+,3ZF MJ$@^I=NJH-AR76>W)A(:!]5%9@Q9$B1/3-- MB/AM5_>"3GB+V,>7*7;J%)%F2=,=S.,M.9S>WU2L^4VJLBY.#:17K'CX8Q6M M$WWB)3:[IKD\:L MEU(3):[I2CD<-]SY>M0''97J&+C7*0B?-3/BO)1Y;$SX= M.&)C5"-P2`M+"MD`2%:0@CTXDOG2I^O3/N'DZ",VV)&L*_7YD"`6+3T`G%4X M+(/CF=,UJ4_\A+>[1VP8X8058BCP2CG$U"H<<]TP"Q#4$ M/LV8L-D0X754+TF`8!;;TYV`KZ8?3+539Y./>=8HI`R=L MLMCL")>@G_*>MY.C<6UE%UDL4I.G8-]Z8,%08MK,D`Q>,]6^8E/>.G9R9(;) MZ2+/!!'Y(\Y?[F#V!E?Y0WH/\WQ#S-;Y\Q8>E0AQ7$4&A6U(C;(DS#.3?+'V MCIV+":?0G)D--AU!<(YI]3B+%UU`NGPR1K>8H:C%' M6F2I05SG6X8<-XH%AU$M4**\=8L48X]H8>VI.7=\K`WOWW'1URI3;6*D)O-$ M&GK"5FH*@3$BOQ'`QIZ&FQ6Z;(E:S=.EI=LS,U9%DSTVXUZ!Q8P+I( MK$&-(P9]NC&FM)2)OH8X,XQ6VWC1_AT9EN+.8>/?]1<#H_]M)3X M._[2\EW;\`RU+I)U*\*.<4/R>U#]01%LV()LP\"F$1H[^M([LQ!5,]\]/&UA55K_=(B.-5)+7 M^@AH,2=D/M91]D@F99=]?(ZBMU\QHG^%FSPK?T,P_G%F?70L@O+BU^QDR(F` M!+=8-+BI_9_-X^9L[CBSA46+5)@K(TIXTZZZ55`9'CX:D)!'`][HHP$?\**L M('B#6Y#A-+N&--5_\1G]A'Y9_@K]ZS'*(/K-_P-02P,$%`````@`48!H0V?/ MU`&S7P``,>L&`!4`'`!V<&EG+3(P,3,P.3,P7W!R92YX;6Q55`D``VI1?5)J M47U2=7@+``$$)0X```0Y`0``[%U;=^JXDGZ?M>8_>'(>IOLA!'.G5_><(83L MPSH$,H'=??IIEF,$T;2Q:=LDH7_]E'S#X)MD6\;VWOW0>V]"I*JO+BJ5I*J? M__ZY4X1WI!M84W^Y$1O-&P&ILK;&ZO:7FZ_+V]%R/)W>"(8IJ6M)T53TRXVJ MW?S]O_[]WW[^C]O;L8XD$ZV%UZ.PG(R_ODS^)3QB!7[7$&:SL?##S?)Q?//C M[:WS];VNK0\R?%]3A593;-^*XFUS(/RW(#9_@C]'3_8W88`_?B+_>Y4,)`"! MJO'3^QX#06^FN?_I[N[CXZ/QCG7S("GP\?;8D+7='1FP.6P#`_9O?+[JRMKT M?H?\LZ'I6_A>LWMG_]#[*IGL;/2/MO5=<3@9DOY M#>VD6ZP2P&0$OV7@GPSKPYDF2Z:%LN_7_52U[SR>([]!_G7K?NV6?'0KMF[; M8N/36+LD!I@)G^0&H!8$&VQ=4]`+V@CDSZ\OTWB@R9?N[B6%,+A\0\@T8&9K MF#<=;7ZY(:*Z=:5!"/N;];X=6TB>B(P.;G*E@P02;O#$A3FU]4-!B\X`V2-?1 M&CX>&098'!NAAK8VI>*HG6PV2#;Q._G\!=:I%R2#RL'Z9-DA*^G(U/7B:/<^ MO$L9&";&R^[GF3O9)>%6K3X6([,VSBK276)3)-!1'G2T6/PF55 M"B.'17"*P45D<\U$L$@>B;BHZ%"YK(Y^,EA04?DH\F*/=)"5NITA"(OH2-&4 M`BAAP493BL#FY)_FFCHF@9="A'C^K9&N2^K6TGE&%@QPSYK"9X6XX(3!96D* M%Y?U#"N22AD[@.X8D$]=)1Y*^YR*=*)I8 MT`+2N."U/+P:Z,\#"&_R3JU"!N)"BJG)?[R!\T&Z,?GS`#L=2F+$(H!A$9:! M^,@J`!`C47R`(E0M]I9&PQ[U-XFX;%I%TJ2/`FEB@@M(XR?%(&T0`H.:P0;# M]_/3C_UNXU'3)T"(=D1LRSKA")/_F1N.^AGD#)9WE]Z<\3?$X` M1QL7&)K&9XG9[23]N-@L\5;%`!)HVDB6M8-*8LMG30'8J)7.D+@$=G0TLADP MD,HIEJ&AE1W7*P++Y'>`5+Z.A\;,V?/FCLU3H+S7D0Y8[@P_<7\"F`K_1 M;+:$6\$C%O[N)/2%\Y,%PE/:4PF;-O0)NYTUN"F+-IC5,'5;Q1D_L-<16HW^.C_]T:2,9K]8YR\&XW4K2WCJ2ND.* M:;B?6$C>-D7GQ.9OSL?A,Y[3KY#C(TUWP8UE@*PTL!"2/XB1SCU0#N8R+G7YOP$T%0N>\@NR3>7>DWJZ;U&-Q&E9@C3L; MKM%K#CK%4,Y?2X.W(4NHD.Q[`NKT@4XK)NGS.M'/4O(NCTL8!.CP#K;;O;X M!171\V;012>9X=RN@L4"/M$/`%Q@LD:WU^&8T:0G)!>M9A'B9>:'$:RZAEP4 M$'+Q;3SL($2"8DML\Y)4?)(0H]V]&H/7L86XT"L9 MI>JD<-@"L;&VVV'3.I@@-RV\@`-`:?0!`'YW3J(G+HFOI(3&6T-K=F+S@/:: M@4TGM31HL0J-M$,OZ/U%$!4MYAD5"SVYP@V MH,UVBU\@'3]Y\=)G`*.N<5$<7EPBA+3'-4G4-\3VH#TL@FSN>AH(5Z+8K&MD M\B3!M"K2C_Y#U"^Z9A@DZS'@=QLV>N)AVFBGZ2;^R_H\DA+@O#_DAT!>9!9L2-VPTZ3\ M\2Y_>#"T[4Y%6\+YBI?Y<5E\.5I?Y-!6`-AMB6+Q7.45"Z>06N)5IDM8ZAJ" M/!YTV!L<='+:_(@_R=\,9[EM=L4AORU2U+S7#D#H`*EK1B02.`>";JO)[UY[ M_.2E=15!:#SMZ)?]F)+-6?@><3YB55(AI%">25Z)H'TZ9.GS2ZG24)"+HJ1C M]?RR6LB=RAKL6_@BER:G7?Z@-/5+.'MP"P;G-D2G-^!WN!LR8T[61']8[7L+ M%\M]#4PI\KA*4WU,]\5VA^L9E7^VJXD[CNVZ&OAHO<8VW<\27D_5L;3'L"`W MN@.>;_O#)[V:X"E`J,[FBTW^+Z3DB8K6$PGV'.K6.$O96)4P&F*OV>7W[CF9 M@*NI!2,VU7D,D/LU+RY[,1YW=L+NG_3;S5:!3!2ESH'=8P+OCOIVRZ^^['=O MG%5]^09T&*0DHJQCNS@:K/$T MOC^87U5L&`?8POA%?'H=3X3=XL=N%M**,H\3YU'VD1I0SWQ*FX4[/ZLZ,Z"? M[P((S^`#AD)F[=A"9L(/9T76?G292%/8++1<&W.5LQHE%UEOI/EB6_^1K'4Q MJW6-6VH1!)4@LYH1Q;HFC6WE4IZ1;KE2DC_C6T6+@H@2*%$* MM.J:@CJ'P@Y(1P?S#9C["ZU)Z;$F/X<;/WGI%"46G;KFJ,(@F%HQ&+&/(;_, M=/3$)56,$%3JFI4*8W]Q,*VNC%C=$L,0^16J2)B]I.H1A4]U4C^IS[$B5]B^ MV.;[_"J!@!*H"B-,CK;T:JPM@66V+W8*.0`M80!""8NC%?W::X6SQH)!\#L@ MC9BTC-H0A,/1A$'M-<&_G/;%7H$.HERA!BTPCF(,*Z@8V7.AHG`KN#V0_7\% MF(2)U1!9".F(3)D+I6FNS)P-C1O44XJ6V`E]OA[>)(-JS/3Y37?T%?PF4)84 M_AM(;FRU][LUPK8MPE\N31`^.ALV%W-+B:SWDCJ&W3;78)O$=LR)+R.Y)TS[-U\S+QJ"G*('8*]NN:.G.1 MLWFWE[5'^,QHM!++T;.NYH$YRB![&@#JFB$[YYTHOLMY7E8?,4/Y!!_&?%W3 M839:CUA!^AB\W%;3R1J75#"&;7$_&[T,XHYGNL()+II(+B[-)P[SRK8D3U8> M1:"$Q,W,-"NH&%DSGZ+5SO8!W*.B&0<=P3^^+*;S+\)X,1]/7N:,FDSF_Y!_+(.U>&(3&;8&.DSE_[15L#)/7SXAT420W(U=)!B_;A?]#*O@8T\ZYJ,T-IX!+4DIX[D M]O=B\ZSC=UB)GQ5)MDZP8+?5;/*\$D9#Q#6,+@4\%;;">$V1CE9!X<7&6II= M-,::0:HZ=MH<.QC%37T5K:"%HJZ'#'ZSL"!8V"]V)I](E[%!;DMVFUV>-P43 MYK^VKT@&I:['$7X4?I-TDIIW`2"V,>CS>_@2-_6U%2(6B@H?5F3?R70OP[;I M?+QXF@BKT;\F2\98;:K"7]%*^KP4.$.,YHUQ(NHDZUZ77Q04,W'Z^"YDT-/F M083_^+W3CILZ%W-DDM2IKS4E(!6.X[+OIKK!W93?+%-OIGP&FG4O52\[7>R1 M+I$N'5;S--(H;:/I'Y*^)A73>QP+=D9/?#T;I02CPA9*I]F3SSU2#72/5+0A M=7%$GA7#(F8M@:>.@:&N472T!0`86+SG^#_FL?B[VLL89U\'HO M&6CM_P))<`)N'#.]/"@ND3KFC']=T\LT8/,IK56,#R>O@&V)*XKV08X.&H.F MW9*"#UL4%!1F)<'*8*SXE#_HCRD`EEGQN534+$;O2?.5_K#/K]%.V(R%*7:@ M-F@2_]5)^P>*@^:Q#6G3;T,FFPV23?R.K'W("QB5\()D396Q8G>_RGE3XLT' MGY/9SB?[OD,YN\?H8N6-'D1L9#XBT'5)(6^B#S#R\>S+C:'8X5'&'L&XE-\9@_X<&P0G86RSKQN*W>OZ0#9ZRZV;Z;&OZX,B&M3&;Y*ZA2_0;,B&/$OUY$QLN74U M)>IU?0)U0NH,I8C3P*381Q3%80%77/*@M00GK;E#7M?,>@1BD2$1P81?>S=& M:DJG:%2PE3_KEZLJ,48P@%2_<#]7E8@Q?XBKD[K+11E90A1R/:=P3:Q$,)@S MN)X.5N\6RS=T"!*^`QAKJHG5`U:WS@T%TB)J*(H#;LS1TW&]`Y-T6%6G0`!; MCS6&56MAOB&=.`>.]5)9R2F=GZ4#SO.JK;)VERHV8VDC-!1#"Y)>-SEY937+ M#5$OY5B]A3R/<^!`*8OHL0V$E&"#\\Z]H[-L@9<,Z'P-Z'SE3>1-_/ M?T,*U$7=UN]W._PNI<;/?3W70(])71-D[F8F$H+!@%\^+&'RZU\(I4"E]G<[ MOV<8JI)AJ&+*-6M@THY_ER[\L")]:;,$&O8`WX,(BYM3U$72KIIJ5U>)<),6 MV(>/)*#3RR]`C@F=I:%,VP&13@W)JK*H&?I8?R&HQJQV;N,:F;3U?3+:#5= MS(7E9+6:39XF\Q5C5#,#R+?V23XR8:)@M3Z&P,9ZJ6FE_+=(E8^>3K1;/7Z) MA(A)TP$+M-G4"-,R"LZ8YZV'(;JW'1TVWE/:$#ZGAUNKS,]^8F:]CM+10 M5'B!I:^5JX(=DH3)"02OUL"(Q+]6%$(J/G(\.&,GZ$J*DPVX"E^VRAZP!8JU MS!>KR5)X'OT^NI]-&-W\7#.1`69,@N/4?OT!O9HA,;O83FQ(E"6C'S9G>J]^ M/MXIXNCW!OSJDT9,FHM-T@KE=!*1",`W'7%U@A'7F>&ECK3\)I@UPDH0>J\* MENC'8_+G@?0,<_FO:9*Q?J`]/EHH"48@AI)1[D M^8JU\"C$Y93-=LCN=NW21UQ$=3;5-<04R6NY?8+7YOZ"76/TB8U&5^P-N8DL M=NI<1,C(G'2S*UF!BI=/`F=(8M3,QT,BPZ20K% M#&UR$!'";575ZY(5NHY(N0@N(N-SWNAGB?:FY9Y7']KJ33L8DKJ>*.@=J2OM M`DOLA?;NC&`JQZDY*VZDT$[I'SXH5GB#FM(^8*>*IH"=[2C"[O@P MFX@W9(8G3F<#@K3A?TC_JF*K.4I[0$]F]$B<=3@.V/-%/9'-NMY@8`)O<'VM M'%^V$25CHW6C[Y30&/"(2",F+5Y[!Y?:2P%'92J*O"/]54M]^-UM:#V`$=FI;RT8[H^GKS@'I"-28/Q1PCJY7HU&@.#.[@3W@HT_ M'G6$IBI0@0S3+I?2&W*LW,"=_A+H:[$R/OF-9VV4I;>#PWGIT:C MWVSS>XN?AJ(2:&%6(.M:^#P4E_F!G,TL-DLD'W3K_NY84A2TOC^&0<1OU<]( M7%G5+AV\=6WU0&[?357#U`_$\S]))L'D:/7X[/>[88=-^5U\#)^W!'I#!TJ% M+](SJ,2C)*/13CNH9J/?Z_"]SATV:^G4(1R0NK[2.4?+]9WDF-88'2`:U/%? M$`V2$UN&VQA4@Y9`\.S,U_42Q0O:.\_5%AL_I@UR385?`].H:4N@&U2(N+<7 M:G>0-Y)E'1'"G>(GC6Z/8T7^R]E*(/XX`%PG4($:NFQ2]W("STBWL@;^N_!. M0A>\X8!A*:`8L@329F7SQMJ:="8QQM(>FY)"/G7V><-6Z%WSG)[D\2&Z!*I;@#A. M-^6J5^T[V(>-\)+H-$%2<75ZMJ==[C7`!T! M.(6]1^IZKJFR_8^&*/;:_-*,%!240,]8<7+S#+6[3D!2KV--?8??PJ1Q&/F; M22I^N]E8_^U[D21D^26CV&@I@1:E!\_5I]JELQ,A.9T!+FPO?4*'8Y7TU&15 M0EACJK-XH4=M._FK_A:KB@L&)Y\5_7==HC597US/V-Z`7@- MZ84S?<5CU;Q*S@TO*U\MGB7-1\S\N9A7DF1.97]9T*CP MT73V`G3#8`&Z2S-,78/NPB`S%_JMH%U>0/!"0A7[7'2.K%)NH=45\N$A=NY" M[9$>A6_<%@,]"H.VZ.]3.-=484QB!(6$#8('LV#A+/C2;T;ZIH47PCNU1H#9 M3Y.??\L_\W>S-QX/)HC3.0UURUL_'-!477UHOR-)-\`(>B(_OICIN:9[8$2K MKH50Z%$!34$N+EV.;5Q24%12/0I'K*Y752/PX]+_O6`/:GF"'C=N**G@J>6! M[O5ID*G.C7RVWO4T6+P@4C=N32XH/T)H)2G$\"V[Y_>((S5=I?.7R>A]PR%[ M.SF'E;:#YX5L,G;QK&(,?=IHG"DFV3Q*BJ]'3!A2_HYL'8Y7E'*AL5";SQ_5 M"L??V7/8[4O[?QZM)O,5:^KZ63)1H-\2@WU_T;3U!U:4D;J>`K7J%H.X['Z% M86T/.T-^CV.92$GO':+']FFI>]K"Z\),$@6Y6'9&V?INSC`!]@TOZYUF.Y@5 M=PP[=1K-,?&LV;!'\-F@L-WD9^`T%*2WZ^C1OQIH`-; MFV:+XT5-&A)RL>QTLO0>7K`B56&+IE49Q\B^Z)IA`.]MCO5.TTW\EW-M_A*\1G$+#O^+5%\1KJ>DD(;\$G,YX<)"5J3[G5(MVND(MB%+3C]V6NHH5J7[/L M]$-[.>:>\TN@XXK;_^!-Z53HE<8&$ANH95`."E\1YW!*@U'V?$'1ZP9;ON#* M.A`*U]7?%61.88O-RTS7RV0V6DT>A.?1R^IW8?4RFB]'X]5T,6?-:K\@!6(N MV(3JYG&E2ZH!'HH\VI4]V1HLF8^XX8]^28.]W0+G!<32.' MG'?$R,X5::L_DA_&W[#YYO\5HM[]POFFI8ZGFXB1?(*;2(5MA5U'K/X]::KY MIAR=T_]'B',!B8-"3O^="B7&,])'6QW9';E:`$I8&C7B\1WC\%=6F"Q@U#6K M'N70[X_^GU@;(UBO^?5.IZ^- MH9W[*IDU7S_#.]B$KF=8>K7:`I%G[9)Z=#/78HM?0='8J7-7S"C!>.\X:8&H MJ^-UUA[)*G%SCU2TP3*6E,6'BG2O4W5'#-.'B,4X><3"I[HURK^<_,_7R7PE3'Y-<4-]>7@UT)\'\G+_/=-5 M]R3UU=\T!6`U['I1Z2TR,!0I1N63 M?)/?G\VU0S[@@=_EE;`9BUEH@QO`!.;+O6.YI!Y^V:[1V6KQ M.R^(F)2'`"-T,4IX(>Q72GZG?1.PW"]*@#GO,+-(,!2`JV\U6&J1A=Z>$#=1#B>6A]S%ZD+G53C+B%0XB&=J#NKVQ MW#XM[1:_^AMQ,U])?VC!J.LQGK6_LHN[/_Q_>U_7W#:.K/U75'MS9B]&*^I; M57NC\<>49Q/+KZU,:O>.EF"+.Q+I0U)*?'[]"Y`$24D@"8```4*ZV&S&2=C` M@Z<;0'>C>^\[[GNL"'&7@6<`3WX.ZG<2_;5(;Y('FY.^Q(@UWZ!46:#Z")KZ MII%PM$PBKA!->:\7"\4*N]XEL5\X"WFA#*)(*:?+DF4I.&*>SU^;*P+'Y,FW MO9+[T3E:RJ=?O[#(A.`V(CB#^3U'9YZ\NKZCR)JF"S@8R;,H1Y(D7@^"HM-J M-@!W_;2UW=R[T%%O*M'))&'$0FQ8^=I3WPYJ`JY<[;OBD`V[U@J3?T&)!R#/2VR5* M,VLS5N/JF4ESZP]MN+)FS`CJ]CP&4 M:3IR[IJR$J[2=-W,V0_6N.OAN$^J2U5@ITH^U6265$D&?OD4]2;?<2SFQ8&_ M/,#_12-*&H4.B4\X"U:KZGO\E"K[,B[7!%RI,_BZZ-CZOG\_^UM'_Z3J*G4*2P8[>Q<:Y$J M0A?[+Z@G"B8*II_L$#GA3S8'QB`+=YU@P7,TI/ZL-'9CFGW!A9"@7$!"5 M6)#*VE=8AXK/:L,%IODG7!B;RH43,UF`!L/#?NH/Z\,'-@P21DQ,8\1B%7IP MKG#V1Z0?UA]8S@PR!AQ-101L3G[7O'#\)J3!C\P(R?UX8=7'@D M')F9QI$7L-K#>3@@>-K[JPWJN8U+DF6VLT_*'BWRNE5]4#T/V.:,(X_&I9:G M5_%[Y^W(7,*?;@\$91@S7#F9/JZ>$OQ88'H8YX[(07)L*0LA83AE,GU<*WHP M8H'I8=Q;A#F3@1@)[W8T[>$)U@7NLAZ"HUA32 MF[EBJT'U7?6:7R(->3$W5\`QY#8T<$ M!_FP51@"&O88;J?,`C2A"#/#!)S/-W[=_W01AGK='HS;#'D(+!]''U!.'' M`M/#N&!*#`D9AP?W[N=J@UXPW'M^7,KH&82.'S]HR+4F8+BYU)6G"XD$(89Y M99SK[!Z\^O`\]TF=)SMD.;VP?5T]9VJ@86I-*.(%L"A;EB&.3_M=]:3@0L#4 M>G%_[+?4,>P10Q(8[7?5TX$+`6P=C+W]%ISE"W"9,@1KV26HYTA-5#!;C/.H MTH,Q9'&>M887///'9##5EWKB6MXX/KKS$;96AN`B^JIX.'+/'3#`QT8>`!$5^+02'+>^'1XQZKHC`!Y/'N!00,CA) MJ>^[G\!?.0%8YQ!A33^F_+:N-*%``C^%-L[M18=(K@%?KI03Q(\TO:VPF!R>`[)'Z$:N$KQH16^W&/5F/Q M]LUUPF"^#S<0]_\#:S3&`=<82SXJF*SED)+K2-),U]3B6\3"U!B0S*-[8V^W M8/W;)U;@(^,>V31&9SH5!_5:`,KFZZIU<">?&\%P#JXAUAF MQ2E.,V>[UJA'?&8MQG[0#4()4SCP,?;-7`5V4Q4G[QMOM_/.@#_U6,R97'?#[B_I_U\ MD;;>>`'DD:%,M!(V4&/1GD)E['S(F>X(A3CD-'?7R4:/#WY!E*#' MX`FG_[+R/8MAXL9FNQ^?]N+&\(NW&_O#">WMW<\/@'K]++W?P+.-G&E1F0R& M*#_CYS4X\+)!8&PB2&5;J:*N4J?^U^#!C3O&(WUB%T0HJ?B;]R:;=IE6)A;.7=DY`14IC@&;P[`?Q.XDYG"'Z5?TV#3:AT M@L96N"LXFV6A/.1*(.;UB-=[HGSERE^-BK$U[=*[&EC?[GUX00_HC\*$!83TNVW`0ZE@]"/-V1\3*T04`!% MY$H\0F)*NMY(9#8AE9P0Q"G1XVW7 M!9L*=5.[H9&CO#$4^1@OPW-DBD]J<+6JGJJI[HSE>><:6@6[3)E-5;(V&(<=<&\^_GA^-&_R3RO$+@1R<^D![4) M(VXEC:N0-[:84'GJU4GZ,,/;?MKO:K0]5TS:V.>.Q)PJ_\7>IFV1NM9P-FXF M^$$>@'(O*`4NQC:*XK:M\7DW!CQO56<:[F>DL;9K)ZM$V]@6(SB[ZM[SOX!W M>_L"PG`;5R&&&MJ?R'O242)9CA3(8A MPSO8R@\J66>V:1K[+#J79)L$E_:OP MJH?,::;'9_OX$232BBB=[L7;KN.=T5D]N$%H;[?1_ADEX$5*%<'+4'*YIC@- MKC_U(#*V:F(E2,\`/1MWW/<8&O3C^[V[!NL,)&Y/-K,X/7G$`)&Q!11+7]!B ME\,S@%#Z"#CTDO8%(K8%R>O:3QPLL!BLDA"A2C@E'BYCNXXV,$&)45(?'E./0[MTD:*44HX M8]Q5N33;*H7CT7-7$)$;>(%P(`[16D3PD%[D-)"A5CHPG5C%BJ.Q58+I\,%J M)]%91S\0C7ETAI.Q#3_KAG1_CXZ*>4\XL2*5'G'TX\&V*_!0C;>QE?/N=A]; M[Q/`RX=_<)(W-.<0;J,51%4KWY[!RGMW46PYABEZ`9Z\^T0_Q4?6?D\>5R4- M6LW!7_X"&%NYCUOA[VW'CP[-<[A.NUC[OX)PXZV_!7$NZTA#2UL^ZG:97(85 MP/0USD$K%#S\YO[6.<#CN;M^ML,H9W$D\3@J>_SMIW3EJF!R&^#JZ"Q_';`3[OJ^%.,7 M_?(GU/G4D8D0F_4DQIX$#K5=IK<*:VQEC6-G@K`;A/X>H1%//I^OO_2RESU1 M%37V>LF47U<9]^8!`)/"N+A!HAF+M[0<\/P=_G(/4'W%T6S*4EBR^%,JT[LK MIX;7UKB8-=J!W0`@A^X/Q.Y[SR^`@B'%F^JC:M2;>;IXY8U+]3[.\$DRG4^J M*)PE=73[X]Z8NT(^I1`-$IYXX,C*B(XNFRGQGT78<-?SHY72"JX0`,G:QK:7 M+%6POJPV8+W/'G?&`"_MURW*5![WH\UU3)6O.O_I!%VK9\V2?Z*P^E`3&)0U M5XN@0-SL'6.APN-3OZ?"F-$VL/94D+T^19-2F!?;!`#1!7D)949L'(S.]+)Y MJQ9/^Y__.)LU7*"_XC\C_A'^DA.B45B]:>?7SJT3K+9>L/+F7YW% MT_)A\?C2F3_>=K[/GY_GC\L7/(JS"1P(M[^!X!EL[!'$BQIDO+IB_PKNMO0J[UEABWG*]L5&I M=CU,\CZ?8`E1_PW^\[^ZT\E,7I9_S<$),7BB28,M@D#@6UR"LJ[Y&?:F/8O> M`'5^N06A[6R#OXLQ1VJ7?$W`6VP[V!\]'MV*I+"M4"R_RA$_F2RDU>O+ MJPQ?(EB(`C`L4>E=]QP+4TG]Y#EN^!_@>_?>WL=O#(^J'$8`X>;?UKC'\&*7 MZ>/R"%#$[#0"P8V!J:Q`8$2HO(`#<.^=`Z"!9Y+ M.,RFKAS^4U;L^!E.IQ(KEHL:IM;W82F+8:HV/R,HHJ/2<#"6EV":BN'7L>@3 MB9V%8Y5WS\L)$L+S$H@Q90OF9NHYXZOC.KO]+IGP8""QWOF1*''+6<1#O*"% M,S1V2>V?1Q.6V'?C2%2#2UHT0P.V!OI0E?#S#7WP>:(TR"4W-5DXON/VGQ_% M)G%_28/%HU[\($D.1+7')SBX+IQ0M5.\B2O1PJB]-%-8Y,\W]>S`E'/#G,]V M_KVV:!A/+E*;\K*D*1#QQI4"-!D9I3T"[;!>;YG8=D2QV)PTMSO8SA91[M[S MH])`Z$D2,<-6K\Z"I\,68_@D\$UT,\+2]3*V<*8@\"Z[?V8;Z%W::].XX^&U MMI/HVDY:$76O2:[P(IIBAMU0+)*Q;POQIMW\):1&<`'[[^#@%L$]JB*LA\4^& M?EG$+UNWE/B&Y0,]^=X*@'60KYRZ\%_LK-!0UQK.QO+.^M4#T)Z$C!CBTX-U M&494[%TE/8U-9TV;5!D3T9[;BM84ZP@7#7*`5@;V^/SCC=R93()4&/Z;G'I3T-Q4">GB`-(R15(\I'SSV` M`)K^"/-@Z87V-O_GZ/G^HQ?^&X19F\KNK&_).W=*&[;V=&YDP?`&;ESSQ:2E M*EB3<4L*UW=',XG5ONC&H#T1V:'$K#*X(^WOGK=&I1ZA`H)C10V6$/3`7D4> M#N3,V'A;"$>`KYB3GL3MO?X`M:>CX#7(KOG&Y[=](;R,N4J)*N/1%9X,LX=+6J,<"H;*"W=T/D-/QJ M^W^!,'+,+-[@6"%XMTDN]$##AZL40]>>O(VM&V[_9IKQY`8P:1H0/6@/\GFP M0PT?;A`':RZYJ]-/KYXH[$EJ(4223$*`FVZSL,LG5%%@$3[K@\$&';C[QO@%J_7 MW<\H0V8)W.1G$=ZD*ZP(A9,[=+-TK,%E3M3JZO(Y.0?DC%AOU:C]LJ2^[6$&[,%X;-DOY24,O!V,%W^FF5/Q@W+AZ9* MCD@"U]'9,DM_B*]Q42.*&_O#">TM^NE\AW;4[JS?DW?OEC1H[P&(E1)]U M!XCHYO"<>UFB7_X$09AV3;>BP%[3+[OXAJH]I:6M"[;8,]->'1S7/<9-M[`F M#_KR//MEDK4G&BULJ2=RW#?*`%+M';G8;?1;^.?1&2E*-6?P7M02IC^5A$&) M;U(S(Z]2//"?/H$(%N$&^,N-[297TS^C+-U<$&$ZTW`K9IR&]I17LIZX%/6U MD"DGFE$6>WK1C6ICME]7CB=UU9SJM<9Z=,W,/7%SSM_???!NA^`D,MT?38EE M@$7':LJ'82ZU&>#'W#73V2PLF>+NYVJ[7R-K@-0_>1X*861X2RM]0,;SF6U) M,+.-*SGV#%8HA3--"$;1U4?T?,0.]W#%/Y<>ZM/DALX!Y&J4Y)J$]TFAP`+6 MUA+6#",+^S1EG`K%! M9FH.4EE7TP1(U-?4.FJ)RMWO-?ZB$,YPM*FEZ>1*F+-"TR%X`9F*7-5=P")S MM=QX^\!VUY'Q3E[=9>7D?>=@AT@)5Y'BYS1QRF2\.*1(IV7A-/5$$HB6 ML64V$HP@)&X(D3K`_]M4084C\3F@1@S'<@$BM>&6,-S2EZ6&\>L>O/H94)$] MY\!I.&5PJ0L0J9Y?HG$S]57,5RAB0V?A2>K'L!OR2U+/)D$HF?IB<0XGLKUW M_"#D.24,B3GW!2RJ(4H]C43A9&QGDP@@#C/=8[!#/#(TH4X=9-(G$H91YH^] M"WAL,D.F#(<(]82IBXNQ_=C_V&\_>8!AV*0X1.A`F'JX&-NW?+Y_WU?OV`3; M2ZR+7;0K\0A13YKZV!C;WSNZ,]P[;WQ^#8;[.K<@]?01@Y&I99@B=)8;QP\_ MJ2X-!(S&#'[%FN(T89,@O-(^$(9Q*O7I(X\KH/&ZDAW[#$D``D2JYY9HW++6 M2881C%4)B3"-&.A56Z!ZKQ9#YPBE&/7M$X&-N[Q=:U2+A,R;6MZAK?C2DD""4C.U+56V& M>PQ)DIIM1V<8 M(DQ\4C3@2'UTLA:PAC'GT3MP'L5'Q*JRA4_]N,2HYXX(?#!YC$O+HE0LHB-@ MQA"IY)6CGCY"$#*VDA6M0&(R,+?=T"U;<\`R);74+*,0M M2#V%Q&!D;*6CKW9E1@E1N<9,[G]V&>J)4QL98SMSTJ0AD>,?#!Y^+B'J65,? M&TP;XU+0XQ#:R.6HIXX0A(SM=9H],&.'9\ARP^(6I)Y!8C#"%#(N&'1JF^G5 M:\Q@@/BDJ">/`'2R;@J&,8?:-)-/@PR''GY)ZADD""5CB[E2:ACY(LIPV^*5 MHYY!0A`RMF3JV9M$%G08$F)XY:CGCQ"$,'^,BY!2HG.VPX^F(_'LT>[\(P"= M[/QC6,G+$_0N/B6:.B M%>=/,RA-]&S(DDS(*48]@T3@DVUA8[/(0WR408\/@[>07Y)Z"@E"*6.18?TG M3I,/J/?Z&5-O"DXQZODC`A^\?QD7+650+C)"==_/M89&PI#"7&ICV/2?_S@# M^@O\0?QGQ#_"8W!"-/YA;]KK=W[MW#K!:NL%>Q_`_WA9+F[^U5D\+1\6CR^= M^>-MY_O\^7G^N'SI_)(V;NA$360Z,=(=B'TG*9_>6<)?`WL5K4#GS?,[Z2[P M]\XOMR"TG6WP=XS%&8P'N()[>POY^?[977F[>.;YCC5S=YU6:G?/.]ID?YP? M"#P6I\-(QG"\'.!G"-PU6/^-XHR9=L%`C0\&<3V!DX>(8IJN'DFB4CFR49'9 M\$/*Q&6,6(C)*E][ZE:#-0'7^Q%H9DP6;_GY/X,MO)9"2((PB&;_FIM],'\- M0A]J:]<:#R;2B%5O;#54<+4!Z_T62N7GQM)^W8+N<#H=R-,[4<,4HFRBB92J MIXS%T%LGG]&$(ILU'(Q'TOB3BN'7E.@3R3$-CE7>'I,3)(2M)1"G[3W)<].; M.E_MG\YNOTN&/1A,Y)F?(U'B%J6(39E;M6"&"A_KTRR,XQX->]J7MS!Y40TN M3-$,M=&8REY[\O;](Z-R:G?T9J[`-M]JKA^5XQ.B(PV01^Q**&R'IAVR13=% M;4R7;,VV>T]NY+#!2,5;->#ZZ5#-Y[RU`MG:L_3N@#> M_03^R@G`D^^L0`HRG<+E@A4]NY"D3MR#A$1H&A9XRL<5P2;8L7P-1FL0+!^PY0(1*PGA^` M;[^?8`DMP5#?\S3E+"Y)%:A7T]0.N%FXMAS+5V8LGP'*DH`7]AO/CWN[ M!/[.@KCV+_KXK!0I5&*:X?%G/6DM MXFY9CXFZ.*>>,,/>'_,'ZN"]-[S MWX`3H@6D!'5*+/2HB2XQ3N>BM:G.TAOM\Z@#ZB+<`#_Z&P_NR@?P;]V"^/]I M,2:^3=9$O>K-[J*U32`QTJA^?W15OCS&OR,B=^ZZ.7-4\?I`^P@BZTL1 MV2!F>9-Q#3OM`=0AM965BQ*L"6G=S(ZGU@7O^.[ZN^\%`8*OI]"[SC[B-O!> M>))@U^5J/Q97.WN=N_#K\8LBL80Y&NGX0/9NFM-^O$C M`DD(,8^H#5J?896J?4WD]8\ASV*U=L$[JKFDCV)KN9OI=@@FN(O0KA(7(]`3 M0L*06V$:)#P;J%@[_?UYQ[9CV>S)@)"*$#V=T[`X1?&(VT!]XVF_VTKB M<8%VL:GA-7V@ND>NM+B*E/EU=0>P1?YXF=$]TKJ9',:H960$O^84[3`&%KKD*[JT&F44;N*3[+-_%G=C\&P05R*!J*%%:>FC@0K M7K(LU^`J?8CN'$:&YET2A](&?DN.GA8OS36*RON0Y!Q3EDYCS0[O(E6@SA*: MZCH2M8;%EJ7/4+Y`[F@NDO0,"Z1_I%VN>_2\(@1#65HN(:UD9'TXKUY4ZJA> M6;KX7=*0,=JH6%HKJQEF*\FNPY)>@[E<:SF]1.<2X^NW([[UFD2-:YAM,"'L M+QH;6%+]$Z%4/6RL\C-:EVA%*'RAS>#2:A>US$!CR;*T/-XHHF'[@*5A^Z/G MI@W8CWJV!_FF[>);LT.Y6&S!W[BV89<2H]6CM$/QB(48M_*UO[9A1[._MF$G MJ."U#?NU#;M"G7Q&$[JV8;^V86>GSK4-NZ;-K*]MV-5KC`;]GHEV1V_FE379-%/%:QZ]\*K_F*?!/F#"@T/5 M2]6:C.7F0C_GZZ+7F]0WE"&D:3RXS=R]-JFOB=RU2;WN MW+XVJ>=%[=JD7C%MKTWJ:X!W;5)ODBIQR+%^9L;PVJ==,8Q2NKUK_MQ[6!WBBCAD2Q7.WJZYUCUI+7(&IS% MSP3BG/H6+^YO>OLR(XE0X\A5DA0B?3(N42OXOQ+WL6C^N/M-:EICG:J%Z] M+[)YA[F6Z!H8&]&M4;WFQNC:J%[Z6QK9(%X;U3?`Q6NC>@UBJK3]S#3EO1:& MHZIEO'X($D;XG0[!I=VB]<3 M0L*06V$[FF@@<;QV^C^2.+8=2P5]VVCZPVN9G5PQ^C:HA/B2-PPKVIIWUNY4SBN[Q6@/8HN"&S%`I M:=T2JS'5WFIP!$4?/?<%KN0>+O,GL;_]:&H12IX6[#CE7VN&7$+Z2F!F,7QKF$5[](U2H6V]L^*0-)LM6X M[H8\"]0:#W+C&V+-KL1-D=_81M,2M*+^DNJ?P*-&71@?>QUA2ZK\($E=.(?9 M!G41?G82L:3Z)_[(CD^>UV-BN%!Q"6DE6>O#><'EK6KZ&IMI=:_;Y9ZJU_S5 M34U)G0;=U%8;!Q.B.8PZ$T[OW:RE[/P/UZ6 MBYM_=19/RX?%XTMG_GC;^3Y_?IX_+E\ZOT3]\8*_X\F,A,;PF*&5(SJBU)G<3*]7B:%O=/;K7FZ!M&?YQ M9!WROP\ZWEOGQ@XVG?NM]R-@WI?Q9R`?X$>.OL&\'\_7_]T'8?2YI?<,5IZ[ M:HJ M8\#\6W?YH?-_T807;_>.:T.@44\:>&3H MCF83>?T3RR2WCT*T.)H:2SV>_RUX#=&AU-N[X9,/=LY^!T&82MS@JL2WG5$5 MB)H:<[P%\/,K)P(!_GX+HJ5QUWEPNM/!2-YADF8$[2,7*ZZM"=(Q\BO",H`# MA\?%6V__&K[MM_-5I&5!UQKU)P-IQ"H3W3Y"40/9&K\\ZP8H$6TYM4WTNB;_ M;CLN$KEPX3;WX05.O._-@P`@!O5&$TL>%*7"M5?&\VHM#&`F^CC35Q]YZZ[@ M1('%6^R4S`)4.=_`PK_9VLX.@H*H(\*=67]^J-,,ZI&N]./;#LYS MR5-[$\4`4`'S-7*WT/(,[E=RQKT MFIP\S:"$J&!=#J3:51]74]V>)1#'FUT.W5%/W@&">APRM`M:=^`<$!'@FO?C M6%Y3TSP?@VS5J5S7:K4I`DQ_+>$^"YWCB9X]94!$YF(R;51#3D:@,7'*P=(_ M-B".-D\^^+"=]=U/%"9!ZC/L-TJ:8_D:4Z8,*/V?#8HCS"V([I^1!N'[I]7O M-[I)G8]!8^)4`:9_!$D<>1[<8.^CB^4+",-MG-)RM'D/K4:)5#X>C4G%`F36 MP=@T@CV"D.3Q2*.U!(_'8"@Q499]//S7!RAD!<`ZN(=,2_("GVP__$2!Q:XU MG,F-=!2*%J(S(M8U%\B@PTG_RP+?E;H&F'+,<)-:\@P/;9])YN3YZH^F0XF' MW3+9JM7D?(^A1\K5CQZ(<#^.#C_GL3\UB*QJDE2:DL+\='_,L2=6I!. M/HN/W'B[':J-&*7!CWKQ*VCI+"'*UYHNU8CI?P^JSYN"=C&CWDA>4F^E?*UY M4XV8J:ER>122Z&M:XP<>7*>39C:D4]%:LZ44)V-SWM)S6]JJ"EG:.%79&@[& M$N-D9;)5,^7\C$N/E/Y9;0I\)K.VWP;I976M07\TTJI5H=JI#G!BVIG9\ MZ(7VMK8Z/;@'$!0D70U&?8D6F7U`-7R0B3U=>O/5_^X='WRUX2*XP/^U[.47C`:Z#^^Z@=*@D:C8< MQ$V0&J+1Z0!:P*!RS,QUW-5`M%-N0X)5'QI%5K$NVAI@K#]K@Z MA1QJRC+)(;3R7)_LXZFE3EE&/5KM\4CFO#)9,I6":>5R2E&`A/ZGD$I/2I-` M2GZZH?^VWE0N>-.O+3A2P9OD'1>`!H1A-,&XXDV(J7&+&N@V>2R5=7B@E!7M MIWT-)JW::M&>Q:LP;$]TA_$L#D\+$([L*N*N4U_K0PAV>43'\G9!ZF'P*P_* M-#H*R4#;ND>PWNY]U)$T'L'"1VE)CKU-_GOIVVX`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`Q1_*>3%,/0[8&E+^&I04(!SI:4#^( M.?&GQ<_-6=:]^CFYI;\?GS>.=8Z/Y.B5`$MV[M+O6I-!_.QUFI*-; M@:.ROL3&=S;!()F:.5D'IOBO1#"1HC42N!3_E59QB0!2>Y(.>;F4X)(O*S]W MUZ@[VPB::=RV^"'%#:&VW/C>_GWSY#L'N#)/6WL5+0\$=HB MF9)P4H>ED)7-P=V:?$'=J)N:@5&/Y%]015WE!K4YN%N3EL9(W;O=Q];[!"#I MQQ![*/,=X=VOWNC'#=87IX\W;+>ZIIRZ2"V5#=B\;,]PEF#ZN*QL(4\=L M:/.#6ZZ#_1@=-7/G3(@7_.D+^`BCG*?2X^:$<%$BE0[@/-P+')IV!WQ9L&,> M&^RGDPAH[M9$JIFDDL>:7E1EP8YY;)R/L.AL^^#^L7=!YZ:RR] M^#FYYT/\YOOW?1#&!W2KUSN[KXV&7%':6F+UVF0YX<+-(5?4 MMI;8]G&+`!?FEO[))75=)P_NT5&6[%(:,MP5V"6H=Z*P@8#)89ROGP67S,,T M9#@WL4O0FAP$$'!9.X-=\-E=F$)K)BQ11G81"NG!!P/FA\%.>0I@,L69,)Q^ M.43HS0\"#)@?QKGI"9&+/VPW2O@8HS=+9+TAUFFFC]Q42%"_N;"!@,EAG.^; M!9=,:49VTD,$-%CT&2V. MR;33QYPPWW5;!$KNXL"P-3%^7E].$*:/WWT:Y[&ERC>/8V+6-+*K)0'^P7&` MGV$GDC0,';,E:L.)N7@!WF&,5=\JMMLL-&.7H(%OF`D$3`Z#7C!,")6:A M<7YDP=!E"FR)BE/P#J+M+"1`B5EHG.>Z8LM(D++&94'!5 M.N,\W=P@Y0X=HE[*5(MK#X<(\&`.782'.D&F7^)@F7(5FJ$6H84;D@4&S(^+ M<%(7`I,Y6*9H1>C-#P(,F!\&^ZDS8&[!JLI!.^'*S*`6H04_6&#`_##8 M3TT!3"[`PY6E02U";WX08,#\,,Y/37#@8URLLM0FAEJS'")TB&,PP8#Y89SW MF0F87)H30P4=#A%Z\X,``^:'<3[E,L,Z*$DOF7(9$'H96NTP5$!@BACG\&5# M)G=XY[(A]#(TIP@!"$P1X[RQQ6\01W"M>P6;;YWR(%4"=-AA&"#`[1,,]H]5 MPI+;=NO4!JD2H#,S"!!@9ICO&O.#``/FQP5XQA[B-@C%2C.I%74I_;QZ7C!,'W/"8&]8!2@Y M%V&M2$OIY_7E!&'ZF!,&>\`R4*)"!26;:ZWH2NGGM>`$[?0Q)R[`ZU4`2FY# MK151*?V\OIP@3!]SPC@W5VFZRX-[X[G_W;LK-+/O3KAY]$(0/-F?]NL61-7] MDVK^N%BLU::.RR=*R^J`Z3W*-H/1$)8.+^ MD9>5'WGO^<\@=/QH(19OPVCNB8-K'O9'A'H]#/$`@:+UHEP-V##/C/,1"P$L ME_S.<'H7*+J=/"/`AGEFG,?Y!+!CO.`2Q%8^,?EI=A$T^H6=FOKG>?/#&?^C M3PDC4LU*V2!CLAKG_I:)8W:MF_&_*Y4P(J/(2@`9D]4X7WS%4Y%'[Q"G6B'H MX,X$3]T'*`!.=/&6/W(3=7TT$'5NK#,0U=24!"EFI'&1``GPY:Y^HDZ8=09B M`B,)D&)&&A>'H(5OEN!W_/@7/_>=D;19E'^1>Q3:Q2M)R(!3$Q$XR(N)4GY)9E/(ZXD#EH).F0'LH"`R6%<%(0%EUS:)%A`K`Q<8T[#['6 M"D-]3Y`KQL*`#6>$:G6B2F#Q#$"ONUIM"#'S3(]$U8$M%VT653B+9P!M9AX! M0LR\RPHK521OY;KG)C!&;F91!H]9NEZ)MQE18U8,,L%-D09.G;Q[:4< M`3[,.>/B0E0-@G!'WV&DD"7'XBRV%AV+&1XMR!J'CK>.^H`F=)P:YUK+=#AS M'-`K+L)HR%7'F4>:0@-7&QQLSXP++U)>^E&CO=/L^A)%1/]D"=RE]PA7*03` M/=)*ABRVAH>GH_63!C\VBL:YE$L/-A`D;`T*T@(C#!=N!)8E*EF#7JQ>YT!. MN+"]O%+K"*OD'R5@BP:P#.7*:^J,1>D0,SD<$$R#&# M+RM^`N$WIZH%H?BAF4> M=PEP8^Y>5C"'$'3]:G^BGME6/W7]#@>$>+\H$\LU`KT861]$3#[CHCHB<NYZN5#W%\<*%\ M$(085=(]5%1>A?#1Z45:N>!C0E^<&TL4IKGCD:BT#>&C,Y;0!/`QH2\KFQ>% MD9]!\`%6X=)[`6&XC8_Q[S[(XB,0N2FA6M10U/&4=Q!ZT5,(E`D+9P;G>@B! M+E/@H:AS*N\@VLY"`I28A<8%UPF/'*-BM%;DTR"_8AMR56BF^[X.KSSI`<"T M,&Z+I$@%,`POZS+BNZ? M5.Q=;AP__'QS_"!<_O"6&V\?V.YZ^0-L#Z`\5^W$)3A@N%\V/D"]?%[2EP`[ M/J[,YHY M\@K69.D-CTLL,+"ZT<'IZ)*0!'WJEC#N0<.=3$"MI3<:Y``=LA3_:6YDS<LMBX*V(5H#E/9>Y="`%6,><2N9',-SMXC03O@U_?;?OC'XB+_P#;,,`_B=CY:\_Z=6!%_$Q^3!!( MQ:."PC:TT&O;[,T9]*E*T%V3RP&E3-&I-5>ZI^`#BR M-9R['_(%-^++QCX,0GB%@'K=G4BE;IGHYFE`#43"!_TS#;CX<'KWS)4AR5E^ MZ_1.&;U_K^%XI12C_"K.`T=6[]&PV#XG.+F*"36"4$S"VL(;`C09>U#DU&#V MG#[&F0W@A$\>B'^%P]H,T,/(`4MU`TM@.1]!PU+.R";@3L_YQOD2I:.9>T(F ML)*/H&&91UX"W"EYC7N/0!-?B-"+@POWI\$%]%,`7+;`F:ABD1+&IQ>=92]` MFDAEW'N*YF#-/6H35:A2PO@,YC5A`5)>Z^^I8>3UO>WX<279MV=PB-RKB<_6 MZDWR#M8I0W8IU4<;9Q#[5--EU]\A4SM>G;M%5GCK\9$G7[5]<);;O?0(@2CT MH5YOMO2L\?@HI,H0`=1HZ!K$NO58ME11C$O09PW*GJ%;%I7M]Y?>>'H4QF*P ML@T.3;OXH2S84R(;E])Q=GY*GDF/"(>DX_IA&/-N?S1AJ2A07Z+Z0V8]D'+' MQOZ53<=`X5/V:#*JXT'EE-M"9A$`R_%K:#B_3HMK#P?C_F22]1?Z:G^RW/:L M:2ZE#R(JL"6$P*&I9VE#L.>(/+X2F1/1G($0V#U'^`!-)C5A"7+4GII%[;.: M&OE"&D4H1MBPY/OR"&G^NE(;BIRKR;K2Q,TI$LN-F%]4.RA#@"5'',/N&`2$ M!JF3/JK?8PV+U(JALB*G&!T(PPQ'CBR#*UF.%8JA)&PM86TA#@&:''T,NV\2 M,,H"@J4;.$-B*I<0'>C""$6.)H9EI7)ADU.D.H4WZ46U@S($6'+$,HV950Q0K(\E):E.`VDHL`69YB9CW; M2;%=O)V_G)V_!J%OKT($=W0A'4M]\UPV!+%$8IML]K0X^>=+U#@(_;U!\O<4 M/BKF1"">\XVW^_!<@+3DIQ-IU8PX\Y._?>OM;,?M6M.)-@#\\Q]G\X?6XJ_X MSXA_A+_DA&@4O=ZP\VLGA2?_^Z#CO746'\"/_FEJTLY&?X#F8V]OH?U\_^RN MO%VLC]EGT%7M]"/Q/,#/$+AKL/X;S0/O($2)57<_/X`;@"!EK=4G7EI$O>TF M2Z722N(\?@2YF/A72A1@;^I7"6L:" M"7Y':EK.W)/OO8$@B$8.@;CQW`@TG)&30C&RIJ2`@QAZT`U"$4LX$&I-C0-& MLL"_Z?D0@V>PA49VG4Z]WR.&%L20@RQ4$1DH$&A-P9,:EN(>P`,[8KR\93\5 MIX'VG\TZ66KCRC`]0Q31.S.(U"TX@*WW$1UA4TLWG9(\;V+6O52V(A+0XY$P MPKC4^J5OPWDCT%#3UA#>1HX0F(R)M4C$,*)4MB)&T..1,,*XRH.5F,W:<3$Z M_6)W,IR,&QM_,_2=G=*W;-*XU;+^A/5">\O@>0-;^*-W..NOMO\70,^G4GT= M3XB]CP3YVPH%*S)>E$@D1##NO>.#N_)V(/43I7CUQ\2G7V)(4""4WVX]PX.( MBXI36&.+&`@5=1R+Q0BA*C7RV<&+,$D#+EC"@:(Q`J9Z)1X]UXL=O>Y[#%R" M0@K"8#239]XKQ:M1'294+M742SGC"3?UCR",O_G%"Z`I'/3'(VF#/Y+5"'// M#J?%TVW/[9KM:'IG^RY4TP"'S7^S`V>%G`W.=A^"=7?6F\B[7E<(5V.]&!`Q M]8+]'3CO&SC7^0%:\7?PN$>U'Y('?KGBRJ?(6-,>L1V0&++P#4H-AP0`:*J# M]\$]@"!$,,:H/B`O%OQ)U[*F$H]*16*%\(/C&)@^GZ6!PX!K1\WC\ZBO[_FY M@.;Q.J;>#6LM_&YS%=';!.PJURB"TG!.T/#X7 M?AJ>D@"(KD-4_S\JD`%2'MNMV?7AKII=E;/ZOS:N76"U=8+]CY`>7;? MOGZ=/_^[L[COO#S\_OAP_W`S?UQVYC7>=-V=EPU/::N7M7;0\3][663FGCD2&3+SS3Z7\(/>%%\/]8K'\ M>EP*T!)B\AO\6W]UK8E%+)8G*"Q!-0@A&LZP=&F,@AVB%A_0ZJKYL%=+T3N_ MW(+0=K;!WZ6H?/+QJ^;##2NYA'X%_FJ#P'KW09RM_-T)-_BGP=*[!:@ZY!*L M-JZW]=X_%^YR`QS_.W@-G#`NW3QC>+,*3IVL+F_A1;>13O">KY#<';'TRFI M.)6@_!:22%5LJ)Q_>^()C(_,5ANPWF_!XNW)1_>C\/-IBXRFNT8/BSZR)U7# MZ814W$/0`9-R%,J.F!PHF1IL*-]?GVP_=.$'*;;7\6#(4"Y&D%A=MAL1J.GO MEY/!L-^=M_#&]M=0$P_.FAHTAF(SHN7KR;F:.*;D,ZRH4;&!AP-(7M<.^V-Y M07:*`=1)8=Y]["$BZ4>_1GT"NI8UD/<^IT"H$+7@6JY<)^(J-$R]^-WO?=<) MX5D78G;O_$2_"Y+9]P9Z28KGJZ4"'B:F[;B%TOWTB\*(J!,.^Q.1WB@'( MY4C91'./_%@(9JKY*(3A2UH'9MB7^/2O6C[_'EGX[6\!>-MOOSAOZ"$?'%CS ML\M&(%<32E:Q4A$*4#)5$YYM]SVQ&8.QO+H'J9@:ST#0)Y+]#(Y5WGDO)T@( M34L@3E]_D.=F*NF^.JZSV^^2"0\&4WF[\I$H<P_JQS(!I3"R+>8Q*=^O;0G['67D_=T37G,*S!DUA.`OZZ? MP6IK!T$$6Z0(Z__NX]<7MR!8^4[$N*XUG!)["8C29[;AJ(KVU((-'Q>,RV\H MK<<48?L95662QQ^*$:BB#"LXF"4]TUCR$MI^^.UCO@J=@Q-"Z%"1!`S`Q)I* MS'PIEJPLV842C(0-,]/()"OGJ3A(LP)CZ M5AYE$:.ZS_#_T&7Z8&]1LM4I$N/I4-Z%C&H(*K.LF?`Q-8?VWG;\/^WM'BS> M[AW7=E>.O7UP(7K[789(=S:1^*:/:@BJB,*,CZGO,KZA=CEW0>CL;)2`:4VF M4WD56XZ%J5K[DBFG08V)69U^4%V98/%V`M;GF6$<].4%!>G&H(H4[`BE7!G/ MC.(*REGUP0:X@7,`\6&;:5$L#I>4&%AZFN_PI#?V6UMU._)LQZTPU`72N&` M*;VK7,J#F(?=!SRFH]\A'/I2>SY5C4`[IA2`DY+$L!/L(_B10\_W7/C;%@7C)'E!DC*94C_O8UD:/LK4Q^ M`[44G#.4*SXC-"W.YJS?_75EDB;ZQ2 M7Y:<94D6S$UY5V6.]R%2EJ29]R%GRU(X0\T7AO@&0L["-/+*XWQABF:H,*^> M+@.LH(&\^)4YEL5O=N,]YR$(]C:\-;PX\)<'^+\(QRB?7U_$OCB@7+GRZ2I_1R!ZNL0S1$N, MW?D*R4IRY2%DP=CAH1N9!;"^W?OHSA6EO$=9B4'\\WO/1RDF76O2G\A+S*,? MB%CM*UFS3`.Y,&KQ+9-AG\0IK$F-QYG,H'J9Y,9900N#L0\@D^Y08(VBP\`- M$E1]9,#CE[397WFR/Z/603]L?[V(IAM`E7D#47T@>/>/-:IKC6=CB>U@Q8^X M>5LD&753,[]NP6N8I;S=>.X!^*$#3R+Q;P.48NL[*V!U)Y.>O/<(U,-HG%A< M`)D:V/_F.F'PLG]%K_M>P1I>CL9#AIKO)_^\\;4L&[ZI.<`YC_*Y(SD-($#( MY+E3J88@E@QLDSV[4I[=Q?2^^9(-GKEV7ARHPI4L1Y,90RUDBD]*)UPAT.F;-,9Y MFWK1_6ZC8S6N8CL:C>55.3D2U3@#SHQ.XX`;X=/6CI.$4FI/B3<`'I6F%:JYTG-A9^I5\FZ'RKH#D-RH4P?@"_`/\((4 M+"%.`3Q_P3]6`F3$<93EDJ-]I:B.C M\#Y+US<6<"I%GR'4S"E&_?*+P$?A\W?A##CB>)_A(LLIIFT,(..CL#X&C?'_ M"?R5@Y[A)A,L9#0IK:S(VM-\5/WJLL]=8;V;FFMYS$U2OA/'6FJDJ>QS5UC2 MJNY:P@7+LY.47<2SFMEG-5_/@OFK+%E'L:1%.TAN)J3,[X*5+/^:^@5DF"U> M-TW]PJ7.AZ7WX!Y``-'-SXP4QN'QT)Q]7?VZUD!#Y2,V)I.;NI.*S@.DFMF5 M%K?LJ^K7E6/V>#W5YW>RK^?QF6`J:#VU/!!1SUYE8>"Z=ACN,/=[E#E$V&<8 M_%0\,M2O=6UD\,IKZJBJFM\S"!T_23E(SAW9)`<,KBIN0?IS@`XC3`1-_57E MAP]R\*=H&QLP.+!$R=6<)KP(8M9HZN.J.>>CS7+`X`83);?UK"$CB%FCJ3>M MRJ!FJ:>+MTKL_\,#N@W*2XY&!A\I94?5&\!V.:,EUY3 M+RAA,F>./)82,%7?TW+YBF>,5T^=Z[*X_%WR)^B75SL`\"?_'U!+`P04```` M"`!1@&A#1B1M!>,:``"AI`$`$0`<`'9P:6'-D550)``-J M47U2:E%]4G5X"P`!!"4.```$.0$``.Q=6W/C-I9^WZK]#UR_3/+@MNB[N]*9 M5`HE>IVTS@'YSOX M<'!P(?C3WU^7GO$,8.@&_J MX(-/1WYP]/>?__,_?OJOX^,>!!8"CO&T-B;]WM=Q_S?CSO6P;&C,'XXF M=[VC'X^/D^(K&#B1C?GP[$(46=[*G<_7'^Q@>4)4=F[."`0/ M+(&/[@*XO`4S*_+0IZ,_<%EWY@+GR,"8_?#C,Y9D51A+O#Y!S\V)D"K!",PK>)^J^`HT;"`8/;IB+35 M<=H<_\(2'S":M`CQR*>CT%VN/)`^LZ!=J#N!:M[8D"L`D0O"D]3V MC9_(@WKQM&BA9![D5O.)%'\Y8.;Z+H>[L,!?V%V>]00\1D_ALG]A3ZT@"''4 MY.F)6.1=.(Q8.,7&&^2'K^-!_;A`O?79\DBLGRP`0.&1X3J);YY"7FLVMJ36 M;'OXSYW.J7%L3'"CT!$-_YS4:\05_W2R*[&K+`J!,_1_IC_OA-I$."E1)YB/ M.>QRNY1BE]QT6W81S$\`2.VQ,B83UM4AN-8&:D5AK83".V\\<# ML90F5G\V`S9RG\GS,9Z!CH&-LQ77;69_6YM?%#;,"!$F],B7OLE#F%-P$(Q?O(&59X4E?WS<[E+BGN M!]/!E^YT,'PT)OWI]+[_T'^<'DBA'BF*0X\72AYT+HM3L%)Z'`8458CR&"`0 MCJPUB>499OA2]W_,XA3K<3C%8\BH^[W[^;Y_(($Z)"A&"5]V:GI>C!(Y.ARB M@RK$&*X`Q.C\^3W`S9HE1>#)#1`WNXP8COIC/&P\?C'N^]W)82U7,2H4PT3@ M20X3-\4PL4N*0Z10E![;E9#'P.^1HQX>&5SRI;H06OZ)9[R&'4:/ABV.-[!G.63%U22AP&"!4(<,8C^<(.",+ MHO44#^&A91.L65K`E=S3*F9GEQ7C_CWFQ2UFQWCZW9B.NX^3;H\LEAUBA:+T M*`8/S!*YX>=!&/[__S.\O^V/ M)W\S,#,&T^\'2J@5'XI#20@DCR1F<20I1(K#`*(,00HQHY0B4F/'>>>JA",E MT>-`$Z5H,ES1=+3K.]\LL@*93S<"ZT7N`'-=2A%C.(IST.[CK?&M.\9IZ2'S M4)0>):$$LT3RPL=U12PI)JH2;894^-S[`RS]#R04'D2%K8::>23N]G(D8X=MAV5 MH4MR_T4XG/6L<''G!2]YFM@SN=,*WG)J$/?^B@E#>5,;)[A^D;6P+\9L8ED;*)&'H*-3I2J MN@8HX9?DNX`NI1#L<&>0HH3#HUMR]BJ_F1X&@5P>G=>.;EL;#LQXZVV/Y=*" MZ^%LXLY]%_=>G"1W;3N(?'(\;Q1XN#_OY,NA)?E$5LDNR,-#=_S=&-X9D\&7 MQ\'=H(>39:/;ZPV_/M)#>Z/A_:`W.!P\UX,^9?-ZS"+)4_I61#I,W/6B5%5D MDAJ:2NZSXF%4:N.!4EI0JF1I"!-*\MI0*T(=UHKDT>FGD]V;QY,G^1O*Z?WD M[G(50&3XI1?'9VEP$_/-!W-R//'(B.^=OP]LJK!.,F'%FMC%CTRTXS4CEA,R@^D)@?Y@'SR<. M<.G5^\<=$RNIM*-4AOQPO!7FM*!P9SZC"U(!@OU"T/GE'P1@,2`K^1@+MJ=D M\5,#?*:TL&-FA4]46Q0>SRUKQ4R&4L$3X*$P?2)$C:Q:`BZ49!#556=1\AD+ M:M*GH^X*NMZ=.T.+Z4LP7011:/G.]`5XSV`$W6<-IM(/(#E$X#;@?%? M`K*^Z]$W]#X=(1CA:&`]A0A:-DK_33^&\7&%6SEPIO3>=R>"R9W&880+NR@B M__H"@VCUZ2@N[B*P/#+B:^+CKV-\=(*EY?H#_`NBI1D_#%$!0[)K-`C#"#C3 MH(=_CCQ$=H^J/"&F14V?3,FZ70$-@4&&A7(/L,DHBC=C]@*GCP#X#6";!;1! MRDMU(16Z>F-SMD34%P4%ZGLBUW&'LWAAOQE_K9@FJ,5;GTE9X7A<):<)QO"L3M?(#Q/QM9NGH9C@`=`2)O6\KR) MZ\\],`%V!/&H^-7/'A/YER1]NWXJ^B5>V$&,;HF?A`L+@I#%*\%R&<1G&,B+ M5#9T:;OBR$?,"Z<+7,]\T3BQ;*=&/:Z4PR$'LB^OKRXZG3I4773=&0&X2Q=I M*LL9\Q1_^^G3D8WI1K\'T=9I\1-L-$`67+?P&BM;%(X=%0:/@0UP2V%3F3$6 M111$FXYJ7=^);ZZV79H,M6G#DD>_@I#L*P^62SR$XH;UUM@#OUH>UM-% MYODT.#_%H_"$Y%89;_W)]2H[_#?Y8>@G7JCVP/`9][`%!.`[L&"8=8(Y#2[. M!)POL])WX_D)6*'4"V=-7C@]G0:7UQ)(<5C;V&$%A-7;JCF@(%SD39>R(@KZX7$;$K=SU8('#RM6@&, M@-0V\.UX4=;RZ(_X]Y3P)>X0U-/05QSP]$9=A6[3#'S<2C11&]&Z2:*13D>F M0?]UY:96;/W!*=B\.B4$-15BAYI8UUV2LW_D3;^5BYL+FPIL1&8>G\'8BM_: MVL7*+BD<&456Z/A;.P&2+"S0!;YNA!8!=/\/.+<1R9+CYHQ_5^D)=@5[:GWF MQ4E>NPN]7TQ>W1$RAR==:XX1%5<`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`IS6!G* ME$V/M^#B(QJS3()![LA+]MD+-\EV*J_M/^TP4&M_E:E#/?D8:ZBYO\ITH2ZY M2C>=SV2@FKL8J]W'KN&]^:2II_+J4:P3AKF.@;&8G5/S[/SJ?+-6%7>'7R(? MG'4R-Y87^\=5^E&21I?ML;U)IGA\KO$ M6@^^;YX&_!EUJQY>:%??CEW!K1O:N.`UW!CZYN31$ MZ<<.Q+,2V17_51S-'^M7KF(9QW2ZU5=5I+`E3>,=0"%>Z\\4SKV97J7K';4`2 MG[&2Z9NM1OT['NO$1[PK\M:@5^>\"V`O\)\!)!_C&,ZR$/EL2C7C7AUF%HSCT7YNZ%>\HK1#7G#:/-IZX[@CH2X?MT( MV`"K-0<9]6M+PS%`;OQ9W>'LG!X1W'QWX_1"F'Q<6E6G'!,8;J)Q:7T7]*H\ MN"RN0[L\5SC/USO#'_AXWO;OR*>O5GYST2([=2O>D46.>_+%G!85*!U^!'#Q M1:(6%>@9E!H`9S9+3%,J!TLUZTR^'*#=3UW*5JPGV?C"O)ZQ/?F`TU5\-8+P ME*51C=)=I=)ZOFC.THYXTYZ3O!7H0DA67,)L MY*U`5RHF:Y3F9>L4K%F3XN2J!L#+HF9-NM)E,[TRV^?L++H4ITP=!%[2L.C2 MDS8[+V33%UK6,Q?F+[2G-]W4O[4H0+/]U*TT+>5"YJ/Q?NK^"]->.N-MU1-,;C2U9+[=J'4@O![$0Y^56K37E=P$VW)8K M3Z5>B_[-T,INW)6G4C-O!0/_&80H@.1C0#'`(0SIG%H MU#14;1%R=K&BH%X=B>P5CT&X`C::!A.`4"S:G4,@\#(4J[;WY:-T_?-:,$$3 MUZ]T(.*'Q1>6Q/7K$Z3BW6OSHB1_+#_-5N<\`67OV%/-?518I3K=U,]!'2(F^'F&@BOY7X/\2>>0JE2U]$-- M6!215M`'/F@U.(C)*^\'7BX(2"OG`[I_5![?F3W10H>:_F";9#4X1%")FAZI MV&'D'44DZ-+>/PVT::-)4=_L?$QL!\6M"X%=NB$B)*V\#P324'$5NGJCJ9.\ M@^PCON&S(I=JGI2*B6ONA88C'3*4O1\/E1WCD*%,10]5)%N5JQKL(BJBC5=P M.1=R..54QEV6&['@9I%3%W=QQ9[MHZZB"M3T1-7`7SM2*4\/Q!6HI='XHG"70#9XJ>P&AV]TC0;?2=[(DQ`ZF:B[V)_ MM!P&SHXCZ"(7A*,(3[BM$%2?U!36H+HO^)V4.`LT1O/;+6Y&%\*00Q MVO7GZ0&T$8";ULPZ@%=2V7-;C[AHTG73RQVWE[YO@GX*BGS].#DRD?FT1?:, MVMFO($3`&2R7&!$>)[SU-*#YQ'=@0:([/D1*%'4Z-]/`O+Q,#Y-F_*N45>^D M[0J]6$QE%V)7HB8YK3X.9"W.DRZM3>[^3PQLZ-F&:#"SHXYMVT<'O[*O^"7I\"?QH\ MNM@2G$;^JVE>#^$S0HV(U MZ.W3-$T]K^^CV5OH>)TJ5,6[\.K.]1CIR(\G9<-GO7V?_RUP\;(>"KJ9W[].ONS88M#6(..,[>&97QA#2KZ8H(LK#2`Z_BFMHI/ M43055!#9]GW&_A^1B];I5G3WU0USR.H+[@&9@SXZ+K:5W`,[*+X>BB".X:T@ MWE(O,8%,BVK4@/=X!D$4L+5BIO3>,4IKP"EYQ`0O*;D?EBYP26A'3Z`52^,U M*#QD;FX0RZSB`[_R:`FWI((_<9?`U!#?H:F3?'EUS%CL?(W/!(QLS*@95# M1KFXF=A>?N"8!36[I+K8Q=,)<16Z>J,ZF1!5H)XGM@83_H8#LK.&*]\],9G% MSBSRUC=@L5J:GIW%SVT@@'1'7CILTJ*K9)E8#/:.P=\`>;<`.-UG`*TYX,#/ MI4@A1Y1LBS8NS5^5+/W+4ZGL:G\5Q&(0;"BH MF^Z,)9NSK]EWX#SR6AR9+!:6,.-?%;TB4ZN"/@ML`!QZA"JSD;8]`YNV?ZY; M<`@U]!('/+U-)_E'9$&$)]:Y=Z/I&Y*5DS9V$>6:N=3TVADJLX0>6-/W5/CP M5DEI@KE^0X=#1E6\]%01;_]E$M(%,4L?9I%1%B\V>WN3:LA>43V1`_Y_(6-B[O/H/844$L]ROEE8B^`$WE@.-L>JL`S MJIW#%[6EU#UXP?..J8YODY;-"P3>MVZG1F>O5"\PM%&BAT=XMT[:*-'7(YP, MT7,#A:ZZ?,8AS^D%RQ7P0UI9E\RKY[3?&XE0B)O?P4&:<(&#&\WU?#6FY]M@26+@O3,<,7^X/ZJ M:':>ZY,@A/:S<2@)6(RFFPQ1\AVWJU^U$^JR8&YZU9Z)6%G16V]DM\>WF$+='=]?D3&R8T7.213):MUNY:];>U=M9ZMY\ M6EF%KNGK[B7C4B=,-*R"XSV89, MMBS2;1EL?_'$#;O(_V^P^A:$P=%&@G>)T3/H_!N:EUE2'`PT.;DH,PFED8DA M,]!9$KQD%C;D"+IH.;,$M*PV#]O)ED2H';2K_Z`EA6=>66IQ27X1ML,S<"L9 M=`D,S:G8CK_`K62P^@:D"D^\H$D/9E_@B0\TZ4'G"U!Y"U[Q"KXHP0U4TA*_ M5)8`L``00E#@``!#D!``!02P$"'@,4````"`!1@&A#&UL550%``-J M47U2=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`48!H0\W22_(%0P``P<0$ M`!4`&````````0```*2!!@`!`'9P:6`Q0````(`%&`:$.0)IM%0!L!`,GL M$P`5`!@```````$```"D@5I#`0!V<&EG+3(P,3,P.3,P7VQA8BYX;6Q55`4` M`VI1?5)U>`L``00E#@``!#D!``!02P$"'@,4````"`!1@&A#9\_4`;-?```Q MZP8`%0`8```````!````I('I7@(`=G!I9RTR,#$S,#DS,%]P&UL550% M``-J47U2=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`48!H0T8D;07C&@`` MH:0!`!$`&````````0```*2!Z[X"`'9P:6'-D550%``-J H47U2=7@+``$$)0X```0Y`0``4$L%!@`````&``8`&@(``!G:`@`````` ` end XML 16 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
PATENTS
9 Months Ended
Sep. 30, 2013
PATENTS [Abstract]  
PATENTS
NOTE 3 - PATENTS

The Company continues to apply for patents.  Accordingly, costs associated with the registration of these patents have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents (20 years).  At September 30, 2013 and 2012, unamortized capitalized patent costs were $604,572 and $268,856.  Amortization expense for patents was $7,718 and $19,617 for the three and nine months ended September 30, 2013 and $3,374 and $7,546 for the three and nine months ended September 30, 2012.

XML 17 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 18 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
PATENTS (Details) (Patents [Member], USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Patents [Member]
       
Finite-Lived Intangible Assets [Line Items]        
Amortization period     20 years  
Unamortized capitalized patent costs $ 604,572 $ 268,856 $ 604,572 $ 268,856
Amortization expense for patents $ 7,718 $ 3,374 $ 19,617 $ 7,546
XML 19 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
Basis of Presentation
Basis of Presentation
The financial statements are presented in accordance with Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") 915 for development stage entities.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from these estimates.
Comprehensive Income
Comprehensive Income
The Company follows FASB ASC 220 in reporting comprehensive income.  Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.  Since the Company has no items of other comprehensive income (loss), comprehensive income (loss) is equal to net income (loss).
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The Company's financial instruments consist of cash, accounts receivable and accounts payable and accrued expenses.  The carrying value of cash, accounts receivable and accounts payable and accrued expenses approximate fair value, because of their short maturity.
Concentration of Credit Risk Involving Cash
Concentration of Credit Risk Involving Cash
The Company may have deposits with a financial institution which at times exceed Federal Depository Insurance coverage of $250,000.  
Cash and Cash Equivalents
Cash and Cash Equivalents
For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents.
Property and Equipment
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation and any impairment losses.  Expenditures for new equipment and major expenditures for existing equipment are capitalized and depreciated using the straight line method at rates sufficient to depreciate such costs over the estimated productive lives.  All other ordinary repair and maintenance costs are expensed as incurred.

The Company's depreciation and amortization policies on property and equipment are as follows:


 
Useful life
 
(in years)
   
Computer equipment
 3 - 5
Furniture and fixtures
 7

Recoverability of Long-Lived Assets
Recoverability of Long-Lived Assets
In accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 360-10-35 "Impairment or Disposal of Long-lived Assets", long-lived assets to be held and used are analyzed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable or that the useful lives of those assets are no longer appropriate. The Company evaluates at each balance sheet date whether events and circumstances have occurred that indicate possible impairment.

The Company determines the existence of such impairment by measuring the expected future cash flows (undiscounted and without interest charges) and comparing such amount to the carrying amount of the assets. An impairment loss, if one exists, is then measured as the amount by which the carrying amount of the asset exceeds the discounted estimated future cash flows. Assets to be disposed of are reported at the lower of the carrying amount or fair value of such assets less costs to sell. Asset impairment charges are recorded to reduce the carrying amount of the long-lived asset that will be sold or disposed of to their estimated fair values. Charges for the asset impairment reduce the carrying amount of the long-lived assets to their estimated salvage value in connection with the decision to dispose of such assets.

For the nine month period ended September 30, 2013 and 2012, the Company determined that no impairment was required after going through the impairment testing related to the operating long-lived assets (property and equipment and patents and trademarks).
Revenue Recognition
Revenue Recognition
In accordance with Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No. 104, Revenue Recognition (Codified in FASB ASC 605), the Company will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, the Company will generally recognize revenue at the time of the sale utilizing Virtual Piggy payment method at checkout.
Income Taxes
Income Taxes
The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes.  Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.  Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.  Tax years from 2008 through 2012 remain subject to examination by major tax jurisdictions.
Loss Per Share
Loss Per Share
The Company follows FASB ASC 260 when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.  Because the Company reported a net loss for the three and nine months ended September 30, 2013 and 2012, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and diluted loss per share were the same.
Start-up Costs
Start-up Costs
In accordance with FASB ASC 720, start-up costs are expensed as incurred.
Research and Development Costs
Research and  Development Costs
In accordance with FASB ASC 730, research and development costs are expensed when incurred. 
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted
Recently Adopted Accounting Pronouncements
As of September 30, 2013 and for the period then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company's financial statements.

Recently Issued Accounting Pronouncements Not Yet Adopted
As of September 30, 2013, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company's financial statements.
Reclassifications
Reclassifications
Certain amounts in the 2012 financial statements have been reclassified in order for them to be in conformity with the 2013 presentation.
XML 20 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
LITIGATION SETTLEMENT (Details) (USD $)
12 Months Ended
Dec. 31, 2012
LITIGATION SETTLEMENT [Abstract]  
Cash payment for settlement $ 450,000
Proceeds from insurance carrier $ 75,000
XML 21 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAXES (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
INCOME TAXES [Abstract]        
Income tax expense            
XML 22 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY TRANSACTIONS (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Related Party Transaction [Line Items]        
Related party expenses $ 6,506 $ 20,001 $ 30,072 $ 32,224
Monthly payment for consulting services per agreement     12,500  
Consultant and Beneficial Owner [Member]
       
Related Party Transaction [Line Items]        
Related party expenses       130,000 172,500
Marketing Company Owned by Secretary [Member]
       
Related Party Transaction [Line Items]        
Related party expenses    $ 14,560    $ 14,560
XML 23 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK OPTIONS AND WARRANTS (Non Employee Stock Options and Warrants) (Details) (Non Statutory Stock Options [Member], USD $)
9 Months Ended 12 Months Ended
Sep. 30, 2013
Dec. 31, 2012
Option/Warrant Shares    
Outstanding, shares, beginning of period 16,531,438 3,184,286
Granted, shares 1,753,750 2,915,000
Issued under Private Placement, shares 1,723,533 11,967,152
Reclassified from (to) employee, shares 235,000 (810,000)
Exercised, shares (2,995,185) (350,000)
Expired, shares (1,405,000) (375,000)
Outstanding, shares, end of period 15,843,536 16,531,438
Exercise Price    
Exercised, exercise price   $ 0.04
Weighted Average Exercise Price    
Outstanding, weighted average exercise price, beginning of period $ 0.63 $ 0.76
Granted, weighted average exercise price $ 0.17 $ 0.12
Issued under Private Placement, weighted average exercise price $ 0.30 $ 0.38
Reclassified from/to employee, weighted average exercise price $ 0.02   
Exercised, weighted average exercise price      
Expired, weighted average exercise price      
Outstanding, weighted average exercise price, end of period $ 0.99 $ 0.63
Exercisable, shares, September 30, 2013 14,388,536  
Exercisable, weighted average exercise price, September 30, 2013 $ 0.93  
Weighted Average Remaining Life, Exercisable, September 30, 2013 (years) 1 year 4 months 24 days  
Minimum [Member]
   
Exercise Price    
Outstanding, exercise price, beginning of period $ 0.35 $ 0.04
Granted, exercise price $ 0.50 $ 0.35
Issued under Private Placement, exercise price $ 1.80 $ 0.50
Reclassified from/to employee, exercise price $ 0.50 $ 0.50
Exercised, exercise price $ 0.35  
Expired, exercise price $ 0.50 $ 0.91
Outstanding, exercise price, end of period $ 0.35 $ 0.35
Weighted Average Exercise Price    
Exercisable, exercise price, September 30, 2013 $ 0.50  
Maximum [Member]
   
Exercise Price    
Outstanding, exercise price, beginning of period $ 2.30 $ 2.30
Granted, exercise price $ 3.28 $ 2.17
Issued under Private Placement, exercise price $ 3.00 $ 1.00
Reclassified from/to employee, exercise price $ 2.30 $ 0.75
Exercised, exercise price $ 0.50  
Expired, exercise price $ 1.00 $ 1.00
Outstanding, exercise price, end of period $ 3.28 $ 2.30
Weighted Average Exercise Price    
Exercisable, exercise price, September 30, 2013 $ 3.28  
XML 24 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYABLE (Details) (USD $)
9 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 1 Months Ended
Sep. 30, 2013
Dec. 31, 2012
Apr. 30, 2012
Private Placement, September 2011 to December 2011 [Member]
Feb. 29, 2012
Private Placement, September 2011 to December 2011 [Member]
Feb. 08, 2012
Private Placement, September 2011 to December 2011 [Member]
Dec. 31, 2011
Private Placement, September 2011 to December 2011 [Member]
Sep. 30, 2011
Private Placement, September 2011 to December 2011 [Member]
Dec. 31, 2012
Private Placement, September 2011 to December 2011 [Member]
Dec. 31, 2011
Private Placement, September 2011 to December 2011 [Member]
Dec. 31, 2011
Private Placement, September 2011 to December 2011 [Member]
Warrant [Member]
Sep. 30, 2011
Private Placement, September 2011 to December 2011 [Member]
Warrant [Member]
Dec. 31, 2011
Private Placement, September 2011 to December 2011 [Member]
Common Stock [Member]
Sep. 30, 2011
Private Placement, September 2011 to December 2011 [Member]
Common Stock [Member]
Notes Payable Equity Issuance [Line Items]                          
Units authorized             10            
Price per unit             $ 50,000            
Note payable included per unit             $ 50,000            
Note payable maturity date             Nov. 12, 2012            
Number of shares entitled by warrants                     15,000    
Exercise price of warrants                     0.50    
Warrants/Options expiration date             Nov. 12, 2012            
Common shares issued per unit 111,386,768 101,417,508                     15,000
Amount raised from private placement 6,070,595         500,000              
Fair value of issued equity                   20,930   82,655  
Pricing model used in calculation of grant-date fair value                   Black-Scholes option pricing model      
Dividend yield                           
Expected volatility, minimum                   39.80%      
Expected volatility, maximum                   62.80%      
Risk free interest rate                   0.10%      
Expected life                   1 year 2 months 12 days      
Fair value per share, common stock, minimum                       $ 0.45  
Fair value per share, common stock, maximum                       $ 0.70  
Accreted interest on notes payable               65,560 38,035        
Repayments of notes payable     25,000 50,000 100,000 150,000              
Accrued interest payable     $ 25,000                    
Common shares issued for notes payable conversion     571,428                    
Fair value of warrants issued as discount for notes payable     285,714                    
XML 25 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statement of Changes in Stockholders' Equity (Deficit) (Parenthetical) (USD $)
1 Months Ended 3 Months Ended 5 Months Ended 9 Months Ended 12 Months Ended 1 Months Ended 3 Months Ended 5 Months Ended 9 Months Ended 12 Months Ended 1 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended 1 Months Ended 4 Months Ended 2 Months Ended 12 Months Ended 2 Months Ended 12 Months Ended 1 Months Ended 4 Months Ended 1 Months Ended 12 Months Ended 3 Months Ended 5 Months Ended 12 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended
Oct. 31, 2009
Issuance of Shares of Common Stock [Member]
Sep. 30, 2009
Issuance of Shares of Common Stock [Member]
Jun. 30, 2009
Issuance of Shares of Common Stock [Member]
Apr. 30, 2009
Issuance of Shares of Common Stock [Member]
Feb. 29, 2008
Issuance of Shares of Common Stock [Member]
May 31, 2013
Warrant [Member]
Dec. 31, 2011
Warrant [Member]
Feb. 29, 2008
Warrant [Member]
Mar. 31, 2013
Warrant [Member]
Sep. 30, 2008
Warrant [Member]
Sep. 30, 2012
Warrant [Member]
Dec. 31, 2012
Warrant [Member]
May 31, 2013
Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]
Dec. 31, 2011
Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]
Feb. 29, 2008
Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]
Mar. 31, 2013
Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]
Sep. 30, 2008
Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]
Sep. 30, 2012
Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]
Dec. 31, 2012
Issuance of Shares of Common Stock and Warrants Through Private Placement [Member]
Mar. 31, 2008
Employee Options Issued for Services Transaction One [Member]
Sep. 30, 2013
Employee Options Issued for Services Transaction One [Member]
Minimum [Member]
Dec. 31, 2012
Employee Options Issued for Services Transaction One [Member]
Minimum [Member]
Sep. 30, 2013
Employee Options Issued for Services Transaction One [Member]
Maximum [Member]
Dec. 31, 2012
Employee Options Issued for Services Transaction One [Member]
Maximum [Member]
Dec. 31, 2012
Employee Options Issued for Services Transaction Two [Member]
Minimum [Member]
Dec. 31, 2012
Employee Options Issued for Services Transaction Two [Member]
Maximum [Member]
Jan. 31, 2011
Nonemployee Options Issued for Services Transaction One [Member]
Aug. 31, 2009
Nonemployee Options Issued for Services Transaction One [Member]
Jun. 30, 2008
Nonemployee Options Issued for Services Transaction One [Member]
Mar. 31, 2008
Nonemployee Options Issued for Services Transaction One [Member]
Nov. 30, 2010
Nonemployee Options Issued for Services Transaction One [Member]
Aug. 31, 2011
Nonemployee Options Issued for Services Transaction One [Member]
Minimum [Member]
Dec. 31, 2012
Nonemployee Options Issued for Services Transaction One [Member]
Minimum [Member]
Aug. 31, 2011
Nonemployee Options Issued for Services Transaction One [Member]
Maximum [Member]
Dec. 31, 2012
Nonemployee Options Issued for Services Transaction One [Member]
Maximum [Member]
Dec. 31, 2012
Nonemployee Options Issued for Services Transaction Two [Member]
Minimum [Member]
Dec. 31, 2012
Nonemployee Options Issued for Services Transaction Two [Member]
Maximum [Member]
May 31, 2013
Exercise of Options Transaction One [Member]
May 31, 2012
Exercise of Options Transaction One [Member]
Apr. 30, 2012
Exercise of Options Transaction One [Member]
Dec. 31, 2010
Exercise of Options Transaction One [Member]
Jan. 31, 2010
Exercise of Options Transaction One [Member]
Dec. 31, 2009
Exercise of Options Transaction One [Member]
Sep. 30, 2009
Exercise of Options Transaction One [Member]
Jul. 31, 2009
Exercise of Options Transaction One [Member]
Jan. 31, 2009
Exercise of Options Transaction One [Member]
Sep. 30, 2008
Exercise of Options Transaction One [Member]
May 31, 2008
Exercise of Options Transaction One [Member]
May 31, 2013
Exercise of Options Transaction Two [Member]
May 31, 2013
Exercise of Options Transaction Three [Member]
Jun. 30, 2008
Options Issued for Services [Member]
Aug. 31, 2008
Issuance of Shares of Common Stock to Investors [Member]
May 31, 2013
Exercise of Warrants Transaction One [Member]
Dec. 31, 2010
Exercise of Warrants Transaction One [Member]
Apr. 30, 2010
Exercise of Warrants Transaction One [Member]
Mar. 31, 2010
Exercise of Warrants Transaction One [Member]
Feb. 28, 2010
Exercise of Warrants Transaction One [Member]
Dec. 31, 2009
Exercise of Warrants Transaction One [Member]
Oct. 31, 2009
Exercise of Warrants Transaction One [Member]
Aug. 31, 2009
Exercise of Warrants Transaction One [Member]
Sep. 30, 2008
Exercise of Warrants Transaction One [Member]
Aug. 31, 2013
Exercise of Warrants Transaction One [Member]
Dec. 31, 2009
Exercise of Warrants Transaction Two [Member]
May 31, 2012
Issuance of Shares of Common Stock for Future Services [Member]
Jun. 30, 2011
Issuance of Shares of Common Stock for Future Services [Member]
Nov. 30, 2010
Issuance of Shares of Common Stock for Future Services [Member]
Oct. 31, 2009
Issuance of Shares of Common Stock for Future Services [Member]
Dec. 31, 2010
Issuance of Shares of Common Stock for Retirement of Options [Member]
Mar. 31, 2013
Issuance of Shares of Common Stock Through Private Placement Transaction One [Member]
Dec. 31, 2010
Issuance of Shares of Common Stock Through Private Placement Transaction One [Member]
Dec. 31, 2012
Issuance of Shares of Common Stock Through Private Placement Transaction One [Member]
Dec. 31, 2012
Issuance of Shares of Common Stock Through Private Placement Transaction Two [Member]
Nov. 30, 2010
Issuance of Shares of Common Stock for Conversion of Notes Payable [Member]
Dec. 31, 2012
Issuance of Shares of Common Stock and Warrants to Discharge Notes Payable and Accrued Interest [Member]
Dec. 31, 2012
Issuance of Shares of Common Stock with Respect to Settlement Agreement [Member]
Sep. 30, 2013
Common Stock Subscription for Units Through Private Placement [Member]
Dec. 31, 2012
Common Stock Subscription for Units Through Private Placement [Member]
Sep. 30, 2013
Nonemployee Options/Warrants Issued for Services [Member]
Minimum [Member]
Sep. 30, 2013
Nonemployee Options/Warrants Issued for Services [Member]
Maximum [Member]
Dec. 31, 2011
Fair Value of Revalued Warrants [Member]
Minimum [Member]
Dec. 31, 2011
Fair Value of Revalued Warrants [Member]
Maximum [Member]
Sep. 30, 2013
Fair Value of Revalued Options [Member]
Equity issuance, number securities issued for cash           1,436,277 625,000 14,285,716 93,750 614,286 10,213,474 1,500,000                                                                                                                           285,714                
Equity issuance, price or exercise price per security issued $ 1.00 $ 1.00 $ 2.00 $ 1.00 $ 0.001               $ 1.80 $ 0.80 $ 0.035 $ 0.80 $ 0.75 $ 0.70 $ 0.80 $ 0.02 $ 0.22 $ 0.11 $ 0.68 $ 0.53 $ 0.14 $ 0.42 $ 0.20 $ 0.31 $ 0.01 $ 0.02 $ 0.01 $ 0.10 $ 0.11 $ 0.19 $ 0.95 $ 0.17 $ 0.40 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.35 $ 0.75 $ 0.07 $ 1.00 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.50 $ 0.04 $ 2.43 $ 0.49 $ 0.90 $ 1.00 $ 0.25 $ 0.75 $ 0.20 $ 0.70 $ 0.75   $ 0.70 $ 0.85 $ 0.80 $ 0.80 $ 0.09 $ 1.66 $ 0.09 $ 0.76 $ 1.07
Retirement of options, shares                                                                                                                                       400,000                            
Conversion of notes payable, price per share                                                                                                                                                 $ 0.20                  
Units subscribed                                                                                                                                                       62,500 62,500          
XML 26 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of the Business
Virtual Piggy, Inc. ("the Company" or "Virtual Piggy") is a development stage enterprise incorporated in the state of Delaware on February 11, 2008.   Virtual Piggy is a technology company that delivers an online e-commerce solution for the family. Its system allows parents and their children to manage and allocate funds and track the child's expenditures, savings and charitable giving online. Its system is designed to allow the child to transact online without a credit card by gaining the parent's permission ahead of time and allowing the parent to set up the rules of use and authorized spending limits.

The Virtual Piggy product enables online businesses to interact and transact with the "Under 18" market in a manner consistent with the Children's Online Privacy Protection Act ("COPPA") and other similar international children's privacy laws.  Virtual Piggy was launched in the US in 2012 and was launched in the European market in 2013.

The Company has secured 143 agreements with merchants, retail and gaming e-commerce platforms and payment processors.  Over 20 of the merchants are using Virtual Piggy live with their e-commerce systems and the Company is in the process of integrating the other signed merchants. The Company is continuing to add merchants. In addition, Virtual Piggy has the capability to offer and deliver digital gift cards.

Basis of Presentation
The financial statements are presented in accordance with Financial Accounting Standards Board Accounting Standards Codification ("FASB ASC") 915 for development stage entities.  
 
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from these estimates.

Comprehensive Income
The Company follows FASB ASC 220 in reporting comprehensive income.  Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.  Since the Company has no items of other comprehensive income (loss), comprehensive income (loss) is equal to net income (loss).

Fair Value of Financial Instruments
The Company's financial instruments consist of cash, accounts receivable and accounts payable and accrued expenses.  The carrying value of cash, accounts receivable and accounts payable and accrued expenses approximate fair value, because of their short maturity.

Concentration of Credit Risk Involving Cash
The Company may have deposits with a financial institution which at times exceed Federal Depository Insurance coverage of $250,000.  

Cash and Cash Equivalents
For purposes of reporting cash flows, the Company considers all cash accounts, which are not subject to withdrawal restrictions or penalties, and certificates of deposit and commercial paper with original maturities of 90 days or less to be cash or cash equivalents.
 
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation and any impairment losses.  Expenditures for new equipment and major expenditures for existing equipment are capitalized and depreciated using the straight line method at rates sufficient to depreciate such costs over the estimated productive lives.  All other ordinary repair and maintenance costs are expensed as incurred.

The Company's depreciation and amortization policies on property and equipment are as follows:


 
Useful life
 
(in years)
   
Computer equipment
 3 - 5
Furniture and fixtures
 7

Recoverability of Long-Lived Assets
In accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 360-10-35 "Impairment or Disposal of Long-lived Assets", long-lived assets to be held and used are analyzed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable or that the useful lives of those assets are no longer appropriate. The Company evaluates at each balance sheet date whether events and circumstances have occurred that indicate possible impairment.

The Company determines the existence of such impairment by measuring the expected future cash flows (undiscounted and without interest charges) and comparing such amount to the carrying amount of the assets. An impairment loss, if one exists, is then measured as the amount by which the carrying amount of the asset exceeds the discounted estimated future cash flows. Assets to be disposed of are reported at the lower of the carrying amount or fair value of such assets less costs to sell. Asset impairment charges are recorded to reduce the carrying amount of the long-lived asset that will be sold or disposed of to their estimated fair values. Charges for the asset impairment reduce the carrying amount of the long-lived assets to their estimated salvage value in connection with the decision to dispose of such assets.

For the nine month period ended September 30, 2013 and 2012, the Company determined that no impairment was required after going through the impairment testing related to the operating long-lived assets (property and equipment and patents and trademarks).

Revenue Recognition
In accordance with Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No. 104, Revenue Recognition (Codified in FASB ASC 605), the Company will recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Subject to these criteria, the Company will generally recognize revenue at the time of the sale utilizing Virtual Piggy payment method at checkout.
 
Income Taxes
The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes.  Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.  Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.  Tax years from 2008 through 2012 remain subject to examination by major tax jurisdictions.
 
Loss Per Share
The Company follows FASB ASC 260 when reporting earnings per share resulting in the presentation of basic and diluted earnings per share.  Because the Company reported a net loss for the three and nine months ended September 30, 2013 and 2012, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and diluted loss per share were the same.

Start-up Costs
In accordance with FASB ASC 720, start-up costs are expensed as incurred.

Research and  Development Costs
In accordance with FASB ASC 730, research and development costs are expensed when incurred.  

Recently Adopted Accounting Pronouncements
As of September 30, 2013 and for the period then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company's financial statements.

Recently Issued Accounting Pronouncements Not Yet Adopted
As of September 30, 2013, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company's financial statements.

Reclassifications
Certain amounts in the 2012 financial statements have been reclassified in order for them to be in conformity with the 2013 presentation.
XML 27 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYABLE
9 Months Ended
Sep. 30, 2013
NOTES PAYABLE [Abstract]  
NOTES PAYABLE
NOTE 4 - NOTES PAYABLE

In September 2011, the Company commenced a private placement of up to 10 units at a price of $50,000 per unit to accredited investors.  One unit consisted of a demand note payable in the amount of $50,000 due November 12, 2012, warrants to purchase 15,000 shares of common stock at an exercise price of $.50 per share with a term expiring November 12, 2012, and 15,000 shares of common stock.  In December 2011, the Company completed the private placement and raised $500,000.  The warrants were valued at $20,930, fair value, using the Black-Scholes option pricing model to calculate the grant-date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 39.8% to 62.8%, risk free interest rate of .1% and expected option life of 1.2 years.  The shares of common stock were valued at $82,655 or $.45 to $.70 per share, fair value.  Both the warrant value and the shares of common stock were treated as a discount to the value of the note payable in accordance with FASB ASC 835-30-25, Recognition and were being accreted over the term of the note payable for financial statement purposes.  During the years ended December 31, 2012 and 2011, $65,560 and $38,035 of interest was accreted on the notes payable.  As of December 31, 2011, $150,000 of the $500,000 was repaid.

On February 8, 2012, February 27, 2012, and April 10, 2012, $100,000, $50,000, and $25,000 respectively, of the notes payable were repaid.   On April 26, 2012, the remaining balance of the notes payable and accrued interest of $25,000 was converted into 571,428 shares of the Company's common stock and warrants to purchase 285,714 shares of the Company's common stock.
XML 28 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOING CONCERN
9 Months Ended
Sep. 30, 2013
GOING CONCERN [Abstract]  
GOING CONCERN
NOTE 2 - GOING CONCERN

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.  The Company has incurred significant losses and experienced negative cash flow from operations during the development stage.  These conditions raise substantial doubt about the Company's ability to continue as a going concern.  The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Since inception, the Company has focused on developing and implementing its business plan.  The Company is paying salaries to management and has utilized offshore programmers on a work for hire basis to assist in developing the demonstration model. The Company believes that its existing cash resources will not be sufficient to sustain operations during the next twelve months.   The Company currently needs to generate revenue in order to sustain its operations.  In the event that the Company cannot generate sufficient revenue to sustain its operations, the Company will need to reduce expenses or obtain financing through the sale of debt and/or equity securities.  The issuance of additional equity would result in dilution to existing shareholders.  If the Company is unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms acceptable to the Company, the Company would be unable to execute upon the business plan or pay costs and expenses as they are incurred, which would have a material, adverse effect on the business, financial condition and results of operations.

The Company's current monetization model is to derive a percentage of all revenues generated by online merchants using the Virtual Piggy service. Merchants are billed at the end of each month for all transactions that have been processed by the Company on their behalf in the prior month.  As the merchant base and consumer base grows, and as the trend to higher online spending levels continues, the Company expects to generate additional revenue to support operations.

If sufficient revenues are not generated to sustain operations or additional funding cannot be obtained in the short term, the Company will need to reduce monthly expenditures to a level that will enable the Company to continue until such funds can be obtained.  The Company raised $6,070,595, net of stock issuance costs of $395,221 through a private placements of its equity securities from January 1, 2013 through September 30, 2013.
 
The Company also raised $185,000 from the exercise of options and $1,427,595 from the exercise of warrants during the nine months ended September 30, 2013.  

The Company is in the development stage at September 30, 2013.  Successful completion of the Company's development program, and the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities and achieving a level of sales adequate to support the Company's cost structure.  However, there can be no assurances that the Company will be able to secure additional equity investment or achieve an adequate sales level.  The Company's current cash is expected to sustain the Company through December 2013.
XML 29 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY (Details) (USD $)
9 Months Ended 12 Months Ended 68 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended 11 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended 1 Months Ended 2 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Dec. 31, 2012
Sep. 30, 2013
Jan. 31, 2012
December 2011 Private Placement [Member]
Dec. 31, 2011
December 2011 Private Placement [Member]
Mar. 31, 2012
December 2011 Private Placement [Member]
Apr. 30, 2012
April 5, 2012 Private Placement [Member]
Sep. 30, 2012
April 5, 2012 Private Placement [Member]
Apr. 30, 2012
April 2, 2012 Issuance [Member]
Apr. 30, 2012
April 10, 2012 Issuance [Member]
May 31, 2012
May 2, 2012 Issuance [Member]
Mar. 31, 2013
May 2, 2012 Issuance [Member]
May 31, 2012
May 2, 2012 Issuance [Member]
Warrant Type One [Member]
May 31, 2012
May 2, 2012 Issuance [Member]
Warrant Type Two [Member]
May 31, 2012
May 21, 2012 Issuance [Member]
May 31, 2012
May 25, 2012 Issuance [Member]
Aug. 31, 2012
July 5th, 2012 Issuance [Member]
Jul. 31, 2012
July 5th, 2012 Issuance [Member]
Jul. 31, 2012
July 5th, 2012 Issuance [Member]
Warrant Type One [Member]
Jul. 31, 2012
July 5th, 2012 Issuance [Member]
Warrant Type Two [Member]
Dec. 31, 2012
November and December 2012 Issuance [Member]
Dec. 31, 2012
December 2012 Issuance [Member]
Mar. 31, 2013
Q1 2013 Issuance [Member]
Apr. 30, 2013
April 15, 2013 Issuance [Member]
Apr. 30, 2013
April 15, 2013 Issuance [Member]
Restricted Stock [Member]
May 31, 2013
May 2013 Securities Purchase Agreement [Member]
May 31, 2013
May 2013 Securities Purchase Agreement [Member]
Warrant Type One [Member]
May 31, 2013
May 2013 Securities Purchase Agreement [Member]
Warrant Type Two [Member]
May 31, 2013
May 2013 Options Exercised [Member]
May 31, 2013
May 2013 Options Exercised Transaction One [Member]
May 31, 2013
May 2013 Options Exercised Transaction Two [Member]
May 31, 2013
May 2013 Options Exercised Transaction Three [Member]
Jun. 30, 2013
May and June 2013 Warrants Exercised [Member]
Jun. 30, 2013
May and June 2013 Warrants Exercised Transaction One [Member]
Jun. 30, 2013
May and June 2013 Warrants Exercised Transaction Two [Member]
Aug. 31, 2013
July and August 2013 Warrants Exercised [Member]
Equity Issued [Line Items]                                                                          
Issuance of shares of common stock, shares         178,572                     1,363,185                   26,521                      
Issuance of shares of common stock, value                               $ 3,312,537                   $ 49,071                      
Equity issuance, price or exercise price per security issued         $ 0.70 $ 0.80   $ 0.70   $ 0.85   $ 0.80       $ 2.43     $ 0.80     $ 0.70 $ 0.75 $ 0.75     $ 1.80       $ 0.04 $ 0.35 $ 0.75        
Proceeds from equity issuance             2,717,650         150,000           100,000       5,560,000 500,000 850,000                          
Units authorized         7,142,858 6,250,000                                                              
Shares per unit           2   2       2             2                                    
Warrants per unit           1   1                       1 1                                
Number of shares entitled by warrants           6,250,000   5,000,000           1 0.5         125,000 62,500             0.5 287,255                
Exercise price of warrants           0.50   0.50           0.50 1.00         0.50 1.00             3.00 1.80           0.04 0.50 0.50
Expected life           2 years   2 years           2 years 3 years         2 years 3 years       5 years                        
Equity issuance, number securities issued for cash           625,000 3,922,356   6,201,831 350,000 250,000 187,500         350,000   125,000     7,942,858 666,667 1,133,334     2,572,553 300,000     750,000 300,000 66,667        
Amount raised from private placement 6,070,595         500,000     4,341,282 297,500 10,000 850,000         14,000   100,000               4,836,157                    
Warrants issued         89,286                                                                
Proceeds from exercise of options 185,000 24,000   569,000                                                   185,000              
Warrants exercised                                                                     2,000,000 2,660,685 34,500
Proceeds from exercise of warrants 1,427,595      1,873,309                                                           1,330,342     17,250
Stock issuance costs including commisions 395,221 28,000   488,221     28,000                                 60,783                          
Common stock subscription      50,000                                                                     
Common stock authorized in private placement, value           5,000,000   3,500,000 4,000,000                                                        
Common stock authorized in private placement, shares           12,500,000   10,000,000                                                          
Warrants authorized in private placement           6,250,000                                                              
Cash payment for settlement     450,000             30,000                                                      
Value of shares covered in agreement                         1,000,000                                                
Options issued                                                 1,050,000                        
Fair value of issued equity                                                 519,080                        
Pricing model used in calculation of grant-date fair value                                                 Black-Scholes option pricing model                        
Dividend yield                                                                           
Expected volatility                                                 29.00%                        
Risk free interest rate                                                 0.69%                        
Vesting period                                                 3 years                        
Expiration period after issuance                                                 5 years                        
Placement agent fees                                                     151,408                    
Expense allowance                                                     $ 155,118                    
XML 30 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
OPERATING LEASES (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
OPERATING LEASES [Abstract]        
Total rent expense under leases $ 117,447 $ 54,640 $ 244,318 $ 113,389
EXCEL 31 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]F,3DX-CAF85\R-C,U7S0U.#)?.34T,E]D-#$V M83EB,&0P-#$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-534U!4EE?3T9?4TE'3DE&24-!3E1?04-#3U5.5#PO M>#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I%>&-E;%=O M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DE.0T]-15]405A%4SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DQ)5$E'051)3TY?4T545$Q%345.5#PO>#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E-43T-+2$],1$524U]%455) M5%D\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D]015)!5$E.1U],14%315,\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E-534U!4EE?3T9?4TE'3DE&24-!3E1?04-#3U5.5#$\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I% M>&-E;%=O#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-43T-+2$],1$524U]%455)5%E?1&5T86EL#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-43T-+7T]05$E/3E-?04Y$7U=!4E)!3E137TEN8SPO M>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D]015)!5$E.1U],14%315-?1&5T86EL#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)%3$%4141?4$%25%E?5%)!3E-!0U1)3TY37T1E=#PO M>#I.86UE/@T*("`@(#QX.E=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@ M(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T7V8Q.3@V.&9A7S(V,S5?-#4X,E\Y-30R7V0T M,39A.6(P9#`T,0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]F,3DX M-CAF85\R-C,U7S0U.#)?.34T,E]D-#$V83EB,&0P-#$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!2 M96=I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)U$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N(&]F("0S,RPR.34@86YD("0Q,RPV-S@\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPOF5D.R!N;VYE(&ES'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO MF5D.R`Q,3$L,S@V+#'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]F,3DX-CAF85\R-C,U7S0U.#)?.34T,E]D-#$V83EB M,&0P-#$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9C$Y.#8X9F%? M,C8S-5\T-3@R7SDU-#)?9#0Q-F$Y8C!D,#0Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R MF%T:6]N/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,S+#(Y-3QS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7)O;&P\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2`H1&5F:6-I="D@*%531"`D*3QB'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M2`Q M,2P@,C`P."!A="`D+C`P,2!P97(@'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2`R,#`X('1H'0^)SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO65E(&]P=&EO;G,@:7-S=65D(&9O'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5R8VES92!O9B!O<'1I;VYS(&]N($UA>2`X+"`R,#`X+"!A="`D+C`T M('!E'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO2!A;F0@=F%L=65D(&%T M("0N,#<@<&5R('-H87)E+"!V86QU97,\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO2!A;F0@=F%L=65D(&%T("0N,#$@<&5R('-H M87)E+"!V86QU97,\+W1D/@T*("`@("`@("`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`S,"P@ M,C`P.2!A="`D+C`T('!E'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO2`S,"P@,C`P.2!A="`D+C`T('!E'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO&5R8VES92!O M9B!W87)R86YT'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5R8VES92!O9B!W87)R86YT'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5R8VES92!O9B!W87)R86YT'0^)SQS<&%N/CPO&5R8VES92!O9B!O<'1I M;VYS(&]N($1E8V5M8F5R(#$P+"`R,#`Y(&%T("0N,#0@<&5R('-H87)E+"!V M86QU97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!O9B!W87)R86YT'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)SQS<&%N/CPO65E(&]P=&EO;G,@:7-S=65D(&9O'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5R8VES92!O9B!O<'1I;VYS(&]N($IA;G5A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2`R,BP@,C`Q,"!A="`D+C`T('!E'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO2`R,BP@ M,C`Q,"!A="`D+C`T('!E'0^)SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO&5R8VES92!O9B!W87)R86YT'0^)SQS<&%N/CPO&5R8VES92!O9B!W87)R86YT'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO2!T:')O=6=H($%U M9W5S="`R,#$P+"!V86QU97,\+W1D/@T*("`@("`@("`\=&0@8VQA2!T:')O=6=H($%U9W5S="`R,#$P+"!S:&%R97,\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4@870@)"XR,"!P97(@'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO&5R8VES92!O9B!O<'1I;VYS(&]N($1E8V5M8F5R(#(L(#(P,3`@870@)"XP M-"!P97(@'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5R8VES92!O9B!W87)R86YT'0^)SQS<&%N/CPO2!A;F0@=F%L M=65D(&%T("0N,#$@<&5R('-H87)E+"!V86QU97,\+W1D/@T*("`@("`@("`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`@("`@("`\ M=&0@8VQA'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO2`R-"P@ M,C`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`R-2P@,C`Q,B!A="`D+C`T('!E'0^)SQS<&%N/CPO65E(&]P=&EO;G,@:7-S=65D(&9O'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO2!T:')O=6=H($1E8V5M8F5R(#(P,3(L('9E2!A;F0@=F%L=65D(&9R;VT@)"XQ,2!T;R`D+CDU('!E'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO2`R,#$R('1H'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES M92!O9B!O<'1I;VYS(&%T("0P+C,U('!E'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5R8VES92!O9B!O<'1I;VYS(&%T("0P+C,U('!E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!O9B!O<'1I;VYS M(&%T("0P+C'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO2`R,#$S+"!S:&%R M97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS M<&%N/CPO&5R8VES92!O9B!W87)R86YT'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5R8VES92!O9B!W87)R86YT'0^)SQS<&%N/CPO&5R8VES M92!O9B!W87)R86YT'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2`R,#$S('1H2!T;R`S('EE87)S(&%N M9"!V86QU960@9G)O;2`D,"XP.2!T;R`D,2XV-B!P97(@'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2`H1&5F:6-I="D@ M*%!A65E($]P=&EO;G,@27-S=65D(&9O M&EM=6T@6TUE;6)E&EM=6T@6TUE;6)E&EM=6T@6TUE;6)E65E($]P=&EO M;G,@27-S=65D(&9O65E($]P=&EO;G,@27-S=65D(&9O65E($]P=&EO;G,@27-S=65D(&9O65E($]P=&EO;G,@27-S=65D(&9O65E($]P=&EO;G,@27-S=65D(&9O65E($]P=&EO;G,@27-S=65D(&9O65E($]P=&EO;G,@27-S=65D(&9O&5R8VES92!O9B!/<'1I;VYS M(%1R86YS86-T:6]N($]N92!;365M8F5R73QB&5R M8VES92!O9B!/<'1I;VYS(%1R86YS86-T:6]N($]N92!;365M8F5R73QB&5R8VES92!O9B!/<'1I;VYS(%1R86YS86-T:6]N($]N M92!;365M8F5R73QB2`S,2P@,C`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`@("`@("`\=&0@8VQA'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4@86YD(&%C M8W)U960@97AP96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO6UE;G0@;V8@;F]T92!P87EA8FQE("T@'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO&5S('!A:60\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@ M("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]F,3DX-CAF85\R-C,U7S0U.#)?.34T,E]D-#$V83EB,&0P-#$-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9C$Y.#8X9F%?,C8S-5\T-3@R M7SDU-#)?9#0Q-F$Y8C!D,#0Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4 M.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^($Y/5$4@ M,2`M(%-534U!4ED@3T8@4TE'3DE&24-!3E0@04-#3U5.5$E.1R!03TQ)0TE% M4SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF M>3L@5$585"U)3D1%3E0Z(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@5FER='5A;"!0:6=G>2P@26YC+B`H(G1H92!#;VUP86YY M(B!O2X@271S('-Y6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@5&AE(%9I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@:&%S('-E8W5R960@/&9O;G0@6UE;G0@<')O8V5S2!I3L@5$58 M5"U$14-/4D%424]..B!U;F1E3L@5$585"U)3D1%3E0Z(#!P="<^ M(%1H92!F:6YA;F-I86P@6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5-464Q% M.B!I=&%L:6,[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$58 M5"U$14-/4D%424]..B!U;F1E'0M86QI9VXZ(&IU6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D]. M5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051)3TXZ M('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^($-O;7!R96AE;G-I=F4@ M26YC;VUE/"]D:78^(#QD:78@'0M86QI M9VXZ(&IU2!F M;VQL;W=S($9!4T(@05-#(#(R,"!I;B!R97!O2!H87,@;F]T(&)E M96X@2!H87,@;F\@:71E;7,@ M;V8@;W1H97(@8V]M<')E:&5N3L@5$585"U$14-/4D%424]..B!U;F1E M6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE M($-O;7!A;GDF(S,Y.W,@9FEN86YC:6%L(&EN'!E;G-E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4 M+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@5&AE($-O;7!A;GD@;6%Y(&AA=F4@9&5P;W-I=',@=VET:"!A(&9I;F%N M8VEA;"!I;G-T:71U=&EO;B!W:&EC:"!A="!T:6UE&-E960@1F5D97)A M;"!$97!O6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D]. M5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051)3TXZ M('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^($-A7,@;W(@;&5S M'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@4')O<&5R='D@86YD(&5Q=6EP;65N M="!A2!I;7!A:7)M96YT(&QO'!E;F1I='5R97,@9F]R(&YE=R!E<75I<&UE;G0@86YD(&UA:F]R(&5X<&5N M9&ET=7)E2!R97!A:7(@86YD(&UA:6YT96YA M;F-E(&-O'!E;G-E9"!A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GDF M(S,Y.W,@9&5P6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0G/B`\ M=&%B;&4@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9#L@5$585"U!3$E'3CH@8V5N=&5R)R!V86QI9VX],T1T;W`@=VED=&@],T0Q M,"4^(#QD:78@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI M9VXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!415A4+4%,24=..B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B`F;F)S<#LS("T@-3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@1G5R;FET=7)E(&%N9"!F:7AT=7)E3L@ M5$585"U$14-/4D%424]..B!U;F1E2!O9B!,;VYG+4QI=F5D($%S6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@ M5$585"U)3D1%3E0Z(#!P="<^($EN8V]M92!487AE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@9F]L;&]W&5S M+B9N8G-P.R9N8G-P.T1E9F5R2!D:69F97)E;F-E'!E8W1E9"!T;R!A9F9E8W0@=&%X86)L92!I M;F-O;64N)FYB"!E>'!E;G-E(&ES('1H92!T87@@ M<&%Y86)L92!O65A&%M:6YA=&EO;B!B>2!M86IO'0M86QI9VXZ(&IU3L@5$585"U$14-/4D%424]..B!U M;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@9F]L;&]W3L@5$585"U$14-/4D%424]..B!U;F1E6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@0V5R=&%I;B!A;6]U M;G1S(&EN('1H92`R,#$R(&9I;F%N8VEA;"!S=&%T96UE;G1S(&AA=F4@8F5E M;B!R96-L87-S:69I960@:6X@;W)D97(@9F]R('1H96T@=&\@8F4@:6X@8V]N M9F]R;6ET>2!W:71H('1H92`R,#$S('!R97-E;G1A=&EO;BX\+V1I=CX@/"$M M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P M="<^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`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`D-BPP-S`L-3DU+"!N970@;V8@'0M86QI9VXZ(&IU2!A;'-O(')A:7-E9"`D,3@U+#`P,"!F&5R8VES92!O9B!O<'1I;VYS(&%N9"`D,2PT,C6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&IU2!I28C,SD[2!I;G9E6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@5&AE($-O;7!A;GDF(S,Y.W,@8W5R7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO M;F%L+F1T9"(@+2T^/&1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@5$585"U)3D1%3E0Z(#!P="<^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z(#!P M="<^(%1H92!#;VUP86YY(&-O;G1I;G5E2!F;W(@<&%T96YT M2P@8V]S=',@87-S;V-I871E9"!W M:71H('1H92!R96=I65A'!E;G-E(&9O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SPA+2U$3T-465!%(&AT;6P@4%5" M3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@ M(FAT='`Z+R]W=W&AT;6PQ+71R86YS M:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&IU6%B;&4@:6X@=&AE(&%M;W5N="!O9B`D-3`L M,#`P(&1U92!.;W9E;6)E2!C;VUP;&5T960@=&AE('!R:79A=&4@<&QA8V5M96YT(&%N9"!R M86ES960@)#4P,"PP,#`N)FYB2!O9B`S.2XX)2!T;R`V,BXX)2P@'!E8W1E9"!O<'1I M;VX@;&EF92!O9B`Q+C(@>65A6QE/3-$)T9/3E0M4U193$4Z(&ET M86QI8SL@1$E34$Q!63H@:6YL:6YE)SY296-O9VYI=&EO;CPO9F]N=#X@86YD M('=E65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@3VX@1F5B2P@;V8@=&AE(&YO=&5S M('!A>6%B;&4@=V5R92!R97!A:60N)FYB7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T M9"(@+2T^/&1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$58 M5"U)3D1%3E0Z(#!P="<^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ M(&IU6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M26YC;VUE('1A>"!E>'!E;G-E('=AF5D('1A>"!B96YE9FET MF5D('1A>"!B96YE9FET7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO&AT;6PQ+T141"]X:'1M;#$M M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/"$M+5-T87)T1G)A9VUE M;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.3U1% M(#8@+2!,251)1T%424].(%-%5%1,14U%3E0\+V1I=CX@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@1&5C96UB97(@,C`Q,BP@=&AE M($-O;7!A;GD@96YT97)E9"!I;G1O(&$@2!T:&4@0V]M<&%N>2!W;W5L9"!P M87D@=&AE(&EN=F5S=&]R("0T-3`L,#`P(&EN(')E='5R;B!F;W(@=&AE(&EN M=F5S=&]R(')E='5R;FEN9R!W87)R86YT2`R,#$S+CPO9&EV/B`\(2TM16YD1G)A9VUE;G0M M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`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`M(%-43T-+2$],1$52 M4R8C,SD[($5154E463PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!C;VUM M96YC960@82!P3L@5$585"U)3D1%3E0Z(#!P="<^($]N($%P28C,SD[2!S;VQD(#8L,C`Q+#@S M,2!U;FET3L@5$585"U)3D1%3E0Z(#!P="<^($]N($%P2X@ M26X@8V]N;F5C=&EO;B!W:71H('1H92!S971T;&5M96YT+"!T:&4@0V]M<&%N M>2!M861E(&$@28C,SD[3L@5$585"U)3D1%3E0Z M(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@07!R M:6P@,3`L(#(P,3(L(&$@8V]M<&%N>2!O=VYE9"!B>2!T:&4@4V5C&5R8VES960@;W!T:6]N M3L@5$585"U)3D1%3E0Z(#!P="<^($]N($UA>2`R+"`R,#$R M+"!T:&4@0V]M<&%N>2!E;G1E2!I&5R8VES92!P65A'0M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z(#!P="<^($]N($UA M>2`R,2P@,C`Q,BP@=&AE($-O;7!A;GD@:7-S=65D(&9I=F4@8V]N6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M8G(@+SX@/"]D:78^(#QD:78@'0M86QI M9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@3VX@2G5L>2`U+"`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`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y M.R!415A4+4E.1$5.5#H@,'!T)SX@1'5R:6YG($UA>2`R,#$S+"!O<'1I;VYS M('1O('!U&5R8VES960@870@)#`N-S4L(')E6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@1'5R:6YG($UA>2!A;F0@2G5N92`R,#$S+"!W87)R86YT6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y M.R!415A4+4E.1$5.5#H@,'!T)SX@1'5R:6YG($IU;'D@86YD($%U9W5S="`R M,#$S+"!W87)R86YT'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SPA+2U$ M3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A M;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@1'5R M:6YG(#(P,#@L('1H92!";V%R9"!O9B!$:7)E8W1O2!IF5D('1O(&=R86YT(&]P=&EO;G,@ M=&\@<'5R8VAA2!O9F9I8V5R+"!O=&AE65E2!A6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P M="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@1'5R:6YG(#(P M,3,L($)O87)D(&%D;W!T960@=&AE(#(P,3,@17%U:71Y($EN8V5N=&EV92!0 M;&%N("@B,C`Q,R!0;&%N(BDN)FYB2!3=&]C:R!/<'1I;VYS+B9N8G-P.R9N8G-P.T%S M(&]F(%-E<'1E;6)E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@ M,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!T:&4@0F]A6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@ M8V]N;F5C=&EO;B!W:71H($EN8V5N=&EV92!3=&]C:R!/<'1I;VYS+"!T:&4@ M97AE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y M.R!415A4+4E.1$5.5#H@,'!T)SX@5F]L871I;&ET>2!I;B!A;&P@:6YS=&%N M8V5S('!R97-E;G1E9"!I28C,SD[2X\+V1I=CX@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^ M/&)R("\^(#PO9&EV/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@1F5B28C,SD[2!U'!E8W1E9"!V;VQA=&EL:71Y(&]F(#(U+C`E+"!R:7-K M(&9R964@:6YT97)E65A65A6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@ M/"]D:78^(#QD:78@'0M86QI9VXZ(&IU M2!I2!U'!E8W1E9"!V;VQA=&EL:71Y(&]F(#(U+CDE+"!R:7-K(&9R964@:6YT M97)E65A65A28C,SD[2!U'!E8W1E9"!V;VQA=&EL:71Y(&]F(#(U+C`E+"!R:7-K(&9R M964@:6YT97)E65A65A6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P M="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@2G5N92`R,#$R+"!T:&4@0V]M M<&%N>2!I6EE;&0L(&5X<&5C=&5D('9O;&%T:6QI='D@;V8@ M,S`N,R4@=&\@,S4N-24L(')I'!I65A6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU28C,SD[2!O9B`S,BXY)2P@'!I M65A3L@5$585"U)3D1%3E0Z(#!P="<^($EN($%U9W5S="`R,#$R+"!T:&4@0V]M M<&%N>2!I&5R8VES92!P'!I65A3L@5$585"U)3D1%3E0Z(#!P="<^($EN(%-E<'1E;6)E M2!I65E(&]P=&EO M;G,@=&\@<'5R8VAA28C M,SD[2!U'!E8W1E9"!V;VQA=&EL:71Y(&]F M(#(T+C4E+"!R:7-K(&9R964@:6YT97)E'!E8W1E9"!O<'1I;VX@;&EF92!O9B!F:79E('EE87)S+B9N8G-P.R9N8G-P M.U1H92!O<'1I;VYS(&5X<&ER92!F:79E('EE87)S(&9R;VT@=&AE(&1A=&4@ M;V8@:7-S=6%N8V4N)FYB'!E;G-E9"!O=F5R('1H92!T:')E92!Y96%R('9E6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`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`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@36%R8V@@ M,C`P."P@=&AE($-O;7!A;GD@:7-S=65D(&]P=&EO;G,@=&\@<'5R8VAA'!I&5R8VES960@ M;W!T:6]N6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD M:78@'0M86QI9VXZ(&IU2!B971W965N(#(S+C,E(&%N9"`R-BXQ)2P@'!E8W1E9"!O<'1I;VX@;&EF92!O9B!F:79E('EE87)S+B9N8G-P.R9N8G-P M.U1H92!O<'1I;VYS(&5X<&ER92!F:79E('EE87)S(&9R;VT@=&AE(&1A=&4@ M;V8@:7-S=6%N8V4N)FYB'!E;G-E9"!O=F5R('1H92!T:')E92!Y96%R('9E6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@26X@07!R:6P@,C`Q,RP@=&AE($-O;7!A;GD@:7-S=65D(&%N M(&5M<&QO>65E(&]P=&EO;G,@=&\@<'5R8VAA2!O9B`R-2XS)2P@'!I65A3L@5$585"U)3D1% M3E0Z(#!P="<^($EN($UA>2`R,#$S+"!T:&4@0V]M<&%N>2!I65E&5R8VES92!P2!U'!E8W1E9"!V;VQA=&EL:71Y(&]F(#(S M+C4E('1O(#(U+C,E+"!R:7-K(&9R964@:6YT97)E65A M65A6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU&5R8VES92!P'!E8W1E9"!O<'1I;VX@;&EF92!O9B!F:79E('EE87)S+B9N8G-P.R9N8G-P M.U1H92!O<'1I;VYS(&5X<&ER92!F:79E('EE87)S(&9R;VT@=&AE(&1A=&4@ M;V8@:7-S=6%N8V4N)FYB'!E;G-E9"!O=F5R('1H92!T:')E92!Y96%R('9E'0M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z M(#!P="<^($EN($%U9W5S="`R,#$S+"!T:&4@0V]M<&%N>2!I&5R8VES92!P6EE;&0L(&5X<&5C=&5D('9O;&%T:6QI='D@;V8@ M,C0N,B4@=&\@,S`N,R4L(')I'!E8W1E9"!O<'1I;VX@;&EF92!O9B!F:79E M('EE87)S+B9N8G-P.R9N8G-P.U1H92!O<'1I;VYS(&5X<&ER92!F:79E('EE M87)S(&9R;VT@=&AE(&1A=&4@;V8@:7-S=6%N8V4N)FYB'!E;G-E9"!O=F5R('1H92!T:')E92!Y96%R M('9E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,'!T)SX@26X@4V5P=&5M8F5R(#(P,3,L('1H92!#;VUP86YY(&ES M2!U'!E8W1E9"!V;VQA=&EL:71Y(&]F(#(Q+C@E M+"!R:7-K(&9R964@:6YT97)E'!I65A3L@5$585"U)3D1%3E0Z(#!P="<^($-U;75L871I=F5L M>2!A;F0@9F]R('1H92!T:')E92!A;F0@;FEN92!M;VYT:',@96YD960@4V5P M=&5M8F5R(#,P+"`R,#$S+"!T:&4@0V]M<&%N>2!E>'!E;G-E9"`D,2PT-#8L M-S@S+"`D,C$P+#,X,"!A;F0@)#4T-BPW-S8@86YD(&9OF5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E M(')E;&%T960@=&\@96UP;&]Y964@;F]N+79E6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`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`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!%>&5R8VES93PO9&EV/B`\ M+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G M/B!3:&%R97,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT M97([(%1%6%0M24Y$14Y4.B`P<'0G/B!0#L@5$585"U!3$E'3CH@;&5F M="<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^)"XP-"!T;R`D+CDP/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^,"XQ.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`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`P<'0G M/B!'6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`Q,'!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XU,#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^,"XP,3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^/&9O;G0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B!296-L87-S:69I960@9G)O;2!N;VXM96UP;&]Y964\+V1I=CX@/"]T9#X@ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XP M-#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`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`P<'0G/B!/=71S=&%N9&EN9RP@1&5C96UB97(@,S$L M(#(P,3(\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1&QE9G0^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`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`P<'0G/B!'6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M17AE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U) M3D1%3E0Z(#!P="<^(#`N,#0@=&\@,"XW-3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@17AP:7)E9"]T97)M:6YA=&5D/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`] M,T1N;W=R87`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`Q M,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($]U='-T86YD:6YG M+"!397!T96UB97(@,S`L(#(P,3,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`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`Q,'!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($5X97)C:7-A8FQE+"!397!T96UB M97(@,S`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`T<'@@9&]U8FQE.R!$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@2F%N=6%R>2`R+"`R,#$R+"!T:&4@ M0V]M<&%N>2!I28C,SD[2!U'!E M8W1E9"!V;VQA=&EL:71Y(&]F(#(Y+C(E+"!R:7-K(&9R964@:6YT97)E'!E8W1E9"!O<'1I;VX@;&EF92!O9B!F:79E M('EE87)S+B9N8G-P.R9N8G-P.U1H92!O<'1I;VYS(&5X<&ER92!F:79E('EE M87)S(&9R;VT@=&AE(&1A=&4@;V8@:7-S=6%N8V4N)FYB'!E;G-E9"!W:&5N('1H92!S97)V:6-E(&ES M('!R;W9I9&5D+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB'0M86QI9VXZ(&IU2!I28C,SD[2!O9B`R."XP)2P@'!I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU6EE;&0L(&5X<&5C=&5D('9O M;&%T:6QI='D@;V8@,S$N,B4L(')I'!E8W1E9"!O<'1I;VX@;&EF92!O9B!F:79E('EE87)S M+B9N8G-P.R9N8G-P.U1H92!O<'1I;VYS(&5X<&ER92!F:79E('EE87)S(&9R M;VT@=&AE(&1A=&4@;V8@:7-S=6%N8V4N)FYB3L@5$585"U)3D1%3E0Z(#!P="<^($]N($%P2!O9B`S,2XR)2P@65A M65A3L@5$585"U) M3D1%3E0Z(#!P="<^($EN($UA>2`R,#$R+"!T:&4@0V]M<&%N>2!I&5R8VES92!P2!O9B`S,2XR)2P@'!I6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!U'!E8W1E9"!V;VQA=&EL:71Y(&]F(#(Y+C,E+"!R:7-K(&9R M964@:6YT97)E'!E8W1E9"!O<'1I;VX@ M;&EF92!O9B!F:79E('EE87)S+B9N8G-P.R9N8G-P.U1H92!O<'1I;VYS(&5X M<&ER92!F:79E('EE87)S(&9R;VT@=&AE(&1A=&4@;V8@:7-S=6%N8V4N)FYB M'!E;G-E9"!W:&5N('1H M92!S97)V:6-E3L@5$585"U)3D1%3E0Z(#!P="<^($EN($%U9W5S="`R,#$R+"!T:&4@0V]M M<&%N>2!I&5R8VES92!P2!O9B`R-RXQ)2!T;R`S,"XU)2P@'!E8W1E M9"!O<'1I;VX@;&EV97,@;V8@9G)O;2!T=V\@=&\@9FEV92!Y96%R'!I65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@26X@4V5P=&5M8F5R(#(P,3(L('1H92!#;VUP86YY M(&ES28C,SD['!I'!E;G-E9"!W:&5N('1H92!S97)V M:6-E(&ES('!R;W9I9&5D+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P M.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@3V-T;V)E2!I28C,SD[2!O9B`R,RXU)2P@3L@5$585"U)3D1%3E0Z(#!P="<^($EN($YO=F5M8F5R(#(P,3(L('1H M92!#;VUP86YY(&ES&5R8VES92!P M2!U'!E8W1E9"!V M;VQA=&EL:71Y(&]F(#(V+C$E+"!R:7-K(&9R964@:6YT97)E'!E8W1E9"!O<'1I;VX@;&EF92!O9B!F:79E('EE87)S M+B9N8G-P.R9N8G-P.U1H92!O<'1I;VYS(&5X<&ER92!F:79E('EE87)S(&9R M;VT@=&AE(&1A=&4@;V8@:7-S=6%N8V4N)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,3`N,7!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@1&5C M96UB97(@,C`Q,BP@=&AE($-O;7!A;GD@:7-S=65D(&$@;65R8VAA;G0@=V%R M6EE;&0L(&5X<&5C=&5D('9O M;&%T:6QI='D@;V8@,C0N-R4L(')I'!E;G-E9"!I;6UE9&EA=&5L>2XF;F)S<#LF;F)S<#M4:&4@=V%R M65A6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@26X@2F%N=6%R>2`R,#$S+"!T:&4@0V]M<&%N>2!I&5R8VES92!P M'!E8W1E9"!V;VQA M=&EL:71Y(&]F(#(S+C,E+"!R:7-K(&9R964@:6YT97)E'!E8W1E9"!O<'1I;VX@;&EF92!O9B!F:79E('EE87)S+B9N M8G-P.R9N8G-P.U1H92!O<'1I;VYS(&5X<&ER92!F:79E('EE87)S(&9R;VT@ M=&AE(&1A=&4@;V8@:7-S=6%N8V4N)FYB'!E;G-E9"!O=F5R('1H92!T97)M(&]F('1H92!A9W)E96UE M;G0N/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^ M($EN($UA&5R8VES92!P M2!O9B`R,BXV)2!A;F0@,C4N-24L(')I6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&IU2!I2!O9B`R-BXU)2P@'!I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!U'!E8W1E9"!V;VQA=&EL:71Y(&]F(#(S+C$E M('1O(#(S+C(E+"!R:7-K(&9R964@:6YT97)E'!I'!E;G-E9"!O=F5R('1H92!T97)M(&]F('1H92!A9W)E96UE M;G0N/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!O9B`R,RXT)2!T;R`R,RXW)2P@65A3L@5$585"U)3D1% M3E0Z(#!P="<^($EN($IU;'D@,C`Q,RP@=&AE($-O;7!A;GD@:7-S=65D('1W M;R!C;VYS=6QT86YT2!U'!E8W1E9"!V;VQA M=&EL:71Y(&]F(#(S+C@E('1O(#(V+C8E+"!R:7-K(&9R964@:6YT97)E'!I M'!E;G-E9"!I;6UE9&EA=&5L>2X\+V1I M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z M(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@4V5P M=&5M8F5R(#(P,3,L('1H92!#;VUP86YY(&ES28C,SD[2!U'!E8W1E9"!V;VQA=&EL M:71Y(&]F(#(R+C$E+"!R:7-K(&9R964@:6YT97)E'!I6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M;W9E3L@5$585"U) M3D1%3E0Z(#!P="<^($-U;75L871I=F5L>2!A;F0@9F]R('1H92!T:')E92!A M;F0@;FEN92!M;VYT:',@96YD960@4V5P=&5M8F5R(#,P+"`R,#$S(&%N9"`R M,#$R+"!T:&4@0V]M<&%N>2!E>'!E;G-E9"`D,2PX,#,L.#0Y+"`D-C@W+#(R M.2!A;F0F;F)S<#LD.#$X+#8Q.2!A;F0@9F]R('1H92!T:')E92!A;F0@;FEN M92!M;VYT:',@96YD960@4V5P=&5M8F5R(#,P+"`R,#$R('1H92!#;VUP86YY M(&5X<&5NF5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E(')E;&%T M960@=&\@;F]N+79E'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I M=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@/'1A8FQE('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P M,"4^(#QT6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4 M.B`P<'0G/B!796EG:'1E9"!!=F5R86=E/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT M97([(%1%6%0M24Y$14Y4.B`P<'0G/B!/<'1I;VXO5V%R'0M86QI9VXZ(&-E;G1E6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO M=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N M=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@4VAA6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!0#L@5$58 M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O M;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@ M4')I8V4\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`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`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^)#`N,#0@=&\@)#(N,S`\+W1D M/B`\=&0@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@ M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XW-CPO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`P<'0G/B!'6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M/C`N,3(\+W1D/B`\=&0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!)6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M/C`N,S@\+W1D/B`\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M/B@X,3`L,#`P/"]T9#X@/'1D('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@;F]W'0M86QI9VXZ(')I9VAT.R!4 M15A4+4E.1$5.5#H@,'!T)SX@,"XU,"!T;R`P+C6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M/BT\+W1D/B`\=&0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B!%>&5R8VES960\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@17AP M:7)E9#PO9&EV/B`\+W1D/B`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`Q+C`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`P<'0G/B!/=71S=&%N9&EN9RP@ M1&5C96UB97(@,S$L(#(P,3(\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M/C`N-C,\+W1D/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P="<^(#`N-3`@=&\@,RXR.#PO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M/C$L-S(S+#4S,SPO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4 M+4E.1$5.5#H@,'!T)SX@,2XX,"!T;R`S+C`P/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!296-L87-S M:69I960@9G)O;2!E;7!L;WEE92P@;F5T/"]D:78^(#PO=&0^(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@,"XU,"!T;R`R+C,P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^ M("XS-2!T;R`N-3`\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@17AP:7)E9"]#86YC96QL960\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT^*#$L-#`U+#`P,#PO=&0^(#QT9"!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#XI/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,"XU,"!T;R`Q+C`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`P<'0G M/B!/=71S=&%N9&EN9RP@4V5P=&5M8F5R(#,P+"`R,#$S/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,34L.#0S+#4S-CPO=&0^(#QT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`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`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($5X97)C M:7-A8FQE+"!397!T96UB97(@,S`L(#(P,3,\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B`F;F)S<#LF;F)S<#M%>&5R8VES86)L92P@4V5P=&5M8F5R M(#,P+"`R,#$S("AY96%R6QE/3-$)U!! M1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`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`@("`\=&%B;&4@8VQA M'0^ M)SQS<&%N/CPO'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!8 M2%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD M:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB'0M86QI9VXZ(&IU2!W87,@;V)L M:6=A=&5D('5N9&5R('9A6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(&%R:6%L.R!415A4+4%, M24=..B!C96YT97(G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@ M=VED=&@],T0T,"4^(#QT'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,SPO M9&EV/B`\+W1D/B`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`Q-3PO9&EV/B`\+W1D M/B`\=&0@"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,C(E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0T,R4^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T M9"(@+2T^/&1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$58 M5"U)3D1%3E0Z(#!P="<^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.3U1%(#$P("T@4D5,051%1"!0 M05)462!44D%.4T%#5$E/3E,\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P M.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@1G)O;2!I;F-E<'1I;VX@=&AR M;W5G:"!$96-E;6)E2!U=&EL:7IE9"!O M9F9I8V5S(&QE87-E9"!B>2!A9F9I;&EA=&5S(&]F(&-E6QE M/3-$)W1E>'0M86QI9VXZ(&IU2P@=V%S M('!A:60@9F]R(&-O;G-U;'1I;F<@86YD('1R879E;"!E>'!E;G-E2!T:&4@0V]M<&%N>2!W;W5L9"!P87D@=&AE(&-O;G-U;'1A;G0@)#$R M+#4P,"!P97(@;6]N=&@@8F5G:6YN:6YG($IA;G5A'!E;G-E3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@1'5R:6YG('1H92!T:')E92!A;F0@;FEN92!M;VYT:',@ M96YD960@4V5P=&5M8F5R(#,P+"`R,#$S(&%N9"`R,#$R+"!A(&UA2!A;F0@:&ES('-P;W5S92!W87,@<&%I9"`D,"!A;F0@)#$T+#4V,"!R97-P M96-T:79E;'DN/"]D:78^(#PA+2U%;F1&'1087)T7V8Q M.3@V.&9A7S(V,S5?-#4X,E\Y-30R7V0T,39A.6(P9#`T,0T*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B]F,3DX-CAF85\R-C,U7S0U.#)?.34T,E]D M-#$V83EB,&0P-#$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\(2TM4W1A6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U7 M14E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051)3TXZ('5N M9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^($)A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE(&9I;F%N8VEA;"!S M=&%T96UE;G1S(&%R92!P6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z M(&ET86QI8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+41%0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^(%5S M92!O9B!%3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!P M2!A8V-E M<'1E9"!I;B!T:&4@56YI=&5D(%-T871E'!E;G-E'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O M+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B M("TM/CQD:78^(#QD:78@'0M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY(&9O M;&QO=W,@1D%30B!!4T,@,C(P(&EN(')E<&]R=&EN9R!C;VUPF5D(&EN('1H92!C86QC=6QA=&EO;B!O9B!N970@:6YC;VUE M+B9N8G-P.R9N8G-P.U-I;F-E('1H92!#;VUP86YY(&AA6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET M86QI8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41% M0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^($9A:7(@ M5F%L=64@;V8@1FEN86YC:6%L($EN'0M86QI9VXZ(&IU28C,SD[&EM871E(&9A:7(@=F%L=64L(&)E8V%U6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U714E'2%0Z(&)O;&0[ M($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051)3TXZ('5N M9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^($-A3L@5$585"U)3D1%3E0Z(#!P="<^($9O7,@;W(@;&5S6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\(2TM4W1A3L@5$585"U)3D1% M3E0Z(#!P="<^(%!R;W!E'!E;F1I='5R97,@9F]R(&5X M:7-T:6YG(&5Q=6EP;65N="!A3L@ M5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY)B,S.3MS(&1E<')E8VEA M=&EO;B!A;F0@86UOF%T:6]N('!O;&EC:65S(&]N('!R;W!E6QE/3-$)TU!4D=)3BU, M1494.B`S-G!T.R!T97AT+6%L:6=N.B!L969T)SX@/'1A8FQE('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(&%R:6%L)R!C96QL6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)R!V M86QI9VX],T1T;W`@=VED=&@],T0Q,"4^(#QD:78@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB'0M86QI9VXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!C M96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#LS("T@-3PO9&EV/B`\ M+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@1G5R;FET=7)E M(&%N9"!F:7AT=7)E6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\(2TM4W1A M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U714E'2%0Z(&)O;&0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1% M3E0Z(#!P="<^(%)E8V]V97)A8FEL:71Y(&]F($QO;F'0M86QI9VXZ(&IU M6EN9R!A;6]U;G0@;V8@86X@87-S970@ M;6%Y(&YO="!B92!F=6QL>2!R96-O=F5R86)L92!O6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M5&AE($-O;7!A;GD@9&5T97)M:6YE6EN9R!A;6]U;G0@;V8@=&AE(&%S6EN9R!A;6]U;G0@;V8@=&AE(&QO;F6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,'!T)SX@1F]R('1H92!N:6YE(&UO;G1H('!E2!A M;F0@97%U:7!M96YT(&%N9"!P871E;G1S(&%N9"!T'0^)SPA M+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@ M5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78@ M'0M86QI M9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@26X@86-C;W)D86YC92!W:71H(%-E8W5R:71I97,@ M86YD($5X8VAA;F=E($-O;6UI2!W:6QL(')E8V]G;FEZ92!R979E;G5E('=H96X@*&DI M('!E&ES=',@;W(@86-C97!T86YC92!O8V-UFEN9R!6:7)T=6%L(%!I9V=Y('!A>6UE;G0@;65T:&]D(&%T(&-H M96-K;W5T+CPO9&EV/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\(2TM4W1A6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U714E'2%0Z(&)O M;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@ M5$585"U)3D1%3E0Z(#!P="<^($EN8V]M92!487AE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1% M3E0Z(#!P="<^($QO'0M86QI9VXZ(&IU2!F;VQL;W=S($9!4T(@05-#(#(V,"!W:&5N(')E M<&]R=&EN9R!E87)N:6YG6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@ M1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051) M3TXZ('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^(%-T87)T+75P($-O M'0M86QI9VXZ M(&IU'!E;G-E9"!A&AT;6PQ+T14 M1"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/"$M+5-T M87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5-464Q%.B!I=&%L:6,[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M:G5S=&EF>3L@5$585"U$14-/4D%424]..B!U;F1E'!E;G-E9"!W:&5N(&EN8W5R2!! M9&]P=&5D($%C8V]U;G1I;F<@4')O;F]U;F-E;65N=',@86YD(%)E8V5N=&QY M($ES'0^)SPA+2U$3T-4 M65!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I M=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78@'0M86QI9VXZ(&IU M'0M86QI M9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU M'0M86QI9VXZ(&IU2!I&AT;6PQ+T141"]X M:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/"$M+5-T87)T M1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5-464Q%.B!I=&%L:6,[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@0V5R=&%I;B!A;6]U;G1S(&EN('1H92`R,#$R(&9I;F%N8VEA;"!S=&%T M96UE;G1S(&AA=F4@8F5E;B!R96-L87-S:69I960@:6X@;W)D97(@9F]R('1H M96T@=&\@8F4@:6X@8V]N9F]R;6ET>2!W:71H('1H92`R,#$S('!R97-E;G1A M=&EO;BX\+V1I=CX@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS M<&%N/CPO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO M6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4 M+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB3L@5$585"U) M3D1%3E0Z(#!P="<^($-O;7!U=&5R(&5Q=6EP;65N=#PO9&EV/B`\+W1D/B`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`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`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E M;G1E6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5. M5#H@,'!T)SX@4VAA6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([ M(%1%6%0M24Y$14Y4.B`P<'0G/B!0#L@5$585"U!3$E'3CH@;&5F="<@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&YO=W)A M<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@4')I8V4\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0G/B!/=71S=&%N9&EN9RP@1&5C96UB97(@,S$L(#(P,3$\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$ M;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/B9N8G-P.SPO=&0^(#QT9"!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@1W)A;G1E9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M/C8L-S,P+#`P,#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M)SX@,"XU,"!T;R`Q+C@R/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M/C`N M,S0\+W1D/B`\=&0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!)6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^-3`P+#6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`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`P+C6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M/BT\+W1D/B`\=&0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`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`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@17AP:7)E9#PO9&EV/B`\+W1D/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3W5T6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@ M+C`T('1O(#$N.#(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@1W)A;G1E9#PO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M/C(L.#`R+#4P,#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4 M+4E.1$5.5#H@,'!T)SX@,"XY.2!T;R`R+CDR/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M/C`N,C8\+W1D/B`\=&0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!296-L87-S:69I M960F;F)S<#MT;R!N;VXM96UP;&]Y964L(&YE=#PO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M/B@R,S4L,#`P/"]T9#X@/'1D M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@;F]W'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,"XU,"!T;R`R+C,P/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M/C`N,#(\+W1D/B`\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M/B@R+#@Q-BPV-C<\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($5X<&ER960O=&5R;6EN871E9#PO M9&EV/B`\+W1D/B`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`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`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`P<'0G/B!/=71S M=&%N9&EN9RP@4V5P=&5M8F5R(#,P+"`R,#$S/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[ M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^,38L-S8T+#0W-SPO=&0^(#QT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^)"XP-"!T;R`D M,BXT,#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`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`P<'0G/B!%>&5R8VES86)L92P@ M4V5P=&5M8F5R(#,P+"`R,#$S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`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`P<'0G/B!796EG:'1E M9"!!=F5R86=E(%)E;6%I;FEN9R!,:69E+#PO9&EV/B`\+W1D/B`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`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("9N M8G-P.R9N8G-P.T5X97)C:7-A8FQE+"!397!T96UB97(@,S`L(#(P,3,@*'EE M87)S*3PO9&EV/B`\+W1D/B`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`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$ M14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/"$M+45N9$9R86=M96YT+2T^/"]D M:78^(#PO9&EV/CQS<&%N/CPO2!O9B!.;VXM16UP;&]Y964@4W1O8VL@3W!T M:6]N6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@ M,'!T)SX\(2TM4W1A6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE M(&9O;&QO=VEN9R!T86)L92!S=6UM87)I>F5S(&YO;BUE;7!L;WEE92`H97AC M;'5D:6YG(&EN9&5P96YD96YT(&)O87)D(&UE;6)E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!%>&5R8VES M93PO9&EV/B`\+W1D/B`\=&0@"<@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$ M14Y4.B`P<'0G/B!3:&%R97,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!! M1$1)3D'0M86QI9VXZ(&-E;G1E M6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`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`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z M(#!P="<^(#`N,S4@=&\@,BXQ-SPO9&EV/B`\+W1D/B`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`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M/C$Q+#DV-RPQ-3(\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^ M(#`N-3`@=&\@,2XP,#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@4F5C;&%S65E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1L M969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^*3PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG M;CTS1&QE9G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XP-#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)U!!1$1)3D'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!%>'!I6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M/C$V+#4S,2PT,S@\+W1D/B`\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!4 M15A4+4%,24=..B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#`N,S4@=&\@ M,BXS,#PO9&EV/B`\+W1D/B`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`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@1W)A;G1E9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M/C$L-S4S+#6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@,"XU,"!T;R`S+C(X/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@27-S=65D('5N9&5R(%!R M:79A=&4@4&QA8V5M96YT/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M/C`N M,S`\+W1D/B`\=&0@65E+"!N970\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)R!V86QI9VX],T1B;W1T;VT^(#QD:78@'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!%>&5R8VES960\+V1I=CX@/"]T9#X@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@;F]W'0M M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+C,U('1O("XU,#PO M9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!%>'!I"<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$;&5F=#X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`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`Q M,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($]U='-T86YD:6YG M+"!397!T96UB97(@,S`L(#(P,3,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B9N8G-P M.SPO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`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`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`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`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`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("9N M8G-P.R9N8G-P.T5X97)C:7-A8FQE+"!397!T96UB97(@,S`L(#(P,3,@*'EE M87)S*3PO9&EV/B`\+W1D/B`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`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$ M14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/"$M+45N9$9R86=M96YT+2T^/"]D M:78^(#PO9&EV/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SPA+2U$3T-4 M65!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I M=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78@'0M86QI M9VXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#(P,30\+V1I=CX@/"]T9#X@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(R)2!A;&EG;CTS1&QE9G0^/&9O M;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-#,E/C$T,BPU-S`\+W1D/B`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`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S)3XD/"]T9#X@ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[ M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-#,E/C(Y."PX.#`\+W1D/B`\=&0@#L@5$585"U!3$E'3CH@;&5F="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@;F]W6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,3DX-CAF85\R-C,U7S0U.#)? M.34T,E]D-#$V83EB,&0P-#$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO9C$Y.#8X9F%?,C8S-5\T-3@R7SDU-#)?9#0Q-F$Y8C!D,#0Q+U=O'0O:'1M;#L@ M8VAA2!I;B!L:79E('5S93PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'1U'0^)SQS<&%N/CPO3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]F,3DX-CAF85\R-C,U7S0U.#)?.34T,E]D M-#$V83EB,&0P-#$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9C$Y M.#8X9F%?,C8S-5\T-3@R7SDU-#)?9#0Q-F$Y8C!D,#0Q+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]F,3DX-CAF85\R-C,U7S0U.#)?.34T,E]D-#$V M83EB,&0P-#$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9C$Y.#8X M9F%?,C8S-5\T-3@R7SDU-#)?9#0Q-F$Y8C!D,#0Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N('!E M'0^)SQS<&%N/CPO M65A MF%T:6]N(&5X<&5N3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]F,3DX-CAF85\R-C,U7S0U.#)?.34T,E]D M-#$V83EB,&0P-#$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9C$Y M.#8X9F%?,C8S-5\T-3@R7SDU-#)?9#0Q-F$Y8C!D,#0Q+U=O'0O:'1M;#L@8VAA6%B;&4@17%U M:71Y($ES'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!W87)R86YT'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!P'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^3F]V(#$R+`T*"0DR M,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6EE;&0\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO2P@;6%X:6UU;3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F M,3DX-CAF85\R-C,U7S0U.#)?.34T,E]D-#$V83EB,&0P-#$-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9C$Y.#8X9F%?,C8S-5\T-3@R7SDU-#)? M9#0Q-F$Y8C!D,#0Q+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO"!E>'!E;G-E/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,3DX-CAF85\R-C,U7S0U.#)?.34T M,E]D-#$V83EB,&0P-#$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M9C$Y.#8X9F%?,C8S-5\T-3@R7SDU-#)?9#0Q-F$Y8C!D,#0Q+U=O'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,3DX-CAF M85\R-C,U7S0U.#)?.34T,E]D-#$V83EB,&0P-#$-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO9C$Y.#8X9F%?,C8S-5\T-3@R7SDU-#)?9#0Q-F$Y M8C!D,#0Q+U=O'0O:'1M;#L@8VAA2`S,2P@,C`Q,CQB2`R+"`R,#$R($ES2`S,2P@ M,C`Q,CQB2`S,2P@,C`Q,CQB2`S,2P@,C`Q,CQB2`R-2P@,C`Q M,B!)2`U=&@L(#(P,3(@27-S=6%N8V4@6TUE M;6)E2`U=&@L(#(P M,3(@27-S=6%N8V4@6TUE;6)E7!E(%1W;R!;365M M8F5R73QB2`R,#$S(%-E8W5R:71I97,@4'5R8VAA2`S,2P@,C`Q,SQB2`S,2P@,C`Q M,SQB2`S,2P@,C`Q,SQB&5R8VES960@5')A;G-A8W1I;VX@3VYE(%M-96UB97)=/&)R M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S2`S,2P@,C`Q,SQB M2`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`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!W87)R86YT'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S(@>65A'0^)S(@>65A'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)S,@>65A'0^)SQS<&%N/CPO'0^)S(@>65A'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D(&EN('!R:79A=&4@<&QA8V5M96YT/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6EE;&0\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S,@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!);F-E;G1I=F4@4&QA;B!;365M8F5R73QB65E65E65E65E2`R,#$S($]P=&EO;G,@27-S=65D('1O($5M<&QO>65E2`R M,#$S($]P=&EO;G,@27-S=65D(%1O($5M<&QO>65E2!3 M=&]C:R!/<'1I;VYS(%M-96UB97)=/&)R/D]P=&EO;G,@:7-S=65D('1O(&YO M;BUE;7!L;WEE97,@6TUE;6)E65E2!3=&]C:R!/<'1I;VYS M(%M-96UB97)=/&)R/DIA;G5A2!3=&]C:R!/<'1I;VYS(%M-96UB97)=/&)R/DUA2!3=&]C:R!/<'1I;VYS(%M-96UB97)=/&)R/D%P M2!3 M=&]C:R!/<'1I;VYS(%M-96UB97)=/&)R/E-E<'1E;6)E2!3=&]C:R!/<'1I;VYS(%M-96UB97)= M/&)R/D1E8V5M8F5R(#(P,3(@3W!T:6]N2!3=&]C:R!/<'1I;VYS(%M-96UB97)=/&)R/D%P2!3=&]C:R!/<'1I;VYS(%M-96UB97)=/&)R/DUA M>2`R,#$S($]P=&EO;G,@27-S=65D(&9O6UE;G0@07=A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO&-E M960\+W1D/@T*("`@("`@("`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`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'!E8W1E9"!V;VQA=&EL:71Y/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S4@>65A'0^)S4@>65A'0^)S4@>65A'0^)S4@>65A'0^)SQS<&%N M/CPO'0^)S4@>65A'0^)S4@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S4@>65A M'0^)S4@>65A'0^)S(@>65A'0^)S$@>65A'0^)SQS<&%N/CPO'0^)S4@>65A'0^)S4@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)S4@>65A'0^)S4@>65A'0^)S4@>65A'0^)S4@>65A'0^ M)S4@>65A'0^)S4@>65A'0^)S4@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S4@>65A'0^)S4@>65A'0^)SQS<&%N/CPO'0^)S4@>65A M'0^)SQS M<&%N/CPO'0^)S4@>65A'0^)S,@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S,@ M>65A'0^)S,@>65A'0^ M)S,@>65A'0^)S,@>65A'0^)S,@ M>65A'0^)S,@>65A'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E8W1E9"!V;VQA M=&EL:71Y+"!M:6YI;75M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&EM=6T\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&EM=6T\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPOF5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&5R8VES960L('-H87)E'!I&5R8VES92!0'0^)SQS<&%N/CPO&5R8VES92!P&5R8VES92!P M'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'!I&5R8VES92!P'0^)SQS M<&%N/CPO&5R8VES86)L92P@4V5P=&5M8F5R(#,P+"`R,#$S("AY96%R'0^)SQS<&%N/CPO M65E+"!E>&5R8VES92!P&5R8VES92!P M'0^)SQS M<&%N/CPO&5R8VES92!P'0^)SQS<&%N/CPO&EM=6T@6TUE;6)E'0^ M)SQS<&%N/CPO65E+"!E>&5R8VES92!P&5R8VES92!P&5R8VES92!0'0^)SQS<&%N/CPO&5R8VES92!P'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA65E(%-T;V-K($]P=&EO;G,@86YD(%=A&5R8VES960L('-H87)E'!I&5R8VES960L M(&5X97)C:7-E('!R:6-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5R8VES92!P M65E+"!W96EG:'1E9"!A=F5R86=E(&5X M97)C:7-E('!R:6-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD M(#`N,#(\&5R8VES960L('=E:6=H=&5D(&%V97)A M9V4@97AE'!I'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A M7,\'0^)SQS<&%N/CPO&5R8VES92!0'0^)SQS M<&%N/CPO&5R8VES92!P65E+"!E>&5R8VES92!P&5R8VES M92!P'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!P'!I M&5R8VES92!P&5R8VES86)L92P@97AE'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V M87-C3X-"B`@("`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ilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 332 347 1 false 108 0 false 5 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.virtualpiggy.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 002 - Statement - Balance Sheets Sheet http://www.virtualpiggy.com/role/BalanceSheets Balance Sheets false false R3.htm 003 - Statement - Balance Sheets (Parenthetical) Sheet http://www.virtualpiggy.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) false false R4.htm 004 - Statement - Statements of Operations Sheet http://www.virtualpiggy.com/role/StatementsOfOperations Statements of Operations false false R5.htm 005 - Statement - Statement of Changes in Stockholders' Equity (Deficit) Sheet http://www.virtualpiggy.com/role/StatementOfChangesInStockholdersEquityDeficit Statement of Changes in Stockholders' Equity (Deficit) false false R6.htm 006 - Statement - Statement of Changes in Stockholders' Equity (Deficit) (Parenthetical) Sheet http://www.virtualpiggy.com/role/StatementOfChangesInStockholdersEquityDeficitParenthetical Statement of Changes in Stockholders' Equity (Deficit) (Parenthetical) false false R7.htm 007 - Statement - Statements of Cash Flows Sheet http://www.virtualpiggy.com/role/StatementsOfCashFlows Statements of Cash Flows false false R8.htm 101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.virtualpiggy.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R9.htm 102 - Disclosure - GOING CONCERN Sheet http://www.virtualpiggy.com/role/GoingConcern GOING CONCERN false false R10.htm 103 - Disclosure - PATENTS Sheet http://www.virtualpiggy.com/role/Patents PATENTS false false R11.htm 104 - Disclosure - NOTES PAYABLE Notes http://www.virtualpiggy.com/role/NotesPayable NOTES PAYABLE false false R12.htm 105 - Disclosure - INCOME TAXES Sheet http://www.virtualpiggy.com/role/IncomeTaxes INCOME TAXES false false R13.htm 106 - Disclosure - LITIGATION SETTLEMENT Sheet http://www.virtualpiggy.com/role/LitigationSettlement LITIGATION SETTLEMENT false false R14.htm 107 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.virtualpiggy.com/role/StockholdersEquity STOCKHOLDERS' EQUITY false false R15.htm 108 - Disclosure - STOCK OPTIONS AND WARRANTS Sheet http://www.virtualpiggy.com/role/StockOptionsAndWarrants STOCK OPTIONS AND WARRANTS false false R16.htm 109 - Disclosure - OPERATING LEASES Sheet http://www.virtualpiggy.com/role/OperatingLeases OPERATING LEASES false false R17.htm 110 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.virtualpiggy.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false R18.htm 201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.virtualpiggy.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R19.htm 301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.virtualpiggy.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) false false R20.htm 308 - Disclosure - STOCK OPTIONS AND WARRANTS (Tables) Sheet http://www.virtualpiggy.com/role/StockOptionsAndWarrantsTables STOCK OPTIONS AND WARRANTS (Tables) false false R21.htm 309 - Disclosure - OPERATING LEASES (Tables) Sheet http://www.virtualpiggy.com/role/OperatingLeasesTables OPERATING LEASES (Tables) false false R22.htm 40101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.virtualpiggy.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) false false R23.htm 40201 - Disclosure - GOING CONCERN (Details) Sheet http://www.virtualpiggy.com/role/GoingConcernDetails GOING CONCERN (Details) false false R24.htm 40301 - Disclosure - PATENTS (Details) Sheet http://www.virtualpiggy.com/role/PatentsDetails PATENTS (Details) false false R25.htm 40401 - Disclosure - NOTES PAYABLE (Details) Notes http://www.virtualpiggy.com/role/NotesPayableDetails NOTES PAYABLE (Details) false false R26.htm 40501 - Disclosure - INCOME TAXES (Details) Sheet http://www.virtualpiggy.com/role/IncomeTaxesDetails INCOME TAXES (Details) false false R27.htm 40601 - Disclosure - LITIGATION SETTLEMENT (Details) Sheet http://www.virtualpiggy.com/role/LitigationSettlementDetails LITIGATION SETTLEMENT (Details) false false R28.htm 40701 - Disclosure - STOCKHOLDERS' EQUITY (Details) Sheet http://www.virtualpiggy.com/role/StockholdersEquityDetails STOCKHOLDERS' EQUITY (Details) false false R29.htm 40801 - Disclosure - STOCK OPTIONS AND WARRANTS (Details) Sheet http://www.virtualpiggy.com/role/StockOptionsAndWarrantsDetails STOCK OPTIONS AND WARRANTS (Details) false false R30.htm 40802 - Disclosure - STOCK OPTIONS AND WARRANTS (Incentive Stock Option and Warrant Transactions for Employees) (Details) Sheet http://www.virtualpiggy.com/role/StockOptionsAndWarrantsIncentiveStockOptionAndWarrantTransactionsForEmployeesDetails STOCK OPTIONS AND WARRANTS (Incentive Stock Option and Warrant Transactions for Employees) (Details) false false R31.htm 40803 - Disclosure - STOCK OPTIONS AND WARRANTS (Non Employee Stock Options and Warrants) (Details) Sheet http://www.virtualpiggy.com/role/StockOptionsAndWarrantsNonEmployeeStockOptionsAndWarrantsDetails STOCK OPTIONS AND WARRANTS (Non Employee Stock Options and Warrants) (Details) false false R32.htm 40901 - Disclosure - OPERATING LEASES (Details) Sheet http://www.virtualpiggy.com/role/OperatingLeasesDetails OPERATING LEASES (Details) false false R33.htm 40902 - Disclosure - OPERATING LEASES (Schedule of Non Cancelable Operating Lease Arrangements) (Details) Sheet http://www.virtualpiggy.com/role/OperatingLeasesScheduleOfNonCancelableOperatingLeaseArrangementsDetails OPERATING LEASES (Schedule of Non Cancelable Operating Lease Arrangements) (Details) false false R34.htm 41001 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.virtualpiggy.com/role/RelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) false false All Reports Book All Reports Element us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights had a mix of decimals attribute values: 0 1. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate had a mix of decimals attribute values: 3 4. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice had a mix of decimals attribute values: 1 2. Element vpig_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodExcludedInValuation had a mix of decimals attribute values: -6 0. Process Flow-Through: 002 - Statement - Balance Sheets Process Flow-Through: Removing column 'Sep. 30, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: Removing column 'Dec. 31, 2008' Process Flow-Through: Removing column 'Feb. 10, 2008' Process Flow-Through: 003 - Statement - Balance Sheets (Parenthetical) Process Flow-Through: 004 - Statement - Statements of Operations Process Flow-Through: Removing column '11 Months Ended Dec. 31, 2008' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2011' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2010' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2009' Process Flow-Through: 006 - Statement - Statement of Changes in Stockholders' Equity (Deficit) (Parenthetical) Process Flow-Through: 007 - Statement - Statements of Cash Flows vpig-20130930.xml vpig-20130930.xsd vpig-20130930_cal.xml vpig-20130930_def.xml vpig-20130930_lab.xml vpig-20130930_pre.xml true true XML 33 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheets (Parenthetical) (USD $)
Sep. 30, 2013
Dec. 31, 2012
Balance Sheets [Abstract]    
Patents and trademarks, accumulated amoritization $ 33,295 $ 13,678
Preferred stock, par value per share $ 0.0001 $ 0.0001
Preferred stock, shares authorized 2,000,000 2,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value per share $ 0.0001 $ 0.0001
Common stock, shares authorized 150,000,000 150,000,000
Common stock, shares issued 111,386,768 101,417,508
Common stock, shares outstanding 111,386,768 101,417,508
XML 34 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY
9 Months Ended
Sep. 30, 2013
STOCKHOLDERS' EQUITY [Abstract]  
STOCKHOLDERS' EQUITY
NOTE 7 - STOCKHOLDERS' EQUITY

In December 2011, the Company commenced a private placement of up to $5,000,000 consisting of up to 12,500,000 shares of the Company's common stock and warrants to purchase up to 6,250,000 shares of the Company's common stock.  The shares and warrants were sold in units with each unit comprised of two shares and one warrant at a purchase price of $.80 per unit. The warrants were for a term of two years at an exercise price of $0.50 per share. During December 2011, the Company sold 625,000 units and raised $500,000.  On January 11, 2012, the Company amended the Securities Purchase Agreement dated December 1, 2011, by reducing the price of one unit from $.80 to $.70.  This increased the number of units to be sold from 6,250,000 units to 7,142,858 units.  It also required the Company to issue to one investor an additional 89,286 units, consisting of 178,572 shares common stock and warrants to purchase an additional 89,286 shares of common stock.  During the three months ended March 31, 2012, the Company issued an additional 3,922,356 units and raised $2,717,650, net of stock issuance costs of $28,000.

On April 5, 2012, the Company commenced a private placement of up to $3,500,000 consisting of up to 10,000,000 shares of the Company's common stock and warrants to purchase up to 5,000,000 shares of the Company's common stock at an exercise price of $.50 per share.  The shares and warrants were sold in units with each unit comprised of two shares and one warrant at a purchase price of $.70 per unit. The warrants were for a term of two years.  In accordance with the terms of the offering documents, the offering amount was increased to $4 million.  From April 5, 2012 to June 30, 2012, the Company sold 6,201,831 units and raised $4,341,282.

On April 2, 2012, the Company entered into a settlement agreement with a former consultant of the Company. In connection with the settlement, the Company made a settlement payment to the consultant of $30,000 and issued the consultant 350,000 shares of the Company's common stock, which were valued at $297,500, fair value, or $.85 per share.  
 
On April 10, 2012, a company owned by the Secretary of the Company and his wife exercised options to purchase 250,000 shares of common stock which raised proceeds of $10,000.

On May 2, 2012, the Company entered into a securities purchase agreement with a non-U.S. person, pursuant to which the Company issued and sold 187,500 units at a purchase price of $0.80 per unit, in consideration of gross proceeds of $150,000.  Each unit consisted of: (i) two shares of the Company's common stock, (ii) a warrant to purchase one share of the Company's common stock at an exercise price of $0.50 per share for a term of two years, and (iii) a warrant to purchase one half share of the Company's common stock at an exercise price of $1.00 per share for a term of three years.  Pursuant to the securities purchase agreement, the purchaser also agreed to purchase an additional $850,000 of units by November 1, 2012.  The Company has received $1,000,000 as of March 31, 2013 under this agreement.
 
On May 21, 2012, the Company issued five consultants an aggregate of 1,363,185 shares of the Company's common stock for services, which were valued in the aggregate at $3,312,537, fair value or $2.43 per share, which was the stock price on the day of issuance.

On May 25, 2012, an investor exercised options to purchase 350,000 shares of common stock which raised proceeds of $14,000.

On July 5, 2012, the Company commenced a private placement of up to $100,000 consisting of up to 125,000 units of the Company's common stock and warrants to purchase up to 125,000 shares of the Company's common stock at an exercise price of $.50 per share with a term of two years ("Series A Warrants") and warrants to purchase up to 62,500 at an exercise price of $1.00 per share with a term of three years ("Series B Warrants").  The shares and warrants were sold in units with each unit comprised of two shares and one Series A warrant and one Series B warrant at a purchase price of $.80 per unit.  As of August 8, 2012, the Company has received gross proceeds of $100,000 under this private placement.
 
During November and December 2012, the Company entered into a private placement for shares of the Company's common stock.  The shares were sold at a purchase price of $.70 per share.  Through December 31, 2012, 7,942,858 shares were sold raising $5,560,000.

In December 2012, the Company entered into a private placement for shares of the Company's common stock. The shares were sold at a purchase price of $.75 per share.  Through December 31, 2012, 666,667 shares were sold raising $500,000.

During the first quarter of 2013, the Company entered into a private placement for shares of the Company's common stock. The shares were sold at a purchase price of $.75 per share.  Through March 31, 2013, 1,133,334 shares were sold raising $850,000.  Issuance costs related to this private placement were $60,783.

On April 15, 2013, the Company issued 26,521 restricted shares of the Company's common stock to five members of the Board of Directors that were valued at $49,071.  In conjunction with this the five members of the Board also received in aggregate options to purchase 1,050,000 shares of the Company's common stock. These options were valued at $519,080, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.0%, risk free interest rate of .69% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted will be expensed over the three year vesting term.
  
On May 28, 2013, we entered into a Securities Purchase Agreement with accredited investors, pursuant to which we issued and sold an aggregate of 2,572,553 units at a purchase price of $1.80 per unit (the "Offering"), with each unit being comprised of one (1) share of the Company's common stock and a warrant to purchase one-half (0.5) of a share of common stock at an exercise price of $3.00 per share for a period of three years. On May 29, 2013, we issued and sold an additional    300,000 units pursuant to the Offering. The Company retained a placement agent in connection with the Offering. The Company paid the placement agent aggregate placement agent fees in the amount of $151,408 plus $155,118 as an expense allowance. In addition, the placement agent received three year warrants to purchase an aggregate of 287,255 shares of the Company's common stock at an exercise price of $1.80 per share (See Note 8-Stock Options and Warrants). Net proceeds of the Offering to the Company, after the expense allowance and other expenses, were approximately $4,836,157.
    
During May 2013, options to purchase 750,000 shares of common stock were exercised at $0.04 per share, options to purchase 300,000 shares of common stock were exercised at $0.35 per share, and options to purchase 66,667 shares of common stock were exercised at $0.75, resulting in proceeds of $185,000.

During May and June 2013, warrants to purchase 2,000,000 shares of common stock were exercised at $.04 per share and warrants to purchase 2,660,685 shares of common stock were exercised at $0.50 per share, resulting in proceeds of $1,330,342.

During July and August 2013, warrants to purchase 34,500 shares of common stock were exercised at $.50 per share, resulting in proceeds of $17,250.
XML 35 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statement of Changes in Stockholders' Equity (Deficit) (USD $)
Total
Common Stock [Member]
Common Stock Subscribed [Member]
Common Stock Subscription Receivable [Member]
Additional Paid-In Capital [Member]
Deficit Accumulated During the Development Stage [Member]
Balance, values at Feb. 10, 2008                  
Balance, shares at Feb. 10, 2008             
Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share, values 19,000 1,900       17,100   
Issuance of initial 19,000,000 shares on February 11, 2008 at $.001 per share, shares   19,000,000        
Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit, values 250,000 714       249,286   
Issuance of shares of common stock and 14,285,716 warrants in February 2008 through private placement at $.035 per unit, shares   7,142,858        
Employee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values 8,825          8,825   
Nonemployee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values 107,859          107,859   
Exercise of options on May 8, 2008, at $.04 per share, values 20,000 50       19,950   
Exercise of options on May 8, 2008, at $.04 per share, shares   500,000        
Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit, values 232,500 665       231,835   
Issuance of shares of common stock and 614,286 warrants in May and September 2008 through private placement at $.75 per unit, shares   6,642,858        
Options issued for services in June 2008, vested immediately and valued at $.07 per share, values 395,467          395,467   
Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share, values 918          918   
Issuance of shares of common stock to investors in August 2008 at $1.00 per share, values 2,560          2,560   
Issuance of shares of common stock to investors in August 2008 at $1.00 per share, shares   2,560        
Exercise of options in September 2008 at $.04 per share, values 70,000 175       69,825   
Exercise of options in September 2008 at $.04 per share, shares   1,750,000        
Exercise of warrants in September 2008 at $.04 per share, values 10,000 25       9,975   
Exercise of warrants in September 2008 at $.04 per share, shares   250,000        
Net loss (983,886)             (983,886)
Balance, values at Dec. 31, 2008 133,243 3,529       1,113,600 (983,886)
Balance, shares at Dec. 31, 2008   35,288,276        
Nonemployee options issued for services on March 3, 2008, vested immediately and valued at $.02 per share, values 37,506          37,506   
Nonemployee options issued for services in June 19, 2008, vested immediately and valued at $.01 per share, values 636          636   
Exercise of options on January 26, 2009 at $.04 per share, values 40,000 100       39,900   
Exercise of options on January 26, 2009 at $.04 per share, shares   1,000,000        
Issuance of shares of common stock on April 7, 2009 at $1.00 per share, values 400,000 40       399,960   
Issuance of shares of common stock on April 7, 2009 at $1.00 per share, shares   400,000        
Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share, values 200,000 10       199,990   
Issuance of shares of common stock on June 29, 2009 valued at $2.00 per share, shares   100,000        
Exercise of options on July 30, 2009 at $.04 per share, values 40,000 100       39,900   
Exercise of options on July 30, 2009 at $.04 per share, shares   1,000,000        
Nonemployee options issued for services on August 18, 2009 vested immediately and valued at $.31 per share, values 10,462          10,462   
Exercise of warrants on August 21, 2009 at $.04 per share, values 40,000 100       39,900   
Exercise of warrants on August 21, 2009 at $.04 per share, shares   1,000,000        
Exercise of options on September 2, 2009 at $.04 per share, values 20,000 50       19,950   
Exercise of options on September 2, 2009 at $.04 per share, shares   500,000        
Issuance of shares of common stock on September 17, 2009 at $1.00 per share, values 100,000 10       99,990   
Issuance of shares of common stock on September 17, 2009 at $1.00 per share, shares   100,000        
Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share, values 1,080,427 108       1,080,319   
Issuance of shares of common stock for future services on October 9, 2009 valued at $1.00 per share, shares   1,080,427        
Issuance of shares of common stock on October 16, 2009 at $1.00 per share, values 100,000 10       99,990   
Issuance of shares of common stock on October 16, 2009 at $1.00 per share, shares   100,000        
Exercise of warrants on October 22, 2009 at $.04 per share, values 40,000 100       39,900   
Exercise of warrants on October 22, 2009 at $.04 per share, shares   1,000,000        
Exercise of warrants on December 2, 2009 at $.04 per share, values 40,000 100       39,900   
Exercise of warrants on December 2, 2009 at $.04 per share, shares   1,000,000        
Exercise of options on December 10, 2009 at $.04 per share, values 10,000 25       9,975   
Exercise of options on December 10, 2009 at $.04 per share, shares   250,000        
Exercise of warrants on December 31, 2009 at $.04 per share, values 40,000 100       39,900   
Exercise of warrants on December 31, 2009 at $.04 per share, shares   1,000,000        
Stock issuance costs (65,000)          (65,000)   
Net loss (2,236,476)             (2,236,476)
Balance, values at Dec. 31, 2009 30,798 4,382       3,246,778 (3,220,362)
Balance, shares at Dec. 31, 2009   43,818,703        
Nonemployee options issued for services on August 18, 2009 vested immediately and valued at $.31 per share, values 27,899          27,899   
Exercise of options on January 5, 2010 at $.04 per share, values 40,000 100       39,900   
Exercise of options on January 5, 2010 at $.04 per share, shares   1,000,000        
Exercise of warrant on February 22, 2010 at $.04 per share, values 35,713 89       35,624   
Exercise of warrant on February 22, 2010 at $.04 per share, shares   892,858        
Exercise of warrants in March 2010 at $.04 per share, values 40,000 100       39,900   
Exercise of warrants in March 2010 at $.04 per share, shares   1,000,000        
Exercise of warrants in April 2010 at $.04 per share, values 100,000 250       99,750   
Exercise of warrants in April 2010 at $.04 per share, shares   2,500,000        
Issuance of shares of common stock in conjunction with notes payable in May through August 2010, values 400,742 48       400,694   
Issuance of shares of common stock in conjunction with notes payable in May through August 2010, shares   483,750        
Issuance of shares of common stock for retirement of 400,000 options at $.25 per share, values    6       (6)   
Issuance of shares of common stock for retirement of 400,000 options at $.25 per share, shares   65,000        
Issuance of share of common stock from August through December 2010 through private placement at $.20 per share, values 1,925,000 963       1,924,037   
Issuance of share of common stock from August through December 2010 through private placement at $.20 per share, shares   9,625,000        
Issuance of shares of common stock on November 1, 2010 for conversion of notes payable at $.20 per share, values 75,000 38       74,962   
Issuance of shares of common stock on November 1, 2010 for conversion of notes payable at $.20 per share, shares   375,000        
Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share, values 100,000 11       99,989   
Issuance of shares of common stock on November 19, 2010 for future services valued at $.90 per share, shares   111,111        
Exercise of options on December 2, 2010 at $.04 per share, values 120,000 300       119,700   
Exercise of options on December 2, 2010 at $.04 per share, shares   3,000,000        
Exercise of warrants in December 2010 at $.04 per share, values 100,000 250       99,750   
Exercise of warrants in December 2010 at $.04 per share, shares   2,500,000        
Nonemployee options issued for services from August through November 2010 vested immediately and valued at $.01 per share, values 13,816          13,816   
Net loss (1,489,190)             (1,489,190)
Balance, values at Dec. 31, 2010 1,519,778 6,537       6,222,793 (4,709,552)
Balance, shares at Dec. 31, 2010   65,371,422        
Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share, values 49,000 10       48,990   
Issuance of shares of common stock for future services on June 1, 2011 valued at $.49 per share, shares   100,000        
Issuance of shares of common stock in conjunction with notes payable from September through December 2011, value 82,665 15       82,650   
Issuance of shares of common stock in conjunction with notes payable from September through December 2011, shares   150,000        
Issuance of shares of common stock and 625,000 warrants on December 20, 2011 through private placement at $.80 per unit, values 500,000 125       499,875   
Issuance of shares of common stock and 625,000 warrants on December 20, 2011 through private placement at $.80 per unit, shares   1,250,000        
Issuance of warrants in conjunction with notes payable from September through December 2011 20,930          20,930   
Fair value of revalued warrants at $.09 to $.76 per share 88,601          88,601   
Nonemployee options issued for services from August through November 2010 vested immediately and valued at $.01 per share, values 3,146          3,146   
Nonemployee options issued for services on January 24, 2011, vested immediately and valued at $.20 per share 46,019          46,019   
Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share 52,243          52,243   
Net loss (2,724,796)             (2,724,796)
Balance, values at Dec. 31, 2011 (362,414) 6,687       7,065,247 (7,434,348)
Balance, shares at Dec. 31, 2011   66,871,422        
Stock issuance costs (28,000)          (28,000)   
Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, values 7,086,932 2,044       7,084,888   
Issuance of shares of common stock and 10,213,474 warrants through June 30, 2012 through private placement at $.70 per unit, shares   20,426,948        
Issuance of shares of common stock and 1,500,000 warrants through December 31, 2012 through private placement at $.80 per unit, values 1,050,000 262       1,049,738   
Issuance of shares of common stock and 1,500,000 warrants through December 31, 2012 through private placement at $.80 per unit, shares   2,625,000        
Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, values 3,312,537 136       3,312,401   
Issuance of shares of common stock for future services on May 21, 2012 valued at $2.43 per share, shares   1,363,185        
Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, values 200,000 57       199,943   
Issuance of shares of common stock and 285,714 warrants to discharge notes payable and accrued interest valued at $.70 per unit, shares   571,428        
Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, values 297,500 35       297,465   
Issuance of shares of common stock with respect to a settlement agreement valued at $.85 per share, shares   350,000        
Issuance of shares of common stock through December 31, 2012 through private placement at $.70 per share, values 5,560,000 794       5,559,206   
Issuance of shares of common stock through December 31, 2012 through private placement at $.70 per share, shares   7,942,858        
Issuance of shares of common stock through December 31, 2012 through private placement at $.75 per share, values 500,000 67       499,933   
Issuance of shares of common stock through December 31, 2012 through private placement at $.75 per share, shares   666,667        
Exercise of options on April 10, 2012 at $.04 per share, values 10,000 25       9,975   
Exercise of options on April 10, 2012 at $.04 per share, shares   250,000        
Exercise of options on May 25, 2012 at $.04 per share, values 14,000 35       13,965   
Exercise of options on May 25, 2012 at $.04 per share, shares   350,000        
Nonemployee options issued for services from July through August 2011, vested immediately and valued from $.10 to $.19 per share, values 2,219          2,219   
Nonemployee options issued for services from January through December 2012, vested immediately and valued from $.11 to $.95 per share, values 759,292          759,292   
Nonemployee options issued for services on January 2012 through December 2012, vesting over three years and valued at$. 17 to $.40 per share, values 39,751          39,751   
Employee options issued for services on January 2012 through December 2012, vesting over three years and valued at $.11 To $.53 per share, values 283,460          283,460   
Employee options issued for services from January 2012 through December 2012, vesting immediately and valued at $.14 to $.42 per share, values 150,631          150,631   
Common stock subscription for 62,500 units through private placement at $.80 per unit       50,000 (50,000)      
Net loss (12,039,726)             (12,039,726)
Balance, values at Dec. 31, 2012 6,836,182 10,142 50,000 (50,000) 26,300,114 (19,474,074)
Balance, shares at Dec. 31, 2012 101,417,508 101,417,508        
Stock issuance costs (395,221)          (395,221)   
Nonemployee options issued for services from January through December 2012, vested immediately and valued from $.11 to $.95 per share, values 34,372          34,372   
Employee options issued for services on January 2012 through December 2012, vesting over three years and valued at $.11 To $.53 per share, values 340,173          340,173   
Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, values 50,000 13       49,987   
Issuance of shares of common stock and 93,750 warrants through March 31, 2013 through private placement at $.80 per unit, shares   125,000        
Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, values 850,000 113       849,887   
Issuance of shares of common stock through March 31, 2013, through a private placement at $0.75 per share, shares   1,133,334        
Issuance of shares on April 15, 2013 common stock for services, values 49,071 3       49,068   
Issuance of shares on April 15, 2013 common stock for services, shares   26,521        
Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, value 5,170,595 287       5,170,308   
Issuance of shares of common stock and 1,436,277 warrants in May 2013, through a private placement at $1.80 per share, shares   2,872,553        
Fair value of revalued options $1.07 per share 780          780   
Exercise of options at $0.04 per share in May 2013, value 30,000 75       29,925   
Exercies of options at $0.04 per share in May 2013, shares   750,000        
Exercise of options at $0.35 per share on May 14, 2013, value 105,000 30       104,970   
Exercise of options at $0.35 per share on May 14, 2013, shares   300,000        
Exercise of options at $0.75 per share in May 2013, value 50,000 7       49,993   
Exercise of options at $0.75 per share in May 2013, shares   66,667        
Exercise of warrants at $0.04 per share on May 26, 2013, value 80,000 200       79,800   
Exercise of warrants at $0.04 per share on May 26, 2013, shares   2,000,000        
Exercise of warrants at $0.50 per share in May through August 2013, value 1,347,593 270       1,347,323   
Exercise of warrants at $0.50 per share in May through August 2013, shares   2,695,185        
Nonemployee options/warrants issued for services from January 2013 through September 2013, vested immediately to 3 years and valued from $0.09 to $1.66 per share 784,247          784,247   
Employee options issued for services on January 2013 through September 30, 2013, vesting over three years and valued at $0.22 to $0.68 per share 206,604          206,604   
Common stock subscription for 62,500 units through private placement at $.80 per unit       (50,000) 50,000      
Net loss (11,366,427)             (11,366,427)
Balance, values at Sep. 30, 2013 $ 4,172,969 $ 11,140       $ 35,002,330 $ (30,840,501)
Balance, shares at Sep. 30, 2013 111,386,768 111,386,768        
XML 36 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheets (USD $)
Sep. 30, 2013
Dec. 31, 2012
CURRENT ASSETS    
Cash and cash equivalents $ 4,583,551 $ 7,371,036
Accounts Receivable 955 53
Insurance receivable    75,000
Prepaid expenses 200,771 20,500
TOTAL CURRENT ASSETS 4,785,277 7,466,589
PROPERTY AND EQUIPMENT    
Computer equipment 99,156 70,149
Furniture and fixtures 53,714 46,130
Gross property and equipment 152,870 116,279
Less: accumulated depreciation (40,054) (19,580)
Total property and equipment 112,816 96,699
OTHER ASSETS    
Deposit 63,510 65,000
Patents and trademarks, net of accumulated amoritization of $33,295 and $13,678 604,572 362,496
Total other assets 668,082 427,496
TOTAL ASSETS 5,566,175 7,990,784
CURRENT LIABILITIES    
Accounts payable and accrued expenses 1,393,206 704,602
Litigation settlement    450,000
TOTAL CURRENT LIABILITIES 1,393,206 1,154,602
CONTINGENCIES      
STOCKHOLDERS' EQUITY    
Preferred stock, $.0001 par value; 2,000,000 shares authorized; none issued and outstanding at September 30, 2013 and December 31, 2012      
Common stock, $ .0001 par value; 150,000,000 shares authorized; 111,386,768 and 101,417,508 shares issued and outstanding at September 30, 2013 and December 31, 2012 11,140 10,142
Common stock subscribed    50,000
Common stock subscription receivable    (50,000)
Additional paid in capital 35,002,330 26,300,114
Deficit accumulated during the development stage (30,840,501) (19,474,074)
STOCKHOLDERS' EQUITY 4,172,969 6,836,182
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 5,566,175 $ 7,990,784
XML 37 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK OPTIONS AND WARRANTS (Details) (USD $)
9 Months Ended 3 Months Ended 9 Months Ended 68 Months Ended 1 Months Ended 3 Months Ended 9 Months Ended 68 Months Ended 1 Months Ended
Sep. 30, 2013
Sep. 30, 2013
2008 Equity Incentive Plan [Member]
Dec. 31, 2008
2008 Equity Incentive Plan [Member]
Sep. 30, 2013
2013 Equity Incentive Plan [Member]
Sep. 30, 2013
Incentive Stock Options [Member]
Dec. 31, 2012
Incentive Stock Options [Member]
Dec. 31, 2011
Incentive Stock Options [Member]
Sep. 30, 2013
Incentive Stock Options [Member]
Options issued to employees [Member]
Sep. 30, 2012
Incentive Stock Options [Member]
Options issued to employees [Member]
Sep. 30, 2013
Incentive Stock Options [Member]
Options issued to employees [Member]
Sep. 30, 2012
Incentive Stock Options [Member]
Options issued to employees [Member]
Sep. 30, 2013
Incentive Stock Options [Member]
Options issued to employees [Member]
Jan. 31, 2012
Incentive Stock Options [Member]
January 27, 2012 Options Issued to Employees [Member]
Feb. 29, 2012
Incentive Stock Options [Member]
February 28, 2012 Options Issued to Employees [Member]
Mar. 31, 2012
Incentive Stock Options [Member]
March 2, 2012 Options Issued to Employees [Member]
Mar. 31, 2012
Incentive Stock Options [Member]
March 5, 2012 Options Issued to Employees [Member]
Mar. 31, 2012
Incentive Stock Options [Member]
March 31, 2012 Options Issued to Employees [Member]
Apr. 30, 2012
Incentive Stock Options [Member]
April 2012 Options Issued to Employees [Member]
Jun. 30, 2012
Incentive Stock Options [Member]
June 2012 Options Issued to Employees [Member]
Jul. 31, 2012
Incentive Stock Options [Member]
July 2012 Options Issued to Employees [Member]
Aug. 31, 2012
Incentive Stock Options [Member]
August 2012 Options Issued to Employees [Member]
Sep. 30, 2012
Incentive Stock Options [Member]
September 2012 Options Issued to Employees [Member]
Oct. 31, 2012
Incentive Stock Options [Member]
October 2012 Options Issued to Employees [Member]
Nov. 30, 2012
Incentive Stock Options [Member]
November 2012 Options Issued to Employees [Member]
Jan. 31, 2013
Incentive Stock Options [Member]
March 2008 Options Issued to Directors [Member]
Mar. 31, 2008
Incentive Stock Options [Member]
March 2008 Options Issued to Directors [Member]
Jan. 31, 2013
Incentive Stock Options [Member]
January 2013 Options Issued to Employees [Member]
Feb. 28, 2013
Incentive Stock Options [Member]
February 2013 Options Issued to Employees [Member]
Mar. 31, 2013
Incentive Stock Options [Member]
March 2013 Options Issued to Employees [Member]
Apr. 30, 2013
Incentive Stock Options [Member]
April 2013 Options Issued To Employees [Member]
May 31, 2013
Incentive Stock Options [Member]
May 2013 Options Issued To Employees [Member]
Jun. 30, 2013
Incentive Stock Options [Member]
June 2013 Options Issued To Employees [Member]
Aug. 31, 2013
Incentive Stock Options [Member]
August 2013 Options Issued To Employees [Member]
Sep. 30, 2013
Incentive Stock Options [Member]
September 2013 Options Issued To Employees [Member]
Sep. 30, 2013
Non-Statutory Stock Options [Member]
Dec. 31, 2012
Non-Statutory Stock Options [Member]
Dec. 31, 2011
Non-Statutory Stock Options [Member]
Sep. 30, 2013
Non-Statutory Stock Options [Member]
Options issued to non-employees [Member]
Sep. 30, 2012
Non-Statutory Stock Options [Member]
Options issued to non-employees [Member]
Sep. 30, 2013
Non-Statutory Stock Options [Member]
Options issued to non-employees [Member]
Sep. 30, 2012
Non-Statutory Stock Options [Member]
Options issued to non-employees [Member]
Sep. 30, 2013
Non-Statutory Stock Options [Member]
Options issued to non-employees [Member]
Jan. 31, 2012
Non-Statutory Stock Options [Member]
January 2, 2012 Options Issued to Consultants [Member]
Jan. 31, 2012
Non-Statutory Stock Options [Member]
January 17, 2012 Options Issued to Consultants [Member]
Mar. 31, 2012
Non-Statutory Stock Options [Member]
March 31, 2012 Options Issued to Consultants [Member]
Apr. 30, 2012
Non-Statutory Stock Options [Member]
April 1, 2012 Options Issued to Consultants [Member]
May 31, 2012
Non-Statutory Stock Options [Member]
May 2012 Options Issued to Consultants [Member]
Jul. 31, 2012
Non-Statutory Stock Options [Member]
July 2012 Options Issued to Consultants [Member]
Aug. 31, 2012
Non-Statutory Stock Options [Member]
August 2012 Options Issued to Consultants [Member]
Aug. 31, 2012
Non-Statutory Stock Options [Member]
August 2012 Options Issued to Consultants [Member]
Minimum [Member]
Aug. 31, 2012
Non-Statutory Stock Options [Member]
August 2012 Options Issued to Consultants [Member]
Maximum [Member]
Sep. 30, 2012
Non-Statutory Stock Options [Member]
September 2012 Options Issued to Consultants [Member]
Oct. 31, 2012
Non-Statutory Stock Options [Member]
October 2012 Options Issued to Consultants [Member]
Nov. 30, 2012
Non-Statutory Stock Options [Member]
November 2012 Options Issued to Consultants [Member]
Sep. 30, 2013
Non-Statutory Stock Options [Member]
December 2012 Options Issued To Consultants [Member]
Dec. 31, 2012
Non-Statutory Stock Options [Member]
December 2012 Options Issued To Consultants [Member]
Jan. 31, 2013
Non-Statutory Stock Options [Member]
January 2013 Options Issued to Consultants [Member]
Mar. 31, 2013
Non-Statutory Stock Options [Member]
March 2013 Options Issued To Consultants [Member]
Mar. 31, 2013
Non-Statutory Stock Options [Member]
March 2013 Options Issued To Consultants [Member]
Minimum [Member]
Mar. 31, 2013
Non-Statutory Stock Options [Member]
March 2013 Options Issued To Consultants [Member]
Maximum [Member]
Apr. 30, 2013
Non-Statutory Stock Options [Member]
April 2013 Options Issued To Consultants [Member]
May 31, 2013
Non-Statutory Stock Options [Member]
May 2013 Options Issued To Consultants [Member]
May 31, 2013
Non-Statutory Stock Options [Member]
May 2013 Options Issued for Private Placement [Member]
Jul. 31, 2013
Non-Statutory Stock Options [Member]
July 2013 Options Issued To Consultants [Member]
Sep. 30, 2013
Non-Statutory Stock Options [Member]
September 2013 Options Issued To Consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                                                                                                                  
Options authorized     25,000,000 5,000,000                                                                                                                          
Outstanding options   14,053,000   3,702,500 16,764,477 17,258,644 9,467,858                                   4,250,000                   15,843,536 16,531,438 3,184,286                                                        
Options available to be issued   61,667   1,297,500                                                                                                                          
Percent of fair market value of common stock the exercise price of options may not exceed 100.00%                                                                                                                                
Percent of fair market value of common stock the exercise price may not exceed, when grantee holds greater than 10% shares outstanding 110.00%                                                                                                                                
Grantee ownership percentage considered in determination of options exercise price 10.00%                                                                                                                                
Options issued                         30,000 25,000 250,000 25,000 4,010,000 80,000 470,000 15,000 380,000 75,000 75,000 1,295,000   4,500,000 260,000 760,000 2,500 200,000 55,000   210,000 10,000                 250,000 200,000 100,000 250,000 100,000 100,000 400,000     100,000 50,000 765,000   500,000 5,000 130,000     100,000 125,000 287,255 100,000 100,000
Minimum option exercise price                                   $ 0.65 $ 1.53   $ 1.26     $ 1.01     $ 0.99 $ 1.07     $ 2.16 $ 2.40 $ 2.00                               $ 0.35                 $ 0.75       $ 3.05   $ 0.75  
Option exercise price                         $ 0.52 $ 0.58 $ 0.58 $ 0.58 $ 0.65     $ 1.23   $ 1.54 $ 1.35           $ 1.36 $ 1.56       $ 1.97                 $ 0.50 $ 0.50 $ 0.65 $ 0.70 $ 2.17 $ 1.55       $ 0.75 $ 0.75 $ 1.01   $ 1.15 $ 1.00       $ 2.04   $ 1.80   $ 1.17
Maximum option exercise price                                   $ 0.97 $ 1.82   $ 1.43     $ 1.35     $ 1.05 $ 1.21     $ 2.29 $ 2.92 $ 2.35                               $ 1.11                 $ 1.48       $ 3.28   $ 2.61  
Fair value of issued equity               $ 210,380 $ 81,588 $ 546,776 $ 274,757 $ 1,446,783 $ 3,718 $ 3,120 $ 33,975 $ 2,680 $ 759,810 $ 17,310 $ 217,293 $ 5,493 $ 123,381 $ 26,303 $ 23,263 $ 371,313     $ 62,662 $ 199,843 $ 728 $ 74,159 $ 26,954 $ 129,343 $ 124,392 $ 4,500       $ 687,229 $ 142,086 $ 818,619 $ 203,593 $ 1,803,849 $ 51,692 $ 31,437 $ 18,947 $ 43,028 $ 79,978 $ 40,373 $ 321,221     $ 81,697 $ 5,381 $ 188,830     $ 1,106 $ 54,228     $ 44,603 $ 51,869 $ 409,749 $ 124,338 $ 26,208
Pricing model used in calculation of grant-date fair value                         Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model     Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing mode Black-Scholes option pricing model                 Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model     Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model   Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model     Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model Black-Scholes option pricing model
Dividend yield                                                                                                                                                                        
Expected volatility                         25.40% 25.00% 25.90% 25.00% 31.20%     32.90%   24.50% 24.50%           22.50% 25.30%       21.80%                 29.20% 28.00% 31.20% 31.20% 31.20% 29.30%       25.60% 23.50% 26.10%   24.70% 23.30%       26.50%       22.10%
Risk free interest rate                         0.80% 0.80% 0.90% 0.90% 1.04%     0.61%   0.62% 0.70%           0.76% 0.76%       1.71%                 0.90% 0.80% 1.04% 1.04% 0.75% 0.64%       0.27% 0.19% 0.76%   0.76% 0.78%       0.68%   0.49%   1.39%
Expected life                         5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years     5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years                 5 years 5 years 5 years 5 years 5 years 5 years   2 years 5 years 2 years 1 year 5 years   1 year 5 years   2 years 5 years 5 years 2 years 3 years 5 years 5 years
Expiration period after issuance                         5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years     5 years 5 years 5 years 5 years 5 years 5 years 5 years 5 years                 5 years 5 years 5 years 5 years 5 years 5 years   2 years 5 years 2 years 1 year 5 years   5 years 5 years   2 years 5 years 5 years 2 years 3 years 5 years 5 years
Senior Vice President of Marketing and Licensing annual compensation                                                                                           150,000                                      
Vesting period                         3 years 3 years   3 years 3 years 3 years 3 years 3 years 3 years 3 years 3 years 3 years     3 years 3 years 3 years 3 years 3 years 3 years 3 years 3 years                                                             3 years
Expected volatility, minimum                                   30.20% 30.30%   23.50%     26.10%     23.30% 22.50%     23.50% 23.60% 24.20%                               27.10%                 22.60%       23.10% 23.40% 23.80%  
Expected volatility, maximum                                   33.40% 35.50%   29.10%     29.30%     26.10% 25.10%     25.30% 26.30% 30.30%                               30.50%                 25.50%       23.20% 23.70% 26.60%  
Risk free rate, minimum                                   0.82% 0.68%   0.63%     0.76%     0.78% 0.78%     0.84% 1.03% 1.38%                               0.27%                 0.25%       0.29%   1.35%  
Risk free rate, maximum                                   1.04% 0.72%   0.69%     0.83%     0.89% 0.88%     0.85% 1.48% 1.61%                               0.67%                 0.80%       0.31%   1.66%  
Share-based compensation                                                                                                                               124,338  
Unrecognized compensation expense               1,746,505   1,746,505   1,746,505                                                   90,984   90,984   90,984                                              
Incremental increase in value                                                 1,253                                                                                
Warrants vested                                                                                                             350,000 150,000                  
Value of vested warrants                                                                                                             $ 549,915 $ 58,595                  
Aggregate options issued                                                               250,000                                                   1,130,000              
Options issued, excluded from valuation                                                               50,000                                                   1,000,000              
XML 38 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOING CONCERN (Details) (USD $)
9 Months Ended 68 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
GOING CONCERN [Abstract]      
Amount raised from private placement $ 6,070,595    
Stock issuance costs 395,221 28,000 488,221
Proceeds from exercise of options 185,000 24,000 569,000
Proceeds from exercise of warrants $ 1,427,595    $ 1,873,309
XML 39 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
LITIGATION SETTLEMENT
9 Months Ended
Sep. 30, 2013
LITIGATION SETTLEMENT [Abstract]  
LITIGATION SETTLEMENT
NOTE 6 - LITIGATION SETTLEMENT

In December 2012, the Company entered into a settlement agreement with an investor, whereby the Company would pay the investor $450,000 in return for the investor returning warrants issued to the investor.  The Company received $75,000 from its insurance carrier with respect to this litigation and the $450,000 settlement was paid in January 2013.
XML 40 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK OPTIONS AND WARRANTS (Incentive Stock Option and Warrant Transactions for Employees) (Details) (Incentive Stock Options [Member], USD $)
9 Months Ended 12 Months Ended
Sep. 30, 2013
Dec. 31, 2012
Option/Warrants Shares    
Outstanding, shares, beginning of period 17,258,644 9,467,858
Granted, shares 2,802,500 6,730,000
Issued under Private Placements, shares   500,786
Reclassified from (to) non-employee, shares (235,000) 810,000
Exercised, shares (2,816,667) (250,000)
Expired/terminated, shares (245,000)   
Outstanding, shares, end of period 16,764,477 17,258,644
Exercise Price    
Issued under Private Placements, exercise price   $ 0.50
Exercised, exercise price   $ 0.04
Expired/terminated, exercise price     
Weighted Average Exercise Price    
Outstanding, weighted average exercise price, beginning of period $ 0.48 $ 0.19
Granted, weighted average exercise price $ 0.26 $ 0.34
Issued under Private Placements, weighted average exercise price   $ 0.01
Reclassified from/to non-employee, weighted average exercise price $ 0.02   
Exercised, weighted average exercise price $ 0.01   
Expired/terminated, weighted average exercise price      
Outstanding, weighted average exercise price, end of period $ 0.70 $ 0.48
Exercisable, shares, September 30, 2013 9,315,310  
Exercisable, weighted average exercise price, September 30, 2013 $ 0.4  
Weighted Average Remaining Life, Exercisable, September 30, 2013 (years) 1 year 9 months 18 days  
Minimum [Member]
   
Exercise Price    
Outstanding, exercise price, beginning of period $ 0.04 $ 0.04
Granted, exercise price $ 0.99 $ 0.50
Reclassified from/to non-employee, exercise price $ 0.50 $ 0.50
Exercised, exercise price $ 0.04  
Expired/terminated, exercise price $ 0.50  
Outstanding, exercise price, end of period $ 0.04 $ 0.04
Weighted Average Exercise Price    
Exercisable, exercise price, September 30, 2013 $ 0.04  
Maximum [Member]
   
Exercise Price    
Outstanding, exercise price, beginning of period $ 1.82 $ 0.90
Granted, exercise price $ 2.92 $ 1.82
Reclassified from/to non-employee, exercise price $ 2.30 $ 0.75
Exercised, exercise price $ 0.75  
Expired/terminated, exercise price $ 2.92  
Outstanding, exercise price, end of period $ 2.40 $ 1.82
Weighted Average Exercise Price    
Exercisable, exercise price, September 30, 2013 $ 2.30  
XML 41 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
OPERATING LEASES
9 Months Ended
Sep. 30, 2013
OPERATING LEASES [Abstract]  
OPERATING LEASES
NOTE 9 - OPERATING LEASES
 
For the three and nine months ended September 30, 2013, total rent expense under leases amounted to $117,447 and $244,318 and for the three and nine months ended September 30, 2012, total rent expense under leases amounted to $54,640 and $113,389.  At September 30, 2013, the Company was obligated under various non-cancelable operating lease arrangements for property as follows:


2013
    116,622  
2014
    142,570  
2015
    39,688  
         
    $ 298,880  

XML 42 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAXES
9 Months Ended
Sep. 30, 2013
INCOME TAXES [Abstract]  
INCOME TAXES
NOTE 5 - INCOME TAXES

Income tax expense was $0 for the three and nine months ended September 30, 2013 and 2012.

As of January 1, 2013, the Company had no unrecognized tax benefits, and accordingly, the Company did not recognize interest or penalties during 2013 related to unrecognized tax benefits.  There has been no change in unrecognized tax benefits during the nine months ended September 30, 2013, and there was no accrual for uncertain tax positions as of September 30, 2013.  Tax years from 2008 through 2012 remain subject to examination by major tax jurisdictions.

There is no income tax benefit for the losses for the three and nine months ended September 30, 2013 and 2012, since management has determined that the realization of the net tax deferred asset is not assured and has created a valuation allowance for the entire amount of such benefits.
XML 43 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Cash Flows (USD $)
9 Months Ended 68 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $ (11,366,427) $ (8,666,655) $ (30,840,501)
Adjustments to reconcile net loss to net cash used in operating activities      
Fair value of warrants issued in exchange for services 549,915    638,516
Fair value of options issued in exchange for services 816,261 478,350 2,756,411
Fair value of stock issued in exchange for services 49,071 3,312,537 4,791,035
Amortization of deferred costs       78,243
Accretion of discount on notes payable    65,560 426,095
Depreciation and amortization 40,091 15,818 73,349
Provision for bad debt       42,768
Loss on disposal of fixed assets       2,726
(Increase) decrease in assets      
Accounts receivable (902) 1,125 (955)
Insurance receivable 75,000      
Other receivable       (42,768)
Prepaid expenses (180,271) (23,735) (200,771)
Deposits 1,490 (62,233) (63,510)
Increase (decrease) in liabilities      
Accounts payable and accrued expenses 238,602 346,561 1,715,704
Net cash used in operating activities (9,777,170) (4,532,672) (20,623,658)
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchase of equipment (36,591) (93,975) (155,595)
Patent and trademark costs (261,693) (198,388) (637,868)
Net cash used in investing activities (298,284) (292,363) (793,463)
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from note payable - stockholders       747,500
Repayment of note payable - stockholders    (175,000) (572,500)
Proceeds from notes payable       75,000
Proceeds from issuance of common stock 6,070,595 7,936,932 23,796,584
Proceeds from exercise of options 185,000 24,000 569,000
Proceeds from exercise of warrants 1,427,595    1,873,309
Stock issuance costs (395,221) (28,000) (488,221)
Net cash provided by financing activities 7,287,969 7,757,932 26,000,672
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (2,787,485) 2,932,897 4,583,551
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD 7,371,036 186,159   
CASH AND CASH EQUIVALENTS - END OF PERIOD 4,583,551 3,119,056 4,583,551
SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES:      
Income taxes paid         
Interest paid       2,498
Fair value of common stock issued as discount for notes payable       483,409
Conversion of notes payable and accrued interest into common stock    200,000 75,000
Fair value of warrants issued as discount for notes payable       20,930
Issuance of common stock for settlement of payable       $ 297,500
XML 44 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 45 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
OPERATING LEASES (Schedule of Non Cancelable Operating Lease Arrangements) (Details) (USD $)
Sep. 30, 2013
OPERATING LEASES [Abstract]  
2013 $ 116,622
2014 142,570
2015 39,688
Total $ 298,880
XML 46 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
Schedule of Property and Equipment, Useful Life
The Company's depreciation and amortization policies on property and equipment are as follows:


 
Useful life
 
(in years)
   
Computer equipment
 3 - 5
Furniture and fixtures
 7

XML 47 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK OPTIONS AND WARRANTS
9 Months Ended
Sep. 30, 2013
STOCK OPTIONS AND WARRANTS [Abstract]  
STOCK OPTIONS AND WARRANTS
NOTE 8 - STOCK OPTIONS AND WARRANTS

During 2008, the Board of Directors ("Board") of the Company adopted the 2008 Equity Incentive Plan ("2008 Plan") that was approved by the shareholders.  Under the 2008 Plan, the Company is authorized to grant options to purchase up to 25,000,000 shares of common stock to any officer, other employee or director of, or any consultant or other independent contractor who provides services to the Company.  The 2008 Plan is intended to permit stock options granted to employees under the 2008 Plan to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended ("Incentive Stock Options").  All options granted under the 2008 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options ("Non-Statutory Stock Options").  As of September 30, 2013, options to purchase 14,053,000 shares of common stock have been issued and are unexercised, and 61,667 shares of common stock are available to be issued under the 2008 Plan.  
 
During 2013, Board adopted the 2013 Equity Incentive Plan ("2013 Plan").  Under the 2013 Plan, the Company is authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based awards of up to an aggregate of 5,000,000 shares of common stock to any officer, employee, director or consultant.  The 2013 Plan is intended to permit, upon stockholder approval, stock options granted to employees under the 2013 Plan to qualify as Incentive Stock Options.  All options granted under the 2013 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be Non-Statutory Stock Options.  As of September 30, 2013, under the 2013 Plan options to purchase 3,702,500 shares of common stock have been issued and are unexercised, and 1,297,500 shares of common stock remain available for grants under the 2013 Plan.

The plans are administered by the Board, or a designated committee thereof, which determines the persons to whom awards will be granted, the number of awards to be granted, and the specific terms of each grant, including the vesting thereof, subject to the terms of the plans.

In connection with Incentive Stock Options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company).

Volatility in all instances presented is the Company's estimate of volatility that is based on the volatility of other public companies that are in closely related industries to the Company.

Employee and Non-Employee Director Grants

On January 27, 2012, the Company issued an employee an option to purchase 30,000 shares of the Company's common stock at $.52 per share.  These options have been valued at $3,718, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.4%, risk free interest rate of 0.8% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

On February 28, 2012, the Company issued an employee an option to purchase 25,000 shares of the Company's common stock at $.58 per share.  These options have been valued at $3,120, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.0%, risk free interest rate of .8% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

On March 2, 2012, the Company issued a Board member an option to purchase 250,000 shares of the Company's common stock at $.58 per share.  These options have been valued at $33,975, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.9%, risk free interest rate of .9% and expected option life of five years.  The options expire five years from the date of issuance.  This option was expensed immediately.

On March 5, 2012, the Company issued an employee an option to purchase 25,000 shares of the Company's common stock at $.58 per share.  These options have been valued at $2,680, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.0%, risk free interest rate of .9% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.
 
On March 31, 2012, the Company issued five employees, options to purchase 4,010,000 shares in the aggregate of the Company's common stock at $.65 per share.  These options have been valued at $759,810, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of 1.04% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.
 
In April 2012, the Company issued six employees options to purchase an aggregate of 80,000 shares of the Company's common stock at exercise prices ranging from $.65 to $.97 per share.  These options were valued at $17,310 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 30.2% to 33.4%, risk free interest rate of .82% to 1.04% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In June 2012, the Company issued three employees and one Board member options to purchase an aggregate of 470,000 shares of the Company's common stock at exercise prices ranging from $1.53 to $1.82 per share.  These options were valued at $217,293, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 30.3% to 35.5%, risk free interest rate of .68% to .72% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term or immediately if there is no vesting term.

In July 2012, the Company issued one employee options to purchase an aggregate of 15,000 shares of the Company's common stock at an exercise price of $1.23 per share.  These options were valued at $5,493 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 32.9%, risk free interest rate of .61% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In August 2012, the Company issued seven employees options to purchase an aggregate of 380,000 shares of the Company's common stock at exercise prices ranging from $1.26 to $1.43 per share.  These options were valued at $123,381, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5% to 29.1%, risk free interest rate of .63% to .69% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In September 2012, the Company issued one employee options to purchase 75,000 shares of the Company's common stock at an exercise price of $1.54 per share.  These options were valued at $26,303, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.5%, risk free interest rate of .62% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In October 2012, the Company issued one employee options to purchase 75,000 shares of the Company's common stock at an exercise price of $1.35 per share.  These options were valued at $23,263 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.5%, risk free interest rate of .70% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In November 2012, the Company issued fourteen employees options to purchase an aggregate of 1,295,000 shares of the Company's common stock at exercise prices between $1.01 and $1.35 per share.  These options were valued at $371,313, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 26.1% and 29.3%, risk free interest rate between .76% and .83% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.
 
In March 2008, the Company issued options to purchase 4,500,000 shares of common stock to three directors.  On January 24, 2013, the expiration date for unexpired and unexercised options of 4,250,000 was extended from March 3, 2013 to March 3, 2015.  The incremental increase in value was $1,253, which was expensed immediately.

In January 2013, the Company issued eighteen employees options to purchase an aggregate of 260,000 shares of the Company's common stock at exercise prices between $0.99 and $1.05 per share.  These options were valued at $62,662 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 23.3% and 26.1%, risk free interest rate between .78% and .89% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In February 2013, the Company issued four employees options to purchase an aggregate of 760,000 shares of the Company's common stock at exercise prices between $1.07 and $1.21 per share.  These options were valued at $199,843 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility between 22.5% and 25.1%, risk free interest rate between .78% and .88% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In March 2013, the Company issued an employee options to purchase 2,500 shares of the Company's common stock at an exercise price of $1.36 per share.  These options were valued at $728 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.5%, risk free interest rate of .76% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In April 2013, the Company issued an employee options to purchase 200,000 shares of the Company's common stock at an exercise price of $1.56 per share.  These options were valued at $74,159, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.3%, risk free interest rate of .76% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In May 2013, the Company issued two employees options to purchase an aggregate of 55,000 shares of the Company's common stock at an exercise price of $2.16 and $2.29 per share.  These options were valued at $26,954, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5% to 25.3%, risk free interest rate of .84% to .85% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In June 2013, the Company issued two employees options to purchase an aggregate of 250,000 shares of the Company's common stock at exercise prices of $2.40 and $2.92 per share.  The vesting of 50,000 of these options is predicated on meeting certain milestones, therefore   such options have not been valued.  The remaining options were valued at $129,343, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.6% to 26.3%, risk free interest rate of 1.03% to 1.48% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.
 
In August 2013, the Company issued three employees options to purchase an aggregate of 210,000 shares of the Company's common stock at exercise prices of $2.00 and $2.35 per share.  These options were valued at $124,392, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.2% to 30.3%, risk free interest rate of 1.38% to 1.61% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

In September 2013, the Company issued two employees options to purchase an aggregate of 10,000 shares of the Company's common stock at an exercise price of $1.97 per share.  These options were valued at $4,500, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 21.8%, risk free interest rate of 1.71% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the three year vesting term.

Cumulatively and for the three and nine months ended September 30, 2013, the Company expensed $1,446,783, $210,380 and $546,776 and for the three and nine months ended September 30, 2012, the Company expensed $81,588 and $274,757 relative to employee options/warrants granted.  As of September 30, 2013, there was $1,746,505 of unrecognized compensation expense related to employee non-vested market-based share awards.

A summary of stock option/warrant transactions for employees and independent board members from December 31, 2011 to September 30, 2013 is as follows:


               
Weighted Average
 
   
Option/Warrants
   
Exercise
   
Exercise
 
   
Shares
   
Price
   
Price
 
Outstanding, December 31, 2011
    9,467,858       $.04 to $.90     $ 0.19  
                         
Granted
    6,730,000    
0.50 to 1.82
      0.34  
Issued under Private Placements
    500,786       0.50       0.01  
Reclassified from non-employee
    810,000    
0.50 to 0.75
      -  
Exercised
    (250,000 )     0.04       -  
Expired
    -       -       -  
                         
Outstanding, December 31, 2012
    17,258,644    
.04 to 1.82
      0.48  
                         
Granted
    2,802,500    
0.99 to 2.92
      0.26  
Reclassified to non-employee, net
    (235,000 )  
0.50 to 2.30
      0.02  
Exercised
    (2,816,667 )  
0.04 to 0.75
      0.01  
Expired/terminated
    (245,000 )  
0.50 to 2.92
      -  
                         
Outstanding, September 30, 2013
    16,764,477       $.04 to $2.40     $ 0.7  
                         
Exercisable, September 30, 2013
    9,315,310       $.04 to $2.30     $ 0.4  
                         
Weighted Average Remaining Life,
                       
  Exercisable, September 30, 2013 (years)
    1.8                  
 
Non-Employee Grants

On January 2, 2012, the Company issued a consultant an option to purchase 250,000 shares of the Company's common stock at $.50 per share.  These options have been valued at $51,692 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.2%, risk free interest rate of 0.9% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed when the service is provided.
 
On January 17, 2012, the Company issued a consultant an option to purchase 200,000 shares of the Company's common stock at $.50 per share.  These options have been valued at $31,437, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 28.0%, risk free interest rate of 0.8% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted were expensed immediately.

On March 31, 2012, the Company issued two consultants options to purchase 100,000 shares in the aggregate of the Company's common stock at $.65 per share.  These options have been valued at $18,947, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of 1.04% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted were expensed immediately.

On April 1, 2012, the Company issued a company owned by the former manager of corporate development an option to purchase 250,000 shares of the Company's common stock at $.70 per share pursuant to an agreement that also required a cash payment of $150,000.  These options have been valued at $43,028, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of 1.04% and expected option life of five years.  The options expire five years from the date of issuance. Options granted were expensed through May 31, 2013, the term of the agreement.

In May 2012, the Company issued a consultant options to purchase an aggregate of 100,000 shares of the Company's common stock at an exercise price of $2.17 per share.  These options were valued at $79,978 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 31.2%, risk free interest rate of .75% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted were expensed immediately.

In July 2012, the Company issued a consultant options to purchase an aggregate of 100,000 shares of the Company's common stock at an exercise price of $1.55 per share.  These options were valued at $40,373 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 29.3%, risk free interest rate of .64% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed when the services are provided.

In August 2012, the Company issued two consultants options to purchase an aggregate of 400,000 shares of the Company's common stock at exercise prices ranging from $.35 to $1.11 per share.  These options were valued at $321,221, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 27.1% to 30.5%, risk free interest rate of .27% to .67% and expected option lives of from two to five years.  The options expire between two and five years from the date of issuance.  Options granted are expensed when the services are provided.

In September 2012, the Company issued a consultant options to purchase 100,000 shares of the Company's common stock at an exercise price of $.75 per share.  These options were valued at $81,697, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 25.6%, risk free interest rate of .27% and expected option life of two years.  The options expire two years from the date of issuance.  Options granted are expensed when the service is provided.
 
In October 2012, the Company issued a consultant options to purchase 50,000 shares of the Company's common stock at an exercise price of $.75 per share.  These options were valued at $5,381, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.5%, risk free interest rate of .19% and expected option life of one year.  The options expire one year from the date of issuance.  The options granted are expensed when the service was provided.

In November 2012, the Company issued four consultants options to purchase an aggregate of 765,000 shares of the Company's common stock at an exercise price of $1.01 per share.  These options were valued at $188,830, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 26.1%, risk free interest rate of .76% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted were expensed immediately.
  
In December 2012, the Company issued a merchant warrants to purchase 500,000 shares of the Company's common stock at an exercise price of $1.15 per share.  The vesting of these warrants was predicated on meeting certain milestones. As of December 31, first milestone was met resulting in the vesting of 150,000 warrants. The fair value of the vested warrants was $58,595, which was expensed immediately. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 24.7%, risk free interest rate of .76% and expected option life of one year. As of September 30, 2013, the remaining milestones were met which provided vesting of the remaining 350,000 warrants.  The fair value of these warrants was $549,915, which was expensed immediately.  The warrants expire five years from the date of issuance.

In January 2013, the Company issued a consultant options to purchase 5,000 shares of the Company's common stock at an exercise price of $1.00 per share.  These options were valued at $1,106 fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.3%, risk free interest rate of .78% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted are expensed over the term of the agreement.

In March 2013, the Company issued two consultants options to purchase 1,130,000 shares of the Company's common stock at exercise prices of $0.75 and $1.48 per share.  130,000 of these options vested immediately and were valued at $54,228, fair value.  The vesting of the remaining 1 million options is predicated on meeting certain milestones, which were not met as of September 30, 2013. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.6% and 25.5%, risk free interest rate of .25% and .80% and expected option life of two to five years.  The options expire two to five years from the date of issuance.  The vested options granted, were expensed immediately.  The remaining unvested options will be expensed when it is probable that the milestones will be achieved.

In April 2013, the Company issued a consultant options to purchase 100,000 shares of the Company's common stock at an exercise price of $2.04 per share.  These options were valued at $44,603, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 26.5%, risk free interest rate of .68% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted were expensed immediately.

In May 2013, the Company issued two consultants options to purchase 125,000 shares in the aggregate of the Company's common stock at exercise prices ranging from $3.05 to $3.28 per share.  These options were valued at $51,869, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.1% to 23.2%, risk free interest rate of .29% to .31% and expected option life of two years.  The options expire two years from the date of issuance.  Options granted are expensed over the term of the agreement.
 
In May 2013, the Company, as part of the cost of the Company's Offering described in Note 7, issued the placement agent warrants to purchase 287,255 shares of the Company's common stock at an exercise price of $1.80 per share.  These warrants were valued at $409,749, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 23.4% to 23.7%, risk free interest rate of .49% and expected option life of three years.  The warrants expire three years from the date of issuance.  The warrants granted were recorded as stock issuance costs and reduced additional paid in capital.

In July 2013, the Company issued two consultants options to purchase 100,000 shares in the aggregate of the Company's common stock at exercise prices ranging from $.75 to $2.61 per share.  These options were valued at $124,338, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 23.8% to 26.6%, risk free interest rate of 1.35% to 1.66% and expected option life of five years.  The options expire five years from the date of issuance.  $124,338 was expensed immediately.

In September 2013, the Company issued a consultant options to purchase 100,000 shares of the Company's common stock at an exercise price of $1.17 per share.  These options were valued at $26,208, fair value.  The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of the options, with the following assumptions: no dividend yield, expected volatility of 22.1%, risk free interest rate of 1.39% and expected option life of five years.  The options expire five years from the date of issuance.  Options granted will be over the term of the agreement, which is three years.

Cumulatively and for the three and nine months ended September 30, 2013 and 2012, the Company expensed $1,803,849, $687,229 and $818,619 and for the three and nine months ended September 30, 2012 the Company expensed $142,086 and $203,593 relative to non-employee options/warrants granted.  As of September 30, 2013, there was $90,984 of unrecognized compensation expense related to non-vested market-based share awards to non-employees.

The following table summarizes non-employee (excluding independent board members) stock options/warrants of the Company from December 31, 2011 to September 30, 2013 as follows:
 
               
Weighted Average
 
   
Option/Warrant
   
Exercise
   
Exercise
 
   
Shares
   
Price
   
Price
 
Outstanding, December 31, 2011
    3,184,286       $0.04 to $2.30     $ 0.76  
                         
Granted
    2,915,000    
0.35 to 2.17
      0.12  
Issued under Private Placement
    11,967,152    
0.50 to 1.00
      0.38  
Reclassified to employee
    (810,000 )  
0.50 to 0.75
      -  
Exercised
    (350,000 )     0.04       -  
Expired
    (375,000 )  
0.91 to 1.00
      -  
                         
Outstanding, December 31, 2012
    16,531,438    
0.35 to 2.30
      0.63  
                         
Granted
    1,753,750    
0.50 to 3.28
      0.17  
Issued under Private Placement
    1,723,533    
1.80 to 3.00
      0.30  
Reclassified from employee, net
    235,000    
0.50 to 2.30
     
.02
 
Exercised
    (2,995,185 )  
.35 to .50
      -  
Expired/Cancelled
    (1,405,000 )  
0.50 to 1.00
      -  
                         
Outstanding, September 30, 2013
    15,843,536       $0.35 to $3.28     $ 0.99  
                         
Exercisable, September 30, 2013
    14,388,536       $0.50 to $3.28     $ 0.93  
                         
Weighted Average Remaining Life,
                       
  Exercisable, September 30, 2013 (years)
    1.4                  
 
XML 48 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
9 Months Ended
Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
Number of merchant agreements with merchants to deploy technology on their websites 143
Number of merchants using technology in live use 20
FDIC insured limit $ 250,000
Computer equipment [Member] | Minimum [Member]
 
Property, Plant and Equipment [Line Items]  
Useful life 3 years
Computer equipment [Member] | Maximum [Member]
 
Property, Plant and Equipment [Line Items]  
Useful life 5 years
Furniture and fixtures [Member]
 
Property, Plant and Equipment [Line Items]  
Useful life 7 years
XML 49 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK OPTIONS AND WARRANTS (Tables)
9 Months Ended
Sep. 30, 2013
STOCK OPTIONS AND WARRANTS [Abstract]  
Summary of Stock Options and Warrant Transactions for Employees
A summary of stock option/warrant transactions for employees and independent board members from December 31, 2011 to September 30, 2013 is as follows:


               
Weighted Average
 
   
Option/Warrants
   
Exercise
   
Exercise
 
   
Shares
   
Price
   
Price
 
Outstanding, December 31, 2011
    9,467,858       $.04 to $.90     $ 0.19  
                         
Granted
    6,730,000    
0.50 to 1.82
      0.34  
Issued under Private Placements
    500,786       0.50       0.01  
Reclassified from non-employee
    810,000    
0.50 to 0.75
      -  
Exercised
    (250,000 )     0.04       -  
Expired
    -       -       -  
                         
Outstanding, December 31, 2012
    17,258,644    
.04 to 1.82
      0.48  
                         
Granted
    2,802,500    
0.99 to 2.92
      0.26  
Reclassified to non-employee, net
    (235,000 )  
0.50 to 2.30
      0.02  
Exercised
    (2,816,667 )  
0.04 to 0.75
      0.01  
Expired/terminated
    (245,000 )  
0.50 to 2.92
      -  
                         
Outstanding, September 30, 2013
    16,764,477       $.04 to $2.40     $ 0.7  
                         
Exercisable, September 30, 2013
    9,315,310       $.04 to $2.30     $ 0.4  
                         
Weighted Average Remaining Life,
                       
  Exercisable, September 30, 2013 (years)
    1.8                  
 
Summary of Non-Employee Stock Options and Warrants
The following table summarizes non-employee (excluding independent board members) stock options/warrants of the Company from December 31, 2011 to September 30, 2013 as follows:
 
               
Weighted Average
 
   
Option/Warrant
   
Exercise
   
Exercise
 
   
Shares
   
Price
   
Price
 
Outstanding, December 31, 2011
    3,184,286       $0.04 to $2.30     $ 0.76  
                         
Granted
    2,915,000    
0.35 to 2.17
      0.12  
Issued under Private Placement
    11,967,152    
0.50 to 1.00
      0.38  
Reclassified to employee
    (810,000 )  
0.50 to 0.75
      -  
Exercised
    (350,000 )     0.04       -  
Expired
    (375,000 )  
0.91 to 1.00
      -  
                         
Outstanding, December 31, 2012
    16,531,438    
0.35 to 2.30
      0.63  
                         
Granted
    1,753,750    
0.50 to 3.28
      0.17  
Issued under Private Placement
    1,723,533    
1.80 to 3.00
      0.30  
Reclassified from employee, net
    235,000    
0.50 to 2.30
     
.02
 
Exercised
    (2,995,185 )  
.35 to .50
      -  
Expired/Cancelled
    (1,405,000 )  
0.50 to 1.00
      -  
                         
Outstanding, September 30, 2013
    15,843,536       $0.35 to $3.28     $ 0.99  
                         
Exercisable, September 30, 2013
    14,388,536       $0.50 to $3.28     $ 0.93  
                         
Weighted Average Remaining Life,
                       
  Exercisable, September 30, 2013 (years)
    1.4                  
 
XML 50 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
9 Months Ended
Sep. 30, 2013
Nov. 08, 2013
Document and Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2013  
Entity Registrant Name VIRTUAL PIGGY, INC.  
Entity Central Index Key 0001437283  
Current Fiscal Year End Date --12-31  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2013  
Entity Filer Category Accelerated Filer  
Entity Common Stock, Shares Outstanding   111,396,768
XML 51 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
OPERATING LEASES (Tables)
9 Months Ended
Sep. 30, 2013
OPERATING LEASES [Abstract]  
Schedule of Future Minimum Rental Commitments Under Non-Cancelable Operating Lease Arrangements
At September 30, 2013, the Company was obligated under various non-cancelable operating lease arrangements for property as follows:


2013
    116,622  
2014
    142,570  
2015
    39,688  
         
    $ 298,880  

H4=L(Y1GH*1,'\M,A1JFRQ-08:H^J&05$16O5ZO-(]:E7;K2":L MU^J5@WJ[`RYF<^H MCK1.T2P8#>\BJ&=Z0T_#ZV@4`='X.KY>P)X'T(1@''X()W.Q-H1?-QG#J:+G MB9P8L3*BE/8/%W`H0$OA*H*[?5[D+U)O%4.=(FOA+S1A)M*V_>#[FE@GPRPOP'H?W=^%O1_[EQVT]-G7_UWM_?F9X[1^06R\::; M>+T?G+\?]`?`A9"9]%A.**D=)[?#V0T`.2R](/3;^62,:!I^'&@1,&_/&/I" MPRJ,24]A-%9&#/[GG3CA3%"9>*CO_-B#GE>'%N/SPI<]SW8!S[;?FR&R$<]6 M^(IU<QB[NU'-Q8.E-6#B0\3T513H`H@@.PZMJ4)<@OI9!E.YY:T2W M/-\#+I(8!/L)?5I%4*_Z<1I.P?%CUL5ZN+@/`%N0/@!(`2E$8@!BUC59*M-; M^L23Z-(V36(6CS5!7V,D0_17/Z@TC@XK[7HK^#A<,.`7`7;+DZ6M;A?S]R:"1M5F76_(>2D\^=[O1N,K\/PV`N8H\U*R!& M(BE8AHL/T0B*C&V&:8?Y;NH68VVP>H#-T70:CA&`A1,-W@1V`TV+!#2V"\`9 M(/B?2D#W4[@814LL_]IQ0%9['TC"BVDO7YK,S:R6$U'T#` M`ZUF@62LYC#:U-'Y0JQ89WVS!DQQYADY[=KVE980P8=.E+^'>8I#\.`B<$=X MM?9(/2PUW';J?-?P%.0];+Q\^LZ0I0:_6MH5_.F%N98 ML:"ZW\93:3AW5&QHB4GR5U(D)VN`!DVMU9Y`2+:-ED];66/.C50;6E=<`&9O MAT#-$M;04CUX%C.,YZ,QC(C;J?1LS1N0)/< M>*0Q?.B(VVGT=\81J0?(CW5I#QXRGTK-DD4VB3.:+[-'B%OPX7$AGM0IB>NP M:'MB7LL\[VN%QWL+YPZI$_7:D\'##>/E\\BGS["=F8XXXR,:\5@*'SIB:1HE MH--TS./YY\0,<='FL1Y&EV+IIZ%K\UCY=)7``5CQ:#[[;3T;R<'EQVAUBZ/@ M%=)<]BQ<>'*/,T=-]KG@F>9'8ZFT:GSS:1^]6CKM!U"5J:4`NX'Q!V4\M(TI.2KGO_ \L_F?9OV"@V&Z\S"K MGZ0^_@9K?]S<^>OV?9156&QT+.9/Y$3+#+B=0M^KQ",^VLD_:+A\ZLK&]WFV MQ&F3V)(2X7Z9(Z_-H*M>2WL6][RN+P6ZLL^7\$1Y.@&9DBR/&HZZGTFJ'AP_ M2:KXZZ;-W]X2J]WN[F7OX[C=.@U?@,$6L1KIW?D#YW\T`WBXV6H<2KF9TZB$ M#=&Z[[H#/`7N\DAMY1,<;CX].=NYXY;^-`*1EH37P\A4'=+++D+C9-RL>HAX M'.#`9+?:;L4:E1ZHK,6BQMI,^X%X`0KI]IRD#WH>.[=HS#^8<;7*$F/DK53( MR[M5.&?A1=VS+FEZG/%3U)TV?ID2=_=\OK',/%]"?:4TH%9IH$[WH'T0EP;8 MA8O5-`6B#<>.`@UJ/YD&(13Y!B1MUR+#V#04%RZA0E5K;9W06R8Y4VJ+Z[+$*-XWU^'#U-[/[5,S]ZS8\V$T829.*OT(PGFO]/6/_3[/SCUY^8 M/W_]!1&L)OAA=!J%F)`PA-;+KF^&J!8H(3`B:<6-J:T%I6>)\\`Q*'!QQ0"6FCU7B2*LM M^`S*).]1QZ[7OIP)WD75;5MI/"B13BI;<>G0_5<3".;5Z\&`3#PL@25*$:AB M9P.0$B1N*A6M'QCVE2@9-17>*&T;_9Z\@D1@U6H0[_'6-,IWK=05H'$/9#XP M\,C&2>+QEX'#2AYR(DVJ)"A+>LA&$(3P4IY0_$.OXXR+W;0/E+ZB8)'/S05[3^P*X M$:)Y*6SM!K*2M?=*UN;!'DJ:K^^EN95'5O%`VTER.9$Q'"J>VYN5M$>G#;C0%&W]Z)PU7EV1)]C=C\X!QWC`IG MPNW)Z7I:_/OPT\;?'TS,X..\<#+$E&Y+,OOEF]>G6#E,)059_2Y@/^,:>NR!7-(G/DMC6E-1[ M?_^B9GVP)AUIDN6:2_=%;>+93VU:"-VUB":[1`+[6RP?.#A8QSU/PK)J6 MG.LR4;AHY:1HQA*#%CN*LDK]9),\P5:@$8=7V7/>+1LUQ)R^<):`HI%%!T4"2"?B%3:D8A%_:\A`WU@/?VZ8*IM%&9.K_ MT9=L+9VLEN$(S296$9MSQ-2S9UT:GV5&0!(5'>G`R]!>F=>_2'"AP]Z;0=-C M)=5XKJ"J8II9I1]."O7,/QI&RR`AHC">T6TN;E_EXA%)A9RP5=_KR?QC81.? MDT[_Y^#UV_-_]X/7E^?O@KAE3N=DT/LEO[/:^#=-*B;ST9H92BM MX7A-EW$9V\1)I\#UDET49N@]8#O2$%)^D"U*VWB/QWSK6F#-W:"8%IDV+=2M/]NG?606-"-,?:0/=B/@K# M\3*0G!`%T=T@V=<6>:;Q45K2+M&F\UZZQF#%#W@/$IJ:T-U924^1?-3Z`7+8 MOS.P^2UGZ/&6L1/E7[#F*?V&VYT[JAM:$0=7]U"@&7H-;=XAMK5"/Z[+;J>/ MCERG7?W7<_PMD,UCOU+Y!YN6_H*&9V#/:#5]TWO;,S[OCY:[;. MZIV?IFDOG`>O=S%]X8O]]Q<7;[MLI-IY&_1/?NZ>OG_;Y>-GYV?[*GHY\O9# M>G[H,+J,!:OA)[FL%(VS#YA^9&RTF/XQZ3Y\,;#6?[B,32M1T\QWONGA-OAI M-;4&&;H2+OQCOE'ZD@1:`7H4<3T#?-(";SRC*ZB"9)M+7^GE]=^_>]>Y_)6; MU.^].>N][IUTV/WWY.3\O?0M#2[.W_9R6Y>6?G-#<^RS\T$WJ$.N'D_'V5!N MB6.);)[Y:KV,9FBBEUSG@IW$?XD6JS4\V45T5F]I<["<;LP%\B0Y[M0HK>\-`Z(%-X ML`@:NKB;:P-KN%PY.H8Q_=1I,Q_DBH"BZQ#QU_Y/,C+N9Z/8/; MD^?1VOUW&5_>>;;4CHKH^,IVS\#XPP\PZ_HLG#QB#XE.;P!Q65)6;(5*OF(6KUS6" M/.#L*=PA8=[P%OWWN3$K"(5;X,?D*YP1%9C!^D[&6:PG>HX*X*ZON(;"`0+7 MV9AO3Z(IRD],'WBHBM>&?P!:DGL,/SA>H]8SG)$SQ):RE5=&7_$74"!&%.C% M\EP9(`$S5[?S'CWE%T$=WR682@M.@9C<.O3%A-3,EFB(R2YU[HT3L\/@R+E. M>,'<^>@^`'*`Q(GH=##AWL[)^<5%!]+/[=:.U$NL;X(FRT+53/J@PGQ8H2&3 MS5B0]Z4(=G+)'^%H)D--\GS2R[DHGR'NFNV2=\.//6R,.[3+]] M\MA8K@"X$MN'H!N7,!IUX_/%6/I6BJB_ M5F")MTQHQ;4B"X!/=RQ@P5[-:2IR?SK!YS[0C5KH@1*\[O1?H4/\"?3@N'XH M,,)K8ZOMJ.D())(284@OXKT&.%TMEPDU@)#I7.")[EKQNYCWRB+ M;*4JJ^2JU]S*&VH>@/0=#F2?!?D@U90N[1E17< M-Y9>XA)LYW3X.QR*I5;V%4'K>JK9&^P_7-`06PX;P3%!.>)YC#J<:@@+^C7( ME5>].%-%!"$\DB'02VZ^"B((QI#2[3[[CLXR-JZ4,^9RA^)71`XN986S-1;* MAVSCWV`<=U_5-0@;0WX;1/811I#@"`Q"SV/JS'H""8]$V"7PPW386L>IC#FB M*5J$M_@B`[5=,7Q:.`98CS59UVBYS)R4%;F@`9."78^I@Y/W1B3FF(9":W(J M_4%!!/(>@DXF,$.@(N9=/.HTA!\=*]"0W<7[DS6,&1_%KU#^Z:%%%9"41,O1;")(I-;]W40M]H^) MSS:(*%"B`(06]Q1GP&U-/#.?\Y6C!\,[>!Z<60L0=+<>*]C?T9"H"'N"_8(W M6^)+"RO8$4!!F*H,+T^0%X7&Q^;N1.';9;3\'6KR83[Y0-J9I=W`4XQ/$8-, MXVL@_%*'<>S#%*L!2$7$/MY&;$,.8$I,#[R)'N[$Z#2'(RBU^CNER#!3?].8@AV@[X;,O8O3@7[?P+M.[`;S M3`%+04.%\?!>IH`3$O!Z14G$LC"K_'_Z&\.8C%``?6(&\RD8_\13 M'$Z>$I@EZ`!>"(`#R<%`:(#6N&;;6!ALD'XS1K4'\52$L"I:B.>CR0@5SG7Y M&1T3R8C'GR%L]&8#VZ;#W[`J\27^@^$G:#.%UWL:NV,^>R'6CTQWM$`"%1YR MR_FUJ>CF%K0SI%.KS/4PJ`2875_S(QETE;!8\0CX`7(M"5%[72%V2F/@`HDR M:/L).G6!'8B2FD^`)NPEI!Z22)4F=?P8&8(&`5,Z+N&6\9O@,($H@#64-K.+ M-#[T18A58?,?<#V0F!FIC'<_R3M,9QQC)BT&9'6]GF!= MUYEV_WOP4W)C(]-/_\OG)K(KAVG)^O*YG?[3)5P6#8#DR>\IXV_GLYO]MV`C ML&/.QWD0\16D+GK`U(]!J(H_@3T[,=*+46P*JBI*;;9J^_AD&BII=3U,VYC, M3<2TB\W>/''*I!=K$A0#)\?ND$281MFS3-O)$/:-B*J@.RXV3.2'9-[HA.F33RS\!'X#?`1N@X,"1]#6Q9_Y6`4+6!A8'K@ MT:@68P8.A"WT,[XC5G!,&4(8*Z2(_YH)/$):A7B)$$GD#6>&F,8-`AI5S*&^ M'`%H#=[6XF70/IO+0AF$T44C%``1R:!/SIW%CH"R<`B+<66^C";?(83I!ME8 M*XAV2Q7WD%B@N-LYC*I\?,E@1;-F[/E8N89\Y!-A!@3`0.!!!HB;JR+ MW!+KB0\NBL,5LQ:/Q=."*8[38M!.@S1BX&'N-L<>--A#FLH<%7)[L<_T7,P5 M2>8"D)V;B!O(2\UN$"]!=H0)(<5H$_C*I5[/;P$ M!11$2([B#U*D\@K\@?T7&?-0I!5>-"!UL(\/*;-T?/&WZBTPU3*6W2B@`HN]N/WUB'TZ4@!Z,E9@41\4?B"$5BL,M`='-3)Y- M\)1L)I")I"9!M5E$BL$95TLHR5>1Z018X"<^F>+DARV!7<`"U-GF?<6,B;8D MPG1*B*T@4V%-/+5C/LXD"B`EU]#7X&9.35F9TEO2X#T/J"(`:(&<-Y53M\$K M6^GWV52"-[X^MIWSZ]@RU&P,$/NJ-]YA2?.YOPX"V[$9-S> M-_3'A?SPX,"W\;K\#F[.V@A5(!%CC,ARMVB'"=(J0=0FBTO2$DBR`Z.F^ MT@T'>]%SRCB^3R.YC)#'R,9;X`Q@C=0#TIC&#B#FN5HC%P%;@V.#&VV>H`:9 M3P"-03\$XHH_@Y7>BS#\$#,R&QPN*E1$-PI>^8A#_1#:C"E`'ZHTC->ZF<_' M^CK>YU+@?V',8/2U/`2O6A5CHE_#KKWHPW-8`HC*"`2DYJAX%N\@F#<9XQDZ5B(*?">5X`,?12"ZXZ@PR'P3-6E)50.=WE^/"=J">;XDJS0A");-/RJJEM?!C:M)!*P**$=3``^*)`,Y MB0&-IW:%9-[>&!H-F/"I`&R`7D'&H4T\@#62RG=-J&MPFW#!IMW`1GQ\%/!2 M."![2HU7QWN')"N-"Q`M_L'MU%#!3S6;1\'X/')]N<6."F$#4*3-!R3K+%]$ ML)FR59P97]!OB\!&"7;%#&B;YEB=L%[%N? M%Y0>I*Z-EE'76(W0+X&GL'+RJB6?8)WY?J`5O#O\!2+NDL"0P&@DTC:.<(R- MWV\9X"0G@[4@)BAQ_+HR9"9/``JJ7 M++D$#=*2P%94<@]=#0O@-*==1?NR(#B-OU,P($/(RZNIMKKHR"?-648P/T5! M,ZR4@;GZ)3Y.GME)H)+%:A]'UR?90CDBH9>]G(2$.>D*V@US;<'#"M\0JE0R MN.@/!2:P+,JJ4JDNL,0[U+^$]-JO6]*&^%_QR^'\%K;SWA/UP8X("Q%_]S:' M.C&$D$)-Q7'^M,I>PDK.5G`^G3&D$]KDI9$N%O,9'*M^Q2[CFSOB9PIB"*M4 MQI9!"NDRQN%8!!H"+\*).((X2>8?FOD]GPN7[,VOONL691E#F"L!,I,@U%-& M."1/S1-G*;&3S*B`6SM+PC8M'0!]%?R*TR?#I#03BUAA%TO_Y*^5-9>8SULJ MJ#3GSC-,=8^I+#_487Z4HT5)KCSAZB=`">XD.[/!)^8PSUH?@P3$H>2"$"'/ M'N69L;%,O,@BS_&I]7<1-9M`"#'5C^S;V_.68J) M;X2?="_/TGN1^'%;%5T#>=[$"^G1!B"(VR3Y:AKR+0L'W7?8;>PMS\/Y@B`N M3S@U(X&%(P!$-(K8>6C"9?P-1RTS]>B>T^*IIM7A@.5/LF5(\NMYA/A"XI$% M,O\C3#T+^2%V9/-=NDNKD,T]`A[R>`?;O@6!%-[H:3'6S8!ASC,..1;"N0/^ MP.L3D%3YXN=XOKZ"F%XQ9^:M#\IGHQ5LTZ\CT3$14(X_?/G,,T=;KL4O@F9W%Q0".?)M!%7( M,!*DV\HZ.77BH)Q2PZUP_.4SJFEX?AI^^0P+B=H>EO7!&,-?!Q_GB]]%SVY1 MMB$08?GE,\:CHB.E"97SR"6WD"Z!0-B3UND<]3G)M/`52@GA9$SHP/6X$RR1 M+[!_CB)]/"!Q.3<-NIT\BEHB\";^S)?`6?@)$O0QG$!D)4N%U)OJH86OSA3*X/8.LT-$?NW28ZG#W%CY:SW)>8NR9:$;5D MDH`*:J)XBX1'B#JQ56YP;\/L/(7#)]5!MYTGY7C!Q%DF/))09WXE>V^T7"RB M?CN#XB>)!"05QKA.0_5Y`1=!"(U<1WP?S5E$^DU-R"`W;0K0<,IL7E`?:3V27C%G/W0MFDV6/+%S$8-G8UI'M3:76KP"J0#YM$SXZUTQ3@ M4,@DO/4IPV)H@XZCY@+`A96"FESB80BH(R<,`2G>BMO'"&NI`-65(/,(:5C? M&="3,"^D`N8$=A?'"LXSS)@4@`EQ)%MW8M,CN?`"::@Q#IM@]I,HRTY8\9RA M\Q0RI^Z!X$-/*)U.>_!X$*\7#;,B+76^IF+6U2YZ9^G)I-52>S=4@W>VZE/V%GFW"?;-*`\0+'/N M'`;4='XREC,$0C#0S$1@&@;:WU;38^$\[A4Z>9$,SMF2!/$Q)6XNZ.Y3R9O8X3>3UJAJM.<'NEP#@V M0T*MM6GQ<)1J;VJJ%QUFCH(9%FIY$54MN:8\6R6,1@`D-LM6:F#10Q2(@#_@ M"79?7D3.2Q0VEEDRQT&<-7`12E!9:^$,`'VAU7YGQJRM$4PU#G9;E5J[5CD\ M1NLVEIGQV$S2!<[-;&0`+[4[9_&,EOMKV.GEDF?K(\0`/+6!TF(C/$6! MW?*'-)!,<_A\;+BB_Q,HAQ?Q\[6YZ.#)-_4`I3",D.&LQ;2;(VMQW]!,!<*4 M>A4G_@MG72A/A"_P?"O2U^O)-0\]*0(^8I3.31#&EG5!#S0$D7E04]?CF[YU@$L4(4U+9!DY@3CV%]1VI&\)63G!%RWA^W#Q@)1N6Z$Z0%^$-CZM<)A4+AMLP`VF=I`3O MZ5(T"B=R`"S+PG"0?_0=QS`,OE`X@Z-E9B)A=;#[HA?Q:;J4DUEUL1/MH619 MZZZ4^#SE$PEEHJ%"Y./F]BG3X';0>-U@C(W1G MN/W7A^#\VGGUMINV>(D?MPG@`00P\4)RM.+HN)?XP&^-U]1\Y8&EA*(R$Y'C MG2@-O"\UQX&W:<4+\RL/CB1FW]4B6LECLU6OB#UO^,,U8T@U!.Y6#:1/'B(4 M@G!3/A$:P.[A?A,R(?Z]:V/^-9O%Q^Q,8Z1AW/><*'(J>,X5@584Y.*BIW&'B)*\P^._[_9$ZFS&<'+SH.+B/4,%7B4T] MBL9A^NPQ>O.X>O0WRE:K@7\@J\[*\FN>`+GZ+YYFDH1J_6_")NF["'04?-POUG;Q^>C MLNF:;W@8A*Q]LG[GS\K;D.VRI5>A"**T(:$%LHY0%#R/J_0K.5E/5_QKKOOY9`.F"PH_F[KL'*(8U;^9;=Y5*FAQ!?S.XFFF\-V MHGZ%9&JTR>V6%"0QF$S<$X#C.XDE+ M$ID,=P0A()?QQ#PX;#/L.?(4E/.9,)#P-.%$,+ZU>+0)SO?8+]+$:EX\2@8V MH#W&^;MN,.C\=[>?]/,X2V$F M!4)`,&RM6;S?WBT9>YH"*IMXUA4U%DYK_01P-1/[`KI!YD@;-`&G%+YIIR*5 M9<)B%X5B*FX#PS&*+I*FM$'N:$0+6'A%2@Y[\"0$NB`F_N.*30:L@F#F#V0C M_C7]3>SN.4!MCL&^`JPKX`.``035G@82:7)S;%T>5-E%KUH4Y,=1DK>A9+F* M'42]2.4([0"%#($Q`J6-@\("JS,6SZL#N7(FMRZD`GB($P-622U9VGG3@),):KR42IQJNIIY;BJ"?3;8/3#^"2H$'[=>:+NNQ#/Z=QIY9V/- M:;S!0G8TJZ363-,*L*(3GK7M);N89<%U31;*7% MDUDX7@H"R7(4>Q_RHI[2E6+8^"N.>>F'_N#\Y)\_G[\][5[VGP5L;33X==M6 MMK&5>>]MV3!61\/_A8[+Z:$%O8Y9Y*'5<:1RT=E,DY25,8-:BWCR1?962G'`K,'3Z6>'\068071BCRDO,. M6]B(9L,XKK"A1!(]&;N8G+!9.6XT*LU#LR112BLP#230V@AID1G8=H[10'!2 MJV5\F$/FB"FS,L:UE4@L(?5F`Y,DOVW>B5,_F=F);5R\"9Z<9-`]9&I[BL@( MM@OI_VCK9+(0U`Z0,BAKG51K(/^IE`'YP6!88"7_0_K!4`O&J*,AUC)GC^[O M!O30%WJJ#:T_0-7/9`(?BKF"UXOYU(1R1F"HC8G/[B9%6BU>!:)5.6K6C74@ MUEPU9CEM'R*O\&6(P1 MDHN:XKP&OB+^F14`9*HB#RGC\J;:1>:.9W54+RQ?GD+&B@F9G;E*Z67QKQD)-\=O7$=$A,%)DP M^6!/*2E!P0-`(?,OUD_&GW$U6>+9?+;_OMJO,B&^9"D:'F45C.QN?)O"KMP9 M[;'ZN_J1[(,5]0(X4O/Q"`\;U5.-<;7=GGBBO(#5Y;;-J'!`Y40VLR\OTIJF)/RGC&8C>.BNG.L^#/&28"+)H:% M/$%-H9=.RO,0@*A/+L@TPGTMQ:W.?A*U8D2T@4=T)?"Z7FFVFA44)5A8OE'L MA/FF_@=^R!1<>_8,ZD"NQU/P#`3G>\A9'C:1O?1/+)#+3W^5VPP(GLC>26F' M`;5EK=M!D77[QQI'T(X4+LG:'@Y= M!I^9E*[:F*7RJ#&[>MP0J\D4[.=03XC(-`_/B,ESE90'V,NBX M3P_A8N\6"LT720MCNI21,!Z!2$J-((^K-"QTT[_RIG?J:CB0H.;K8URW8&LE M.3[-M/GAE0UIRT;!7SYWQ&[@.R8H&`[<48$O8PF+D^>3#+3WC`UT+7GHF5$P M$R,Y<\>%^''SYD169GPU*"PT=8#7J$C*6:4W*-Z3PKR!0>:RH^;U5*E*',RU M*\.+8*-92.R=:HC_SJY0>(L*G$K[*%LH%2-Z]1LI]AFWCM.X M0Y0V0FND&QD`I)&*S5X`AE\`P50JM9S&:?].O'J*U,T(U_SI?B%50J@7J!P< MH_JRKHL6V/L;3D4$](JYE>6J&*#@+'<.DR,RV6&`A1@HY`4<0$D/B*_D,@8. MT>Q(:?(/4:I4.TK$648K8K^,FRJ*/9Z\,L-0]92%&8WC:NUOF^LQ6L>;"S)$ M',0O.E98]DFY#74:FZF>TY6L2O$)Y,7!,#DJ-A&CU*=`(FW!HBDB@[]SA_T. ML[LO<=)19RP+1\V)>`7TJL>#=GQ$U)H\+=F<4U5DP)/]5)547KB(P8W&T<]) M2B0-H`%LV_C?0X)V20L7Q(WNL\L2^>U13W;.V?X4OF4';3N$KCAKKH42@(FP M'\S5@MO$"WOUYZKJBFJRQAD>Y7'DO=%16M.T!?.8=. MR%4_DB?K+.>2%["8X4"5Y9@'"7'9%FXYX'@Q/U&4/XZ<*7&:]"BQN4K_0=)8MWC>Q:6H9 M+H*,F6QW6:I>;2R;B?,:2&XT4$%5RD\4[KP38I68O3Y0]1DK!X_V^Q*LG1LC M0'7YMTK?\GD57PI8)?(A_A;:U)O!?<@J2%\D/I+AD,BU]EHTORUI`2"\TI5$ MVZDBYMH]0-*R5:D?MG.-2IYA,34KZO'>;!_5_[:W)F+R1DZ"NK2"YY*+$UOB"N1;"7HATR'#5 MXQZW7O+*"OZ,#4I*9\.E/\JO.?FY=LY2,'0+T*J52&AL9Z=?=+IQ_0"&-22^ MLTEOPP$)^4FS1T9RFHVOK['PH2\?\/EWY_*R MD_.%G^(GMYV:']E3\U+S&*:Q"XO:NQPHNKXNDA,81Z$,"6"]PB1N*-=$IL=$ M#L!6X=$U[H3*F979K>1P^B:PG`08!_@0N]G^'M$>.R9?\L+/FF3C4`<_UH^/ M4*3(K45JC93N[<2BD'!/.\]EC1U<_4E3GT,P/(QVNX:;F,0]]R%=5<<8[:O[T7XFR5@;P=?R80719]O;-0]6N'-\4F8Q*^,_R`3F_V M=A*6:8;,8:@P/PWLG2E@QD#-0%+!43%8K.#X415! MU25D41R""[2Y+]F_6/0/RZ\**"/L\[HIX*@;5PU!.H;(.QA/^*RT7;`*QK9Z M&K+3%L1VP%-AL_Y\%<9=A#N+]]7V&;LXG."C0R*!5CZWJK>=**G>!5I12O_< MUCVM_FW0,R6K4,M\6;;+M?S!LAWX;E;:-<2$Q7:^M.(A&]70X^$BEV'ZE<7: MQW(HV:RD]37T9I#;0,,<=#H1)1ZC$PMO![&&QWA&449U-BC:9%<5*4NB@$:K M%=P2G51(?Z3[Y.I`-9.BA['B9.!]\+DL50:;'C!RI?H95R.9I\!5F!+W#($5 M/14KV=G:)2Z5D,A9GO,O@/)9-.00*.NH]%J[\7>F'EPJ[`Y>/OMYG5XV>"R0 M:UV&-9YPM::*3Y0R('8BD!UR$G.%V##!+) M&U./$H<,'KV9%!"BS^IA(W,$P)NLUFC%=LA+\\)ZU0''XZ-:YTT,9]CG7??L M+Y$E/:P>;,Z2HJ3C3\N24BH?GR&%9,67@W(/`4N+ECE,?H!H(:N%X$1>L!*R M7;3JN!#Y/8G6M@3\7UBR]&`LMX;/2I4!ZGK64V"SLE5C6XW68R0+U;9,77U' M5NMXL]6J_G%'.P,6(AGTPCI39[`B5+&,V3MADFX8MWH)VZ02A%W)5H%:"<(! M0^Q6[1P^EOY#[!)N%W]7!X.'6P\&_SCA.4^="WZUQTL`,IMIJJ5+;'8BJ_:A\>5(Q;L?B^VJHEK_9MM M%:JS#OZB$*OG;D!GOO5AA&T9H1:$$I14GR9M#T[2X M-B"OC6/DAK\C@6VJP!Y6#S>;SVI+&[!4VQ!<[B0!F'Q3PH`RVU\E+M:Q$9ES M?7@%J>+'E_,\R&TS&^UA0W;[A(EC`D9NJ+N47%[5#PRN'*(68D:*L15LMSS? MLZ=%.-,8:+.YQ>M)B\L\%`2VT7R0?3VL'!PWOQ]I;2#>P+''AMX_K?I?0S@S MB3VZ>*VC+I2Y)<\:G=25\_+-)W7SD+^6L9P'#Q/$>@/EK$>X)?*]6,Y&$P:3 MO$`!9'V;4*J-K?Z)A9`/LIQYPAD?^!;*YU:;:!HQE$WO%=G`PX,'V4#4*3=K MWY'/;AQL=]5_$1>=)VCGH]7\"CG=/UW,_.HVBV2\W'(&&S8KC=;WXVM+2%F[ M]M?UM>[N4*&87>,S"3B.?*C#Y5FY]ILI:^:2."_^>!S07JTN2!O_>J`P-M'! MK,DBEN_"W5Z9S^DU6K:W(YQNH17/!?(6C)LXCF#,35)]H3 M4)/ZR0N@I:HS%3+C*#JNJP=PT>C7;H[@WV8>99Y MLOW.(0_)(HO%*L79CO6CT8Z*=QZ>^^4(.)?#JZ:4*X;R(XS(=(^_R6,`>E+E ME4"C(DMY"TYF$@I- MDQ/!`0?E>EZ?("%:M=-I[1@&.,2[Y_-@7!"7!2T&T,;/QO%KM38`3*U]W3Q( M#TZ)6M44#;LO!:.@4UV!400$EAGD?1AMGL`,`5%RM\A4BT1#PHFMHU+9L`!( M7ZNI'D`J9$I(A@>A),V)E;6(9/F^BN4(,R8;'G9JP5\765YW`O9`:5L$=G&, MB!:&'?K>5;=%7)!.`1Q#@$GPTJ%\5;GR&(`ADUH=!-=M(P`,<8<[`V1'I8SW M:P@S2M93X^N.QC9'%9Z3HSN#!0ZNUZA:SD[\BSD2-:!4$[P)$'#&U0>1-!`.V%`H MKUC\5,6U550V9U46!H)]ARD>BI-R*_]AT=7!NYJJJ-.PTCQ@/ULGB*/$Z>[0 M`X'&@ZP2G12>!M>NS!+-1OL58@#96'RLV@V7C-IMR6M!6&J>]1545,46@\Z)XA=2/Q[DX]!A9,],C?0`[M>5"!#,Q=(XL!* MY"ZV<00M*]KF2GJ,$<2%]2CUMUZ;B=UR%T%1U>17A)4_C99_GZQU["T+G3KH M,)!M>RC:^(3FG%32C7>5O>2KU=+YRJX1+XDK=+H*@P&*F_R2T*Q_!Q09E@5G_V0Z,_*$TXDLAB_Z/-S;T;]^FNI--^:W?4*H.;!0NJ0?!-_\'#IF; M//H__<%EXH-&]\C_]L[_08XV6/Z>9O?]#C_X/_25&ZY#%:O]W.33P6\&-[Z%60).3"X:]%)P4 M';4^E_<4G3OE@&._]UZKG5A+N./4\6"_X$W[S9VQ MPC/R7WAV9^2G2^3EWO<'(W$L,7^VQQFX`H#+!:ZFXU7+8G>1)AWIM3!@%3FV.A"'=X9E/TF%4^!1?Q\F=50<4E'H.I4,$3*= M7D;JV]D:TXZ!&[[<<235@M$2HSX*XN$/DZ% MA?V1D="L(#+*?5%KC03\.MH]=E4/H'$)=5*!0I3!!=J MVP.4)=H9BOL=P:]D_)*<-RJ[I4&+4"8L-I\^%0)#NGMR MVPI0)_L*L,^5)_9KI)FCO:*Z=SDZ!BZW?D1-2HS^$RV/VNPXT-.BA'PMV^X) MPOUWQW\@#8"01O\PEJ\Z_@1XE<=N_4'PA;##>@Y\;6C8NCOB&P6DD/#918M& MYSL)T/9%"I67+"I4`.*L&:H8IU5A!'VTUJZ)UO(X+0C1AA4*2!2^Y,UZ/GJ' M+;C7XK^=H;2M+KF1XRP.H3(JMP4T6EUNV>C@_Z1K)2*8#WJ%OI=('NOTZ)8Q M;CH"5CS_J`,-:WOH@2`!2%(UHHI<9X@4+DK-NC*4.1?751]LK?HI&@>1Q):> M_*+)O_95*+"6%E-?T)9:Q!>&@0Z2$NX.4!XU.A5@L1@&/W(*/0*FTC(*IL%+ M`EFIN@68,1G/E02P(-^Y(VA_,_@ZVL%PU7+GT&9"GT?AG01>(J")R4W%A@`" M]?<$<`V!VH2IUS8Z3HMHQ`L?B[%UKHSV5HOE2NIA?/+;[;R$]QX'<=61*IK' MQZ@;L$.9>1*1&L3W29A62%T59K/D,09\MD4"_'P"6DNN,*;4$FH)_;S9*,KZIJ M&;<\?I-/**B1J])`>%G2:F!G38VX916J3HJUD(BF0%O,I1F/_>8(M;812)F* MZ>((,?&+W+RJE*#M1C=!\%//0C"NW)CEYL2HKX+WK".DN4!=MIZN4"5,%@3K M7B#=I^TKM2GEGLQ3#&[4A[PW1ZC:=8(,**G;)`Z7Z(-,(:2ETNOV[9.D!TB% M]Z5YCQ=PX`8)<&K'RK$Y^DW&04[R6U1_.^CL#F=+,7OEK$?WNW-`K:[(!+:/ MAX\2QYVT_Z#6W]=%BP+7HL8/!"B2#B#@M_W`P?(!%# MT(KHVAU\GT<73:G\;KB]6E[?"BOQ0N;P[R9$!1JQ(+E]_ZW41@1:D/CYR MA`HF=1%:^XKBWS%EA!4$*ZDA"#QS#1/,$^%F#3(>"P_43JFU#!/O0)0@/(>4 M;.;>*)*(W_1G(0#E790M_T&5]"`S$@&92\6F2.C^,,E0SGR*]$BAP9]T<\B` M/XN_T20->!D%1RM7.TH.Q7F+_J-KM_<[.Y6WII.$<$HQ5Z;AL'R`G)]!+H"< MKTHM%P??`KXB&2:6Q/GYC,+3VC;_]A`P&N=:1/N#$==W8I7O%0 MZWJ1KRN1'Q;!=4K7>]@LAT*C1HL!H6F00*>^+)I3YMI*I=5YD8)$%ER,ZAG% MD$7:H@K!\K=5TDH-2BJN,EY.'^"E"J"\IK**4+**-PMP+XJ3*!=7V/=AW+6L M.NB(=;G[!H4>Y;"!,8UX$*#,@Y/]+F2-/X9WEF6!%D[7GYE2*6]J"D&#\^_F M266A_C-\7%$SZ=?IXP3\VI?I9(8"5T;UD2\F`K"%30QGBS]2XF([H'-RFBCR^$)0#&JQI-IG8-B4/[N8,,`+4WEJ0O$(_]N,J8TI MN@IGD"E#W7CT/$6RER*_`3'LQD-JDI@W;U1[:0Z*S\R^07+9-_K(6=]D&$^7<2V@_%;Z MB*8,^G_B)Z$#K.>N@F#P%I6XM.H:0:FOU),4#COE>@7`50(E?DN&4DLFY71< M5&*0`#\BO(XAB^XB%6.U1]0LDY_#[ M[VDU=_B[RE[K_XXPB";-4[06N^.BTT`A9?0C"'']4W;9[PWZ`_]4_.^I*M`GJ`+M]_''/-\V/G9!V0B7)`!I M3*8C`6>4G1`<[M-BPW4%Z3$T$6G2;NL4:2VH=0Z;*J)U.SP*FTZ=V:&[[4C& MCB9RGRADN2Y0I2I[D2!IPI<+E#'\Q&DZ5*CCKZ/E=+%1J&K,`,)(;`$E M`^)C(>CP"<"B3P5"V/^7L,F2(G+09(VPY#AVN>M?]H;]L^RV=S?\)1NB*OB@ M=\J%POU[B[=,006JC;S+XMW]BM)+ MRKEMUM,9\#F*77`-[94Z$ZYE.L(O,RI6Q;IL27>2Q];P:S* MRT^3@#G058MI!8J'(/FJ2IRWPP[DF%;J_S"93U#<=`HPIP@#CB5P]HAR1K]Q M:A5;I9-Y*=PQ%3X7!0-6;@:>WK?'\568[TL(A_RH4`P]8 M[YP/3^R3"HK@ZHN]C[@8+)V/,>^2611Z[%PV(+4D+JG.9V=C5!N`0PY=H^/[ M.`&D\;D^;I;TPQ90PD+]&QWJ+Z8D@A'S6U=M,7>'M2=J\67=3:9/#YOEBK'* MPV8U10X@4^R-'\T;"M+7_"(9SKHM97OXNEURB7'([<04Z*S+ARWPO^T7&%SM MS$ZAF(7''%?';F.I'R MHW,`ZD85CE4RB0#G#.ZOKGIWOV0WY]G@XJ?KB_.+T][U,.N=GM[<7S,1O[VY MO#B]Z`^RO=L%*N&B!&X0!CPD;AB!U7-&,T`4:TTP2!'Z;&OS(I9H3"HE(C?J M29Z;7CU\`:FE`QA086`NGJX*#!5^.ET\4M%FE*:0%[Q`Z+G\"\<3#O:A MI\^Z)*O0CLUP[C*TVLPUL"D#V7R\60)SX>7XDX%/Q$*0!J3W"!4*D)MS&K?+ MQ1R'IE,5\.)-<\V)QUM?PQK["ZRQ>EQ_WCJ`,:1''H+%8/P9RL$9^[1BJ9IM MP`GW_[&9\OGN9_>KR[1L0-0\?G6^,J= MLSK?K#<`D2OD/'O:/"%\GU-F`P.@1#I!Y2J[GS^""M&:%&_/2/8&!ZQ8MTM. MK=US6#=_9[WOCVFL`W!G0(#3V>J';.]^<):]"1#2]>:)2D^`]AHO/A/%"(\I MTNK+!^9"'B?/LP4H_F3\>;Z8+3XA&I,M>=,EJ,;#:@HVSS_!<(H5`KB9,MM1 MH)6>48(;H&>___G9Q2D8E15N^A&-<+5^"T+Y&[`#V42>2_;7JPEM[&_9_QKH MD)_\WO+@]C,D,P$FHQ=@WEWVUTO0X^P">'KU-[_GVT/E?>[_GEC/Z'>&UMAZ MWAX5CWJ^6)A?KHA@?/TYOJT?W>=[:4`I,=R M'8H?3BD[$8O?<"[@W"_&,.9/?0N9AI&/'?P6E([>HVP:^*P0'OUV_M`@@X"Q M=Y>`E5O*R.,O-3>?R,PL&*JS\-M?WPS!.]SV?NG]>-E/7TR0@<=- MAP()C74T1FKC'^3P_9F1;+V!8#45?%WXD;3H&"+(90/-8P-!1?RQZ?>\ABUU ME=V.OC#2I2<%89BH+7,U95=UCTN&2F$#(7!)Y^R/C+V#+R+Y8H.6_E>:E^02 MGA:2+%2*N+9*K9]&>%2T3`I%"L8UN%+[,@.BIVMHBS)(1F)6]#OI?#'$W=&: M@6AC+3757;T74@R8F1*=`H8M6@Z1.7S2:R\DNST?`T*I^!):@&Q.Z7'_Q M5TR'2]CY:?$($10(69LH9V/.M(8I,0*;/]_1LASKBC_2VQ]A.O_[.W`W"W`] M6I/-!V'&][NI0C\R0J%@E5[/'^_R8GCQ$S2P-]?9H#\< M7O:O0+?2`Y^ZB1QH_:`]P`-T6/X,8"[&D\DCV&>E5@,7P]AO#!9[.EGZS0?$ MR?_7S>59_V[P-NO_Y?X":L'D1H'KKTC/LLKZ8'<#;`F="Y"TTK@$&#Q/(0*B M8@BVO](KA$5%!U7^A_!^)YJ151]4^RWJ?I94:&;.7X-J3KI(GB?9GIW8JC8V M0M"7YPGT:9/H2>0:#N%?&B.S/+V^!H<.1C;'K>4(DUM#-';\.MB'Y&C]N>K6 MT3X^F(D]4QH`B-12NRZ])Q?86NGF?VG2Q1ZF&P(0L&`%!X<1*%%'66$PJ#C6 M((&$+)7X6GJ?M#XHFHAK@+XDN]U0+!1T3#UDZV",4`X.U%WHO;`*C]MT<63U M4F@51\Z"6=TADG!!E]+^BD@"&TVE,R@\IV=E= M:-GCKK02=["R@^-W2$NSN1,.Z^S,8:$!G&4,M,$7(-V:0<1?>29#_>Z_EBH] MF8_T.^8IG6(MF=$D>N4#$$\*YW@E#B3@*T3WH:5::O-`_F4L@7-7T.NH15QP#P19YP7 MK/<5R_YU0Q3?LSF*Q!+\N7\>S38LQFBP&I.W#_-^-OV5WT<07/&E&*[:,O7^ M`#\#)=/Q`UX*I'8,('*2:I"-/I(V2&[1'\WDK-4.O60Q\MO0HI"/&3F\D!NX M$()+=*Y6[5&LY&BAL"&KF$@>QNN`&`G5%VF?HI@?E%-(\D'@/<%$4I!#M?'L MM'D5;0Q=YZ^0;([BA&%U.OX9BJVO!7]J9M!DD`LEJV(0HU".;MP6@M,J"$.X MZHP";I6"UKYB'6H$X<>VV8D:0?CPK;:A^6-BJK=9@4MS`T%`:.VV0\/PLO4E M6WJXW>S6`6[K)2!IASRP4,WE9O38ZN3!-!MN)SAYPU%OO7A7P@OX7PW[A'-" MH#E#"-%XO5A6>,4NQU?G[2GMHGJ]P>+L\]YV>-F>PTC769UY4I8/U]V'5=!3 MP$[7Z2Q/;KNI[:/9KG_NT6PW!-G58(->;P!!7[2T)#!6G9*X/J`5X#"*Q+43 M"&PXZ5$D%7+!DZ@R3!*75QE$JR^^:C\:_HK09I4EL$0203M5^EL8W'8%.2C< M=I`$?JZRDQ02KC)&7KTA#\%BA"IC&*:I&!]6&2*.$8'2J@Q0BA.K#%""%;^F M.ZE:JRL372U60'<$\(OP7I4EYL!VZT%("M8%4R`6VHHKCD,"V9986M;M;I52 M/NO]1F5/RG0``G]6P/,9=*_JJXKL,$TC&YCZX^3Y]) M8"7QCERJQE`:(/Y1R\J/,,:H$AMDWH-N1O:=/Q%_!O%T4:V]X_,;*P!(-+K2 MW@B51DP;]/PU:*N8__-@,I_B,?],)M%;F*-P,,J%%K@+181(UB<]V26^X]3X M7RA;/R/]BWDE_IC6B$<.LE$C6M"LV&#FOKFR6>_G8*`7G^;*-16_7P4Q*_VZ*417&\_9>D4K9'.TOPRV6D7\SXH5#7R[>G,E;F9P6[*ZE.*1 M+*L7^GWCS"F94^S/^LB;^* M)`AHURK6#5@&2NXHWD#N8WJ1,& MEWVJ$^8AW'I0E!C,WVGR1&N.%\#=>Y#[/-35'%$.$I=6NV<(IS6'J'=/52"; M6"!Y6*[#5ONB567V6\#P)LNB@=?%ZEY"^7K!+[F)K0 M.3'>*\>%WBNY$\V_J7J`GN_KPW4%."P?H'2=U2\Z/TF5"RJCA5"7&(VWIRTA M;D>(?8[J49^4BJ4:Y8L0OG(4(K">O*","908!6+=-&:.?4ZM)?&`DHLD;&:7 M6',TL_::_>1IM>5I(<*FR#$LM?D\+-;<:WEGL[7R9J&/ON7.BBU=P_*X37\3 MX01N9`0]A8I>_+DG5+RT>$2DRW1&^E*P/HR>M\@R],7E7TL%\CO=BW(3?1'Q M(+`\LB<7C"G:^X[C+DAVW,Q8+-(EW^"V!]G4N.K[!VE5&,QI_VA#&V\XM#&F MG+7B%^DC*+:*VK.#JXVF"CN_7ZW6__E_`@```/__`P!02P,$%``&``@````A M`+HR]AC)"P``(&T```T```!X;"]S='EL97,N>&ULW%W[;^+8%?Z]4O\'R]-6 MNU(3P)@`V9#50.)VI&FZVDG52MVJ,F`2;_R@QLPDN^K_WG.N7^=B;%]CPV6Z MT0Y@N.=\YSN/^_"U??/]J^LHGZU@8_O>1.U==E7%\A;^TO:>)NK?'HV+D:IL M0M-;FH[O61/US=JHW]_^]CEL%L^6:VXN M_;7EP3VHDX=I=B`AQS>!EN[Y8 M^.[:#.VY[=CA&Y.E*N[B^L.3YP?FW`&HKSW=7"2RV8><>-=>!/[&7X67(*[C MKU;VPLJC''?&'9!T>^-M7<,--\K"WWKA1-720TKTS8?E1+U2E=?_][7?__-%:_NNG;_+?_?2MVDG4$)G@@W*9E]U2L?!U M)+D36W![L_(]8D@?:$*VKE\\_XMGX'<0#&`>_NSV9O.+\METX$@/X2U\QP^4 M$+P,]K$CGNE:T2]FIF//`QM_MC)=VWF+#FMX@`5&_#O7!C?AP4ZDX;1ZYH@F ML6F$,#B;^GB$VN2"228>++?)_'F/39RN0;6N)OQQNI@5Y7:UIBL?%SD.F^A* M?47T!$_SB6H84$-ZW2[22AUV)&7C61?TG4S9U>!DEO6-OC%LU3(N%O-^0X5] MHTTJ*Q0:[X=W)Z.S?65%UL5E^%09@`G7+HLVI&Y)?@\-_#M%G)RX0VO58UQT M,,E`1^4^/WC MVQI&8AZ,SU%P)_I=Q:^?`O.MI['QB%B#C>_82T3Q-&/CO[C_G5W=&[-[II<@ M$T51(-0P9L,C"+V?CF?M(YV-QVT+U0SX:UGH^P'^M2S4@/]FK7$:5V"]+9"I M/"6T<;[6O1R.Q^-1[VHT&HWU?D_7&J;*\2!)*\2A!(\BJ;,G1: MJ/QQIL#JB>1<)0@D>94@D.358"C=JP2!)*\2!)*\RA:Z6LQ56)64G*L$ M@22O$@22O-K:X#.NP&/I7B4()'F5(#BU5Y-IU>S^WF#+'OF166OCXU@7#N+K MZV*S1IBGSOU@":>/DG,B/3PI$AV[O7&L50@STL!^>L;7T%_#OW,_#.%DR^W- MTC:??,]TX&TG:9&\EK2$TU%PYFFBAL_VX@64<2L=$3>1BF-I2*N>CK,)?:AW MA_I`NXHF;"VI=JVEO77SUJ6Z]\8ET(C<5AM../12)7$X9"MN'?1"[#[!%LS5 MS-."#2`FDI`0;-&&C=GJLZB-I(68C:2!H(VDA:B-D#K[DBMAR)F/PC2)L]G99,]C%:VJ6LKU)=<;DPU_&.CXSV65K3( MVUG18(^5%2U$;>3C)O$N)SQ=NL#RO`?)#M_<+S#]$9 M".%JQUN;4[-C23T]<<\%'>'" ML9\\UV)+9&HDYH?`#ZU%R#:%L.7R(CRP)OKU`OW`DS`?3?3# M$LQ>^X$7J?HAN(3UMQD/N/TE#FIP`0WJ,CQM(H")=H(`G"`#`6[7B3F`\)2! M`"8P"0((T`P!P"F)BB9YT"/5#&(@4PGZCZ42:DQB):?RB%86E5_07V*EP97? M1C23>@N!GM$,'TH`-%)95&)EE1CB=LBTC`+X4$*!`;UN.UU>KZCF2R.$%%W` MD#$"9:",D?:BDM1HP3TD`@R*J0)!HT62628I!5(S-7 M:+)*)($@JT)23\@JD12#K!I)7"&K1!((P(B4"DD](:M$4@RR:F3FBKZL$DD@ MR*J0Q!/](Y?(#ETVC191R?KIL'O0^JGRNJI<2.T539K`[TGS:/84S1S!%VPN M1:;2>(&4F:R=*L]^8/\"DTR\4&H!BZE6H.*%=:&]H$>^!.;ZT7J%J6AT!N9U M5;S6"TB2]8W=8.01%F+*],,*OJK44=XZ/PVP-">BTG(VJ:]`VT8>;5[MXIX/[N'+0,<'0NHQ;<-`5:\OFQ\>X/@5JC)X[>W>GU MN=-[9+PMT"M<'@M'QI5C,511=Y!1J*U!X..*Y7EU!3V8G)\7(IIMX#=N!:4L MV0K]U7A(<51$20*=-H8;<](\:2D$W'_'#_,4O(`/1['1I69EW?510SB/[.#1 M`U#6.'[KPSEJR:D/I_5DZ`FO)UA-'AH0G9/P*67'Z>[;C_#!V9(V]OX!>5CW)O?@WEHVJV MSY>W@^;^@B6:3%^*2_0)X+8:I"?`VY!>+H1/`+L=D]]#I%UZO08B@FK/X9D;V=7D%!YC!4 M%8R#(B1>+:@#JF(@SZ]@\YDHM*02!4$M1%R<`FEETV()B*H\QT,ZR(\'D,95 M]WR)*O/C01`%.\^BBEH!]RNIJ!56M$YZPXK*Y_I9QC%7(RMR7ZC^",8IJ&KO M%$!N:E1K7GEN2W*P*VP5GS'G`ZC"/7P=/)*S<%OO2='M[LH+6KQGZG%_*X;XK%-E+"UDER(3I_&7JZT5+! M.\'"W>N[OUO*`O61K#Y82V3!-?JU9<%F]5@6;EO/ M<.FP-:TN+F@2R^*Y'PARK^_S(TYS""XT6007E97Y$3,MLQ'N15M;5N9'02KF'+^K*ROS(UPE=L$Y0&S,_\MP/!+G? MK:A\Q&N"$1])R7P'[PA'..82X2B2DGF-C_*^8)1'4C)_\?&M"\9W)"7S%,@C M%NGPA;A%J8_Z/+NZ(+M3DU[&H#'((0@W"L M(F+0[-E:O"@SN'E,*HC/!^Q&103=OZX=TS-#/WA3\`J#5!SO](&@N#_Y?LH1 M+T&#CR*`_@S/^H''""G`2\00'\.X8[F.F#07>'IZ@AY+T$#K"`T??SC!JH,& M6D=B^***XR<1,1^\]3;U$%]+L>L6$?'1]EZL)1\Y/,,:@!21]&!MPP#N2A]; MQ*>4)DC,`]YR*)7!EXCHAOO)_9'B\><#W&$H48D[V4GNX!A:!/A?MR&A$5L1 M(9I@77JT0[A'6FP[G\,(2P3'HP]7_:0B=BJ*H(R_FX&'V<*E[DZ,%EB474,% MH__E:W;[*<9[B$_#8C>F2N<#0-326IE;)WQ,OYRHV?N_L+L/0C#%O_K!_NR' M3,1$S=Y_Q-LZ0A;#[!?*S<<-W"H07I5M8$_47^^GP_'=O:%=C+K3T87>MP87 MX\'T[F*@SZ9W=\:XJW5G_P7*\-%AU_#LJ0:/YF*/$(,5_YY^O7'@`5Y!;&P, M_E-V;**2#Q%\MK,;8,/^[L2(SB9]M-GM_P```/__`P!02P,$%``&``@````A M`/MBI6V4!@``IQL``!,```!X;"]T:&5M92]T:&5M93$N>&UL[%E/;]LV%+\/ MV'<@=&]M)[8;!W6*V+&;K4T;Q&Z''FF9EEA3HD#227T;VN.``<.Z89UC1"SF67"72(6=L#/F-^ M-"0/E(<8E@HFVE[5_+S*UM4*WDP7,;5B;6%=W_S2=>F"\73-\!3!*&=:Z]=; M5W9R^@;`U#*NU^MU>[66\/7.=K?;=/`&9/'-)7S_ M2JM9=_$&%#(:3Y?0VJ']?DH]ATPXVRV%;P!\HYK"%RB(ACRZ-(L)C]6J6(OP M?2[Z`-!`AA6-D9HG9()]B.(NCD:"8LT`;Q)__/QY.1`R:"'1BR^?_/;LR8NO/OW]N\*1R5D1SBB!4-?A.KL$S(P5SX15Q/*O!T0!A'O3&1LFS-;0'Z%IQ^`T.] M*G7['IM'+E(H.BVC>1-S7D3N\&DWQ%%2AAW0."QB/Y!3"%&,]KDJ@^]Q-T/T M._@!QRO=?9<2Q]VG%X([-'!$6@2(GIF)$E]>)]R)W\&<33`Q509*NE.I(QK_ M7=EF%.JVY?"N;+>];=C$RI)G]T2Q7H7[#Y;H'3R+]PEDQ?(6]:Y"OZO0WEM? MH5?E\L77Y44IABJM&Q+;:YO..UK9>$\H8P,U9^2F-+VWA`UHW(=!O-29#`P<7""P68,$5Q]1%0Y"G$#?7O,TD4"FI`.)$B[AO&B&2VEK//3^ MRIXV&_H<8BN'Q&J/C^WPNA[.CALY&2-58,ZT&:-U3>"LS-:OI$1!M]=A5M-" MG9E;S8AFBJ+#+5=9F]B(K5"MQ:FNP;<#N+DXKL MZBO89=Y[$R]E$;SP$E`[F8XL+B8GB]%1VVLUUAH>\G'2]B9P5(;'*`&O2]U, M8A;`?9.OA`W[4Y/99/G"FZU,,3<):G#[8>V^I+!3!Q(AU0Z6H0T-,Y6&`(LU M)RO_6@/,>E$*E%2CLTFQO@'!\*])`79T74LF$^*KHK,+(]IV]C4MI7RFB!B$ MXR,T8C-Q@,'].E1!GS&5<.-A*H)^@>LY;6TSY1;G-.F*EV(&9\F_W4`BA M;JI)6@8,[F3\N>]I!HT"W>04\\VI9/G>:W/@G^Y\;#*#4FX=-@U-9O]2!=(.SB"QLD. MVF#2I*QIT]9)6RW;K"^XT\WYGC"VENPL_CZGL?/FS&7GY.)%&CNUL&-K.[;2 MU.#9DRD*0Y/L(&,<8[Z4%3]F\=%];QRWE]CLW)\NXESZQG*B3CQER"Q8QE3KY6H;>7) MXO%0<$%V&?A^\6Y(4FM7%SWYG"6"2[Y7$Y!S=*!]SW-G[H#2>IDR<(#+;@FZ M7]GWWB+V/-M9+ZL%^LGH6;9^6_+(SQ\%2S^S@L)J0YXP`SO.GQ!]3'$()CN] MV0]5!KX**Z5[JN\S2]5Q94^#R2QTIQ[@UHY*]88U32[,IL\$\RZRK1%<0=2-ZH$W74,UK@E,'UAJ M?,%JM7W].5-U^`AC^/5S-WH`M!L_OA%JGPB-T*(^8HC$?:(ETK$S_1<["$.) MM:(/Y\:C-YJY:3$SP^$H$8T2\1#1\0>!7)\NA%GKAL:RQ=W[ON^?]/H=VS!CFK;PMTUA=-GN!IQDFGO M3;_:&!O-0!3-$ICI&R4B3035$L%!Y+J-A^H9\9!"QV7P/RYQDNG2\+#1S)#+ M42(:)>(AHN,3SK=V-H>SB/#8)M3,D+]1(AHEXB&BXP_;E=:[8-@?PF;^S$VH MF;:_J5%DVW$DTLBE3F$S]@JU`X2=2N[XFW?]7;<;<9+ITSA--III^S0J>3M* M1*-$/$1T?'IPQ%R?R(H>J]0+-&1Q'(G&D7@0Z;K$5__5Y0KM83^/9KU>H+;+ M7L%>&/UF\6YF@5'1T14BV*QB-'\2T1YU*ZH[M9R*`]W2+)-6PD_89D[AS&Y& MFQ;XWL<&QAC?>`MHJ_KC$;;,..XT$Z!C+83_)A0:-G<"\)YS55_@`YI_.^O?````__\#`%!+`P04 M``8`"````"$`0=1E'W<#``"["P``&````'AL+W=O3WK\>;6^)I MP_*$I3+G(7GEFMRM/GY8'J5ZTGO.C0<.N0[)WIABX?LZWO.,Z8$L>`YOME)E MS,"MVOFZ4)PEY:`L]8/A<.IG3.3$.BQ4'P^YW8J8/\CXD/'<6!/%4V:`7^]% MH4]N6=S'+F/JZ5#2U/B9?'BRRZ7BFU2F/<+';/XY%W>=.PS M$2NIY=8,P,ZWH-TYS_VY#TZK92)@!IAV3_%M2.[I(J(CXJ^698+^"'[4C6M/ M[^7QDQ+)5Y%SR#:LDV&;GSSEL>$)K!SQ<$4V4C[AT"_P:`A!="G`(/K?*31@^T*W+I@N/GI`HPO M9P72@=I[%(=D!NL6$@U+\[P:+OUG2'Y<*=96`;^U@K85T4F!ZP<,-0BDIC\( MBA$$EPO)UO9!,V[@Q.TJ1K6B!0)9:(+@?AG!5GT[,S@(=(UYCVMW2V@5XX9B MTE9$;RE:A)'R;#,4A@=G7*S)MQUU;19-LUE9$7<69O44&%=&?#,5MLMMV MW+55-,GF;47455PAF[Z'#,5M,NIN="N9E$4PII.QFS+[OHE^!0RJJ7_*4.R` M.?6UMI)F8.J60E=RA0T_G+T/!Q0[;.<*LS5@)2TVITRBKN0*V_P];"AVV,ZV MELU*6FQ.H41=R=FD5084SHO^B2O5#IVSG=:5IH7G5$MT07.-#P_AW@M+[9'= M/$*H4X?K2M/D"YR2B2YHKO'A8=V?SQ[M3;[`K0IJ-2T^MRPN:*[QX5'=X.OW MC8#6R-V%@5LAE:;)>68H-RIV6&@S+8\>2NEH/IU-SWO!;D3;&MDO?<;5CD<\ M3;47RP.V.A3&UD_KWJUJJNH7T`45;,>_,;43N?92OH6AP\$,SEQE^RA[8V11 M]A$;::#_*2_WT"1S^"X/!R#>2FE.-_C5K]ONU7\```#__P,`4$L#!!0`!@`( M````(0!=&!2`%P,``.((```9````>&PO=V]R:W-H965T[K=$(543U&W2)DW3+L\.F&`5,+*=IOWW^XP#Y;*U MZ8O!]O'Q^<[W8;.Y?:HKXY%P05F3(,>TD4&:C.6T.2;HU\_[FQ@90N(FQQ5K M2(*>B4"WVX\?-F?&'T1)B#2`H1$)*J5LUY8ELI+46)BL)0W,%(S76$*7'RW1 MGX=@AHXT"$O*>*$1G9 M24A6_]$8Y\*D.=P+AP?B+_.NZ<:!$[R'Q;^PP+-G"4W?#:+8>5N+I",CQXS:(@HWU M"(G)+IC=$N-,$?L>H;*@:%,]`.U`&]G#&@LB&,(`B\=A_#N[O5H%5FK[?79Z M8+R/.VS3*=DO$=%,?;J$O)!,M$(97*]5@:'F1A9X<3@5M],8R-Y@T\S[_9N( M]#7$1#UL<[UZ!4X0./.B+)JKUYBXJYK0CNQ@-5>O$="^L$P=2%]#3-3#1WN] M>@6>JG?\:+KS3F/"3KVW"EQW5A;[,<"-;?NE@'6-C^?].!X33)2'[U&NP%/E MGCOW76.T>:XRN&,=WHV7% M:,2X8KRY[Q.2./(\>S6D5LO7=XH^+6O"CV1/JDH8&3NI^\*%E`^CPU5VYZI3 M93:^<]9PML&X-4S`%=/B(_F&^9$VPJA(`92V&4$U<'U)Z8YD;7=&'YB$VZ5[ M+>%?@L#I:)L`+AB3?4=M,/R=;/\"``#__P,`4$L#!!0`!@`(````(0"R`J%B M0P0``#P.```9````>&PO=V]R:W-H965T?Q'`V325YF48#M?' MY_CZVC>++V]-;;RBCE2X79JNY9@&:DN\K]KCTOS[1_XY-@U"BW9?U+A%2_,= M$?/+ZK=/BRON7L@)(6H`0TN6YHG2YZIKU:\`7ZIT)7,OC?("=\_=I5 M^]^K%L%J0YY8!G88O[#0[WL&P6!;&YWS#/S9&7MT*"XU_0M?OZ'J>**0[A`< M,6/)_CU%I(05!1K+"QE3B6L0`'^-IF);`U:D>.//:[6GIZ7I1U8X%H[//2CA6M%4!@[1(*/![KYF$HHA;\^=1'(]Y[CS%/(+ZV_GP-6C?>^]Y@XF^(;UY,S9%/<2:`SNX'X"MZJ. MKX-D#3KU#YL@@9OJ#AXF8T&5'C"FZH5-T/_N6_T$``#_ M_P,`4$L#!!0`!@`(````(0`814XHL@(``%,'```9````>&PO=V]R:W-H965T MI(==S.%15"<9O%=M)WEE/HGE+ M+>1O&M&;%S;)YM!)JA]V_053L@>*K6B%?1Y(,9(LOZ\[I>FV!=]/44K9"_?P M>,Y(18%JO2@$.7-F1YE6!-U%^DV&R7@WU^2WXWDR> MD6G4_K,6Y5?1<2@V;)/;@*U2#PYZ7[H0+"9GJ^^&#?BN4.":F6D@`KD@*UQE0$/HTW/>BM$V!XS181F&6 M+(%ERXV]$XX2([8S5LD_'A0=J#Q)?""!^X$DN0P6RS")0/,_),0G-/B[I9:N M5UKM$?0,2)J>N@Z,`Q< M1TPT(@B(CLJ@-E_9@9VR*ZU+Y<8'IC+QZS+)>V0DTXP MBQ%Q9!`@\PTZ,'0%V)I(G];6@V9(0S_,EW;@07HLKH]$TV32,'S=Y>5[I!SX M6,I'TN'T3;L#FFSJP!VX)`/PVPWJ5AWS^T@TW=(T_$='NF$]^RPX\+&4CYQ; MR8YIA]D1+0(H\MMFW+IC!1\Y,7/:]WZ(^4,NN:[Y)]ZV!C&UP%BINX*FR8@2Z(0N95<7]/>OFXL%)=;QKN2M[J"@3V#IY?KS MI]5>FWO;`#B"#)TM:.-*9.TQ>T2LIC+:Z<@G2L9CH:\]+MF3(M%Z5 M$AWXLA,#54$W:7XUIVR]"O7Y(V%OC]Z);?3^JY'E=]D!%ANWR6_`5NM[#[TM M?0@7LU>K;\(&_#"DA(KO6O=3[[^!K!N'NSU%0]Y77CY=@Q584*1)LJEG$KK% M!'`D2OK.P(+PQ_#`U=WR],GI/L&E0TO;<&$3(^08]N*`9VCJ2?EG;"#I#&IOJ M?&D/#M)#<6,D/4UF-M3AQ.7L(U(>?"H5(Y-P_(Z[`YOLV$$X<3-L]_=:U*\[ M58B1]'13YR_,Q*,?3X8"4\,7:%M+A-[Y8YUAKP_1X<;99#[KE_%)O@EMRH8/ M>!/TO(8[;FK96=)"A92C9(Y>3+Q+XL3I/IS'K79X!837!J]\P'8?>>.5UNYY M@L)L^(FL_P$``/__`P!02P,$%``&``@````A`#BT"^]``P``GPH``!@```!X M;"]W;W)KX#BLB$?-BOW;__'ZXF;N.TK2(:28*MG9?F7)O-Y\_K8Y"/JF4,>T`0J'6 M;JIUN?1]%:4LI\H3)2O@GT3(G&KXE'M?E9+1V"S*,W\4!%,_I[QP+<)2#L$0 M2<(C=B^B0\X*;4$DRZB&^%7*2_6&ED=#X'(JGP[E323R$B!V/./ZU8"Z3AXM M'_>%D'27@>X7,J;1&[;YZ,'G/))"B41[`.?;0/N:%_["!Z3-*N:@`-/N2):L MW2U9WI&9ZV]6)D%_.3NJQF]'I>+X5?+X.R\89!OJA!78"?&$KH\QFF"QWUO] M8"KP4SHQ2^@AT[_$\1OC^U1#N2>@"(4MX]=[IB+(*,!XHPDB12*#`.#IY!Q; M`S)"7\S[R&.=KMW1U"/C8`K>SHXI_<`1T76B@](B_V=]2(5D,485!KPKC'#J M369!2"Z#^#8>(^^>:KI927%TH&>`4I44.Y`L`?BT'A""OEMT7KLSUX%8%13A M>1/.)RO_&1(753YWU@>>M0^I/7P@K9F!;3@S.B,S9A9#N;.&)LWH-$UX#0TZ MKUUXUL&'\VF-:YFMS[CA\YZ"ED!P&2X0G:$I0%:#^AW84ENG`=305,.IT=E0 MU\FU%M(.9E;GH:5R>@T5.K>IK&5L-E^S.Z#)F@KL?@N]&83V<8_BPC:%M9!V M5>>GU>"\'KP=T+E-92U]-8LV+*H)QQ>EX*HVOK5TI"Q.2R$PY(9K,=YMLLK4 M5T-PCS>R-+PX9F6'I1H8K?(L@C.:<-LWF#]N!6S@3@(KTPE-N*T;R$;3&&*[ M0&&G`>S;>O-@=8"U7:3%F2%(KAH2QKN3/CL3(+$00&MCXO'4530A`W:06=AA MJ29"NTAG)BZY:B08[P[;N:$`)WQ/$EE`E2\4J3\3#%*O2&&GZ^QUP)Z7.9-[ M]H5EF7(B<<"C?@0G8&VMKR%;TPI=^WBYM=<3O_X'K@\&P'UJ4YIC>"0TW`_,SA8L@@U,P\*`NB1#Z[0-[H+Y:;OX#``#__P,` M4$L#!!0`!@`(````(0#*&APXU0D``*8P```8````>&PO=V]R:W-H965T&ULK%M=;^.Z$7TOT/]@^/W&UJ>=(,E%XL6V%VB!HKB]]]FQE=A8 MVS(L9;/[[WN&(D7.#-=>N7W9;&:&P^$YY"%%*?>_?MOO1E^K4[.M#P_CY&8Z M'E6'5;W>'MX>QO_Y_?,O\_&H:9>']7)7'ZJ'\?>J&?_Z^->_W'_4IR_-IJK: M$3(3=#HM M)_OE]C#N,MR=?B9'_?JZ756?ZM7[OCJT79)3M5NVJ+_9;(^-R[9?_4RZ_?+T MY?WXRZK>'Y'B9;O;MM]-TO%HO[K[[>U0GY8O.XS[6Y(O5RZW^46EWV]7I[JI M7]L;I)MTA>HQWTYN)\CT>+_>8@0$^^A4O3Z,GY*[Q2P;3Q[O#4!_;*N/)OC_ MJ-G4'W\[;=?_V!XJH`V>B(&7NOY"H;^MR83&$]7ZLV'@7Z?1NGI=ON_:?]4LIQZ/5>]/6^S^[H,2FZI*D-@E^NB3)33HODJ*D M+&=:9K8E?MJ627&3I\5L;OK7+2==_0:.3\MV^7A_JC]&F&.HL#DN:<8F=\CF M<.@R],C\"!@@0DF>*,O#>#8>8AQ$UPC0),>2@GGGUM(M<)I>B]#"IC.628C`^9XHF/=D M+0#8,Y3+F=L'R6'2!B;7>YY>@3\EXH59"Q`."LO$].V#9&&WO+#SJ%`P[]Q: M`OQ#"\,_P5*5&,R@WH/7BDG$RW`F#D(N0/!1$H6$-##@YSP,)EH4T(DH)`2I MCC/I/81PH&DDGE%`-U^FS,W$@I)CY*`4$Z5Q0V@4@K"J& M!81":8$(31P(DJN?[\V*6]B;-?%564K>^R@U7.`4%D!,%*!R*!&41DP(:^)$ MS&1E?92J;)`P)EH9G:GL)\>"F3@1@\0QT>KH3)R(N1SN#_4QB0GD-4M"ZZ-) M#7(X$^*8M/!1BHE!$IEHC72F4!M^J)*I4,GS"]!$\XGG3(R)0IQX%CY*#I=. M07)))%51P#6QP#2-Y/DR[*F#@20BPOX*X% M,;.FL+?0Q'L;I'Z95C]K2LSL[AY9G(GC[4\JO``AB$0\[@5IGVXWV]67YYH, MT7NJ#)=VIL>G3.ND-;&ZNB@ZR".GO?(K_9&"U95'=#*LZ_?Z^*.ZL*^YPDP6 M/AFL*2R,F7@5@P0QUX)H3?2$X<(I%FBN7DO-W1>%EI!G8F1,9,'&A^EJANDEX762V<*R;!1QL3)("$+UN@% M,JSL!.!Q4<;$F1!J>8$)+8B%-0$[OW/-_$'!#K>/4L,5@FB6 MQ1778X45P1`(:^),^`.#+:V/4J4)];R`C5;(PIK"-1&:&!/E(#DTT7SB.1-G M0IXA?)0<;BD4TJR):UYIFD2B-JNGG`IYA'`-]1&B%.)YG@H3+0JPDAE0X:*T M/)6#Q-!$B]ZL\G$JY"G!-=3'N1(-E3Q=104E$K59$Z=";MNF`C2,4$'*]=/: M75*T*,":0BI"$U\5@]2PU&KH3)P*N6W[*+4JA$#2JKCBC5:IE=.9,':OG'.Y M9?LH59E0S@MK0NMC:4TA$:&)$R'$T*@#!C5PPRRU2CH38V@N]W(?)7&8">&D MRJZ[2C:9^&1U)DZ2W,U]E"I.B.IYDF;ZV.E,`4G,Q$B:#9))$RV&:V42+`5S M4N[FKN&MNK[$MVY,'/X'+JR$!ONY26XT*2Q.[N<^JN>B^WRN^UYL7YW>JD6U MVS6C5?U.G\:!O,?[WMQ]M_=%QXQ1>3+WZ:#TE&B#S2M6&]I@5XEY>$A[SNEMY9O"8 MPZ3T%&B#TV:D@@)M<%B,>8`UCF\Q#[#&(2KB*8$UCC(Q#[#&02+B*=`&#X@Q M#]I`U&,>8(VGII@'6..A)^8!UGCTB'F`-1X9(IX<;7`)%/.@#>Y68AY@C=N2 MF`=8XPXBY@'6N%6(>8`U'M8CG@PCQ4N!F`=5XP(_YD'5N#Z/>5`UKKIC'E2- MF^J()T<%N'V+>%*TP8N\F`S!"\ MSXEX4K3I7HW+59*B3?>5D?)@I'B#'-(FV2-`"GYQ%6B1` M&I^'Q3Q`&E]GQ3Q`.HDBG0#I[BY>X(FON9_BN=`@U@?1'+/3@HK8G_*[I^YK M<='Q,ZE#I,$S6(R2"`ZC%(+!*('@S]`WZ3O&5^+'Y5OUS^7I;7MH1KOJ%5OE MU+R$.77?F7>_M/:EQTO=XOMP\_YC@[\'J/#IZ)2NGU_KNG6_@(5)_Q<&C_\% M``#__P,`4$L#!!0`!@`(````(0!U0A"D70@``*$F```8````>&PO=V]R:W-H M965T&ULG%K;;N,V$'TOT'\P].Y8)'4-XBQ6(K8MT`)%TWJOCU_JU+)L9 M6-C72^^U:0[WBT6]>BUW17U7'']8;8&#"/CN6STOOL[C70>@M'A_:`/V[*=]KY^]9_5J] M_W+> MBN["V%<"X+.GLFZ^;(Q);[9ZJYMJ]Q^"A'&J,R*M$7BU1H2\V8BR1N"U-R*3 M4(31#:X$U@J\GJQ$=X$,XV0"H04&IXVU+IKB\>%8O<^@@(%^?2A,.XA[L'P* M,H:D"_NEJ$.DC)'/QLK2B[T9!+2&4OGVJ'S_8?$-TKNRF&R($121GQ`F`<:L MQ@_@=V[I/AA^X]Y',M2$B9M[K(:0W0GR% M,G!]-2%7T!WC/IN+`.>$0OG,@PPQD,4N7"&C<16AQQ"$!=S&93'NO0$O/8A0 MYYD0,?4M0TS25L]<"!5%@628G&"2"'Y"1E$3B/*3P`^=0!$*,`9<"M,282[B MB>@3W=9MAACPI*/+O,RO(O08@K"(/L+"7$03HGS%$H*8J$U(&*2IX"00X-)4 M?7MB![LV(@4C+^IN0DC`Z+@]%>8B3B+H[&,J$(,D$A')B#5-[@*".%$AI^`" M9!Q&@>A-$`YFX<%&Z?6^-A=Q#BS.&6*00Y#Z?/+D[O?*R)MB?:-=1!"GPE?] M/0B'E'(8[VH#YK[W^<7X(V:L1O+K$(T0C$"*]@#'JIF#<_1;-_6>1 MRRQHE(#%H'LPD2)>0@00R,A/+X1?&,5S:N@*`=1'=ZS"P&,-T)I<>K9Z?#_M MJ[?-4$X`(DP$LZ`)(%8J2+M;T.@;!9SN/.HE=;ZWC-4C$#0>_>L8;>W8(,@X MZCE2"D;^IE-`L204!,M])H:*RJ=D/@&C+08IR%CVC4890*QN8,V<\6:3 M@"`W"7WYVAJZ"M%B#$(I&.F;G@042IH$+LCFN0%X!KBX2'WV?6Z_Q^`*F*!= MA;?\-+O>6710SXW<3?<)+P<: M3"%2Q8["VAHB1F`S(7:,T"08N9M.`,61$N#+(.$JJ(!%!&68D^_GD92*I5$S MA`J=24>\ES>)<(OF$XBU7V9!;@DQ2'X=HD4&7)5'EB.E!XX7?W%*8&#YVM:2,,/8BE++\. MT:,0FA&XTPT9,6B>D3Y(-B,(LAF!*`Y6>)(@4I7&C*.F"!&&X:45JMFPNH'` M.7'F&M>:/*U0Y_"$%J5L^.04(M)$)2P,FD(B%2>7]$'>I-(MFN5`LO&969#- M@4P3F?0M:9O"5?*Y3*'>&4M-K<0I='\/H67$9'IB1Z#*DHZ0['$@DT,I9M62 M7X?H40BEPM1Z(I4SJBW9C,DD@J#Z^PG`,I=/P&B+P>S&@5F&=?))N3#AGLCE MC(#+/O&VRQ$TSL45^;DXLUS4DD#"6%[D8K8NIC=ZB^9=PEH@LZ!1#A,PVF)L M/LBBF*1#?4C&VZLX%=8"F06A"Y$?^^[`Q(8G$&AFF&JL0#6!P)HQ!0GL@T:Y MW"3EZHR4.T^,6%(6A!Q$0N)H*:`91,A@\/2AB8DP2ET$=9])^/C&AD+IAKOW MC(:H0R8>$^;3^J,B$LFOYD%(9-8)E#+?1AM-:$= M"XE#Z(E!0[@0V">#_[@Z*T?*A:GX1"ZHPK2RF*.9HE(=)W&0L`&0$XP$)DG* MDJL))`AA:SGLQ99R^9"<*U1JPH4_^V<69(.N8MCZ[7>.;%[0#D)$$HF0!41; M(Q?ZB%+YD)RK,W*N^F"U?F86A'[R>%HJ:`]ZV[AAC5E0>,LT-`81EL[6'@R2/OQ2!D80;VYI`)S%<\'JY?, M@L:\S"=@M,78+DM4<$D.`R;IT]JCO8IS83V:6=`X%]1V&W%0"F=1WN966RN( MH(MAFA2XSP>28J[B1)@$9`&"QHE7L!7AY`VYX(D@/*6R*X\O95YNM_5L5;V9TSX2]O"[3[N3 M2)^E.YUET7\`!H4/Q4OY1'%\V^WJV+9_!I'\7@U-'/&*$;YKJ MT)Z->:H:.!K4_OD*1\%*.)7BWP'XN:J:TQNX\:([7/;X/P```/__`P!02P,$ M%``&``@````A`(0#%ZM"#@``?F4``!@```!X;"]W;W)K4@EZ$.0`/J`$$E1W__WU]OKTI^#\60X>M^H-9;KM:7!^\/H MS"I_>_'?__S_?=H_,?D93"8+H4: MWB<;M9?I]&-]967R\#)XZT^61Q^#]Q!Y&HW?^M/PW_'SRN1C/.@_SC9Z>UUI MUNN=E;?^\+V6U;`^7J2.T=/3\&&P.7KX]39XGV:5C`>O_6DX_LG+\&-2U/;V ML$AU;_WQ'[\^OCV,WCY"%3^'K\/IW[-*:TMO#^M[S^^C*[CVF16'C M%;/U]FP$3L=+CX.G_J_7Z?GH]^Y@^/PR#C14L]QL MIS4]C%[#`82_E]Z&:6J$'NG_M5'KA!T/'ZCM)H,:>559)=V\DD8KUM+H+3=6ZYU_4$EC-:^E'7;V[X^EW2RJ M"?\HJFDO-WOM1ON?'$X[M&76,[W/1BW>-2M9-\]&;;,_[?_X/A[]7@HJA+9- M/OJI6(WUM.9BO++>C2/XU0"&D4MKD;2:C5KH]S`VDY!U?_YHMCK?5_X,F?*0 M,^HQW2J3%$R:&&G%FUBPA07;6+"#!;M8L(<%^UE!^#L>?F>M>F0'%FFV>E7F MT#*-*G%DB68+]G2<,=6^A'XZ*9BBGTZQX,SN"9MT;A'3I`O+0),N+6&:=.4Q MT*1KR\">;BQA]G1K&:CE+B.JW0M#<%\P1?=*3/!8LD@ZB\EG,0DM)J,E3^EP M$#$=FZOU:B9)GN95"-HJ>>I7(,PWR76H0*M84Z[(W&Z37)+N;#*>S0NY$J62 M7(%J19`+$AV(W6TR7DS*2Y[SI9WE*5XJR1.Z5)(G<*DD3]=229Z>J52F*JQ5:8Q%*36!H3J]A*31:IR2(U6:1F8E0S,ZJ9&M7,C1I'/AZ/-Q=B M?FH<^5(2MV"<-29#K-N,O)J15S/RZLQV9FI09[[#*5&=^<[,B1HSIMPTF$+4 M))'&&2XV-B;1O(I,7FF>5V5A05?-$ZV,F`Y)8NY][A[J24PR)C$9/S>R-9O\ M3/+\+!_0Y[Y6PF(DKDC",JFR(O%7CL7"(Z73A4?LTZR@O)_F:K,Z=R8>LUIE M-CVF766V/`96/=L>`QKLY$Q]MG!:;:PV84>[7B60<'L>`SO:=Y@VG%@./.9S MJ&:KLD/+=`$YL@BVZCA'OFSVB5/'*C3[U&.@V6<.@\T^]QAHTX5EL-F7%L%F M7WE(JYI9UPY3)6X<`K+FUD&JE=PY!%1RSQ&1!1CU&%@_BR=F!_)3/#,[,%+B MJ=F&3A;/S0[,%5+(65Z,=;`F3U#H2/$$-16YAE8'35Q#@7$,Q3R40M$O_1,T MM&X&PU.T`U.@>(YVP%'Q).U@@GB6XCE<'$V;JS"]BR=J%U/-4Q6-%\_5-N9C MH6O6UZVU]AK,8U+8^O5H%+9^37BRHAKJV=J%9-5"UR_WI:ZK,*CJN=J%057/ MU2YTCWJN]F"\U'45:_)35L[6'D*YRF(*>,KBR5<]97&&4$]9S%O/6&0\87':UT+8L_%X*LOY<$VQLIQ/ M+S!VPF7E^`Q,?KL+,'L+,/L+ M,`<+,(<+,$<+,,<.TX9)YF0!YG0!YFP!YGP!YF(!YG(!YLIC8!:^7H"Y68"Y M78"Y6X"Y]QB8RD46@=2#X!PLGJIMA#Q7#>3):B#/5@-YNAK(\]5`GK`&\HPU MD*=L!U))/&<-Y$G;@;.,>-8:R-/60)ZW!O+$-9!GKH$\=0WDN6L@3UX#>?8: MR-/70)Z_79@GQ1.X"R<_\0SN0JJH9W`7/JZI9W`7Y@+U##:09["!/(,-Y!EL M(,]@`WD&&\@SV$">P0;R##:09W`/LD`]@WN0!>H9;"#/8`-Y!AO(,[@'LXIZ M!O09;"#/X!ZFKV=P#]9FZAG<@[.4>@:OX2=%S^`U_!#H&8Q0XAF\ M!JF2>`8;R#-X#?(I\0PVD&?PVN?44_DX$!ZJJ'PDB)E_$)(R8 MC)&8,G/Z3&(:S8-B:I4A;$A,MWE03,$RA/T6T[(,X>Y,JHK)53')*B9;Q:2K MF'P5D[!B,E9,RDK,V3BR,4-C2C`CB<-)>TJ(<(0[)UPZX=8)UTZX=Y*+-R<9)3=O'I*[-P_)W9N'Y/K-0W(! MYR&Y@/,0;J!P!84[*%Q"X18*UU"XA\)%%&ZB$R)G-EK"R]PW>._L72.]T* ME]ZP4M2,Z64+VGB??#8HR9S89CD&%_FVRC&XE+B=Q=:R_6U]@ZMZ.UEXSDEQ MEQ)[E-BGQ`$E#BEQ1(GCC,@[8QDN\IZ4HW6,GI:CK>5L`3];Q:=_M;:^P:"< ME7E3VWDUB@]=74"XFB>7U2@TXZH:K<-Q75?#30C?5,,-2*?;:AB?RKNKAO$Q MR_MJ.'P+K_(']B52Q?&A(\E=RH8S?(FPVDN2ZU2$6UA]KE01KV,\URK&L?Z* M6O5ELWWN5K$]5I^+%<,8S[6*<;C;(+E411P_XTNN5!%OP'T/R84JXG""D-RF M(ES'>,6ET'J,@TTF7O')V1[\,=N#028."IDX2&3BJ!&V#SPRVX-()@XFM>`" MC(!*.$-(Q:7NKUKYB/-;7+//`HJX=$JN&3BZ!+TEJ)+&$>7,`XNF?V# M3"8.,IDXR&3B(!,,EH)+9O.*3,WEU59EN&!B45`+G[A34`LF!LW-\@<:M,(G MP16TPK13T`H/':R".4=!*E-[+M6-\'F,I*)1>'7"9^LKJ]?PC4N*>$"$>4(UP[X=X)%T^X><+5$^Z>8MO2FQ28HL2VY38H<0N)?8HL4^)`TH<4N*($L>4.*'$*27.*'%.B0M* M7%+BBA+7E+BAQ"TE[BAQ3PD1CBA'$HYP[X2+)]P\X>H)=T^X?,+M$ZZ?G-*ZXX3J\9LR\%34.*/$.24N*'%) MB2M*7%/BAA*WE+BCQ#TE1#C"K9.$U\*]$RZ>'R";=/N'["_1,N MH'`#A2LHW$'A$@JW4+B&PCT4+J)P$X6K*-Q%X3(*MU&YC@VPCX17&Z^D[BIU($B+A-<0V$C8)7PBUY=I8#R^_MN7'C77W>.]" M/>$-RG8#"36E;W5W(OLA$EZ,'2(KL5_"KU]\])\'1_WQ\_!]LO0Z>`J=6E_N MAF^7C;/?S\C^,QU]S'ZNX>=H&G[W8O;/E_`[)X/P%H3ZM2ZM;09*#HPNU M!]@%%HN]?/8X3F),'`>V9S+GWV]11/D__^VNCI<7SR\W/S[??'_\ M+BC"C^>/E]]>7GZ^O[Y^OOUV]W#S M_.[QY]T/.O+E\>GAYH7^\^GK]?//I[N;S_-)#]^OR]VNN7ZXN?]QR1'>/^7$ M>/SRY?[V;GB\_>/A[L<+!WFZ^W[S0N5__G;_\WF)]G";$^[AYNGW/WY>W3X^ M_*00O]U_OW_YYQST\N+A]OT_OOYX?+KY[3O=]U]%?7.[Q)[_(PK_<'_[]/C\ M^.7E'86[YH+&]]Q>M]<4Z=.'S_=T!Q[[Q=/=EX^7?R_>3\6^OKS^]&$F]+_W M=[^>-_]^\?SM\=?T=/_YW^]_W!%N>E#^$?SV^/B[E_[CL_^_Z.3KZ&PW/X+_ M?+KX?/?EYH_O+__U^.O?[NZ_?GNAY[VG6_)W]O[S/X>[YUM"2F'>E7L?Z?;Q M.Q6`_KQXN/>Y04AN_IK__G7_^>7;Q\NJ>;<_[*J"Y!>_W3V_N'L?\O+B]H_G ME\>'_V-1$4)QD#($H;]#D*)X5]2[Y@TQJA"#_@XQROJM,>H0@_Y>;J9^=RAV M;77(OQE2SD3H[R7(VXDT(0C]O02A0F7B/(23Z>_EY.P27//SG=-EN'FY^?3A MZ?'7!55">H+//V]\E2[>4V"?)Q5E6SI/*$'\.7_W)\VGDOJ9LOO/3^WNP_6? ME(^W0=(E)(64]`E)*25#0E))R9B0U%+B$I*]E$P)2;-*KHG5"HR2>0M,!^7% M'R_ISU=0AS7LS+)C"67!*JF`96]+!ELRVA)G2R95(D!1CD#'Z8_3^;D:$NL.!;3" MPW)422I;XD0AZK8\OC;3HHR:=%LRVA*G MEV-2(PA2;4S*KG[^)"0%]:=C36B)=H?C'AK]G@4J*ULRVA)GE6128PA:!;5, MF%@9_M.?A;P@=;HY],?+T%XEFJL@X/9J#XW9L!Y5VJL,C1/%*-H6+S3I020M M;U.A&F;08G-+SFWMSHL=-)M=P:)M]@#0/D@8Z-S^1\S,(*-]'6=+)E4BD7G# M"LCL^EBPS97(T+D'44BPRG>)TD?U0<$9UC0`=%@/OSX8;-W&#(V#@A3'"JXT MZ5$D,&]>WPZ,+:\$!GU:5VB^>.Z]^R!AIDV3ZAGM**,M<;9D4B62&54;9&9W MCX4_"ULQ:-2[(&(@5;NO&TC#/BBV-1>S:,C0C!D:9Y9FTJ-(:M[2OCW3V`B+ M3"N@XG5^JHO0Z[>8T8<9Y1ETF-(8M[?OIT8NV))##U^ MH5GGT):Q)/0/$=3!#C':$F=+)E4B@7F?"\`R#`:[8PD,C7ZQ==B'E!U;/+:O M*,4!NK`AG*^EX)BA<:(<31L-.28]B,3EC>[;<;$]EKC0[1>QAP8B?9!P?A&P MF.E@1QEMB;,EDRH1S,JS'/]\%O25!0#I@B@`B7'T0<#=`HXUA_5HLBGF!BQ# MXT0QVA8S>=)C2%AG&?XR8?@+-/Q!M*U/P+,/DJ4!BX$.=I#1ECA;,JD2B8SJ MU;9.ZG.II5=C7H'#ZH*(.5RUQ^J(LTY]D&QI1B8L0S-F:%R&9@J:=)$E+_#[ M!J^$ST=/TY4L"O6PJLH:.H->**I]":YW",^" M*,Q$5!$QV[L/:PBM>[3CN#6.]WD-%F5:#R14@OOH:6IB[$";G>TJL\.<4TZ1>2N,XR]V7"W)!2!+:$3Y:C:ML71_Z1?2?#RU6_;1^:M)YG/@KZR!,_0!9&68T%R M&NE@!QEMB;,EDRJ1R!(>WY[6J1(>O\2>,HB8!RW!HW]D\]$'Q=*,R:/#>E1) ML0R-$^6@=R#4CLDK37H4R0L,?MZBB2IA]'$$V`61FF(K MA-\O8;:^"Z(%2-U`3]H'P18JYL>0H1DS-,XJS*0'DOT+/'T2<8K.YD!UA'P3<\N.RAV$] MFGSP/$+*T#A1C-3Z"CV(I'66VZ\2;K^"-JH+(C7#.`X#3:ZOL(.,ML39DDF5 M"&1UPO#;[G4^"_K*"@U_$"WM?L*]!L7B+63^#>M1)<,R-$Z4(V5>]2`2UUEF MOTZ8_0K-?A!I&18DIXD.=I#1ECA;,JD2B>PLOU\G_#XNB^F":.%QW-4E&+8^ M2)84`V\RK(>U'..B;!\,=D`N*DE5P%SQI%]*(DOX_8Q*F?#[.#W7U;$7QYXR M2!2J@QUEM"7.EDRJ1#*CYX.F/X.9/PL;,LBAKF;1`B35D+%BR3)LR):C6I+9 M&B?*D6S(U"`25\+O9^!*^/T*ZE3GPQ!3*LNZ7C%*,9:<)CK8049;XFS)I$HD MLK/L?IVP^Q6T#5T0,8^4W0^")<%P0+D>?D6.3=28H7&B'"F[KP>1N,ZR^W7" M[N/4:1=$:H;9=M^.,MH29TLF52*9G67WZX3=K]'N!Y&28ASE9(HMA[44LS5. ME".98FH0B>LLOU\G_'Z-?C^(U!3;^OWTB-*.,MH29TLF52*8[1.&WYZTF,^" M?A)7!71!M&G594?8!P&G&,[>#NM1)<,R-$X4([%^1X\A827L?@:LA-VOT>[O M6:0E6)`PS]0OM@8[R&A+G"V95(E$EK#[&<@2=K\&U]#M672Z"0N"4TW8>EA+ ML`RS+\J1:L+T"TE<":N?@2MA]6NJ6UM%T$;UB"R(F4AZ.+5#M@V!+-6Z]5./-,_H9<9Q5F$D/(IF= MY?#W"8>/+S"Z(`I9E)C4"8*3;H(OHB$=UQ"O#P^Q.U&.I)M0+R1P^73"%+/= MQ'P6F/L]CA^#:'N[6"^#A(FF!T1VE-&6.%LRJ1+)["R/WR0\_AX:[2Z(&$BU M/Q302O5!P"EVA$H[K$=/9\^8H7%0C`;7&4UZ$$G+^V-HQ#(RC%VU:,3V`*-K M6*1F&$L8Z)&^'A%]=\$.,MH29TLF52*1G67QFX3%W^,@,HA.MV%!<*H-6P]K M&18/(Z(V3)0CU8;I%Y*X*`'.R#!_%K9AT$!U#8O4#&.)VH:944;[0LZ63*I$ M,@./G[=`K$EX_3V.(H-H"T1:K3XH.,=HFD(>'M;#6H[9@P4G"N*G=>!"DWXA MR0L,O<@6M[;0>3480L`X)KV_#FL^"?K)! MKQ]$6GX%">=78KYLL&.,ML39DDF52&()I^_'"7J-/"2<_F8^9$Z=+H@81]'. MC;I,H#Y(N`EK&W"_PWHX^>1Y])VA<5B2>E=!%S7I820R;[C![F<@8YM.?[[. M6>`-=P<6J4G&$J;:TF=GHVG9P8XRVA)G2R95(IDE_'Y&Q4SX_0:ZG^[`(@8R M?S$`DVPQZ[YUP9490SA]BQS[P#%#XV0Q:GHRLAB3'D32HM)@AF70\F=A,P;= M5W=@T?9V0=('"0/UG23.^P]VD-&6.%LRJ1*)+.'V,Y`EW'X#_4_G/ZA,7$,[ MYB?%P#;T01%&E-!S#.O1UYH?9QA?8_M84.-$.6BI$\Z-3/J%)*Z$V<_`E3#[ M^.VF[F";_2`)1.DW[$7$S`PRVM=QMF12)1)9PNO;LSR'A-=OX.U"%T2!1VK= M>5!PAE68@,-Z6$NQ#+,O"U*T]$T;;,74*!)8PNQG`$N8_09F`;N#Z=/[(`FM MV%QKX5X&.\IH2YPMF52)9)9P^QG,$F[_`'?;'5BD-6.+G?<=93QI$0)H;=28 MH7&B(*E)"SV(X'5,&'Z;UWP6])0':(*Z(-K>+O:40<)(TY,6=I31ECA;,JD2 MR>PLRW],6/X#>)PNB$*.T5M(Z$O[(-A"Q7YNR-",&1IG%6;2@TAFWG5O/+\^ M/#JR1Z<_7[U^M&`@B)C555$?6_JJN6QM^Z#1$[^E[(6GV.,P;PG$=UC)>>'UZF*-.7J4-V>36V7C@J.K)H>Z-1Z\423D#/BC[:#15ZL,.,ML39 MDDF52%AG.?UCPNGC5\RZ(&(B=6*/@2`(1A]JZ[`>/9TX8X;&R6+0P@6XT*0' MD;3.,OK'A-''U4Q=$*DIQG%"?Y`8.@UVD-&6.%LRJ1*)+&'T[?F=8\+H'V"6 MJ0LBYG$LH\\G]T$0$@QJ[+`>U1),->CSG)G#8N`\^*1?2-)*N/P,6@F7CXUY M=[1=?I"$!)M_8"J[T,$.,MH29TLF52*1)4Q^!K*4R<>!T7%K\F<@;<)MX]K5;L@"BW_L=D!U#X(=&895C\CCK,*,^E!)#/P M^9Y91MU,^7TPGUV[]?M5@8OY^W!<1V:;^3$CCC/*,NDQ)#$J\-;M9Q+S9V%K M!F..KF419UE-20;]0Q\$.C(.HFG&C#C.*LRD!Y',$J8_(\L2IO^((Z6610H1DS-,XJS*0'D[UO;[0<(X/:O$ MG(4=9K0ESI9,JD3"`L=OP$HX?7Q47;MU^E?E,7XK&11:W@P9FC%#X\S23'H4 M08N6R9_30_)IV$5"BG>+BE/HL#LV+7[8J)>:LMBEC#\4A-BQ:IM2T.`1.];P#1&[ MDE8,0B#B9P8B?*:&Z)D:HJ=I`%YB`)`#+S4"`.M%\%C%8(I=8K*"X"T.?WX% MAVM(B-MR_/30F\#9(B(G2U.W!UP:0^340(#NK'%`L4L,!'"^D]#%+C[..]:$ MO$LNC,J(0_3,:Q$\4T/P-`VPHPJ%(P)[K%[L_&G0WK4PKB1VK&(NE=_L'-^* M4-JQ)DP*X0>2*.V6XVK:V2(BAZ6I<21,Y-1`@"XQ,,A!EQ@9M#C^I#H:M?)Q MVFV'#[090U6@!R1\9AQ*.U-#\$P-P=,TP`X&"'D#4=IG,9%V.!)=5$LWX.?^ MI=FDK%M&`;ZQPQ\-$+7EL)ITMHBXL2BTO+1T"C_30=C4.,`-A@FYW!+C!5Q, M3]4U=O)QSK&&[X=^0D=;"DJV!,\,0REG:@B=J2%VF@;0P:@A%UUB^-`"%D+' MJI!R_MZZ7`'(4%W=#C>JA'&882CE30^A,#;'3-!+=O!?M9NE&)KJPA2TY MH!4*+3B0U8QVF-VZ]SWMAY=HYM;-<'W.';#&#TN,+?YX++$&>2T.BFB365F: M?5OB/C*TR^P;QA+SEK1GH&/#+=%!"T7H-%L^#WQH=U[6<(TF=(D?MRZ:+3[( M7MJ@U[P6P3,U!$_30-IY[WP&.[;\F^79YD6SO!\)0OFF^GY=]9&@HW[0X@,Y[YC/0L=66 MZ*+Q@]@RM_#?_Y25F<`MECWMY=;#R228B1"U)<9I$>4;B_@)%54;6SD]#%#S M;OD,:FRR)35\EU6HV^(N#1Q'XMM)6SD[#*'37/^2<*:&$D[3`#KOF`%=QO1< MV/U6HH,*1'Y$./8R>G6Z"+:U<-.JS'=,78-JZI>LLT64=7IY")P:!O/NMF^G%S;%E?3`3'2%V%JWHE$K=+W]HM`33]^!-R1>AL@MEPOM0UR@:5&< M*!"P\Y89V&74V;`YKF07C2&"BHM:'BM:\H"]1&*7W3CS,D1CD2$B>#Q".%TB MHA*@)X]-"W\(RN(FRCNX5&77N4(&JN,K+-%!,X6$3I;1.A8%!Y!5')@YTWT)O$L=NRYM^Q*_$DL)1RKN`3- ML6H*7&5(Y+8:>O.)'XVA9-LJ$IE$S+:*$\FVE90-_2"5QESR61.QK>BJ:.M# MO3N\JH"8]]AO(,:67!*+AE]AWUTFYFD4-"<,G0@Q$_8^K2)NK*(L6!L%L)!$ MSM10LID:(J=I@)MWSV_@QF9[RZV(EI848H?>JZJE57&Q*8EM.S9_!,T6$35; M1-A8%*I?JDB$30T$W+QYWG#SL\(9ACCLLKOE%\VQ4DW=6G=:0X6_DZ2<4[W[ MTJ_:(J)GBXB>42!BIX8!=MXZ`[L<2\>.6[*#VDCLMM:]HK?#^#-`@J=:]P6> M+2)XMHC@624B>FH<2<]/+IU!;SX-+!U^.[,K@HJK2:)U[Q?%\JI?-MK#Z^'7 M9@ZK]9@C:UH4VR9URJB%CMR:-N)V];8 M4]\634@1.S,,H3,U1,[4$#M-`^CH[L]).'\:)AQ@(72LXJ=\3&<<2T+&8=8 MPW#I30#]\^J?0CMGQZ&D,Z]%[$P-P=,TP,[;96"7,:T>-N>5[*)11%`M31&SXNR\.NSVN/:&$6RR[?QE18KM#W);CK]P2*6>+B!R+..5\:2H< MTA`Y-1"@\Z[Y#'1LM@6Z,IHD47?UG2L:H=M:>T)7[O$SV(0OMO9QVID:@F=J M")ZF`7;>-0.[G%:.S;9D!U6->HC%DL_K1O"7J\1M.7XZI0B<+:(*:XL(W2)* M%H>P+<>3Q0%NWB^?P8UMMN06C?K#1K]<06AJ(GYSN&X%/-\*)!(Q4]W\TCW8 M(F+&(BY*V=(W,",/K(:1U.8]>=].+6SE*ZE!G]C1&U9Z)/(7#5#8?M'P[PS#AM^ MHA:[>12-.2+B)LM"R_KA$1$V]6+`C6[]'&[^-!@[8.X3-U8IN4(IQYI-98;[ M(7AF&&)G:@B=J2%VF@;0>;-\1LJQQZ;KK`:KQ!ER0L2UBIH8!:-XMGP'-GX;Y%@T;PE[!>KYQ)`:;7/QE M1Z%TXRC*E0B;-\!CGVV#+=HK&#?VE&?)F*_ZDA5$*JIXM7]^D6 MK;RCA%N.OZ9U(N%L$7';EH4V#<.R$#4U#&#S3OD,;&RP);9HX)#8&3CN4[=V M?O[T)]X0P8OM/,2AE#,UA,[4$#Q-`^R\43Z#'?MKP0YS@5HX5G'*T2B:UI6` M9Z&D6YSZG'38TQ&WY;B:=+:(R&%IJA)*0^340(#.F^4ST+''ENBB@4/83EAI M?0@=1V*\]!/-?>)G2W8<2KO8]4-J$CQ30_`T#;#SEAG89;RZ"=L!2W;1X"&H MF,OA6$>_D2=TJF4/TW(9(H)G1R)Z+#I=(H*GQI'TYIU^@5[&3$G8(%C2@RK0 MT1H2>C1+/T$OQIH=F.5^D6R3$RO_D",:KZ[ M,5[PAZV"!;UX14EB0V%$0_Q4]QZR+XCXKE.O\(G>=J"0<)"$SKX2P5-%`(_N M?PO/@N;ETM0E5I2(C8>O:)*\:>H2K!]1XU@GGO%"S181-UM$Z&P1H6-1>$A1 MR8&=-]&;Q+/8L>>F*[R.(O#=`5575ATO??])BR/*%K^T3>2V&OH!3`W6CRHK M*S2VA,T6$;;MM?S*Y++""D#8MJ(KFORL:<3]V@<"-BK56[!YN4RYLH+^C+"Q MBA\<(:F.S0$G_@E?+W[CYNGK_<_GB^^WWVA\NW>^7[VZ?ZK7RW!__'R^//C);4!OSV^O#P^ MS/_Z[>[F\]V3%Y#XR^/CR_(?UY\^7/]Z?/I]OL:G_Q<```#__P,`4$L#!!0` M!@`(````(0`R$V>T1P,``-X*```9````>&PO=V]R:W-H965T5<$%9,T>!ZR.'-!G+:;.:H]^_GN_&R!$2 M-SFN6$/FZ)T(=+_X^&&V8?Q%E(1(!Q@:,4>EE.W4\T16DAH+E[6D@7\*QFLL MX9*O/-%R@G,=5%=>Z/N)5V/:(,,PY==PL**@&7EBV;HFC30DG%18@GY1TE;L MV.KL&KH:\Y=U>Y>QN@6*):VH?->DR*FSZ==5PSA>5N#[+8APMN/6%P?T-[(TJV M^6 M1,AGJBB1DZV%9/5?`PJ4*$L2;DG@F M!G**%JL9#*;`O'-F=%BOIZR"/$7RH%CF*$4.N!#0G]=%G$0S[Q5JFFTQCP8# M[Q836(0':JPDD-&5=+S(N\P*K#*K2BDIC^:';IKP>)I1/XUR/H+).)].!0&N M8V(4^9;?*#"8J(.)+:)G%"!=HTI!='*J=H95T!R!2UO&.-GS&P4&$^E&!-'H M>';(-,Q^V;\*&F9/++_);C`F>[@O3L]ZTD]^ON@*/$R:#I(:S%A;#F,?7A;0 M2PPS>KMK%304,+;\QK7!7-%U]5`8W'&7ZZZ"^G,7)Y.!`H.Y0L&DK^!\\16X M[WV4[&]IG3$_4/X!:[W;Z.ZJN(TZ&*+:@GPY:H-P2!VD4W]T!'76K" M%G2-B)OV7&#V6O>^/^S#%M1+GIY8?\%@_YV?`HT>-F"_6,P8;$&]]"<:`)C_ M:("*NM@``[I&Q&`#7JC`X>H[TH#=[NMLYW3_(#1#:(X9YBE<$[XBGTA5"2=C M:W6$"&"%V5_M\>8AU`<4^P><+EJ\(M\Q7]%&.!4I(-1W4\C/S?G$7$C6ZF?\ MDDDX5^BO)9PC"3PI?1?`!6-R=Z%.0/9DNO@'``#__P,`4$L#!!0`!@`(```` M(0!G+?E*U@(``"<(```9````>&PO=V]R:W-H965TO^ZL51MK0-J>U;'F& MG[G&-YN/']8'J1YTQ;E!P-#J#%?&="DAFE6\H3J0'6_A2R%50PV\JI+H3G&: MNT5-3>(P7)"&BA9[AE1-X9!%(1B_DVS?\-9X$L5K:B!_78E.O[`U;`I=0]7# MOKMBLNF`8B=J89X=*48-2[^6K51T5X/OIRBA[(7;O9S1-X(IJ65A`J`C/M%S MS]?DF@#39IT+<&#+CA0O,KR-TMLHPF2S=@7Z(_A!#YZ1KN3ALQ+Y-]%RJ#;L MD]V!G90/%OHUMR%83,Y6W[L=^*%0S@NZK\U/>?C"15D9V.XY.++&TOSYCFL& M%06:()Y;)B9K2`"NJ!&V-:`B],G=#R(W58;C6;":SY/%:@DT.Z[-O;"<&+&] M-K+YZU'.4L\2'UG@?F29+8+Y,IQ%(/H&"?$9.8-WU-#-6LD#@JX!2=U1VX-1 M"L27'8$5B]U:<(:7&$&N&K;A<9.$LS5YA-*Q(^;68^#:8Z(>04"T5P:UZ